covid<NUMBER> pandemic radically changed world knew dramatically impacting worlds health finances social interactions surgical world operating rooms come full circle shut reallocated intensive care units icus peak covid crisis periodic use curve flattening ramping progress path toward new normal terror fizzling crisis feels less forceful aweinspiring individual team efforts extraordinary motivation determination carried us fear uncertainty still present clear regional element covid<NUMBER> pandemic parts world regions large nations united states substantially affected others result cardiothoracic surgery recovery covid<NUMBER> different strategies guidelines light regional variations time pause come terms fact previously experienced normal gone future brings new normal next reactivation phase cardiothoracic surgery opportunity improve upon ability care patients examine adjust recalibrate new baselineone hope may ultimately superior remarkable reference point left behind <NUMBER> wood da mahmud e thourani vh et al safe reintroduction cardiovascular services covid<NUMBER> pandemic guidance north american society leadership j coll cardiol <NUMBER> <NUMBER> considerations barriers recovery phase surgical services reintroduction cardiovascular services must aim maximize benefits population large prioritizing procedures impact terms lives saved healthrelated quality life preserved improved procedures less impact andor benefit fewer people systematic approach applied weighs risk treatment delay risk worsening covid<NUMBER> spread sufficient resources including staff testing equipment personal protective equipment ppe must considered may remain barrier institutions finally reintroduction procedures implemented equity across patient populations regardless ethnicity ability pay factors mind two barriers deserve emphasis include trust patient community medical profession healthcare equity regional aspect covid<NUMBER> result strategies time lines differ city city state state country country depending number patients affected resource availability recommendations hospital leadership government officials variability strategies time lines thoughtfully appropriately planned may perceived patient community chaos confusion within medical community may result lack trust confidence medical profession could lead desire avoid surgery invasive procedures fear becoming infected inpatient reactivation phase protection patients hcws must prioritized systematized screening retesting plan patients hcws must place continuously reexamined modified new data testing resources become available health check hcws hospital entrance temperature symptoms visitor restrictions place specific protocols visitors remain particularly difficult pediatric population almost exclusively depend parent guardian psychosocial support hospitalization guidelines institutionspecific undoubtedly continue change consideration must made patient regarding adequate psychosocial support minimizing exposure time institutions allow one visitor per patient cases one visitor time ability alternate two designated guardians covid screening visitor depends resource availability symptoms management covidpositive parents handled casespecific basis remodeling patient pathways waiting rooms ongoing strategies minimize contact patients hcws utilizing telemedicine cumulative number facetoface contacts perioperative phase employed consolidation multiple tests procedures shortest time interval goal however must done manner minimizes depersonalization avoids imparting fear patients families choice polymerase chain reaction pcr nasal swabs saliva rapid serum antibody tests may vary institution institution guided hospital infectious disease experts coordinated regional health officials present pcr typically required day morning surgery appropriate ppe essential protect hcws even asymptomatic patients may range n<NUMBER> masks routinely operating room team members limiting use anesthesia team members unless covid positivity established need protect staff must balanced need conserve ppe supplies event resurgence rules regulations certainly key continuing practices helped curtail covid<NUMBER> pandemic fostering culture practices may feel burdensome times embraced cannot underestimated gawande writes people tend focus two desires safety freedom keep safe leave alone times need community worry safety others <NUMBER> congenital heart surgery programs accustomed necessity case selection prioritization within confines given programs resources whether urgent emergent case bumps elective case selecting cases based limited bed availability children relatively spared covids clinical impact disease far limited effect course children congenital heart disease <NUMBER> case prioritization drastically changed congenital heart programs covid severe restriction resources restrictions due two causes resources redirected care adult patients covid staffing strategies decrease exposure risk covid spread setting limited resources proper prioritization surgical cases essential cardiac surgery inherent immutable risks substantial potential benefits indications surgery symptomatic improvement prevention premature death nature truly elective cardiac surgeries may suitable delay surgery cases eventually operations become necessary delay could risk patients quality life survival recent article published jointly several cardiothoracic surgery journals promoted websites european congenital heart surgeons association echsa world society pediatric congenital heart surgery wspchs congenital heart surgeons society chss identified multiple factors must taken account order prioritize cases including <NUMBER> resource utilization anticipated ventilator duration icu stay blood product usage supplies may become limited <NUMBER> clinical status patient risk delaying surgery <NUMBER> risk exposure patient family health care staff <NUMBER> comorbidities complexity procedure implications usage hospital resources <NUMBER> teaching hospitals training may curtailed experienced surgeons used liberally <NUMBER> safety patients social clinical situation surgery delayed table publication included table <NUMBER> may help guide us begin recovery phase pediatric heart surgery <NUMBER> patients require surgery test positive covid yet display antibodies decisionmaking around timing surgery becomes even difficult ideally surgery wait serology testing demonstrates antibodies least symptoms present resolve always possible furthermore remains unclear degree antibodies provide immunity patient must considered individually considering risks waiting current albeit continuously changing knowledge regarding risks proceeding surgery based covid testing results presence symptoms expanding precovid<NUMBER> pandemic levels congenital heart surgery volume might logically achieved one following occurred development vaccine effective treatment reliable rapid widely available testing staff patients decreased infection rate community low level meantime mitigation efforts social distancing physical barrier creation frequent hand washing surface cleaning masking preoperative patient testing need continue setting reactivation terms case selection pool cases expand emergent urgent highpriority elective operations increasing surgical volume social distancing primary mitigation strategy requires limiting persontoperson exposure remain challenge health care environment hospitals designed maximize occupancy provide social distancing provide volume service honoring social distancing institutions may need consider addition routine weekend surgery andor increasing operating room utilization adding evening shifts pandemic evolves work strategies change aim strike riskbenefit balance healthcare providers patients short achieving goals would permit precovid<NUMBER> level social interaction continue require altered work schedules necessarily limit ability care patients depend even careful individual assessment patient risk prioritization table <NUMBER> doubt reliance telemedicine reactivation even postcovid integral part health care including care patients congenital heart disease decrease exposure risk critical covid pandemic provides convenience patients minimizes geographical limitations remain important benefit postcovid setting decreased resources covid telemedicine important facet triaging surgical patients play essential role manner moving forward challenges remain however regarding telemedicine including understanding limitations optimizing role must decipher patients cannot adequately assessed using telemedicine would benefit inperson visit despite slightly increased risk patient providers need determine telemedicine technology providers patients skills using telemedicine improved allow effective communication optimized patient experience must guard implementation telemedicine reinforcing propagating health care disparity whether access resources digital literacy payment structure credentialing must examined altered support effective telemedicine challenges answered time since clear many aspects telemedicine stay <NUMBER> <NUMBER> hollander je carr bg virtually perfect telemedicine covid<NUMBER> n engl j med <NUMBER> ohannessian r duong ta odone global telemedicine implementation integration within health systems fight covid<NUMBER> pandemic call action jmir public health surveill <NUMBER>e<NUMBER> many institutions peak covid<NUMBER> pandemic care model drastically dynamically changed staff resources flexed provide needed care even institutions severely impacted strategies employed decrease exposure preserve workforce reactivation redeployment staff clinical areas longer occur key principles still remain relevant particularly given risk resurgence many alternate models provided opportunity critically reevaluate workflow efficiency reduced redundancy careful thoughtful planning regarding optimal use staff continue essential duplicate work andor increase unnecessary exposure block schedules considered help preserve workforce selective application applied hospitals move <NUMBER>day work week decrease population density various areas hospital example parking offices labdiagnostic testing pharmacy certain elements patient care likely remain virtual computergenerated visits triage patients preand postoperative visits many nonclinical support staff may continue work remotely foreseeable future indefinitely sustained surveillance symptoms appropriate ppe testing remain important constant emphasis physical distancing essential reactivation intense collaboration medical surgical specialties required face many challenges pandemic united front thus far strengthen preexisting strong bonds members care team moving forward <NUMBER> <NUMBER> stephens trainees specialties require clinical experience part education core component training surgery handson involving real patients operating room specialties simulation remote learning tools may compensate diminished inperson clinical experience case learning congenital cardiac surgery question becomes optimize training experience minimizing risk trainee staff patient additionally trainees role staffing model clinical service needs considered institution evaluate staffing model educational needs trainee example case log date identify need experience certain procedure deficiencies case logs coordinated operations performed setting pandemic contrast trainee adequate experience shown competence specific operation consideration given whether additional exposure trainee patient necessary important regard service staffing duplicative efforts trainees avoided one resident plays primary role inpatient needs rounding rotation schedules planned objective decreasing hcwpatient exposure role physician extenders help cover patient care needs essential optimize trainees focus educational opportunities ensuring adequate coverage service needs institutions must provide adequate ppe well training proper use reallocation trainees departments done carefully trainees skill set matches patient needs optimization webbased learning simulation supplement replace handson training specialty finally american board thoracic surgery accreditation council graduate medical education consider educational experience case logs individual trainees period flexibility regard case requirements considered major deficiencies likely result need additional training optimize ensure competence certification <NUMBER> specialty congenital heart surgery small relative remainder cardiothoracic field professional organizations play increasingly important role providing sense community necessary among colleagues sharing information ideas support especially times crisis connectivity provided professional organizations example chss society thoracic surgeons american association thoracic surgery european congenital heart surgeons association world society pediatric congenital heart surgery essential organizations provide us ongoing uptodate information impact covid<NUMBER> specialty guidance best care patients advocacy make sure voices heard social distancing mandated pandemic however greatly impacted cases halted normal interactions organizations annual meetings educational opportunities potential undermine sense community involvement incumbent professional organizations adapt rapid changes world experienced increased dependence electronic opportunities face time peers addition dramatic essential increase email online communication value seeing one another interacting via live video webinars meetings conference calls ever pivotal maintaining community network undoubtedly role virtual meetings optimizing delivery become integral specialty least shortterm potentially play role longerterm even restrictions lifted properly orchestrated meetings allow even increased worldwide participation collaboration help specialty organizations quickly adapted ongoing development new normal need critically evaluate interact organizations going forward important members understand constraints faced organizations impacted crisis including financial challenges major shifts staffing models everchanging restrictions face uncertain future corollary necessity organizations strong presence membership reassurance despite challenges working hard continue support mission membership travel restrictions remain indeterminate time limiting ability profession meet collectively essential collaboration innovation education research advocacy organizations need determine rapidly implement strategies maintain professional connectivity assure membership despite restrictions remain stalwart leaders profession wood da mahmud e thourani vh et al safe reintroduction cardiovascular services covid<NUMBER> pandemic guidance north american society leadership j coll cardiol <NUMBER> <NUMBER> institutional resource strategies place event resurgence key consideration reactivation phase significant risk resurgence institutions must vigilant commit constant surveillance indications covid<NUMBER> resurgence localregional area within institution institution make clear staff community reopening activities possibility resurgence would require reinstituting restriction measures preparations include strategies fluidly progress one stage reopening another back need case volume prioritization may need fluctuate depending local incidence covid<NUMBER> resurgence models optimizing staff operating room icu may also need change depending local occurrence resurgence screening protocols evolve based hospital protocols government guidance shortage ppe experienced many institutions peak pandemic prompt programs examine prior data regarding ppe requirements plan sufficient inventory accordingly institutions consider covid pathways noncovid pathways allow noncovid patients receive treatment despite resurgence new normal changing target requires constant readiness adaptability <NUMBER> wood da mahmud e thourani vh et al safe reintroduction cardiovascular services covid<NUMBER> pandemic guidance north american society leadership j coll cardiol <NUMBER> <NUMBER> contingency plans resurgence involve hospital include collaboration local regional hospitals particularly hospitals may normally viewed competitors program beyond programmatic institutional considerations imperative congenital heart surgery programs continue safeguard ability fulfill collective responsibility fundamental public health resource median number surgeons programs united states three many locales number one two beyond operating room icu critical multidisciplinary team members may also staffing models limited redundancy thus neighboring programs programs regional overlap encouraged maintain contingency plans assisting one another capacity challenges arise even programs considered competitors normal circumstances provision made temporary emergency privileging frequent transparent conversation regarding emerging personnel supply shortages crucial <NUMBER> <NUMBER> stephens <NUMBER> approaches implemented address maintain physician health care workers wellness minimize posttraumatic stress disorder one dangers traumatic worldchanging events like <NUMBER>and covid<NUMBER> crisisis trigger sudden intense feelings helplessness hopelessness although physical safety physician hcws focus essential managing evolving pandemic psychological emotional spiritual wellbeing also key functioning adverse conditions include unprecedented ethical moral dilemmas inevitably result degree burnout mental healthrelated problems mental health collateral damage covid<NUMBER> even cited second expected pandemic <NUMBER> maintaining healthy eating sleeping exercise habits along adopting novel stressrelieving activities important ever stanford medicines chief wellness officer tait shanafelt md stated recycling wellness offerings past retooled versions approaches current needs need approach situation fresh eyes ask people need develop response based needs theyve expressed effectively compassionately communicate <NUMBER> ensuring adequate appropriate mental health care needed may help physicians hcws develop improved emotional cognitive resilience withstand impact traumatic events cardiothoracic surgeons natural leaders respective teams examplesetters others many staff working home battling challenges homeschool children provide childcare also working without normal workhome boundaries work support system others face furlough associated financial strain along physical isolation sincere gratitude leaders coworkers powerful source support listening colleagues specifically asking concerns needs important steps although physically distant intellectually socially connected essential overall resilience fortitude weekly leadership town halls conference calls large interactive webinars andor smaller scale virtual meetings allow teams stay informed enable relay evolving needs concerns us relay incorporation nonworkrelated joyful experiences balance professional personal life also desired helpful abigail adams wrote son john quincy adams still calm life repose pacific station great characters formed rather habits vigorous mind formed contending difficulties great necessities call great virtues <NUMBER> importance leadership compassion support turbulent time underestimated <NUMBER> <NUMBER> <NUMBER> shanafelt ripp j trockel understanding addressing sources anxiety among healthcare professionals covid<NUMBER> pandemic jama published online april <NUMBER> <NUMBER> pmid <NUMBER> goodwin covid<NUMBER> highly transmissible disease infects populations exposed exists significant variability virus clinically manifests within specific host age affected individual recognized significant factor clinical presentation impact infected children covid<NUMBER> virulent respiratory syndrome commonly seen adults although respiratory symptoms along fever sore throat common presentations instead seem less frequent even rare severe systemic inflammatory response occur weeks following initial exposure children present rash hands feet diarrhea vomiting hypotension multiple groups developed evaluation protocols classification schemes assessing disease severity pediatric population unlike adults mortality pediatric population extremely low majority patients hospitalized significant comorbidities one theory postulated proven immaturity childs immune system allows active resistance new organism since exposure new adults innate immature immune ability several theories advanced increased exposure future trials help us better understand differences two populations clinicians also aware increased incidence kawasakilike disease post covid exposure reported children clinical significance remains defined <NUMBER> several countries china asian countries experienced sides curve returning health care systems full capacity united states countries peak curve recent learn successes mistakes countries experienced many publicly shared published observations strategies get back online recent submission lancet consortium <NUMBER> major heart centers china analyzed experience increasing care centers first started increase care testing covid<NUMBER> insufficient therefore <NUMBER> centers required <NUMBER>day quarantine made providing care need cumbersome increased risk exposure reported cases since initial experience testing programs became universal mandatory covid<NUMBER> testing individuals presented health care system <NUMBER>day quarantine period abandoned rapid return outpatient clinic inpatient procedural capacity reported centers chinas numbers covid<NUMBER> cases facilities remained near zero experience centers reinforces key tenet testing reactivation services <NUMBER> shi g huang j xiao huang g st louis j impact covid<NUMBER> outbreak congenital heart surgery program children congenital heart surgery observations study china lancet <NUMBER> press doubt postcovid world including congenital heart surgery specialty never covid presents tremendous opportunity emerge pandemic stronger resilient cohesive poised provide superior care patients learn effectively utilize telemedicine effectively compassionately care convenient fashion adept evaluating prioritizing problems patients result pandemic cardiothoracic surgery cardiologymedical communities come even closer together many professional organizations strengthened connections advocacy arm governing organizations support needs medical community shined darkest hours covid applied emerge improved online medical education touches broadest audiencephysicians advanced practice providers nurses hcws around world perhaps importantly covid tested physical emotional resilience fortitude external world seen experienced human side medical community cardiothoracic surgery specifically specialty impressive congenital heart surgeons carry broad set skill sets deployed areas hospital provide help dearth heart surgery cardiothoracic surgery stage every day harder act better performance grit professionalism empathetic side cardiothoracic surgeon projected outside world way instills confidence hope unity reminder us went gratifying specialty first place authors declared potential conflicts interest respect research authorship andor publication article introducción objetivos la organización mundial de la salud calificó la enfermedad de coronavirus covid<NUMBER> como una pandemia global está claro si el tratamiento previo con inhibidores de la enzima de conversión de la angiotensina ieca antagonistas de los receptores de angiotensina ara tiene un impacto en el pronóstico de los pacientes infectados con covid<NUMBER> el objetivo fue evaluar la implicación clínica del tratamiento previo con iecaara en el pronóstico de la covid<NUMBER> métodos estudio observacional retrospectivo unicéntrico de cohortes basado en todos los habitantes del área de salud el análisis de los resultados principales mortalidad insuficiencia cardiaca hospitalización ingreso en la unidad de cuidados intensivos uci eventos cardiovasculares agudos mayores un compuesto de mortalidad e insuficiencia cardiaca se ajustó mediante modelos de regresión logística multivariada modelos de coincidencia de puntaje de propensión conclusiones el tratamiento previo con iecaara en pacientes con covid<NUMBER> tuvo efecto sobre la mortalidad la aparición de insuficiencia cardíaca ni en la necesidad de hospitalización ni ingreso en uci la supresión de iecaara en pacientes con covid<NUMBER> estaría justificada en ningún caso de acuerdo las recomendaciones actuales de las sociedades científicas las agencias gubernamentales palabras clave antagonistas del receptor de la angiotensina inhibidores de la enzima de conversión de la angiotensina covid<NUMBER> <NUMBER> april <NUMBER> <NUMBER> disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> known covid<NUMBER> coronavirus disease <NUMBER> spread <NUMBER> countries infecting <NUMBER> million people designated global pandemic world health organization <NUMBER> although infection cause severe disease anyone one largest analyses conducted date <NUMBER> reported severe outcomes intensive care unit icu admission mechanical ventilation death patients hypertension coronary artery disease diabetes interaction sarscov<NUMBER> reninangiotensinaldosterone system cornerstone covid infection virus links membranebound angiotensinconverting enzyme <NUMBER> ace<NUMBER> internalized cells transmembrane proteases <NUMBER> <NUMBER> angiotensin upregulates metalloprotease adam<NUMBER> increases solubility ace<NUMBER> form valid sarscov<NUMBER> binding <NUMBER> also releases proinflammatory cytokines downregulate ace<NUMBER> cell surface expression reducing ability sarscov<NUMBER> cause damage <NUMBER> given possible increased susceptibility patients taking acei covid<NUMBER> pandemic proposed discontinue medication <NUMBER> moment impact angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arb clinical course covid controversial <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current study performed scientific societies government agencies recommending continuing treatment due lack evidence hypothesis <NUMBER> <NUMBER> lack evidence field available data based observational studies conducted china none based whole population little information virus affects western population performed singlecenter retrospective observational cohort study university hospital covering city metropolitan area whose population confined study period state j u r n l p r e p r f alarm beginning <NUMBER> march <NUMBER> included cases laboratoryconfirmed sarscov<NUMBER> infection area according interim guidance world health organization <NUMBER> independently outcome diagnosis covid<NUMBER> based nasopharyngeal swab real timepolymerase chain reaction high sensitivity virus detection however sensitivity decrease patients viral load low deficiencies sample collection could affect sample size probably results since distribution homogeneous population study complied edicts <NUMBER> declaration helsinki approved galician medication research ethics committee standardized forms used set database including demographic information epidemiological data tests performed drugs received hospital admission discharge according physician criteria relevant clinical information clinical information collected electronic medical records providing access entire clinical history primary hospital care well electronic prescriptions confirm treatment adherence work conducted properly typify clinical implications previous chronic treatment aceiarb prognosis covid main outcome impact previous chronic treatment acei arb prognosis evaluated mortality heart failure need hospitalization intensive care unit icu stay major adverse cardiovascular events composite death heart failure heart failure defined following current guidelines <NUMBER> based clinical analytical radiological data also studied whether reninangiotensinaldosterone system inhibition maintained <NUMBER> year could change results comparison patients treated treated aceiarb continuous variables expressed mean ± standard deviation compared student ttest discrete variables expressed percentages assessed chisquare fishers exact test necessary logistic regression models performed explain independent association aceiarb treatment hospital admission icu admission mortality heart failure multivariate adjustment variables showing significant association p <NUMBER> events univariate analyses included see tables <NUMBER> <NUMBER> supplementary data selection selected multivariate models good discrimination cstatistic <NUMBER> total population <NUMBER> hospitalized patients good calibration p value hosmerlemsehow test <NUMBER> total population <NUMBER> hospitalized patients results expressed odds ratios <NUMBER> confidence intervals <NUMBER>ci hypothesis tests null hypothesis rejected type error alpha error <NUMBER> due substantial differences baseline characteristics patients receiving receiving aceiarb analysis complemented propensity score matching analysis patients matched according aceiarb therapy based propensity scores applied greedy <NUMBER> matching algorithm without replacement caliper <NUMBER> propensity scores estimated using nonparsimonious multivariable logistic regression model aceiarb therapy dependent variables characteristics differed p <NUMBER> patients treated treated aceiarb table <NUMBER> covariates propensity score matching performed patients repeated patients hospital admissions propensity score matching <NUMBER> paired patients identified balanced baseline characteristics significant differences according aceiarb therapy standard deviation <NUMBER> variables propensity scorematched population outcomes compared using stratified logistic regression model similar analyses repeated hospitalized patients using logistic regression propensity score matching <NUMBER> paired patients statistical analysis performed spss <NUMBER> covid patients <NUMBER> <NUMBER> acei arb treatment time diagnosis <NUMBER> <NUMBER> taking <NUMBER> year age sex distribution population covid involvement summarized table <NUMBER> table <NUMBER> summarizes baseline characteristics covid patients provides comparison cohort aceiarb treatment receiving treatment cohort patients aceiarb older <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> cardiovascular risk factors hypertension diabetes smoking dyslipidemia cardiovascular comorbidities coronary artery diseases ventricular dysfunction cohort without aceiarb fewer women aceiarb group <NUMBER> vs <NUMBER> p <NUMBER> renal impairment peripheral vasculopathy also prevalent patients taking aceiarb admission patients previous treatment aceiarb lower oxygenation peripheral <NUMBER> saturation <NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> respiratory insufficiency <NUMBER> vs <NUMBER> p <NUMBER> higher creatinine troponin levels figures <NUMBER> figure <NUMBER> show events covid patients admitted figure <NUMBER> shows hospital admissions according type treatment table <NUMBER> shows univariate analysis treatment aceiarb combined individually significantly increased risk hospitalization association disappeared multivariate analysis logistic regression performed model created propensity score matching adjust potential risk arguments hospitalized patients aceiarb showed frequent need icu admissions previous treatment aceiarb combined individually showed impact mortality heart failure either multivariate analysis propensity scoreadjusted model taking treatment <NUMBER> year also effect table <NUMBER> analyzed subgroup patients requiring hospitalization absence impact mortality heart failure remained multivariate analysis propensity score model including evaluation treatment taken <NUMBER> year table <NUMBER> lack effect remained applied models combined endpoint mortality heart failure table <NUMBER> knowledge one studies analyzes impact aceiarb covid<NUMBER> prognosis based large westernworld population includes positive cases health area also largest cohort patients studied date main findings neutral effect aceiarb mortality heart failure combination mortality heart failure previous treatment aceiarb patients covid<NUMBER> showed association need hospitalization icu admission taking aceiarb <NUMBER> year also effect findings confirmed overall analysis sample propensity score model based data withdrawal chronic treatment aceiarb patients ace<NUMBER> <NUMBER> soluble formnot valid sarscov<NUMBER> binding cleavage adam<NUMBER> angiotensin upregulates adam<NUMBER> thus increasing soluble ace<NUMBER> levels <NUMBER> furthermore adam<NUMBER> also mediates release membranebound precursors proinflammatory cytokines tumor necrosis factorα interferonγ interleukin<NUMBER> circulation interaction sarscov<NUMBER> ace<NUMBER> triggers massive production proinflammatory cytokines attracts leucocytes hyperactive macrophages release cytokines inducing obliteration alveoli developing characteristic hyaline membranes acute respiratory distress syndrome <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore downregulation ace<NUMBER> cell surface expression reduces ability arscov<NUMBER> cause damage <NUMBER> ace inhibitors arb highly recommended drugs patients cardiovascular diseases refractory hypertension heart failure coronary artery disease <NUMBER> <NUMBER> chronic treatment medications increases expression ace <NUMBER> based mechanism authors hypothesized persistent downregulation j u r n l p r e p r f reninangiotensinaldosterone system may cause harm increasing ace<NUMBER> expression <NUMBER> <NUMBER> hand angiotensin ii takes part immune response acute respiratory distress syndrome depuration though ace<NUMBER> may beneficial <NUMBER> <NUMBER> <NUMBER> study performed scientific societies government agencies recommending continuing treatment <NUMBER> <NUMBER> advice supported results study upgrading expertconsensus recommendation evidencebased one according registry cases covid<NUMBER> infection western health area ongoing randomized clinical trial losartan patients help us make stronger recommendation nct<NUMBER> nct<NUMBER> <NUMBER> obtain overall picture relevance results highlight area study conducted <NUMBER> <NUMBER> <NUMBER> inhabitants chronic treatment acei arb covid patients <NUMBER> <NUMBER> acei arb time diagnosis according latest estimates likely end year <NUMBER> spanish population infected new coronavirus <NUMBER> hence importance identifying effects widely used drugs prognosis new disease observational nature unmeasured confounders could constrained causal inference present study false negatives polymerase chain reaction test could affected sample size underestimating number individuals infected virus withdrawal chronic treatment aceiarb patients testing positive covid<NUMBER> would justified line recommendations scientific societies government agencies study supports continuation treatment authors declare conflict interest regarding publication article unclear whether previous treatment acei arb affects prognosis covid<NUMBER> patients chronic treatment medications increases ace expression based mechanism hypothesis postulating persistent downregulation reninangiotensinaldosterone system may harmful increases ace<NUMBER> expression data suggest chronic administration acei arb safe covid<NUMBER> patients therefore withdrawal recommended hemoglobin gdl <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> leukocytes x <NUMBER>µl <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> lymphocytes x <NUMBER>µl <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> platelets j u r n l p r e p r f sarscov<NUMBER> virus newly discovered member coronavirus family first described end <NUMBER> wuhan china third severe respiratory syndrome caused coronavirus <NUMBER> due easy spread via droplets direct contact quickly spread globally leading world health organization declare public health emergency <NUMBER> countries around world taking measures aimed preventing spread coronavirus main mechanism fighting disease <NUMBER> measures significant impact peoples lives many countries imposed travel restrictions <NUMBER> <NUMBER> leaving millions people change travel plans psychological economic impact mandatory isolation following possible exposure virus another matter concern <NUMBER> <NUMBER> <NUMBER> clinically disease presents incubation period <NUMBER> <NUMBER> days <NUMBER> cdc reports common symptoms fever cough shortness breath dyspnea chest pain confusion cyanosis represent alarm symptoms prompt people seek medical attention <NUMBER> largest metaanalysis available time writing article reports fever cough presenting symptoms <NUMBER> <NUMBER> patients respectively <NUMBER> fatigue gastrointestinal symptoms also frequently reported <NUMBER> hypertension diabetes mellitus commonly reported comorbidities <NUMBER> <NUMBER> <NUMBER> older individuals comorbidities likely develop endorgan damage requiring icu admission <NUMBER> acute respiratory distress syndrome ards acute kidney injury aki cardiac injury reported severe cases ards common <NUMBER> leukopenia less commonly eosinopenia typical laboratory findings bilateral groundglass patchy opacities lungs common radiologic abnormalities <NUMBER> <NUMBER> <NUMBER> creactive protein ddimer procalcitonin levels elevated especially cases severe disease <NUMBER> time writing clear guidelines treating sarscov<NUMBER> infections published clinicians seem treating manner similar seasonal flu purpose article look impact sarscov<NUMBER> infection hypertensive patients considering extremely high prevalence hypertension society fact hypertension among frequent comorbidities patients severe cases sarscov<NUMBER> infections believe important look deeply relationship two conditions angiotensin converting enzyme ace enzyme essential component human metabolism dysregulation associated number different clinical conditions including hypertension many studies done assess potential role ace ards development multiple animal models shown protective effect ace ii ards development <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> similarly sarscov uses ace ii receptor invade alveolar epithelium considered potential target future anticovid<NUMBER> therapies <NUMBER> <NUMBER> cardiovascular pathology ace inhibitorsangiotensin receptor ar blockers lead increased ace ii levels potentially increasing risk sarscov<NUMBER> infections pointed hanff et al <NUMBER> also evidence sarscov<NUMBER> lead downregulation ace ii toxic accumulation angiotensin ii <NUMBER> also noted ace ii expressed organs tissues well fact ace expressed gut heart kidney sarscov infections associated gastrointestinal symptoms virus often isolated stool cardiac damage aki speaks favor strong correlation ace expression covid infection <NUMBER> overall exact role ace enzyme angiotensin lung injury general well pathogenesis sarscov<NUMBER> covid <NUMBER> infections clear models true ace ii protective role ards ards feared complication covid <NUMBER> would reasonable assume ace ii would protective effect covid <NUMBER> ace ii receptor used virus infect alveolar epithelium raises issue whether availability receptor associated severity clinical findings moreover large percentage population treated ace inhibitors arbs whether treatments associated change outcomes covid <NUMBER> infections currently debated recognize difficulties performing basic science research especially animal models light current epidemic agree hanff et al would strongly encourage scientists keep researching possible connection ace receptor angiotensin ards ace inhibitors ar blockers currently among frequently prescribed medications western world commonly used patients suffering hypertension congestive heart failure proteinuria commonly due diabetes mellitus act reducing activity reninangiotensin system ras ras plays significant role sarscov<NUMBER> pathogenesis ards development would reasonable assume patients treated ace inhibitorsar blockers would impacted animal models suggest administration ace inhibitors ar blockers leads elevated number ace ii receptors pulmonary circulation <NUMBER> marin reported many patients latin america spain intending discontinue taking ace inhibitorsar blockers due fear infection <NUMBER> despite animal models showing potential association ace inhibition worsening lung injuries due sarscov clinical evidence support association <NUMBER> european society cardiology recommends discontinuing either drugs potential risks associated uncontrolled hypertension seem outweigh risks ace inhibition worsening covid <NUMBER> infection <NUMBER> danser et al reached conclusion <NUMBER> french health minister claimed use antiinflammatory medications ibuprofen could worsen covid <NUMBER> symptoms <NUMBER> although ace ii levels increased use nsaids evidence association severity covid <NUMBER> symptoms weak <NUMBER> fang et al however recommend monitoring patients taking controversial drugs possible choosing alternative treatments <NUMBER> despite health authorities including nhs suggest using paracetamolacetaminophen instead precautionary measure <NUMBER> overall impact ace inhibition sarscov<NUMBER> covid <NUMBER> pathogenesis point time difficult establish belief association two exists mostly based animal models clinical evidence association lacking despite lack clinical evidence appears case number patients plan discontinuing longterm therapies believing would decrease risk contracting andor dying covid <NUMBER> evidence relationship nsaid use severe sarscov<NUMBER> infections also weak although possible pathophysiologic link hypothesized case however many health authorities recommend using nsaids evidence comes light believe lot basic science research pathophysiology coronavirus infections ards development general needed clearer patterns emerge point may reasonable avoid starting new patients nsaids ace inhibitorsarbs avoided comes patients require treatments conditions discontinuation unlikely benefit patients evidence exacerbations comorbidities stronger evidence covid <NUMBER> disease severity news reports expert opinions patients hypertension presenting severe cases covid <NUMBER> moreover hypertension among frequently reported comorbidities patients <NUMBER> <NUMBER> <NUMBER> taken account however hypertension among prevalent chronic conditions western world affecting millions people fang et al point association diabetes hypertension covid <NUMBER> infections likely due association ace ii enzyme <NUMBER> li et al reported significantly higher prevalence hypertension cardiovascular comorbidities among covid <NUMBER> patients treated icu compared require icu treatment <NUMBER> also reported <NUMBER> infected sarscov<NUMBER> developed cardiac injury <NUMBER> chen et al also reported similar association <NUMBER> elevated troponin levels seen icu patients also pointed towards development myocardial injury <NUMBER> odds ratio developing severe case compared nonsevere case hypertensive patients <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> <NUMBER> none studies analyzed age potential confounder considering prevalence hypertension rises age older patients general likely suffer serious complications infectious diseases addressed international society hypertension point evidence patients hypertension overrepresented among severe sarscov<NUMBER> infections adjusted age <NUMBER> difficult assess impact hypertension outcome patients infected sarscov<NUMBER> multiple studies point significant association hypertension adverse outcomes however number potential confounders main age vast previously mentioned association antihypertensives severe covid <NUMBER> presentations also needs taken account number studies published far insufficient properly address questions hope case reports review articles become available literature clearer pattern emerge outcomes patients uncontrolled hypertension compared normotensive controls similar baseline characteristics outcomes hypertensive patients managed ace inhibitorsar blockers compared hypertensive patients managed calcium channel antagonists besides hypertension cardiovascular comorbidities also frequently reported patients severe cases covid <NUMBER> considering significant associations hypertension cardiac disease correlation would expected moreover significant association heart failure pulmonary disease particularly pulmonary hypertension possible consequences even mild cardiac damage would expected significant among patients preexisting cardiac disease li et al reported cardiocerebrovascular disease among prevalent comorbidities among patients severe cases covid <NUMBER> second hypertension <NUMBER> <NUMBER> respectively <NUMBER> zhou et al reported coronary disease third prevalent comorbidity hypertension diabetes <NUMBER> chen et al also found previous history coronary disease independent risk factor adverse outcomes <NUMBER> proposed mechanism findings pericytes high ace ii expression might cells targeted sarscov<NUMBER> <NUMBER> pericyte injury could lead endothelial dysfunction <NUMBER> patients preexisting heart failure likely elevated ace ii expression due pathophysiology chf could increase risk infection <NUMBER> et al found mortality critically ill patients infected sarscov<NUMBER> develop cardiac injury high <NUMBER> <NUMBER> also found elevation nterminal probtype natriuretic peptide levels usually biomarker congestive heart failure associated myocardial injury caused covid <NUMBER> considered together studies point association preexisting cardiovascular comorbidities adverse outcomes following sarscov<NUMBER> infections likely contributing factor finding observed myocardial damage subset covid <NUMBER> patients patients preexisting heart disease less likely recover moreover increased expression ace ii congestive heart failure could explain increased susceptibility virus ability address myocardial damage icu may prove important prognostic factor patients considering lack currently approved treatments aimed virus especially important ensure people comorbidities exposed first place research needed exact impact sarscov<NUMBER> cardiovascular system order develop protective potentially curative strategies covid <NUMBER> caused sarscov<NUMBER> talkedabout disease first half <NUMBER> elderly suffering chronic conditions risk adverse outcomes hypertension frequently reported comorbidity among patients severe infections followed diabetes cardiovascular diseases possibly related expression ace ii facilitating viral entry cells relationship ace inhibitorar blocker use incidence severe covid<NUMBER> conflicting present authorities recommend discontinuing longterm ace inhibitorar blocker treatments concern remains patients may inclined stop taking prescribed medicines fear another point contention use nsaids number public health authorities released statements claiming evidence association existed nevertheless recommended choosing alternative drugs possible pending investigation nsaids finally available evidence clearly points correlation preexisting cardiovascular comorbidities adverse outcomes sarscov<NUMBER> infections severe cases associated myocardial damage considering high prevalence hypertension cardiovascular diseases important continue researching association conditions covid<NUMBER> disclosures j u r n l p r e p r f inflammatory disease impact vascular hematopoietic system hypercoagulability common among hospitalized covid<NUMBER> patients <NUMBER> sarscov<NUMBER> may interact cardiovascular system multiple levels increasing morbidity patients underlying cardiovascular conditions provoking myocardial injury dysfunction <NUMBER> figure <NUMBER> <NUMBER> since early stages pandemic higher mortality rates among covid<NUMBER> patients acquired cardiovascular disease hypertension coronary artery disease diabetes reported compared patients without acquired cardiovascular disease heart failure may precipitated acute illness patients preexisting cardiovascular disease <NUMBER> past decades new cardiovascular population adults congenital heart disease achd emerged developed countries due medical surgical advances unfortunately complete cure congenital cardiac defects childhood exceptional many face lifelong increased risk cardiovascular complications heart failure arrhythmias pulmonary circulation disorders andeven death due hemodynamic residuae <NUMBER> sequelae previous repair strategies therefore reasonable assume achd patients increased risk adverse outcomes contract covid<NUMBER> achd patients outnumber children congenital heart disease chd available evidence suggests overall achd prevalence <NUMBER> per million included group patients mild defects eg repaired atrial septal defect ligated ductus arteriosus moderate severe chd whose natural history forever changed therapeutic interventions analyses registry data adults various forms chd spain switzerland allowed detailed phenotyping patients followed j u r n l p r e p r f respectively <NUMBER> mild defects <NUMBER> swiss adult congenital heart disease registry sacher <NUMBER> <NUMBER> patients cyanotic complex congenital heart disease <NUMBER> lesions affecting right heart ie tetralogy fallot ebsteinanomaly <NUMBER> complex diseases left ventricular outflow tract <NUMBER> valvular lesions <NUMBER> shunt pathology <NUMBER> expected spanish swiss achd patients undergone previous repair procedures <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> reinterventions <NUMBER> <NUMBER> considering potential outcome covid<NUMBER> achd patients competing risks taken account first age per se independent risk factor covid<NUMBER>related mortality <NUMBER> <NUMBER> immune responses older adults slower less coordinated less efficient younger adults making susceptible coronavirus infections <NUMBER> addition circulating plasma concentrations angiotensinconverting enzyme ii higher adults children also higher men women <NUMBER> covid<NUMBER> invades cells binding angiotensinconverting enzyme ii expressed surface alveolar cells lungs making older men potentially vulnerable sarscov<NUMBER> hand typical achd patients median age <NUMBER> years may less susceptible milder covid<NUMBER> course due protective effects age independently underlying defect complexity addition although number achd patients older <NUMBER> years steadily increasing acquired cardiovascular risk factors fatal covid<NUMBER> outcomes infrequently found achd population spanish cohort <NUMBER> patients younger <NUMBER> years prevalence hypertension diabetes ischemic heart disease <NUMBER> <NUMBER> <NUMBER> respectively unpublished data thus many achd patients without major comorbidities may higher risk poor outcome contract covid<NUMBER> corresponding general population appropriate management potentially direct effect morbidity mortality know young achd patients loss followup transition period pediatric adult care lapse care associated late complications higher need urgent cardiac interventions <NUMBER> desire minimize risk coronavirus exposure given achd patient must obviously weighed need inperson visits particularly decompensated congestive heart failure arrhythmias possible scheduled clinic visits converted telehealth visits accustomed since childhood surrounded technological devices young achd population may particularly inclined use mobile health technologies wide range clinical data including visual examination auscultatory sounds physiological parameters echocardiographic images transmitted realtime across telemedicine links facilitating accurate diagnosis effective decision making promoting access specialist opinion telemedicine programs continue provide state art high quality personalized care individuals community beyond coronavirus pandemic conclusion current covid<NUMBER> pandemic poses unprecedented challenges changes patients specialists assumptions derived theoretical reasoning extrapolation data patients acquired heart disease might sufficiently accurate risk stratification achd predicting risk poor outcomes remains challenging due variety cardiac defects repair strategies covid<NUMBER> pandemic may represent special burden patients severe chd cyanotic patients patients overt heart failure associated pulmonary vascular disorders page <NUMBER> <NUMBER> j u r n l p r e p r f involvement organs may adversely impact prognosis however fairly young achd patients without comorbidities may particularly vulnerable covid<NUMBER> since also exposed potentially farreaching socioeconomic impact pandemic recommendations patients needs based sound clinical evidence therefore national international collaborations aiming address issue must fostered way permission obtained © european society cardiology <NUMBER> rights reserved since last november almost <NUMBER> million confirmed covid<NUMBER> infections <NUMBER> <NUMBER> deaths reported <NUMBER> evidence mounting become clear covid<NUMBER> initially affects airways lungs inflammatory storm occurring later infection also involves cardiovascular system leads venous thrombosis pulmonary embolism <NUMBER> heart blocks <NUMBER> myocardial infarction well myocarditis <NUMBER> <NUMBER> <NUMBER> heart failure <NUMBER> furthermore cardiac condition seems represent major risk factor unfavourable outcome covid<NUMBER> infection finally less apparent initially lockdown affected countries produced extensive collateral damage patients afraid visit hospitals acute cardiac conditions deprived necessary care outpatient elective inpatient services cancelled second focus issue covid<NUMBER> cardiovascular disease addresses issues starts fast track association hypertension antihypertensive treatment covid<NUMBER> mortality retrospective observational study fei li colleagues china investigated whether treatment hypertension especially reninangiotensinaldosterone system raas inhibitorsas suggested initially <NUMBER> would influence mortality patients covid<NUMBER> infection admitted huoshenshan hospital wuhan china <NUMBER> hospital designed treating covid<NUMBER> opened <NUMBER> february <NUMBER> hypertension treatment stratified according medical history medications prior infection among <NUMBER> patients <NUMBER> history hypertension adjustment confounders patients hypertension twofold increased relative mortality risk compared without hypertension patients history hypertension without antihypertensive treatment even higher risk mortality compared treatment hazard ratio <NUMBER> quarter patients treated least one raas inhibitor rest received betablockers calcium antagonists diuretics raas inhibitors mortality numerically lower reach significance figure <NUMBER> thus largest cohort published far issue hypertension appears independently associated mortality covid<NUMBER> furthermore data support hypothesis raas inhibitors worsen outcomes among persons infection important findings put context debate role ace<NUMBER> covid<NUMBER> thoughtprovoking editorial luis ruilope hospital <NUMBER> de octubre madrid spain <NUMBER> troponins known risk factors outcome patients acute coronary syndromes <NUMBER> <NUMBER> heart failure <NUMBER> valvular heart disease <NUMBER> pulmonary embolism <NUMBER> even normal individuals important also study aspect patients covid<NUMBER> infection article entitled characteristics clinical significance myocardial injury patients severe coronavirus disease <NUMBER> bo yang colleagues wuhan university renmin hospital china investigated aspect <NUMBER> patients severe covid<NUMBER> infection <NUMBER> <NUMBER> died patients comorbidities commonly myocardial injury ie <NUMBER> vs <NUMBER> survivors area receiver operator characteristic curve highsensitivity cardiac troponin inhospital mortality <NUMBER> optimal cutoff points ie <NUMBER> ngml high levels highsensitivity cardiac troponin predicted inhospital death hazard ratio <NUMBER> <NUMBER> respectively multivariable logistic regression older age comorbidities hypertension coronary artery disease chronic renal failure chronic obstructive pulmonary disease high level creactive protein predictors myocardial injury thus risk inhospital death among patients severe covid<NUMBER> predictable markers myocardial injury associated inflammatory response cardiovascular comorbidities additionally covid<NUMBER> pandemic affected infection also cardiac patients large appears recommendations governmental agencies stay home probably deterred cardiac patients visiting hospital acute symptoms occurred outlined article reduction hospitalizations myocardial infarction italy covid<NUMBER> era authored ciro indolfi division cardiology magna graecia university catanzaro italy colleagues società italiana di cardiologia ccu academy investigators group <NUMBER> conducted multicentre observational nationwide survey admissions acute myocardial infarction italian intensive cardiac care units <NUMBER>week period covid<NUMBER> outbreak compared equivalent week <NUMBER> observed <NUMBER> reduction admissions compared equivalent week <NUMBER> reduction significant stsegment elevation myocardial infarction stemi admission <NUMBER> reduction nonstemi nstemi <NUMBER> reduction among stemis reduction greater women <NUMBER> men <NUMBER> similar reduction acute myocardial infarction admissions registered north italy <NUMBER> central italy <NUMBER> surprisingly also southern italy <NUMBER> fewer covid<NUMBER> cases observed thus covid<NUMBER> pandemic led significant collateral damage even noncovid<NUMBER> patients cardiac disease outlined insightful editorial chadi alraies wayne state university washington dc usa <NUMBER> causes may multifactorial may related fact patients may afraid visit hospital pandemic fewer plaque ruptures occurred due standstill life lockdown finally comprehensive review entitled covid<NUMBER> epidemiology treatment jose miro colleagues hospital clinicidibaps barcelona spain reminds us cardiologists cardiovascular surgeons must aware virus infections patients impact general <NUMBER> healthcare workers educated trained tackle enormous challenge posed sarscov<NUMBER> viruses wards operating theatres icus cardiac catheterization laboratories review provides necessary knowledge covid<NUMBER> focuses relevant aspects prevention management specialists within cardiovascular field much patients clinical service suffered covid<NUMBER> pandemic research running clinical trials particular indeed countries running protocols stopped impacted recruitment followup eventually integrity safety results trials issue discussed current opinion article conducting clinical trials heart failure covid<NUMBER> pandemic expert consensus position paper heart failure association hfa european society cardiology esc stefan anker charité berlin germany colleagues figure <NUMBER> <NUMBER> heart failure trials covid<NUMBER> may particularly impactful patients heart failure likely greater risk infection covid<NUMBER> consequences might also serious furthermore also risk adverse outcomes clinical care compromised authors note physicians clinical trialists moral ethical duty ensure safe effective care delivered trial participants without affecting integrity trial many regulatory authorities different world regions issued guidance statements regarding conduct clinical trials covid<NUMBER> crisis however international trials may benefit expert guidance global panel experts supplement local advice regulations thereby enhancing safety participants integrity trial accordingly heart failure association european society cardiology conducted webbased meetings clinical trialists europe north america south america australia asia article authors highlight challenges pandemic poses conduct clinical trials heart failure offers advice might overcome practical examples panel experts focused heart failure clinical trials discussions recommendations may apply clinical trials therapeutic areas issue complemented discussion forum contributions contribution entitled clinically suspected myocarditis course coronavirus infection krzysztof ozieranski colleagues warszawski uniwersytet medyczny poland comment recent article coronavirus fulminant myocarditis saved glucocorticoid human immunoglobulin yuan fang colleagues sichuan university west china hospital china <NUMBER> <NUMBER> fang et al respond ozieranski separate contribution <NUMBER> <NUMBER> finally contribution entitled reninangiotensinaldosterone system dysregulation severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection thadathilankal john colleagues stellenbosch university faculty medicine health sciences bellville south africa comment recent viewpoint article sarscov<NUMBER> inhibitors reninangiotensin system withdrawn patients covid<NUMBER> gabriela kuster fro university hospital basel switzerland <NUMBER> <NUMBER> kuster et al respond comment separate manuscript <NUMBER> editors hope readers issue european heart journal find interest following brief editorial designed summarize current understanding sarscov<NUMBER> effects heart several potential expected effects based virology precedent also discussed updates provided coming weeks knowledge expands matures first case sarscov<NUMBER> causing covid co stands corona vi virus diseaseinitially called <NUMBER> novel coronavirus <NUMBER>ncov may occurred early november <NUMBER> earliest reported symptoms traced december <NUMBER> <NUMBER> <NUMBER> december <NUMBER> <NUMBER> world health organization china country office informed cases pneumonia unknown cause detected wuhan city hubei province china initial evaluation cases undertaken four lower respiratory tract samples including bronchoalveolarlavage bal fluid collected patients wuhan compared seven samples collected patients beijing pneumonias known cause <NUMBER> <NUMBER> viral reads individual specimens obtained matched genome lineage b genus betacoronavirus showing greater <NUMBER> identity bat sarslike cov december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> <NUMBER> cases patients pneumonia unknown cause reported national authorities china january <NUMBER>th <NUMBER>th <NUMBER> chinese national health commission identified source exposures seafood market wuhan city huanan seafood wholesale market fig <NUMBER> cohort fortyone cases caused sarscov<NUMBER> reported huang et al <NUMBER> majority <NUMBER> men median age <NUMBER> years iqr <NUMBER> common initial symptoms included fever <NUMBER> cough <NUMBER> myalgias fatigue <NUMBER> <NUMBER> patients bilateral multilobar pneumonia abnormal findings chest computed tomography ct scans patients leukopenic low white blood cell count lymphopenic <NUMBER> × <NUMBER> <NUMBER> l hospital admission ddimer levels elevated particularly among patients required intensive care unit iculevel care median ddimer level <NUMBER> mgl vs <NUMBER> mgl majority patients normal procalcitonin levels <NUMBER> ngml first confirmed case covid<NUMBER> united states <NUMBER>yearold man snohomish county washington presented urgent care center <NUMBER>days cough subjective fever <NUMBER> recently returned washington state visiting family wuhan china viral panels routine respiratory pathogens negative nasopharyngeal oropharyngeal swabs sent center disease control prevention cdc following notification washington state department health swabs positive sarscov<NUMBER> progressive bilateral infiltrates chest xray new requirement supplemental oxygen persistent fevers day <NUMBER> prompted initiation treatment remdesivir see subsequent section potential treatments study serial negative procalcitonin levels negative cultures bacterial pathogens prompted discontinuation vancomycin cefepime rapid clinical improvement observed next <NUMBER> h coronaviruses belong subfamily coronavirineae family coronavitidae order nidovirales subfamily includes alpha coronavirus beta coronavirus gamma coronavirus delta coronavirus <NUMBER> <NUMBER> genome singlestranded positivesense rna <NUMBER> kb <NUMBER>′ cap structure <NUMBER>′polya tail sarscov<NUMBER> virus belongs cluster beta coronaviruses originating likely horseshoe bats homotrimers proteins make spikes virus surface enable binding host receptors case covid<NUMBER> oralpharyngeal cell angiotensin convertingenzyme ace<NUMBER> primary receptor <NUMBER> known pathogenic coronaviruses <NUMBER> infect humans overwhelming majority associated respiratory infections syndromes varying severitythe pathogenic coronaviruses cause fatal pulmonary infections multiorgan system failure sarscov merscov sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> coronaviruses contain least <NUMBER> openread frames orfs orfs near <NUMBER>′ terminal genome encode primary structural proteins spike membrane envelope e nucleocapsid n mentioned previously proteins responsible attachment host receptors proteins contain transmembrane domains contribute virus shape curvature binding nucleocapsid e protein involved virus assembly pathogenesis n proteins package encapsulate genomes virions antagonize innate proteins silencing rna <NUMBER> <NUMBER> <NUMBER> <NUMBER> trimeric sarscov<NUMBER> surface protein consists three s<NUMBER>s<NUMBER> heterodimers bind cellular receptor ace<NUMBER> mediate fusion viral cellular membranes pretopost fusion conformational change available information obtained cryoelectron microscopy shows one receptorbinding domain binds ace<NUMBER> adopts upward conformation <NUMBER> fig <NUMBER> moreover binding receptor opens receptor binding domain s<NUMBER> promotes release s<NUMBER>ace<NUMBER> complex s<NUMBER> monomers soluble complexes bind host cell unoccupied ace<NUMBER> receptors available data suggest combinant receptor binding domain rbd portion sarscov<NUMBER> protein evolved effectively target ace<NUMBER> sarscov<NUMBER> protein effective binding human cells scientific community concluded result natural selection <NUMBER> <NUMBER> <NUMBER> true backbone overall molecular structure <NUMBER> population genetic analyses <NUMBER> sarscov<NUMBER> genomes indicated viruses evolved two major types designated l well defined two different single nucleotide polymorphisms snps analyses showed near complete linkage across viral strains sequenced date although l type <NUMBER> prevalent type <NUMBER> type believed ancestral version whereas l type prevalent early stages outbreak wuhan china frequency l type decreased early january <NUMBER> human intervention may placed severe selective pressure l type might aggressive spread quickly <NUMBER> <NUMBER> unique characteristics sarscov<NUMBER> initially determined december <NUMBER> suggested strongly humans would possess herd immunity ie absence prior exposure made existing antibodies sarscov<NUMBER> unlikely turn signaled alarms potential infectivity robust immune resulting inflammatory responses infection burst inflammatory cells proteins often referred cytokine storm believed responsible many deaths <NUMBER> flu pandemic h<NUMBER>n<NUMBER> bird flu outbreaks <NUMBER> sars outbreak <NUMBER> <NUMBER> unique characteristics virus include stability large scale infected people also suggest strongly second multiple waves sarscov<NUMBER> coming years angiotensin converting enzyme ii ace<NUMBER> receptor sarscov<NUMBER> binds invades human cells <NUMBER> zou et al constructed risk map human organs utilizing singlecell rna sequencing data sets derived major human physiological systems analysis available data identified organs risk sarscov<NUMBER> infection specific cell types ace<NUMBER> expression vulnerable organs cell types follows lung type ii alveolar cells heart myocardial cells kidney proximal tubule cells ileum esophagus epithelial cells bladder urothelial cells fig <NUMBER> ace<NUMBER> receptors also found venous arterial endothelial cells arterial smooth muscle cells <NUMBER> expression ace<NUMBER> receptors increases age varies little either sex race normal circumstances <NUMBER> <NUMBER> binding srscov<NUMBER> ace<NUMBER> necessary step virus entry followed multiplication spread finding particular relevance patients sarscov<NUMBER> viremia <NUMBER> may hold key better understanding cardiac injury heart failure arrhythmias circulatory shock covid<NUMBER> time writing <NUMBER> confirmed cases covid<NUMBER> <NUMBER> deaths <NUMBER> countries territories reported cases world health organization situation report <NUMBER> april <NUMBER> <NUMBER> wwwwhoint wwwcdcgov overall case fatality rate covid<NUMBER> based published reports <NUMBER> however statistics changing hourbyhour daybyday clear consistent morbidity mortality increase significantly age rising <NUMBER> patients ages <NUMBER> <NUMBER> patients greater <NUMBER> addition recognized impairment immune response increases age comorbid illnesses including heart metabolic lung disease also likely among older persons access health care may also impacted age varying degrees around world initial cohort hospitalized patients laboratory confirmed sarscov<NUMBER> infections included mostly men <NUMBER> <NUMBER> <NUMBER> approximately onethird underlying diseases diabetes mellitus <NUMBER> hypertension <NUMBER> cardiovascular disease <NUMBER> similar profile predisposition reported mers middleeast respiratory syndrome <NUMBER> <NUMBER> li et al performed metaanalysis studies summarized prevalence cardiovascular metabolic disease among patients covid<NUMBER> <NUMBER> total six studies including <NUMBER> patients identified proportion patients hypertension cardiac cerebrovascular disease diabetes mellitus <NUMBER> <NUMBER> <NUMBER> respectively among severely affected patients requiring iculevel care incidence rates twofold threefold twofold higher respectively compared patients able receive treatment nonicu setting fig <NUMBER> ace<NUMBER> receptors expressed multiple organs greatest density potential upregulation lungs heart blood vessels arteries veins macrovessels microvessels direct relationship ace<NUMBER> receptor density target organ involvement injury among patients covid<NUMBER> zou x front med https doiorg<NUMBER> s<NUMBER> <NUMBER> permission patients within initial cohort confirmed cases pneumonia <NUMBER> reported complications included acute respiratory distress syndrome ards <NUMBER> rnaemia <NUMBER> acute cardiac injury <NUMBER> based high sensitivity troponin value <NUMBER>th percentile normal two patients placed venovenous extracorporeal membrane oxygenation ecmo mechanical support refractory hypoxia mortality rate <NUMBER> circulating plasma factors inflammatory state increased levels interleukin il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fibroblast growth factor fgf interferonifn p interferoninducible protein ip<NUMBER> monocyte chemoattractant protein mcp<NUMBER> plasma membrane intrinsic proteinmip<NUMBER>a mip<NUMBER>β plateletderived growth factor pdgf tumor necrosis factor tnfα vascular endothelial growth factor vegf compared healthy adults severity covid<NUMBER> linked viral load upper respiratory track acute lung injury cardiac injury angiotensin ii plasma levels <NUMBER> <NUMBER> metaanalysis performed li et al <NUMBER> <NUMBER> patients covid <NUMBER> infection acute cardiac injury <NUMBER> required iculevel care <NUMBER>fold higher incidence acute cardiac injury compared lower acuity covid<NUMBER> confirmed cohort patients clinical course covid<NUMBER> similarities sarscov merscov also linked fatal illness <NUMBER> zhou cardiovascular complications attributed covid<NUMBER> infection summarized chen et al <NUMBER> <NUMBER> total <NUMBER> consecutive patients fever clinic tonglin hospital wuhan china served study population male sex elevated nt nterminalpro btype natriuretic peptide bnp elevated ctni history coronary heart disease common critically ill patients compared patients mild symptoms multivariable logistic regression analysis elevated ctni <NUMBER> <NUMBER> ci <NUMBER> past history coronary heart disease <NUMBER> <NUMBER> ci <NUMBER> independently associated critical illness status yang et al <NUMBER> performed retrospective single center study <NUMBER> critically ill patients hospitalized wuhan hin tintam hospital covid<NUMBER> total <NUMBER> <NUMBER> patients died <NUMBER>day followup period nonsurvivors older <NUMBER> years vs <NUMBER> years likely develop ards <NUMBER> vs <NUMBER> survivors majority infected patients survive hospitalizations organ damage including <NUMBER> <NUMBER> ards <NUMBER> <NUMBER> acute kidney injury <NUMBER> <NUMBER> cardiac injury <NUMBER> <NUMBER> liver failure shi et al <NUMBER> evaluated impact cardiac injury mortality <NUMBER> hospitalized patients covid<NUMBER> total <NUMBER> patients <NUMBER> cardiac injury comparing patients without cardiac injury former older greater number comorbid conditions higher levels creactive protein procalcitonin ntprobnp multilobar pneumonia also higher incidence ards requiring mechanical ventilation acute kidney injury coagulation abnormalities mortality rates <NUMBER> <NUMBER> respectively cox regression analysis cardiac injury associated threefourfold higher risk death hr <NUMBER> <NUMBER> ci <NUMBER> myocarditis known occur wide range acute viral infections including adenovirus human immunodeficiency virus hiv epsteinbarr virus influenza virus name observational data coupled virologic molecular diagnostic techniques suggest enteroviruses including coxsackieviruses parvoviruses adenoviruses among common causes myocarditis given duration viral shedding sarscov<NUMBER> infection covid<NUMBER> well relatively high density ace<NUMBER> receptors expressed cardiomyocytes one would expect see cases myocarditis myopericarditis chen et al <NUMBER> highlighted potential sarscov<NUMBER> cause fulminant myocarditis citing frequency cardiac injury robust inflammatory response cytokine storm core pathophysiological mechanism fulminant myocarditis viral causes myocarditis presenting signs symptoms diagnostic features vary chest discomfort shortness breath electrocardiographic stt wave abnormalities elevated ctni ntprobnp levels heart failure cardiogenic shock appropriate clinical index suspicion required addition patients preexisting cardiovascular disease either ischemic nonischemic cardiomyopathies vulnerable progressive precipitous change ventricular performance clinical decompensation pivotal questions medical scientific communities must answer elevated cardiac biomarkers portend worse prognosis among patients covid<NUMBER> epiphenomenon infection severity reflect vital organ viral load viremia andor direct myocardial microvessel invasion sarscov<NUMBER> might marker systemic inflammatory response red flag impending cytokine storm adults severely affected covid<NUMBER> emerging data show infants children adolescents contracted sarscov<NUMBER> well <NUMBER> nationwide case series <NUMBER> pediatric patients reported chinese center disease control prevention <NUMBER> laboratoryconfirmed <NUMBER> suspected cases median age <NUMBER> years interquartile range <NUMBER> <NUMBER> cases considered mild severity severe critically ill patients well proportion severe critical cases greatest age group <NUMBER> year <NUMBER> <NUMBER> years age <NUMBER> critical illness features including ards encephalopathy myocardial injury heart failure circulatory shock case series centers countries underscored potential impact covid<NUMBER> neonates infants children adolescents <NUMBER> <NUMBER> <NUMBER> <NUMBER> also impact neonates born mothers infected time delivery <NUMBER> addition early diagnosis supportive care american college cardiology emphasized importance cardiac complications patients covid<NUMBER> optimal management include assisting clinical specialties prepared treat critically ill patients advanced medical mechanical therapies ecmo venovenous venoarterial recommending diagnostic testing echocardiography patients heart failure arrhythmias electrocardiographic ecg abnormalities cardiomegaly chest xray acc clinical bulletincovid<NUMBER> clinical guidance cv care team march <NUMBER> table <NUMBER> expression ace<NUMBER> increased among patients diabetes mellitus patients treated either ace inhibitors angiotensin receptor blockers <NUMBER> one could postulate treatment either acei arb predisposes patients sarscov<NUMBER> infection insufficient data make recommendation clinicians patients either avoid transition alternative treatments position emphasized recently joint statement american heart association american college cardiology heart failure society america websites accessed march <NUMBER> <NUMBER> wwwheart org potential statins ability reduce inflammation impact severity covid<NUMBER> untested devise clear plans quickly identify isolate patients cvd covid<NUMBER> symptoms advise patients cvd heightened risk contracting covid<NUMBER> provide instruction precaution geographies active covid<NUMBER> outbreaks telephonic telehealth options considered place npatient visits patients stable cvd aware classic signs symptoms acute myocardial infarction may overshadowed setting covid<NUMBER> infection devise specific protocols management acute myocardial infarction context covid<NUMBER> infection place particular emphasis acute pci cabg craft protocols limit catheterization operating room time staff provide personnel protection assess postprocedural sterilization carefully assess riskbenefit less urgent pci cabg providers mindful health requires adequate sleep good eating habits fdaapproved treatment covid<NUMBER> time however substantial effort undertaken national institutes health world health organization private foundations pharmaceutical industry march <NUMBER> <NUMBER> fda issued emergency use authorization eua permitting chloroquine phosphate medical grade hydroxychloroquine sulfate added strategic national stockpile sns sns exists authority us department health human services hhs accepted <NUMBER> million doses hydroxychloroquine sulfate donated sandoz novartis generics biosimilars division one million doses chloroquine phosphate donated bayer pharmaceuticals potential use treating patients hospitalized covid<NUMBER> use clinical trials addition sns donations companies potentially others offer additional doses likely accelerate production commercial markets wwwfda gov openlabel trial <NUMBER> patients laboratory confirmed sarscov<NUMBER> severe covid<NUMBER> compared lopinavirrhonavir versus standard care differences time clinical improvement detectable viral rna various time points <NUMBER> days mortality <NUMBER> embarked megatrial known solidarity test <NUMBER> drugsremdesivir malaria medications chloroquine hydroxychloroquine combination two hiv drugs lopinavir ritonavir combination plus interferonbeta immune system modulatory pragmatic trial design employed person confirmed case covid<NUMBER> deemed eligible physician enter patients data website including comorbid conditions diabetes cardiovascular disease hiv infection participant sign informed consent form scanned sent electronically physician states drugs available hospital website randomize patient one drugs available local standard care covid<NUMBER> global data safety monitoring board perform interim analyses regular intervals determine whether drugs clear beneficial effect whether one drugs dropped offer benefit first patients recently enrolled drugs could tested employing solidarity trial network wwwwhoint inserm founded <NUMBER> public scientific technological institute operates joint authority french ministries health research announced recently coordinate addon trial europe discovery follow whos methods include <NUMBER> patients least seven countries including <NUMBER> france trial test drugs exception chloroquine wwwinser mcom remdesivir nucleotide analog prodrug incorporates nascent viral rna chains results premature termination effects occur postviral entry <NUMBER> chloroquine known inhibit virus infection increasing endosomal ph required viruscell fusion interferes glycosylation cellular receptors sarscov<NUMBER> functions entry postentry stages virus infection gilead sciences foster city ca wwwgilea dcom embarked upon two phase iii clinical trials testing antiviral drug remdesivir treatment covid<NUMBER> adults randomised openlabel multicenter studies assess safety efficacy drug nearly <NUMBER> patients fiveday tenday dosing regimen intravenous formulation remdesivir tested trials mainly conducted sites asian countries however sites countries likely added one trials enroll approximately <NUMBER> patients severe covid<NUMBER> second trial include approximately <NUMBER> patients moderate severity covid<NUMBER> clinical improvement primary outcome measure first trial normalization temperature oxygen saturation focus second trial record measures based proportion patients discharged day <NUMBER> addition two phase iii clinical trials currently five trials remdesivir treatment covid<NUMBER> results least one trials initiated china expected coming weeks national institute allergy infectious diseases wwwnihgov conducting randomized controlled trial evaluate safety efficacy remdesivir adults hospitalized covid<NUMBER> trial conducted university nebraska medical center potential subjects undergo baseline physical examination receiving treatment either investigational treatment placebo addition standards care participants investigational treatment group receive <NUMBER> mg remdesivir intravenously first day enrollment study receive another <NUMBER> mg day duration hospitalization <NUMBER> days clinicians regularly monitor participants assign daily scores based predefined scale clinical outcomes consider factors including body temperature blood pressure use supplemental oxygen participants also asked provide blood samples nose throat swabs approximately every two days analyzed sarscov<NUMBER> niaid expand adaptive covid<NUMBER> treatment trial actt many <NUMBER> sites globally include <NUMBER> subjects convalescent plasma derived patients laboratory confirmed sarscov<NUMBER> infection absent viral shedding could considered passive immune therapy <NUMBER> given public health emergency expanding covid<NUMBER> outbreak presents clinical trials conducted fda facilitating access covid<NUMBER> convalescent plasma use patients serious immediately lifethreatening covid<NUMBER> infections single patient emergency investigational new drug applications einds individual patients <NUMBER> code federal regulations cfr <NUMBER> process allows use investigational drug treatment individual patient licensed physician upon fda authorization include use covid<NUMBER> convalescent plasma prevention infection monoclonal antibody administration also suggested <NUMBER> addition sarscov rbdspecific antibodies could crossreact sarscov<NUMBER> receptorbinding domain rbd protein sarscov rbdinduced antisera could crossneutralize sarscov<NUMBER> <NUMBER> rigorous clinical trials required determine safety efficacy monoclonal antibody administration time writing <NUMBER> clinical trials study covid<NUMBER> registered clinical trialsgov wwwclini caltr ialsgov identifying potential targets sarscov<NUMBER> vaccine must take full advantage high genetic similarity sarscov <NUMBER> ever mindful safety considerations prior investigations ahmed et al identified b cell cell epitopes derived sproteins nproteins mapped identically corresponding sarscov<NUMBER> proteins <NUMBER> immune targeting epitopes could basis vaccine development potentially global scale mutations epitope sequences identified different parts world <NUMBER> united states first participant dosed phase study modernas™ mrna vaccine mrna<NUMBER> novel coronavirus sarscov<NUMBER>the national institutes health nih conducting trial investigational new drug ind application phase study enroll <NUMBER> healthy adults evaluate safety immunogenicity <NUMBER> μg <NUMBER> μg <NUMBER> μg dose levels mrna<NUMBER> administered twodose vaccination schedule wwwfdagov researchers chinas academy military medical sciences reportedly received approval launch earlystage clinical trials potential coronavirus covid <NUMBER> vaccine starting week englishnmpagovcnaccording chinese clinical trial registration database nmpa phase test evaluating safety experimental shot humans intends recruit <NUMBER> healthy people <NUMBER> march <NUMBER> december chinas academy military medical sciences hong konglisted biotech company cansino biologics™ conduct clinical trial pfizer™ recently announced joined forces german biotech company biontech™ develop potential rna vaccine prevent spread covid<NUMBER> collaboration focus potential speed rna vaccines constructed unique mechanisms effectrna vaccines work introducing type rna containing genetic sequence produced without growing virus body cells use information build antigen specific virus immune system recognizes antigen builds immunity wwwpfize rcom wwwbreak throu ghscom time writing five covid<NUMBER> vaccine clinical trials registered clinical trialsgov www clini caltr ialsgov according website <NUMBER> vaccines preclinical development wwwwhoint clinical trials bacilluscalmetteguerin bcg vaccine recently initiated around world scientific premise study based prior observations vaccinated individuals protected tuberculosis viral parasitic infections well emergence new strain coronavirus sarscov<NUMBER> cause covid<NUMBER> represents unprecedented period history lay medical scientific communities working closely together learning oneanother additional efforts needed available information derived case studies show covid<NUMBER> direct indirect cardiovascular effects ranging cardiac injury myocarditis arrhythmias respiratory failure requiring mechanical ventilation venovenous ecmo circulatory failure requiring inotropes vasopressors venoarterial ecmo clinicians must also aware covid<NUMBER> overshadow acute cardiac events including st segment elevation myocardial infarction <NUMBER> delay treatment given current strains emergency rooms emergency medical services must maintain appropriate level balanced fullfield vision midst global event dominating presence everyones mind last time writing <NUMBER> references topic sarscov<NUMBER> covid<NUMBER> cited pubmed represents <NUMBER> publication increase past <NUMBER> days wealth information doubt reflects extraordinary level interest commitment worldwide health threat must vigilant interpretation published literature source level scientific rigor potential translation scientific clinical advances novel coronavirus disease <NUMBER> covid<NUMBER> pandemic caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> affected millions medically billions due social economic psychological impact disrupting global order <NUMBER> covid<NUMBER> pandemic dominating attention reports emerging patients urgent noncovid<NUMBER> health concerns may getting adequate standard treatment due resource constraints concerns regarding risk coronavirus exposure self patients healthcare workers hcw ripple effects may affect many patients adversely longlasting deleterious outcomes hospitals healthcare systems must adopt standardized approach provide best possible care patients regardless covid<NUMBER> status particularly important cardiology community given patients preexisting cardiovascular disease risk factors potentially likely acquire covid<NUMBER> experience adverse outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> spread virus increases many cardiac patients seek medical care either covid<NUMBER> related illnesses traditional cardiac issues acute coronary syndrome arrhythmia heart failure many patients require cardiac procedure simultaneously infected sarscov<NUMBER> additionally increasing reports acute de novo cardiac presentations myocarditis arrhythmia heart failure patients without prior cardiovascular disease significant risk factors also emerging possibly due accentuated host immune response cytokine storm <NUMBER> international cardiovascular community urgently needs develop consensus algorithms provide best care issues minimizing risk hcw present consensus guidance management various cv conditions patients suspected confirmed covid<NUMBER> important note recommendations made setting emerging limited evidence likely evolve additional clinical information becomes available recommendations best practice document used general clinical guidance decisions need individualized writing group consisting experts fields cv medicine compiled extensive literature review performed using pubmed index reports world health organization well chinese center disease control prevention search incorporated text words medical subject headings mesh coronavirus sarscov<NUMBER> covid<NUMBER> references review articles also searched relevant titles authors also searched clinicaltrialsgov ongoing relevant clinical trials incorporate rapidly evolving knowledge subject also included search unpublished nonpeer reviewed literature available medrxiv included selective evidence careful review priority given first evidence randomized controlled trials metaanalysis followed evidence cohort casecontrol studies finally expert opinion clinical practice recommendations detailed document based available literature may <NUMBER> <NUMBER> represent consensus agreement among writing group early singlecenter report china describing hospitalized patients infected pneumonia due sarscov<NUMBER> <NUMBER> preexisting cvd particularly coronary artery disease cad cerebrovascular disease <NUMBER> however following larger cohort china describe lower overall rate affected patients underlying cad <NUMBER> beyond preexisting cvd consistent data described high prevalence sarcov<NUMBER> infection among elderly concomitant cv comorbidities particularly hypertension <NUMBER> diabetes <NUMBER> <NUMBER> higher prevalence cvd diabetes hypertension reported patients severe covid<NUMBER> impact comorbid conditions adjusting age obesity remains unknown early reports china show covid<NUMBER> mortality rate among hospitalized patients highest among elderly patients cvd <NUMBER> compared comorbidities disproportionately higher patients cv risk factors diabetes <NUMBER> hypertension <NUMBER> compared approximately <NUMBER> patients without comorbidities <NUMBER> many patients covid<NUMBER> experience acute myocardial injury evident increase cardiac troponin levels significant proportion hospitalized patients particularly severe illness developed heart failure <NUMBER> <NUMBER> moreover troponin levels significantly higher patients admitted icu nonsurvivors suggesting cv complications might contribute severity illness adverse outcomes myocarditis arrhythmias cardiac arrest also reported <NUMBER> exact mechanisms covid<NUMBER> associated cv injury well understood however several potential mechanisms include <NUMBER> <NUMBER>  direct toxicity viral invasion cardiac myocytes ie myocarditis ii ace<NUMBER> receptormediated cv cardiac endothelial injury iii microvascular dysfunction thrombosis iv cytokine release syndrome mainly il<NUMBER> mediated v stress cardiomyopathy due imbalance myocardial supply demand ace<NUMBER> serves cellular entry point coronaviruses including sarscov sarscov<NUMBER> <NUMBER> spike protein coronaviruses binds ace<NUMBER> highly expressed lungs endothelium heart leading respiratory also potential cv damage <NUMBER> one potential explanation higher risk acquiring infection severe symptoms adverse outcomes covid<NUMBER> patients preexisting cvd could higher usual expression ace<NUMBER> patients autopsy specimens animal models sarscov infection marked decrease cardiac ace<NUMBER> expression thus possible like sarscov sarscov<NUMBER> may decrease ace<NUMBER> expression heart promote vascular myocardial injury <NUMBER> possible mechanisms cv injury include excessive cytokine release triggered imbalanced response type <NUMBER> type <NUMBER> thelpercells hypoxemia secondary respiratory dysfunction <NUMBER> yet understand longterm cv impact sarscov<NUMBER> infection similar pathogen sarscov associated dysregulation lipid glucose metabolism longterm survivors given structural similarities two pathogens sarscov<NUMBER> may also cause chronic damage cv system <NUMBER> provide recommendations applicable common scenarios cardiology consultants may encounter caring patients new era covid<NUMBER> infection figure <NUMBER> <NUMBER> general principles summarized figure <NUMBER> suspected confirmed covid<NUMBER> <NUMBER> approximately <NUMBER> patients covid<NUMBER> experienced de novo myocardial injury defined elevated cardiac troponin without cardiomyopathy <NUMBER> <NUMBER> understanding entity limited evolving typically rise troponin reported late course <NUMBER> days onset symptomspresentation many typical cv symptoms elevated troponin associated worse outcomes including need admission intensive care unit icu increased mortality <NUMBER> management strategy patients covid<NUMBER> associated myocardial injury well defined largely targeted towards supportive care well management infection figure <NUMBER> <NUMBER> patients without significant cv symptoms lowlevel troponin release eg troponin <NUMBER> times upper limit normal uln absence hemodynamic instability recommend routine assessment left ventricular function therefore would routinely recommend echocardiography acute covid<NUMBER> reduce exposure hcw echocardiography unlikely change management significantly patients however strategy may need reevaluated casebycase basis b patients hemodynamic electrical instability mild troponin elevation heart failure cv testing including bedside echocardiography point care ultrasound pocus considered based expertise <NUMBER> patient suspected confirmed covid<NUMBER> specific cv symptoms ecg abnormalities arrhythmiaheart block elevated troponin cad myocarditis considered although cardiac mri considered gold standard noninvasive test diagnosis myocarditis patients covid<NUMBER> suspected myocarditis risk exposure hcw patients weighed carefully needed abbreviated imaging tailored specific clinical question considered role endomyocardial biopsy situation unclear may considered suspicion alternative etiology specific proven treatment covid<NUMBER> associated myocardial injury current therapy based reducing viral replication modulating host inflammatory response choice therapy guided severity illness hemodynamic compromise nsaids often used management myopericarditis however theoretical concern may increase ace<NUMBER> levels <NUMBER> additionally nsaids may also increase risk acute kidney injury aki hence recommend avoiding nsaids patients suspected confirmed covid<NUMBER> several antiviral therapies investigation early experience hydroxychloroquine without azithromycin france china covid<NUMBER> patients mild symptoms promising <NUMBER> subsequent larger study patients severe covid<NUMBER> shown significant clinical benefits <NUMBER> similarly recent large scale multinational registry well metaanalysis demonstrate clinical benefit hcq <NUMBER> furthermore combination hydroxychloroquine azithromycin may cause qt prolongation lifethreatening arrhythmias used caution continuous telemetry monitoring <NUMBER> compassionate use openlabel singlearm study <NUMBER> patients severe covid<NUMBER> <NUMBER> receiving invasive ventilation remdesivir associated clinical improvement <NUMBER> patients younger patients <NUMBER> years requiring noninvasive ventilation likely benefit remdesivir <NUMBER> united states food drug administration issued emergency use authorization use remdesivir treatment hospitalized patients severe covid<NUMBER> <NUMBER> evidence limited patients remain severely ill despite supportive care medications may considered consultation infectious disease specialists corticosteroids typically avoided treatment covid<NUMBER> due concern prolonging viral illness later stages inflammation typically associated excessive cytokine release leading hemodynamic instability endorgan damage corticosteroid administration may considered multidisciplinary discussion use corticosteroids efficacious treating myocarditis immune checkpoint inhibitors giant cell myocarditis <NUMBER> use coivd<NUMBER> related myocarditis limited case reports <NUMBER> il<NUMBER> contributes development cytokine release syndrome crs may play significant role sarscov<NUMBER> associated lung myocardial injury antiil<NUMBER> antibodies tocilizumab siltuximab may role management patients covid<NUMBER> <NUMBER> evidence use limited ongoing clinical trials clarify value tocilizumab shown reduce cv injury associated adverse outcomes patients chimeric antigen receptor car tcell therapy associated crs <NUMBER> <NUMBER> recommend patients hemodynamic electrical instability high cardiac troponin troponinx<NUMBER> uln newonset lv systolic dysfunction ef <NUMBER> context highgrade grade≥<NUMBER> crs even without significant cv complications therapy il<NUMBER> antibody considered second dose given <NUMBER> hours first dose needed intravenous immunoglobulin ivig utilized limited number cases covid<NUMBER> associated myocarditis evidence currently limited single case reports <NUMBER> given ivig welltolerated potential efficacy improving passive immunity modulating inflammation might considered severely ill patients early stage clinical deterioration patients covid<NUMBER> especially antiil<NUMBER> agent available convalescent plasma patients recovered sarscov<NUMBER> infection also studied potential therapy severely ill covid<NUMBER> patients <NUMBER> however specific utility patients covid<NUMBER> associated cv injury feasibility therapy unknown time reports acs patients covid<NUMBER> however incidence relationship unclear <NUMBER> hyperinflammatory response seen covid<NUMBER> may lead coronary plaque destabilization thrombosis therefore crucial develop strategy provide timely optimal care patients acs regardless covid status figure <NUMBER> caution recommended diagnosing acs particularly nstemi patients covid<NUMBER> mild elevations troponin could secondary multiple etiologies rather plaque instability stemi patients suspected confirmed covid<NUMBER> may represent plaque destabilization due acute systemic inflammation endothelial ace<NUMBER> receptor modulation sarscov<NUMBER> <NUMBER> microthrombi formation myopericarditis considered differential diagnosis particularly young patients without prior cvd significant risk factors <NUMBER> evidencebased guidance treating covid<NUMBER> stemi patients high suspicion myopericarditis cause stelevations extremely low suspicion plaque rupture coronary ct angiogram may considered stable patients rule cad pocus may also useful rule regional wall motion abnormalities use thrombolytic therapy suggested firstline therapy patients presenting nonanterior stemi hemodynamically stable <NUMBER> primary percutaneous coronary intervention pci standard practice available unless contraindicated even patients covid<NUMBER> given higher risk incomplete revascularization bleeding complications thrombolytic therapy <NUMBER> although doortoballoon time emphasized quality measure patients presenting stemi patients suspected covid<NUMBER> may slight delay due necessity using appropriate ppe minimize exposure hcw appropriate ppe available patient considered good candidate pci thrombolysis could considered <NUMBER> thrombolytic therapy used anticoagulation provided <NUMBER>hours patient admitted monitored evidence incomplete reperfusion revascularization many patients covid<NUMBER> may experience type ii mi given acute stress hypoxemia excessive inflammation secondary cytokine release <NUMBER> covid<NUMBER> associated hypercoagulability reported early clinical autopsy data although mechanism well understood likely multifactorial influenced <NUMBER> similarly microthrombi segmental pulmonary arteries noted autopsy <NUMBER> however findings could secondary cellular debris rather microthrombi cases could however may reasonable transition oral anticoagulant upon discharge case series <NUMBER> patients arrhythmias including atrial fibrillation reported <NUMBER> hospitalized patients higher rates critically ill patients <NUMBER> <NUMBER> another study <NUMBER> hospitalized patients wuhan china <NUMBER> noted ventricular arrhythmias <NUMBER> recommend baseline <NUMBER>lead electrocardiogram ecg telemetry monitoring hospitalized covid<NUMBER> patients hemodynamically stable patient af without heart failure rate control anticoagulation preferable attempt rhythm control echocardiogram deferred <NUMBER> weeks recovery atrioventricular nodal blocking agents betablockers calcium channel blockers digoxin used rate control drugdrug interactions considered patients antiviral therapy example hydroxychloroquine may increase level betablockers well digoxin may result toxicity <NUMBER> patient cardiomyopathy heart failure hypotension shortterm amiodarone considered urgent electrical cardioversion performed appropriate precautions hemodynamically unstable patients transesophageal echocardiogram tee considered aerosolizing procedure high risk contagion cardiac ct considered instead stable patients evaluation left atrial appendage thrombus cardioversion minimize potential exposure anticoagulation considered based individual risk profile appropriate monitoring patient sustained ventricular arrhythmia heart block myocarditis considered differential recommend cardiac troponin measurement echocardiogram pocus assessment qtc interval prolongation secondary antiviral therapies hydroxychloroquine electrolyte disturbances crs also lead ventricular arrhythmia see recommendations qtc monitoring <NUMBER> antiarrhythmic therapy used consideration drugdrug interactions patient sustained ventricular arrhythmias hemodynamic instability prompt defibrillation performed temporary transvenous pacemaker required bedside placement preferred instead catheterization electrophysiology laboratory minimize exposure hcw incidence arrhythmias patients less severe illness patients recover critical illness related covid<NUMBER> remains unknown research required guide need additional arrhythmia monitoring ambulatory setting determine need implantable wearable cardioverter defibrillator persistent impaired left ventricular function covid<NUMBER> associated myocardial injury hydroxychloroquine blocks voltagegated potassium channel kv<NUMBER> cause druginduced qt prolongation prolonging action potential duration <NUMBER> however clinically significant arrhythmia mostly seen context either longterm use patients sarscov<NUMBER> uses ace<NUMBER> coreceptor cellular entry remains unclear clinical trials underway assess safety efficacy reninangiotensinaldosterone system raas modulators patients covid<NUMBER> <NUMBER> present major societies escahaacc recommend continuing acei arb patients take medications chronically <NUMBER> besides covid<NUMBER> patient develops cardiomyopathy heart failure agents administered per guidelines tolllike receptor pathway protein myd<NUMBER> suggested play role coronavirus associated lung injury statins hypothesized reduce severity coronavirus infection stabilizing myd<NUMBER> levels attenuating nfκb activation <NUMBER> significant clinical data available based upon potential benefits established safety record recommend continuing statins patients mechanical support cardiogenic shock use extracorporeal membrane use percutaneous mechanical circulatory support mcs setting cardiogenic shock generally supported weak evidence demonstrating favorable hemodynamic impact given paucity supportive evidence mcs devices calculus even complicated setting infectious disease undefined clinical course risk posed operators involved deployment management devices thus far covid<NUMBER> pandemic little reported use mcs devices even venovenous ecmo respiratory failure used rarely support patients refractory hypoxemia <NUMBER> despite lack clarity may still prudent offer mcs select patients young age limited comorbid ailments without multisystem organ failure cardiogenic shock refractory optimal medical therapy figure <NUMBER> patients critically ill covid<NUMBER> high risk cardiac arrest either pulseless electrical activity ventricular arrhythmia <NUMBER> <NUMBER> crucial identify patients highrisk acute decompensation goals care discussed early avoid unwarranted resuscitation efforts risk viral aerosolization setting unplanned resuscitation early intervention intubation considered patients impending respiratory failure <NUMBER> currently focused navigate medical care covid<NUMBER> pandemic need recognize many nonurgent required cv testing procedures significantly delayed may longterm adverse impact try reopen normalize one daunting tasks identify highrisk patients limited resources prioritized expedite care patients although required ramp outpatient visits cv testing well procedures order minimize delay care need maintain highindex suspicion precautions prevent resurge covid<NUMBER> furthermore policies strategies developed today serve basis addressing next similar crisis patients preexisting cv risk factors cvd amongst vulnerable potentially increased risk acquiring sarscov<NUMBER> infection developing cv complications related covid<NUMBER> adverse outcomes provide consensusbased guidance management various cv conditions covid<NUMBER> pandemic dennison himmelfarb baptiste discuss implications coronavirus disease covid<NUMBER> cardiovascular socially atrisk populations covid<NUMBER> infectious respiratory disease caused newly discovered pathogen sarscov<NUMBER> novel rnadependent rna polymerase betacoronavirus thought derive bats time specific vaccines treatments covid<NUMBER> best way prevent slow transmission well informed covid<NUMBER> virus disease causes spreads coronavirus disease covid<NUMBER> implications cardiovascular socially atrisk populations novel coronavirus disease emerged december <NUMBER> less <NUMBER> months evolved worldwide pandemic <NUMBER> <NUMBER> <NUMBER> virus spread rapidly leading unprecedented global crisis shows signs abating near future wednesday april <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> <NUMBER> deaths reported globally <NUMBER> confirmed cases united states <NUMBER> <NUMBER> <NUMBER> deaths <NUMBER> statistical models predict <NUMBER> <NUMBER> hospital beds used united states end april <NUMBER> <NUMBER> impact covid<NUMBER> daily lives work families overall operations unprecedented modern times situation continues change daytoday basis addition constantly evolving information misconceptions among public pathology etiology transmission treatment risks associated covid<NUMBER> covid<NUMBER> infectious respiratory disease caused newly discovered pathogen sarscov<NUMBER> novel rnadependent rna polymerase betacoronavirus thought derive bats <NUMBER> incubation period covid<NUMBER> thought within <NUMBER> days exposure transmission occurs humantohuman contact <NUMBER> covid<NUMBER> virus spreads primarily droplets saliva discharge nose infected person coughs sneezes <NUMBER> understanding pathobiology clinical presentation virus risk factors morbidity mortality seen covid<NUMBER> although limited rapidly increasing see table <NUMBER> <NUMBER> infected asymptomatic creates challenges prevention efforts asymptomatic carriers often unaware covid<NUMBER> status people infected covid<NUMBER> virus experience mild moderate respiratory illness recover without requiring special treatment older people underlying medical problems cardiovascular disease diabetes chronic respiratory disease cancer likely develop serious illness <NUMBER> <NUMBER> clinical presentation severe cases covid<NUMBER> characterized hypoxia dyspnea greater <NUMBER> lung involvement imaging critical cases people infected covid<NUMBER> experience acute respiratory distress syndrome multipleorgan failure shock death <NUMBER> time specific vaccines treatments covid<NUMBER> <NUMBER> best way prevent slow transmission well informed covid<NUMBER> virus disease causes spreads world health organization centers disease control prevention cdc reliable public information sources <NUMBER> early data suggest covid<NUMBER> hypertension cardiovascular disease mortality rate <NUMBER> <NUMBER> times higher general covid<NUMBER> population suggesting highly susceptible severe effects disease <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> china underlying cardiovascular disease <NUMBER> furthermore early reports profound myocarditis fatal dysrhythmias suggest deleterious impact covid<NUMBER> cardiovascular systems <NUMBER> <NUMBER> <NUMBER> acute chronic cardiovascular complications pneumonia common covid<NUMBER> result various mechanisms including ischemia systemic inflammation pathogenmediated damage <NUMBER> <NUMBER> chronic cardiovascular conditions may become exacerbated setting viral infection consequence imbalance infectioninduced increase metabolic demand reduced cardiac reserve <NUMBER> patients coronary artery disease heart failure may particular risk result coronary plaque rupture secondary virally induced systemic inflammation rigorous use plaque stabilizing agents aspirin statins bblockers angiotensinconverting enzyme ace inhibitors suggested possible therapeutic strategy <NUMBER> procoagulant effects systemic inflammation may increase likelihood stent thrombosis assessment platelet function intensified antiplatelet therapy considered history previous coronary intervention <NUMBER> clear yet whether heightened systemic inflammatory procoagulant activity persist resolution covid<NUMBER> infection addition conjecture ace inhibitors angiotensin receptor blockers ubiquitously used cardiovascular patients may increase patients susceptibility virus <NUMBER> however currently american college cardiology american heart association recommended preemptively stopping starting ace inhibitor angiotensin receptor blocker setting covid<NUMBER> <NUMBER> <NUMBER> million americans form cardiovascular disease urgency increase awareness among healthcare providers potential impact covid<NUMBER> highrisk population cdc released general preventive measures covid<NUMBER> infection however socially atrisk persons underlying cardiovascular chronic conditions bear burden elevated risk developing severe complications death <NUMBER> <NUMBER> april <NUMBER> <NUMBER> general preventive measures including recommendations frequent handwashing social distancing curfews stayathome orders sanctioned hospitals healthcare systems across united states suspended elective surgeries procedures inpatient visits changing way people seek receive healthcare facilitated new legislation many healthcare providers offer telemedicine use mobile health technologies efforts limit exposure patients healthcare providers <NUMBER> options provide protection ongoing care many highrisk individuals feasible american heart association advising intensified caution underlying heart conditions including persons diabetes cardiovascular chronic lung kidney conditions <NUMBER> additional recommendations heart failure society america american college cardiology noted see table <NUMBER> <NUMBER> evidence guide clinical decision making generated extraordinary pace hypervigilance close attention guidelines needed critical time substantial concern socially atrisk persons cardiovascular conditions could experience delays seeking healthcare result selfisolation low health digital literacy lack primary care medical home <NUMBER> furthermore persons already limited access healthcare could compromised specifically ethnic minorities low income experience food insecurity housing instability lack social support transportation increase selfisolation due covid<NUMBER> particularly among older persons may also accelerate risks cardiovascular neurocognitive mental health problems <NUMBER> <NUMBER> addition concerns public health crisis may exacerbate discrimination racism stigma widespread disinformation across social media outlets <NUMBER> assessment health disparities covid<NUMBER> warranted fully understand burden pandemic atrisk populations including children removed school environment preventive measure aspects healthcare delivery affected pandemic <NUMBER> sudden rapid advancement covid<NUMBER> created unanticipated risk healthcare providers beyond transmission contraction disease frontline healthcare providers higher risk covid<NUMBER> infection impact underlying cardiovascular disease • covid<NUMBER> virus mainly targets lungs affect heart making work harder carry oxygenated blood throughout body increases risk heart attack rapidonset heart failure • covid<NUMBER> infection could exacerbate symptoms heart failure • viral illnesses known destabilize plaques develop blockages arteries putting one increased risk heart attack • patients older age comorbid cardiovascular risk factors weakened immune systems infected covid<NUMBER> highest risk developing serious complications including death • previous coronaviruses similar covid<NUMBER> sars mers linked inflammation heart muscle increases risk heart attack myocarditis rapidonset heart failure experiencing anxiety depression insomnia due burnout compassion fatigue <NUMBER> accelerating demands hospital beds personal protective equipment lifesaving apparatus ventilators continuous renal replacement machines introduced new financial burdens otherwise highresource health systems united states although close daily monitoring ongoing global battle covid<NUMBER> examination pandemics impact healthcare workers healthcare delivery systems warranted <NUMBER> many states enforcing stayathome orders healthcare providers challenged changing modes practice uncertain lengths time healthcare settings across nation expeditiously transitioning inperson telehealth visits retain access healthcare chronic conditions moreover telehealth visits used reduce visits emergency departments nonurgent matters timely intervention preserve emergency services severe symptoms silver lining may acceleration adoption expanded reimbursement telehealth broadening reach increasing efficiency chronic disease care <NUMBER> efforts sustain care improvements critical rapid spread phase pandemic covid<NUMBER> pandemic expected persist months must become familiar reliable sources information world health organization cdc <NUMBER> multitude ongoing studies clinical experience individuals covid<NUMBER> provide us much needed data illuminate understanding virus impact potential effect individual risk factors medications unclear time covid<NUMBER> impact physical mental health individuals recovery overall health disparities among socially atrisk populations information covid<NUMBER> rapidly evolving imperative healthcare providers reinforce general prevention guidelines addition recommendations persons cardiovascular disease american heart association heart failure society america american college cardiology <NUMBER> novel coronavirus cov emerged wuhan hubei province china december <NUMBER> known severe acute respiratory syndrome coronavirus type <NUMBER> sarscov<NUMBER> rapidly spread throughout chinese provinces subsequently propagated across globe <NUMBER> cases ≈ <NUMBER> deaths <NUMBER> countries httpswwwwho intemergenciesdiseasesnovelcoronavirus<NUMBER> situationreports world health organization therefore declared coronavirus disease <NUMBER> global pandemic march <NUMBER> <NUMBER> europe worlds covid<NUMBER> epicenter italy country highest number reported cases deaths march <NUMBER> italian institute health iss reported <NUMBER> cases <NUMBER> dea th italy httpswwwepicentroiss itcoronavirus overtook china country coronavirusrelated casualties pandemic propagating across usa <NUMBER> cases <NUMBER> deaths reported march <NUMBER> <NUMBER> currently sarscov<NUMBER> presents estimated r<NUMBER> ranging <NUMBER> <NUMBER> means infected individual may transmit disease <NUMBER> people susceptible population madjid et al <NUMBER> older adults dadamo et al <NUMBER> suffering multiple comorbidities sarscov<NUMBER> enveloped positivestrand rna virus belongs βcoronavirus βcov family presents <NUMBER> nucleotide identity sarslike covzxc<NUMBER> identified bats human sarscov nucleotide identity merscov reduced ≈ <NUMBER> chan et al <NUMBER> wan et al <NUMBER> lu et al <NUMBER> sarscov<NUMBER> mainly targets respiratory tract mammals including humans thereby inducing wide spectrum clinical features ranging asymptomatic paucisymptomatic forms interstitial pneumonia upon progressive alveolar damage severe acute respiratory failure may require advanced respiratory support intensive care two organ systems fact covid<NUMBER> may progress towards adult respiratory distress syndrome ards andor multiple organ acute failure eg kidney liver heart even death zhou et al <NUMBER>b wu et al <NUMBER>a wang et al <NUMBER>d although covid<NUMBER> respiratory disease one third patients severe covid<NUMBER> conjunctivitis wu et al <NUMBER>b patients showed gastrointestinal symptoms nausea vomiting diarrhea jin et al <NUMBER> interestingly epithelial cells several body compartments including oral nasal mucosa hamming et al <NUMBER> respiratory tree alveoli hamming et al <NUMBER> intestinal mucosa hamming et al <NUMBER> well human aqueous humor holappa et al <NUMBER> show high levels metallopeptidase named angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov<NUMBER> lan et al <NUMBER> ace<NUMBER> also expressed coronary intrarenal endothelial cells renal tubular epithelial cells donoghue et al <NUMBER> since ace<NUMBER> catalyzes cleavage angiotensin ii vasoconstrictor angiotensin <NUMBER> ang <NUMBER> vasodilator extrarespiratory localization supported hypotheses relationship sarscov<NUMBER> infection cardiovascular cv system indeed adult patients affected cvds arterial hypertension diabetes andor chronic obstructive pulmonary disease copd show worse clinical outcome following contraction viral illness fatality rate attaining <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> patients covid<NUMBER> pneumonia developed ards acute cardiac injury shock arrhythmia represent common lifethreatening complications along acute kidney injury chen et al <NUMBER>b huang et al <NUMBER> wang et al <NUMBER>a long known acute respiratory infections including flu pneumonias may trigger severe cv disease cvd events vice versa madjid et al <NUMBER> although experimental evidence topic still infancy hypothesize discuss suggestive cellular molecular mechanisms whereby sarscov<NUMBER> may lead detrimental consequences cv system focus aging cytokine storm nlrp<NUMBER>inflammasome hypoxemia air pollution emerging cv risk factor associated rapid urbanization globalization finally discuss impact clinically available cv drugs clinical course covid<NUMBER> patients understanding role played sarscov<NUMBER> cv system indeed mandatory get insights covid<NUMBER> pathogenesis design therapeutic strategy cardioprotection frail patients zheng et al <NUMBER> sarscov<NUMBER> cardiovascular system suggestive relationship first reports describing clinical features patients affected covid<NUMBER> hinted relationship sarscov<NUMBER>mediated infection cv system mainly due high inflammatory burden affecting myocardium vessels table <NUMBER> zheng et al <NUMBER> madjid et al <NUMBER> although suggestive causal relationship translational research carefully performed order avoid confounding factors hasty conclusions order support mention clinical evidences emerged best knowledge prevalence risk death severe covid<NUMBER> higher elderly patients chronic comorbidities arterial hypertension type <NUMBER> diabetes cardiac cerebrovascular disorders copd note diagnosis major cardiac complications ie acute myocardial injury lethal arrhythmias recently emerged analysis initial representative populations covid<NUMBER> patients first report analyzed cohort <NUMBER> patients median table <NUMBER> demographics baseline characteristics major complications patients infected sarscov<NUMBER> summary major studies huang et al <NUMBER> chen et al <NUMBER>b wang et al <NUMBER>a zhou et al <NUMBER>a guan et al <NUMBER> ards acute respiratory distress syndrome copd chronic obstructive pulmonary disease cvd cardiovascular disease age <NUMBER> years <NUMBER> men majority n <NUMBER> <NUMBER> exposed huanan seafood liveanimal market original epicenter covid<NUMBER> outbreak underlying comorbidities reported <NUMBER> patients including diabetes n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> hypertension n <NUMBER> <NUMBER> moreover increased blood levels highsensitivity cardiac troponin ctni reported <NUMBER> patients <NUMBER> initial finding cautiously suggests onset acute cardiac ischemic injury covid<NUMBER> patients yet measurements ctni levels always associated electrocardiogram ecg imaging findings myocardial ischemia giannitsis katus <NUMBER> make diagnosis intriguingly rising levels ctni also independent predictors mortality critically ill patients hospitalized severe pneumonia without evidence acute coronary syndrome lee et al <NUMBER> regard cannot exclude onset transient myopericarditis mimicking acute myocardial infarction severe covid<NUMBER> patients due cytokine storm inciardi et al <NUMBER> previously observed severe ards patients fact increased serum level proinflammatory cytokines instance interleukin<NUMBER>β il<NUMBER>β interferon γ ifnγ mcp<NUMBER> reported icupatients nonicu patients observation consistent development cytokine storm syndrome previously reported sars sarscov middle east respiratory syndrome coronavirus merscov infections de wit et al <NUMBER> second report analyzed cohort <NUMBER> patients median age <NUMBER> <NUMBER> men half n <NUMBER> <NUMBER> also exposed huanan seafood market chen et al lancet <NUMBER>b large percentage subjects n <NUMBER> <NUMBER> suffered cvd cerebrovascular disorders represent common chronic comorbidities cohort chen et al <NUMBER>b cardiac injury diagnosed measuring changes myocardial zymogram evaluates activity metalloproteinases myocardial zymogram results however risk overinterpreted since assay timp tissue inhibitor metalloproteinases free environment lindsey <NUMBER> since considered gold standard assay diagnose acute cardiac injury hospital setting established cardiac specific biomarkers tested fact authors also reported high circulating levels creatine kinase lactate dehydrogenase <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients respectively chen et al <NUMBER>b biomarkers generally used perform early diagnosis acute myocardial infarction yet since enzymes also present tissues myocardium diagnostic specificity limited diagnostic sensitivity also suffers presence sizeable baseline enzyme concentration circulation without cardiac pathology bodor <NUMBER> falsepositive results indeed may occur renal failure muscle fatigue vitamin deficiency pneumonia asthma malignancies pulmonary embolism hypoxia smokers particular <NUMBER> dead patients presented long history tobacco smoke exposure chen et al <NUMBER>b enhances risk respiratory cardiovascular disease well third report analyzed cohort <NUMBER> patients median age <NUMBER> <NUMBER> men hypertension n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> cancer n <NUMBER> <NUMBER> common coexisting underlying comorbidities small fraction subjects n <NUMBER> <NUMBER> suffering cerebrovascular disease note admission rate icu n <NUMBER> <NUMBER> remarkably increased among patients age displaying hypertension n <NUMBER> <NUMBER> cvd n <NUMBER> <NUMBER> cerebrovascular disease n <NUMBER> <NUMBER> underlying comorbidities finally arrhythmias n <NUMBER> <NUMBER> acute cardiac injury n <NUMBER> <NUMBER> defined increased blood levels hypersensitive ctni common complications arising icu patients affected ards n <NUMBER> <NUMBER> acute kidney injury n <NUMBER> <NUMBER> fourth singlecenter study analyzed epidemiological clinical features <NUMBER> hospitalized covid<NUMBER> patients median age <NUMBER> <NUMBER> men none exposed huanan market ninety patients <NUMBER> suffered least <NUMBER> underlying comorbidity common hypertension n <NUMBER> <NUMBER> followed diabetes n <NUMBER> <NUMBER> note lower fraction severe covid<NUMBER> patients suffered preexisting arrhythmia n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> finally singlecenter large study conducted <NUMBER> patients affected covid<NUMBER> <NUMBER> hospitals <NUMBER> chinese provinces median age <NUMBER> <NUMBER> men confirmed <NUMBER> subjects preexisting comorbidities guan et al <NUMBER> hypertension n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> cerebrovascular disease n <NUMBER> <NUMBER> guan et al <NUMBER> study acute cardiac injury defined increase circulating levels creatine kinase lactate dehydrogenase <NUMBER> <NUMBER> patients respectively guan et al <NUMBER> additional features acute myocardial infarction considered among different clinical reports retrospective multicenter cohort study including <NUMBER> adult covid<NUMBER> patients median age <NUMBER> <NUMBER> men confirmed preexisting comorbidities almost half individuals n <NUMBER> <NUMBER> hypertension n <NUMBER> <NUMBER> diabetes n <NUMBER> <NUMBER> coronary heart disease n <NUMBER> <NUMBER> zhou et al <NUMBER>a likewise nonsurvivors displayed higher rate comorbidities compared survivors including hypertension <NUMBER> vs <NUMBER> diabetes <NUMBER> vs <NUMBER> coronary heart disease <NUMBER> vs <NUMBER> zhou et al <NUMBER>a addition sepsis n <NUMBER> <NUMBER> respiratory failure n <NUMBER> <NUMBER> ards n <NUMBER> <NUMBER> acute kidney injury n <NUMBER> <NUMBER> common secondary outcomes cohort patients onset acute heart failure n <NUMBER> <NUMBER> acute cardiac injury n <NUMBER> <NUMBER> zhou et al <NUMBER>a note nonsurvivors presented higher rates acute heart failure <NUMBER> vs <NUMBER> acute cardiac injury <NUMBER> vs <NUMBER> compared survivors moreover laboratory findings showed high levels nonspecific biomarkers lactate dehydrogenase creatine kinase hypersensitive ctni amino acid sequence similar skeletal troponin c xu et al <NUMBER> proinflammatory biomarkers eg interleukin<NUMBER> il<NUMBER> serum ferritin zhou et al <NUMBER>a since measurement circulating biomarkers enough diagnose acute cardiac injury caused sarscov<NUMBER> certainty clinical investigations based multimodal approach encouraged similarly retrospective multicenter study conducted smaller cohort n <NUMBER> covid<NUMBER> patients confirmed risk death greater presence cvd note isolated myocardial injury resulted one main causes death patients <NUMBER> presence high levels il<NUMBER> creactive protein relationship sarscov<NUMBER> infection cvd corroborated recent descriptive analysis <NUMBER> covid<NUMBER> cases diagnosed china february <NUMBER> <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> study confirmed fraction patients affected cvd <NUMBER> including arterial hypertension <NUMBER> although retrospective studies cannot helpful made causal association confirmed mortality rate increased cvd <NUMBER> diabetes <NUMBER> chronic respiratory disease <NUMBER> arterial hypertension <NUMBER> novel coronavirus pneumonia emergency response epidemiology team novel coronavirus pneumonia emergency response epidemiology team <NUMBER> madjid et al <NUMBER> cvds really make difference worse prognosis covid<NUMBER> patients although italy european country highest percentage population aged <NUMBER> mortality rate due covid<NUMBER> among highest world madjid et al <NUMBER> still unknown whether greater vulnerability illness depends higher percentage older patients meanwhile iss recently listed common comorbidities observed deceased patients italy march <NUMBER> <NUMBER> table <NUMBER> <NUMBER> screened patients comorbidities majority patients presented one <NUMBER> two <NUMBER> three <NUMBER> comorbidities finally assume clinical outcome covid<NUMBER> progressively worsened italian elderly patients due combined impact multiple comorbidities frailty since cardiometabolic disease common people <NUMBER> risk developing increases people get older conceivable underlying cv metabolic comorbidities ie hypertension ischemic heart disease atrial fibrillation stroke diabetes contribute unfavorable prognosis older covid<NUMBER> patients addition <NUMBER> patients died acute myocardial injury httpswwwepicentroiss itcoronavirussarscov<NUMBER>decessiitalia first independent analyses suggest besides arising frequently individuals suffering underlying cv comorbidities sarscov<NUMBER> may cause severe myocardial injury even absence ards multiple organ dysfunctions often leading death besides local ischemia fatal myocardial damage covid<NUMBER> patients may due acute myocarditis unresponsive conventional therapy recently autopsy male covid<NUMBER> patient revealed myocardial infiltration interstitial mononuclear inflammatory cells xu et al <NUMBER>b evidence severe myocarditis associated low cardiac output syndrome even observed covid<NUMBER> patients italy inciardi et al <NUMBER> china findings consistent reported upregulation il<NUMBER> serum covid<NUMBER> patients chronic il<NUMBER> production viral infection long known boost myocarditis fontes et al <NUMBER> however investigation underlying mechanisms required although wellknown epidemic viruses ie sarscov merscov flu viruses influenza b virus may lead arrhythmia myocardial infarction acute heart failure aberrant systemic release proinflammatory cytokines cannot exclude factors activated sarscov<NUMBER> exacerbate cardiac injury characterizing covid<NUMBER> herein analyze potential role angiotensin converting enzyme <NUMBER> ace<NUMBER> pathway nlrp<NUMBER>inflammasome hypoxemia aging air pollution role reninangiotensin system ace<NUMBER> sarscov<NUMBER>induced cardiac injury best knowledge critical initial step underlying sarscov<NUMBER> entry target cells binding receptor binding domain rbd viral spike protein ace<NUMBER> receptor follows protein priming ser proteases tmprss<NUMBER> furin hoffmann et al <NUMBER> lan et al <NUMBER> since binding affinity protein ace<NUMBER> receptor major determinant viral replication rates disease severity li et al <NUMBER> cleavage spike protein plays critical role covid<NUMBER> airborne viral illness therefore first ace<NUMBER>rich cells encountered sarscov<NUMBER> delivered particle droplets upper respiratory tract particular goblets ciliated cells nasal epithelium sungnak et al <NUMBER> however ace<NUMBER> expressed active many human tissues preliminary evidence indicated ace<NUMBER> cardiomyocytes coronary pericytes could play potential role myocardial vulnerability sarscov<NUMBER> infection onset acute cardiac injury ace<NUMBER> one major player reninangiotensin system ras acts balance angiotensinconverting enzyme ace tikellis et al <NUMBER> contrary ace converts angiotensin ang angiotensin ii ang ii ace<NUMBER> mainly involved degradation ang ii thereby resulting formation ang <NUMBER> tikellis et al <NUMBER> ang ii induces vasoconstrictive proinflammatory prooxidative effects increasing expression endothelial von willebrand factor activating endothelial ang ii receptor type <NUMBER> at<NUMBER> dushpanova et al <NUMBER> ang <NUMBER> mediates antiinflammatory antioxidative vasodilatory effects binding mas receptor masr thus exerting beneficial effect several pathological conditions hypertension diabetes cvd tikellis et al <NUMBER> reference therein order maintain homeostasis ace<NUMBER> opposes actions ang ii negatively regulates ras physiological mechanisms shift balance towards prevalence effects ace ace<NUMBER> yet clear ace<NUMBER> carboxypeptidase removes single amino acids cterminus peptides ace peptidyl dipeptidase removes cterminal dipeptides pagliaro penna <NUMBER> addition ace<NUMBER> considered important enzyme outside classical ras hydrolyzes apelin ghrelin desarg bradykinin desarg neurotensin dynorphin a<NUMBER> well peptide substrates pagliaro penna <NUMBER> however precise interaction tissue ace ace<NUMBER> substrates byproducts yet clear humans ace<NUMBER> gene located x chromosome region xp<NUMBER> well known local ace<NUMBER> gene polymorphisms associated hypertension cvd well yagil et al <NUMBER> donoghue et al <NUMBER> komatsu et al <NUMBER> crackower et al <NUMBER> harmer et al <NUMBER> warner et al <NUMBER> fan et al <NUMBER> lower risk fatal cv events females vangjeli et al <NUMBER> evidence really important since women seem protected sarscov<NUMBER> infection preferentially targets elderly men although mechanisms underlie genderbased tolerance still unknown localization ace<NUMBER> x chromosomes may pivotal conceivable second x chromosome could protect women fatal polymorphisms make infection aggressive males eg favoring viral binding even hormonal changes may responsible estrogeninduced ace<NUMBER> expression reduced postmenopausal women hilliard et al <NUMBER> would make less amenable sarscov<NUMBER> infection compared agematched men prone systemic toxic effects due higher ang ii levels despite scarcity data humans suggestion supports recent hypothesis supporting view worse outcome older covid<NUMBER> italian patients due upregulation ang ii proinflammatory pathways throughout body presence lower ace<NUMBER> levels alghatrif et al <NUMBER> mentioned ace<NUMBER> largely expressed lungs kidney heart small intestine colon rectum endothelium donoghue et al <NUMBER> turner et al <NUMBER> represent main organs targeted damaged sarscov<NUMBER> herein first recall ace<NUMBER> regulates respiratory kidneys functions focus attention ace<NUMBER> could contribute acute myocardial injury covid<NUMBER> patients ace<NUMBER> lungs ras activity known elevated lung tissues fact endothelium pulmonary vessels important site ace therefore one main sources systemic ang ii ace<NUMBER> also strongly expressed lung upper airway pulmonary ace<NUMBER> may play role regulating balance circulating levels ang iiang <NUMBER> note ang ii contributes pulmonary vasoconstriction response hypoxia important pathophysiological mechanism useful prevent shunt patients lung injury pneumonia however local increase ang ii levels increases vascular permeability thus promoting onset pulmonary edema ards ras appears crucial maintaining oxygenation lionetti et al <NUMBER> ace<NUMBER> knockout mice showed severe symptoms wildtype mice kiely et al <NUMBER> imai et al <NUMBER> overexpression appears protective correlation ace polymorphism ards severity described humans matsuda et al <NUMBER> acute lung injury ace ang ii at<NUMBER> receptor function factors promote lung injury oudit et al <NUMBER> despite normal lung structure function ace<NUMBER> knockout mice show serious pathology case ardsacute lung damage compared wildtype mice since ace<NUMBER> plays important antiinflammatory role ace<NUMBER> knockout mice characterized increased vascular permeability pulmonary edema neutrophil accumulation recent studies ace<NUMBER> protects pulmonary vasoconstriction chronic pulmonary lesions fibrosis moreover ace<NUMBER> inhibits neutrophil infiltration lung inflammation limiting il<NUMBER> signaling reducing activity stat<NUMBER> pathway response bacterial infection rats sodhi et al <NUMBER> therefore ace<NUMBER> proposed new therapeutic target acute lung injury chronic lung disease bacterial pneumonia well indeed efficacy recombinant soluble human ace<NUMBER> protein acute respiratory failure currently studied humans phase ii clinical trial kuba et al <NUMBER> addition drugs developed increase pulmonary ace<NUMBER> expression antidiabetic glucagonlike peptide <NUMBER> receptor glp<NUMBER>r agonist liraglutide order improve lung function normalizing expression surfactant protein b romanípérez et al <NUMBER> reduced patients severe viral pneumonia kerr paton <NUMBER> ace<NUMBER> kidney ace ace<NUMBER> highly expressed adult kidney even different areas ace<NUMBER> mainly expressed proximal tubule edge brush ace seems evenly distributed apical basolateral membrane polarized cells tubules interestingly renal development kidney function normal ace<NUMBER> knockout mouse crackower et al <NUMBER> however angiotensinogen ace at<NUMBER> receptor lack results series alterations kidney morphology therefore ace<NUMBER> marginal role regulating renal function least healthy state however action ace<NUMBER> critical ras activation fact ang <NUMBER> exerts limited renal effects healthy state plays profound beneficial effects diabetic patients states associated renal damage instance ace<NUMBER> deficiency mouse models associated increased agerelated glomerulosclerosis enhanced ang iiinduced renal oxidative stress leading greater renal injury particular downregulation tubular ace<NUMBER> associated albuminuria tubular injury diabetic kidney inhibition ace<NUMBER> results augmented renal damage doan et al <NUMBER> li et al <NUMBER> oudit et al <NUMBER> wong et al <NUMBER> soler et al <NUMBER> hence ace<NUMBER> proving protective molecule kidney disease especially context negative regulation classical ras axis deletion ace<NUMBER> leads spontaneous lateonset nephrotic glomerulosclerosis accelerates diabetic kidney injury indeed glomerular disease albuminuria occur pharmacological inhibition ace<NUMBER> soler et al <NUMBER> note several forms chronic kidney disease especially diabetes found tubular ace<NUMBER> expression reduced however studies showed glomerular expression ace<NUMBER> increases acute kidney injury likely differential expression pattern tubular glomerular ace<NUMBER> may important determinant determining progression kidney disease kuba et al <NUMBER> cardiac resident cells ie endothelial cells pericytes cardiomyocytes ace<NUMBER> main enzyme involved local clearance ang ii previous experimental evidences indicate ace<NUMBER> essential regulator cardiac function involved response various cardiac cells multiple injuries especially associated overactivation classical ras pathway imai et al <NUMBER> different experimental models indeed ace<NUMBER> deficiency induces progressive cardiac fibrosis aging andor pressure overload moreover ace<NUMBER> deficiency accelerates postinfarct adverse ventricular remodeling causes early cardiac hypertrophy mice detrimental effects may prevented reversed following treatment ace inhibitors at<NUMBER> receptor blockers sartans hand ang<NUMBER> peptide treatment hamper cardiac remodeling improve myocardial performance even survival rodent heart failure models schindler et al <NUMBER> furthermore use mas receptor selective ligands ave<NUMBER> exerts cardioprotective effects similar ang<NUMBER> ischemiareperfusion ir injury myocardial infarction zeng et al <NUMBER> hypertensioninduced cardiomyopathy models ferreira et al <NUMBER> observations suggest altered balance ace ace<NUMBER> cv system critical driver progressive heart disease reverted inhibiting classical ace upregulating ace<NUMBER> pathway however still unknown myocardial ace<NUMBER> may worsen covid<NUMBER> clinical scenario contribute vulnerability sarscov<NUMBER> infection least role cardiac ace<NUMBER> sarscov<NUMBER>induced myocardial injury facts hypotheses patients cvds higher risk severe covid<NUMBER> show worse prognosis presence systemic inflammatory response immune system deregulation zheng et al <NUMBER> madjid et al <NUMBER> far unclear whether cardiac ace<NUMBER> signaling may play role cardiac injury yet following clinical evidences helpful support next focused investigations firstly since epithelial ace<NUMBER> gateway sarscov<NUMBER> entry cells attractive hypothesis sarscov<NUMBER> may directly affect myocardial tissue ace<NUMBER> endothelial cells pericytes cardiomyocytes cannot discounted priori agreement hypothesis preliminary reports provided evidence symptoms myocarditis covid<NUMBER> patients xu et al <NUMBER>b ruan et al <NUMBER>b hu et al <NUMBER> inciardi et al <NUMBER> also consistent rise hypersensitive ctni levels even reports lack histological detection myocardial inflammation myocardial localization sarscov<NUMBER> remains confirmed certainty cannot ignore viruses seasonal flu parvovirus b<NUMBER> cause myocarditis fung et al <NUMBER> however detection sarscov viral rna <NUMBER> cardiac biopsies performed patients sars outbreak toronto <NUMBER> suggestive support hypothesis coronavirus cardiotropism furthermore pulmonary infection human sarscov led ace<NUMBER>dependent myocarditis mice oudit et al <NUMBER> therefore conceivable sarscov<NUMBER> also infects cardiomyocytes secondly loss ace<NUMBER> associated increased susceptibility heart failure augmented ace<NUMBER> levels prevent reverse heart failure phenotype emerging key protective pathway heart pathology patel et al <NUMBER> accordingly cvd associated decreased baseline levels ace<NUMBER> expression chamsipasha et al <NUMBER> replication sarscov able progressively downregulate ace<NUMBER> protein expression dijkman et al <NUMBER> therefore hypothesized loss ace<NUMBER> function may also occur sarscov<NUMBER> infection garami <NUMBER> henry et al <NUMBER> particular binding sarscov<NUMBER> ace<NUMBER> might reduce residual ace<NUMBER> activity thereby altering ace ace<NUMBER> balance generating ras dysregulation higher ace andor lower ace<NUMBER> combination phenomena result cooccurrence lung heart renal acute failure garami <NUMBER> henry et al <NUMBER> predominance aceang ii at<NUMBER> axis function compared ace<NUMBER>ang<NUMBER> mas counterpart could responsible typical vasoconstrictive proinflammatory prooxidative effects ang ii occurring conditions could ultimately evolve acute heart failure ards zhang baker <NUMBER> henry et al <NUMBER> accordingly ace<NUMBER> production dramatically impaired ards resulting dominant ace activity wöstenvan asperen et al <NUMBER> considering peripheral ang ii levels found significantly higher covid<NUMBER> patients respect healthy subjects positively correlated viral load lung injury liu et al <NUMBER>b hypothesis ras pathway dysregulation lung cardiac injury sarscov<NUMBER> infection investigated garami <NUMBER> henry et al <NUMBER> third sarscov<NUMBER>dependent ace<NUMBER> downregulation could trigger monocytemacrophage activation induce severe lung inflammation contributing pathogenesis acute lung injury onset respiratory failure sodhi et al <NUMBER> garami <NUMBER> hypoxemia consequent severe interstitial pneumonia stimulate renin secretion renin gene expression kramer et al <NUMBER> thereby leading vicious circle garami <NUMBER> could enhance cardiac damage covid<NUMBER> patients notably high ang ii levels associated hypertension heart failure packer mcmurray <NUMBER> diabetes hao et al <NUMBER> represent common underlying comorbidities patients vulnerable sarscov<NUMBER> infection course relationship virus load onset magnitude covid<NUMBER> ace<NUMBER> downregulationdependent ras dysregulation lungs heart requires lot compelling evidence moreover additional studies mandatory investigate whether acute myocardial injury due sarscov<NUMBER> infection might related ace<NUMBER> expression rather activity role ace inhibitors arbs development sarscov<NUMBER> infection inhibiting classical ras pathway ace inhibitors angiotensin receptor blocker arb represents firstline pharmacological strategy treat arterial hypertension paz ocaranza et al <NUMBER> usually associated reduced lung function schnabel et al <NUMBER>b intriguingly ace<NUMBER> expression humans enhanced treatments thomson <NUMBER> whereas arbs losartan olmesartan found increase threefold cardiac ace<NUMBER> expression rat model acute myocardial infarction ami gurwitz <NUMBER> observation led investigators speculate mechanistic link preexisting use drugs predisposition sarscov<NUMBER> infection thomson <NUMBER> kuster et al <NUMBER> esler esler <NUMBER> described ace<NUMBER> heart section however ace<NUMBER> confers protection lung cardiac injury also proposed use ace inhibitors arb therapeutics treating covid<NUMBER> patients prior ards development gurwitz <NUMBER> although ace inhibitors provide imperfect renoprotection advanced type <NUMBER> diabetes cv risk remains elevated zoja et al <NUMBER> preliminary evidence limited cohort patients n <NUMBER> demonstrated difference fatality rate covid<NUMBER> patients pretreated ace inhibitors arb guo et al <NUMBER>a moreover inhibition classical ras pathway proved exert beneficial outcome patients affected viral pneumonia likely reducing respiratory inflammatory burden cytokine storm induced virus infection increased ace<NUMBER> expression henry et al <NUMBER> effect drugs ace<NUMBER> levels lungs still unknown larger clinical studies required assess impact ace inhibitors arb severity sarscov<NUMBER> infection recent joint statement american heart association american college cardiology heart failure society american recommended interrupting medications covid<NUMBER> patients affected chronic arterial hypertension unless otherwise required changes patients conditions madjid et al <NUMBER> indeed lifesaving drugs difficult replace since common antihypertensive drugs betablockers cause bronchoconstriction aggravating lung function general population schnabel et al <NUMBER>a common calciumchannel blockers may cause cardiac conduction defects impair myocardial contractility cause peripheral edema involvement ace<NUMBER> sarscov<NUMBER>induced acute myocardial injury remains controversial doubt cytokine storm associated virus infection highly detrimental heart acute respiratory infections characterizing interstitial pneumonia sarscov merscov long known result major acute cardiac complications may lead <NUMBER> increase shortterm fatality rate corralesmedina et al <NUMBER> cardiac complications associated viral pneumonia include malignant arrhythmias ami heart failure likely result increased myocardial workload infections accelerate myocardial injury infarction bonow et al <NUMBER> addition sarscov<NUMBER> shown trigger exaggerated systemic inflammatory response besides acute lung injury ards may ultimately lead multiple cv complications zheng et al <NUMBER> including ami unstable angina tachycardia heart failure stroke gorla et al <NUMBER> interestingly sarscov<NUMBER> promotes aberrant release proinflammatory cytokines chemokines alveolar epithelial cells vascular endothelial cells activated monocytes lymphocytes express ace<NUMBER> cells surface furthermore sarscov<NUMBER> could also induce lymphocyte death pyroptosis would explain covid<NUMBER> patients undergo lymphopenia thereby contributing exacerbate organ injury cytokine hypothesis cardiac damage postulates deleterious effects chronic cytokine release myocardium vascular endothelium may facilitate onset ami heart failure instance proinflammatory cytokines ie interleukin<NUMBER> il<NUMBER> il<NUMBER> tnfα exert negative inotropic effect cardiac contractility likewise sustained activation inflammatory signaling eg tnfα il<NUMBER>β may induce massive cardiomyocyte apoptosis lead adverse left ventricular remodeling favors onset acute heart failure additionally cytokine storm stimulates monocytesmacrophages release matrix metalloproteinases mmps boost atherosclerotic plaque growth rupture favor secretion procoagulant factors induce hemodynamic changes thereby increasing probability ami occur mann <NUMBER> newby <NUMBER> toldo abbate <NUMBER> indeed shortterm il<NUMBER> release exerts cardioprotective effect chronic activation il<NUMBER> signaling leads autoimmune myocarditis fontes et al <NUMBER> scenario underlying cvds predicted worsen outcome patients viral infections heart already established pneumonia seasonal flu several observations support contribution deregulated inflammatory signaling sarscov<NUMBER>induced myocardial injury zheng et al <NUMBER> instance huang et al observed plasma levels inflammatory mediators including il<NUMBER>β ifnγ ip<NUMBER> cxcl<NUMBER> mcp<NUMBER> ccl<NUMBER> upregulated covid<NUMBER> patients interestingly study also showed cytokine levels remarkably higher critically ill patients particular serum levels granulocytecolony stimulating factor gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a ccl<NUMBER> tnfα higher icupatients require icu admission thereby suggesting cytokine storm clinical predictor mortality ifnγ signature cytokine thelper<NUMBER> th<NUMBER> response rose <NUMBER> findings suggest balance proinflammatory th<NUMBER> response antiinflammatory thelper<NUMBER> th<NUMBER> response tipped favor former zheng et al <NUMBER> line observations zhu et al reported hypersensitive ctnt inflammatory biomarkers eg serum ferritin il<NUMBER> significantly higher nonsurvivors covid<NUMBER> patients zhou et al <NUMBER>a high inflammatory burden severe covid<NUMBER> confirmed another independent study reported higher levels serum ferritin il<NUMBER> creactive protein patients survive likely fulminant myocarditis ruan et al <NUMBER>b note overproduction inflammatory cytokines chemokines common sarscov wong et al <NUMBER> merscov mahallawi et al <NUMBER> patients acute lung injury diagnosed investigations required elucidate potential role cytokine storm pathogenesis cv complications including cardiomyopathy acute myocardial injury myocarditis following sarscov<NUMBER> infection understand potential mechanistic relationships cvd covid<NUMBER> outcomes discussed next paragraph nlrp<NUMBER> inflammasome might play triggering role cytokine storm induced sarscov<NUMBER> nlrp<NUMBER>inflammasome common feature viral infections cvd covid<NUMBER> innate acquired immune systems represent crucial defense pathogens indeed conceivable viral antigens firstly enroll innate immunity activating pattern recognition receptors prrs suppress viral replication modulate adaptive immune responses expression type interferon proinflammatory cytokines bowie unterholzner <NUMBER> last decades nlrp<NUMBER>inflammasome pathway emerged important mediator virusinduced inflammation mechanisms nlrp<NUMBER>inflammasome activation nlrp<NUMBER> prr belonging nod nucleotide oligomerization domainlike receptors nlrs able recognize damageassociated molecular patterns damps pathogenassociated molecular patterns pamps schroder tschopp <NUMBER> specific virus molecules stimulating downstream pathways contribute systemic immune response farag et al <NUMBER> nlrp<NUMBER> inflammasome multiprotein platform made sensor protein nlrp<NUMBER> adaptor protein asc cysteine protease precursor procaspase<NUMBER> schroder tschopp <NUMBER> zhou et al <NUMBER> activated nlrp<NUMBER> induces inflammasome assembly interacting asc turn triggers conversion zymogen procaspase<NUMBER> active caspase<NUMBER> franchi núñez <NUMBER> lastly caspase<NUMBER> established inflammatory caspase martinon tschopp <NUMBER> converts inactive proil<NUMBER>β proil<NUMBER> active proinflammatory cytokines il<NUMBER>β il<NUMBER> epstein dinarello <NUMBER> finally il<NUMBER>β stimulates release tnfα il<NUMBER> whereas il<NUMBER> increases circulating levels ifnγ il<NUMBER> il<NUMBER> il<NUMBER> thereby contributing immune inflammatory responses il<NUMBER>β il<NUMBER> represent key factors host defense davis et al <NUMBER> role nlrp<NUMBER>inflammasome covid<NUMBER> viral infection always associated inflammation farag et al <NUMBER> viroporins seem play triggering role rather viral pamps viroporins new class virus proteins composed <NUMBER> amino acids homooligomerize forming hydrophilic pores across organelle membranes thereby increasing permeability monovalent divalent cations ie na k ca <NUMBER> wang et al <NUMBER> nieva et al <NUMBER> structures appear play crucial role virus infectionlife cycle genome replication assembly farag et al <NUMBER> paving way consider possibility target viroporins antiviral strategies scott griffin <NUMBER> increase intracellular ca <NUMBER> concentration well reduction cytosolic k regarded among suitable triggering signals nlrp<NUMBER>inflammasome activation note viroporins mediate nlrp<NUMBER>inflammasome activation excessive production il<NUMBER>β guo et al <NUMBER> farag et al <NUMBER> date nlrp<NUMBER> inflammasome activation following viral infection reported influenza virus iav hepatitis c virus hcv encephalomyocarditis virus emcv sarscov liu et al <NUMBER> ichinohe et al <NUMBER> farag et al <NUMBER> reported increase proinflammatory cytokines levels il<NUMBER> il<NUMBER>β plasma also lungs lymphoid tissues patients affected sars mers recently covid<NUMBER> potentially consistent nlrp<NUMBER>inflammasome activation chen et al <NUMBER> huang et al <NUMBER> well known coronaviruses encode viroproteins e <NUMBER>a responsible least replication virulence nlrp<NUMBER>inflammasome activation ie sarscov castañorodriguez et al <NUMBER> chen et al <NUMBER> farag et al <NUMBER> sarscov proteins e <NUMBER>a ic differ intracellular distribution biophysical properties protein e locates endoplasmic reticulum ergolgi intermediate compartment functionality strictly dependent lipid environment composition nietotorres et al <NUMBER> induces ca <NUMBER> efflux sarscov<NUMBER> infection activates inflammasome complex leading acute proinflammatory response associated virus pathogenicity hand detailed targeting protein <NUMBER>a remains still elusive castañorodriguez et al <NUMBER> chen et al <NUMBER> farag et al <NUMBER> addition vitro studies revealed also sarscov open reading frame <NUMBER>a orf<NUMBER>a accessory protein strong inducer nlrp<NUMBER> inflammasome siu et al <NUMBER> may serve viroprotein chen et al <NUMBER> therefore plausible sarscov<NUMBER> may use mechanism action induce nlrp<NUMBER>dependent storm cytokines resulting severe systemic inflammation often causes fatal outcome surprising inhibition nlrp<NUMBER>inflammasome recently put forward promising strategy treat prevent acute cardiac injury ir injury liu et al <NUMBER> toldo abbate <NUMBER> pasqua et al <NUMBER> likewise targeting nlrp<NUMBER>inflammasome may represent attractive therapeutic strategy treatment virusassociated diseases cvd liu et al <NUMBER> pasqua et al <NUMBER> instance demonstrated nlrp<NUMBER>inflammasome activation hypertension induces sterile inflammation results chronic lowgrade inflammation characterized increased activity nfκb zhu et al <NUMBER> bullón et al <NUMBER> sustained nfκb signaling turn leads increased tissue andor circulating levels proinflammatory mediators il<NUMBER>β il<NUMBER> induces activation immune cells consequent detrimental effects respiratory tract heart dalekos et al <NUMBER> rabkin <NUMBER> krishnan et al <NUMBER> based upon evidences reasonable refer nlrp<NUMBER>inflammasome common pathogenic mechanism included vicious cycle triggers supports covid<NUMBER> common cv comorbidities arterial hypertension context targeting nlrp<NUMBER>inflammasome might serve therapeutic tool counteracting severe systemic inflammation following sarscov<NUMBER> infection time also mitigating underlying cvd reducing mortality rate hospitalized patients regard promising data provided drug recently acquired novartis namely ifm<NUMBER> already clinical trial mullard <NUMBER> agreement pulmonary diseases covid<NUMBER> poses remarkable challenge health hurdled blood oxygenation oxygen delivery tissues oxygen supply tissues becomes insufficient sustain normal function situation called hypoxia ensues whereas organstissues survive short response nonsevere hypoxia periods organstissues hypoxia represents intolerable hit may lead lethal outcomes myocardium cerebral tissues endangered heart brain represent primary targets acute respiratory failure several criteria recommend transfer patients icu one arterial blood oxygen saturation <NUMBER> pao<NUMBER> <NUMBER> mmhg smith nielsen <NUMBER> covid<NUMBER> pathology mainly concerns lung dysfunction patients may face severe hypoxia several days treatments aim correcting hypoxia oxygen therapy mechanical ventilation several concerns related effects prolonged hypoxia cv system first hypoxiadriven hyperventilation response mediated carotid bodies aimed restoring normal oxygenation necessarily implies excessive washout carbon dioxide shifts acidbase balance towards alkalosis response found healthy subjects even moderate altitude periods time ranging days samaja et al <NUMBER> several months porcelli et al <NUMBER> although often partially compensated metabolic acidosis alkalosis either origin represents common finding critically ill patients maehle et al <NUMBER> kreü et al <NUMBER> although yet documented alkalosis expected damage brain pulmonary tissue enhances oxidantinduced apoptosis several cell lineages auer <NUMBER> ando et al <NUMBER> second chronic hypoxia weakens myocardial resistance stress milano et al <NUMBER> acute hypoxiainduced pulmonary vasoconstriction last induces histological changes right ventricular rv myocardium netzer et al <NUMBER> contributing increase rv systolic pressure hypertrophy common features pulmonary hypertension mclaughlin mcgoon <NUMBER> addition effects elicited acute hypoxia chronic hypoxia leads pulmonary remodeling include increased pulmonary vessel density increased frequency small <NUMBER> μm wall thickness vessels increased thickness pulmonary lamina nydegger et al <NUMBER> nydegger et al <NUMBER> changes imputable excessive stimulation bone marrowderived progenitor cells favre et al <NUMBER> chronic hypoxia well known contribute significantly pulmonary hypertension ramchandran et al <NUMBER> associated many pulmonary hypertensionrelated diseases including chronic obstructive pulmonary disease cystic fibrosis diffuse interstitial fibrosis bronchopulmonary dysplasia infiltrative lung tumors congenital hearts defects ischemic events third odds happens healthy subjects exposed altitude hypoxia well known stimulate erythropoiesis piperno et al <NUMBER> goetze et al <NUMBER> systemic hypoxia represses erythropoiesis ards patients often develop severe anemia <NUMBER> gdl correlates poor prognosis may require blood transfusion silver <NUMBER> jenq et al <NUMBER> clinical scenario common icu patients nguyen et al <NUMBER> may attributable anemia inflammation whose etiology scarcely known physiological response hypoxia compensatory increase hemoglobin requires increase iron transport use fact demands stabilization ferroportin transmembrane protein enables iron release cells increased intestinal absorption degradation ferroportin mediated hepcidin hep decreases healthy subjects thereby enabling compensatory response hypoxia gassmann muckenthaler <NUMBER> however hep levels increase ards patients galesloot et al <NUMBER> despite hypoxic condition consequent loss hep regulation may limit efficacy ironreplacement therapies lasocki et al <NUMBER> mechanism may relevant ards covid<NUMBER> patients iron release circulation deregulated uptake tissues use iron may saturate transferrin increase nontransferrinbound aliquot iron possibly triggering unspecific oxidative stress injury fourth although correction hypoxia oxygen therapy remains major lifesaving concern icu patients excess oxygen delivery hyperoxia may cause considerable harm ottolenghi et al <NUMBER> facts hyperoxia caused breathing mixtures <NUMBER> oxygen markedly elevates reactive oxygen species ros release circulation contributes tissue injury oxidative stress nagatomo et al <NUMBER> hyperoxiainduced injury may occur even patients undergoing laparoscopic surgery breathing mixtures containing <NUMBER> <NUMBER> oxygen ottolenghi et al <NUMBER> hyperoxiadriven oxidative stress expected alter expression genes regulate pathways underlying different responses oxidative stress terraneo samaja <NUMBER> intuitively direction alterations driven hyperoxia opposite elicited hypoxia however evidence case many instances example regulation gene transcription hypoxiainducible factors hifs hifs well known respond hypoxia acting transcriptional factors array genes participate various cell processes angiogenesis metabolism cell proliferation control rosinduced damage many others giordano <NUMBER> including apoptosis autophagy ziello et al <NUMBER> gui et al <NUMBER> recent studies show hif<NUMBER>α hif<NUMBER>α indeed upregulated response hyperoxia well least brain benderro et al <NUMBER> types cancer terraneo et al <NUMBER> terraneo et al <NUMBER> hepatocytes wikenheiser et al <NUMBER> marconi et al <NUMBER> heart gyongyosi et al <NUMBER> although injury led hyperoxia yet studied led hypoxia established hyperoxia reduces expression angiogenic vascular endothelial growth factor vegf signaling capillary density benderro et al <NUMBER> reduces antiapoptotic defense increasing expression proapoptotic proteins bax bad decreasing activation antiapoptotic proteins bcl<NUMBER> bclxl brutus et al <NUMBER> increases neuronal apoptosis concomitantly decreased protective pakt erythropoietin signaling accumulates oxidized lipids prot eins ta r k v e l <NUMBER> <NUMBER> <NUMBER> w n r e g u l e neurotrophins provide tropic support developing neurons felderhoffmueser et al <NUMBER> stimulates ferroptosis newly discovered irondependent form cell death thereby contributing brain damage li et al <NUMBER> striking feature covid<NUMBER> pandemics high incidence fatalities elderly patients guan et al <NUMBER> wang et al <NUMBER>a zhou et al <NUMBER>a recent analysis italian institute health revealed overallcase fatality rate increased aging china italy however fatality rate italy remarkable higher compared china <NUMBER> vs <NUMBER> higher death tolls italy among subjects aged <NUMBER> years <NUMBER> vs <NUMBER> among older <NUMBER> <NUMBER> vs <NUMBER> increase covid<NUMBER>related mortality rate italy may ascribed demographic characteristics country <NUMBER> population aged <NUMBER> years <NUMBER> onder et al <NUMBER> note aging represents one detrimental risk factors cv system obas vasan <NUMBER> addresses issue frailty older population critical parameter accounted control covid<NUMBER> pandemics frailty labeled problematic expression population ageing clegg et al <NUMBER> often confounded disability comorbidity frailty assuming separate distinguished features highlight presence welldefined phenotype characterizes elders many elders multiorgan dysfunction frailty representing unifying notion care elderly patients directs attention away organspecific diagnoses clegg et al <NUMBER> concept frailty universally defined individuals state increased vulnerability susceptibility adverse health outcomes death exposed stressor case pulmonary diseases arising sarscov<NUMBER> infection presence agedependent excess ros reactive nitrogen species rns frailty may viewed result disruption organisms homeostatic balance leads heterogeneous clinical manifestations individual exposed endogenous exogenous stressors minor non negligible number people <NUMBER> years old considered frail prevalence physical frailty ranges <NUMBER> <NUMBER> mean <NUMBER> higher prevalence persons <NUMBER> years old among patients multiple comorbidities collard et al <NUMBER> absence pandemics prevalence frailty cvd increase age making coexistence common epidemiological studies suggest frailty may represent important prognostic marker patients several types cvds including coronary artery disease heart failure well older people undergoing surgical transcatheter interventions afilalo et al <NUMBER> despite unclear biological underpinnings frailty unexplored interaction heart failure appears frailty cvd share common pathophysiological pathways bellumkonda et al <NUMBER> among cvds ami major cause death morbidity loss quality life industrialized countries accounting <NUMBER> million deaths per year worldwide steg et al <NUMBER> aging classically regarded greatest risk factor ami indeed endothelial cell senescence due increased ros production dysfunction nuclear factorerythroid<NUMBER>related factor <NUMBER> nrf<NUMBER>mediated antioxidant response pathway may compromise endothelial nitric oxide bioavailability exacerbate inflammatory response pathogenesis agerelated vascular diseases ie ami stroke older patients fulop et al <NUMBER> ungvari et al <NUMBER> excess ros rns central many pathways leading cardiac hypertrophy failure tocchetti et al <NUMBER> accordingly incidence ami casefatality mortality rate markedly higher elderly patients also prone develop postami heart failure afilalo et al <NUMBER> compared younger subjects aged patients less amenable receive percutaneous coronary intervention less sensitive fibrinolytics carro et al <NUMBER> therefore impaired resilience cardiovascular cells oxidative stressors presence deficiency relevant antioxidant mechanisms ie nrf<NUMBER>related pathway may lead sarscov<NUMBER> detrimental consequences aged heart vasculature moreover correct finetuning nitrosoredox balance fundamental function main components excitationcontraction coupling machinery tocchetti et al <NUMBER> despite predominance older patients cvd among population randomized clinical trials generally focused young subjects without comorbidities thereby generating data cannot extended elderly patients feature related higher case fatality rate older vs younger subjects hospitalized ami individuals aged ≥ <NUMBER> years old benefit pharmacological interventions established younger counterparts ami fleg et al <NUMBER> lower sensitivity cv drugs elderly depends ageassociated physiological changes pharmacodynamics pharmacokinetics together intrinsic deficits signaling pathways protection reasons higher incidenceseverity ami elderly subjects multifactorial easy reconcile single triggering event endothelial dysfunction regarded early mechanism among leading mismatch oxygen supply demand finally culminates ami moccia et al <NUMBER> addition aged endothelial cells lose capability proliferate replace neighboring damaged cells thereby aggravating impact coronary endothelium dysfunction moccia et al <NUMBER> consequently aged subjects susceptible develop coronary artery disease since aging endothelial cells coronary microcirculation unable express cytoprotective prosurvival antioxidant macromolecular damage repair antiinflammatory genes due deregulation relevant transcription factors pathways nrf<NUMBER> signaling oxidative damage quite remarkable microvascular endothelial cells affected nad depletion sirtuin <NUMBER> dysregulation kiss et al <NUMBER> dampening angiogenic activity thus leading microvascular rarefaction established hallmark aging valcarcelares et al <NUMBER> likewise nrf<NUMBER> signaling disrupted aging also cardiac myocytes silvapalacios et al <NUMBER> fibroblasts nacarelli et al <NUMBER> thereby contributing enhance cardiac vulnerability oxidative stress thus appears impairment nrf<NUMBER> transcriptional activity key increase cv risk aging could therefore worsen cv damage older covid<NUMBER> patients scenario could even worsened oxygen therapy required hyperoxiainduced ros release postulated exert stronger cytotoxic effect aged vasculature due lower resilience oxidative stress agreement hypotheses recent study demonstrated genetic depletion nrf<NUMBER> worsened agerelated impairment endothelial bioavailability endothelial monolayer integrity addition genetic silencing nrf<NUMBER> resulted dramatic increase secretion proinflammatory cytokines fulop et al <NUMBER> also known senescenceassociated secretory phenotype sasp cytokines include il<NUMBER>β tnfα ungvari et al <NUMBER> recently shown mediate covid<NUMBER>induced cytokine storm enhancing proinflammatory phenotype might represent another mechanism whereby agingdependent nrf<NUMBER> dysfunction contributes exacerbate detrimental consequences sarscov<NUMBER> cv system moreover aging associated significant perturbation ca <NUMBER> signaling toolkit cardiomyocytes leads dramatic impairment heart muscle contraction hamilton terentyev <NUMBER> higher mortality ami individuals linked agerelated decline endogenous protective mechanism myocardial ir injury indeed preand postconditioning powerful interventions aimed reduce infarct size eliciting endogenous cardioprotection response one several brief cycles sublethal myocardial ir precede follow respectively sustained potentially lethal ischemic insult conditioning protocols recruit complex cascade intracellular signaling pathways mainly risk safe converge mitochondria limit cell death pagliaro et al <NUMBER> although pharmacological conditioning recapitulates endogenous mechanisms cardioprotection induced preand postconditioning might exploited therapy ami conditioning protocols barely effective aged hearts thereby exacerbating ir injury loss cardioprotection elderly people irreversible might either rescued preserved alternative strategies exercise boengler et al <NUMBER> also promotes angiogenesis increases vascular density aging mouse models ami bei et al <NUMBER> presently experimental evidencebased difference clinical management young vs elderly presumably frail subjects least cvd conversely sharp decrease endogenous mechanisms cardioprotection angiogenic repair aging suggests older subjects undergo distinct treatment compared younger individuals older patients left effective therapeutic methods alleviate symptoms restore distal perfusion preserve tissue viability calling innovative approaches restore efficiency cardioprotective mechanisms aging example pursuing alternative strategies foster preconditioning postconditioning endogenous protection boengler et al <NUMBER> matter facts actual strategies treatments covid<NUMBER> patients essentially young elder patients cv patients respond differently depending age frailty shouldnt occur covid<NUMBER> patients one could however suggest restoring endothelial function eg microvascular level improving vascular health aging could represent effective strategy treat covid<NUMBER> critical patients instance activation nrf<NUMBER> drugs eg propofol mechanical ventilation oltipraz zhou et al <NUMBER>c ruan et al <NUMBER>a epigenetic compounds eg nicotinamide mononucleotide resveratrol histone deacetylase inhibitors csiszár et al <NUMBER> pooladanda et al <NUMBER> kiss et al <NUMBER> could rescue least partially stress resilience endothelial cardiac cells aging individuals affected covid<NUMBER> otherwise regular physical exercise dietary intake functional foods lionetti et al <NUMBER> also shown activate nrf<NUMBER> myocardium well across variety tissues could advised frail older people reduce risk develop major cv complications case sarscov<NUMBER> infection mcphee et al <NUMBER> done traustadóttir <NUMBER> correlation pm exposure cvd covid<NUMBER> conjecture preliminary evidence provided favor relationship number days exceeding limits particulate matter pm <NUMBER> ie fine material airborne diameter <NUMBER> μm recorded control units cities number hospitalizations covid<NUMBER> northern italy setti et al <NUMBER> area country suffered highest number cases fatalities pm worldwide recognized important prompt cvd inhalation pm certainly trigger multiple cv disorders ami heart failure stroke urban communities liang et al <NUMBER> inhalation smaller pm pm <NUMBER> ie fine material airborne diameter <NUMBER> μm leads pulmonary inflammation cardiotoxicity via secondary systemic effects mills et al <NUMBER> easily reach alveolar space irritating alveolar wall onset lung dysfunction xing et al <NUMBER> cohen colleagues reported four million deaths attributable pm <NUMBER> nearly <NUMBER> due cvds cohen et al <NUMBER> link emphasized countries air pollution concentration continuing rise mills et al <NUMBER> exposure pm still associated incidence coronary events europe even though limit value set <NUMBER> μgm <NUMBER> daily cesaroni et al <NUMBER> scientific literature reports air pollution pm associated plethora cv events angina ami arrhythmia heart failure dockery et al <NUMBER> samet et al <NUMBER> peters et al <NUMBER> mann et al <NUMBER> brook et al <NUMBER> bhatnagar <NUMBER> mills et al <NUMBER> hence comorbidity pathologies obesity hypertension seems impact cvdassociated mortality adults daily exposed higher levels pm mazidi speakman <NUMBER> timestratified casecrossover study design evaluated milan area lombardy region italy winter period <NUMBER> independent shortterm effect flu outbreaks air pollution temperature murtas russo <NUMBER> observed statistically significant relationship pm <NUMBER> levels flu cvd mortality flu temperature deaths natural causes wuhan region china air quality index extremely low average daily pm concentration <NUMBER> μgm <NUMBER> similar association air pollution mainly no<NUMBER> cvd mortality <NUMBER>year period <NUMBER> <NUMBER> <NUMBER> <NUMBER> observed albeit correlation found directly among pm <NUMBER> cvd liu et al <NUMBER> positive relationship pm <NUMBER> influenzalike illness flu season reported period january <NUMBER>december <NUMBER> observed via timeseries analysis beijing feng et al <NUMBER> lombardy wuhan areas hitherto clusters worldwide pandemic covid<NUMBER> higher number people deceased contrast rest nations italy china virus also spread less aggressiveness march <NUMBER> chen al provided evidence avian influenza h<NUMBER>n<NUMBER> may subjected intercontinental transportation via saharian dust chen et al <NUMBER> thus one wonders air pollution impact upon covid<NUMBER> spread ciencewicki jaspers <NUMBER> position paper italian society environmental medicine proposed pm could represent factor favors longterm persistence viruses atmosphere h p w w w n l u w p w p contentuploads<NUMBER>covid<NUMBER>positionpaper engpdf indeed lombardy region number infected persons quarantine lockdown mean number pm <NUMBER> exceedancesmonitoring stations results r<NUMBER> correlation <NUMBER> study concluded tangible risk pm may serve carrier viruses northern regions italy whereas investigation solid data necessary disentangle hypothesis strengthen hypothesis exceedance pm period february <NUMBER> <NUMBER> number covid<NUMBER> cases reported march <NUMBER> italian national institute health visually correlated clear analysis selected provinces lombardy piedmont emiliaromagna majority covid<NUMBER> cases occurred far pm <NUMBER> exceedances increment higher preliminary data hint correlation air pollution represents established risk factor covid<NUMBER> indepth retrospective crosssectional investigations required keeping mind quarantine drastically reduced pm concentration aforementioned regions httpswwweeaeuropaeuhighlightsairpollutiongoesdownas search effective treatment proposal repurposing antihypertensive drugs treat covid<NUMBER> covid<NUMBER> outbreak poses complex challenge biomedical community design immediate effective therapy reduce high fatality rate among patients especially older andor comorbidities present specific antiviral drugs provided satisfactory outcomes treatment disease whereas suitable largescale vaccine still far available regard worth noticing even sarscov pandemic emerged <NUMBER> years ago <NUMBER> <NUMBER> still awaits specific antivirals approved vaccines conventional safety protocols including quarantine affected individuals tracing patients contacts social distancing selfmonitoring use masks travel restriction adopted mitigate spread covid<NUMBER> nevertheless approach sufficient constrain disease propagation basic reproduction number r <NUMBER> lower <NUMBER> andor percentage identified contacts higher <NUMBER> mitjà clotet <NUMBER> scenario growing number patients throughout globe require effective treatment repurposing clinically available antivirals treat covid<NUMBER> already described case ebola sarscov outbreaks kruse <NUMBER> repurposing clinically approved drugs invocated effectively treat patients greater risk death instance raising hope lopinavir ritonavir employed human immunodeficiency virus hiv protease inhibitors could display clinical efficacy covid<NUMBER> recently dashed failure clinical trial china reviewed li de clercq li de clercq <NUMBER> clinical trials already launched china usa evaluate therapeutic efficacy multiple food drug administration fdaapproved antiviral treatments including nucleoside analogues favipiravir ribavirin experimental nucleoside analogue remdesivir nct<NUMBER> holshue et al <NUMBER> list antiviral agents proposed fight covid<NUMBER> include oseltamivir pencicloviracyclovir ganciclovir sarilumab galidesivir nitazoxanide rapamycin recombinant interferons chlorpromazine li de clercq <NUMBER> guo et al <NUMBER>b note randomized controlled clinical trial sarilumab nct<NUMBER> monoclonal antibody il<NUMBER> receptor currently assessing whether modification inflammatory response induced treatment could provide benefit reducing lung inflammation improving lung function covid<NUMBER> patients blocking sarscov<NUMBER> entry cytoplasm target vaccines plasmaderived therapy alternative mutually exclusive strategy consists identification small molecule drug could repurposed inhibit interaction virus target cells gunaratne et al <NUMBER>b kruse <NUMBER> mentioned section <NUMBER> sarscov<NUMBER> entry requires priming protein furin tmprss<NUMBER> hoffmann et al <NUMBER> walls et al <NUMBER> coutard et al <NUMBER> promising report revealed camostat mesylate fdaapproved drug blocks tmprss<NUMBER> activity effectively prevented sarscov<NUMBER> spread vitro hoffmann et al <NUMBER> addition fully surfaceexposed glycoprotein represents source accessible epitopes production neutralizing antibodies thus target ongoing vaccine design efforts walls et al <NUMBER> line use antibodyrich plasma donated patients fully recovered covid<NUMBER> evaluation determine could shorten length lessen severity illness blocking sarscov<NUMBER> entry targeting endosomal compartment chloroquine ca <NUMBER> antagonists finding opens way repurposing clinically available drugs interfering endocytic pathway mediating sarscov<NUMBER> entry target cell eg inhibition phmediated endocytosis bulk alkalinization endolysosomal el vesicles blockade el proteases instance fdaapproved cardiotonic steroids ouabain bufalin known selective blockage na k atpase significantly impair merscov infection endocytic pathway burkard et al <NUMBER> remarkably lysosomotropic compound chloroquine cheap widely available antimalarial drug shown block sarscov<NUMBER> infection vitro clinically relevant concentration wang et al <NUMBER>c according preliminary reports proved exert beneficial exerts covid<NUMBER> patients colson et al <NUMBER> mitjà clotet <NUMBER> gao et al <NUMBER> inciardi et al <NUMBER> chloroquine could indeed accumulate within acidic vesicles interfere el vesicle trafficking golden et al <NUMBER> note chloroquine also employed autoimmune disorders potential counteract cytokine storm associated covid<NUMBER> severity liu et al <NUMBER>a obviously therapeutic efficacy chloroquine covid<NUMBER> patients needs supported randomized clinical trials conducted large cohorts patients since margin effective therapeutic dose toxic dose narrow chloroquine poisoning associated serious cv disorders friskholmberg et al <NUMBER> nevertheless preliminary evidences endorse view usage single compound potentially able block viralhost cell interaction attenuate inflammatory response could provide effective weapon disease view hint alternative therapy covid<NUMBER> suggested cv comorbidities affecting patients ca <NUMBER> antagonists long used first line antihypertensive drugs due ability block ltype voltagegated ca <NUMBER> channels vascular smooth muscle cells godfraind <NUMBER> oparil et al <NUMBER> ca <NUMBER> antagonists include dihydropyridines eg nifedipine nicardipine nimodipine well phenylalkylamines eg verapamil benzothiazepine diltiazem godfraind <NUMBER> rosenfeldt et al <NUMBER> nifedipine verapamil diltiazem often used combination ace inhibitors sartans reduce arterial hypertension quite tolerable side effects godfraind <NUMBER> rosenfeldt et al <NUMBER> furthermore nicardipine strongly recommended antihypertensive agent stroke rosenfeldt et al <NUMBER> whereas verapamil largely employed treat hypertension ventricular arrhythmia godfraind <NUMBER> long known ca <NUMBER> antagonists may block endolysosomal el twopore channels <NUMBER> tpc<NUMBER> genazzani et al <NUMBER> moccia et al <NUMBER> play crucial role el trafficking patel <NUMBER> concentrations reported block ltype voltagegated ca <NUMBER> channels tpcs gated multiple agonists including nicotinic acid adenine dinucleotide phosphate naadp sphingosine el phospholipid phosphatidylinositol <NUMBER>bisphosphate galione <NUMBER> tpcsmediated ca <NUMBER> release recruits ellocated ca <NUMBER>sensitive decoders including calmodulin synaptotagmin vii arf<NUMBER> faris et al <NUMBER> regulate vesicular fusion trafficking galione <NUMBER> screening campaign aiming repurposing fdaapproved drugs novel antiviral compounds recently revealed classical ca <NUMBER> antagonists blocked ebola virus merscov infections vitro sakurai et al <NUMBER> gunaratne et al <NUMBER>a b ebola virus entry host cells occurs macropinocytosis followed relocation endosomal compartment thereafter virus binds endosomal membrane protein npc<NUMBER> fuse acidic late endosomeslysosomes release capside cytoplasm falzarano feldmann <NUMBER> recent series investigations demonstrated inhibiting tpcsmediated el ca <NUMBER> release nifedipine verapamil nicardipine diltiazem prevented viral genome entry cytoplasm sakurai et al <NUMBER> penny et al <NUMBER> subsequently strategy worked find clinically available tools treat mers first described saudi arabia <NUMBER> zaki et al <NUMBER> subsequently reported affect <NUMBER> subjects zumla et al <NUMBER> described sarscov<NUMBER> viral protein mediates merscov entry upon binding host cell receptor dipeptidyl peptidase <NUMBER> followed proteolytic priming via tmprss<NUMBER> raj et al <NUMBER> park et al <NUMBER> following clathrinmediated endocytosis merscov redirected el system protein proteolytically cleaved lysosomal proteases results vesicular fusion capside release cytoplasm millet whittaker <NUMBER> burkard et al <NUMBER> notably merscov pseudovirus translocation also attenuated blocking el tpcs verapamil nicardipine nimodipine gunaratne et al <NUMBER>b tpcs function homodimers subunit comprises two homologous sixtransmembrane domain motifs therefore represent molecular ancestors α cav subunits voltagegated na ca <NUMBER> channels share structural motifs within pore regions patel <NUMBER> line docking analysis ca <NUMBER> fluxes measurements confirmed ca <NUMBER> antagonists avidly bind tpc pore rahman et al <NUMBER> support proposal probe ca <NUMBER> antagonists treat covid<NUMBER> worth recalling chloroquine inhibits sarscov<NUMBER> virus entry promoting alkalinization el vesicles wang et al <NUMBER>c liu et al <NUMBER>a common strategy perturb el membrane fusion notably elevating el ph would also result significant reduction el ca <NUMBER> concentration usually around <NUMBER> μm el ca <NUMBER> refilling mainly driven h gradient morgan et al <NUMBER> faris et al <NUMBER> instance lysomotropic weak base nh <NUMBER> cl abrogates el ca <NUMBER> storage morgan et al <NUMBER> well merscov gunaratne et al <NUMBER>b sarscov yang et al <NUMBER> vincent et al <NUMBER> entry cytoplasm furthermore lysosomotropic agents also affected ace<NUMBER> localization vitro viral receptor remains trapped within perinuclear vacuoles upon pretreatment chloroquine nh<NUMBER>cl bafilomycin a<NUMBER> wang et al <NUMBER> besides supporting viral entry host cells preliminary evidence suggested tpcs contribute deliver el ca <NUMBER> signal responsible nlrp<NUMBER> inflammasome activation tseng et al <NUMBER> thus appears blocking tpcsmediated el ca <NUMBER> release either chloroquine ca <NUMBER> antagonists might represent potential perspective treat covid<NUMBER> patients interfering sarscov<NUMBER> infection subsequent inflammatory response hypothesis remains probed devoted experimental pipeline clinical trial launched china evaluate therapeutic outcome tetrandrine sarscov<NUMBER>infected subjects clinicaltrialsgov identifier nct<NUMBER> tetrandrine alkaloid isolated root stephania tetrandra vine grows china taiwan widely employed china treat autoimmune diseases cv disorders hypertension cancer tetrandrine targets multiple intracellular signaling pathways including ltype voltagegated ca <NUMBER> channels could explain beneficial effects cv system yao jiang <NUMBER> note tetrandrine recently shown inhibit tpcsmediated el ca <NUMBER> release attenuate ebola sakurai et al <NUMBER> merscov<NUMBER> gunaratne et al <NUMBER>b entry host cells findings however may suggest hypothesis repurposing ca <NUMBER> antagonists could prove effective treating sarscov<NUMBER> infection time attenuating cv respiratory dysfunction cooccurring older covid<NUMBER> patients covid<NUMBER> pandemic rapidly spread throughout globe preferentially affecting older individuals underlying cv comorbidities besides ards acute kidney injury cardiovascular complications also represent common consequence disease time cause adverse outcome covid<NUMBER> patients although cannot ignore emerging events druginduced sudden cardiac death among treated covid<NUMBER> patients chorin et al <NUMBER> clinical reports well support careful evaluation pathogenic mechanisms promote onset severe covid<NUMBER> due cvd following sarscov<NUMBER> infection include example classical ras pathway ace<NUMBER> nlrp<NUMBER>inflammasome hypoxemia fig <NUMBER> furthermore prevalence death toll covid<NUMBER> increases aging well frailty seems correlated prolonged exposure air pollution represent lifethreatening cv risk factors opinion understanding cellular molecular mechanisms exacerbate impact covid<NUMBER> patients existing cv pathologies lead major cardiac complications mandatory design truly cardioprotective therapy waiting vaccine fig <NUMBER> simplified scheme showing potential role regulation intracellular organelles calcium stores involved activation inflammasome following triggering cytokine storm inset top complex molecular mechanism plasma membrane level underlying different functional outcomes covid<NUMBER> infection vp viroporins caa calcium antagonists td tetrandrine cc chloroquine tpc two pore channels tmprss<NUMBER> serine protease el endolysosomes ace angiotensinconverting enzyme angiotensin ii receptor ang angiotensin apj apelin g protein coupled receptor mas angiopoietin <NUMBER> receptor evwf endothelial von willebrand factor et<NUMBER> endothelin <NUMBER> nitric oxide funding source involvement study design collection analysis interpretation data writing report decision submit paper publication conflict interest authors declare conflict interest availability data material applicable code availability applicable consent publication authors read approved revised manuscript willing publish ongoing pandemic coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarcov<NUMBER> many casualties <NUMBER> although acute respiratory syndrome main manifestation disease <NUMBER> understanding impact virus organs importance multiple organ dysfunctionfailure including cardiovascular manifestations contributed increased mortality patients covid<NUMBER> studies reported cardiac injury evidenced elevated levels biomarkers highsensitivity cardiac troponini hsctni brain natriuretic peptide bnp <NUMBER> <NUMBER> <NUMBER> cardiac complications several case reports included acute heart failure cardiac rupture sudden cardiac arrest <NUMBER> <NUMBER> <NUMBER> however autopsy studies found evidence direct myocyte assault virus apparent cardiac myocyte necrosisapoptosis <NUMBER> present prospective serial echocardiographic study aimed investigate cardiac structural functional changes patients covid<NUMBER> admitted intensive care unit icu compare cardiac characteristics deceased surviving patients january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> conducted prospective observational study investigate cardiac structural functional characteristics transthoracic echocardiographic examinations cohort patients admitted icu covid<NUMBER> trial registration nct<NUMBER> including criteria patients <NUMBER> diagnosed covid<NUMBER> according criteria established interim guidance <NUMBER> <NUMBER> <NUMBER> <NUMBER> admitted icu severe critical conditions patients <NUMBER> years old whose entire stay hospital lasted <NUMBER> hours excluded severity disease categorized according published criteria <NUMBER> <NUMBER> criteria severe cases included following <NUMBER> respiratory rate ≥ <NUMBER> per minute <NUMBER> blood oxygen saturation spo<NUMBER> ≤ <NUMBER> rest <NUMBER> partial pressure arterial oxygen fraction inspired oxygen ratio <NUMBER> <NUMBER> <NUMBER> lung infiltrates within <NUMBER> <NUMBER> hours patients needing mechanical ventilatory support presenting septic shock multiple organ dysfunction failure constituted critical cases study protocol conformed ethical guidelines <NUMBER> declaration helsinki identification information would impact personal privacy removed data collection hospital ethics commission approved study protocol waived written informed consent emerging infectious diseases according regulation issued national health commission peoples rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> epidemiological clinical laboratory outcome parameters prospectively collected standardized data collection forms electronic medical records system personal history confirmed patients family members two researchers hg mz independently reviewed forms double check data collected echocardiography performed using ge vingmed ultrasound system ge healthcare horten norway special protection contaminated area twodimensional <NUMBER>d doppler echocardiographic measurements followed recommendations american society echocardiography <NUMBER> protections echocardiographer cleaning equipment accordance latest esc recommendations <NUMBER> conventional parasternal longaxis view well apical <NUMBER>chamber <NUMBER>chamber <NUMBER>chamber views obtained images analyzed using ge echopac commercial software echocardiography determinations based observations two independent experienced reviewers jd ww blinded data left atrial la anteroposterior diameter left ventricular lv enddiastolic diameter lvedd lv endsystolic diameter lvesd interventricular septum ivs rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> thickness measured parasternal longaxis view using mmode echocardiography <NUMBER>d echocardiography la anteroposterior dimension <NUMBER>mm male <NUMBER>mm female patients defined la enlargement lvedd <NUMBER>mm male <NUMBER>mm female patients defined lv enlargement ivs thickness <NUMBER>mm defined ivs hypertrophy lv ejection fraction lvef calculated use modified simpsons rule apical <NUMBER>chamber <NUMBER>chamber views mitral ea ratio abnormality ea ratio <NUMBER> mitral inflow pattern apical <NUMBER>chamber view colorcoded tdi apical <NUMBER>chamber view used determine mean early late velocities septal lateral mitral annuli average ee ratio <NUMBER> considered abnormal mitral regurgitation categorized mild moderate severe according width vena contracta right atrial ra diameter measured apical fourchamber view distance lateral ra wall interatrial septum ra diameter <NUMBER>mm defined ra enlargement right ventricular rv basal diameter measured rvfocused view rv basal diameter <NUMBER>mm defined rv enlargement pulmonary artery systolic pressure pasp estimated tricuspid regurgitation pressure gradient pasp <NUMBER>mmhg defined increased pulmonary artery pressure tricuspid annular plane systolic excursion tapse measured mmode echocardiography cursor aligned along direction tricuspid lateral annulus apical <NUMBER>chamber view tapse <NUMBER> mm defined rv systolic dysfunction tricuspid regurgitation categorized mild moderate severe according width vena contracta clinical outcomes censored time data cutoff occurred april <NUMBER> <NUMBER> patients discharged april <NUMBER> followup continued telephone interview time diagnosis death recorded data analyses performed using spss <NUMBER> spss inc chicago illinois sas version <NUMBER> sas institute cary north carolina categorical data expressed absolute values percentages compared using chisquare fisher exact tests continuous data reported median interquartile range iqr compared using kruskalwalliswilcoxon rank sum tests cox proportional hazards regression model used estimate hazard ratios hrs <NUMBER> confidence intervals cis adjustment potential confounders mortality risk multivariable cox regression models used determine independent risk factors death two criteria considered necessary variable entered multivariable analysis model <NUMBER> univariate p value survivors vs nonsurvivors comparison ≤ <NUMBER> <NUMBER> plausible association risk death covid<NUMBER> according data provided literature time events described kaplanmeier curves groups compared using logrank test inferential statistical tests conducted significance level <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> authors full access take full responsibility integrity data authors read agreed report written rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> jan <NUMBER> <NUMBER> april <NUMBER> <NUMBER> total <NUMBER> patients admitted icu underwent serial echocardiography examinations prospectively enrolled study patients laboratoryconfirmed covid<NUMBER> infection observed patients evidenced increased peak concentrations highsensitivity creactive protein hscrp <NUMBER> interleukin<NUMBER> il<NUMBER> <NUMBER> elevated levels cardiac markers including hsctni bnp observed <NUMBER> <NUMBER> patients respectively according severity disease <NUMBER> <NUMBER> <NUMBER> classified critically ill <NUMBER> patients <NUMBER> classified severely ill demographic variables rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> including prevalence underlying cardiovascular diseases comorbidities similarly distributed severely ill critically ill patients table <NUMBER> however compared severely ill patients critically ill patients higher blood leukocyte count p<NUMBER> neutrophilic granulocyte percentage fortytwo <NUMBER> least one abnormal left andor rightheart echocardiographic parameter <NUMBER> patients <NUMBER> least one abnormal left heart echocardiographic manifestation <NUMBER> patients <NUMBER> least one abnormal right heart echocardiographic manifestation detailed comparisons echocardiographic manifestations severely critically ill patients illustrated figure <NUMBER> table <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> almost patients reduced lvef history cardiovascular diseases previous myocardial infarction mi <NUMBER> congestive heart failure <NUMBER> hypertension <NUMBER> regional wall motion abnormalities observed patients previous mi two patients previous mi reduced lvef thrombus formation within lv aneurysm eight patients <NUMBER> enlarged lv five <NUMBER> presented moderatesevere mitral regurgitation pericardial effusion noted <NUMBER> <NUMBER> patients median thickness <NUMBER>mm iqr <NUMBER>mm range <NUMBER> mm similar rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> prevalence critically ill <NUMBER> severely ill <NUMBER> cases p<NUMBER> twelve <NUMBER> patients died median age nonsurvivors <NUMBER> years iqr <NUMBER> years range <NUMBER> years <NUMBER> male shown table <NUMBER> table <NUMBER> comparing echocardiographic findings observe significant leftheart parameters except thicker ivs nonsurvivors <NUMBER> iqr <NUMBER> mm vs<NUMBER> iqr <NUMBER> mm p<NUMBER> however nonsurvivors abnormal rightheart parameters including elevated pasp <NUMBER> vs <NUMBER> figure <NUMBER> shows serial changes cardiac structural functional parameters <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity cox proportional hazards regression model used estimate mortality risk leftheart abnormality rightheart abnormality adjustment potential confounders leftheart abnormality associated mortality hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p trend <NUMBER> however abnormalities right heart associated increased mortality patients covid<NUMBER> hr <NUMBER> ci mortality <NUMBER> <NUMBER> <NUMBER> p trend <NUMBER> patients rightheart abnormality vs patients without rightheart abnormality shown figure <NUMBER> kaplanmeier survival curves similar patients vs without leftheart abnormalities p<NUMBER> logrank test however patients manifested rightheart abnormalities survival rate decreased p<NUMBER> logrank test nine <NUMBER> patients received ecmo monitored dynamic changes cardiac rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> structural functional parameters ecmo figure <NUMBER> nonsurvivors illustrated supplementary figure <NUMBER> univariate cox proportional hazards regression analyses previous malignancy neutrophilic granulocyte percentage lymphocyte percentage platelet count albumin level hsctni level il<NUMBER> level ivs thickness ra enlargement rv enlargement elevated pasp decreased tapse significantly associated mortality table <NUMBER> multivariable analyses identified hsctni hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> il<NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> independently associated mortality icu patients covid<NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> present echocardiographic study cohort icu patients covid<NUMBER> provided new insights structural functional features cardiac involvement main findings follows <NUMBER> echocardiographic abnormalities prevalent covid<NUMBER> patients severe critical condition <NUMBER> typical echocardiographic manifestation covid<NUMBER> rightheart dysfunction preserved lvef <NUMBER> rightheart abnormalities leftheart abnormalities associated increased mortality <NUMBER> multivariable analyses identified hsctni il<NUMBER> levels independent predictors increased mortality although emerging acute infectious pulmonary disease covid<NUMBER> cause extrapulmonary manifestations complications <NUMBER> early reports included patients died significant heart injury <NUMBER> <NUMBER> fact covid<NUMBER> virus invades cells angiotensinconverting enzyme<NUMBER> receptor also abundant heart raised question whether virus directly targets myocardium <NUMBER> study increased hsctni levels observed <NUMBER> severely critically ill icuadmitted patients covid<NUMBER> finding consistent previous reports increased levels cardiac injury biomarkers covid<NUMBER> <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> elevated hsctni level significantly higher mortality <NUMBER> exact mechanism underlying cardiac injury caused covid<NUMBER> remains unclear although speculation includes mechanistic link hyperinflammationcytokine storm <NUMBER> <NUMBER> present study severe systemic inflammatory stress observed among icu patients covid<NUMBER> evidenced significantly elevated hscrp il<NUMBER> levels moreover identified hsctni il<NUMBER> predictors mortality lessons previous coronavirus influenza epidemics suggested virus would either induce new cardiac pathologies andor exacerbate underlying cardiovascular diseases <NUMBER> postulated systemic inflammatory storm covid<NUMBER> might lead acute myocarditis <NUMBER> stress cardiomyopathy <NUMBER> acute coronary syndromes <NUMBER> recently described acute covid<NUMBER> cardiovascular syndrome <NUMBER> latter significantly impair lv systolic function might expected key characteristic cardiac involvement patients covid<NUMBER> lvef confirmed key determinant prognosis cardiac patients <NUMBER> <NUMBER> therefore surprising unexpected find cohort severely critically ill covid<NUMBER> patients majority preserved lvef <NUMBER> reduced lvef often associated preexisting heart disease moreover lvef comparable critically ill vs severely ill covid<NUMBER> patients covid<NUMBER> survivors vs nonsurvivors serial echocardiography reveal lvef deterioration nonsurvivors icu admission death leftheart abnormalities associated increased mortality covid<NUMBER> patients rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> thus findings support notion lv systolic dysfunction principal form cardiac involvement associated covid<NUMBER> contrast observed abnormal echocardiographic manifestations associated impaired lv diastolic function covid<NUMBER> patients evidenced ea ratio ee ratio abnormality ivs hypertrophy impaired lv diastolic function could attributed underlying cardiovascular comorbidities comorbidities comparable critically ill vs severely ill patients well nonsurvivors vs survivors moreover ivs thickness paralleled disease severity even increased significantly nonsurvivors icu admission death similarly previous study found subclinical diastolic left ventricular impairment common acute severe acute respiratory syndrome sars infection <NUMBER> findings impaired lv diastolic function preserved lv systolic function accordance findings several recent autopsy studies covid<NUMBER> <NUMBER> <NUMBER> one hand apparent myocardial necrosisapoptosis found myocardium covid<NUMBER> autopsy <NUMBER> <NUMBER> consistently although prevalence high elevation hsctni level mostly mild median <NUMBER> iqr <NUMBER> cohort may explain preserved lvef among patients studied hand diastolic lv dysfunction current study similar clancys report many <NUMBER> patients severe sepsis echocardiographic manifestations diastolic dysfunction <NUMBER> furthermore several studies reported diastolic rather systolic lv dysfunction independent predictor mortality patients severe sepsis <NUMBER> xu et al rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> taking together increased ivs thickness deteriorating lv compliance observed study might reflective interstitial inflammatory edema found sepsis studies <NUMBER> one third study patients rightheart abnormalities evidenced elevated pasp larger ra rv diameters decreased tapse among <NUMBER> history chronic lung disease moreover rightheart dysfunction leftheart dysfunction associated increased mortality cohort mechanism rightheart dysfunction covid<NUMBER> unclear may related vascular thickening lung <NUMBER> hypoxemia proinflammatory cytokines would provoke pulmonary vasoconstriction <NUMBER> possibility pulmonary embolism suggested extremely high concentration ddimer observed cohort populations close relationship mortality <NUMBER> postmortem study eight patients died sars showed four patients pulmonary thromboembolism <NUMBER> rapid development progression rightheart dysfunction reported patients acute respiratory distress rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint syndrome acute pulmonary embolism <NUMBER> adverse impact rightheart impairment prognosis also reported ards patients <NUMBER> reports ecmo utility covid<NUMBER> patients scarce clinical effectiveness outcomes remained unknown monitored dynamic changes cardiac structural functional parameters ecmo implantation ecmo implantation tended alleviate elevated pasp rightheart dysfunction critically ill patients theoretically application ecmo might reduce pulmonary hypertension improving oxygenation correcting hypoxemia alleviating pulmonary vasoconstriction moreover rv volume may unloaded venoarterial ecmo however nonsurvivors treated ecmo echocardiographic improvement temporary rightheart dysfunction deteriorated death supplementary figure <NUMBER> similar post ecmo scenario children pulmonary hypertension pertussis <NUMBER> thus seems key value ecmo implantation temporary life support gain time therapy treatment primacy pulmonary disease vital final prognosis first although data study prospectively collected analyzed blinded fashion sample size small second new echocardiographic technologies ie speckle tracking technology global regional function rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> deformation cardiac magnetic resonance imaging mri used fact current study included icu patients mechanical respiratory andor circulatory support strong infectious inherence limited application new imaging technologies third data obtained severely critically ill icu patients may representative general population rightheart dysfunction preserved lvef typical characteristic cardiac involvement icu patients covid<NUMBER> moreover rightheart leftheart dysfunction associated disease severity increased mortality findings facilitate unraveling underlying mechanisms myocardial injury optimize treatment strategy patients covid<NUMBER> grateful dr gary mintz critical constructive discussion manuscript refinement certified peer review authorfunder granted medrxiv license display preprint perpetuity certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ivs interventricular septal thickness pasp pulmonary artery systolic pressure rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> patients n<NUMBER> critically ill patients n<NUMBER> severely ill patients n<NUMBER> p value cox proportional hazards regression model used estimate hazard ratios hrs <NUMBER> confidence intervals cis adjustment potential confounders mortality risk multivariable cox regression models used determine independent risk factors death two criteria considered necessary variable entered multivariable analysis model <NUMBER> univariate p value survivors vs nosurvivors comparison <NUMBER> less rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> <NUMBER> plausible association risk death covid<NUMBER> according data provided literature ast aspartate aminotransferase altalanine aminotransferase bun blood urea nitrogen fdp fibrin degradation product bnp brain natriuretic peptide hsctni hypersensitive troponin hscrp hypersensitive creactive protein il<NUMBER> interleukin<NUMBER> interventricular septalivs lvef left ventricular eject fraction mr mitral regurgitation tr tricuspid regurgitation tapse tricuspid annular plane systolic excursion left atrium ap dimension <NUMBER>mmmale <NUMBER>mmfemale defined left atrial enlargement lvedd <NUMBER>mmmale <NUMBER>mm female defined left ventricular enlargement interventricular septum thickness <NUMBER>mm defined interventricular septal hypertrophy lvef <NUMBER> defined lvef reduction right atrium diameter <NUMBER>mm defined right atrial enlargement right ventricle basal diameter <NUMBER>mm defined right ventricular enlargement pasp<NUMBER>mmhg defined pasp elevation tapse <NUMBER>mm defined decreased tapse mitral tricuspid regurgitation categorized mild moderate severe according width vena contracts rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> past two decades outbreak prevalence severe acute respiratory infections seen one serious hazards global health two prominent coronaviruses <NUMBER> sarscov <NUMBER> merscov markedly affected humans causing <NUMBER> <NUMBER> infections well <NUMBER> <NUMBER> deaths respectively <NUMBER> <NUMBER> early december <NUMBER> series pneumonia cases unknown reason emerged wuhan hubei china highthroughput sequencing lower respiratory tract samples revealed novel coronavirus named <NUMBER> novel coronavirus <NUMBER>ncov also named sarscov<NUMBER> <NUMBER> february <NUMBER>th <NUMBER> <NUMBER> confirmed cases <NUMBER> death cases documented china <NUMBER>ncov also targets respiratory tract shares many similar clinical symptoms sarscov merscov <NUMBER> common symptoms include fever fatigue dry cough followed always anorexia myalgia dyspnea bo li jing yang contributed equally article bo li libosubmit<NUMBER>com yunhe zhao zhaoyunhemedmailcomcn <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphopenia prolonged prothrombin time also common characteristics <NUMBER> <NUMBER> <NUMBER> addition cardiologists also concerned whether patients cardiovascular disease greater risk <NUMBER>ncov whether new coronavirus infections impact cardiovascular system previous studies shown relationship cardiovascular metabolic diseases sars mers <NUMBER> <NUMBER> <NUMBER> systematic analysis <NUMBER> merscov cases showed diabetes hypertension prevalent <NUMBER> patients cardiac diseases present <NUMBER> cases <NUMBER> diabetes seen independent predictor mortality morbidity patients sars <NUMBER> spread <NUMBER>ncov increase cases <NUMBER>ncov infected individuals exhibit comorbidities hypertension diabetes cardiacerebrovascular disease chens study <NUMBER> cases <NUMBER> patients cardiacerebrovascular disease <NUMBER> huangs study <NUMBER> cases <NUMBER> patients diabetes <NUMBER> cardiovascular metabolic comorbidities might render susceptible poor prognosis given rapid spread <NUMBER>ncov updated metaanalysis significantly larger sample sizes integrating published studies urgently warranted accordingly present analysis identify cardiovascular epidemiological clinical characteristics <NUMBER>ncov infection greater precision also unravel impact infection cardiac injury preferred reporting items systematic reviews metaanalyses individual participant data prismaipd statement followed conduct reporting metaanalysis <NUMBER> identify studies illustrating prevalence impact cardiovascular metabolic diseases <NUMBER> novel coronavirus infection china embase pubmed carefully searched december <NUMBER> february <NUMBER> following search terms keywords used alone combination novel coronavirus influenza pneumonia cardiovascular disease hypertension diabetes cardiac injury inclusion criteria follows <NUMBER> comparative studies randomised controlled trials rcts nonrcts published english <NUMBER> study population ten participants included study <NUMBER> study intervention patients studies confirmed infected <NUMBER> novel coronavirus <NUMBER> parameters comorbidities cardiovascular metabolic diseases outcome cardiac injury given case reports nonhuman studies studies without adequate information studies written chinese fear data duplication excluded present metaanalysis prevalence comorbidities including hypertension cardiovascular cerebrovascular diseases diabetes table <NUMBER> fig <NUMBER> together clinical outcome cardiac injury confirmed elevation troponin creatine kinase seen second choice troponin provided extracted identified studies table <NUMBER> fig <NUMBER> primary outcome measure compare prevalence comorbidities impact cardiac injury icu nonicu cases severe nonsevere data second choice icu data provided cochrane collaborations tool followed assess risk bias analyses performed using openmeta analyst version <NUMBER> https wwwcebmbrown eduopenmeta revman software version <NUMBER> forest plots used illustrate prevalence cardiovascular metabolic diseases <NUMBER>ncov infection severity selected studies well impact <NUMBER>ncov infection cardiac injury results included studies performed fixedeffect models mantelhaenszel method <NUMBER> randomeffect models cases significant heterogeneity estimates <NUMBER> used <NUMBER> statistics assess magnitude heterogeneity <NUMBER> <NUMBER> <NUMBER> represented low moderate high degrees heterogeneity respectively chosen proper effect model based analysis results fixed effect model used <NUMBER> <NUMBER> random effect model used <NUMBER> ≥ <NUMBER> <NUMBER> initially identifying <NUMBER> articles <NUMBER> duplicate documents identified leaving trials review titles abstracts <NUMBER> documents nonhuman researches reviews studies clinical trials excluded leaving <NUMBER> studies carefully detailed evaluated last six studies excluded participants trials meet criteria set one study published medrxiv added finally total six studies <NUMBER> patients included <NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> selected studies published <NUMBER> different sample patient sizes ranged <NUMBER> <NUMBER> patients table <NUMBER> summarizes study characteristics systematic analysis studies described epidemiological clinical features covid<NUMBER> cases reported prevalence cardiovascular metabolic diseases well impact cardiac injury infectious disease identified six reports <NUMBER> patients table <NUMBER> majority cases localized wuhan recent travel wuhan contact people wuhan median ages respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> years old according six studies infection diagnosed throughout whole spectrum age covering new born <NUMBER> years old studies men likely infected women overall proportion male <NUMBER> metaanalysis identified studies showed prevalent cardiovascular metabolic comorbidities hypertension <NUMBER> <NUMBER> ci <NUMBER> cardiacerebrovascular disease <NUMBER> <NUMBER> ci <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates comorbidities among identified studies <NUMBER> index varied <NUMBER> <NUMBER> fig <NUMBER> compared difference prevalence three diseases severe patients nonsevere patients icu patients vs nonicu patients according data studies hypertension cardiacerebrovascular disease heterogeneity test results calculated <NUMBER> <NUMBER> <NUMBER> thus fixedeffect model used analyses results three included studies total amount <NUMBER> patients showed hypertension accounted <NUMBER> icu severe cases <NUMBER> nonicusevere cases similar pattern found cardiacerebrovascular disease statistics accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases proportion hypertension cardiacerebrovascular disease statistically significant higher icusevere patients compared nonicusevere patients hypertension rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> cardiacerebrovascular disease rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> diabetes heterogeneity test showed <NUMBER> <NUMBER> random effect model used diabetes accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases result indicated higher proportion diabetes icusevere patients without statistical significance rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> last focused impact covid<NUMBER> cardiac injury two studies gave clear data statistically analyzed data showed <NUMBER> <NUMBER> ci <NUMBER> patients might suffered acute cardiac injury another two studies gave data creatine kinase seen biomarker cardiac injury proportion might <NUMBER> <NUMBER> ci <NUMBER> attempted compare differences cardiac injury incidences icusevere patients nonicusevere patients included two studies specifically identified myocardial injury data showed significant higher incidence acute cardiac injury icusevere patients compared nonicusevere patients rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> funnel plots demonstrated symmetrical distributions effect size hypertension cardiacerebrovascular diseases cardiac injury either side pooled estimate nonsymmetrical distribution effect size diabetes fig <NUMBER> coronaviruses enveloped rna viruses include six species cause diseases humans knowledge <NUMBER> four viruses among <NUMBER>e oc<NUMBER> nl<NUMBER> hku<NUMBER> reported cause common cold symptoms immunocompetent individuals <NUMBER> however two strains infamous sarscov merscov linked fatal illness caused plagues large numbers deaths <NUMBER> complete genome sequences <NUMBER>ncov showed identified novel betacoronavirus belonging sarbecovirus subgenus coronaviridae family subgenus sarscov <NUMBER> according previous research sarscov presence comorbidities increased mortality risk cardiac disease diabetes important components predict adverse outcomes <NUMBER> cardiac disease diabetes increase risk death twice much risk factors <NUMBER> thus necessary us evaluate prevalence cardiac metabolic diseases covid<NUMBER> present systematic analysis summarized data five studies covid<NUMBER> results demonstrated overall proportion hypertension cardiacerebrovascular disease diabetes respectively <NUMBER> <NUMBER> <NUMBER> according summary <NUMBER> report cardiovascular diseases china morbidities hypertension diabetes respectively <NUMBER> <NUMBER> <NUMBER> million cerebrovascular disease patients <NUMBER> million cardiovascular patients <NUMBER> therefore comparing data report find people hypertension diabetes susceptible <NUMBER>ncov infection prevalence hypertension diabetes people infected virus general population even slightly lower however comparing general population incidence cardiacerebrovascular disease patients covid<NUMBER> obviously much higher due sample size limited time far data collection still incomplete studies analyzed comorbidities death cases relationship cardiovascular metabolic diseases covid<NUMBER>induced death cannot determined assuredly patients hypertension cardiacerebrovascular diseases diabetes likely develop severeicu cases <NUMBER>ncov infection overall proportion hypertension cardiacerebrovascular diseases diabetes twofolds threefolds twofolds respectively higher icusevere cases nonicusevere counterparts although difference diseases metaanalysis statistical fig <NUMBER> metaanalysis proportion hypertension cardiacerebrovascular disease diabetes covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions <NUMBER> diseases covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences <NUMBER> diseases icusevere nonicusevere patients ◂ fig <NUMBER> metaanalysis incidence cardiac injury covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions cardiac injury covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences cardiac injury icu severe nonicusevere patients fig <NUMBER> funnel plots comparisons hypertension cardiacerebrovascular disease diabetes acute cardiac injury icusevere nonicusevere patients rr value <NUMBER> consider might sample size included studies algorithm adopts random effect model conservative approach speculate result might reach statistical significance researches publish data another important finding damage virus heart according present summary least <NUMBER> patients covid<NUMBER> suffered acute cardiac injury chens report first death <NUMBER>year old man previous chronic underlying disease admitted icu developed severe respiratory failure heart failure sepsis experienced sudden cardiac arrest <NUMBER>th day admission declared dead <NUMBER> case reminded us patients novel coronavirus might develop acute cardiac injury analysis indicates us incidence myocardial injury much higher icusevere patients <NUMBER> folds nonicucardiac patients furthermore observation also reminded us patients covid<NUMBER> associated unstable angina stemi poor cardiac reserve lower tolerance severe pneumonia likely develop cardiac insufficiency leading deterioration according information released shanghai health commission first covid<NUMBER> death shanghai patient <NUMBER> years old serious history hypertension cardiac dysfunction analysis death causes suggested patient died heart failure systemic multiple organ dysfunction course onset <NUMBER> ncov infection inducement pathogenesis <NUMBER> ncov infectionrelated acute myocardial injury still unknown according clinical presentation lab data disease well pathogenesis sarscov speculated <NUMBER>ncov infection may affect cardiovascular system multiple mechanisms first viral infection directly causes damage cardiomyocyte according oudits study sarscov viral rna detected <NUMBER> autopsied human heart samples sarscov infected patients toronto sars outbreak <NUMBER> also confirmed pulmonary infection human sarscov mice led ace<NUMBER>dependent myocardial infection <NUMBER> ace<NUMBER> important target sarscov <NUMBER> molecular modelling shown high structural similarity receptorbinding domains sarscov <NUMBER>ncov <NUMBER> ace<NUMBER> expression highly tissuespecific mainly expressed cardiovascular renal gastrointestinal systems small amount expressed lung cells therefore addition coronaviruses causing pneumonia ace<NUMBER> receptors lung epithelial cells also need pay attention possible viral effects myocardial tissue second hypoxaemia may also important reason cardiac injury huangs study <NUMBER> covid<NUMBER> patients various degree hypoxaemia need required highflow nasal cannula higherlevel oxygen support chens study <NUMBER> patients require oxygen therapy due severe <NUMBER>ncov infection pneumonia may cause significant gas exchange obstruction leading hypoxaemia significantly reduces energy supply cell metabolism increases anaerobic fermentation causing intracellular acidosis oxygen free radicals destroy phospholipid layer cell membrane meanwhile hypoxiainduced influx calcium ions also leads injury apoptosis cardiomyocytes third huangs study noted high concentration il<NUMBER>β ifnγ ip<NUMBER> mcp<NUMBER> could detected patients infected <NUMBER>ncov might lead activated thelper<NUMBER> th<NUMBER> cell responses <NUMBER> furthermore also found icu patients much higher concentrations inflammatory factors nonicu patients suggesting cytokine storm associated disease severity <NUMBER> addition repeated floods catecholamines due anxiety side effects medication also lead myocardial damage conclusion patients previous cardiovascular metabolic diseases may face greater risk infection <NUMBER>ncov also greatly affect development prognosis pneumonia simultaneously pay close attention viral infectionrelated heart damage course disease treatment human rodent angiotensin converting enzyme <NUMBER> ace<NUMBER> endotheliumbound carboxymonopeptidase single activesite catalytic region whose expression limited mainly endothelial cells arteries arterioles venules various organs including heart lungs kidneys <NUMBER> <NUMBER> loss ace<NUMBER> leads agedependent cardiomyopathy <NUMBER> <NUMBER> <NUMBER> kidney disease <NUMBER> also enhancing pulmonary <NUMBER> cardiac <NUMBER> renal injuries <NUMBER> addition peptidase action ace<NUMBER> also functions receptor severe acute respiratory syndrome coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expression necessary pulmonary infection sarscov <NUMBER> <NUMBER> <NUMBER> severe acute respiratory syndrome sars spread rapidly world leading significant morbidity acute often lethal lung failure mortality approximately <NUMBER> despite modernday therapies <NUMBER> <NUMBER> toronto sars outbreak associated loss lives considerable burden healthcare system huge economic impact <NUMBER> <NUMBER> <NUMBER> fatal sars associated viraemic response suggesting sarscov may affect organs <NUMBER> interestingly patients infected sarscov suffered cardiac disease including systolic diastolic dysfunction <NUMBER> arrhythmias sudden death <NUMBER> hypothesized interaction sarscov ace<NUMBER> heart could contribute sarsmediated myocardial inflammation damage showed pulmonary infection sarscov mice leads myocardial sarscov ace<NUMBER>dependent manner coupled downregulation myocardial ace<NUMBER> mrna loss ace<NUMBER> protein patients died sars presence sarscov heart associated greater macrophage infiltration myocardial damage association decreased myocardial ace<NUMBER> protein expression results demonstrate ace<NUMBER> plays key role mediating sarscov infection heart combination downregulation myocardial ace<NUMBER> could underlying pathophysiological mechanism sarsassociated heart disease mutant mice previously described <NUMBER> male littermate ace<NUMBER> mutant ace<NUMBER> ⁄ wildtype ace<NUMBER> ⁄ controls used study experiments performed accordance institutional guidelines sarscov beijing strain pumc<NUMBER> isolate used infect mice via intranasal route <NUMBER> day <NUMBER> mice killed hearts removed analyses wildtype c<NUMBER>bl ⁄ <NUMBER> mice age <NUMBER> weeks maintained sterile pathogenfree environment injected peritoneally <NUMBER> plaqueforming units encephalomyocarditis emc virus normal saline previously described <NUMBER> mice killed <NUMBER> days postinfection hearts aseptically removed frozen liquid nitrogen animal experiments performed accordance institutional guidelines canadian council animal care greater toronto area ontario canada <NUMBER> patients died sars <NUMBER> patients underwent autopsies dr j butany staff cardiovascular pathologist university health network official pathologist sars victims control group consisted autopsies ageand gendermatched patients intubated ventilated died pneumonia sepsis time period study carried accordance institutional research ethics board review trichrome haematoxylineosin staining visualization carried previously described assess architectural alterations inflammation fibrosis <NUMBER> <NUMBER> macrophage tlymphocyte specific staining using anticd<NUMBER> anticd<NUMBER> antibodies respectively carried previously described <NUMBER> <NUMBER> paraffinembedded sections pretreated using pepsin digestion method followed treatment mouse monoclonal anticd<NUMBER> antibody dako labs clone pgm<NUMBER> <NUMBER> <NUMBER> dilution mississauga canada rabbit polyclonal anticd<NUMBER> antibody dako labs <NUMBER> <NUMBER> dilution sections incubated biotinylated multilink secondary antibody id labs biotechnology inc london canada treated horse peroxidaseconjugated strepavidin labelling reagent id labs biotechnology inc macrophage counts degree inflammation fibrosis cardiomyocyte crosssectional area obtained three sections heart five random views section previously described <NUMBER> apoptosis assessed terminal deoxynucleotidyl transferasemediated dntp endlabelling tunel using apoptag plus kit intergen purchase new york ny usa <NUMBER> immunohistochemistry ace<NUMBER> carried using antiace<NUMBER> antibody previously described <NUMBER> quantified previously described <NUMBER> ethics approval realtime pcr analysis human heart samples sarscov performed previously described <NUMBER> <NUMBER> reverse transcriptase polymerasechain reaction rtpcr analysis agreement diagnostic criteria sars established various agencies including world health organization centre disease control cdc homogenized heart samples purified using q<NUMBER>a shredder columns prior rna isolation using rneasy mini kit qiagen inc mississauga canada rtpcr carried using real art hpacoronavirus virus lightcycler rt reagents assay artus gmbh hamburg germany <NUMBER> lightcycler realtime platform roche diagnostics laval canada <NUMBER>bp region sarscov rna polymerase gene amplified using previously published methods <NUMBER> western blot analysis myocardial ace<NUMBER> protein carried using primary mouse ace<NUMBER>specific polyclonal antibody generated laboratory <NUMBER> <NUMBER> dilution secondary goat antimouse antibody <NUMBER> <NUMBER> bd biosciences mississauga canada previously described <NUMBER> <NUMBER> analysis myocardial ace<NUMBER> mrna expression carried using taqman realtime pcr using forward primer <NUMBER>¢ggatacctacccttcctacatcagc<NUMBER>¢ reverse primer <NUMBER>¢ctaccccacatatcaccaagca<NUMBER>¢ probe <NUMBER>¢famccactggatgcctccctgccctamra<NUMBER>¢ previously described <NUMBER> <NUMBER> <NUMBER>ae<NUMBER> used anova followed students neumankeuls test multiple comparison testing students ttest used comparisons two groups angiotensin converting enzyme <NUMBER> functional receptor sarscov mediates sarscov pulmonary infection <NUMBER> <NUMBER> examined myocardial response pulmonary infection sarscov within <NUMBER> days following sarscov infection marked presence sarscov heart wildtype ace<NUMBER> ⁄ mice sarscov levels reduced hearts ace<NUMBER> ⁄ mice providing first evidence dependence myocardial sarscov infection ace<NUMBER> expression fig <NUMBER>a interestingly process lead partial downregulation ace<NUMBER> mrna expression wildtype mice fig <NUMBER>b association complete loss myocardial ace<NUMBER> protein levels fig <NUMBER>cd results show wellvalidated pulmonary murine model sars <NUMBER> sarscov clearly infect heart modulate ace<NUMBER> expression decipher whether effects ace<NUMBER> expression mediated directly sarscov vs secondary myocarditis process studied encephalomyocarditis emc virusinduced murine model viral myocarditis consistent impact sarscov myocardial ace<NUMBER> mrna expression emc viral myocarditis associated significant decrease ace<NUMBER> mrna fig <NUMBER>e contrast myocardial ace<NUMBER> protein levels showed significant increase fig <NUMBER>fg suggesting increased transcriptional efficiency ace<NUMBER> mrna ⁄ reduced proteolytic processing ace<NUMBER> results demonstrate pulmonary infection sarscov murine model leads myocardial sarscov ace<NUMBER>dependent manner association decreased myocardial ace<NUMBER> mrna expression specific reduction myocardial ace<NUMBER> protein levels presence sarscov autopsied heart samples association myocardial damage interestingly severe cardiac dysfunction also described patients sars <NUMBER> <NUMBER> given high expression ace<NUMBER> heart <NUMBER> <NUMBER> coupled observation sarscov detectable plasma sars patients <NUMBER> <NUMBER> examined whether pulmonary sarscov infection leads myocardial sarscov infection patients died sars examined archived postmortem autopsy heart tissues patients succumbed sars crisis evidence myocardial sarscov infection twenty patients confirmed diagnoses sars sarscov detected lungs studied reverse transcriptasepolymerase chain reaction analysis showed <NUMBER> patients <NUMBER> <NUMBER> positive sarscov genome detected heart fig <NUMBER>a average viral load <NUMBER>ae<NUMBER> · <NUMBER> <NUMBER> copies sarscov per gram heart tissue age <NUMBER> ± <NUMBER> years <NUMBER>m ⁄ <NUMBER>f importantly duration illness significantly shortened patients detectable sarscov hearts n <NUMBER> <NUMBER>ae<NUMBER> ± <NUMBER>ae<NUMBER> days vs patients without sarscov heart n <NUMBER> <NUMBER>ae<NUMBER> ± <NUMBER>ae<NUMBER> days p <NUMBER>ae<NUMBER> fig <NUMBER>a results indicate patients sars pulmonary sarscov infection clearly lead negative impact illness duration compared patients died sars without sarscov heart sarscov closed bar n <NUMBER> p <NUMBER>ae<NUMBER> compared sarscov group bh representative trichromestained myocardial section obtained patient died nonsars related sepsis bacterial pneumonia b sars evidence sarscov heart c sars without evidence sarscov heart showing increased interstitial fibrosis inflammation e cardiomyocyte hypertrophy based myocyte crosssectional area mcsa f without evidence apoptosis patients died sars g without h evidence sarscov heart scale bar represents <NUMBER> lm p <NUMBER>ae<NUMBER> compared groups vlve vhve patients died nonsars related sepsis open bar vlve vhve patients died sars sarscov heart grey bar vlve vhve patients died sars without sarscov heart closed bar n <NUMBER> per group european journal clinical investigation vol <NUMBER> <NUMBER> ace<NUMBER> heart disease severe acute respiratory syndrome sarscov infection heart resulting aggressive illness earlier death trichromestaining showed increased myocardial inflammation interstitial fibrosis patients sarscov detected hearts fig <NUMBER>ae presence myocardial inflammation reduced ace<NUMBER> expression response myocardial sarscov infection associated pathological hypertrophy shown increased cardiomyocyte crosssectional area fig <NUMBER>f assessment apoptosis using tunel staining revealed increased apoptosis autopsied heart samples fig <NUMBER>gh presence sarscov heart suggests could lead myocardial inflammation used positive control group consisted <NUMBER> patients died sars without evidence sarscov heart age <NUMBER> ± <NUMBER> years <NUMBER>m ⁄ <NUMBER>f negative control group consisting patients died bacterial pneumonia sars n <NUMBER> age <NUMBER> ± <NUMBER> years <NUMBER>m ⁄ <NUMBER>f immunohistochemical staining postmortem myocardial tissue using macrophagespecific cd<NUMBER> cellsurface marker revealed significant amount macrophage infiltration fig <NUMBER>ad clearly increased patients sarscov hearts minor elevation patients without sarscov heart fig <NUMBER>e contrast immunohistochemical staining tcell specific cd<NUMBER> cellsurface marker showed myocardial lymphocytic infiltration minimal fig <NUMBER>fh significant difference lymphocyte count groups fig <NUMBER>i fi representative anticd<NUMBER> immunohistochemistry illustrating representative section patient died sars evidence sarscov heart f sars without evidence sarscov heart g positive control section obtained human spleen h quantification myocardial lymphocyte count scale bar represents <NUMBER> lm p <NUMBER>ae<NUMBER> compared groups vlve vhve patients died nonsars related sepsis open bar vlve vhve patients died sars sarscov heart grey bar vlve vhve patients died sars without sarscov heart closed bar n <NUMBER> per group ability sarscov utilize ace<NUMBER> receptor vivo presence sarscov heart suggests sarscov interact myocardial ace<NUMBER> system hypothesized presence sarcov hearts could associated decreased ace<NUMBER> protein expression consistent observations murine model immunohistochemistry myocardial ace<NUMBER> protein expression showed presence sarscov heart associated marked downregulation ace<NUMBER> protein expression fig <NUMBER>ac quantified shown fig <NUMBER>f specificity antiace<NUMBER> antibody shown preincubation human recombinant ace<NUMBER> <NUMBER> mg ml <NUMBER> kindly provided apeiron biologics austria blocked immunostaining native ace<NUMBER> protein fig <NUMBER>e patients infected sars virus suffered cardiac disease ranging systolic diastolic dysfunction <NUMBER> arrhythmias sudden death <NUMBER> study provided evidence ace<NUMBER> functions myocardial sarscov receptor vivo respiratory sarscov infection murine model leads ace<NUMBER>dependent sarscov infection heart decreased myocardial ace<NUMBER> mrna expression cytokinemediated transcriptional downregulation ace<NUMBER> mrna could lead decreased ace<NUMBER> mrna level sarscov emcmediated viral myocarditis <NUMBER> virusmediated receptor downmodulation described multiple viruses including hiv measles pulmonary sarscov <NUMBER> complete loss ace<NUMBER> protein hearts infected sarscov could secondary activation adam<NUMBER> ⁄ tace sars spike protein known cleave release ace<NUMBER> <NUMBER> ⁄ due sarscov binding ace<NUMBER> endothelial cells leading endocytosis ligand ⁄ receptor complex <NUMBER> <NUMBER> subsequent intracellular degradation ace<NUMBER> patients succumbed sars sarscov detected heart <NUMBER> subjects suggesting sarscov capable infecting myocardium susceptible individuals showed patients sarscov hearts died considerably earlier suggesting myocardial sarscov infection associated aggressive course illness sarscov interaction ace<NUMBER> led sarsassociated cardiomyopathy likely contributed signif icantly morbidity mortality patients sars <NUMBER> <NUMBER> consistent cardiac disease patients succumbed sars previously reported bilateral pulmonary oedema association bilateral pleural effusions frequently observed time autopsy <NUMBER> increased myocardial interstitial fibrosis patients sarscov heart consistent recent findings showing sarscov nucleocapsid n protein potentiates transforming growth factorbetamediated fibrosis <NUMBER> consistent observations lung tissue patients affected sars <NUMBER> cd <NUMBER> positive macrophages detected sarspositive hearts absence lymphocytic invasion contrast classic viral myocarditis seen enteroviruses herpesvirus type <NUMBER> associated prominent lymphocytic infiltration <NUMBER> sarscovinduced myocardial inflammation mediated predominantly macrophages resultant production chemokines <NUMBER> <NUMBER> deleterious effects myocardial sarscov infection could perpetuated prompt severe downregulation ace<NUMBER> resulting increased ang ii action ⁄ loss cardioprotective effects ang <NUMBER> <NUMBER> <NUMBER> <NUMBER> ⁄ activation adam<NUMBER> ⁄ tace sars spike protein leading increased release tnfa <NUMBER> <NUMBER> myocardial dysfunction could also secondary strong interferonmediated immunopathological events associated immune response patients sars <NUMBER> <NUMBER> cardiovascular involvement could explain marked age dependence mortality seen patients sars <NUMBER> <NUMBER> decreased cardiovascular reserve ageing consistent ace<NUMBER> key sarscov receptor patients diabetes mellitus ace<NUMBER> expression increased <NUMBER> showed greater susceptibility sars <NUMBER> <NUMBER> results imply interactions infectious agents key receptor ⁄ signalling pathways cardiovascular system may confer unique sensitivity sarscov potentially viral infections indeed interaction subsequent activation pi<NUMBER>k signalling influenza virus important determinant viral replication may lead adverse cardiovascular effects setting avian influenza epidemic <NUMBER> coronavirus disease <NUMBER> presented substantial challenges patient care impacted health care delivery including cardiac electrophysiology practice throughout globe based upon undetermined course regional variability pandemic uncertainty resume deliver electrophysiology services arrhythmia patients joint document representatives heart rhythm society american heart association american college cardiology seeks provide guidance clinicians institutions reestablishing safe electrophysiological care achieve aim address regional local covid<NUMBER> disease status role viral screening serologic testing returntowork considerations exposed infected health care workers risk stratification management strategies based covid<NUMBER> disease burden institutional preparedness resumption elective procedures patient preparation communication prioritization procedures development outpatient periprocedural care pathways keywords covid<NUMBER> cardiac electrophysiology arrhythmia management abbreviations cied cardiac implantable electronic device ecg electrocardiography ep electrophysiology hcw health care workers icd implantable cardioverter defibrillator icu intensive care unit pcr polymerase chain reaction ppe personal protective equipment pui person investigation tee transesophageal echocardiography coronavirus disease <NUMBER> covid <NUMBER> presented unprecedented challenge world impacting everyday living resulting widespread international restrictions combat global pandemic restrictions travel schools businesses social gatherings including lockdowns imposed singular aim reducing spread dangerous viral illness health care services severely impacted posing challenges delivery care well preservation resources personal protective equipment ppe need limit exposure patients health care workers hcws led hospitals severely limit eliminate elective nonurgent services many hospitals meeting challenges covid<NUMBER> resulted reassignment hospital beds repurposing personnel reallocation financial resources toward care covid<NUMBER> patients order manage evolving challenges heart rhythm society american heart association american college cardiology issued guidance document aid electrophysiologists defining priorities electrophysiological procedures <NUMBER> collective efforts professional societies helped minimize patient health care professional exposure postponement elective cases careful management urgent otherwise timesensitive procedures even <NUMBER> months restrictive measures vigilant observation uncertainty remains forecasting course pandemic seen great regional variability surge volumes incidence curve flattening outcomes <NUMBER> stayathome orders lifted businesses reopen concerns remain regarding prospect secondary peaks disease incidence possibility continuation expansion existing restrictions clinical services likely global pandemic continue exert significant effects resistance pathogen developed vaccination herd immunity discovery definitive therapy degree patient outcomes adversely impacted delaying delivery usual cardiac care due resource limitations andor patient reluctance fully understood early data suggested cardiac patients presenting myocardial infarction experiencing heart failure may suffering worse outcomes due delayed presentations <NUMBER> <NUMBER> <NUMBER> many chronic diseases acute medical conditions often require nonurgent timesensitive intervention prevent becoming emergencies longterm sequelae questions remain long one delay nonurgent medical interventions prevent patients developing undesirable outcomes immediate critical needs pandemic response met least partially addressed ppe shortages improved many regions result efforts industry government even individuals manufacture masks develop methods process n<NUMBER> respirators reuse effective flattening curve sharing resources across hospital systems increased production eased concerns ventilator availability however pandemic far control access accurate testing serology remain limited <NUMBER> potentially effective antiviral drugs evaluated limited availability candidate vaccines still early stages development testing given remaining shortcomings still undetermined course pandemic uncertainty resume effectively deliver muchneeded electrophysiology ep services noncovid<NUMBER> arrhythmia patients covid<NUMBER> continue coexist present significant health care delivery challenges many patients remain fearful exposure health care settings <NUMBER> <NUMBER> creating relatively covid<NUMBER> safe clinical care continuum environment important strategy regain patient confidence enable health care institutions start providing elective cardiovascular <NUMBER> ep procedures rebooting ep many institutions may challenging shutting electrophysiologists may work services limited resources space may require hospital leadership understanding urgency ep care relates services accurate tracking modeling understanding covid<NUMBER> status well collaboration local regional state federal authorities critical health care organizations making informed decisions resumption ramping services considerations include hospital intensive care unit icu census ventilator ppe availability staffing capability areas severely affected entire hospitals converted covid<NUMBER> care units likely require longer time capacity provide care noncovid<NUMBER> nonurgent cases however may quite different regions less affected significantly lower prevalence incidence covid<NUMBER> cases general significant sustained drop local incidence observed health care organizations areas experiencing high case level increase elective medical interventions timing rollout process dictated governmental health system policies areas fortunate enough avoided high covid<NUMBER> burden assiduous attention ongoing local covid<NUMBER> incidence essential managing reboot process need respond rapidly second wave occurs accordingly resumption nonurgent ep services approached measured cautious manner contingency plans specific criteria limit stop elective cases event second wave predefined advance reopening compliance local regulations testing covid<NUMBER> infection critical tool embark safely restarting elective semielective procedures figure <NUMBER> illustrates model evolution detectable virus virusspecific immunoglobulin severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection current understanding regarding limitations tests timing results course exposure infection impacts interpretation test results shown figure <NUMBER> patient screening diagnostic testing important tools limit patient staff exposure however lack widespread access timely accurate viral testing major limitation onset pandemic <NUMBER> likely persistent variations regional availability testing greatly affecting ability identify infected individuals schedule cases prevent disease transmission clarify policies minimize risk restarting elective procedures test platforms available different advantages limitations including differences turnaround time throughput fortunately false positive rates low established viral polymerase chain reaction pcr tests <NUMBER> however sensitivity pcrbased viral testing varies among platforms significantly variable false negative rates available test kits reported may compounded sampling limitations variation presence virus different sites course disease <NUMBER> considerations may prompt repeat testing <NUMBER> evidence exposure typical symptoms clinical presentation although atypical symptom presentations well described <NUMBER> whether positive pcr test late course disease asymptomatic person represents detection noninfectious viral particles transmissible virus remains uncertain serologic antibody testing may supplement viral detection pcr available <NUMBER> remains controversial susceptible misinterpretation used make decisions related individual patient management pcr viral testing may accurate igm assessment early stages infection igg may helpful identification prior infection time figure <NUMBER> unfortunately limitations sensitivity specificity associated serologic testing compared covid<NUMBER> viral testing could result improper clinical decisions false positive serology tests uncertainties whether true seropositivity confers protection reinfection potential continued viral transmissibility could create false sense security ongoing research may clarify issues serologic testing likely continue improve time seropositivity used determine decreased standards ppe containment approaches given limitations viral antibody testing patients regardless test results treated universal precautions major concern inhibiting patients coming hospitals fear contracting covid<NUMBER> patients health care workers asymptomatic carriers potential infect patients health care staff <NUMBER> availability implementation universal testing policies patients prior procedures health care workers well universal masking sanitization hand hygiene favorably impact confidence institutions need define standardized comprehensive protocols testing including testing prior planned procedures electrophysiologists laboratory managers outpatient clinical team leaders define workflow processes preprocedure testing operational plans concordant hospital local policies many institutions testing policies extensive include multiple locations clinics procedural areas eg cardiac catheterization laboratory endoscopy suite interventional radiology suite etc offsite locations including drivethrough testing accommodations testing need based patients clinical condition geographic location inpatient versus outpatient status type urgency intervention test capability local conditions ideally viral pcr testing performed within <NUMBER> hours prior procedure whenever feasible allow sufficient time test results obtained reviewed event positive test results may change procedure planning mandatory preoperative isolation period testing procedure performance important mitigate possibility infection preoperative testing unavailable locally hospital health care system yet patients undergo nonurgent procedures alternative screening methods must established conjunction health care system local public health officials regardless availability testing organizations utilize mandatory symptom screening temperature analysis mandatory masking postoperative postprocedure covid<NUMBER> testing may need considered patients develop symptoms procedure performed atelectasis fever volume overload uncommon postoperative period establishing operational guidelines covid<NUMBER> testing patients management testing results determined transmission covid<NUMBER> exposed hcws documented since negative test preclude subsequent infection even soon testing periodic viral testing asymptomatic health care workers currently standard approach enhanced surveillance health care workers even mild symptoms fever history exposure universal masking generally adopted may reduce patient fear developing hospitalacquired covid<NUMBER> infection quarantine hcws confirmed suspected covid<NUMBER> returntowork criteria follow centers disease control prevention cdc guidelines local policy <NUMBER> active viral shedding remains possibility asymptomatic individuals positive igm andor igg serology <NUMBER> available viral testing performed help determine whether hcw true convalescence without active viral shedding institutions offer serology testing hcws may suggest exposure coronavirus whether antibodies confer immunity recurrent infection unproven ability perform elective semielective cases highly dependent covid<NUMBER> burden region regional risk categorized based severity disease burden state resource utilization projections figure <NUMBER> follows <NUMBER> high prevalence incidence <NUMBER> medium prevalence incidence <NUMBER> low prevalence incidence factors could impact whether health care systems region capacity start engaging elective procedural medical care availability ppe resources remains major consideration timing resumption semielective elective procedures adherence ppe policies according cdc local policies remains critical hcws hospital operatingprocedure rooms supply chains ppe needed aerosol airborne droplet contact precautions ideally project maintain adequate supplies covid<NUMBER>related care addition covering extra ppe needs elective procedures comprehensive hospitalwide multispecialty operational committees leadership oversee process valuable include supply chain data analytics strategic planning quality assessment infection prevention clinical expertise patients hcws need continue using ppe particularly masks community spread virus reduced threat level local federal regulations dictate important data needed inform health care system planning include following bed icu ventilator capacity procedural recovery room availability depth diagnostic laboratory services cleaning capacity housekeeping clinical areas along continuum care addressed eg clinic preoperative ep laboratories recovery areas icus ventilators transesophageal echocardiography probes cardiac implantable electronic device cied programmers etc operating room procedure schedules staffing need flexible accommodate influx cases modifications may include limiting block time assignments increase open scheduling time extending hours elective procedure scheduling repurposed rooms may need refitted appropriate equipment expand return prior capacity specific procedures need prioritize scheduling cases according urgency need hospitalization continue ideally preprocedure testing patients performed outside preoperative assessment areas facilitate appropriate preservation ppe preferably registration preand postprocedural areas ep laboratories ideally near proximity minimize exposure transport appropriate staffing reorientation redeployed staff new old processes important case scheduling escalation increasing caseload implemented gradually allow time assessment impact covid<NUMBER> positivity transmission note changes use ppe related precautions may increase procedure times adequate hcw staffing anticipated accommodate covid<NUMBER> surge second wave occur many physician practices shifted telehealth platforms communicate patients provide medical care informing patients organizational processes instituted minimizing exposure covid<NUMBER> facilitys preparedness restarting elective cases help allay patients fears coming hospital clinic facilities honest open communication infection mitigation strategies available testing options specific institutional plans help patient decide whether proceed elective procedure shared decisionmaking concerning risks benefits moving forward procedural options versus continuing noninvasive approaches critical shared decisionmaking ideally documented electronic medical records scheduling decisions complex involve provider patient also public health considerations procedure considered high medium prevalence region figure <NUMBER> elective procedure may delayed longer even patient provider usual shared decision participants would like proceed conversation completed patient agrees proceed written instruction preprocedural care notes location preanesthesiacovid<NUMBER> testing details periprocedural care helpful send patient policies may continue limit number family members accompany patient accordingly appropriate arrangements required drop pick patient avoiding areas known covid<NUMBER>positive patients timely updates patient condition procedural status facilitated dedicated patient navigator communicator readily accessible family members call written instructions routine procedural care covid<NUMBER> prevention strategies helpful suspension elective cases due covid<NUMBER> resulted accumulation deferred ep procedures ethical values used prioritize procedures need balance public health societal concerns commitment individual patient example risks postponing procedure individual fully weighed risk covid<NUMBER> spread transparency communication regarding scheduling decisions essential patient community trust covid<NUMBER>positive patients nonemergent cases delayed recovery change patients condition warrants reconsideration procedure prioritization essential contingent upon facility capacity nature deferred procedures well regional local policy restrictions emergent urgent procedures take precedence followed semiurgent timesensitive procedures followed elective procedures <NUMBER> triaging procedure categories vary geographic temporal variations covid<NUMBER> burden figure <NUMBER> ultimate decision regarding time sensitivity procedure based clinical judgment individual patient factors many tertiary referral institutions communication hospitals referring physicians availability vital ensure patients prioritized according medical need prioritizing inpatient procedures may minimize need reschedule later visits reducing exposure testing inpatient procedures require similar preprocedural covid<NUMBER> testing according local policies considerations include availability anesthesia team whose personnel may repurposed covering icus care sick covid<NUMBER> patients case type delay might impact patient outcomes long patients already waiting procedure risk given might impact bed resource needs complications result prolonged hospitalization icu stays one ensure appropriate followup assure deterioration clinical status attention local state federal orders also considered geographies may ongoing restrictions limiting scheduling elective procedures surgeries addition hospitals may require physician attestation medical necessity timesensitive procedure covid<NUMBER> successfully moved many clinical practices adopt digital telehealth platforms care pathways minimize patient exposure model though initially cumbersome proved useful means providing continued care patients similarly remote monitoring continued valuable resource patients cieds reestablishment inperson visits vary geographic temporal variation viral incidence use ppe patientfacing outpatient clinic visits continue per cdc local authority guidelines clinic areas configured comply regional social distancing directives regions high covid<NUMBER> burden inperson clinic visits may still need minimized using telehealth options majority incisionsite inspections following cied implantation catheter ablation managed via telehealth inspecting site utilizing video conference asking patient send picture via secure email often conjunction simple questions similarly many clinic followups new consults performed via telehealth leveraging electronic medical record data obtaining vital signs electrocardiography ecg tracings using digital wearables available number appbased technologies evolves continue integral part telehealth examples lowrisk patients inperson visits could deferred include asymptomatic patients satisfactory cied battery longevity primary prevention implantable cardioverter defibrillator icd patients without symptoms suggesting worsening heart failure arrhythmia burden patients antiarrhythmic drugs dofetilide require qtc laboratory monitoring may need defer testing prior values clinical condition remained stable new drugs may prolong qtc added addition remote monitoring may offer valuable supplement perhaps shortterm alternative ecg situations qtc clinical condition remained previously stable patients borderline values may need continued access ecg laboratory testing studies evaluated use mobile ecg devices qtc monitoring <NUMBER> <NUMBER> pandemic eases exceptions use less secure platforms may change practitioners advised remain date current reimbursement documentation requirements urgent semiurgent clinical indications evaluated person individualized basis might include patients worsening heart failure associated uncontrolled arrhythmia significant arrhythmia symptoms need device reprogramming icd patients recent shocks syncope cied patients recent symptoms suggesting possible device malfunction eg syncope heart failure exacerbation suspected device infection select patient populations vulnerable infants children arrhythmias may also warrant inperson evaluation possible inperson visits procedures coordinated day minimize multiple exposures patient patients presenting outpatient visits hcws masked measures taken screen concerning symptoms eg fever cough practitioners aware covid<NUMBER> may present atypical symptoms including diarrhea anorexia anosmia multisystem inflammatory disease consisting limited rash lymphadenopathy swelling hands feet mucus membrane changes seen children adolescents <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggestive symptoms fever present patients redirected appropriate screening clinic facility appropriate measures taken including testing covid<NUMBER> clinics follow local policies figure <NUMBER> depending regional stage pandemic local hospital departmental guidance may vary regions continuing concern pandemic spread order minimize exposure ep staff device manufacturer representatives patients suspected confirmed covid<NUMBER> infection prudent consider limiting inperson cied interrogations following indications • clinically actionable suspected cied abnormality • need reprogramming • evaluation potential arrhythmic symptoms alerts patients without access remote monitoring potential strategies maintain social distancing include reconfiguring waiting areas andor notifying patients time seen importantly device interrogation programmers cables wands disinfected patients plastic sleeves cover cable wand may also considered may helpful inform patients disinfecting procedures systematically performed visits current expert consensus statement gives remote monitoring class recommendation routine use patients cieds <NUMBER> based multiple studies demonstrating reduction unnecessary icd therapies mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite effectiveness prior pandemic remote monitoring significantly underutilized due variety patientand systembased issues <NUMBER> pandemic use remote monitoring even important used circumstances reduce need nonurgent clinic visits feasible remote monitoring reconsidered patients currently enrolled quality improvement programs care pathways help standardize support safe highquality highvalue patient care riskadjusted data used evaluate patient care outcomes based principles discussed example stepwise care pathway summarized follows figure <NUMBER> step <NUMBER> initial consultation intervention • appropriate covid<NUMBER> precautions followed • unnecessary exposure patient clinic hospital environment minimized carefully prioritizing problem utilizing telehealth platforms wherever necessary • patients comorbidity profile assessed event potential procedural complication remote possibility patient may acquire covid<NUMBER> infection periprocedural period • appropriate patient education provided potentially web resources thorough orientation health care environment review patients clinical situation greater transparency help patient understand risks benefits alternatives planned intervention • outpatient clinic visits universal masking social distancing may require blocking rearranging waiting exam room seating andor limiting number family members accompanying patient maximum one per local policy continue engaging family members via telehealth video options patient seeing clinician consultation way involve process step <NUMBER> preoperative period • decision intervene made prior authorization completed necessary hospitals states attestation necessity procedure covid<NUMBER> pandemic may necessary • formulation guidance previously obtained laboratory testing diagnostic imaging history physical consent utilized helpful determine whether need repeated rescheduled procedures previously deferred • avoidance elective interventions covid<NUMBER>positive patients persons investigation puis patients high comorbidity profile considered • use telehealth consolidation preoperative assessment day procedure preoperative area help minimize patient exposure significant change patients clinical status • preoperative covid<NUMBER> testing performed within <NUMBER> hours procedure feasible patients advised maintain isolation time testing planned procedure emergent procedures rapid testing feasible patients treated pui use appropriate ppe preoperative testing consolidated much feasible determining pathway followup reporting results patient procedure team important along standardized recommendations patients test positive covid<NUMBER> • limiting minimizing companions procedure facilities may still required initial limitations zero accompanying companions may able relaxed one minimal family members friends later evolution covid<NUMBER> pandemic telehealth digital platforms used communicate update patients family patient navigator excellent resource providing single point contact active discharge planning ahead time facilitate arrangements resources needed procedure step <NUMBER> intraoperative period • ppe use follow cdc hospital guidelines similar rules earlier covid<NUMBER> pandemic • procedure patient pui unless tested otherwise step <NUMBER> postoperative period • available recovery perioperative unit close ep laboratories minimize patient transport recovery within relatively covid<NUMBER> safe environment minimizing exposure patients hospital personnel involved care • possible sameday discharge considered patients need monitored overnight could potentially stay room discharged next day possible minimize contact • periodic viral pcr serologic testing may become routine health care workers periprocedure areas including housekeeping dietary staff • prohibiting minimizing family members accompanying persons recovery area reduce unnecessary exposure exceptions may considered minors adults special needs patients transported pickup area discharging staff member patient coordinator meet caretaker review discharge instructions • patient needs potential delayed complications anticipated appropriate standard care testing eg chest xrays device checks echocardiograms needed performed discharge especially sameday discharges • ppe use per guidelines step <NUMBER> postdischarge period • maintaining social distancing universal masking remain important patients • patients educated reminded importance avoiding covid<NUMBER> exposure infection recovery phase • single easy mechanism patients get touch ep care team address postprocedural concerns • incision checks device checks even postablation followup cases performed using telehealth platforms possible ep covid<NUMBER> working group representing stakeholders involved ep care continuum pathway coordinate institutional hospitallevel covid<NUMBER> leadership group may include electrophysiologist ep laboratory manager outpatient clinic manager ep nurse advanced practice providers device technician anesthesiologist imaging team provide insights various aspects workflow team clarify interpret iterate disseminate policies also provide necessary operational support plan successfully execute reboot process efforts contain covid<NUMBER> continue effective communication rest ep team extended cardiology team relevant clinical hospitalhealth care system teams essential logical methodical approach easing restrictions slowly revamping work without causing major disruptions work done care teams extremely important coordination hospital covid<NUMBER> teams developing similar pathways would synergistic regularly scheduled appraisals process adjustments made fit needs facility care teams decisions data driven transparency data sharing teams encouraged teams patients benefit collective experiences establishing institutional programs assess successes failures consistent progress occurs advantageous institutional teams take lead understanding implementing regulatory body policies new information testing changes ppe guidance patient waitlists insurance prior authorization issues implementation periodic timely communications patients keeping abreast ground situation covid<NUMBER> region pandemic far stayathome orders lifted people emerge social isolation fail practice masking social distancing humantohuman spread may surge could second even recurring waves covid<NUMBER> pandemic health care teams hospitals must continue prepared preserve adequate resources contingencies appropriate planning dealing second wave mandatory component elective reboot plan learn create relatively covid<NUMBER> safe zones within hospitals help isolate patients second waves yet able provide regular care noncovid<NUMBER> patients covid<NUMBER> presented health care systems across globe novel challenges ep professionals need determine minimize ravages living covid<NUMBER> ensuring provide exemplary care arrhythmia patients across agegroups document tried provide ep clinicians institutional administrators series guiding suggestions principles move forward start reboot provide necessary heart rhythm care patients understandably appropriately delayed main goal health care professionals whether serve clinical teaching research administrative role everything create safe environment patients receive excellent care deserve american college cardiology electrophysiology council contributed development endorses document figure <NUMBER> representative model illustrating presence viral rna igm igg human body time infection sarscov<NUMBER> understanding particularly important using polymerase chain reaction pcr serologic testing tools identify whether individual actively infected convalescence watershed time period test results interpreted care differences polymerase chain reaction pcr serologic testing well features limitations need understood prior using incorporating reboot testing workflow ppe personal protective equipment type procedures restarted see figure <NUMBER> figure <NUMBER> stepwise approach creating care continuum ep reboot ppe personal protective equipment • emphasize patient need maintain appropriate social distancing masking • maximize telehealth postdischarge care wound care device checks groin care monitor postop complications update workflow based testing availability national regional institutional guidelines novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> continues spread across globe millions people may affected <NUMBER> knowledge regarding complications fatality rate associated sarscov<NUMBER> covid<NUMBER> infection evolving preliminary data china suggests patients preexisting comorbidities particularly cardiovascular disease cvd cancer may among highest risk acquiring infection also worse outcomes <NUMBER> risk adverse outcomes may even higher afflicted dual diagnosis particularly elderly extremely concerning public health perspective since cancer cvd amongst prevalent diseases worldwide <NUMBER> impact current pandemic coronavirus disease <NUMBER> covid<NUMBER> could devastating patients world health organization recently declared covid<NUMBER> public health emergency international concern <NUMBER> covid<NUMBER> caused sarscov<NUMBER> originated wuhan hubei province china spreading rapidly efficiently <NUMBER> sarscov<NUMBER> novel enveloped rna betacoronavirus similar severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov pathogens responsible severe acute respiratory syndrome sars outbreaks <NUMBER> guangdong province china severe respiratory disease outbreaks <NUMBER> middle east respectively <NUMBER> although phylogenetic similarities coronaviruses responsible sars covid<NUMBER> transmission exponential covid<NUMBER> additionally transmitted people mildly ill even asymptomatic leading <NUMBER> times many cases sars quarter time <NUMBER> <NUMBER> <NUMBER> understanding risk infection sarscov<NUMBER> impact limited examine interaction two common disease entities cancer cvd patients cancer typically higher risk infection due compromised host defenses sequelae antineoplastic treatment namely leukopenia disruption barriers infection shifts microbial flora current covid<NUMBER> pandemic particularly concerning given potential spread asymptomatic carriers <NUMBER> report china suggests among confirmed infected sarscov<NUMBER> approximately <NUMBER> patients cancer <NUMBER> <NUMBER>fold higher general incidence cancer china <NUMBER> persons <NUMBER> retrospective analysis merscov infection demonstrated likely occur patients underlying cvd patients merscov infection severe symptoms <NUMBER> hypertension diabetes <NUMBER> heart disease <NUMBER> early single center report describing hospitalized patients infected pneumonia due sarscov<NUMBER> <NUMBER> preexisting cvd particularly coronary artery disease cad cerebrovascular disease <NUMBER> recent emerging data china assessing broader population covid<NUMBER> describe lower overall rate affected patients underlying cad <NUMBER> elderly patients comorbidities particularly hypertension <NUMBER> diabetes <NUMBER> likely infected sarscov<NUMBER> <NUMBER> <NUMBER> small retrospective study patients history cancer infected sarscov<NUMBER> older <NUMBER> versus <NUMBER> years likely current former smokers likely experience rapid breathing abnormal lung ct scans without cancer study <NUMBER> people confirmed covid<NUMBER> china <NUMBER> patients <NUMBER> history cancer lung cancer common greater proportion patients history cancer severe disease defined either admission intensive care unit mechanical ventilation death compared without cancer <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> among cancer patients <NUMBER> <NUMBER> <NUMBER> received recent chemotherapy surgery developed severe disease compared <NUMBER> <NUMBER> <NUMBER> recently treated cancer odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> even adjusting risk factors including age smoking history comorbidities <NUMBER> suggesting potentially recent antineoplastic therapy may impair immunity impact outcomes related covid<NUMBER> mortality rate small study also significantly higher cancer patients <NUMBER> compared approximately <NUMBER> general covid<NUMBER> related mortality <NUMBER> updated report demonstrates similarly high mortality <NUMBER> among patients cancer <NUMBER> data regarding type cancer antineoplastic therapy available early reports however patients undergoing antineoplastic therapy hematological malignancies baseline lymphopenia theoretically may even higher risk adverse consequences early reports china suggest covid<NUMBER> mortality rate highest among patients cvd <NUMBER> compared comorbidities disproportionately higher patients cardiovascular risk factors diabetes <NUMBER> hypertension <NUMBER> compared around <NUMBER> patients without comorbidities <NUMBER> <NUMBER> another coronavirus merscov previously reported cause acute myocarditis heart failure <NUMBER> yet unknown pathogenic similarities merscov sarscov<NUMBER> make plausible similar cardiovascular complications may occur covid<NUMBER> many patients covid<NUMBER> experienced acute myocardial injury evident increase highsensitivity cardiac troponin levels <NUMBER> could secondary direct cardiotoxicity could represent type ii myocardial injury context supplydemand mismatch moreover cardiac biomarker levels significantly higher patients admitted icu nonsurvivors <NUMBER> <NUMBER> suggesting cardiovascular complications might contribute severity illness adverse outcomes <NUMBER> <NUMBER> significant proportion patients subsequently developed heart failure <NUMBER> first autopsy <NUMBER>yearold woman chronic kidney disease china demonstrated acute myocardial infarction unpublished report similarly various arrhythmias particularly atrial fibrillation cardiac arrest reported likely precipitated high cardiometabolic demand <NUMBER> mechanism covid<NUMBER>associated cardiovascular injury well understood however angiotensinconverting enzyme <NUMBER> ace<NUMBER> implicated <NUMBER> ace<NUMBER> widely expressed lungs cardiovascular system plays vital role immune system thought play critical role cardioprotective arm reninangiotensinaldosterone pathway ace<NUMBER> serves cellular entry point coronaviruses including sarscov sarscov<NUMBER> <NUMBER> spike protein coronaviruses binds ace<NUMBER> highly expressed lungs heart leading respiratory also potential cardiovascular damage <NUMBER> one potential explanation higher risk acquiring infection severe symptoms adverse outcomes covid<NUMBER> patients preexisting cvd could higher usual secretion ace<NUMBER> patients although clear <NUMBER> another possible mechanism cardiovascular injury includes excessive cytokine release triggered imbalanced response type <NUMBER> type <NUMBER> thelpercells hypoxemia secondary respiratory dysfunction caused covid<NUMBER> <NUMBER> know longterm cardiovascular impact sarscov<NUMBER> infection similar pathogen sarscov associated dysregulation lipid glucose metabolism longterm survivors given structural similarities two pathogens sarscov<NUMBER> may also cause chronic damage cardiovascular system however remains seen <NUMBER> awareness local sarscov<NUMBER> cases concerning symptoms excellent hand hygiene well avoidance sick contacts large gatherings key measures curb widespread infection centers disease control cdc advised every individual frequently thoroughly wash hands avoid touching face practice respiratory hygiene <NUMBER> important entire population affected areas highrisk patients including elderly preexisting cvd cancer strictly follow guidelines given may likely acquire infection develop severe disease disease sarscov<NUMBER> infection cause severe acute respiratory illness due lung involvement however myocardial damage caused infection undoubtedly increase difficulty complexity patient management particularly vulnerable patients already affected cancer cvd patients covid<NUMBER> symptoms cough fever shortness breath areas covid<NUMBER> reported history travel highly affected regions including china italy south korea iran exposure known case covid<NUMBER> evaluated necessarily person clinically stable based cdc guidelines determine meet criteria person investigation pui requires testing quarantine per local federal guidelines <NUMBER> important note although majority adult patients covid<NUMBER> present symptoms patients cancer may weakened immune systems hence may typical symptoms symptoms may subtle despite underlying complex severe disease hence heightened awareness required among patients clinicians majority patients present respiratory symptoms national health commission china reports patients present cardiovascular symptoms heart palpitations chest tightness rather respiratory symptoms <NUMBER> hence patient suspicious symptoms endemic regions evaluated determine meet criteria pui hemodynamic monitoring supportive care key components management currently evidence support widespread use routine cardiac biomarker echocardiographic monitoring might considered select highrisk patients preexisting cvd history exposure cardiotoxic antineoplastic therapy either significant cardiovascular symptoms lack improvement usual care evidence patients severe illness covid<NUMBER> highly elevated inflammatory markers suffer cytokine storm elevated il<NUMBER> use agents block il<NUMBER> including tocilizumab sarilumab treat severely ill patients codiv<NUMBER> active area investigation <NUMBER> similarly remedesivir investigational antiviral agent also study clinical trial patients covid<NUMBER> highrisk severely ill patients <NUMBER> transmission areas figure <NUMBER> patients cancer recent cancer therapy severely affected covid<NUMBER> thus far guidance patients united states defer cancer treatment landscape covid<NUMBER> continues change rapidly patients stable cancer areas high transmission sarscov<NUMBER> postponing antineoplastic therapy elective surgery may need considered decision made casebycase basis careful discussion treating physicians based cancer type status also considering overall health patient type antineoplastic therapy needed patients undergoing cancer therapy recent history stemcell transplantation areas high transmission reasonable consider selfquarantine avoid exposure also testing sarscov<NUMBER> becomes widely available close contacts highrisk patients low threshold selfquarantine obtain testing concerning symptoms due similarities respiratory cardiac symptoms clinicians maintain high suspicion acute myocardial infarction heart failure patients covid<NUMBER> avoid underdiagnosis cvd although management acute cardiovascular complications necessarily change patients without covid<NUMBER> areas high transmission high suspicion maintained patients suggestive symptoms known exposure isolated promptly even without confirmatory test minimize spread infection among cv team members patients furthermore reduce rate transmission among patients stable cancer cvd substituting inperson visits telehealth visits deferring nonurgent procedures strongly considered <NUMBER> many patients preexisting cvd hypertension diabetes well patients cancer undergoing cardiotoxic chemotherapy may angiotensinconverting enzyme inhibitor acei angiotensin receptor blocker arb whether treatment acei arb increases risk associated covid<NUMBER> controversial speculative time <NUMBER> cancer cvd complex diseases represent two common causes morbidity mortality worldwide covid<NUMBER> pandemic impact patients cvd well cancer proven patients particularly vulnerable patients potentially higher risk acquiring infection depressed immunity patients cancer poor baseline physiologic reserve combined direct cardiotoxicity patients cvd increases likelihood severe disease adverse outcomes community need pay close attention growing patient population particularly times increased susceptibility ince beginning year <NUMBER> several studies regarding epidemiological physiopathological clinical aspects novel coronavirus disease <NUMBER> covid <NUMBER> published rapid manner greatly contributed fast understanding novel disease rapidly helped physicians relatedhealth care workers policy makers better comprehension covid<NUMBER> novel disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> date may <NUMBER> <NUMBER> disease resulted considerable morbidity mortality worldwide <NUMBER> laboratoryconfirmed cases <NUMBER> deaths increasing evidence higher mortality risk associated presence cardiovascular involvement patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel coronavirus sarscov<NUMBER> appears easily transmittable contagious greater infectivity somehow similar higher morbidity mortality depending area considered compared severe acute respiratory syndrome coronavirus sars middle east respiratory syndrome coronavirus mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapidly increasing incidence patients sarscov<NUMBER> developed severe pneumonia pulmonary edema acute respiratory distress syndrome cardiovascular compromise multiple organ failure death cardiovascular diseases cvd still number one killer world represent leading noncommunicable epidemic since numerous patients cvd using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockade arb drug agents clinical studies may necessary explore potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> despite theoretical concerns physiological uncertainties concerning effect ace inhibitors arb angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace inhibitors arb continued patients covid<NUMBER> otherwise stable condition position supported multiple medical scientific societies needs explored randomized clinical trials search potential associations pharmacological drugs susceptibility prognosis covid <NUMBER> exact mechanism cardiac injury among patients covid<NUMBER> still remains uncertain however different possible mechanisms manifested recent studies elaborated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonischemic events ischemic myocardial involvement <NUMBER> main pathophysiological mechanisms acute cardiac injury covid<NUMBER> patients <NUMBER> believed nonischemic myocardial injury predominant secondary multiple mechanisms analyzed article huang et al <NUMBER> reported recently <NUMBER> patients covid<NUMBER>associated acute cardiac injury manifesting myocardial inflammation troponin tni elevation decreased left ventricular systolic function wang et al <NUMBER> recently reported findings <NUMBER> patients hospitalized covid<NUMBER> found <NUMBER> patients developed acute cardiac injury patients intensive care unit likely cardiac alterations <NUMBER> nonicu patients cardiac arrhythmias seen <NUMBER> patient known coronary artery disease heart failure patients higher risk others higher mortality covid<NUMBER> associated acute myocarditis acute myocardial infarction rapidonset heart failure <NUMBER> observation clearly suggests cardiovascular involvement especially cardiac injury possibly associated morbid clinical outcomes covid<NUMBER> therefore assess potential mechanisms cardiac injury association inflammation covid<NUMBER> patients aim analyze effect different serum biomarkers inflammation cardiac involvement incidence clinical outcomes mortality delineate importance guiding therapeutic management better cardiovascular outcome especially hospitalized patients covid<NUMBER> conducted electronic search pubmed medline web science scopus identify journal articles published english december <NUMBER> april <NUMBER> using medical subject heading text words coronavirus disease <NUMBER> covid<NUMBER> sarscov<NUMBER> cardiac injury biomarkers inflammation cardiac involvement fig <NUMBER> search articles reported observational studies clinical trials promoting relation cardiac involvement inflammation covid<NUMBER> considered articles eligible initial inclusion focused subject citations relevant articles reviewed capture additional studies also manually searched reference previous reviews records received fulltext review additional articles search years included referenced existing articles included pertinent important data present article randomized trials neither interventional studies available time investigation hence observational studies longterm prospective cohort studies casecontrol crosssectional studies also included article eligible inclusion studies written english published peerreviewed journal provides outcome data cardiac injury inflammation covid<NUMBER> study accordance ethical standards institutional research committee <NUMBER> helsinki declaration later amendments comparable ethical standards included studies first categorized whether study compared clinical outcomes cardiac involvement inflammation covid<NUMBER> patients initial search authors separately screened abstracts based eligibility criteria abstracts articles disagreement uncertainty reviewed discussed consensus reached due lack prospective randomized controlled clinical studies inflammation cardiac involvement exact mechanism cardiac injury among patients covid<NUMBER> still remains uncertain however different possible mechanisms manifested recent clinical observational studies elaborated discussed table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirusassociated acute myocarditis alhogbani <NUMBER> described evidence coronavirusassociated acute myocarditis manifested myocardial edema acute myocardial injury apical lateral walls left ventricle regional myocardial injury may result direct viral myocardial infection inflammation however according recent pathological study performed xu et al <NUMBER> scarce interstitial mononuclear inflammatory infiltrates myocardial tissue without substantial cardiac muscle tissue damage patient covid<NUMBER> suggesting coronavirus might directly impair hand study performed guo et al <NUMBER> plasma troponin levels positively linear correlated significant manner plasma highsensitivity creactive protein crp levels indicating myocardial injury may closely associated inflammatory pathogenesis progress disease considering patients elderly people probable association coronary heart disease whether myocardial injury directly associated sarscov<NUMBER> infection still unclear direct evidence demonstrating sarscov<NUMBER> infects myocardial tissue pericardial effusion liquid patients covid<NUMBER> currently lacking interest hundred thousands bodies available autopsy studies prospective investigation reported far elucidation disease pathogenesis prospective histopathological studies crucial future proper treatment case renewed outbreaks another plausible mechanism involves ace<NUMBER> latter human cell receptor strong binding affinity virus spike protein sarscov<NUMBER> since ace<NUMBER> also highly expressed heart reasonable hypothesize covid<NUMBER>induced cardiac injury might mediated ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> key counter regulatory enzyme degrades angiotensin ii angiotensin<NUMBER> thereby attenuating effects vasoconstriction sodium retention fibrosis although angiotensin ii primary substrate ace<NUMBER> enzyme also cleaves angiotensin angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also participates hydrolysis peptides ace<NUMBER> expressed broadly including heart kidneys lung alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> complexity underlying reninangiotensinaldosterone system raas clearly shows different responses different modulators presence sarscov <NUMBER> infection fig <NUMBER> enzyme active sites ace ace<NUMBER> distinct therefore ace inhibitors clinical use directly affect ace<NUMBER> activity <NUMBER> experimental animal studies shown mixed findings respect effects ace inhibitors arb ace<NUMBER> levels activity tissue <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies shown arb may increase messenger rna expression protein levels ace<NUMBER> tissue <NUMBER> <NUMBER> others showed effect <NUMBER> ostensibly inconsistent results demonstrate complex raas responses emphasize notion findings experimental animal studies may extrapolate similar physiological responses humans fact shows importance relevance human studies performed matter shed light comprehension least theoretically druginduced increased ace<NUMBER> expression produced acei arb might aggravate lung injury patients covid<NUMBER> however henry et al <NUMBER> previous clinical study showed beneficial effect acei patients admitted viral pneumonia retrospectively investigated impact ace inhibitors statins rates intubation death <NUMBER> adult patients positive respiratory viral polymerase chain reaction test found lower rates death intubation patients continued use ace inhibitors odds ratio ¼<NUMBER> <NUMBER> confidence interval ci <NUMBER> hospital stay moreover patients ace inhibitors hospital admission subsequently discontinued medication higher mortality patients ace inhibitor admission observed significantly reduction pulmonary inflammatory response cytokine release caused virus infection <NUMBER> addition mortensen et al <NUMBER> found significant decrease mortality length stay mechanical ventilation patients taking ace inhibitors arb hospitalized pneumonia compared matched cohort study done kuba et al <NUMBER> provided first genetic proof molecular evidence severe lung failure mortality associated sarscov demonstrated infections sarscov resulted ace<NUMBER> downregulation binding sarscov spike protein ace<NUMBER> contributed severity lung pathologies showed severity could attenuated blocking reninangiotensin pathway <NUMBER> authors mentioned fact providing molecular link sarscov pathogenesis role raas lung failure envisioned novel target therapeutic management recombinant ace<NUMBER> protein could treatment block virus spreading modulation reninangiotensin system could also utilized protect patients covid<NUMBER> beneficial effect aceiarb may related compensatory increase ace<NUMBER> <NUMBER> however evidence regarding use aceiarb patients covid<NUMBER> infection still emerging larger prospective randomized clinical studies required present patients covid<NUMBER> previously used acei arb use drug agents may need discontinued based current data another possible mechanism involved cardiac injury may increased cytokine secretion covid<NUMBER> previous research <NUMBER> patients established clinical diagnosis sarscov prospectively studied li et al <NUMBER> found significantly higher left ventricular index myocardial performance <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> longer isovolumic relaxation time <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> milliseconds p <NUMBER> lower flow propagation velocity <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> cms p <NUMBER> dopplerderived cardiac output <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> lmin p <NUMBER> observed acute infection compared <NUMBER> days decrease left ventricular ejection fraction correlated moderately elevated lactate dehydrogenase level r −<NUMBER> p <NUMBER> whereas higher index myocardial performance correlated weakly increase creatine kinase level r <NUMBER> p <NUMBER> <NUMBER>day echocardiographic followup study found reversible subclinical diastolic left ventricular impairment appears common finding acute sarscov infection even among patients without underlying cardiac disease suggested left ventricular dysfunction acute phase disease might attributable cytokine storm syndrome resulting overaggressive host immune response sarscov infection <NUMBER> huang et al <NUMBER> found severely ill patients covid<NUMBER> admitted intensive care unit higher plasma levels cytokines including interleukin il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor igginduced protein <NUMBER> also higher plasma levels monocyte chemoattractant protein<NUMBER> macrophage inflammatory protein <NUMBER>alpha tumor necrosis factor α indeed serious lifethreatening disease clinical features systemic inflammation methemoglobinemia hemodynamic instability multiple organ failure trademark clinical endorsement cytokine storm syndrome severe uncontrolled dysfunctional immune response involving continuous activation proliferation lymphocytes macrophages markers inflammatory response crp procalcitonin leukocytes also found significantly increased among patients suffered cardiac injury <NUMBER> infectionrelated increased cytokine release identified elevated plasma level several inflammatory biomarkers various inflammatory serum markers shown elevated patients covid<NUMBER>related cardiac injury crp procalcitonin ferritin ddimer il<NUMBER> il<NUMBER> granulocyte colonystimulating factor igginduced protein <NUMBER> chemokine ligand <NUMBER> tumor necrosis alpha therefore storming activation secretion inflammatory cytokines lead apoptosis necrosis myocardial cells covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> regard huang et al <NUMBER> demonstrated imbalance helper <NUMBER> helper <NUMBER> responses resulting cytokine storm may contributed myocardial injury patients covid<NUMBER> release inflammatory cytokines infection may cause reduction coronary blood flow decreased oxygen supply another interesting factor consider presence preexisting cvds might also render patients susceptible covid<NUMBER>induced heart injury shi et al <NUMBER> demonstrated patients cardiac injury history coronary heart disease <NUMBER> hypertension <NUMBER> significantly prevalent patients without cardiac injury wang et al <NUMBER> found similar percentages patients critically ill covid<NUMBER> <NUMBER> underlying heart diseases <NUMBER> hypertension reasonable assume patients predisposing cvds coronary artery disease heart failure susceptible cardiac injury patients infected covid<NUMBER> myocardial ischemia infarction left ventricular systolic dysfunction likely occur ultimately leading sudden deterioration intrinsic inflammatory process within atherosclerotic plaques coronary walls exacerbated systemic inflammatory response covid<NUMBER> making susceptible fissure initiating acute coronary syndrome <NUMBER> altered myocardial demandsupply ratio association increased cardiometabolic demand myocardial tissue result myocyte hypoxia alteration context systemic infection associated acute respiratory illnessrelated hypoxia impair myocardial oxygen demandsupply relationship lead acute myocardial injury <NUMBER> addition systemic inflammation also causes endothelial dysfunction increases procoagulant activity blood contribute formation occlusive thrombi ruptured coronary plaque context inflammation hypoxemic state covid<NUMBER> atrial fibrillation may supervene worsening prognosis developing heart failure <NUMBER> several observational studies reported evidence higher morbidity mortality risk associated findings inflammation cardiovascular involvement especially cardiac injury patients covid<NUMBER> therefore concluded cardiac injury common condition among hospitalized patients covid<NUMBER> associated higher risk inhospital mortality <NUMBER> first study showing cardiac injury independently associated increased risk mortality patients covid<NUMBER> unfortunately study lacks imaging evidence nuclear magnetic resonance ct scans echocardiography determine features myocardial injury inflammation hence due current limited evidence based clinical investigation observational studies question whether novel coronavirus directly injure cardiac tissue requires investigation demonstration context <NUMBER> recent case reports documenting myocardial inflammation damage mri histological studies patients covid<NUMBER> <NUMBER> <NUMBER> recent case reports highlight importance clinical surveillance laboratory testing directly targeting serum troponin levels guarantee appropriate rapid identification atypical cases acute illness covid<NUMBER> proceed prompt isolation patients eventually reduce transmission viral diseases harm myocardial cells direct myocyte damage virus systemic inflammatory responses han et al <NUMBER> studied analyzed detail main laboratory markers associated cardiac injury covid<NUMBER> patients investigated correlation heart injury severity disease specifically analyzed serum levels creatine kinase isoenzymemb myohemoglobin myo cardiac tni ultratni nterminal probrain natriuretic peptide ntprobnp <NUMBER> covid<NUMBER> patients patients divided <NUMBER> groups according strict diagnostic criteria clinical condition mild <NUMBER> cases severe <NUMBER> cases critical <NUMBER> cases positive rate myo ultratni ntprobnp higher severe cases critical cases compared mild cases differences among groups statistically significant p <NUMBER>these findings showed higher concentrations venous blood creatine kinase isoenzymemb myo ultratni ntprobnp associated severity mortality covid<NUMBER> note authors analyzed <NUMBER> cardiac injury parameters death n <NUMBER> alive patients n <NUMBER> <NUMBER> parameters significantly higher death alive group p <NUMBER> therefore authors concluded careful monitoring myocardial enzyme profiles great importance reducing complications mortality covid<NUMBER> patients <NUMBER> context interesting metaanalysis performed lippi et al <NUMBER> total number <NUMBER> patients found tni plasma values significantly increased patients severe covid<NUMBER> compared patients milder forms disease therefore seems rational assume initial measurements serum biomarkers cardiac injury performed immediately hospitalization covid<NUMBER> patients inhospital monitoring may help identifying subset severe cases possible cardiac involvement consequently predict progression towards worse clinical scenario guo et al <NUMBER> performed retrospective singlecenter case series study analyzed <NUMBER> patients confirmed covid<NUMBER> mean age <NUMBER> ± <NUMBER> years evaluated association underlying cvd myocardial injury fatal outcomes patients covid<NUMBER> <NUMBER> patients <NUMBER> patients <NUMBER> discharged hospital <NUMBER> patients <NUMBER> died overall <NUMBER> <NUMBER> patients underlying cvd including hypertension coronary heart disease cardiomyopathy <NUMBER> <NUMBER> exhibited myocardial injury indicated elevated troponin tnt levels mortality hospitalization <NUMBER> patients without underlying cvd normal tnt levels <NUMBER> underlying cvd normal tnt levels <NUMBER> without underlying cvd elevated tnt levels <NUMBER> underlying cvd elevated tnts fig <NUMBER> patients underlying cvd likely exhibit elevation tnt levels compared patients without cvd <NUMBER> vs <NUMBER> plasma tnt levels demonstrated high significantly positive linear correlation plasma highsensitivity crp levels β <NUMBER> p <NUMBER> ntprobnp levels β <NUMBER> p <NUMBER> hospitalization patients elevated tnt levels frequent malignant arrhythmias use glucocorticoid therapy <NUMBER> vs <NUMBER> mechanical ventilation <NUMBER> vs <NUMBER> higher compared patients normal tnt levels mortality rates patients without use aceiangiotensin receptor blockers <NUMBER> <NUMBER> therefore authors concluded myocardial injury significantly associated fatal outcome covid<NUMBER> prognosis patients underlying cvd without myocardial injury relatively favorable myocardial injury associated cardiac dysfunction arrhythmias inflammation may potential mechanism myocardial injury aggressive treatment may considered patients high risk myocardial injury interestingly authors demonstrated high significantly positive linear correlation troponin plasma highsensitivity crp levels biomarkers cardiac injury systemic inflammation respectively fig <NUMBER> guo et al <NUMBER> observed <NUMBER> <NUMBER> patients exhibited myocardial injury demonstrated elevation troponin levels mortality markedly higher patients elevated tnt levels normal tnt levels <NUMBER> vs <NUMBER> nearly <NUMBER> mortality covid<NUMBER> patients underlying cvd elevated troponin levels addition data ntprobnp showed serum elevation presence malignant arrhythmias significantly common patients elevated tnt levels moreover serum levels ntprobnp significantly correlated tnt levels respect gao et al <NUMBER> studying <NUMBER> patients covid<NUMBER> reported best cutoff value ntprobnp <NUMBER> pgml predicting inhospital death found excellent sensitivity good specificity fig <NUMBER> patients high ntprobnp values significantly increased risk death comparing low values adjustment potential risk factors ntprobnp independently correlated inhospital death <NUMBER> results <NUMBER> latter studies argue favor concept greater cardiac injury greater ventricular dysfunction covid<NUMBER> patients also patients underlying cvd prone experience myocardial injury course covid<NUMBER> known direct association sarscov<NUMBER> qt interval prolongation electrocardiogram covid<NUMBER> patients however known association prolonged qt interval cardiac arrhythmias among certain drug agents may utilized therapeutic management covid<NUMBER> hydroxychloroquine azithromycin utilized potential pharmacological agents prophylaxis therapeutic management covid<NUMBER> drug agents known provoke malignant ventricular arrhythmias certain patients <NUMBER> <NUMBER> <NUMBER> hydroxychloroquine acts entry postentry stages sarscov<NUMBER> via effects endosomal ph resulting underglycosylation ace <NUMBER> receptors required viral entry since may prolong qt interval develop ventricular arrhythmias given extreme cautious association qt interval prolonging drugs fig <NUMBER> case reports patients systemic lupus erythematosus showing hydroxychloroquineinduced qt interval prolongation developing torsade de pointes <NUMBER> <NUMBER> azithromycin increasingly recognized antibiotic may cause qt prolongation malignant ventricular arrhythmias nonpausedependent polymorphic ventricular tachycardia torsade des points increased risk sudden cardiac death <NUMBER> limited data evaluating safety clinical outcome combination therapy <NUMBER> pharmacological agents effect combination qt interval arrhythmia risk studied therefore multiple randomized clinical trials currently ongoing studies table <NUMBER> shows certain care safety considerations consider novel coronavirus sarscov<NUMBER> appears transmittable greater infectivity somehow similar higher morbidity mortality depending area considered compared sars mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> far greater incidence patients sarscov<NUMBER> developed severe pneumonia pulmonary edema acute respiratory distress syndrome cardiovascular compromise multiple organ failure death oudit et al <NUMBER> previously demonstrated sarscov genome positively detected myocardial tissue <NUMBER> patients sarscov infection raises possibility direct damage cardiomyocytes virus sarscov<NUMBER> may share mechanism sarscov <NUMBER> viruses highly homologous genome <NUMBER> <NUMBER> animal experimental studies shown strains coronavirus infection may seriously affect heart example coronavirus infection may induce cardiomyopathy results cardiac chamber dilatation impairment systolic function simulating dilated cardiomyopathy rabbits <NUMBER> context cardiomyopathy interesting note dong et al <NUMBER> reported <NUMBER> endstage heart failure patients infected covid<NUMBER> <NUMBER> severe illness presentation <NUMBER> patients male typical lymphopenia significantly increased crp level three patients elevated tni later evolution period tni increased significantly days death moreover levels crp brain natriuretic peptide significantly higher interesting finding tni level <NUMBER> critically ill patients increased significantly <NUMBER>fold indicating important myocardial injury patients endstage heart failure seemed older comorbidity poor general condition greater myocardial injury higher mortality rate covid<NUMBER> according novel knowledge acquired recent studies covid<NUMBER> patients manifested cardiac injury presented severe acute illness requiring noninvasive invasive ventilation compared patients without cardiac injury also manifested clearly abnormal laboratory radiographic findings mortality half hospitalized patients worth comparing cardiovascular findings covid<NUMBER> sars <NUMBER> years ago <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> yu et al <NUMBER> studied cardiovascular complications sars <NUMBER> hospitalized patients observed hypertension occurred <NUMBER> patients <NUMBER> developed persistent tachycardia including <NUMBER> continued tachycardia outpatient followup therefore tachycardia could explained fever already subsided neither explained coexisting hypotension present comparatively small number patients although tachycardiarelated cardiovascular complications common patients sars generally selflimiting associated mortality types cardiac arrhythmias uncommon patients sars transient atrial fibrillation occurred <NUMBER> patient history cardiac disease therefore cardiac arrhythmiaassociated effect coronavirus causes sars low total <NUMBER> <NUMBER> patients developed arterial desaturation needed oxygen therapy however <NUMBER> <NUMBER> patients admitted intensive care unit <NUMBER> <NUMBER> patients died due pneumonia <NUMBER> contrast sars findings half patients cardiac injury experienced inhospital death covid<NUMBER> indicating novel coronavirusinduced cardiac injury associated major adverse clinical outcomes worse prognosis <NUMBER> indeed cardiac injury found independently associated increased risk mortality patients covid<NUMBER> myocardial injury common pathways inflammation significantly associated higher risk inhospital mortality figure <NUMBER> hydroxychloroquine therapy according cardiovascular risk hcq hydroxychloroquine qtc corrected qt interval reprinted permission ind pac electrophysiol j <NUMBER> overall fatal outcome covid<NUMBER> identified several potential mechanisms myocardial tissue damage namely coronavirusassociated acute myocarditis ace<NUMBER> receptor binding affinity virus spike protein increased cytokine secretion hypoxiainduced cardiac myocyte apoptosis myocardial injury found related cardiac dysfunction ventricular arrhythmias independently associated increased risk mortality patients covid<NUMBER> inflammation may potential mechanism myocardial injury high significantly positive linear correlation troponin plasma highsensitivity crp levels biomarkers cardiac injury systemic inflammation respectively although several possible mechanisms myocardial tissue damage exact mechanism cardiac injury needs explored welldesigned clinical studies strong efforts continued research cardiovascular complications identification risk factors poor prognosis covid<NUMBER> steadily needed given high infectivity lethality covid<NUMBER> enormous economic social impact worldwide outbreak elucidation disease pathogenesis prospective histopathological studies crucial future treatment case renewed outbreaks cvds still number one killer world represent leading noncommunicable epidemic since numerous patients cvd using aceiarb drug agents clinical studies may necessary explore potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> despite theoretical concerns physiological uncertainties concerning effect raas inhibitors ace<NUMBER> ace inhibitors arb drug agents continued patients covid<NUMBER> otherwise stable condition <NUMBER> <NUMBER> <NUMBER> position supported multiple medical scientific societies needs explored randomized clinical trials search potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> high morbidity mortality covid<NUMBER> monumental economic burden social impact despair new pandemic outbreak thread potential utilization novel sarscov<NUMBER> biologic weapons make preponderant necessity better comprehend therapeutic management lethal disease emerging acute infectious disease covid<NUMBER> may become chronic epidemic genetic recombination therefore ready reemergence covid<NUMBER> coronaviruses near future nothing declare considerations <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus infects cells via membrane bound angiotensin converting enzyme<NUMBER> ace <NUMBER> receptors <NUMBER> multiple studies reported spectrum clinical manifestations disease highlighted involvement cardiovascular system <NUMBER> prevalence cardiovascular disease cvd patients covid<NUMBER> reported range <NUMBER> <NUMBER> evidence growing presence linked unfavorable outcomes including limited icu admissions increased mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent metanalysis showed increased allcause mortality risk severe form covid<NUMBER> infection patients underlying cvd <NUMBER> several small studies showing elevated biomarkers covid<NUMBER> patients suggesting myocardial injury however conflicting data regarding association cardiac biomarkers severity disease <NUMBER> <NUMBER> paucity data outcomes covid<NUMBER> patients underlying congestive heart failure chf <NUMBER> <NUMBER> conducted study delineate influence various cardiac conditions especially chf outcomes patients covid<NUMBER> determine prognostic value cardiac biomarkers troponin creatine kinasemb ckmb nterminalprobtype natriuretic peptide ntprobnp ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint systematic review conducted following guidelines laid preferred reporting items systematic reviews metaanalyses prisma <NUMBER> objectives <NUMBER> evaluate demographics occurrence cardiac injury arrhythmias patients covid<NUMBER> <NUMBER> assess impact hypertension htn chf mortality patients covid<NUMBER> infection based severity illness severe nonsevere final outcome alive deceased systematically searched pubmed medline httpspubmedncbinlmnihgov embase google scholar databases using following search terms keywords covid clinical heart myocard covid covid troponin coronavirus heart two authors sl td independently reviewed <NUMBER> citations identify number studies satisfying inclusion criteria <NUMBER> duplicates <NUMBER> correspondence letters case reports review articles <NUMBER> articles irrelevant study question based titles abstracts hence excluded review abstracts fulllength articles <NUMBER> studies evaluated <NUMBER> included qualitative synthesis <NUMBER> articles report biomarkers interest leaving <NUMBER> studies included quantitative assessment figure <NUMBER> one study later excluded owing article retraction leaving total <NUMBER> studies final meta ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> analysis conflicts regarding study selection resolved mutual consensus <NUMBER> invivo studies animals tissue samples excluded published studies december <NUMBER> may <NUMBER> reported covid<NUMBER> patients characteristics coexisting comorbidities laboratory data stratified basis patient outcome andor disease severity included systematic review exclusion criteria confined articles either report laboratory values cardiac biomarkers classify patients outcomes based severity infection final patient outcome data extraction quality assessment two authors sl td extracted data collected following variables authors names year publication study design duration study period sample population demographic baseline characteristics patients laboratory biomarkers identify cardiac injury namely ckmb cardiac sensitive troponin ntprobnp disease severity severe nonsevere inhospital patient outcomes alivedeceased criteria used authors classifying patients severe nonsevere provided etable <NUMBER> supplement acute cardiac injury often identified presence elevated serum levels highsensitivity troponin <NUMBER> however specific cutoff value exists classified patients spectrum fulminant based severity disease progression including death whereas survivors nonsevere cases collectively classified ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint nonfulminant spectrum illness also compared relative risk death index admission hospital patients without preexisting chf categorical variables patient groups summarized using manelhaenszel risk ratios rr <NUMBER> <NUMBER> continuous data variables summarized using mean difference md along corresponding <NUMBER> ci pooled estimates calculated using randomeffects metaanalysis model calculating tausquare τ <NUMBER> used hartungknappsidikjonkman hksj method traditional dersimonianlaird method known perform better fewer number studies lower typei error rates even combining studies unequal sample size <NUMBER> studies reported descriptive values median interquartile range transformed mean ± standard deviations using wan method <NUMBER> publication bias evaluated constructing funnelplots effect size standard error se performing eggers linear regression test funnelplot asymmetry betweenstudy heterogeneity calculated higgins <NUMBER> statistic twosided p value <NUMBER> considered statistical significance used meta metafor packages conducting metaanalyses <NUMBER> <NUMBER> statistical analyses conducted sl r v<NUMBER> reviewed sr zs overall collected <NUMBER> patients <NUMBER> individual study reports table <NUMBER> outlines details studies demographics patients included systematic review age patients ranged <NUMBER> years prevalence females ranging <NUMBER> prevalence hypertension diabetes mellitus smoking observed ranging <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> <NUMBER> respectively ten studies reported findings stratified according patient outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies reported findings severe nonsevere covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> assessment underlying cardiac conditions found nonsurvivors severe covid<NUMBER> infection fulminant group <NUMBER>fold increased risk acute cardiac injury compared survivorsnonsevere patients nonfulminant group pooled rr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER> similar trend increased risk observed cardiac arrhythmia pooled rr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER> also found risk death significantly higher chf patients rr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> however risk inhospital death patients underlying hypertension found statistically significant rr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint elicit better understanding confounding effects variables used metaregression models cardiac biomarkers adjusting patients age hypertension diabetes smoking status regression model showed statistically significant association mean difference serum levels ntpro bnp diabetes mellitus status patients etable <NUMBER> supplement observed patients suffered severe covid<NUMBER> infection nonsurvivors fulminant group substantially higher burden cardiovascular diseases compared nonsevere cases survivors nonfulminant group patients also found increased risk acute cardiac injury cardiac rhythm irregularities likely owing involvement myocardium coronavirus infection evidenced elevated levels cardiac biomarkers results consistent metaanalyses concluded patients underlying cardiovascular disorders higher propensity develop severe fulminant covid<NUMBER> infection <NUMBER> <NUMBER> furthermore latest study lala et al found presence cardiovascular diseases covid<NUMBER> patients increases susceptibility develop myocardial damage associated higher mortality risk <NUMBER> although prior systemic reviews metanalyses looked combined effect underlying cardiovascular comorbidities covid<NUMBER> outcomes study novel largely focused impact isolated chf covid<NUMBER> outcomes also prior studies patients mostly southeast asia whereas incorporated patients geographic regions well covid<NUMBER> novel infectious disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> binds angiotensin converting enzyme <NUMBER> ace <NUMBER> receptors ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint gain entry human body <NUMBER> receptors present various organs including lung alveolar epithelial cells vascular endothelial cells cardiac myocytes pericytes <NUMBER> <NUMBER> <NUMBER> precise mechanisms myocardial injury covid<NUMBER> cases unclear moment however <NUMBER> proposed hypotheses myocardial insult could either due cytokine storm suggested elevated levels interleukin<NUMBER> lactate dehydrogenase among biomarkers due direct effect myocardium causing downregulation expression ace<NUMBER> protein expression within cardiac myocytes ace<NUMBER> protein speculated protective effect myocardial lung injury reducing ace<NUMBER> protein speculated protective effect myocardial lung injury reducing blood pressure inflammation fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> several rhythm abnormalities like atrioventricular block atrial fibrillation polymorphic ventricular tachycardia pulseless electrical activity associated covid<NUMBER> <NUMBER> exact mechanism underlying rhythm abnormalities still completely elucidated myocarditis associated covid<NUMBER> elevation inflammatory biomarkers also suggest direct involvement electrical conduction system <NUMBER> moreover medications used treatment covid<NUMBER> patients increase qtcinterval cause life threatening arrhythmias <NUMBER> presence inflammatory milieu direct myocardial insult might led increased risk cardiac arrhythmias noted study also observed presence heart failure associated increased mortality among covid<NUMBER> patients consistent studies shown similar findings <NUMBER> ace <NUMBER> counteracts effect angiotensin ii states excessive activation reninangiotensin system like heart failure <NUMBER> chf patients known dysregulation intracellular calcium handling mechanism <NUMBER> covid<NUMBER> cause hypoxia induced excessive ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint intracellular calcium leading cardiac myocyte apoptosis <NUMBER> lead increased mortality observed patients chf ntpro bnp known elevated patients chf <NUMBER> elevation associated poor prognosis patients sepsis pneumonia <NUMBER> increased ventricular wall stress due hypoxia induced pulmonary hypertension impaired clearance critically ill patients renal failure mechanisms lead elevation ntpro bnp levels covid<NUMBER> patients <NUMBER> high ntpro bnp levels associated increased mortality covid<NUMBER> patients <NUMBER> recent systemic review predominantly included patient population china showed similar finding increased mortality <NUMBER> although patients different geographical regions world yet findings consistent study systematic review inevitably certain limitations betweenstudy heterogeneity potential publication bias another concerning aspect retrospective study designs included researches lack individual patient severity medical information smoking status unable adjust confounding effects comorbidities variables summary presence chf patients covid<NUMBER> associated increased mortality worse outcomes index admission increased risk acute cardiac injury cardiac arrhythmia among nonsurvivors severe covid<NUMBER> patients elevated cardiac biomarkers like ntpro bnp ckmb associated poor prognosis ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint help identify atrisk covid<NUMBER> patients suggest close monitoring severe covid<NUMBER> patients underlying cardiac comorbidities reduced mortality none authors declare conflicts interest disclose none tarun dalia httpsorcidorg<NUMBER> shubham lahan https orcidorg<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> total studies included metaanalysis n<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> studies marked asterisk compared outcomes severe nonsevere cases covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure <NUMBER> relative risk inhospital death patients without preexisting congestive heart failure without preexisting hypertension g ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> studies marked asterisk compared severe nonsevere covid<NUMBER> cases ng ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint outbreak pneumonia eastern europe usa severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> serious social issue high number pulmonary complications needing intensive care units icu treatment mortality risk particularly elevated north italy even severe respiratory disease key factor precipitating poor outcome factors could also play role previous study reported communityacquired pneumonia cap associated cardiovascular disease heart failure myocardial infarction atrial fibrillation myocardial damage depicted elevated highsensitivity cardiac troponin hsctn detectable <NUMBER> cap patients cap severity among factors favoring myocardial injury <NUMBER> troponin elevation associated poor prognosis reviewed data far reported regarding behavior troponins sarscov<NUMBER> patients relation disease severity searched pubmed database without language restriction studies human patients published <NUMBER> present time combination text words medical subject headings including troponin troponins myocardial injury laboratory coronavirus covid<NUMBER> <NUMBER>ncov sarscov<NUMBER> initially <NUMBER> documents evaluated excluding papers report data troponin levels reviews commentaries letters seven papers selected one excluded data prevalence patients troponin elevation expressly reported six selected studies five set china one usa included total number <NUMBER> patients table <NUMBER> myocardial injury evaluated cardiac troponin ctni two measured hsctni <NUMBER> <NUMBER> myocardial injury ie troponin levels exceeding <NUMBER>th percentile upper reference limit observed prevalence ranging minimum <NUMBER> maximum <NUMBER> two studies prevalence myocardial injury compared patients severe conditions requiring icu patients notrequiring icu finding significantly higher prevalence troponin elevation icu patients particular wang et al <NUMBER> population <NUMBER> hospitalized patients covid<NUMBER>associated pneumonia found myocardial injury present <NUMBER> icu vs <NUMBER> nonicu patients p <NUMBER> similarly huang c et al <NUMBER> cohort <NUMBER> patients found myocardial injury prevalence <NUMBER> icu vs <NUMBER> nonicu patients p <NUMBER> three studies reported data icu patients <NUMBER> <NUMBER> prevalence myocardial injury ranged <NUMBER> <NUMBER> liu et al <NUMBER> cohort <NUMBER> hospital infected workers without severe pneumonia showed prevalence myocardial injury <NUMBER> large difference terms troponin elevation may depend time analysis troponin levels tend increase time admission accordingly patients needed icu treatment arentz et al <NUMBER> reported troponin elevation admission <NUMBER> patients occurrence cardiomyopathies seen larger number <NUMBER> suggesting even higher incidence troponin elevation icu treatment icu patients myocardial injury may important impact prognosis covid<NUMBER>associated pneumonia yang et al <NUMBER> found mortality <NUMBER> patients myocardial injury <NUMBER> patients without xw et al <NUMBER> reported inhospital mortality significantly higher patients myocardial injury patients without <NUMBER> vs <NUMBER> respectively p <NUMBER> together data indicate myocardial injury often detectable sarscov<NUMBER> patients impact much evident according disease severity thus highest percentage troponin elevation reported patients needed icu treatment also interest patients troponin elevation higher risk mortality potentially relevant association biased small sample size lack confounders analysis finally mechanisms accounting myocardial injury sarscov<NUMBER> investigated therefore still unclear angiotensin converting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase localized heart vascular system lung implicated hypertension interestingly ace<NUMBER> serves functional receptor sarscov<NUMBER> therefore triggers lung infection upon binding spike protein ace<NUMBER> <NUMBER> interaction may lead ace<NUMBER> downregulation potentially deleterious heart ace<NUMBER> serves degrade angiotensin ii angiotensin <NUMBER> counteract angiotensins vasoconstrictive activity <NUMBER> thus ace<NUMBER> downregulation sarscov<NUMBER> may potential trigger oxidative stress impaired angiotensin ii degradation could lead activation nox<NUMBER> among important enzymes generating reactive oxidant species ros <NUMBER> fig <NUMBER> note nox<NUMBER> localizes heart rises acute phase cap <NUMBER> independently correlates troponin elevation <NUMBER> associated experimentallyinduced heart failure furthermore nox<NUMBER> independently correlates heart failure often complicates cap <NUMBER> <NUMBER> far nox<NUMBER> measured sarscov<NUMBER> patients evaluation might useful investigate mechanism disease myocardial injury study limitation implications study focused chinese population included small number subjects however myocardial injury almost impressive impact clinical outcomes studied prospectively due potentially already reported interplay myocardial nox<NUMBER> cell injury heart failure fig <NUMBER> targeting nox<NUMBER> may approach limit myocardial injury patients affected sarscov<NUMBER> far however drugs market inhibits nox<NUMBER> alternative possibility interruption vicious circle nox<NUMBER> activation rosnox<NUMBER> activation perpetuates oxidative stress fig <NUMBER> context simple cheap approach may provided intravenous infusion vitamin c behaves antioxidant vivo millimolar concentrations intravenous infusion <NUMBER> g ascorbic acid resulted antioxidant effect ultimately downregulate nox<NUMBER> activation without eliciting side effect <NUMBER> note another drug commonly used arthritis ie tocilizumab investigation sarscov<NUMBER> patients behaves also antioxidant may interrupt vicious circle nox<NUMBER>rosnox<NUMBER> conclusion data far reported indicate patients sarscov<NUMBER> display signs myocardial injury evident patients severe disease prospective study needed assess impact myocardial injury clinical outcomes nox<NUMBER> downregulation may option limit myocardial injury sarscov<NUMBER> <NUMBER> hypothetic mechanism accounting oxidative stress sarscov<NUMBER> interaction sarscov<NUMBER> nox<NUMBER> heart interaction sarscov<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> may lead impaired angiotensin ii degradation subsequent nox<NUMBER> activation ultimately production reactive oxidant species ros ros promote myocardial injury effect may blunted vitamin c tocilizumab cardiovascular diseases andor risk factors highly prevalent severe forms coronavirus <NUMBER> infection <NUMBER> <NUMBER> clinical manifestations principally respiratory patients may also show cardiovascular complications <NUMBER> present article reviews current state knowledge regarding relation reninangiotensinaldosterone system raas particularly angiotensinconverting enzyme <NUMBER> ace<NUMBER> covid<NUMBER> raas blockers covid<NUMBER> human physiology peptides degraded limited number nonspecific extracellular enzymes known peptidases proteases membrane proteins active sites face extracellular space endopeptidases cut within peptide chain exopeptidases release cor nterminal amino acids angiotensinconverting enzymes exopeptidases carboxypeptidases relatively specific amino acids surrounding cut site although may common several peptides angiotensinconverting enzyme <NUMBER> ace<NUMBER> enzyme carboxypeptidase mainly located membrane cell circulating forms remaining largely underrepresented ace<NUMBER> homologous angiotensinconverting enzyme formerly simply known ace better denoted ace<NUMBER> first described <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> acts deactivator angiotensin ii also known angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> active peptide causing vasoconstriction profibrosis proinflammation action stimulating aldosterone secretion binding at<NUMBER> receptor converting angiotensin<NUMBER> active peptide opposite properties angiotensin ii <NUMBER> several vitro studies showed angiotensin<NUMBER> binding mas receptor induced vasodilatation showed antifibrosis antiinflammatory properties fig <NUMBER> <NUMBER> angiotensin ii also deactivated aminopeptidase converts angiotensin iii induces vasodilatation increases natriuresis bradykinin preferential binding at<NUMBER> receptors <NUMBER>fold greater affinity at<NUMBER> receptors <NUMBER> <NUMBER> ace<NUMBER> also converts angiotensin <NUMBER> also known angiotensin<NUMBER> angiotensin<NUMBER> unknown action converted angiotensin<NUMBER> ace<NUMBER> raas includes activator system including classical historical angiotensin iiace<NUMBER>at<NUMBER>raldosterone pathway inhibitor system including angiotensin<NUMBER>ace<NUMBER>masr pathway latter able deactivate angiotensin ii counter effects pharmacology angiotensin<NUMBER>ace<NUMBER>masr pathway contrast angiotensin iiace<NUMBER>at<NUMBER>raldosterone pathway little explored invitro studies showed beneficial cardiovascular impact activated possibly involving gmpcelevation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> also reported interact angiotensin<NUMBER> receptor at<NUMBER>r targeted angiotensin ii receptor blockers arb arbs counter at<NUMBER>rmediated effects angiotensin ii thus stimulating angiotensin ii liberation response increase angiotensin ii thus increase ace<NUMBER> expression <NUMBER> moreover ace<NUMBER> via mas receptors heterooligomerize at<NUMBER> receptor inhibit actions angiotensin ii therefore play pivotal role angiotensin ii regulation <NUMBER> ace<NUMBER> seems expressed cells various organs including heart brain kidney vessels digestive tract testicles adipose tissues lung <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> specific sars cov<NUMBER> virus sarscoronavirus spikes surface glycoprotein utilizes ace<NUMBER> membrane receptor cellular protease tmprss<NUMBER> enter target cells <NUMBER> <NUMBER> membrane enzyme extracellular domain ace<NUMBER> seems provide entry human cells sars cov<NUMBER>covid<NUMBER> therefore acts receptor coronavirus fig <NUMBER> <NUMBER> <NUMBER> precise identification sars cov<NUMBER> spike glycoproteins ace<NUMBER> binding site shows latter identical sars cov <NUMBER> despite two viruses distinct showing <NUMBER> homology spike protein viral surface sarscov<NUMBER> shown bind ace<NUMBER> <NUMBER> times affinity sarscov<NUMBER> coronavirus responsible sars outbreak <NUMBER> <NUMBER> <NUMBER> higher ace<NUMBER> affinity sarscov<NUMBER> may explain ease humantohuman transmission current pandemic spike protein activation tmprss<NUMBER> proteases followed sars cov<NUMBER> binding extracellular domain membrane ace<NUMBER> explains virus binds penetrates cell fig <NUMBER> reference <NUMBER> conversely circulating soluble ace<NUMBER> bind sars cov<NUMBER> unable induce cell infection experimentally antibodies targeting sars cov seem also block sars cov<NUMBER> binding ace<NUMBER> suggesting possible therapeutic strategies notably repositioning certain protease inhibitors <NUMBER> consequently ace<NUMBER> cell entry receptor sarscov<NUMBER> establishes link covid<NUMBER> raas invitro studies reported positive correlation membrane expression andor tissue activity ace<NUMBER> risk covid<NUMBER> infection <NUMBER> moreover binding ace<NUMBER> virus induces downregulation ace<NUMBER> tissue activity infected cells thus assumed aggravating covid<NUMBER>induced inflammation organs lungs also reducing sarscov<NUMBER> infection tissues <NUMBER> invitro study reported decreased ace<NUMBER> membrane expression levels mouse lung following sars cov administration concomitant respiratory impairment <NUMBER> administration arb losartan improved respiratory function maybe restoring ace<NUMBER> membrane expression tissue activity allowing angiotensin ii bind pulmonary at<NUMBER> receptor thus decreasing risk lung injury thus ace<NUMBER> membrane expression levels andor tissue activity may influence onset covid<NUMBER> infection thus risk developing severe inflammatory tissue injuries likewise recent retrospective study <NUMBER> chinese covd<NUMBER> patients requiring hospital admission <NUMBER> showed hypokalemia authors explained altered angiotensin ii deactivation shift ace<NUMBER>ace<NUMBER> balance reduced ace<NUMBER> tissue activity covid<NUMBER> favor ace<NUMBER> thus inducing aldosterone synthesis hypokalemia occurrence fig <NUMBER> <NUMBER> line hypothesis role mineralocorticoid receptor antagonists must examined ability correct hypokalemia also increase angiotensin ii levels might play protective well deleterious role lung injury therefore ace<NUMBER> particularly membrane expression tissue activity appear key player covid<NUMBER> infection exact roles however complex may deleterious contamination phase ace<NUMBER> acts receptor covid<NUMBER> severity may correlate membrane expression tissue activity <NUMBER> <NUMBER> beneficial inflammatory lesion phase <NUMBER> <NUMBER> many questions remain unanswered date knowledge pharmacologic ace<NUMBER> activators inhibitors available date humans ace<NUMBER> activators currently used vitro experiments andor veterinary use including xanthenone diminazene aceturate antiparasitic drug <NUMBER> ace<NUMBER> activators demonstrated vitro interesting antifibrotic antiinflammatory properties could represent valuable therapeutic option sarscov<NUMBER> infection humans <NUMBER> groups suggested using circulating soluble ace<NUMBER> capture many viruses possible plasma restricting fixation cellmembrane ace<NUMBER> thus limiting cell infection invitro studies showed genetically engineered recombinant soluble ace<NUMBER> could useful therapeutic option <NUMBER> <NUMBER> moreover soluble ace<NUMBER> might favor angiotensin<NUMBER>ace<NUMBER>masr pathway angiotensin iiaceat<NUMBER>raldosterone pathway preventing treating severe inflammatory tissue lesions <NUMBER> human recombinant soluble ace<NUMBER> fdaapproved treatment since <NUMBER> <NUMBER> phaseii trial acute respiratory distress syndrome <NUMBER> would allow rapid transfer covid<NUMBER> application dedicated clinical trial must start soon nct<NUMBER> angiotensin ii also hypothesized confer protection covid<NUMBER> infection angiotensin ii represents major substrate ace<NUMBER> may compete sarscov<NUMBER> ace<NUMBER> receptor fig <NUMBER> angiotensinconverting enzyme inhibitors acei principally inhibit ace<NUMBER> thus blocking angiotensin ii release figure <NUMBER> ace<NUMBER> insensitive aceis <NUMBER> <NUMBER> acei like arb widely prescribed maintenance therapy several chronic cardiovascular diseases including arterial hypertension heart failure diabetic nephropathy invitro models free covid<NUMBER> reported acei arb treatment increased membrane expression ace<NUMBER> especially heart <NUMBER> <NUMBER> <NUMBER> available human studies performed healthy subjects covid<NUMBER>free confirm observations <NUMBER> <NUMBER> <NUMBER> <NUMBER> also noted circulating ace<NUMBER> levels may line membrane expression tissue activity latter possibly varying depending tissue invitro studies reported low levels circulating ace<NUMBER> despite high membrane thus tissue expression <NUMBER> also evidence impact aceiarb pulmonary expression ace<NUMBER> notably context covid<NUMBER> groups suggested increased angiotensin ii expression may underlie <NUMBER> <NUMBER> <NUMBER> <NUMBER> since findings animals inconsistent <NUMBER> humans groups speculated arbs could induce ace<NUMBER> levels elevation aceis inhibit angiotensin ii release <NUMBER> date human studies allow draw definitive conclusions <NUMBER> moreover arbs blocking at<NUMBER> receptors may favor conversion angiotensin ii angiotensin iii enhancing benefit at<NUMBER> receptor activation fig <NUMBER> importantly cardiovascular diseases notably ischemic cardiopathy heart failure arterial hypertension diabetes associated increased ace<NUMBER> membrane expression levels tissue activity noncovid<NUMBER> animal models independently aceiarb administration <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical situation infection contracted yet contracted patient without cardiovascular history covid<NUMBER> infection probably plays major role studies reported high levels aceiarb covid<NUMBER> cases especially severe forms requiring hospital icu admission although noticed arterial hypertension common general population especially elderly aceiarb prescribed <NUMBER> cases <NUMBER> thus positive negative impact aceiarb covid<NUMBER> humans remains unknown appears complex <NUMBER> possibly even depending clinical stage viral contamination phase versus tissue inflammation phase <NUMBER> <NUMBER> studies question forthcoming nct<NUMBER> early data extracted retrospective cohort performed china favor protective impact overall mortality aceisarbs results must consider caution presence several potential confounders factors included analyses <NUMBER> line vitro results suggested arbs aceis may confer protection covid<NUMBER> infection preventing onset severe tissue lesions <NUMBER> <NUMBER> two clinical trials losartan arb covid<NUMBER> without hospital admission due launched nct<NUMBER> nct<NUMBER> thus many scientific societies including french society arterial hypertension sfhta <NUMBER> european society cardiology <NUMBER> many publications <NUMBER> <NUMBER> <NUMBER> advise stopping maintenance treatments attempt prevent covid<NUMBER> infection especially imbalance blood pressure heart failure may deleterious remains difficult unanswered question longcourse aceiarb therapy case covid<NUMBER> infection especially severe individual personalized attitude seems essential considering clinical presentation severity hemodynamic respiratory renal failure blood pressure etc indications acei arb noncomplicated hypertension heart failure impaired lvef etc also noticed effects acei arb covid<NUMBER> infection unknown two may guidelines may rapidly revised light incoming data ongoing clinical trials especially concerning arb antihypertensive cardiovascular drugs dihydropyridines <NUMBER> <NUMBER> <NUMBER> combination sacubitrilvalsartan <NUMBER> thiazide diuretics <NUMBER> mineralocorticoid receptor antagonists <NUMBER> <NUMBER> <NUMBER> affected invitro ace<NUMBER> tissue expression regarding betablockers retrieved single invitro study reporting impact atenolol aortic tissue expression ace<NUMBER> <NUMBER> found studies impact loop diuretics tissue expression ace<NUMBER> although impact physiologically conceivable present theoretical concerns around ace<NUMBER> aceiarb covid<NUMBER> require detailed dedicated human studies seems clear ace<NUMBER> key point sars cov<NUMBER> cellentry therefore represents reasonable pharmacological target reducing ace<NUMBER> membrane activity tissue expression especially lung prevent infection reduce severity patients yet experiencing inflammatory lesions may represent valuable option prevent onset severe inflammatory tissue lesions especially lung hand angiotensin<NUMBER>ace<NUMBER>masr pathway favored angiotensin iiaceat<NUMBER>raldosterone pathway order increase ace<NUMBER> membrane expression andor tissue activity pharmacological therapeutic target eg arbs questions currently unresolved scrupulously investigated ongoing trials authors competing interest declare study supported first cases respiratory illness reported december <NUMBER> novel coronavirus designated severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified cause socalled coronavirus disease meanwhile become worldwide pandemic <NUMBER> <NUMBER> general three distinct phases characterize progression covid<NUMBER> initial infection phase followed respiratory distress phase finally culminating severe hyperinflammation state <NUMBER> sarscov<NUMBER> infections showing mild even absent symptoms <NUMBER> characteristics covid<NUMBER> outbreak reported china <NUMBER> provided important lessons respect cardiovascular involvements primary target well comorbidity infection phase marks virus infiltration proliferation epithelium lung parenchyma accompanied mild symptoms monocyte macrophage activation initial immune response ensuing inflammatory processes like vasodilation endothelial leakiness leukocyte extravasation lead pulmonary distress pulmonary damage fluid extravasation hypoxemia turn augments cardiovascular stress finally amplification host inflammatory response essentially culminate systemic inflammation eliciting cytokine storm <NUMBER> importantly cardiovascular system emerges primary target well important secondary comorbidity factor three covid<NUMBER> progression phases fig <NUMBER> accumulating evidence heart might direct target viral infection sarscov<NUMBER> <NUMBER> previous studies examining cardiovascular effects viral respiratory infections influenza epidemics revealed profound sixfold increased incidence ratio acute myocardial infarction within <NUMBER> days infection part due heightened prothrombotic activity leading intracoronary thrombotic events <NUMBER> hypotension tachycardia imbalance metabolic demand diseased heart exaggerated systemic inflammation profoundly increased circulating levels prototypical inflammatory markers il<NUMBER> il<NUMBER> tnfalpha mcp<NUMBER> crp well established contribute cardiac injury irrespective presence hypoxemia indeed biomarkers shown associated high mortality retrospective clinical series covid<NUMBER> patients hospitalized china <NUMBER> indicating potential serious bystander effects organs including heart support collateral damage heart increased inflammatory markers correlate electrocardiographic abnormalities biomarkers cardiac injury <NUMBER> finally elevation cardiac biomarkers documenting cardiac involvement prominent feature covid<NUMBER> also associated profoundly worse clinical outcome <NUMBER> <NUMBER> myocardial damage heart failure contributed almost <NUMBER> deaths critically ill cohort hospitalized wuhan <NUMBER> cox regression analyses revealed mortality risk associated acute cardiac damage significantly higher age chronic pulmonary disease prior history cardiovascular disease <NUMBER> <NUMBER> thus direct indirect mechanisms cardiovascular injury likely play pivotal role deleterious consequences sarscov<NUMBER> infection addition severe acute respiratory distress syndrome ards last patients underlying cardiovascular disease likely infected sarscov<NUMBER> likely develop severe symptoms infected sarscov<NUMBER> may also vulnerable adverse cardiotoxic effects treatment antiviral drugs recent analysis leoss registry <NUMBER> displaying prevalence comorbidities covid<NUMBER> patients germany disclosed classes disease severity <NUMBER> patients suffered cardiovascular comorbidity fig <NUMBER> summary consequences sarscov<NUMBER> infection cardiovascular system summarizing primary targets left secondary comorbidities right far prominent comorbidity associated covid<NUMBER> fig <NUMBER> taken together cardiovascular involvement highly prevalent significant prognostic importance covid<NUMBER> therefore important fully involve cardiologists managing cardiovascular complications severe cases covid<NUMBER> also pay particular attention cardiovascular protection patients risk develop covid<NUMBER> essential allocate sufficient resources cardiovascular diagnostic therapeutic procedures even times health care systems globally overwhelmed hospitals guided measures contain treat infectious disease need advice patients cardiovascular emergencies like stemi decompensated heart failure lifethreatening arrhythmias need immediate attention treatment emergency calls delayed fear admitted hospital potential acquire covid<NUMBER> need setup emergency treatment strategies noncovid<NUMBER> patients inhospital assure protection patients sarscov<NUMBER>infected patients additionally need make sure hospital staff health care workers general adequately protected diagnostic interventional procedures covid<NUMBER> patients guided clinical necessity fortunately major cardiovascular professional societies meanwhile process publishing guidance various aspects cardiovascular care covid<NUMBER> patients including perform diagnostic therapeutic interventions guidance publications referenced following chapters article without doubt lead greater awareness immediate cardiovascular implications infectious disease nevertheless stop hospitalization pneumonia previously shown associated significantly increased risk cardiovascular disease <NUMBER> years followup <NUMBER> likely sarscov<NUMBER> infections respiratory impairment also lead similar longterm adverse events need monitor covid<NUMBER> patients acutely elevated markers cardiac damage respect longterm consequences cardiac function including definite proof sarscov<NUMBER>induced myocarditis myocardial biopsy likewise important assess potential longterm cardiotoxic effects antiviral therapy thus cardiovascular care covid<NUMBER> pandemic already implement strategies capture longerterm implications prolonged clinical followup covid<NUMBER> spread almost countries world unexplained different impact disease different countries slow increase infections africa southeast asia surprisingly low fatality rate <NUMBER>th april <NUMBER> south africa <NUMBER> infections <NUMBER> deaths despite detailed surveillance system wwwcoron aviru sjhuedu accessed <NUMBER>th april <NUMBER> currently unknown far slower expected rise cases case mortality lowtomiddle income countries population demographics underlying comorbidities vastly different countries mean age many lowtomiddle income countries <NUMBER> decades lower higher income countries example uganda life expectancy birth males females <NUMBER> <NUMBER> years wwwwhoorg <NUMBER> population age range <NUMBER> years old <NUMBER> population older <NUMBER> years age pyramid influences current uganda cardiovascular health challenges include hypertension coronary artery disease mainly urban areas rheumatic heart disease rhd heart failure due cardiomyopathies remain enormous challenges patients access balloon valvotomy surgery <NUMBER> untreated symptomatic patients rheumatic heart disease mortality rate <NUMBER> per annum leaving patients able live beyond <NUMBER> years age <NUMBER> however factors might impact countrybycountry difference covid<NUMBER> morbidity mortality could possibly explained national policies bacillus calmette guerin bcg vaccination bcg live attenuated strain derived isolate myocobacterium bovis used widely across world vaccine tuberculosis many lowtomiddle income countries also highincome countries japan universal bcg vaccination policy newborns bcg vaccinations shown produce nonspecific immune effects leading improved response nonmyocardial pathogens another possible protective mechanism could high number people living hivaids antiretroviral therapy south africa population <NUMBER> million <NUMBER> hivinfected sa worlds largest antiretroviral therapy art program subsidized government provided freeofcharge time tell lowto middle income countries catch pandemic <NUMBER> <NUMBER> remain relatively spared <NUMBER> world heart federation published briefing prevention coronavirus disease <NUMBER> lowincome countries <NUMBER> includes six easy rules reduce risk corona virus transmission staying home avoiding large gathering total shut country far biggest impact lower number infections early case detection role reninangiotensinaldosterone system covid<NUMBER> reninangiotensinaldosterone system raas regulates blood pressure also involved cardiovascular endorgan damage like myocardial hypertrophy interstitial myocardial fibrosis atherosclerosis plaque rupture acute coronary syndromes therefore blockers raas recommended use hypertension prevent cardiovascular events heart failure <NUMBER> <NUMBER> protease renin cleaves angiotensin angiotensinogen ang <NUMBER> processed angiotensin ii ang <NUMBER> angiotensinconverting enzyme ace <NUMBER> angiotensin ii stimulates at<NUMBER>receptors results adverse cardiovascular effects like vasoconstriction cell proliferation hypertrophy <NUMBER> contrast at<NUMBER>receptor mediates vasodilation antiproliferative actions apoptosis suggested involved antiproliferative effects upon binding angiotensin ii <NUMBER> angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cleaved angiotensinconverting enzyme <NUMBER> ace<NUMBER> angiotensin <NUMBER> <NUMBER> exerts directly stimulation called masreceptor mediating vasodilation antiproliferative effects antiinflammatory responses <NUMBER> well established corona virus family binds via spike protein ace<NUMBER> <NUMBER> <NUMBER> well characterized binding residues <NUMBER> proteolytic modification ace<NUMBER> <NUMBER> coronavirus spike protein <NUMBER> <NUMBER> membranebound proteinase adam<NUMBER> virus internalized clathrincoated pits trypsin cleavage viral rna released cellular cytoplasm causing sars infection <NUMBER> <NUMBER> ace<NUMBER> degraded shedfrom cell membrane circulation cleavage adam<NUMBER> <NUMBER> <NUMBER> result downregulation ace<NUMBER> corona virus <NUMBER> role ace<NUMBER> corona virus infection scrutinized fact several animals cannot infected corona virus knockout ace<NUMBER> renders resistant infection <NUMBER> role ace<NUMBER> specific corona virus ace<NUMBER> also used respiratory syncytial rs virus types influenza viruses <NUMBER> <NUMBER> ace<NUMBER> also regulated several cardiopulmonary disease conditions like copd pulmonary hypertension asthma viral infections influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> well sepsis <NUMBER> ace<NUMBER> potentially degrading maladaptive angiotensin ii stimulating antiinflammatory responses mas receptor <NUMBER> shown improve lung injury viral infections clinical injuries <NUMBER> furthermore ards prominent rs virus infections ace<NUMBER> knocked <NUMBER> addition recombinant human ace<NUMBER> tested pilot study human ards shown reduce circulating interleukin<NUMBER> concentrations accompanied increases ang <NUMBER> reductions angiotensin ii <NUMBER> therefore ace<NUMBER> might crucial entry corona viruses cells hence infectivity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however might also mediate beneficial effects pulmonary complications infection <NUMBER> <NUMBER> fact major risk factor adverse outcomes covid<NUMBER> age ace<NUMBER> downregulated aging population argues favor role poor outcome risk group <NUMBER> furthermore drugs like chloroquine indometazine <NUMBER> well ace inhibitors arbs <NUMBER> <NUMBER> <NUMBER> shown upregulate ace<NUMBER> human heart systemic well pulmonary vasculature <NUMBER> association outcomes heart failure <NUMBER> atrial fibrillation <NUMBER> pulmonary hypertension <NUMBER> findings highlight complex interaction covid<NUMBER> ace<NUMBER> inhibition would thus raise hypothesis pathophysiological conditions drugs enhancing ace<NUMBER> expression might lead greater infectivity time potentially reduce mortality due lung complications fig <NUMBER> arterial hypertension prevalent risk factor cardiovascular disease particular china <NUMBER> several early trials covid<NUMBER> populations hypertension prevalent cardiovascular risk factor comorbidity amounting approximately <NUMBER> overall population diseased individuals china <NUMBER> <NUMBER> <NUMBER> italy <NUMBER> patients complications even died hypertension prevalent diabetes coronary <NUMBER> hypothetical scheme interaction corona virus angiotensin converting enzyme<NUMBER> ace<NUMBER> corona virus binding spike protein ace<NUMBER> processed proteinase adam<NUMBER> leading internalization corona virus ace<NUMBER> cell viral genome released internalization well shedding ace<NUMBER> cell surface release circulation reduces membranebound ace<NUMBER> furthermore ace<NUMBER> reduced pathological conditions like pulmonary fibrosis asthma copd pulmonary hypertension smoking old age <NUMBER> contrary membranebound ace<NUMBER>concentrations higher following treatment aceinhibitors at<NUMBER>blockers potentially ibuprofen ace<NUMBER> abundantly expressed childhood young age ace<NUMBER> forms ang <NUMBER> angiotensionii stimulate masreceptor mediating antiproliferative antiinflammatory action hypothetically enhanced ace<NUMBER>expression might cause infection acting receptor viral cell entry protect pulmonary complications conditions downregulation ace<NUMBER> less infection might occur severity covid<NUMBER>related ards severe hypothesis fits higher likelihood pulmonary complications certain disease conditions aging notably data derived experimental observational data controlled clinical studies need scrutinized clinical conditions artery disease chronic obstructive lung disease malignancies <NUMBER> hypertension comorbidity highest prevalence deceased patients claimed risk factor covid<NUMBER> however would case deviation overall prevalence hypertension chinese population china prevalence hypertension high comparing chinese populations agematched reports covid<NUMBER> approximately <NUMBER> years becomes clear overall prevalence hypertension <NUMBER> increase populations higher age <NUMBER> therefore prevalence comorbidity hypertension covid<NUMBER> patients lower exceed overall prevalence relevant populations china therefore evidence hypertension increases likelihood suffer covid<NUMBER> cardiovascular risk factors comorbidities elevated patients fatal outcomes covid<NUMBER> <NUMBER> therefore cardiovascular comorbidities concert add myocardial injury shown closely associated death measured cardiac troponin levels <NUMBER> next question arises whether cardiac treatments treatments reninangiotensin system inhibitors rasi particular aceinhibitors acei angiotensin receptor blockers arbs associated differential outcome covid<NUMBER> guidelines management hypertension european society cardiology <NUMBER> also chinese guidelines <NUMBER> guidelines american college cardiology acc american heart association aha <NUMBER> recommend ace arbs treatment hypertension drugs shown effective secondary prevention heart failure protection adverse renal outcomes germany countries europe prescription rate ace arbs higher prescribed daily doses antihypertensive drugs combined <NUMBER> however adequate blood pressure control china age group covid<NUMBER> prevalent <NUMBER> <NUMBER> according <NUMBER> chinese guidelines <NUMBER> <NUMBER> according <NUMBER> accaha guidelines <NUMBER> particular frequency aceinhibitor treatment particularly low asian population particular females aceinduced coughing prevalent populations <NUMBER> therefore low density treatment rasi argue favor significant role drugs likelihood covid<NUMBER> upregulation ace<NUMBER> rasi allow argue favor use rasinhibitors hypertension recently expressed various short communications letters causing lot discussion media attention <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although large body evidence generated cell models animal models observational studies data necessary scrutinize definite role ace<NUMBER> infection frequency causation pulmonary complications corona infections moment thus compelling evidentiary background change rasi therapy hypertension cardiovascular conditions cardiac manifestations sarscov<NUMBER> infection include acute myocardial injury heart failure myocarditis ventricular tachyarrhythmias <NUMBER> along ards acute myocardial injury identified important independent predictor outcomes associated <NUMBER>fold higher risk death <NUMBER> cohort <NUMBER> hospitalized patients prevalence cardiac injurybased presence elevated hsctni values <NUMBER>th percentile healthy reference populationwas <NUMBER> risk death increased magnitude myocardial injury expressed multiples reference value hstni <NUMBER> unequivocally cohorts investigating prevalence prognostic implications myocardial injury covid<NUMBER> outbreak wuhan china reported similar rates acute myocardial injury ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> presentation based elevations hsctn uln report <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> patients received care intensive care unit likely cardiac injury nonicu patients <NUMBER> vs <NUMBER> ´consistently another study <NUMBER> admitted hospital patients laboratoryconfirmed covid<NUMBER> <NUMBER> proportion patients requiring care intensive care unit icu significantly higher among patients evidence acute myocardial injury <NUMBER> vs <NUMBER> several studies demonstrate association acute myocardial injury mortality <NUMBER> <NUMBER> study <NUMBER> patients covid<NUMBER> evaluated role hsctnt relative presence cardiovascular disease <NUMBER> mortality rates highest among patients elevated hsctnt uln history cardiovascular disease lowest among normal hsctn irrespective presence absence cv disease <NUMBER> survey <NUMBER> hospitalized patients wuhan <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> patients received ecg particularly periods elevation cardiac biomarkers imaging tests echocardiography reported consistently reports <NUMBER> <NUMBER> report rates ecg imaging tests except lung ct hence limited diagnostic workup selection bias precludes speculations etiology hsctni elevation discordant recommendations <NUMBER>th version universal myocardial infarction mi definition udmi <NUMBER> investigators wuhan studies used different definition acute myocardial injury differentiate acute chronic myocardial injury concentration change rise andor fall hsctni acute myocardial injury rather defined blood levels high sensitivity troponin <NUMBER>th percentile upper limit normal upper limit normal uln <NUMBER> ngl new abnormalities shown electrocardiography echocardiography <NUMBER> investigators report rates subtypes acute myocardial infarction based criteria <NUMBER>th version udmi <NUMBER> interestingly hsctn values increased serial monitoring patients fatal outcome whereas persistently low values observed among survivors allowing speculate whether monitoring hsctn might useful even absence suspected acute coronary syndrome <NUMBER> overall presence myocardial injury ed populations uncommon occurring many <NUMBER> consecutive patients presenting chest pain dyspnea less specific symptoms <NUMBER> however fraction elevations ultimately attributed type <NUMBER> type <NUMBER> mi majority cases unrelated myocardial ischemia often multifactorial exact reason remained unsettled <NUMBER> stable asymptomatic cardiovascular ischemic heart disease cardiac troponin elevation may explained presence underlying structural heart disease stable cad chronic kidney disease <NUMBER> accordingly western countries presence hsctn <NUMBER>th percentile uln reported many <NUMBER> asymptomatic patients without cardiovascular disease presenting routine outpatient visits <NUMBER> across different subspecialities patients hospitalized reasons acute coronary syndrome <NUMBER> <NUMBER> regardless underlying reason acuity clinical presentation presence myocardial injury indicated hsctn <NUMBER>th percentile uniformly associated adverse longterm outcomes patients elevated hsctn baseline higher risk die acutely precipitating event due cardiovascular morbidity <NUMBER> accordingly data pandemia wuhan confirm current knowledge provide fundamental new information interpretation troponin elevations based findings corona influenza infections past speculated acute myocardial injury might triggered facilitated covid<NUMBER> infection <NUMBER> <NUMBER> previous study incidence myocardial infarction outbreak influenza infections ontario reported sixfold higher incidence ratio ami within <NUMBER> days positive influenza test compared negative test time frame <NUMBER> hypothesized exaggerated inflammatory response mediated viral infection influenza b respiratory syncytial virus rsv virus potential trigger acute plaque rupture addition anecdotal evidence sporadic case reports raised suspicion acute myocarditis although direct sarscov<NUMBER> infiltration heart confirmed absence histological confirmation endocardial biopsy detection viral genome myocardial tissue yet <NUMBER> previously decline left ventricular ejection fraction lvef highly prevalent reversible subclinical diastolic left ventricular impairment reported acute sarscov<NUMBER> infection attributed cytokine storm syndrome characterized uncontrolled dysfunctional immune response <NUMBER> finally cardiotoxic effects antiviral therapies reported <NUMBER> acute myocardial injury may occur independently covid<NUMBER> may manifest type <NUMBER> myocardial infarction stemi nstemi type <NUMBER> mi absence plaque rupture intracoronary thrombus acute myocardial injury independent myocardial ischemia fig <NUMBER> cases acute mi autopsy hospitalization covid<NUMBER> reported <NUMBER> systematic evaluation lacking given paucity data exact prevalence reasons acute myocardial injury covid<NUMBER> interpretation hsctn elevations discussed knowledge previously derived acute critical conditions foremost severe infections causing sepsis septic shock <NUMBER> investigation hsctnt setting severe infection median concentrations hsctnt found increase <NUMBER> ngl sepsis <NUMBER> ngl severe sepsis <NUMBER> ngl septic shock <NUMBER> likewise prevalence hsctnt uln increased <NUMBER> sepsis <NUMBER> septic shock <NUMBER> similar covid<NUMBER> mild elevations hsctnt associated high mortality rate <NUMBER> days <NUMBER> however risk associated myocardial injury baseline persisted <NUMBER> years index event suggesting major prognostic role preexisting structural heart disease longterm outcomes similar sarscov<NUMBER> infection impairment right left ventricular function echocardiography common severe infections clear association myocardial injury cardiac overload hemodynamic stress indicated natriuretic peptides inflammatory response <NUMBER> significant elevations hsctn demonstrated following rapid atrial pacing irrespective presence inducible myocardial ischemia <NUMBER> experimental human model utilized transcardiac production lactate objective evidence myocardial ischemia hsctnt increased absence cad lactate suggesting tachycardia capable induce acute myocardial injury likewise administration catecholamines found release hsctnt healthy volunteers <NUMBER> mechanisms related release ctn include respiratory failure due severe hypoxemia sepsis acute kidney failure hypertension hypotension bradycardia fever anemia many causes <NUMBER> <NUMBER> acute mi without covid<NUMBER> represents lifethreatening condition requires adjunctive medical therapies potent antiplatelet drugs monitoring anticipate complications however enhanced infectious potency humans <NUMBER> mandates fundamental risk assessment carefully weigh relative advantages disadvantages treating cardiovascular disease preventing risk sarscov<NUMBER> transmission patients suspected acs without stsegment elevation absence hemodynamic rhythm instability covid<NUMBER> cannot ruledout due suspicious clinical presentation personal recommendation author obtain nasopharyngeal swabs realtime reverse transcriptasepolymerase chain reaction rtpcr assay available perform ct lung scan waiting pcr result covid<NUMBER>associated pneumonia provides typical picture characterized bilateral lung infiltrates glass ground opacities consolidation reticular pattern socalled crazy paving pattern <NUMBER> <NUMBER> sensitivity ct reported high <NUMBER> superior rtpcr <NUMBER> ct scan could ideally performed multidetector ct angiography providing additional information coronary anatomy presence pulmonary embolism since elevations ddimer uncommon <NUMBER> <NUMBER> values exceeding twosixfold uln associated high mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> regarding measurement cardiac biomarkers american college cardiology acc released statements liberal use troponin covid <NUMBER> <NUMBER> given frequency nonspecific nature abnormal troponin results among patients covid<NUMBER> clinicians advised measure cardiac troponin acute myocardial infarction suspected clinical grounds <NUMBER> european society cardiology esc expands recommendations restricting measurement cardiac troponin ti concentrations patients suspected type <NUMBER> mi infarct type likely benefit adjunctive antiplatelet therapies early revascularization therapies personal communication paper revision moreover order reduce length stay ed dedicate monitoring capacities critically diseased patients accelerated rapid ruleout andor rulein mi seem particularly helpful <NUMBER> real world evidence suggests patient disposition may completed within <NUMBER> h without increase adverse outcomes compared standard protocols <NUMBER> <NUMBER> use echocardiography coronary angiography restricted patients procedures would expected meaningfully affect outcomes <NUMBER> timing invasive coronary angiography depends individual estimation anticipated risk death heart failure infarctrelated complications factors supposed favor immediate early coronary angiography full protection medical staff include stemi high risk nonst segment elevation mi suggested either unstable hemodynamics dynamic st segment changes rhythm instability high clinical score recommended <NUMBER> esc guidelines <NUMBER> cardiac troponin values interpreted continuous variables since risk death benefits early invasive strategy incline increasing values <NUMBER> <NUMBER> unclear whether benefit revascularization outweighs potential disadvantages contamination medical staff patients smalltointermediate elevations hsctn whether yet unsettled refined risk stratification required identify patients likely benefit <NUMBER> hence patients nstemi lower risk managed according local expertise capability deliver echocardiography invasive procedures effectively patient without exposing medical staff increased risk contamination <NUMBER> <NUMBER> <NUMBER> <NUMBER> heart failure risk factor covid<NUMBER> long known patients chronic heart failure chf increased risk adverse consequences seasonal influenza <NUMBER> causes pneumonia <NUMBER> conversely infections particular pneumonia frequent triggers heart failure exacerbations <NUMBER> note influenza vaccination decreases mortality chf patients beneficial effects repetitive influenza vaccinations may even exceed guidelinedirected pharmacotherapy <NUMBER> severe coronavirus infections sarscov<NUMBER> shown result severe course disease patients preexisting cardiovascular disease including heart failure <NUMBER> thus surprising covid<NUMBER> associated higher morbidity mortality patients cardiovascular comorbidities <NUMBER> <NUMBER> yet likely due lower prevalence known chf china still limited specific information patients preexisting heart failure nevertheless early reports <NUMBER> indicate covid<NUMBER> associated myocardial injury frequent patients heart failure cardiovascular comorbidities <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> <NUMBER> reveal elevated troponin levels marker myocardial injury precise mechanisms myocardial necrosis context sarscov<NUMBER> unknown troponin elevations potent predictors adverse outcome shi et al <NUMBER> reported increased troponin levels associated higher likelihood mechanical ventilation development ards acute kidney failure remarkably <NUMBER> <NUMBER> patients myocardial injury died <NUMBER> whereas <NUMBER> <NUMBER> troponin negative patients lethal outcome similarly guo et al <NUMBER> showed elevated troponin predicted ards ventricular arrhythmias vts vfib death interestingly continuous increase ntprobnp troponin observed patients ultimately died survivors revealed constant levels note troponin elevations appear predictive prognosis presence comorbidities patients higher troponin levels without preexisting cardiovascular pulmonary disease significantly worse prognosis troponin negative patients cardiovascular comorbidities guo seems likely myocardial injury marker adverse outcome also direct cause notion supported data show covid<NUMBER> nonsurvivors frequently develop heart failure <NUMBER> shock <NUMBER> <NUMBER> similarly ruan et al <NUMBER> reported <NUMBER> patients died covid<NUMBER> myocardial dysfunction sole contributing factor death <NUMBER> cases obvious reason elevated troponin level could acute coronary syndrome obviously may also occur covid<NUMBER> patients likely underdiagnosed due reluctance invasive management however high proportion typically rather moderately increased high sensitive troponin levels hospitalized covid<NUMBER> patients renders explanations likely including acute myocarditis due sarscov<NUMBER> myocardial damage due proinflammatory cytokines cytokine storm ace<NUMBER> potential receptor coronavirus infection highly expressed cardiomyocytes vascular pericytes <NUMBER> thus seems plausible sarscov<NUMBER> may directly cause viral myocarditis associated cell death subsequent myocardial injury measured increased troponin levels indeed first still anecdotal autopsy endomyocardial biopsy reports describe evidence acute lymphocytic myocarditis <NUMBER> <NUMBER> however sarscov<NUMBER> genome could detected myocardium several early cases indicating mechanisms myocardial injury must involved least subset patients myocardial injury another attractive hypothesis myocardial injury context covid<NUMBER> may explained hyperinflammatory state dysregulated cytokines mediate cardiomyocyte stress ultimately cell death cytokine storm wellknown <NUMBER> underappreciated syndrome complicating sepsis <NUMBER> cases <NUMBER> clinical characteristics include multiorgan failure associated persistent fever lymphopenia well high levels ferritin several cytokines interleukin<NUMBER> example elevated interleukin<NUMBER> il<NUMBER> levels closely correlate mortality sepsis il<NUMBER> shown directly impair contractile function cardiomyocytes <NUMBER> similarly lymphopenia excessively elevated ferritin interleukin<NUMBER> levels demonstrated severe cases covid<NUMBER> also revealed myocardial injury increased high sensitive troponin specific treatment cytokine storm heart failure covid<NUMBER> multiple clinical trials underway test antiviral agents potentially effective sarscov<NUMBER> remdesivir several antivirals previously shown effective eg hiv infections reviewed <NUMBER> myocardial injury associated dramatically worsened outcome covid<NUMBER> question arises whether therapy also specifically aimed prevention myocardial damage andor hyperinflammation indeed limited experience inhibition cytokine storm immunosuppression points towards possibility example interleukin<NUMBER> blockade anakinra shown reduce mortality sepsis hyperinflammation <NUMBER> similarly tocilizumab interleukin<NUMBER> receptor blocking antibody shows early promise covid<NUMBER> nonrandomized trial involving <NUMBER> patients crp levels oxygen levels almost normalized within days <NUMBER> promising targets include jak inhibitors baricitinib <NUMBER> immunoglobulins fingolimod finally even proposed angiotensin receptors blockers eg losartan may harmful covid<NUMBER> fact beneficial upregulate ace<NUMBER> could ameriolate tissue damage due sarscov<NUMBER> <NUMBER> data removal cytokines adsorbent polymer beads cytosorb sparse coronavirus disease <NUMBER> covid<NUMBER> pandemic outbreak pneumonia caused novel coronavirus occurred wuhan china meanwhile spread throughout world associated mortality rates <NUMBER> <NUMBER> cardiovascular disease important risk indicator adverse outcomes covid<NUMBER> might affect cardiovascular system directly angiotensinconverting enzyme <NUMBER> ace<NUMBER> shown coreceptor viral entry downregulating ace<NUMBER> cardiovascular consequences cardiovascular disease dyspnea prime symptom like heart failure myocardial ischemia hypertensive emergency important differential diagnosis ignored covid<NUMBER> needs recognized important indicator poor outcome evidence changing cardiovascular therapy complete cardiovascular workup necessary covid<NUMBER> patients particular patients cardiorespiratory symptoms even acute respiratory distress syndrome turn cardiopulmonary symptoms distract physicians unbiased workup cardiovascular conditions patients could suffer lifethreatening cardiovascular conditions absence covid<NUMBER> healthcare providers high middle low income countries need aware importance cardiovascular disease patients sars covid<NUMBER> infections providing optimal cardiovascular care abstract debate continues medical literature role renin angiotensin system ras coronavirus disease <NUMBER> covid <NUMBER> pathophysiology implications use cardiovascular drugs acting ras could drugs include angiotensin converting enzyme inhibitors aceis angiotensin receptors blockers arbs harmful potential key therapeutic agents covid <NUMBER> debate arisen due finding underlying cardiovascular disease hypertension associated significantly increased risk hospitalisation death covid<NUMBER> <NUMBER> <NUMBER> addition viral receptor angiotensinconverting enzyme<NUMBER> ace<NUMBER> <NUMBER> <NUMBER> coronaviruses downregulate ace<NUMBER> antiinflammatory actions leading imbalance aceace<NUMBER> <NUMBER> may fundamental covid<NUMBER> pathophysiology key gender genetic differences regulation aceace<NUMBER> balance <NUMBER> <NUMBER> <NUMBER> may explain differences observed disease severity <NUMBER> <NUMBER> <NUMBER> social media amplification concern continuation ras medications current pandemic prompted cardiovascular societies publish position statements strongly advising continued use given lack evidence ras drugs unsafe substantial risk hospitalisation drugs withdrawn patients valid indications treatment <NUMBER> <NUMBER> three <NUMBER> large observational studies published new england journal medicine nejm support view evidence harm due ras medications covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> however given fundamental role ras covid<NUMBER> broader therapeutic indication acei arbs treatment patients established cardiovascular indications suggested <NUMBER> <NUMBER> yet tested randomised trials vitamin status may also linked ras impacts covid<NUMBER> vitamin negative regulator renin synthesis small study reported high rates vitamin deficiency covid patients requiring intensive care <NUMBER> vitamin ace role immune system may add complex dimension issue ras drugs vitamin status covid<NUMBER> <NUMBER> <NUMBER> covid<NUMBER> severe course patients preexisting cardiovascular disease <NUMBER> <NUMBER> <NUMBER> causes significant rate cardiovascular events <NUMBER> research required define pathological mechanisms basis observed gender age racial differences severity ras medications used greater confidence covid<NUMBER> patients valid indications use broader role manipulation ras covid<NUMBER> require randomised trial data coronavirus<NUMBER> sarscov<NUMBER> believed gain cell entry via viral spike protein binding ace<NUMBER> receptor <NUMBER> <NUMBER> virology research similar coronaviruses indicates viral cell infection followed rapid downregulation ace<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> system yang yinyang balance ras hypertension system ace<NUMBER> zinc metalloprotease discovered <NUMBER> <NUMBER> mainly breaks angiotensin ii ang ii main effector ras system ang<NUMBER> resulting decrease blood pressure vasoconstriction decreased inflammation ace<NUMBER> usually membrane bound shed covid infection acute lung injury myocardial infarction <NUMBER> whilst role circulating ace<NUMBER> unclear conditions advanced heart failure higher plasma ace<NUMBER> proportional worsening clinical status <NUMBER> <NUMBER> serum ace<NUMBER> levels also significantly higher hypertensive patients <NUMBER> gender differences described <NUMBER> greater levels male patients <NUMBER> debate whether observed higher levels male hypertensive diabetic patients related increased ace<NUMBER> expression compensatory mechanism whether due increased ace<NUMBER> shedding limiting tissue ace<NUMBER> activity causing excess tissue ang ii role circulating versus tissue ace<NUMBER> levels susceptibility covid infection unclear <NUMBER> viral downregulation ace<NUMBER> unopposed ace generates high ang ii causing increased bp vasoconstriction inflammation cell damage exacerbate matters active metabolite generated ace<NUMBER> ang<NUMBER> broken ace accentuating ras imbalance caused covid<NUMBER> <NUMBER> figure <NUMBER> covid<NUMBER> highly contagious spreading one province december <NUMBER> whole china <NUMBER> days despite extreme shutdown measures <NUMBER> may <NUMBER> disease infected <NUMBER> people <NUMBER> deaths worldwide <NUMBER> causing enormous global economic social impacts epidemiology <NUMBER> confirmed suspected asymptomatic cases china suggested mild disease <NUMBER> <NUMBER> fatality overall <NUMBER> early mortality figures different countries shown striking differences greater mortality europe compared asian countries <NUMBER> may relate fundamental differences racial ace ace<NUMBER> polymorphisms impacting susceptibility disease subsequent pathological severity population demographics clearly play role elderly patients greatest risk severe disease death key differences speed government actions implement extensive public health measures recommended world health organization also impacted mortality rates hospitals countries overwhelmed rapid rise cases <NUMBER> cases mild disease yet <NUMBER> severe disease chinese center disease control prevention ccdc epidemiology showed overall mortality <NUMBER> <NUMBER> death rate increased age comorbidities particularly cardiovascular disease <NUMBER> diabetes <NUMBER> hypertension <NUMBER> risk factors typically seen metabolic syndrome whilst clear comorbidities age increase mortality clear whether excess due impact comorbid conditions host inflammatory response alone impact treatment patient group taking <NUMBER> since ras system fundamentally involved covid<NUMBER> pathogenesis great speculation drugs widely used hypertension heart failure treatment acting ras may impact disease severity suggesting protective effect <NUMBER> <NUMBER> others concerned potential harm <NUMBER> drugs include arbs aceis combination drug valsartansacubitril entresto combines arb neprilysin inhibitor also known angiotensin receptorneprilysin inhibitor arni whilst evidence acei arb treatment may increase expression ace<NUMBER> tissues animal models data supporting quantifying effect human subjects clinical doses ras medications lacking <NUMBER> hence relevance possible medicationinduced alteration ace<NUMBER> levels welldescribed significant differences circulating levels ace<NUMBER> advanced heart failure hypertension males diabetics implications covid<NUMBER> severity unclear <NUMBER> <NUMBER> <NUMBER> increased ace<NUMBER> speculated increase susceptibility covid<NUMBER> allowing virus cells turn may exacerbate disease severity counter argument infected ace<NUMBER> could protective viral attack downregulation ace<NUMBER> antiinflammatory system <NUMBER> <NUMBER> three <NUMBER> large observational studies reported nejm examined issue found evidence increased risk adverse outcomes covid<NUMBER> patients taking acei arbs <NUMBER> <NUMBER> <NUMBER> adding weight previously reported smaller retrospective clinical studies <NUMBER> <NUMBER> <NUMBER> also showed excess mortality aceiarbs mehra et al <NUMBER> reported data <NUMBER> patients admitted covid<NUMBER> <NUMBER> hospitals europe asia north america confirmed age coronary disease heart failure cardiac arrhythmia chronic obstructive pulmonary disease current smoking associated increased inhospital mortality increased risk mortality associated risk acei arbs find use acei statins common survivors however randomised data multicentre chinese study <NUMBER> hospitalised patients covid<NUMBER> preexisting hypertension showed death rate <NUMBER> acei arb versus <NUMBER> nonusers p<NUMBER> data observational randomised even adjustment confounding variables lower mortality hazard ratio <NUMBER> p<NUMBER> persisted receiving aceiarbs hr <NUMBER> p<NUMBER> compared use antihypertensive agents <NUMBER> study separate treatment arbs acei <NUMBER> answer observed differences covid<NUMBER> death rates could lie key differences aceace<NUMBER> system balance related age gender racial variation genetic ace ace<NUMBER> polymorphisms environmental factors influencing ace<NUMBER> expression <NUMBER> <NUMBER> ace gene polymorphisms cause insertion deletion sequence gene ace activity levels dd carriers approximately twice found ii genotypes <NUMBER> possible impact ace genotype covid<NUMBER> disease state ability breakdown ang ii impaired could hypothesised cause greater quantity circulating ang ii marked imbalance ras severe disease genetic environmental factors influencing ace<NUMBER> expression could also result differences risk becoming infected first place affecting affinity ace<NUMBER> binding domain viral spike protein causing differences density ace<NUMBER> receptors present tissues lungs ace<NUMBER> polymorphisms may contribute significant differences disease severity determining extent aceace<NUMBER> imbalance particularly endothelium lungs virus attacks time disabling ace<NUMBER>mediated repair systems chen coworkers <NUMBER> <NUMBER> analysed <NUMBER> tissues thousands individuals found significantly higher tissue ace<NUMBER> asian females compared males ethnic groups described agedependent decrease ace<NUMBER> expression highly significant decrease type ii diabetic patients loci higher ace<NUMBER> expression almost <NUMBER> east asians <NUMBER> higher ethnic groups ace<NUMBER> suppressed inflammatory cytokines diabetes induced oestrogen androgen decreased elderly work chen coworkers suggests negative correlation covid<NUMBER> mortality tissue ace<NUMBER> levels population molecular level <NUMBER> circulating ace<NUMBER> however described increase pathological states hypertension diabetes heart failure perhaps differences circulating shed ace<NUMBER> tissuebound ace<NUMBER> key virus susceptibility subsequent disease severity gender differences ace<NUMBER> ace<NUMBER> x chromosome hence men one allele women two <NUMBER> <NUMBER> oestrogen believed upregulate ace<NUMBER> expression <NUMBER> giving premenopausal women advantage two alleles oestrogen upregulation making deficiency ace<NUMBER> ability rally less likely event viral attack support hypothesis chinese cdcc reported overall female mortality <NUMBER> including suspected cases well serologically confirmed cases versus <NUMBER> males difference marked serologically confirmed cases <NUMBER> female versus <NUMBER> male mortality overall ratio <NUMBER> males <NUMBER> females believed infected <NUMBER> hence men significantly less likely become infected likely severe pathophysiological expression disease whilst suggested <NUMBER> gender differences may driven substantially greater rates smoking chinese male population rates smoking covid<NUMBER> cases provided epidemiological study xlinked nature ace<NUMBER> gene females greater range phenotypes may greater role yet fully defined coronavirus pathogenesis gender differences range ace<NUMBER> phenotypes ability upregulate compensatory mechanisms face viral ace<NUMBER> downregulation may play role marked gender differences disease confirmed large observational studies marcia et al reporting <NUMBER> women <NUMBER> patients covid mehra et al reported <NUMBER> female patients <NUMBER> covid<NUMBER> patients requiring hospital admission furthermore reported improved survival female patients independent older age <NUMBER> serum ace<NUMBER> levels reported significantly lower females <NUMBER> fundamental differences immune responses viral infections based gender stronger humoral cellular immune responses described females <NUMBER> smoking linked upregulation ace downregulation ace<NUMBER> <NUMBER> could hypothesised make smokers less likely general population become infected virtue less ace<NUMBER> required viral entry however smoker becomes infected preexisting aceace<NUMBER> imbalance may result severe disease due greater inflammation higher risk ards multifactorial issues including poor baseline lung function bacterial superinfection evidence supporting picture seen data wuhan although smokers said comprise <NUMBER> male population china <NUMBER> rate current smokers reported covid<NUMBER> series seems well <NUMBER> huang et al due extreme complexity ras system another component may relevant causing greater mortality smokers covid<NUMBER> neprilysin metalloprotease number functions act breakdown ang ii ang<NUMBER> <NUMBER> role usually performed ace<NUMBER> highly expressed airways pulmonary interstitium alveolar cells study examining circulating neprilysin levels <NUMBER> communitybased subjects <NUMBER> years found lowest tertile group highest rates smokers p<NUMBER> higher rates hypertension p<NUMBER> <NUMBER> smokers low lung neprilysin activity may lack important safety mechanism could overcome virally mediated loss ace<NUMBER> might relevant patients taking entresto sacubitrilvalsartan medication proven benefit treatment patients heart failure neprilysin inhibition sacubitril component entresto may block alternate method generating antiinflammatory mediator <NUMBER> ace<NUMBER> viral attack less able clearly complex question impossible answer without data even recently reported observational studies sufficient patients taking entresto report safety drug covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> reports china showed patients severe disease leading intensive care unit icu admission death features consistent unopposed ras activity higher blood pressure bp admission hospital higher bp admission icu nonsurvivors <NUMBER> <NUMBER> mean systolic bp <NUMBER> mmhg requiring icu admission versus <NUMBER> mmhg milder cases p<NUMBER> <NUMBER> lower serum potassium levels combined high urinary potassium also reported severe patients <NUMBER> <NUMBER> suggesting ang iimediated activation aldosterone presence significant hypertension instead hypotension group patients admitted icu versus requiring icu particularly interesting clinical finding implications pathogenesis covid<NUMBER> excess ras activity without ace<NUMBER> balance break ang ii block adverse effects cellular damage fibrosis may play key role determining disease severity similar ras proinflammatory effects well known contribute heart failure figure <NUMBER> autopsy data published four covid<NUMBER> patients <NUMBER> described platelet rich clot formation occluding small vessels microangiopathic picture consistent virally mediated vascular damage aceace<NUMBER> imbalance caused viral ace<NUMBER> downregulation understanding aceace<NUMBER> imbalance covid<NUMBER> role age gender racial differences disease severity difference tissue bound circulating ace<NUMBER> could prove key treating disease support fundamental aceace<NUMBER> imbalance clinical relevance reported serum ang ii levels indeed significantly elevated covid<NUMBER> correlate viral load lung injury <NUMBER> <NUMBER> whilst ace formation ang ii blocked ace inhibitors <NUMBER> ang ii formed via nonace pathways chymase <NUMBER> making ace inhibitors potentially less effective arb blockers diminishing problem excess ang ii since acei may block <NUMBER> formation ang ii hand arbs highly selective blockers main receptor ang ii angiotensin receptor type <NUMBER> <NUMBER> receptor arbs decrease amount ang ii produced first place blocking <NUMBER> receptors activate key counter regulatory antiinflammatory cascade restore aceace<NUMBER> balance excessive circulating ang ii unable bind blocked <NUMBER> receptors binds at<NUMBER> receptors trigger counterregulatory antiinflammatory actions upregulates ace<NUMBER> expression <NUMBER> remove excessive circulating ang ii protective role increased tissue ace<NUMBER> expression seems plausible since groups higher levels younger people premenopausal women possibly asian populations <NUMBER> seem lower disease severity mortality <NUMBER> <NUMBER> compared european populations older population high rates comorbidities diabetes hypertension cardiovascular disease described higher circulating ace<NUMBER> levels due increased ace<NUMBER> shedding pointed another rna virus human immunodeficiency virus hiv higher expression binding sites cd<NUMBER> actually protected rather increased virulence <NUMBER> males one xlinked ace<NUMBER> allele could vulnerable phenotypes causing impaired ace<NUMBER> regulation patients preexisting hypertension may greater frequency ace polymorphisms result excessive ang ii levels exacerbated viral impairment ang ii clearance covid<NUMBER> disease major battlefront endothelium fought tissue ras already cases reported media families tragically affected high rates severe disease mortality line genetic factors playing significant role covid<NUMBER> pathophysiology <NUMBER> coronaviruses directly impact cellular systems ras important inflammatory pathways rna viruses remodel host membranes lipid metabolism creating suitable environment replication <NUMBER> lipid metabolism pathways impacted corona virus infection glycerophospholipids fatty acids significantly elevated sars cov<NUMBER>e infected cells upregulated phosphatidylinositol pi may promote coronavirus entry <NUMBER> covid<NUMBER> associated cardiac events significant serum troponin level elevation clinical setting <NUMBER> elevated lysophospholipids including lp<NUMBER> reported acute coronary syndromes causes undergoing coronary angiography <NUMBER> hcov<NUMBER>e infection upregulates fatty acids believed promote efficient coronavirus replication however yan coworkers <NUMBER> reported exogenous addition fatty acids may interfere viral replication upsetting delicate balance fatty acids causing reversion lysophospholipids phospholipids limiting viral replication possible manipulation fatty acids clinical setting may upset balance needed viral replication use drugs statins may also impact viral ability harness cellular lipid pathways clearly data needed investigate role fatty acid cholesterol manipulation finding statins decrease inhospital mortality even nonrandomised study <NUMBER> interest long term sequelae sars caused related coronavirus sars cov reported followup studies survivors <NUMBER> years include sleep disturbance characterised increased stage <NUMBER> sleep percentage diffuse myalgia chronic fatigue depression lung damage avascular femoral head necrosis <NUMBER> <NUMBER> <NUMBER> deranged lipid metabolism also reported sars survivors lipid metabolites including phosphatidylinositol pi lysophosphatidylinositol lpi associated cellular entry andor egress respiratory viruses lpis pis markedly upregulated recovered sars patients lpis thought critical role glucose homeostasis large proportion recovered sars patients reported glucose metabolic disorders including hyperinsulinaemia insulin resistance hyperglycaemia type <NUMBER> <NUMBER> diabetes <NUMBER> patients died sars found extensive lung damage well features systemic vasculitis autoantibodies human epithelial endothelial cells develop sarscov infection could explain severe deterioration patients phase ii disease may lead postinfectious cellular injury sarsinduced immunopathology survivors <NUMBER> longterm immunopathology could also risk covid<NUMBER> related virus also acts inflame endothelium due gender differences immune function female survivors may greater risk autoimmune mediated sequelae <NUMBER> immune system role vitamin ace vitamin deficiency related immune system dysfunction <NUMBER> inflammation cause prothrombotic state common europe winter vitamin potent negative endocrine regulator ras works predominantly suppressing renin synthesis <NUMBER> vitamin deficiency genetic geographical variation function may another factor contributing greater imbalance aceace<NUMBER> system leading differences disease severity covid <NUMBER> suggested vitamin supplementation could reduce risk covid<NUMBER> infection death <NUMBER> lau et al <NUMBER> reported small study vitamin levels <NUMBER> patients yet peer reviewed described vitamin deficiency <NUMBER> covid<NUMBER> patients icu <NUMBER> patients admitted ward bed found <NUMBER> patients age <NUMBER> admitted icu vitamin deficiency n<NUMBER> ace best known role blood pressure regulation converting angiotensin ang ii fact cleaves many peptides role innate adaptive immune responses ace expressed neutrophils macrophages role ace immune responses inflammation complex includes defence intracellular pathogens mediated via actions dependent ang ii reviewed bernstein coworkers <NUMBER> complex interactions mean acei arbs may impacts covid<NUMBER> disease impacting haemodynamic inflammatory pathways many agents investigation clinical trial treatment covid<NUMBER> far antiviral drugs vaccine officially approved covid<NUMBER> treatment hundreds trials listed covid<NUMBER> trial data base wwwwhoint international clinical trials registry small trial using hydroxychloroquine azithromycin showed promise decreasing viral carriage <NUMBER> <NUMBER> days <NUMBER> improvement <NUMBER> days reported china <NUMBER> combination could however carry risk arrhythmia due long qt group patients abnormal troponins endothelial dysfunction present arrythmias reported china <NUMBER> longer trials needed preliminary clinical data investigational rna antiviral agent remdesivir show survival benefit study <NUMBER> patients china show trend earlier recovery <NUMBER> adaptive covid<NUMBER> treatment trial actt study <NUMBER> patients lung involvement usa yet peer reviewed press release national institutes health nih <NUMBER> reports <NUMBER> faster recovery time p<NUMBER> <NUMBER> versus <NUMBER> days possibly trend survival benefit <NUMBER> versus <NUMBER> mortality p<NUMBER> variety therapeutic approaches addition vaccine may contribute covid<NUMBER> treatment prevention medium long term however current urgent situation <NUMBER> active cases <NUMBER> <NUMBER> serious critical many countries still exponential rise phase new cases treatment distributed large quantities needed economic impact pandemic addressed metaanalysis cardiac troponin results covid patients reported higher levels correlated severe disease <NUMBER> consistent either myocarditis acute coronary syndrome conditions manipulation ras commonly available drugs already indication based treating endothelial myocardial inflammation use drugs covid<NUMBER> patients meeting definition acute coronary syndrome another valid cardiovascular indication given confidence light recent studies showing detriment drugs covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> approach may one directed fundamental viral vascular pathogenesis broader therapeutic role ras inhibition covid<NUMBER> investigated two randomised trials examining effects arb losartan severity prognosis covid<NUMBER> hospitalised covid<NUMBER> patients nct <NUMBER> nonhospitalised patients nct<NUMBER> current global covid<NUMBER> pandemic many countries lockdown social economic paralysis impact covid<NUMBER> described warzone many patients dying lonely death isolated loved ones overcrowded hastily expanded hospitals currently supportive care available whilst many therapeutic agents investigation <NUMBER> <NUMBER> none yet approved use covid<NUMBER> demonstrated significant survival benefit even agents proven effective take time trials production large scale thinking covid<NUMBER> fundamentally cardiovascular disease attacks endothelium could provide momentum use safe established widely available medications acting ras already indicated acute coronary syndrome cardiac dysfunction present many patients covid<NUMBER> whilst data role vitamin covid pathogenesis needed replacing essential vitamin deficient seems safe cost effective easily achieved therapeutic strategy successful shift milder disease severity ease burden health care systems switching endogenous antiinflammatory pathways may also play key role decreasing risk longterm vascular autoimmune sequelae covid<NUMBER> survivors could pose economic burden pandemic although may questions answers hot debate medical literature role ras drugs acting system covid<NUMBER> consensus opinion safe use covid<NUMBER> <NUMBER> <NUMBER> view supported retrospective clinical data <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> managing global pandemic high death rate treatments aimed fundamental pathology meet scale problem appealing option data randomised clinical trials examining broader role ras agents covid<NUMBER> beyond existing indications awaited define role medications pandemic covid<NUMBER> taking lives worldwide caused novel coronavirus human lack defensive function whole population targets humans lung causes serious damage lungs based early reports people underlying heart issues concerns serious appears people <NUMBER> coronary heart diseases hypertension likely infected develop severe symptoms addition hospitalized covid<NUMBER> patients cardiovascular diseases china characteristic analysis covid<NUMBER> patients hypertension severe myocardial damage contribute severity <NUMBER> mortality covid<NUMBER> patients <NUMBER> therefore better understand development covid<NUMBER> impacts cardiovascular diseases add valuable measures management covid<NUMBER> patients coronavirus kind positivechain singlestranded rna virus diameter <NUMBER> nm classified α β δ γ type coronavirus characteristics various strains wide distribution cross species covid<NUMBER> belongs β genus capsule mushroomlike protein spike make virus crownlike round oval size often pleomorphic diameter <NUMBER> nm detection viral genes showed nucleotide sequences covid<NUMBER> genome share <NUMBER> identity severe acute respiratory syndrome virus sarscov genome <NUMBER> current studies shown covid<NUMBER> transmission route bathuman intermediate host studied transmitted mainly respiratory droplets well transmitted contact humanhuman transmission <NUMBER> <NUMBER> potential mechanism cardiovascular diseases induced covid<NUMBER> confirmed portion region amino terminal sarscov spike protein could bind human angiotensinconverting enzyme <NUMBER>ace<NUMBER> mediate fusion virus host cell <NUMBER> covid<NUMBER> likely similar infection pathways sarscov words ace<NUMBER> may also binding receptor covid<NUMBER> ace<NUMBER> homologous enzymes angiotensinconverting enzyme ace important components reninangiotensin system ras renin hydrolyzes angiotensinogen angiotensin ang converted angiotensin ii ang ii ace ang ii leads vasoconstriction elevated blood pressure vascular remodeling binding angiotensin type ii <NUMBER> receptor at<NUMBER>r ace<NUMBER> act ang generate ang <NUMBER> generate ang <NUMBER> dependent independent ace<NUMBER> pathways ace<NUMBER> directly hydrolyze ang ii ang <NUMBER> ang <NUMBER> bind g proteincoupled mas receptors mediate vasodilation antioxidant stress inhibit cell proliferation protect vascular endothelium damage well physiological functions like delaying reversing vascular remodeling protecting cardiovascular system aceang iiat<NUMBER>r axis ace<NUMBER>ang <NUMBER>mas axis antagonize balance maintain dynamic balance human vascular system ace<NUMBER> expressed human alveolar epithelial cells gateway virus invasion also mediates lung injury lung failure caused virus infection clinical observations showed plasma ang ii levels increased significantly covid<NUMBER> patients <NUMBER> suggests covid<NUMBER> binding ace<NUMBER> leads excessive release ang ii ras turn burdens heart vascular system increasing heart loading eventually cardiomyocyte hypertrophy high blood pressure virus replicates cells fusion host cells invasion lung surface cells directly causes lung inflammation invasion cardiomyocytes lead edema degeneration necrosis cardiomyocytes meanwhile proinflammatory cytokines released following cell lysis interleukin lung injury caused covid<NUMBER> leads hyoxemia partial pressure circulating oxygen oxygen saturation decrease continuously lead accumulation oxygen free radicals lactic acid metabolites again，by circulating around whole body myocardial cell injury becomes inevitable order ensure supply systemic cell metabolic energy demand heart pump blood intensified prone cardiac dysfunction heart failure addition hypoxemia also one inducing factors inflammatory response promote formation inflammatory storm certain extent <NUMBER> first strong reaction virus invasion activation human immune inflammatory responses interactions among tissues organs pathogens complex stress process especially severe infection time emotional response human like anxiety fear et al also increases stress patients process catecholamine released large quantities plasma catecholamine content related blood pressure level blood perfusion coronary heart disease sudden cardiac death high catecholamine direct myocardial toxicity lead microcirculation disturbance vasospasm arrhythmia <NUMBER> <NUMBER> first important clinical observations pointed patients infected covid<NUMBER> might sign respiratory symptoms patients complained palpitation chest tightness shortness breath exercises et al soon patients confirmed suspected covid<NUMBER> sudden acute myocardial infarction heart failure occur immediately important early identify patients acquired quarantine measures covid<NUMBER> patients show increased respiratory rate lower blood pressure even shock electrocardiogram ecg prolonged qrs interval clinical characteristics covid<NUMBER> patients showed hypertension closely related severity covid<NUMBER> infection <NUMBER> inpatients <NUMBER> intensive care unit icu patients <NUMBER> death cases known covid<NUMBER> infects human combining spike protein surface ace<NUMBER> alveolar cell membrane turn activates immune system releases cytokines inflammatory factors ace<NUMBER> important protective protein human body covid<NUMBER> infection causes downregulation ace<NUMBER> level body obvious effect ace <NUMBER> <NUMBER> angiotensinconverting enzyme inhibitor aceiangiotensin receptor antagonist arb associated ras regulation animal studies shown aceiarb drugs significantly increase expression level ace<NUMBER> biological activity rat cardiomyocytes <NUMBER> <NUMBER> unclear whether aceiarb application upregulate expression activity ace<NUMBER> lung tissue therefore evidence aceiarb increases susceptibility covid<NUMBER> lung damage following infection high blood pressure patients currently receiving aceiarb treatment antihypertensive drugs advised change treatment plan without <NUMBER> clear contraindications serious adverse reactions affect blood pressure homeostasis increase risk hypertension emergencies patients hypertension covid<NUMBER> treatments aceiarb depend conditions patients mild illness given longterm medication aceiarb may continue severe critical illness treatment plan decided careful monitoring vital signs hemodynamics damage target organs avoid dry cough caused acei covid<NUMBER> infection patients recommended use acei delayed american heart society acc published clinical bulletin cardiac implications novel wuhan coronavirus stated covid<NUMBER> potential effects heart especially patients cardiovascular disease among covid<NUMBER> patients <NUMBER> diagnosed chronic diseases <NUMBER> cardiovascular cerebrovascular diseases patients chronic potential diseases obesity hypertension diabetes chronic obstructive pulmonary disease chronic kidney disease higher risk complications death infection virus infection destroy stability atherosclerotic plaque promote occurrence coronary atherosclerosis coronary heart disease experts suggest outbreak people previous cardiovascular diseases strictly accept tailored optimized drug treatments provide additional protection including statins β receptor blockers acei drugs aspirin accordance doctors advice guidance <NUMBER> people basic cardiovascular disease likely infected virus poor prognosis virus infection also lead deterioration basic heart disease covid<NUMBER> patients complicated cardiovascular basic diseases recommended give priority treatment meanwhile pay attention vigilance recurrence aggravation original basic diseases <NUMBER> <NUMBER> <NUMBER> although pathogenic mechanism covid<NUMBER> fully elucidated ace<NUMBER> currently found key molecular target covid<NUMBER> occurrence progression heart lung tissues important target organs covid<NUMBER> hypoxemia respiratory distress inflammatory storms caused covid<NUMBER> adverse effects heart pay attention cardiovascular damage induced covid<NUMBER> early identification timely effective treatment maintenance hemodynamics electrophysiological stability great significance alleviate disease save lives ensure longterm prognosis coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported wuhan china december <NUMBER> <NUMBER> initial presentations wuhan consistent viral pneumonia subsequent deep sequencing confirmed novel rnabased virus coronaviridae family june <NUMBER> <NUMBER> <NUMBER> million confirmed worldwide cases covid<NUMBER> <NUMBER> deaths <NUMBER> covid<NUMBER> become worldwide pandemic mobilized healthcare workers disciplines since initial presentation covid<NUMBER> much learned pathophysiology specific cardiovascular manifestations disease early pandemic evidence preexisting cardiovascular conditions overrepresented cases severe infection <NUMBER> since time become clear certain racial ethnic groups disproportionately affected covid<NUMBER> <NUMBER> additionally covid<NUMBER> appears several unique cardiovascular manifestations cardiologists must understand including worsening heart failure myocarditis proclivity thrombosis arrythmia finally speed clinical trials covid<NUMBER> conducted using repurposed new therapies means cardiologists must aware potential cardiovascular side effects agents commonly used cardiovascular practice article based previously conducted studies contain studies human participants animals performed authors pathophysiology sarscov<NUMBER> novel rna coronavirus emerged causative infection responsible current covid<NUMBER> pandemic viruses coronavirus family include merscov virus responsible middle east respiratory syndrome mers outbreak sarscov virus responsible severe acute respiratory syndrome sars outbreak <NUMBER> <NUMBER> <NUMBER> <NUMBER> initial infection sarscov<NUMBER> process still understood known involve viral proteins host angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor transmembrane protease serine <NUMBER> tmprss sarscov<NUMBER> expresses numerous spike proteins surface viral envelope facilitates viral entry host cell tmprss serine protease expressed host cell primes viral proteins enable interaction host ace<NUMBER> receptor <NUMBER> primed protein binds s<NUMBER> subunit host ace<NUMBER> receptor allowing viral entry cell <NUMBER> role ace<NUMBER> receptor human physiology remains investigation believed provide counter regulation reninangiotensin system <NUMBER> <NUMBER> ace<NUMBER> receptor commonly found lungs type <NUMBER> alveolar cells also expressed vascular endothelium gut epithelium proximal tubule kidneys <NUMBER> <NUMBER> <NUMBER> location ace<NUMBER> receptor implicated multitude disease presentations associated sarscov<NUMBER> infection binding ace<NUMBER> receptor virus internalized viral rna released immediately rnadependent rna polymerase translated allows viral replication spread infection role ace<NUMBER> receptor expression blockade within sarscov<NUMBER> infection disease severity remains controversial protective deleterious effects hypothesized united states surpassed countries worldwide case numbers <NUMBER> million cases june <NUMBER> <NUMBER> <NUMBER> epicenter spread china many european countries usa significant clusters around country number covid<NUMBER>related deaths worldwide climbed past <NUMBER> due heterogeneity testing strategies case ascertainment mortality rates remain controversial estimates ranging <NUMBER> <NUMBER> covid<NUMBER> broad spectrum severity phenotypic presentation typical presentation involves consequences direct respiratory infection ranging cough dyspnea hypoxia acute respiratory distress syndrome ards initial cohort study covid<NUMBER> patients included data <NUMBER> hospitals china <NUMBER> patients covid<NUMBER> disease <NUMBER> study reported common symptoms presentation cough <NUMBER> fatigue <NUMBER> temperature c <NUMBER>°c <NUMBER> largest published cases series sequential covid<NUMBER> cases united states new york city <NUMBER> patients admitted <NUMBER> different hospitals <NUMBER> patients presented initial fever <NUMBER> presented hypoxia <NUMBER> tachypnea present <NUMBER> tachycardia <NUMBER> mechanical ventilation required <NUMBER> patients early mortality seen <NUMBER> <NUMBER> patients surviving discharge <NUMBER> remaining hospital thus sarscov<NUMBER> infection commonly causes respiratory illness wide range severity outcomes relatively consistent presentation cough dyspnea fever hypoxia across globe preexisting burden comorbid chronic disease well recognized contribute severity sarscov<NUMBER> infection concerns underlying comorbid illnesses play role diverse spectrum phenotypic presentation initial study <NUMBER> patients wuhan china demonstrated predominance male patients <NUMBER> preexisting comorbidities including diabetes <NUMBER> hypertension <NUMBER> cardiovascular disease <NUMBER> <NUMBER> median age patients group <NUMBER> years old <NUMBER> initial patients history tobacco use however since initial studies number prospective retrospective studies china demonstrated higher rates underlying comorbid conditions common underlying comorbidities include hypertension <NUMBER> diabetes <NUMBER> cardiovascular coronary artery diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> smoking history obstructive lung disease diagnoses low documented <NUMBER> studies comorbidities associated worse severity illness mortality review <NUMBER> confirmed covid<NUMBER> cases wuhan china demonstrated increased mortality patients cardiovascular disease <NUMBER> diabetes <NUMBER> hypertension <NUMBER> significantly higher overall casefatality rate <NUMBER> <NUMBER> united states similarities notable differences european chinese experience among <NUMBER> patients admitted covid<NUMBER> <NUMBER> men <NUMBER> age <NUMBER> years majority <NUMBER> <NUMBER> years old <NUMBER> comorbidities included hypertension <NUMBER> obesity <NUMBER> diabetes mellitus <NUMBER> chronic lung disease <NUMBER> cardiovascular disease including coronary disease heart failure <NUMBER> less frequently renal disease <NUMBER> immunocompromised conditions <NUMBER> initial cases series shown similar relationship underlying cardiac comorbidities higher prevalence hypertension diabetes coronary artery disease obesity patients requiring mechanical ventilation <NUMBER> concerning trend alarming rate black hispaniclatino americans infected dying covid<NUMBER> <NUMBER> early data cities states across country indicating higher mortality covid<NUMBER> black hispaniclatino populations included milwaukee wi experiencing <NUMBER> mortality rate black patients make <NUMBER> population chicago il <NUMBER> mortality <NUMBER> population states louisiana <NUMBER> mortality <NUMBER> population michigan <NUMBER> mortality <NUMBER> population covidnet catchment population usa higher percentage black patients infected <NUMBER> compared percentage overall population black <NUMBER> <NUMBER> trend repeated across country brought stark reality devastating impact covid<NUMBER> communities color <NUMBER> well known black hispaniclatino patients higher incidence diabetes hypertension alone explain increased infected mortality rates studies prior epidemics continued demonstrate similar healthcare disparities smaller scales likely related multiple factors including access care racial ethnical stigmas among medical professionals crowded living conditions income instability continued rates exposure protection <NUMBER> <NUMBER> <NUMBER> <NUMBER> crucial acknowledge institutionalized barriers health first step incite change narrow outcome gap improve healthcare marginalized individuals de novo cardiac injury also described patients presenting covid<NUMBER> disease initial studies provide insight prevalence incidence acute cardiac injury patients presenting covid<NUMBER> early studies reported prevalence acute cardiac injury <NUMBER> entire cohort defined either high sensitivity troponin hs tn mb fraction creatinine kinase ckmb <NUMBER> th percentile new echocardiographic electrocardiographic abnormalities greater elevations cardiac biomarkers among patients requiring icu care <NUMBER> <NUMBER> metaanalysis clarified prevalence acute cardiac injury among chinese patients presenting covid<NUMBER> disease reporting similar prevalence acute cardiac injury defined ckmb hs tn exceeding <NUMBER>th percentile <NUMBER> case cohort studies included data patients outcome illness course helped elucidate role cardiac injury covid<NUMBER> disease zhou et al showed initial hs tn dramatically elevated illness onset nonsurvivors rapid rise starting day <NUMBER> seen survivors <NUMBER> ruan et al reported cause death nonsurvivors majority <NUMBER> due respiratory failure clinically significant number related combined respiratorycardiac failure <NUMBER> cardiac failure <NUMBER> <NUMBER> based studies authors hypothesize myocardial injury occurs frequently patients severe covid disease myocardial dysfunction involved pathophysiology severe disease pandemic progressed patient outcomes defined investigators sought evaluate association myocardial injury mortality multivariable cox regression acute cardiac injury point hospital stay associated increased risk mortality hr <NUMBER> <NUMBER> confidence interval <NUMBER> guo et al examined association cardiac comorbidities acute cardiac injury defined hs tn <NUMBER>th percentile mortality retrospective cohort <NUMBER> patients <NUMBER> cohort <NUMBER> patients acute cardiac injury proportion nonsurvivors increased groups underlying cardiac comorbidities hypertension coronary artery disease cardiomyopathy myocardial injury highest groups authors assess measures association beyond descriptive statistics thus myocardial injury occurs infrequently covid<NUMBER> disease presence myocardial injury portends severe disease higher mortality mechanism acute cardiac injury remains elusive data zhou et al guo et al shown rise troponin typically occurs late disease process typically occurring <NUMBER> days onset symptoms coincides progressive respiratory decline multiorgan failure <NUMBER> <NUMBER> would suggest myocardial injury may marker severe infection causally associated however reports systematic cardiac testing patients covid<NUMBER> disease cardiac injury limited ability understand causal associations number mechanisms proposed including direct myocardial injury myocarditis systemic hyperinflammatory response leading cytokine storm myocardial injury microvascular thromboses acute plaque rupture physiology stress cardiomyopathy extreme oxygen supplydemand mismatch due critical illness <NUMBER> <NUMBER> relative mystery surrounding pathophysiology acute cardiac injury resulted conflicting recommendations regarding use troponin screen evaluate cardiac dysfunction patients covid<NUMBER> disease communication american college cardiology acc recommended routine cardiac biomarker testing patients presenting covid<NUMBER> disease <NUMBER> subsequent review papers advocated systematic use highsensitivity troponin biomarker severe illness proven prognostic value covid<NUMBER> disease <NUMBER> <NUMBER> however risk prediction strategy yet evaluated prospectively sarscov<NUMBER> implicated cases myocarditis acute decompensated heart failure initial reports myocarditis china described cases cardiogenic shock reduced left ventricular ejection fraction among covid<NUMBER> patients <NUMBER> <NUMBER> patients extremely elevated levels cardiac biomarkers namely troponin ckmb bnp required inotropy extracorporeal membrane oxygenation ecmo maintain adequate cardiac output based clinical presentation elevations biomarkers cases deemed fulminant myocarditis treated combination steroids ivig antivirals antibiotics antiinflammatory agents renal replacement mechanical ventilation outbreaks similar coronaviruses last <NUMBER> years namely sarscov mers evidence support direct myocardial involvement among patients died sarscov toronto canada viral rna detected <NUMBER> samples presence viral rna associated increased levels interstitial fibrosis macrophage activity within myocardium thus potentially leading rapid clinical course compared patients without viral rna myocardium <NUMBER> however hemodynamically significant myocarditis appears relatively rare complication sars one case series noting one instance potential myocarditis requiring inotropy among <NUMBER> cases <NUMBER> myocarditis also appears potential complication mers outbreak mri findings consistent myocarditis reported <NUMBER> additional evidence sarscov<NUMBER> similar effect myocardium sarscov mers myocardial involvement confirmed sarscov<NUMBER>positive patients via mri endomyocardial biopsy <NUMBER> <NUMBER> <NUMBER> cardiac biopsy findings covid<NUMBER> patients shown inflammatory infiltration myocardium tlymphocyte macrophages interstitial edema cases evidence cytoplasmic vacuoles indicating direct viral involvement myocardial cells <NUMBER> <NUMBER> postmortem case series <NUMBER> patients china <NUMBER> covid<NUMBER> patients died circulatory failure degree myocardial involvement marked elevations troponin <NUMBER> however unclear cases truly classified myocarditis given lack ejection fraction assessment via tte mri biopsy different case series seattle wa troponin elevation seen <NUMBER> patients none patients underwent tte evidence reduced ejection fraction <NUMBER> currently standardized approach treatment covid<NUMBER> cardiomyopathy cases severe fulminant myocarditis resulting cardiogenic shock treatments immunomodulating drugs namely steroids ivig also specific agents like tocilizumab inhibit il<NUMBER> used clinical trial data yet lacking efficacy therapies covid<NUMBER>related myocarditis extrapolated causes fulminant myocarditis namely giant cell subtype decompensation preexisting heart failure appears common cardiovascular manifestation sarscov<NUMBER> infection clinically significant myocarditis prior covid<NUMBER> pandemic influenzalike respiratory infections significantly increased risk hospitalization decompensated heart failure high influenza activity months may contribute <NUMBER> heart failure hospitalizations across united states <NUMBER> relationship respiratory infection decompensated heart failure appears also true covid<NUMBER>like seasonal influenza two retrospective case series china <NUMBER> <NUMBER> patients heart failure observed <NUMBER> <NUMBER> deaths respectively <NUMBER> <NUMBER> appears broad spectrum disease severity ranging stable fulminant heart failure requiring inotropes potentially mechanical circulatory support refractory shock hypoxia use ecmo covid<NUMBER> cases studied prospective manner part extracorporeal life support organization elso registry june <NUMBER> <NUMBER> ecmo used <NUMBER> covid<NUMBER>confirmed cases worldwide <NUMBER> discharged alive vast majority patients receiving venovenous ecmo respiratory support <NUMBER> interest role aceiarb overall risk covid<NUMBER> severity lung disease studies suggesting possibility deleterious beneficial effects <NUMBER> <NUMBER> major guideline committees continued advocate use ace arb medications hemodynamically stable heart failure patients hypertension ischemic heart disease <NUMBER> <NUMBER> covid<NUMBER> hypothesized increase risk acute coronary syndromes acs systemic thrombosis premise based prior experience viral infections influenza predisposes patients developing acs may increase risk myocardial infarction mi least sixfold week following infection <NUMBER> increase mi incidence also seen following infection respiratory infections respiratory syncytial virus nonviral respiratory illnesses bacterial pneumonia many mis due covid<NUMBER> disease likely related supplydemand mismatch hypoxia resulting myocardial injury troponin release however mi acute atherothrombotic events first reported wuhan china soon onset pandemic chinese hospitals soon developed treatment algorithms aimed providing urgent reperfusion covid<NUMBER>suspected patients maintaining safety catheterization lab staff setting stelevation mi stemi suspected sarscov<NUMBER> infection thrombolytics often first choice acute reperfusion therapy china <NUMBER> following early experience china accscai released joint recommendation outlining care covid<NUMBER>suspected patients <NUMBER> document highlights need adequate personal protective equipment catheterization lab staff need differentiate true acs supplydemand mismatch consideration deferring invasive angiography lowrisk nonst elevation myocardial infarction nstemi patients hospital resources improve potential use thrombolytics st segment elevation myocardial infarction stemi cases risks exposing staff sarscov<NUMBER> outweigh benefits primary percutaneous coronary intervention pcibased approach however authors still expect primary pci remain standard care patients stemi possible covid<NUMBER> thrombolytics reserved nonpcicapable hospitals <NUMBER> adding complexity treating patients stsegment elevations seen covid<NUMBER> patients found nonobstructive coronary disease case series <NUMBER> patients new york ny developed stsegment elevations nine patients underwent invasive angiography nine patients three obstructive coronary artery disease <NUMBER> obstructive disease underwent pci <NUMBER> receiving thrombolytics <NUMBER> cases stsegment elevation obstructive coronary disease angiography may related perimyocarditis although pathophysiology remains investigation importantly mortality among patients without obstructive coronary lesion higher <NUMBER> among obstructive coronary lesions <NUMBER> although absolute numbers limited similar incidence obstructive nonobstructive coronary lesions reported population italian patients stemi <NUMBER> high prevalence stemi mimics population emphasizes need angiography either invasive noninvasive opposed empiric fibrinolytic therapy given potential harm administering fibrinolytics nonacs presentations covid<NUMBER> may potentially increase risk acs activations stemi united states decreased significantly pandemic among nine highvolume centers us <NUMBER> reduction stemi activations compared <NUMBER>month period pandemic <NUMBER> finding similar <NUMBER> reduction stemi activations seen spain <NUMBER> unclear responsible significant reduction stemi activations may related patients fear exposure sarscov<NUMBER> presenting hospital hong kong china patients presented stemi height outbreak presented hospital significantly longer onset symptoms compared year prior <NUMBER> vs <NUMBER> min <NUMBER> currently unknown many people worldwide may seeking medical care possible acs due fear covid<NUMBER> possible due delays seeking appropriate medical care patients may eventually present hospital heart failure cardiogenic shock mechanical complications acs studies must performed assess impact covid<NUMBER> could cardiovascular mortality indirect mechanisms sarscov<NUMBER> infection theorized predispose hypercoagulable state inflammation immune dysregulation activation cytokines process implicated acs also cases thrombosis outside coronary arteries among <NUMBER> icu patients netherlands <NUMBER> diagnosed pulmonary embolism deepvein thrombosis ischemic stroke myocardial infarction systemic embolismall receiving standard prophylactic doses anticoagulation recommended <NUMBER> remarkably none patients study developed disseminated intravascular coagulopathy dic known risk factor development arterial venous thromboembolism critically ill patients ddimer levels <NUMBER> ngml sensitivity <NUMBER> specificity <NUMBER> detecting venous thromboembolism cohort china <NUMBER> centers advocated use treatment dose anticoagulation select patients covid<NUMBER> elevated ddimer levels however practice yet well validated among <NUMBER> patients confirmed sarscov<NUMBER> wuhan china arrhythmia occurred <NUMBER> patients admitted <NUMBER> elevated troponin statistically significant prognostic marker <NUMBER> either ventricular tachycardia fibrillation unclear whether elevated troponin preceded succeeded arrhythmic events furthermore among <NUMBER> patients admitted single hospital wuhan china arrhythmia type specified reported <NUMBER> majority <NUMBER> occurring critically ill patients intensive care unit <NUMBER> among patients suffered cardiac arrest predominant rhythm asystolepulseless electrical activity <NUMBER> followed shockable ventricular tachycardiafibrillation <NUMBER> <NUMBER> similar rates new york city population reported goyal et al arrhythmia seen <NUMBER> entire cohort higher rates patients receiving icu care <NUMBER> compared nonicu care <NUMBER> <NUMBER> arrhythmias may induced presence acidosis metabolic disturbances seen critical illness multiorgan dysfunction catecholaminergic pressor infusion hypotension shock finally qtprolonging agents given covid<NUMBER> patients may increase susceptibility arrhythmia discussed <NUMBER> <NUMBER> unfortunately limited data available trends apparent yet <NUMBER> <NUMBER> suspicion aggressive nature coronavirus pneumonia related exaggerated immune response mediated interferon interleukins seen prior coronavirus infections <NUMBER> <NUMBER> targets covid<NUMBER> therapies therefore focused intrinsic viral make including proteins ace<NUMBER> cell surface receptor <NUMBER>chymotrypsinlike protease spike rnadependent rna polymerase papainlike protease also human immune system <NUMBER> ongoing covid<NUMBER> pandemic poses enormous threat globally given high prevalence existing cardiovascular disease worldwide surprising cardiovascular comorbidities significantly impact disease severity unique properties sarscov<NUMBER> infection pathophysiology raise concern de novo cardiac injury covid<NUMBER> cardiovascular presentations covid<NUMBER> still elucidated appear least include decompensated heart failure myocarditis acs arrhythmia thrombosis effect covid<NUMBER> pandemic cardiovascular systems care whether patients delaying necessary treatment great importance understand pandemic progresses months years come lastly emerging therapeutic approaches expected unexpected cardiac effects must monitored treatment algorithms expand cardiologists play vital role care covid<NUMBER> patients worldwide ongoing research pathophysiology populationbased effects sarscov<NUMBER> virus funding funding sponsorship received study publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work whole given approval version published disclosures gregory l judson benjamin w kelemen joyce n njoroge vaikom mahadevan nothing disclose relation article compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors data availability data sharing applicable article datasets generated analyzed current study open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> pandemic caused novel coronavirus sarscov<NUMBER> enormous impact health economy entire world <NUMBER> total number cases fatalities continue rise mortality rate currently estimated <NUMBER> <NUMBER> multiple symptoms clinical findings attributed covid<NUMBER> infection fever cough common <NUMBER> significance terms widespread screening defined temperatures ≥ <NUMBER>° f<NUMBER>°c <NUMBER> cardiac injury cardiac mortality also become part emerging clinical picture covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> raises prospect use implantable devices implantable cardiac monitors icms aid screening triage suspected patients daily remote monitoring capabilities screening device could occur without reliance patient compliance recognized symptoms even among nonambulatory mobilitylimited quarantinedselfisolated population describe application temperature measurement within icm biotronik biomonitor iii screen systemic infection based measurements fever concomitant cardiac resting rate changes biomonitor iii icm contains internal integrated solidstate temperature sensor enabled research data collection purposes evaluated vivo approval product additionally statistics like percent activity per day resting heart rate mean rate per day currently available icm known relationship fever heart rate parameters <NUMBER> onboard temperature sensor evaluated possible use screening tool patients implants although retrospective study clinical confirmations fever performed across entire population describe details one patient clinical confirmation device data possible elderly female residing new york city metropolitan region implanted biomonitor iii november <NUMBER> following cerebrovascular accident trend data daily measurements temperature activity mean heart rate daily mean heart rate rest night time implant first <NUMBER> days shown figure <NUMBER> note stable temperature trend metrics time period postimplant standard deviation daytoday measurements <NUMBER>°c implant first <NUMBER> days confirming stable measurement device within subcutaneous pocket february <NUMBER> rd patient admitted emergency department workup negative fever sensor confirmed observations related temperature timeframe however late march patient reported fever coincident onset rapid disease spread city time spouse resided diagnosed covid<NUMBER>positive advised remain home emergency medical services considered covid<NUMBER> presumptive positive trend data period shown figure <NUMBER> note sharp increase temperature march <NUMBER> coincident patient contacting emergency services temperature measured device trended upwards average <NUMBER>°c <NUMBER> days preceding episode <NUMBER>°c average following onset fever activity measured device trended downwards average <NUMBER> preceding fever average <NUMBER> afterwards heart rate rest <NUMBER> bpm <NUMBER> bpm temperature increase daily mean heart entire day average times increased <NUMBER> <NUMBER> bpm patient remained home fever episode resolved within approximately seven days utilizing criterion two consecutive days <NUMBER>° c temperature elevation identified multiple additional patients clinically realistic episode trend data additional example shown figure <NUMBER> device implanted midjuly <NUMBER> shown full trend daily data transmitted case temperature trend relatively unremarkable except short episode early november showing brief decrease activity increases heart rate metrics midmarch however significant clinical episode detected preand postdetection <NUMBER> day averages <NUMBER>°c <NUMBER>°c <NUMBER> <NUMBER> activity <NUMBER> bpm <NUMBER> bpm mean rate <NUMBER> bpm <NUMBER> bpm mean rate rest information beyond trend data available patient report demonstrates utility performing temperature monitoring implantable device specifically biomonitor iii implantable cardiac monitor home monitoring service biotronik provides daily messages without patient interaction patient unit within range device allows tracking heart rate arrhythmia data ecg snapshots among statistics numerous existing temperature measurement methods traditional contact noncontact wearable varieties mainstream solutions require subject play role remember take reading properly acquire varying accuracy coverage time achieved reality new temperature monitoring functionality evaluated context screening triage related covid<NUMBER> highly contagious infectious diseases handsfree rf transmission capabilities device make highly suitable means remote monitoring scenario quarantined populations monitored easily clinics remotely screen patients follow temperature sensor data provided device confirmed fevernegative episode validated emergency department subsequently detected fever positive episode strongly presumptive covidpositive episode second example anonymous data demonstrated dramatic fever heart rate response via trend data would also warrant investigation context either general care specifically cardiac care patient given impact coivd<NUMBER> cardiac health retrospective analysis available temperature heart rate data <NUMBER> patients performed provide perspective sensor data population level goal determine data could used screening tool without undue false alerts exploratory analysis conducted utilizing real world evidence methodology approved irb granting waiver informed consent full waiver hipaa authorization temperatures rises exceeding <NUMBER>°c compared <NUMBER>day mean temperature two consecutive days considered clinically significant analysis total <NUMBER> daily measurements temperature average <NUMBER> days monitoring per patient analyzed <NUMBER> patients within population identified using criteria relatively small number findings devicelevel prevalence <NUMBER> observation period align well actionable alert paradigm would overwhelm holter triage units identifying patients possible clinical interest according guidelines case report somewhat limited due extenuating circumstances covid<NUMBER> pandemic public health policy keep infected noncritical victims away hospitals prevented patient obtaining covid<NUMBER> testing time symptoms anonymized nonclinically validated assessment possible across broad number devices confirmation performed presented case study possible sources temperature elevation fever could also detected sensor present false positives fever infection notably heat stroke malignant hyperthermic reactions anesthesia certain drugs heat application implant site even intense muscular activity could theory generate temperature deviations subcutaneous implant however time scale processes typically quite short minutes hours comparison <NUMBER>hour average used thus represent significant confounder sensor temperature monitoring capability icm specific covid<NUMBER> cannot confirm fever related covid<NUMBER> instead represents tool screening triage device patient significant fever temperature monitoring need remote monitoring alone would warrant implantation icm however due severity covid<NUMBER> pandemic implications cardiac complications related disease screening fever existing cardiac monitor population makes intuitive sense early detection additional follow low overall detection rate multiple variables heart rate activity possible remotely construct broader picture patient health based vital data vital data easily incorporated current remote monitoring infrastructure trend data would available internet biotronik home monitoring cardiac monitoring units traditional credentials alerts could programmed directly push messages specified contacts upon meeting preselected criteria onedegree celsius increase future expansion specified contacts could permit new distribution channels general practitioners general triage teams even patients within appropriate framework especially important case health data temperature wider traditional cardiac implications identical remote monitoring capabilities available biotronik pacemakers icds well development temperature sensors extension capabilities devices would confer similar benefits although wider patient population could addressed based current capabilities biomonitor iii icm additional possibility making temperature data available believe device offers unique opportunity facilitate screening triage context current coronavirus pandemic potential benefits numerous <NUMBER> earlier detection especially among atrisk patient groups reduce mortality may subjectively aware relatively minor temperature elevation <NUMBER> early suspicion possibly contagious patients could protect caregivers family others <NUMBER> fever specifically could monitored remotely handsfree manage athome care <NUMBER> additionally normal icm surveillance remains place screening diagnosis cardiac injury complications recovery temperature monitoring functionality demonstrated could important addition implantable monitors move devices towards vital sign monitors high compliance significant clinical impact trend data elderly female presumptive positive covid<NUMBER> patient plot displays daily trend data received biomonitor iii icm daily temperature b physical activity percent per day c daily mean heart rate daily resting heart rate determined nighttime hours device data first <NUMBER> days since implant significant episodes shown illustration full trend data term implant biomonitor iii icm patient fever episode associated presumed coronavirus infection march <NUMBER> see temperature trend along decreases activity b modest moderate increases daily heart rate c resting heart rate respectively daily trends second exemplar patient biomonitor iii display dramatic increase daily temperature biomonitor iii subject march subplot b activity data subject shown note drop activity period temperature increase subplot c subplot daily mean hr bpm daily mean resting hr shown respectively note remarkably concordant dramatic increase hr temperature spread novel coronavirus <NUMBER>ncov shook world highly virulent transmissibility manifesting largely severe acute respiratory syndrome <NUMBER> million people confirmed infectedwith approximately <NUMBER> million cases usaand <NUMBER> deaths worldwide time writing <NUMBER> originating china covid<NUMBER> epidemic surpassed predecessors number hospitalizations intensive care unit admissions required handle infectious process within short period time grand scale <NUMBER> early sars epidemic emerged <NUMBER> similarly involved humantohuman transmission animal vectors linked outbreaks confirmed laboratory isolates <NUMBER> initially described pneumonia unknown origin covidishan asokan soniya v rabadia contributed equally work coprimary authors article part topical collection cardiooncology <NUMBER> believed linked bats based genomic similarity known bat coronavirus batcov ratg<NUMBER> <NUMBER> though coronaviruses mild two betacoronaviruses severe acute respiratory syndrome sarscov middle east respiratory syndrome coronavirus merscov also took place within last two decades <NUMBER> two unique predecessors preceded pandemic began china <NUMBER> virus originating wuhan hubei province china late december resulted nearly <NUMBER> cases initially considered worldwide pandemic <NUMBER> routes transmission virus documented include respiratory droplets contact fomites fecaloral transmission <NUMBER> <NUMBER> common symptoms onset illness include fever cough myalgia fatigue rare complaints sputum production headache hemoptysis loss taste andor smell diarrhea addition clinical characteristics patients showcased groundglass opacities chest computed tomography scans however half patients early studies notably developed dyspnea correlated patchy infiltrates chest radiographs mean duration symptoms roughly <NUMBER> days progression acute respiratory distress syndrome ards occurring days <NUMBER> <NUMBER> <NUMBER> patients receiving mechanical ventilation wuhan cohort typically required icu admission <NUMBER> weeks following symptom development foreshadowed scale pandemic mirrored data obtained mers epidemic <NUMBER> <NUMBER> <NUMBER> epidemiological data china confirmed median age patients impacted disease <NUMBER> years disease distribution disproportionately impacting males <NUMBER> data hypothesized children might less likely become infected infected demonstrated far milder symptoms italy documented nearly <NUMBER> cases march <NUMBER> largest proportion cases fatalities impacting males greater <NUMBER> years age <NUMBER> lombardy study <NUMBER> patients least one existing comorbidity hypertension frequently cited predisposing factors included cardiovascular disease hypercholesterolemia rare subset preexisting lung disease manifesting chronic obstructive pulmonary disease roughly <NUMBER> lombardy patients managed noninvasive ventilatory support <NUMBER> need invasive ventilatory support varied across regions world wuhan cohort directly transitioned extracorporeal membrane oxygenation ecmo resuscitation purposes <NUMBER> underlying risk factors hypertension diabetes cardiovascular disease immunosuppression explored prognosticators regarding clinical outcomes covid<NUMBER> infections hospitalized patients <NUMBER>• however impact pandemic patients history cancer preexisting andor cancer treatmentassociated cardiovascular diseasethe cardiooncology patientis unknown theoretically population likely higher risk morbidity mortality covid<NUMBER> infection unique healthcare needs put higher risk exposure community healthcarerelated transmission examples risks include needing ongoing cancer treatments outpatient inpatient setting well imagingrelated procedures operations cancerrelated staging treatments patients also preexisting cardiovascular disease andor acquired cardiotoxicity treatments also warrant additional evaluation finally appears strong correlation worse outcomes hospitalized covid<NUMBER> patients cardiovascular andor cancerrelated comorbidities reviewed multiple retrospective analyses including china usa italy shown high cardiovascular disease cvd prevalence patients develop covid<NUMBER> particularly severe disease worse outcomes mechanism cardiovascular patients higher risk contracting covid<NUMBER> developing severe disease unknown potentially may due poor cardiovascular reserve greater associated age cardiovascular conditions dysregulated immunity existing inflammation underlying diseases hypertension diabetes <NUMBER> observational database surgical outcomes collaborative registry comprised <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> hospitals asia europe north america found age greater <NUMBER> diagnosis history coronary artery disease heart failure andor cardiac arrhythmias independently associated increased risk inhospital death <NUMBER> n <NUMBER> cohort dying hospital <NUMBER> studies analyzing risk factors associated clinical outcomes geography described metaanalysis <NUMBER> chinese studies evaluating <NUMBER> affected patients showed prevalent cardiovascular metabolic comorbidities included hypertension <NUMBER> cardiac andor cerebrovascular disease <NUMBER> diabetes <NUMBER> importantly patients hypertension cardiac cerebrovascular disease significantly accounted icu cases compared nonicu cases prevalence <NUMBER> rr <NUMBER> hypertension <NUMBER> rr <NUMBER> cardiac andor cerebrovascular disease <NUMBER> data world health organization chinese center disease control prevention confirm patients comorbidities higher case fatality rate cfr without comorbidities <NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed cases china <NUMBER> cfr higher rates seen cvd <NUMBER> diabetes <NUMBER> hypertension <NUMBER> <NUMBER>• cohort study <NUMBER> patients wuhan jinyintan hospital showed hypertension significantly associated patients progressing acute respiratory distress syndrome ards <NUMBER> vs <NUMBER> p <NUMBER> later death <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> march <NUMBER> <NUMBER> cfr italy <NUMBER> total <NUMBER> cases detailed chart review subsample <NUMBER> deceased patients found high underlying disease prevalence ischemic heart disease <NUMBER> diabetes <NUMBER> atrial fibrillation <NUMBER> cancer <NUMBER> <NUMBER> case series patients covid<NUMBER> icus lombardy region demonstrated hypertension common comorbidity <NUMBER> cardiovascular disease <NUMBER> second furthermore statistically significant higher prevalence hypertension among patients died compared discharged icu <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> epidemiologic data usa remains dynamic limited studies date major urban centers report <NUMBER> confirmed cases linked longterm facility washington state also conferred similar findings showing high underlying disease prevalence hypertension <NUMBER> cardiac disease <NUMBER> diabetes <NUMBER> <NUMBER> large new york study examined total <NUMBER> patients median age <NUMBER> years age new york cohort found hypertension <NUMBER> patients obesity <NUMBER> patients diabetes <NUMBER> patients patients died diabetes likely mechanically ventilated hospitalized icu <NUMBER>• another case series <NUMBER> patients admitted new york hospitals found <NUMBER> patients hypertension <NUMBER> cardiovascular disease <NUMBER> studies detailed specifics defined cardiac disease therefore difficult delineate covid<NUMBER> direct associations coronary artery disease cardiomyopathy heart failure large sample size standpoint however case series seattle washington state <NUMBER> <NUMBER> critically ill patients covid<NUMBER> underlying congestive heart failure <NUMBER> addition underlying cvd risk factor contracting covid<NUMBER> patients develop acute myocardial injury worse outcomes even without baseline cardiovascular dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> acute myocardial injury categorized three varieties elevated troponin levels <NUMBER>th percentile upper reference limit development new worsening heart failure myocarditis several studies china found elevated troponin levels significantly associated higher mortality <NUMBER> <NUMBER> <NUMBER> case series <NUMBER> patients seventh hospital wuhan city china found patients elevated troponin tnt levels significantly higher mortality rate normal tnt levels <NUMBER> vs <NUMBER> p <NUMBER> patients underlying cvd including underlying hypertension coronary heart disease cardiomyopathy likely elevated tnt levels hospital course <NUMBER> lipid metabolism also observed dysregulated patients sarscov infection serum concentrations f r e e f c l p h p h l c h l n e n phosphatidylglycerol remained elevated contributed chronic cardiovascular damage post infection patients sarscov <NUMBER> longterm cardiovascular atherosclerotic changes patients suffer covid<NUMBER> documented yet given recent nature pandemic case series <NUMBER> critically ill covid<NUMBER> patients seattle also found onethird patients developed new cardiomyopathy cardiogenic shock absence prior systolic dysfunction progression illness <NUMBER> unclear patients developed cardiomyopathy truly myocarditis underlying cvd predisposed clinical course however covid<NUMBER> shown directly cause myocarditis otherwise healthy individuals several case reports <NUMBER> <NUMBER> thus covid<NUMBER> demonstrates various patterns myocardial injury higher mortality risk associated elevated troponin levels addition cardiooncology population elevated cardiac biomarkers pose additional layer complexity challenge dealing management abnormal elevations troponin bnp biomarkers indicative cardiotoxicity cancer physiology treatments <NUMBER> elevations may nonspecific reflective subclinical cardiotoxicity patients receiving anthracyclines andor antiher<NUMBER> agents stable patients medically managed <NUMBER> <NUMBER> however patients receiving agents certain tyrosine kinase inhibitors prothrombotic risk ie ponatinib fluoropyridines ie <NUMBER>fluorouracil may suffer cardiotoxicity form coronary ischemiavasospasm may warrant invasive diagnostictreatment strategies <NUMBER> <NUMBER> <NUMBER> elevated cardiac biomarkers also associated worse outcomes cardiac hemodynamic instability including cytokine release syndrome chimeric antigen therapy cart heart failure proteasome inhibitor use ie carfilzomib myocarditis immune checkpoint inhibitor therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> disease processes may confound treatment cancer patient also afflicted covid<NUMBER> thus multidisciplinary assessment particularly cardiooncologist may essential provide optimal care highrisk population cancer patients shown higher risk contracting virus likely immune dysregulation setting malignancy various treatments remain high risk sustaining severe outcomes <NUMBER> <NUMBER> per joint mission report cfr cancer patients <NUMBER> higher overall cfr <NUMBER> covid<NUMBER> patients china <NUMBER>• reports italy washington also support cancer patients similar findings <NUMBER> <NUMBER> <NUMBER> however specific type cancer neither reported studies linked specific outcome several studies indicated cancer patients trend toward severe disease case series patients admitted new york hospitals identified <NUMBER> patients cancer <NUMBER> patients required invasive ventilation support <NUMBER> prospective cohort study following <NUMBER> covid<NUMBER> patients china demonstrated <NUMBER> patients cancer lung cancer frequently incurred malignancy moreover cohort history cancer associated higher risk severe events icu admission requiring ventilation death faster progression severe events median time cancer patients <NUMBER> days vs <NUMBER> days noncancer patients history chemotherapy surgery past month higher risk severe events even adjusted risk factors including age <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> described wuhan group roughly <NUMBER> received chemotherapy <NUMBER> targeted therapy however age alone also independent risk factor severe events cancer group patients history lung cancer versus cancer types predict severe outcome <NUMBER> another study china evaluating cancer patients admitted zhongnan hospital wuhan university determined cancer patients <NUMBER> infection rate compared overall citys <NUMBER> infection rate total <NUMBER> patients affected <NUMBER> nonsmall cell lung carcinoma nsclc approximately <NUMBER> undergoing treatment chemotherapy resulting mortality rate march <NUMBER> <NUMBER> <NUMBER> additionally nsclc patients greater age <NUMBER> higher incidence covid<NUMBER> compared younger patients nsclc <NUMBER>• findings corroborated study examined <NUMBER> cancer patients admitted <NUMBER> hospitals china lung cancer common cancer type among patients <NUMBER> diabetes <NUMBER> chronic cardiovascular cerebrovascular disease <NUMBER> common comorbidities listed clinical factors significantly predicted worse outcomes group patients included age patchy consolidation imaging receipt antitumor treatment last <NUMBER> days <NUMBER> studies suggest patients cancer higher risk covid<NUMBER> older age cancer even higher risk poor outcomes lung cancer reported common studies total sample size cancer patients remains low draw meaningful conclusions malignancy may associated severity covid<NUMBER> infections lastly although recent anticancer treatment increases risk severe outcomes unclear anticancer agents associated higher risk acquiring covid<NUMBER> infection severity infection andor mortality although formal studies assessed direct impact covid<NUMBER> cardiooncology patients study shown cvd patients cancer patients increased risk cardiac injury independent predictor mortality <NUMBER> additionally since data suggests cvd cancer potentially independent risk factors virus acquisition severe outcomes reasonable assume patients risk factors may posit higher cumulative risk also concern cancer treatments may induce disease states hypertension cardiovascular diseaseboth frequently associated risk factors worse outcomes covid<NUMBER> patients <NUMBER>• example clinical scenario could involve metastatic renal carcinoma patients develop hypertension antivegf tyrosine kinase therapy cardiomyopathy antiher<NUMBER> anthracycline therapy breast cancer <NUMBER> <NUMBER> however definition cardiovascular disease patients classified studies always clearly delineated thus risk stratification patients regard covid<NUMBER> risk requires refined investigation longterm followup regarding outcomes elevated risk cancer patients face covid<NUMBER> pandemic poses many challenges include providing ongoing cancer treatments especially patients undergoing curative therapy enrolling patients experimental drug trials continuing close cardiotoxicity surveillance providing treatments patients optimal window adequate functional status <NUMBER> <NUMBER> given concerns hospitalacquired covid<NUMBER> infections additional risk factor impact continuation therapy initiation regimens aggressive malignancy require hospitalization closer monitoring <NUMBER> <NUMBER> <NUMBER> moreover patients may rely drugs stem cell donations treatment may necessitate access unique global sources rendered disadvantage due travel restrictions quarantine policies <NUMBER> response climactic changes national comprehensive cancer network national cancer institute provided guidance providers providing care oncology patients resource allocation managing drug trials <NUMBER> referenced unique source transmission cardiooncology population healthcare exposure healthcarerelated exposure given greater importance attributable vector past experience sarscov demonstrated virus transmitted via aerosolizing procedures endotracheal intubation placing anesthesiologists great risk acquiring infection <NUMBER> <NUMBER> outbreak covid<NUMBER> implementation infection control establishment safe personal protective equipment ppe remained remains key intense aerosolizing procedures emergent intubations cardiopulmonary resuscitation bronchoscopies require stringent ppe maintain adequate protection despite attempting roll precautions review whochina joint mission covid confirmed nearly <NUMBER> healthcare workers tested positive covid<NUMBER> infection resulting <NUMBER> deaths <NUMBER> initial understanding pathogen remained poor longtime exposure largescale infected patients directly increased risk infection healthcare workers risk asymptomatic carrier <NUMBER> fatigue lack available healthcare workers limited resources intensity response led several healthcare workers succumbing infection though unsettling doubly important place value healthcarerelated exposure established risk factor dealing cancer patients preexisting risk factors coronaviruses large collection singlestranded enveloped nonsegmented positivesense rna viruses fall within family coronaviridae order nidovirales <NUMBER> six specific coronaviruses identified humansusceptible among alpha beta subsets demonstrated lower pathogenicity caused milder respiratory symptoms respectively genomic analysis sarscov<NUMBER> showcased <NUMBER> shared sequencing bat cov ratg<NUMBER> thus positing bat variant served natural host virus <NUMBER> however severe acute syndromes belong bgenus envelopeanchored spike protein mediating viral entry host cells first binding host receptor subsequently fusing membranes <NUMBER> covid<NUMBER> infection welldefined capsular structure <NUMBER> binding residues <NUMBER> conserved prior sarscov infections viral genome contains several open reading frames majority viral rnaencoding nonstructural proteins nsps play role pathogenesis disease recent research studies focusing nsp<NUMBER> nsp<NUMBER> demonstrated vivo role subunits may play infectious capability differentiation covid<NUMBER> <NUMBER> mechanistically covid<NUMBER> found linked angiotensinconverting enzyme <NUMBER> membranebound aminopeptidase highly expressed lung intestinal heart tissue beyond implicated hypertension diabetes ace<NUMBER> functions receptor coronaviruses <NUMBER>• covid<NUMBER> translocates lung parenchyma via damaging epithelial cells resulting respiratory symptoms symptom severity worsening patients cardiovascular disease ace<NUMBER> secretion noted elevated cvd patients due increased reliance angiotensinreceptor blockers management hypertension receptor level receptorbinding domain sarscov spike protein specifically recognizes ace<NUMBER> contributes crossspecies humantohuman transmission <NUMBER> <NUMBER> documented variability demonstrated various strains sarscov terms binding affinity viral attachment preserved across humans animal models disease transmission <NUMBER> preserved domains across merssars may contribute heightened inflammatory response cytokine milieu leads severe pneumonia <NUMBER> molecular level specific associations descriptive characteristics patients identified cytokine abnormalities iculevel patients versus noniculevel admissions compared nonicu patients icu patients higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa <NUMBER>• though cytokine thumbprint linked covid<NUMBER> infection ards similarly showcases elevations inflammatory markers questioning origin role virally mediated hyperinflammation <NUMBER> multiple treatments assessed various trials including antivirals antiinflammatories immunotherapies cardiovascular medications treatment covid<NUMBER> although therapies potential provide benefit numerous potential cardiac toxicities drugdrug interactions may harmful cardiooncology patients critically relevant since high percentage covid<NUMBER> patients cardiovascular comorbidities <NUMBER> <NUMBER> <NUMBER> <NUMBER> appraisal agents potential cardiotoxicitiesof current proven efficacy timeis beyond scope review however agents actively used treatment cardiovascular disease andor cancerrelated conditions unique disease states cardiooncology population may yield insights mechanisms covid<NUMBER> pathophysiology instance idea using medications already wellstudied target host responses boosting host immunity discussion prior significant outbreaks epidemics including ebola influenza <NUMBER> <NUMBER> ace inhibitors acei angiotensinreceptor blockers arb statins particular importance current pandemic theoretical uncertainty regard safety aceiarb use patients covid<NUMBER> based ace<NUMBER> viral entry mechanism <NUMBER> <NUMBER> virus gains cellular entry attaching ace<NUMBER> receptor <NUMBER> ace<NUMBER> expression activity shown increased aceiarb use <NUMBER> although theoretical risk ace<NUMBER> upregulation may increase susceptibility infection conflicting evidence indicates upregulation ace<NUMBER> fact protective effect studies mouse models shown ace<NUMBER> protective acute lung injury blocking reninangiotensinaldosterone system pathway decreases lung failure <NUMBER> <NUMBER> based review literature date heart failure society america recommends continuation aceiarb use patients prescribed heart failure hypertension ischemic disease <NUMBER>•• abrupt discontinuation medications recommended worsen clinical stability especially patients existing cardiovascular conditions <NUMBER> additionally statins long shown antiinflammatory properties multiple studies instance simvastatin shown decrease pulmonary inflammation human subjects <NUMBER> although benefits cardiovascular patients numerous lipid lower standpoint important note ability statins decrease inflammation also improves mortality <NUMBER> retrospective analysis patients veterans administration showed statin use acei use arb use independently improved <NUMBER> day mortality patients <NUMBER> years old hospitalized pneumonia <NUMBER> however era covid<NUMBER> pandemic studies needed evaluate role covid<NUMBER>related illness although cancer patients considered immunosuppressed result underlying malignancy cytoreduction therapies patients undergo immunotherapy including immune checkpoint inhibitors icis cart cell therapy may different immunophysiology responds covid<NUMBER> differently <NUMBER> antipd<NUMBER>pdl<NUMBER> antictla<NUMBER> icis approved fda use variety cancers drugs primarily work enhancing patients immune response tumors inhibiting negative regulators cell function <NUMBER> cart cell therapy involves reprogramming patients cells directly target specific tumor <NUMBER> adverse effect occur either antipd<NUMBER> therapy cart cell therapy involves cytokine release syndrome crs similar cytokine storm phenomenon occurs patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> crs occurs result hyperimmune activation response tumor death whereas cytokine storm covid<NUMBER> patients occurs result cell hyperactivation immune dysregulation <NUMBER> <NUMBER> similar markers elevated phenomena including il<NUMBER> tnfalpha ifnλ il<NUMBER> also shown mortality predictor covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients develop cytokine storm syndrome risk developing ards multiorgan failure <NUMBER> <NUMBER> immunosuppression tocilizumab il<NUMBER> inhibitor used treat crs associated cart cell therapy <NUMBER> <NUMBER> additionally tocilizumab immunosuppression used treat immunerelated adverse events iraes pd<NUMBER> inhibitors refractory steroids iraes also occur result hyperimmune activation <NUMBER> <NUMBER> moreover cytokine storm observed covid<NUMBER> also noted similar secondary hemophagocytic lymphohistiocytosis hlh also treated immunosuppression <NUMBER> current trials underway using tocilizumab sarilumab another il<NUMBER> inhibitor treat covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> although immunotherapy may thought reinstate cancer patients immunocompetence potential synergy crs covid<NUMBER> cytokine storm pathogenesis worsen patients mortality risk unfavorable synergy ici immunerelated adverse events iraes also seen potentially pneumonitis icis cause lung involvement covid<NUMBER> <NUMBER> pneumonitis occurs <NUMBER> patients treated antictla<NUMBER> antipd<NUMBER> icis potentially lifethreatening <NUMBER> therefore combined lung injury covid<NUMBER> theoretical potential poor outcomes potential cancer treatments may counteract pathogenesis covid<NUMBER> ccr<NUMBER> treatments tyrosine kinase inhibitors tkis <NUMBER> <NUMBER> <NUMBER> ccr<NUMBER> receptor g proteincoupled receptor selectively expressed macrophages cells eosinophils dendritic cells microglia implicated chemokinemediated signaling <NUMBER> receptor historically targeted hiv antiviral therapy setting disrupting viral entry specifically small molecule inhibition maraviroc vicriviroc monoclonal antibody treatment leronlimab <NUMBER> moreover multiple cancers shown overexpress ccr<NUMBER> linked cancers metastatic potential ccr<NUMBER> therapies currently studied metastatic colorectal breast cancers <NUMBER> <NUMBER> due immune system restorative properties leronlimab investigated compassionate use treatment covid<NUMBER> patients <NUMBER> <NUMBER> studies examining receptor blockade leronlimab preliminarily shown decreases il<NUMBER> restoration cd<NUMBER>cd<NUMBER> ratios reduction overall covid<NUMBER> viremia <NUMBER> collective findings suggest possible therapeutic role establishing immune reconstitution patients critically ill may provide dual benefit patients shared cancer diagnoses tkis like sunitinib erlotinib specifically inhibit aak<NUMBER> protein regulator allows passage virus cells theorized utility <NUMBER> sunitinib antivascular endothelial growth factor vegf tki used firstline treatment advanced renal cell carcinoma <NUMBER> erlotinib antiepidermal growth factor receptor egfr tki used firstline treatment metastatic egfrmutant nonsmall cell lung cancer <NUMBER> tkis shown reduce infectivity dengue ebola vivo studies murine models showed decreased viremia mortality treatments moreover vitro studies cultured cells hepatitis c study showed use tkis reduced intracellular trafficking inhibited viral entry <NUMBER> however high doses required achieve effect may potentially exhibit harm patients <NUMBER> <NUMBER> regardless potential cancer patients receiving therapies achieve dual benefit referenced warrant investigation studies warranted tracking outcomes cancer patients covid<NUMBER> type treatments received patients underlying hypertension diabetes cancer higher risk developing thrombotic events coagulopathy coronavirus infection associated high mortality manifests high ddimer elevations <NUMBER> lung inflammation impaired pulmonary gas exchange contributes cytokine storm leads spike ddimer proinflammatory response impaired endothelial function tissue factor tf expressed tumor cells contributes thrombosis metastasis tumor growth tumor angiogenesis leading release procoagulant microparticles circulation triggering thromboembolism patients cancer <NUMBER> tf circulating tumor cells leads coating cells fibrin traps within microvasculature thereby contributing worsening endothelial dysfunction <NUMBER> patients preexisting cancer diagnoses shared covid infection well hypoxia places even greater risk developing incurring thrombotic events <NUMBER> early heparin initiation posited delay spike inflammatory biomarkers may reduce contributions procoagulopathic state <NUMBER> retrospective study china examined <NUMBER> patients classified severe covid<NUMBER> infection <NUMBER> one chronic underlying diseases hypertension heart disease patients assigned receive various forms heparin treated heparin lower mortality rate <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> data regarding initiation choice anticoagulation remains limited randomized clinical trials necessary determine prophylactic treatment strategies cardiooncology patients infected covid<NUMBER> represent population elevated theoretical risk suffering thromboembolic events covid<NUMBER> pandemic added significant layer complexity patient care delivered due concerns bidirectional transmission protective algorithm widely place dictate ongoing management cancer patients <NUMBER>•• initiating cancer treatments targeted immunotherapies chemotherapy require special consideration covid<NUMBER> era previously described compromised immune systems render patients cancer higher risk acquiring covid<NUMBER> infection sequelae may ensue cancer treatment centers cardiooncologists must consider patient also integral healthcare workers regularly interfacing highrisk exposures devising strategies ensure robust testing services clearance mechanisms protect patient healthcare personnel one many methods employed continue ongoing treatments <NUMBER> <NUMBER> <NUMBER> though clear evidencebased modifications systems care reduce transmission risk balancing highstandard cardiooncology care various strategies proposed table <NUMBER> lifeprolonging surgeries procedures slowly pursued continued although risks delaying advanced treatmentsincluding bone marrow transplantation chimeric antigen receptor treatmentneed weighed carefully covid<NUMBER> screening testing prior surgeriesprocedures infallible considered available due rising concern asymptomatic carriers following completing anticancer treatments patients may additionally benefit receiving immune system restorative treatments filgastrim additionally transition telemedicine conduct interval cardiovascular oncologic appointments potentially protect patients unnecessarily harmful nosocomial exposures <NUMBER> <NUMBER> certain chronic conditions ie hypertension stablecompensated congestive heart failure may necessarily require facetoface visit whereas highly symptomatic patients still seen cardiooncology clinic preferably day cancer outpatient visits deferring primary prevention assessments example cholesterol monitoring unless otherwise indicated augment protective mechanisms place cardiovascularrelated blood draws necessary coincided cancerrelated treatments addition specter cardiotoxicity related certain cancer treatments also requires reexamination risk benefit respect frequent cardiac monitoring due previously mentioned concerns perichemotherapeutic events development cardiomyopathy ischemia lifethreatening arrhythmias worsened simultaneous covid infection reducing reliance frequent cardiac imaging otherwise asymptomatic patients providing inmail ambulatory rhythm monitors patients symptomatic possible arrhythmias assist mitigating exposure risk limited cardiacimaging protocols ie focused ventricular function andor pericardial disease necessary symptomatic patients necessitating cardiotoxicity surveillance also devised reduce exposure time healthcare setting addition patients low risk cardiotoxicity andor prior serialdocumented normal cardiac function considered defer serial cardiac imaging certain treatments ie antiher<NUMBER> without anthracyclines brafmek treatments multidisciplinary discussions oncology patient asymptomatic <NUMBER> covid<NUMBER> pandemic caused unprecedented global impact healthcare delivery trajectory continues remain unclear vulnerable patient populations include cardiovascular disease cancer cardiooncology patient possessed risk factors may unfortunately significantly increased risk experiencing worse outcomes related covid<NUMBER> infection writing known studies focusing cardiooncology population remain many opportunities study epidemiology unique also significant group patients clinical trials ongoing rigorous randomized highquality science warranted study efficacy previously mentioned treatments also may potentially reveal critical mechanistic insights covid<NUMBER>s pathophysiology overlap cardiovascular cancer disease states <NUMBER> addition abrupt possibly permanent alteration cardiovascular cancer systems carewith dramatic rise telemedicine changesto mitigate transmission risk covid<NUMBER> era also warrants close study evaluate clinical outcomes much remains unknown pandemic affect cardiooncology population cared certain ongoing close multidisciplinary care communication cardiac cancer care providers patients remains critical ever order guarantee best care possible bmt bone marrow transplantation cart chimeric antigen receptor therapy hcw healthcare workers ppe personal protective equipment cvd cardiovascular disease cad coronary artery disease chf congestive heart failure lvef left ventricular ejection fraction human transmission infection novel coronavirus known covid<NUMBER> appeared wuhan december <NUMBER> rapidly spread become global pandemic consequent acute respiratory syndrome placed considerable strain healthcare systems resulting significant morbidity mortality <NUMBER> even countries able limit number individuals infected covid<NUMBER> seismic shift traditional platforms health care delivery effort reduce community transmission <NUMBER> although major attention coronavirus infection clinical perspective focussed respiratory complications likely considerable cardiovascular implications cvd sequelae pandemic <NUMBER> earlystage case fatality rates underlying health conditions china highest cvd <NUMBER> ten times without cvd <NUMBER> also recognised <NUMBER> patients hospitalised acute respiratory illness coronavirus develop either myocarditis myocardial injury arrhythmia venous thromboembolism <NUMBER> however potential cardiovascular complications pandemic almost certainly widereaching beyond direct cardiac effects efforts reduce social contact community concerns regarding potential transmission led reduction emergency department presentations acute coronary syndromes <NUMBER> <NUMBER> patients miss opportunity receive evidencebased interventions demonstrated protective effects future cardiovascular events death furthermore patient established atherosclerotic cvd changes access health care system potential implications high risk patients receive secondary prevention strategies important given patients coronary heart disease <NUMBER> absolute risk <NUMBER> years experiencing new heart attack stroke cardiovascular death <NUMBER> <NUMBER> greatest risk occurring first year following hospitalisation acute coronary syndrome <NUMBER> given concern regarding longterm cardiovascular sequelae coronavirus pandemic cardiac society australia new zealand csanz thought appropriate define potential impact effective use secondary prevention cardiac rehabilitation make recommendations patients health care workers living document reflects current state knowledge recommendations read conjunction uptodate advice state federal health departments randomised controlled trials pharmacological strategies repeatedly demonstrated reduction risk recurrent cardiovascular events patients established cvd consequently use antiplatelet blood pressure lipid blood glucose lowering agents complement lifestyle modification attention psychosocial risk factors recommended national international guidelines <NUMBER> patients discharged recent acute coronary syndrome referral cardiac rehabilitation also demonstrated promote medication adherence optimal risk factor control covid<NUMBER> setting optimal uptake availability secondary prevention measures likely impaired patients avoid unable attend inperson medical clinics rehabilitation programs therefore critical emphasise patients health care professionals evidencebased routine care works continue promoted implications continuing use secondary prevention therapies attainment guidelineadvocated treatment goals accordingly every effort made lower manage cholesterol blood pressure use antiplatelet agents highrisk patients require ongoing efforts maintain adherence therapy monitoring risk factor control furthermore increasing evidence benefits sglt<NUMBER> inhibitors glp<NUMBER> receptor agonists patients diabetes established vascular disease supports need maximise use <NUMBER> guidance maintain use evidencebased therapies particularly important respect use agents target renin angiotensin aldosterone system raas established interaction covid<NUMBER> virus ace<NUMBER> raised speculation regard impact use raas blockers setting covid<NUMBER> viral infection currently evidence support need stop agents <NUMBER> australians worried risk covid<NUMBER> infection medical clinics <NUMBER> similarly patients appear avoiding attending pathology collection centres tests pharmacies medications although telehealth services widely available many patients may know access health care workers via service patients chronic diseases cvd diabetes medicarefunded medical consultations telephone videoconferencing enables doctors arrange prescriptions faxed subsequently posted directly patients chosen pharmacy pharmacies turn deliver patients medicines directly home similarly pathology radiology request forms sent directly pathology collection radiology centres patients essential tests monitoring however although patients access medical advice testing medicines covid<NUMBER> pandemic likely worsen treatment gap despite evidence base supporting benefits intensive lipid lowering many patients needing secondary prevention treated either low doses statin therapy maximally tolerated statin doses used regardless need lipid testing patients may reluctant attend either pharmacy medical clinic blood pressure measured efforts made encourage patients elevated blood pressure access validated blood pressure monitor home use clinics may also able lend devices individuals purchase independently online pharmacies health care insurance may cover cost disadvantaged patients additional government payments social security veteran income support recipients eligible concession card holders could cover cost monitor similar arrangements made support use home glucometer patients established type <NUMBER> diabetes international guidelines care cvd patients covid<NUMBER> pandemic includes advice address cvd risk factors promote recovery <NUMBER> cardiac rehabilitation programs wellestablished efficacy supporting patients lifestyle change <NUMBER> current social distancing restrictions substantially limit conventional methods support lifestyle change attending gyms participating group exercise programs flip side social distancing may also provide opportunity focus positive lifestyle changes heart foundation provides guidance health professionals <NUMBER> patientfocussed resources suitable different levels health literacy <NUMBER> smoking presents significant risk cvd patient covid<NUMBER> pandemic addition promoting greater risk future cardiovascular events <NUMBER> smoking also increases risk infection via handtomouth contact<NUMBER> provides potential adhesion site covid<NUMBER> virus upregulation angiotensinconverting enzyme<NUMBER> receptors <NUMBER> associates severe pulmonary complications <NUMBER> also possible social distancing strategies may increase loneliness reduce opportunities positive coping strategies may result greater rates smoking relapse previously quit <NUMBER> therefore strongly recommended smokers cvd informed risks offered evidencebased assistance quit including nicotine replacement therapy pharmacological interventions guidelines exercise physical activity unchanged context covid<NUMBER> general recommendations <NUMBER> minutes per week least moderate intensity exercise including least two sessions resistance strength exercise appropriate modifications setting comorbidities <NUMBER> current social distancing restrictions afforded increasing opportunities walking forms exercise within close proximity home need selfisolate home efforts made exercise within outside residence making priority keeping active household tasks avoiding long periods sitting advice activity plans available online <NUMBER> <NUMBER> <NUMBER> additional support provided telehealth <NUMBER> use activity trackers <NUMBER> engaging household family members provide additional support development maintenance exercise regimens covid<NUMBER> also presents new dietary recommendations cvd patient associated number challenges social distancing requirements may result change healthy eating routines including shopping meal preparation food choices given poor nutrition obesity identified associate poor outcomes setting covid<NUMBER> <NUMBER> efforts maintain healthy diet worthwhile older isolated individuals may limited access grocery stores may rely family neighbours home delivery services particularly vulnerable poor access food need assistance meal preparation referred relevant local social support organisations meal delivery nutrition maintained period isolation exposure extreme mental emotional stress established cardiovascular risk factors <NUMBER> <NUMBER> early evidence direct indirect psychological consequences covid<NUMBER> infectious disease associated public policy emerging <NUMBER> current pandemic social distancing requirements associated considerable fear community largely due evolving nature uncertainties particularly risk illness death substantial <NUMBER> anxieties motivate suboptimal behavioural changes shape population cardiovascular health ways may unintended consequences including disengagement health care system treatment nonadherence excess risk covid<NUMBER> patients cvd may exacerbate emotions fear anxiety vulnerability helplessness hopelessness trepidation thoughts mortality experienced many following acute coronary syndrome <NUMBER> perceived actual loss commonly results depression prevalent cvd patients <NUMBER> potential financial uncertainty combined isolation unknown indefinite period especially elderly induce rumination maladaptive thought processes contribute feelings loneliness china life satisfaction declined covid<NUMBER> outbreak period <NUMBER> periods extreme stress including natural disasters economic hardship present vulnerabilities also exacerbate family violence including alcohol drug taking financial stressors <NUMBER> family violence perpetration victimisation maladaptive dysfunctional relationships directly impact ones cardiovascular system likely elevate long term cvd risk <NUMBER> maladaptive behavioural responses neuroticism extreme hypervigilance infectious disease outbreaks may exaggerate induce compulsive behaviour may include obsessive monitoring media social media hand washing compulsive behaviours case reports emerged documenting brief psychotic episodes covid<NUMBER> outbreak <NUMBER> understanding mental health implications pandemic moving postcovid era also critical context cvd management covid<NUMBER> related anxieties unwillingness burden health care system may persist resulting continued health service avoidance disengagement noncompliance selfmanagement regimes could result missed cardiovascular psychiatric medication scripts referrals psychologists specialists allied health professionals promote cvd selfmanagement increasing caregiver burden life events characterised extreme distress grief including relationship breakdown increase risk takotsubo cardiomyopathy <NUMBER> existing cvd also develop covid<NUMBER> recovery need occur parallel ongoing secondary prevention enormous implications psychosocial sequelae rehabilitation patients known cardiac rehabilitation results improved psychosocial outcomes <NUMBER> inclusion psychosocial interventions part routine heart health checks cardiac rehabilitation promotion established mental health services warranted early evidence china suggests establishment external emergency mental health expert teams provision online public education psychological counselling hotline services may helped buffer negative mental health outcomes associated covid<NUMBER> <NUMBER> need expand upon support services postcovid era especially rural remote settings play critical part longerterm cvd management secondary prevention ongoing care patients cvd must continue covid<NUMBER> pandemic core elements include assessment information individualised care ongoing support delivered via variety formats including expansion telehealth options <NUMBER> facetoface health services groupprograms including cardiac rehabilitation closed however many services adapted enable ongoing care australian government expanded telehealth make care accessible affordable potential reduce disparities access care rural regional remote areas <NUMBER> vulnerable populations people disabilities aboriginal torres strait islanders elderly nonenglish speaking backgrounds low socioeconomic groups <NUMBER> benefits include convenience people workforce reducing transport costs improved safety continuous remote monitoring increased patient decisionmaking selfcare increased access care improved medication adherence increased crossprovider communication potential integrated care <NUMBER> recent systematic review found telehealth secondary prevention used instead combination cardiac rehabilitation associated better risk factor control less clinical events <NUMBER> range formats telehealth delivery including use telephone communication internet websites smartphone applications <NUMBER> text messaging developed examples approaches include telephonebased programs used nationally coach program <NUMBER> <NUMBER> directed patients living regional remote areas catch <NUMBER> textme program <NUMBER> consumer apps medication adherence cardiac rehabilitation eg medappchd <NUMBER> cardihab <NUMBER> wearable devices activity trackers smart watches demonstrated potential patients monitor behaviours physical activity heart rate <NUMBER> evaluated regard potential integration clinical practice national heart foundation australia also established programs enable patients receive personalised support hearthealthy lifestyle strategies telephone email <NUMBER> complemented current media campaign highlighting need ongoing attention prevention measures deemed high risk cardiovascular event parallel social media provided important platform range professional societies reinforce need patients cvd continue secondary prevention • important message patients existing cvd must continue receive management support • recommendations applied conjunction contemporary advice commonwealth state public health officials • patients established cvd greatest risk future cardiovascular events setting chest pain recommendations seeking emergency medical attention remain important • efforts made take advantage range telehealth formats ensure many patients possible access health care professionals consideration made best interact patients depending access familiarity different technologies • similar ehealth strategies used continue deliver evidenced based therapies patients secondary prevention • emergency ehealth responses welcomed strong argument retain initiatives practice pandemic • preventive therapies continued patients every effort made monitor risk factor control consideration made regarding potential barriers patients access prescriptions imaging blood tests blood pressure measurement referral cardiac rehabilitation never important avoid undertreatment patients • inclusion psychosocial interventions part routine heart health checks cardiac rehabilitation promotion established mental health services warranted • consensus statements support initiation use ace inhibitors angiotensin receptor blockers cvd patients setting covid<NUMBER> pandemic unless contrary evidence emerges • patients receive influenza vaccine unless specific contraindication use • era integrating new processes routine clinical care important opportunity evaluate efficacy cost effectiveness implications longerterm use beyond pandemic december <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused outbreak pneumonia led pandemic <NUMBER> may <NUMBER> world health organization reported <NUMBER> million cases <NUMBER> <NUMBER> deaths coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> covid<NUMBER> highly transmissible spreads rapidly population many infected develop fever persistent cough progress severe lung injury <NUMBER> <NUMBER> acute respiratory failure may lead severe complications death particularly patients preexisting cardiovascular disease <NUMBER> <NUMBER> covid<NUMBER> pandemic poses potential serious additional risks participants staff engaged clinical trials safety key importance patient perspective potential risks entail additional exposure infection research visits also risks due disruption general clinical care due failure monitor adequately continuation withdrawal research interventions safety patients care paramount also ensure far possible clinical trials still able answer questions designed address <NUMBER> <NUMBER> importance social contract clinical trials investigators participants funders enter social contract decide participate trial participants make largest investment health wellbeing time effort often made period years valued immensely investigators funders provide intelligence expertise curiosity questions trial designs investigators guide patient care investigation trial considering trialspecific general medical issues arise funders provide opportunities resources management expertise different stakeholders social contract also expectations motivations common diverse patients would like better treatment others similar situation future investigators physicians nurses want help patients expand professional knowledge skills help answer important medical questions patients wider society commercial companies specialist knowledge several important areas often exceeds parties may offer substantial resources terms manpower organization equipment expertise finances however return investment needed order reward stakeholders financed research enable company invest future research physicians trial leaders consequently moral ethical duty patients many thousands people currently participating clinical trials provide reliable results responsible safety trial participants must also ensure commitment trial volunteers worthwhile integrity clinical trials reliability results essential current future generations patients remains true heart failure hf trials even covid<NUMBER> crisis covid<NUMBER> epidemic subsided hf still remain major cause morbidity mortality recognizing unprecedented challenges facing clinical trials pandemic many national regional regulatory authorities issued guidance conduct clinical trials face covid<NUMBER> crisis supplementary material online appendix s<NUMBER> efforts important many clinical trials international crossing jurisdictional borders single document provides general internationally relevant guidance modified according local circumstances regulations recognized could help enhance safety trial participants maintain validity trials results overall consensus document may also impact regional guidance accordingly heart failure association european society cardiology <NUMBER> <NUMBER> march <NUMBER> conducted webbased meetings expert clinical trialists europe north america south america australia asia main objectives expert position paper highlight challenges pandemic poses conduct clinical trials hf offer advice might overcome practical examples expert panel acknowledges suitable solutions depend many factors including whether trial recently started nearing completion trial design type timing interventions nature patient population enrolled local regional severity covid<NUMBER> outbreak local governing laws healthcare resources pandemic evolves recommendations patients requiring urgent care avoid hospitals clinics whilst local regulations advise social distancing hf patients generally older higher burden comorbidities make especially highrisk group get coronavirus infection every attempt made reduce risk exposure clinical trials might still able enrol new patients pandemic without increasing patient exposure example recruiting patients acute hf index hospital admission extra trial visits hospitals clinic required discharge rest trialrelated data collection accomplished remotely however circumstances difficult recruit new participants hf trials currently progress many reasons including fact research staff may redirected support clinical services covidrelated research may therefore available enrol patients clinical trials sponsors assess feasibility safety initiating new clinical trials evolution covid<NUMBER> pandemic becomes clearer rate infection control currently trials hf directly address specific issues relevant covid<NUMBER> eg preventing infection consequences infection treat aspects covid<NUMBER> disease progression hf patients use antiinflammatory therapies encouraged timing safe initiate new clinical trials strongly influenced local circumstances rules regulations instance national institute health research uk suspended new clinical trials prioritize covid<NUMBER> research enable redeployment staff clinical duties <NUMBER> guidance ongoing clinical trials various stages recruiting new participants clinical trials interrupted cases least severely curtailed due additional risk infection reduced availability research staff cases screening cease whether advisable contact patients telephone ask trialrelated questions depend ethical permissions obtained anticipated reaction patients patients may reassured contact healthcare professional know however also possible patients may think inappropriate asked trial participation family members might crisis whether medical financial might depend nature research trials protection infection complications covid<NUMBER> might expected patients greeted enthusiasm countries load healthcare system gradually decreasing authorities considering reducing restrictions whilst still maintaining social distancing depending region resilience healthcare system may possible restart patient recruitment even social distancing measures still recommended strategies heavily depend local regulations burden covid<NUMBER> healthcare system particular region require frequent reassessment situation followup visits existing trials possible enrolment new patients also possible however patients may wary agreeing participate clinical trials confident covid<NUMBER> pandemic firmly control patient recruitment international clinical trials reflect confidence sponsors particular country controlled current risk covid<NUMBER> infection also risk resurgence predict covid<NUMBER> pandemic might recur waves next years funders sponsors need confident necessary treatment delivered followup measurements done physically remotely clinical outcomes determined risk infection covid<NUMBER> may influence geographic distribution patient recruitment permanent cessation ongoing clinical trials rarely best course action unless nearing planned completion yet started trials continue follow patients already enrolled provided increase risk even enrolment new participants temporarily halted globally almost twothirds deaths due effects chronic diseases hf <NUMBER> <NUMBER> ethical responsibility biomedical research community towards patients continue seek better therapies conditions shorten life even difficult times termination clinical trial may require patient contact study closeout visits hospital final investigations safetyrelated assessments occasionally downtitrate stop investigational drugs start conventional treatments safely hence ending trial could cases also increase patient contact local hospital research workload short period time circumstances patient safety cannot ensured trial data simply cannot collected trial may need paused stopped altogether eg early course trials require close frequent followup complex investigations require detailed discussions determine optimum strategy followup trials devices already implanted cannot managed remotely may require followup ensure safe effective device performance eg implantable pulse generators regular battery changes may needed neurostimulation devices may require clinically supervised titration lastly decision restart enrolment trial reassessed regular intervals depend epidemiological data pertinent given region site review institutional capacity policies local regulations prerandomization period trials runin phases special considerations trials runin phases views controversial instance runin phase requires optimization guidelinerecommended therapy argued risks additional visits balanced advantages optimizing therapy pandemic however runin period time limited must immediately followed randomization active treatment phase preferable commence runin runin phase cannot lead randomization serves purpose also orderly timely delivery investigational product data collection cannot ensured runin phase cannot continue time hence consideration given moratorium commencing patients runin phase local staff see realistic prospect successful safe trial participation aim runin phase sponsorsclinical academic research organization first harm commitment mandates every effort made minimize risk infection trial patients trial staff converting physical visits virtual visits whenever possible ensure safe documented study drug administration investigational medicinal products imps may mailed patients home address using dedicated couriers risk management plans storage backup transportation modalities considered documented casebycase basis major importance may ill advised patients attend facetoface visits furthermore healthcare facilities may overwhelmed especially research staff reassigned clinical duties quarantined due sarscov<NUMBER> exposure physical visits reduced andor deferred whenever feasible trial procedures endpoints adequately assessed using remote visits symptoms questionnaires eg eq<NUMBER>d require inperson visit table <NUMBER> followup alternative solutions using validated tools apps encouraged <NUMBER> <NUMBER> <NUMBER> heart rate heart rhythm blood pressure may potentially recorded patients carers appropriate equipment training available <NUMBER> participants asked comply standard operating procedures developed trial management team ensure uniform data collection facetoface visits home might necessary blood test device check cannot done remotely intravenous therapy required patients would appreciate see patient statements supplementary material online appendix <NUMBER> however regions inperson visits may possible due local laws regulations data critical addressing primary hypothesis trial prioritized riskbenefit analysis applied primary secondary endpoints balancing safety participants staff impact missing data results interpretation example specialized investigations including blood tests investigation mechanisms action treatment study recording surrogate endpoints ancillary trial aims may need interrupted period time entirely sacrificed improve patient safety primary endpoint clinical event hospitalization death usually documented although accurate ascertainment reporting might delayed inperson visits deemed essential patients contacted via telephone first screen symptoms suggestive viral illness addition visits arranged patient waiting times overlap avoided spreading visits working day nonessential companions discouraged accompanying patients visits trial processes absolutely essential resolving data queries relaxed low value omitted altogether reduce burden research staff moreover healthcare workers could unknowingly vector coronavirus sarscov<NUMBER> testing available performed trial staff improve patient safety however currently possible places local circumstances rules prevail importantly testing patients staff known exposure symptoms covid<NUMBER> prioritized visitor logs contact informationregularly maintainedshould collected enable subsequent contact tracing required personal protective equipment available used patients staff facetoface encounter however personal protective equipment reserved frontline healthcare staff shortages addition careful cleaning surfaces equipment required patient contact number staff trial participants interact minimized delegation logs named individuals approved undertake certain duties specific trials created ensure many team members crosscover case staff absence alternative authorized person case report forms cfrs changed covid<NUMBER> dropdown box missing visits tests drug supply check list screening questions expedite central endpoint committee deliberation may helpful well local regional national rules take precedence must adhered understandable different policies laws exist different regions meaning final decision taken locally determined patients must informed changes trial planned followup speedily possible strongly believe adjudication endpoints future consider covid<NUMBER> infection consequences patient known infected covid<NUMBER> assist interpretation future analysis results eg sensitivity analyses based covid<NUMBER> status many regions limited resourcestest kits covid<NUMBER> diagnosis thus routine testing trial participants may possible however testing may become less costly much widely available regions perhaps rapid point care test <NUMBER> covid<NUMBER> status cannot assessed immediately might possible retain specimens future testing providing permitted suitable safeguards healthcare staff place moreover covid<NUMBER> pneumonitis cause signs symptoms similar hf may also cause acute systolic hf myocarditis careful documentation tests cardiac function eg echocardiography invasive haemodynamic measurements treatments directed hf eg intravenous diuretic inotropic vasodilator agents crf might assist differentiation acute respiratory distress syndrome hf event adjudication committee blinded assigned intervention may later asked assess whether covid<NUMBER> contributed presumed cardiovascular endpoint event based emerging evidence publications graded classification relatedness eg proven likely unlikely may useful future trial analysis could added crf patient hospitalized determination covid<NUMBER> status strongly advocated particularly hospitalization part primary endpoint trial sites encouraged focus collection narratives whenever possible especially valuable patients complex disease information medical chart may lacking many structural personnel expediting reasons example phone interviews patient may uncover useful clinical information documented patients hospital trial notes patients may avoid hospitals coronavirus pandemic hospitals may overwhelmed admit hf patients way would normally clinical decision threshold admitting patient decompensated hf may changed covid<NUMBER> pandemic may impact event rates uncertain period time similarly proportions deaths due cardiovascular noncardiovascular uncertain cause may change due covid<NUMBER> infection true period time covid<NUMBER> crisis assumption hf trial majority undetermined cause deaths probably cardiovascular origin may need reconsidered data monitoring committee independent data monitoring committees dmcs play crucial role conduct cardiovascular trials adjustments work covid<NUMBER> pandemic dmc implemented trials <NUMBER> recruitment completed dmc may asked perform interim analysis assess study question already answered trials already answered primary question futility harm benefit may stopped thus limit unnecessary exposure patients investigators similarly <NUMBER> anticipated events accrued power trial may affected severely thus decision regarding stopping continuing trial end could made also addresses concern results almost complete trial might changed impact epidemic example epidemic struck <NUMBER> paradigmhf trial could stopped well march <NUMBER> without adversely affecting result reducing risk patients staff without exposing trial risk including many deaths due infection terminating trial opposed pausing recruitment possibility future resumptionwhich generally recommendis without risks patients cases discussed hence careful evaluation required making decision case case based interim analysis appropriate statistical methods used eg promising zone approach <NUMBER> cannot applied posthoc generally steering committee blinded study results provide relevant boundaries related decision rules dmc use order make recommendations early stopping trial consequences likely scenarios considered looking unblinded data process important maintaining integrity clinical trial <NUMBER> lastly dmc flexible regarding ability trial organizers provide timely reports may unavoidable delays reporting serious adverse events endpoints due covid<NUMBER>related measures institutional review board irb policies adapted support clinical trials extraordinary circumstances trial protocol modifications expected occur frequently irb policies adjusted avoid need repeated reporting protocol deviations flexibility may considered timing scheduled visits long invalidate results example facetoface visit may safely deferred allowed provided safety concerns eg imp date cannot supplied acceptable condition consideration vary depending trial design study intervention waivers eligibility criteria due difficulty performing evaluations allowed addition definitions protocol deviations may need revisited certain tests cannot performed within expected time frame logistical reasons covid <NUMBER>related protocol modification considered eligible waiver expedited review often needed posttrialcloseout sponsorsacademic research organization sponsors describe appropriate sections clinical study report measures taken manage trial conduct disruption study caused covid<NUMBER>related factors moreover listing patients affected covid<NUMBER>related study disruption mentioned unique participant number identifier investigational site explanation altered participation trial registration sites clinicaltrialsgov consider reporting covid<NUMBER>related changes clinical trials statistical analysis plans reviewed carefully modified necessary reflect changes trial precipitated covid<NUMBER> pandemic statistical approaches may change power calculations may need revised rigorous methods analysis including principles intention treat approach prevail covid<NUMBER> status may may important outcomes seen trial unclear data acquired prolonged delay conduct trial trial temporarily halted statistical analysis plans may need revised determine calculate manage events occur waiting time delays recruitment also alter temporal distribution events hence power calculations may need revision may also useful select date distinguish data collected covid<NUMBER> bc covid<NUMBER> ac date defined per centre first documented covid patient admitted local hospital allow postcovid<NUMBER> sensitivity analyses done ensure part investigators may greatest confidence integrity data date threshold must specified per site per country andor trial overall prior looking trial data may useful describe prepost covid analysis trials running time start covid<NUMBER> crisis several reasons intervention might alter susceptibility consequences infection ii may uncertainty cause events iii benefit intervention may overwhelmed exaggerated impact virus iv delivery intervention population studied may affected finally v general care care specifically hf may affected eg monitoring laboratory values trial participants electronic monitoring ie records hospital may provide attractive alternative form monitoring enrolment patients may consented blanket electronic approval provide important information improve future trials light covid<NUMBER> pandemic countries patient consent requirements cros certain data protection issues abandoned covid<NUMBER>related data clinical purposes <NUMBER> specific examples trials heart failure summary covid<NUMBER> pandemic caused various issues related conduct clinical trials figure <NUMBER> challenging times moral ethical responsibility keep trial participants safe safeguard investment already made ongoing clinical trials provide answers promised clearly patients hf serious risk infected covid<NUMBER> additional risk participation clinical trials avoided minimized balance risk receiving optimal therapy often attained patients participate clinical trials receive expert specialist protocoldriven care provided research team important remember social contract patients trialists funders patients enter trials good faith help improve future healthcare scientific knowledge recommendations make may evolve time epidemiology covid<NUMBER> remains dynamic supplementary material available european heart journal online late december <NUMBER> chinese physician li wenliang warned unusual cases pulmonary infection suspecting new highly contagious coronavirus might involved heard within weeks unthinkable became reality pandemic evolved took path around globe sounded initially like harmless flu suddenly arose black swan many unprepared expected event virologists philanthropists bill gates nassim taleb popularized term <NUMBER> introduced sir karl popper almost century ago <NUMBER> refused call black swan many national healthcare systems well prepared event disinfectant masks lacking enough hospital beds intensive care units icus ventilators scarce things costed many livesfor sure austerity politics pay healthcare killed many indeed many affected countries cardiologists pandemic indeed black swan vast majority never dealt viruses epidemics exception interested myocarditis <NUMBER> turned cardiovascular diseases cvds became major risk factors unfortunate course pulmonary infection major cause death affected patients within weeks cvds came centre stage pandemic outlined viewpoint coronaviruses cardiovascular system acute longterm implications bernard prendergast et al john radcliffe hospital oxford uk <NUMBER> authors remind us much learnt course preceding epidemics including severe acute respiratory syndrome sars middle east respiratory syndrome mers h<NUMBER>n<NUMBER> influenza recognized overall health burden may underestimated since extrapulmonary manifestations frequent acute chronic cardiovascular complications pneumonia common result various mechanisms including relative ischaemia systemic inflammation pathogenmediated damage including myocarditis <NUMBER> <NUMBER> <NUMBER> note influenza vaccination reduces major cardiovascular events patients coronary disease <NUMBER> thus covid<NUMBER> outbreak emphasizes need greater awareness acute longterm cardiovascular implications viral infections significant gaps knowledge future research need address benefit patients second viewpoint entitled sarscov<NUMBER> inhibitors reninangiotensin system withdrawn patients covid<NUMBER> gabriela kuster et al university hospital basel switzerland discuss hypothesis angiotensinconverting enzyme inhibitors aceis could foster cell entry covid<NUMBER> virus turn provide risk factor fatal outcomes due upregulation ace<NUMBER> virus uses dock cell membrane figure <NUMBER> <NUMBER> authors discuss knowns unknowns regarding reninangiotensin system aceis sarscov<NUMBER> interaction provide two interpretations ie <NUMBER> possible negative impact aceis meantime appears unlikelyin spite well established protective effects agents <NUMBER> <NUMBER> reverse causality since patients aceis commonly older comorbidities <NUMBER> <NUMBER> <NUMBER> brief communication entitled cell typespecific expression putative sarscov<NUMBER> receptor ace<NUMBER> human hearts stefanie dimmeler et al johanwolfgang goethe universität frankfurt main germany continue subject <NUMBER> determined tissue levels ace<NUMBER> sarscov<NUMBER> binds via glycosylated outer membrane spike proteins found ace<NUMBER> highly expressed lung heart complementing previous observations increased myocardial infarction <NUMBER> although sarscov<NUMBER> mainly invades alveolar epithelial cells also cause myocardial injury assessed increased troponin ntprobnp levels covid<NUMBER>infected patients outlined issue <NUMBER> current pandemic coronavirus sarscov<NUMBER> predominantly affects elderly individuals especially men cvd often receiving aceis manuscript circulating plasma concentrations ace<NUMBER> men women heart failure effects reninangiotensinaldosteroneinhibitors potential implications coronavirus sarscov<NUMBER>infected patients adriaan voors colleagues university medical center groningen netherlands expand issue heart failure patients <NUMBER> men <NUMBER> women heart failure index cohort validated <NUMBER> men <NUMBER> women strongest predictor elevated plasma levels ace<NUMBER> index validation cohort male sex index cohort use aceis angiotensin receptor blockers arbs mineralocorticoid receptor antagonists independent predictor plasma ace<NUMBER> validation cohort aceis independent predictors lower plasma ace<NUMBER> mineralocorticoid receptor antagonists higher plasma ace<NUMBER> concentrations thus surprisingly patients heart failure plasma concentrations ace<NUMBER> higher men women use neither acei arb associated higher plasma ace<NUMBER> concentrations data might explain higher incidence fatality rate covid<NUMBER> men support previous reports suggesting aceis arbs increase vulnerability covid<NUMBER> increased plasma ace<NUMBER> concentrations provocative findings discussed editorial gavin oudit university alberta edmonton canada marc pfeffer harvard medical school boston massachuttets usa <NUMBER> impact cvd covid<NUMBER> outcomes investigated article clinical characteristics outcomes caucasian patients covid<NUMBER> history cardiac disease northern italy marco metra colleagues università degli studi di brescia italy one centres highest case load mortality <NUMBER> analysed <NUMBER> consecutive patients confirmed covid<NUMBER> history cvd admitted <NUMBER> <NUMBER> march <NUMBER> epidemic reached peak mean age <NUMBER> years <NUMBER> males main cause admission either covid<NUMBER> pneumonia history cvd <NUMBER> acute cardiac condition concomitant covid<NUMBER> <NUMBER> note <NUMBER> presented acute heart failure <NUMBER> acute coronary syndrome acs <NUMBER> pulmonary embolism figure <NUMBER> hospitalization <NUMBER> died <NUMBER> developed thromboembolic events <NUMBER> developed acute respiratory distress syndrome ards <NUMBER> suffered septic shock nonsurvivors tended older higher burden cardiac comorbidities impaired renal function lower blood cells count higher ddimer highsensitivity troponin ntprobnp elevated admission groups trend towards higher levels among nonsurvivors patients died also likely lower po <NUMBER> fio <NUMBER> ratio need highflow oxygen support compared lived thus caucasian patients cvd superimposed covid<NUMBER> extremely poor prognosis findings put context editorial pierpaolo pellicori hull east yorkshire medical research teaching centre kingston upon hull uk <NUMBER> impact viral pneumonia cvd various mechanisms reviewed manuscript entitled deleterious effects viral pneumonia cardiovascular system ling yang colleagues third affiliated hospital soochow university changzhou china <NUMBER> even though viral pneumonia regarded pulmonary disease characterized dyspnoea hypoxaemia cardiovascular events outweigh causes death many viral pandemics pursued three aspects summarize knowledge epidemiological characteristics clinical manifestations viral infections recent pandemics ii explore cardiovascular response infections iii identify coping strategies experienced wuhan epidemic future viral infection pandemics pandemics covid<NUMBER> massively affect health services general efforts focused patients affected furthermore outcome interventions may affected covid<NUMBER> patients physicians charge latter issue addressed current opinon eapci position statement invasive management acute coronary syndromes covid<NUMBER> pandemic prepared andreas baumbach st bartholomews hospital london uk colleagues behalf eapci <NUMBER> note covid<NUMBER> pandemic poses unprecedented threat healthcare worldwide number patients requiring hospital admission intensive care overwhelms many healthcare systems negatively affects standard care leading collateral clinical damage position statement aims assist cardiologists invasive management acs context covid<NUMBER> pandemic modified diagnostic treatment algorithms proposed adapt evidencebased protocols unprecedented challenge various clinical scenarios well management algorithms patients diagnosed suspected covid<NUMBER> infection presenting stsegment nonstsegment elevation acs described well scenarios reorganization acs networks redistribution hub spoke hospitals addition inhospital reorganization emergency rooms cardiac units issue also complemented various discussion forum pieces first entitled decline acute coronary syndrome admissions austria since outbreak covid<NUMBER> pandemic response causes cardiac collateral damage bernhard metzler colleagues university hospital innsbruck austria discuss pandemic based numbers country another contribution entitled fulminant myocarditis caused circulating human coronaviruses ryan dare colleagues university arkansas medical sciences little rock arkansas usa comment recent contribution coronavirus fulminant myocarditis treated glucocorticoid human immunoglobulin yuan fang colleagues sichuan university west china hospital chengdu sichuan china <NUMBER> <NUMBER> fang et al respond contribution separate piece <NUMBER> switching another antihypertensive effective drug using aceisarbs treat arterial hypertension covid<NUMBER> michele mario ciulla university milan italy comment viewpoint article also published issue entitled sarscov<NUMBER> inhibitors reninangiotensin system withdrawn patients covid<NUMBER> kuster et al <NUMBER> <NUMBER> kuster et al respond separate contribution <NUMBER> editors hope issue european heart journal interest readers severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel pathogen rapidly caused devastating pandemic coronavirus disease <NUMBER> covid <NUMBER> june <NUMBER> <NUMBER> sarscov<NUMBER> infected <NUMBER> million people killed <NUMBER> people throughout world <NUMBER> although majority patients develop covid <NUMBER> mild presentations <NUMBER> <NUMBER> patients hospitalized require mechanical ventilation <NUMBER> hospitalized patients die <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigations risk factors intubation mortality covid<NUMBER> hospitalized patients largely focused patient characteristics older age obesity comorbidities well presenting symptoms laboratory parameters <NUMBER> <NUMBER> <NUMBER> <NUMBER> contrast impact sarscov<NUMBER> viral load clinical outcomes hospitalized patients thoroughly investigated two studies hospitalized patients china severe presentations covid<NUMBER> higher viral loads mild presentations impact sarscov<NUMBER> viral load risk intubation death evaluated <NUMBER> <NUMBER> current standardofcare test diagnose covid<NUMBER> collect nasopharyngeal np swab use reverse transcriptionpolymerase chain reaction rtpcr assay detect sarscov<NUMBER> rna <NUMBER> rtpcr assays report clinicians whether sarscov<NUMBER> detected detected however assays also contain quantitative information cycle threshold ct values inversely correlated viral load reported clinically hypothesized assessing sarscov<NUMBER> viral load analyzing ct values initial np swab sample could clinically valuable tool identify patients highest risk intubation death provide insights pathogenesis covid<NUMBER> therefore conducted retrospective analysis sarscov<NUMBER> viral loads admission clinical presentations outcomes two affiliated new york city hospitals using highthroughput rtpcr assay n u c r p <NUMBER> retrospective observational study consisted patients hospitalized newyorkpresbyterian hospitalweill cornell medical center affiliated lower manhattan hospital np swab sample collected analyzed sarscov<NUMBER> cobas <NUMBER> rtpcr system roche molecular systems inc branchburg nj march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> predominant np swab collection transport kits used bd universal viral transport system becton dickinson company franklin lakes nj universal transport medium hardy diagnostics santa maria ca patients np swab sample collected analyzed within one day hospital admission whose sample analyzed different diagnostic platform different institution excluded policy study period perform sarscov<NUMBER> tests patients thought require hospital admission however patients tested subsequently discharged emergency department ed without hospital admission cobas sarscov<NUMBER> rtpcr test received emergency use authorization approval united states food drug administration performed according manufacturers instructions <NUMBER> assay amplifies two different targets within sarscov<NUMBER> genome orf<NUMBER>ab sarscov<NUMBER>specific target e gene pansarbecovirus target present sarscov<NUMBER> sarscov seasonal coronaviruses c c e p e n u c r p <NUMBER> middle east respiratory syndromecov routine clinical care results classified detected either orf<NUMBER>ab e gene detected detected neither target detected however instrument also generates ct value target correlates inversely quantitative viral load released clinicians ct value represents number replication cycles required sufficient gene amplification produce fluorescent signal crosses predefined threshold study reviewed ct values gene targets initial sarscov<NUMBER> tests performed np swab samples collected study subjects routine clinical care within one day hospital admission separated ct values sarscov<NUMBER>specific target orf<NUMBER>ab terciles based upon quantitative values designated high viral load samples lowest ct tercile medium viral load samples middle tercile low viral load samples highest tercile specimens designated positive sarscov<NUMBER> e gene detected designated low viral load samples data retrospectively abstracted manually electronic medical record using qualitycontrolled protocol entered redcap database <NUMBER> data collectors trained random resampling data previously showed high interrater reliability mean cohens kappa <NUMBER> <NUMBER> data included demographics comorbidities social characteristics selected outpatient medications admission presenting symptoms arrival hospital oxygen supplementation required within three hours presentation laboratory parameters chest radiograph findings concurrent bloodstream infections inhospital complications inhospital mortality clinical data hospital discharge consistently available thus c c e p e n u c r p <NUMBER> outcomes occurred hospital admission analyzed study approved institutional review board <NUMBER> weill cornell medicine waiver informed consent compared baseline characteristics outcomes hospitalized patients covid<NUMBER> high medium low initial viral loads using nonparametric nptrend command stata statacorp college station tx tests trend across ordered groups continuous variables represented medians interquartile ranges iqr categorical variables represented proportions twosided p value ≤<NUMBER> used designate statistical significance risk inhospital intubation death also compared across eight different numerical ct value ranges also constructed cox proportional hazard models compare cumulative risks intubation death inpatient admission among patients high medium low viral loads identified baseline factors associated inhospital mortality intubation using univariate logistic regression models variables statistically significantly associated outcome entered separate multivariate logistic regression models adjusted odds ratios mortality intubation calculated variables <NUMBER> confidence intervals ci analyses conducted using stata version <NUMBER> n u c r p <NUMBER> total <NUMBER> np swab samples available analysis unique hospitalized patients met study inclusion criteria figure <NUMBER> ct values orf<NUMBER>ab locus ranged median age patients high medium low viral loads <NUMBER> <NUMBER> <NUMBER> years respectively p<NUMBER> table <NUMBER> addition older age patients higher viral loads likely coronary artery disease congestive heart failure cerebrovascular disease hypertension chronic obstructive pulmonary disease copd chronic kidney disease active cancer also likely former current smoker received recent chemotherapy patients high viral loads median <NUMBER> days symptom onset hospital admission compared <NUMBER> <NUMBER> days patients medium low viral loads respectively p<NUMBER> patients higher viral loads also likely c c e p e n u c r p <NUMBER> require oxygen nonrebreather highflow nasal cannula mechanical ventilation within three hours presentation ed less likely present fever nausea vomiting lymphopenia anemia thrombocytopenia common among patients higher viral loads whereas alanine aminotransferase elevations less common differences chest xray findings among patients high medium low viral loads also differences viral loads among different racial ethnic categories patients use angiotensinconverting enzyme inhibitors aceis angiotensin ii receptor blockers arbs hydroxychloroquine last day study followup june <NUMBER> <NUMBER> day <NUMBER> patients died admission <NUMBER> discharged alive <NUMBER> transferred another hospital <NUMBER> still hospitalized risk intubation death increased higher viral loads inhospital mortality <NUMBER> patients high viral load compared <NUMBER> patients medium viral load <NUMBER> patients low viral load p<NUMBER> table <NUMBER> risk intubation <NUMBER> patients high viral load compared <NUMBER> <NUMBER> patients medium low viral load respectively p<NUMBER> table <NUMBER> associations also observed timebased analyses figure <NUMBER> compared low viral load high viral load associated hazard ratio hr multivariate model adjusted age race coronary artery disease congestive heart failure cerebrovascular disease hypertension copd days symptoms prior admission symptoms upon presentation initial chest xray findings level oxygen support within three hours arrival ed table <NUMBER> high viral load independently associated increased risk inhospital mortality adjusted odds ratio aor <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> compared low viral load risk inhospital mortality also higher patients medium viral load compared low viral load association statistically significant aor <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> compared low viral load high viral load also independently associated increased risk intubation aor <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> whereas risk intubation associated medium viral load reach statistical significance aor <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> patients higher viral loads also likely develop myocardial infarction congestive heart failure acute kidney injury requiring hemodialysis table <NUMBER> study demonstrated patients admitted hospital high sarscov<NUMBER> viral loads assessed ct values np swab samples likely intubated die hospitalization association persisted even adjusting age comorbidities presenting symptoms chest radiography findings degree presenting hypoxia prior studies indicated viral load correlates severity covid<NUMBER> presentation <NUMBER> <NUMBER> study larger cohort hospitalized patients adds knowledge c c e p e n u c r p <NUMBER> base identifying admission viral load important prognostic implications reporting sarscov<NUMBER> viral load based ct values admission np swab samples could therefore help identify patients highest risk adverse outcomes therefore may benefit intensive monitoring identifying high viral load patients could also helpful allocating scare therapeutic interventions antiviral agents eg remdesivir <NUMBER> findings also suggest stratification adjustment baseline viral load would benefit design clinical trials antiviral agents covid<NUMBER> also possible viral load could used along factors age comorbidities severity symptoms hypoxia decide upon need hospital admission however additional studies evaluate viral loads clinical outcomes among patients present ed warranted prior pursuing strategy clinically older age presence comorbidities hypertension coronary artery disease congestive heart failure copd cancer known associated worse outcomes covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients may decreased cardiopulmonary reserve thus less likely tolerate physiologic insults caused covid<NUMBER> findings suggest patients also higher sarscov<NUMBER> viral loads present hospital may contribute worse outcomes observed patients reasons higher viral loads specifically populations well understood warrant investigation given sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> receptor ace<NUMBER> entry host cells <NUMBER> concerns use aceis arbs may upregulate ace<NUMBER> expression lead increased viral proliferation host cells <NUMBER> although patients hypertension congestive heart failure likely higher viral loads use aceis arbs associated higher viral load findings consistent observational studies demonstrated worse outcomes c c e p e n u c r p <NUMBER> patients use aceis arbs <NUMBER> <NUMBER> <NUMBER> support recommendations professional societies discontinuing medications setting covid<NUMBER> <NUMBER> another notable finding study differences admission sarscov<NUMBER> viral loads outcomes among different racial ethnic groups us hispanic black communities disproportionately affected covid<NUMBER> greater proportion deaths among patients would expected based population proportions <NUMBER> <NUMBER> <NUMBER> finding admission viral loads different among race ethnicity groups suggests disparities related viral load instead may related comorbid illnesses nonbiological factors social determinants health underscores importance studies examine impact social determinants health outcomes covid<NUMBER> pandemic also found patients higher viral loads likely develop myocardial infarction congestive heart failure acute kidney injury unclear whether associations chance related increased hypoxia heart kidney tissue related increased viral infection organs recent autopsy study demonstrated sarscov<NUMBER> frequently directly infects heart kidney <NUMBER> kidney injury myocardial injury commonly reported complications severe covid<NUMBER> <NUMBER> <NUMBER> additional studies warranted assess relationship viral loads np swab samples disease burden heart kidney clinical outcomes ct values cobas <NUMBER> assay used study <NUMBER> <NUMBER> thus suspect findings may also applicable diagnostic platforms encourage others evaluate relationship clinical outcomes ct values using diagnostic platforms patient populations another potential role reporting sarscov<NUMBER> viral loads ct values guide use isolation precautions given viral load correlates infectivity <NUMBER> <NUMBER> <NUMBER> study assess potential use ct values believe important area future investigation another limitation study retrospective relied data documented electronic medical record thus could misclassified patient characteristics outcomes however data abstraction process utilized standardized protocol queries identified high interrater reliability data collection lastly focused inhospital mortality capture deaths occurred discharge hospital conclusion found admission sarscov<NUMBER> viral loads determined ct values generated standardofcare diagnostic assays independently associated intubation death among hospitalized patients covid<NUMBER> c c e p e n u c r p <NUMBER> <NUMBER> p values calculated using nonparametric nptrend command stata version <NUMBER> tests trend across ordered groups <NUMBER> variable assessed participants denominator listed next variable <NUMBER> ast elevation indicates value <NUMBER> unitsl <NUMBER> alt elevation indicates value <NUMBER> unitsl c c e p e n u c r p <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> leading current coronavirus disease pandemic putting high pressure healthcare systems several countries hemispheres start progression pandemic varies regions countries countries outside china currently making phased tightlyregulated attempts ease previously imposed social restrictions however many experts argue disease may part public life many months come requiring longterm plan cope varying influx patients protection healthcare workers awaiting development effective pharmacological treatment <NUMBER> <NUMBER> therefore radiology departments need remain vigilant cope pandemic near future known covid<NUMBER> highly infectious disease submitted small droplets prodromal phase varying intensity length preceding onset potential severe symptoms majority patients resulting large cohort nonor mildly symptomatic infected people accelerates spreading disease complicates triage infected noninfected patients covid<NUMBER> predominately characterised wide range respiratory symptoms neurological gastrointestinal cardiovascular symptoms described well various stages disease <NUMBER> <NUMBER> <NUMBER> given established fundamental diagnostic role cardiovascular imaging modern healthcare specific value cardiopulmonary radiology covid<NUMBER> patients departmental organisation imaging programs need restructured pandemic order provide access modern cardiovascular services ensuring safety healthcare professionals patients uninterrupted availability cardiovascular radiology services remains crucial particularly current pandemic outbreak establish correct diagnosis avoid unnecessary complications different patient populations suspected established covid<NUMBER> patients may concomitant cardiovascular symptoms require imaging investigations noninfected patients preexisting acute cardiac events still must granted access cardiac imaging order underdiagnose delay treatment relevant cardiovascular disease therefore potential noninfected patients cardiovascular symptoms still encouraged present hospital pandemic despite current social restrictions pathway clinical evaluation imaging examinations provided finally current imaging protocols tailored specific situation provide fast comprehensive approach detect cardiothoracic involvement covid <NUMBER> paper represents knowledge experiencedbased expert opinion ensure continuous availability cardiac imaging current covid<NUMBER> pandemic may tailored local resources workflow hygiene guidelines characteristics national regional healthcare systems outbreak protecting patients healthcare professionals levels must main goal providing highquality imaging services pandemic reports italy outbreak indicate around <NUMBER> subjects tested positive corona virus healthcare professionals death toll around <NUMBER> medical doctors end april <NUMBER> <NUMBER> therefore restructuring departmental workflow ensure optimal save pathways imaging modalities tremendous importance patients healthcare professionals radiology departments different imaging modality rooms designed used viral pandemic outbreak nevertheless deliver important contribution covid<NUMBER> disease diagnosis management must subsequently adapt keep functioning current unusual conditions intense pressure <NUMBER> possible suspected confirmed covid<NUMBER> patients imaged dedicated covid<NUMBER> xray ct mr equipment radiology department order prevent crosscontamination infected noninfected patient populations hospitals even resorted expedited new installation dedicated ct scanners exclusive purpose investigating potential covid<NUMBER> patients <NUMBER> possible eg due limited number available primary scanners scanner types eg spectct scanners conebeam function angiography suites could used covid<NUMBER> patient scanners general purpose use objective would either divert potentially infected patients specific scanner previously mentioned increase capacity ctscanners better suited cardiovascular applications depending local situation notably scan protocols nonroutine ctscanners eg spectct scanners must adapted provide sufficient diagnostic quality close cooperation coordination industrial partners might helpful finally dedicated ctscanner infected patients available least dedicated covid<NUMBER> time slots available equipment must defined preferable end day timeslots also made available investigation potential covid<NUMBER> patients require highquality cardiovascular ctimaging may available dedicated covidscanner access routes scanners must highlighted transport services clinicians also clearly indicated nonradiology staff routes well corresponding waiting areas must separated normal patient pathways sarscov<NUMBER> virus reported survive variable amount time several types surfaces environmental conditions <NUMBER> <NUMBER> cleaning imaging facility every suspected positive patient scanning negative patient mandatory must performed according local guidelines conversely cleaning scanning two even established sarscov<NUMBER> positive patients necessary unless bacterial superinfection known local guidelines may differ currently universally accepted guidelines clean radiology imaging equipment sarscov<NUMBER> although centres published experience proposing different methods solutions disinfecting several components ct mr examination rooms <NUMBER> lists disinfectants effective sarscov<NUMBER> published https wwwepagovpesti cideregis trati onlistndisin fecta ntsuseagain stsarscov<NUMBER> solution <NUMBER> ethanol <NUMBER> hydrogen peroxide <NUMBER> sodium hypochlorite within <NUMBER> min possible contamination also suggested <NUMBER> additionally several manufacturers published equipmentspecific guidelines disinfection imaging equipment table <NUMBER> downtime disinfection patients varies according local available resources also targeted imaging equipment immediate availability cleaning teams scanners mixed populations sarscov<NUMBER> positive negative patients advised achieve maximum safety productivity possible scanner facilities ventilated low pressure compared surrounding rooms similar concept septic surgical areas ensure potential contaminated aerosols cleared via climate controls contaminate scanner control rooms corridor healthcare professionals represent prototype possible super spreader due multiple contacts colleagues patients consequently protection healthcare professionals radiological department radiographers nurses radiologists medical staff potential infection subsequent transmission patients colleagues must ensured order maintain continuous medical service patients need involves multiple organisational entities beyond imaging department especially hygiene allied disciplines transport services furthermore standardized hospitalwide communication protocol must implemented requesting imaging services established potentially infected patients order avoid misunderstandings maintain separated indepartment pathways patient populations preventing staff patient nosocomial infections departments eg established dedicated phone number radiology department request examinations special digitalonly pathway transfer forms covid<NUMBER> wards personal protective equipment ppe maintaining safe patient service onsite highest importance however global market products currently pressure therefore local health care authorities professional bodies encouraged help assist buying process ppe ppe must include high number various types masks ranging simple surgical masks general staff highly protective ffp<NUMBER> masks technicians doctors direct contact covid<NUMBER> patients protective gowns eyeglasses eye shields also need provided table <NUMBER> provide overview kind ppe used imaging procedures avoid wastage precious products levels healthcare professionals involved imaging procedures must repeatedly taught correct use <NUMBER> finally many hospitals make wearing protective masks mandatory hospital personnel incoming visitors imaging staff must trained correct use ppe measures infection control mistakes dressing especially undressing main source contamination staff surrounding area furthermore instructions basic hygiene like handwashing implemented local hygiene protocols must strictly implemented clinical workflow appropriate training <NUMBER> pandemic outpatient throughput decreased cancellation many elective investigations order avoid crosscontamination inand outpatients refocus inhouse resources possible work schedules imaging professionals reorganized teams working completely separated teams radiographers radiologists changed simultaneously possible measure high importance decrease potential impact quarantine measures department cohort member staff might infected nonessential meetings must cancelled andor shifted virtual online meetings absolutely necessary meetings reduced minimum participants held ensuring adequate distance <NUMBER> sufficiently large meeting room reconfigurations radiology department applied association protection education well training personnel reports indicate radiology staff effectively protected sarscov<NUMBER> infections <NUMBER> reverse transcription polymerase chain reaction rtpcr testing nasopharyngeal mucosal swab currently reference standard proving active sarscov<NUMBER> infection also used mild even asymptomatic patients rtpcr high specificity making positive test pragmatically diagnostic reported sensitivity varies <NUMBER> <NUMBER> leading potential <NUMBER> falsenegative results also due factors given multiple patient contacts sometimes difficult conditions healthcare imaging professionals especially risk infection might also transfer infection vulnerable patients colleagues avoid pathway spreading potential catastrophic impact patients hospital departments high vigilance potential infections staff members necessary rtpcr testing policies vary hospitals regions countries depending several factors many hospitals rtpcr test indicated asymptomatic staff members consequently routine swab testing asymptomatic hospital personnel screening purposes performed given indicated lower sensitivity rtpcr test negative result necessarily equate free infection possible strategies followup healthcare professionals contact infected patients inor outside hospital include selfscreening fever twice day vigilance respiratory symptoms healthcare worker shows clinical sign infection must removed staff pool investigation antibody testsalso known serological teststhat detect immune response existing infection yet reliable enough widely available currently developed prepared mass deployment potential play role complex situation results tests help identify infected developed antibodies may protect future infections well identify still risk nevertheless many questions regarding individual immune response sarscov<NUMBER> infection remain unresolved current knowledge weak recommend specific guidelines regarding timing use interpretation antibody tests social distancing home working solutions proven efficient barriers viral spread therefore teleradiology possible implemented ensure safety imaging staff remote reporting within hospital also beneficial working smaller cohorts people home backup inhouse staff care must taken terms data protection technical setup outsourced teams several investigators reported involvement cardiovascular system covid<NUMBER> patients however particular moment time lack large multicentre studies fundamental research establish exact mechanism disease effect covid<NUMBER> disease cardiovascular system nevertheless several reports point exacerbated inflammatory response myocardial injury heart failure increased risk presence preexisting disease presence preexisting cardiovascular disease covid<NUMBER> patients significantly increases reported death rate <NUMBER> compared preexisting conditions like diabetes cancer <NUMBER> important covid<NUMBER> patients preexisting cardiac disease form large proportion symptomatic patient population also exacerbation preexisting cardiovascular diseases secondary cardiac involvement case systemic spreading infection may compromise prognosis <NUMBER> <NUMBER> <NUMBER> recent singlecentre analysis almost <NUMBER> hospitalised covid<NUMBER> patients cardiac injury ie elevation troponin levels associated increased complication rate need mechanical ventilation compared covid<NUMBER> patients without cardiac involvement <NUMBER> myocardial injury recently significantly associated fatal outcomes covid<NUMBER> patients several series <NUMBER> <NUMBER> patients covid<NUMBER> pneumonia age ≥ <NUMBER> years preexisting cardiovascular disease cerebrovascular disease especially presence cd<NUMBER> cd<NUMBER> cells ≤ <NUMBER> cell µl −<NUMBER> elevated cardiac troponin ≥ <NUMBER> ng ml −<NUMBER> identified important predictors mortality <NUMBER> publications report increased troponin levels association ecg abnormalities indicating cardiac injury covid<NUMBER> patients metaanalysis based <NUMBER> studies total <NUMBER> patients demonstrated significant difference cardiac troponin levels subjects severe nonsevere covid<NUMBER> disease <NUMBER> main cause high troponin levels myocardial injury could represented acute myocarditis varying severity cases occurrence myocarditis covid<NUMBER> reported rarely associated cardiac dysfunction recent autopsy study revealed significant viral rna heart among organs exceeding levels viremia <NUMBER> data suggests sarscov<NUMBER> spreads bloodstream infect organs additionally myocarditis associated past coronavirus diseases mers <NUMBER> <NUMBER> case series <NUMBER> patients <NUMBER> deaths reported related acute heart failure consequent myocarditis <NUMBER> nevertheless exact relation presence sarscov<NUMBER> virus pathogenesis myocardial damage fully understood investigation necessary increased troponin levels could also related acute type ii myocardial infarction mismatch oxygen supply demand without unstable coronary artery disease plaque rupture caused severe inflammation type myocardial infarction relation inflammation cardiovascular events previously reported influenza coronavirus infections <NUMBER> heart failure reported <NUMBER> covid<NUMBER> patients one study <NUMBER> case fatality rate among preexisting comorbidity related cardiovascular disease <NUMBER> china <NUMBER> date remains unclear fatality caused acute myocardial injury exacerbation preexisting cardiac disease cardiogenic pulmonary oedema relatively common situation differential diagnosis ards always easy even using imaging berlin criteria <NUMBER> nevertheless cardiogenic component acute failure important establishing ecmo procedure abnormal coagulation parameters reported particularly increased ddimer associated worse prognosis <NUMBER> disseminated intravascular coagulation vascular inflammation prolonged immobilization may contribute overall increased thromboembolic risk particularly patients rapid clinical worsening hypoxia pulmonary embolism considered ct pulmonary angiography may performed investigation <NUMBER> noninvasive ct mr cardiac imaging indications pandemic balanced continuously maintaining best possible care ability perform procedures safely correctly appropriate time good interdisciplinary communication essential inhouse conditions possibilities invariably differ different centres categorising assignments vital emergency situations urgent indications elective indications considered using interdisciplinary approach elective patients nonurgent indications postponed later time point clinically possible furthermore choice modality relevant healthcare professionals patient safety one must consider echocardiography especially transoesophageal echocardiography highrisk procedure like intubation cannot performed keeping distance least one meter patients andor requested bedside test icu ct mr hand also need patient preparation cannulation require patient contact radiographers nurses <NUMBER> transportation contamination mr ct scanners also considered source potential infection finally length examination also must optimised also associated potential virus contamination scanner systems well reduced patient tolerance sicker find supine imaging difficult maintain atrial fibrillation arrhythmic events may occur course disease due fever hemodynamic stress volume overload prevent renal failure ruling left atrial appendage thrombus transesophageal echocardiography prior cardioversion setting appears high risk performing physician need intubation probe patient additionally procedure stressful patient may also suffer shortness breath due underlying disease therefore ccta including late phase may considered noninvasive procedure patients <NUMBER> holds true evaluation valve endocarditis ccta also considered alternative transoesophageal echocardiography carefully read close correlation clinical circumstances <NUMBER> previously explained patients covid<NUMBER> develop raised troponin levels especially advanced stage disease yet unclear mechanism myocardial damage minor thromboembolic events associated hypercoagulable state <NUMBER> therefore case preexisting unknown suspected cardiac disease exclusion coronary artery disease cad ccta helpful avoid cardiac catheterization latter procedure current conditions challenging usual crisis might moment expand utilization ccta detect cad clinical reality suggested current esc guidelines consider ccta class level indication patients chronic coronary syndromes irrespective age <NUMBER> additionally coronary cta considered covid<NUMBER> patients presenting acute chest pain raised troponins without stelevation ecg rule cad addressing possible myocarditispericarditis takotsubo disease avoid unnecessary invasive coronary angiography risk operator furthermore ruling pulmonary embolism provided covid<NUMBER> patients increased risk venous thromboembolism common presentation elevated ddimers hypoxia dyspnea <NUMBER> clinical cardiac symptoms remain unclear triple ruleout protocolseven often provide perfect diagnostic statements diagnostic relevant targetsfor evaluation pulmonary circulation coronary arteries might also considered <NUMBER> assessment aortic stenosis need surgical nonsurgical aortic valve replacement tavr ccta might used alternative preinterventional angiography emergency urgent situation used device selection assessment valve composition <NUMBER> <NUMBER> <NUMBER> ccta general also provides insights lung structure pathologies covid<NUMBER> patients especially relevant patients moderate severe respiratory symptoms screen complications include lung fields <NUMBER> therefore depending local equipment may considered add additional lowdose scan whole lung ct imaging heart <NUMBER> nongated lowdose ct preferably iv contrast medium also helpful detect cardiac abnormalities eg right ventricularor left ventricular dilatation intracardiac thrombi furthermore every heavily diseased patient covid<NUMBER> patients could affected sideeffects medication usually administered cardiacct eg betablockers want underline possibility interdisciplinary discussion referring physician prevent adverse events due sideeffects reports increasing cmr detect covid<NUMBER> associated myocarditis hypercoagulable state also reported associated disease potential differential diagnosis myocarditis could myocardial infarction nonobstructive coronary arteries minoca furthermore literature reported cases stressinduced cardiomyopathy takotsubo syndrome coexistence covid<NUMBER> <NUMBER> independent sarscov<NUMBER> pandemic differentiating minoca myocarditis causes acute myocardial injury possible using cmr therefore impacts patient management secondary prevention <NUMBER> additionally cmr potential incidentally detect extracardiac findings eg lung involvement pleural effusion may clinically relevant however direct diagnostic prognostic implications cmr imaging specific sars cov−<NUMBER> pandemic actually known therefore usefulness cmr might limited diagnosis differentiation myocarditis takotsubo syndrome minoca additionally cmr timeconsuming ct therefore poses potential higher risk patients staff eg viral transmission overcome obstacle statement would propose fast focused cmr protocol comprehensive assessment cardiac involvement covid<NUMBER> protocol incorporates cine sequences functional assessment oedema imaging detection acute myocardial injury t<NUMBER> mapping well late gadolinium enhancement lge imaging differentiation ischemic nonischemic causes myocardial injury protocol accompanied fast one breathhold sequences assessment thoracic complications efforts reduce acquisition time eg use accelerated imaging compressed sensing reduction time delay lge imaging used proposed imaging protocol summarized table <NUMBER> indications cardiac imaging summarized table <NUMBER> outpatients covid<NUMBER> related impact hospital departmental organisation varies regions countries types hospitals hospitals heavily affected regions accommodating large proportion covid<NUMBER> patients making potentially less able handle outpatients nevertheless aim always continuously provide safe cardiovascular ctand mr imaging services close collaboration referring clinician pandemic cardiac imaging procedures planned elective setting evaluated carefully planning adjusted inhouse healthcare guidelines imaging capacity clinical urgency valid ccta well cmr indications cardiac imaging pandemic must immediate impact patient management imaging procedure interrupts social distancing potentially put sarscov<NUMBER> negative patient risk infection ct mr imaging procedures confirmed covid<NUMBER> negative inpatients may performed inhouse period order delay diagnosis prevent patient undertreatment medical condition however depending pandemicimposed burden local hospital evolution time proper interdisciplinary communication necessary ensure examinations performed adequate moment patient staff order ensure overall safety availability properly disinfected equipment hospitals may ability continue delivering ctmr imaging services others therefore indications ccta include kind preoperative ccta scans including tavr coronary artery bypass adult congenital heart disease cardiac transplant ruleout coronary heart disease well pulmonary lge imaging <NUMBER> min post contrast administration adjust contrast media protocol thoracic t<NUMBER> one breathhold sequences lung pathology restoring cardiac imaging program prepandemic levels activity challenging long established vaccination sarscov<NUMBER> safety healthcare professionals patients must warranted time higher patient turnover mandatory many examinations initially rescheduled first step patients subacute indications imaging ccta cmr rescheduled scanned done close accordance referring physicians eg preoperative examinations preoperative scans may scheduled close operations uptodate covid<NUMBER> testing available number patients seems manageable program might reopened routine outpatients preferably patients contacted advance order recent information wellbeing patients suspected covid<NUMBER> symptoms either tested prior imaging rescheduled use ppe phase may strongly recommended patients radiographers nurses radiologists guidelines may vary depending local situation patients wearing surgical mask whereas radiographers nurses contact patients maintain necessary precautions cmr ppe free ferromagnetic conducting materials terms mr safety nevertheless questions remain regarding availability distribution ppe material hospital staff general population many regions cardiac imaging especially cmr might important role pandemic myocardial involvement changes myocardial structure scar induction consecutive left ventricular dilatation might impact patients prognosis surviving covid<NUMBER> episode additionally currently clear impact covid<NUMBER> leave lung structure might influence right ventricular function size induction pulmonary hypertension early evaluation patient cohort cmr ct might scientific interest might also immediate impact patient therapy cardiac imaging initial phase covid<NUMBER> pandemic challenging patient healthcare professionals safety must highest priority therefore ppe resources must provided training teaching use ppe hygiene procedure adherence actual cdc guidelines working separated teams possible use telemedicine essential importance avoid virus spreading health care professionals cardiac imaging services help avoid least cut number risky invasive time consuming procedures like cardiac catheterization transoesophageal echocardiography therefore ccta might favoured ruling coronary heart disease left atrial appendage thrombus offered covid<NUMBER> positive patients needed cmr may deliver insights myocardial involvement sarscov <NUMBER> patients discriminate types myocardial damage due associated hypercoagulable state ruling pulmonary embolism ct must also offered clinicians based local capacities possibilities ensure safe imaging non sarscov<NUMBER> infected patients undergo cardiac imaging indicated prevent undertreatment cardiac conditions setting cardiac imaging program first critical phase pandemic tailored need allied disciplines focused safety patients healthcare professionals made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreat iveco mmons orglicen sesby<NUMBER> china late <NUMBER> quickly become pandemic significantly impacting health economy united states rest world<NUMBER> several hundred thousands cases thousands deaths related covid<NUMBER> disease caused sarscov<NUMBER> worldwide estimated mortality rate ranging <NUMBER> <NUMBER> united states impacted pandemic significantly hundreds deaths reported numbers continue worsen<NUMBER> healthcare crisis imposed unprecedented strain society challenged ability health care organizations provide adequate care electrophysiologists play important role cardiovascular health <NUMBER> cardiology encounters arrhythmiarelated recent report wuhan china <NUMBER> bronchoscopy open tracheal suctioning intubation extubation noninvasive positive pressure ventilation endoscopy transesophageal echocardiography <NUMBER> prevalence covid<NUMBER> increases exponentially patients presenting seemingly nonrelated medical problems may expose health care providers increased risk contracting disease properly protected exposure puts electrophysiology ep staff physicians clinical personnel increased risk contracting covid<NUMBER> reducing contact health care personnel covid<NUMBER> patients integral step limiting spread resource utilization including use personal protective equipment ppe hospital number individuals rounding minimized social distancing practiced patients suspected confirmed covid<NUMBER> infection time personnel spent room also limited many ep consults may completed without facetoface visit reviewing chart monitoring data nonurgent nonemergent procedures postponed later date clinic visits person cardiac implantable electronic device cied checks converted telehealth remote checks whenever feasible minimizing fellow trainee contact patients may include rotation days involved direct patient service managing remote checks conducting patient telehealth visits attempts similarly made limit exposure ep allied professionals including nurses device clinic personnel hospital administrators medical device company representatives additional steps may need taken minimize exposure higher risk individuals eg age <NUMBER> years pregnant immunocompromised comorbid conditions exhibit wide range clinical manifestations ranging asymptomatic state severe disease hypoxia acute respiratory distress syndrome ards type lung injury <NUMBER> <NUMBER> setting hypoxemic respiratory failure ground glass opacification chest imaging found <NUMBER> majority patients experience mild symptoms including fever cough headache anorexia diarrhea andor malaise difficult distinguish covid<NUMBER> common cold covid<NUMBER> potential cause myocardial injury least <NUMBER> found elevated troponin <NUMBER> noted heart failure study <NUMBER> inpatients wuhan china<NUMBER> cases fulminant myocarditis cardiogenic shock also reported associated atrial ventricular arrhythmias <NUMBER> <NUMBER> given hypoxia electrolyte abnormalities common acute phase severe illness potentiate cardiac arrhythmias exact arrhythmic risk related covid<NUMBER> patients less severe illness recover acute phase severe illness currently unknown improved understanding critical primarily guiding need additional arrhythmia monitoring eg mobile cardiac telemetry post discharge whether implantable cardioverter defibrillator icd wearable cardioverter defibrillator needed impaired left ventricular function thought secondary covid<NUMBER> patients suspected covid<NUMBER> infection recommended ppe donned clinicians health care providers includes face mask protective eyewear gown gloves initial ppe recommendations patients included use fitted n<NUMBER> powered air purifying respirator papr masks protective eyewear gloves gowns however due shortage n<NUMBER> masks increased understanding droplet airborne transmissibility routine care suspected positive covid<NUMBER> patients substitution surgical mask face shield combination protective eyewear routine nonprocedural care recommended centers disease recommendations related ppe may continue change based supply chain contingency andor crisis capacity status consultation hospital infection control team strongly recommended appropriate donning doffing procedures followed outlined cdc see useful links also important know report potential covid<NUMBER> cases exposure public health authorities local hospital covid<NUMBER> hotlines useful regard urgent semiurgent clinical indications evaluated inperson individualized basis select patients worsening heart failure arrhythmia symptoms need device reprogramming may warrant office evaluation include limited af patients worsening heart failure icd patients recent shocks syncope cied patients recent symptoms suggesting possible device malfunction eg syncope heart failure exacerbation suspected device infection limited physical examination may well appropriate based clinical presentation possible inperson visits procedures coordinated day minimize multiple exposures patient patients coming outpatient visits measures taken screen patients concerning symptoms eg fever cough present clinic suggestive symptoms fever present patients redirected appropriate screening clinic facility appropriate measures taken figure <NUMBER> order minimize exposure ep staff device manufacturer representatives patients suspected confirmed covid<NUMBER> infection prudent perform inperson cied interrogations follows importantly device interrogation programmers cables wands disinfected patients first case pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sars‐cov‐<NUMBER> reported wuhan hubei province china december <NUMBER> <NUMBER> march coronavirus disease <NUMBER> covid‐<NUMBER> caused virus spread around world sars‐cov‐<NUMBER> human coronavirus belong group benign coronaviruses cause common cold smaller group coronaviruses cause acute respiratory distress syndrome severe acute respiratory syndrome coronavirus—sars middle east respiratory syndrome coronavirus—mers <NUMBER> <NUMBER> recently published studies showed arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease prevalent among patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigations outcome patients scarce data limited nevertheless hypertension considered one important risk factors covid‐<NUMBER> relationship hypertension adverse outcome still questionable aim review paper summarize current knowledge relationship hypertension covid‐<NUMBER> role hypertension outcome patients comprehensive search performed pubmed scopus web science google scholar find review papers topic published may <NUMBER> <NUMBER> sars‐cov‐<NUMBER> infection triggered s‐protein virus binds angiotensin‐converting enzyme <NUMBER> ace<NUMBER> highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways <NUMBER> sars‐cov‐<NUMBER> binds ace<NUMBER> much higher affinity compared sars‐cov <NUMBER> additionally sars‐cov‐<NUMBER> shows pathogenic activity attacking type ii alveolar epithelial cells expressing ace<NUMBER> previous studies coronavirus causes sars demonstrated virus binds ace<NUMBER> pulmonary alveoli superficial spike proteins causes lung damage even lung function failure <NUMBER> loss ace<NUMBER> caused binding sars‐cov‐<NUMBER> may shift system overall higher angiotensin ii lower angiotensin‐<NUMBER>‐<NUMBER> tone role angiotensin ii covid‐<NUMBER> hypertensive patients seems crucial due role functioning renin‐angiotensin‐aldosterone system raas promotes vasoconstriction sodium retention oxidative stress inflammation fibrosis increases bioactive peptide angiotensin‐<NUMBER>‐<NUMBER> <NUMBER> epidemiological data coming china indicate arterial hypertension cardiovascular diseases diabetes chronic obstructive pulmonary disease prevalent concomitant diseases patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> number investigations provided least short follow‐up intrahospital outcome limited even though data demonstrated prevalence hypertension covid‐<NUMBER> patients lethal outcome high <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> still debated whether hypertension predictor mortality independently cardiovascular risk factors age obesity diabetes comorbidities coronary artery disease heart failure atrial fibrillation cerebrovascular disease renal impairment prevalence hypertension among patients covid‐<NUMBER> different studies ranged <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several reasons variations average age significantly higher patients elevated prevalence hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> might important reason different prevalence hypertensive patients among studies advanced age associated higher prevalence comorbidities diabetes renal impairment arterial hypertension obesity altogether increased proportion hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence overweight obesity reported available studies covid‐<NUMBER> “circulus vitiosus” hypertension obesity diabetes difficult break therefore conclusion cannot made without detailed data links chain impact smoking forgotten relation copd hypertension higher propensity covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however results conflicting majority authors find higher prevalence smoking patients adverse outcome <NUMBER> <NUMBER> <NUMBER> level renal damage cannot excluded one contribute factor higher percentage hypertension advance stage covid‐<NUMBER> hypertensive patients studies reported large prevalence cardiovascular diseases covid‐<NUMBER> patients also classified therefore difficult estimate individual effect coronary artery disease heart failure atrial fibrillation occurrence severity covid‐<NUMBER> li et al summarized findings <NUMBER> studies showed prevalence hypertension cardio‐ cerebrovascular disease diabetes patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> incidences hypertension cardio‐cerebrovascular diseases diabetes two‐ threefolds higher patients severe type covid‐<NUMBER> non‐severe counterparts yang et al included <NUMBER> covid‐<NUMBER> patients <NUMBER> studies reported prevalent comorbidities hypertension diabetes cardiovascular diseases respiratory system disease <NUMBER> frequent comorbidities severe patients hypertension respiratory system disease cardiovascular disease large meta‐analysis included <NUMBER> patients covid‐<NUMBER> found pooled prevalence hypertension cardiovascular disease smoking history diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> table <NUMBER> authors meta‐analyses agreed large heterogeneity studies obviously limited quality study partly explained different designs large variation sample size among studies <NUMBER> <NUMBER> essential data still missing would dangerous ascribe large portion risk sars‐cov‐<NUMBER> infection severity covid‐<NUMBER> risk factor including hypertension would reasonable hypothesize uncontrolled comorbidities well combination concomitant diseases may increase risk infection severity covid‐<NUMBER> examined many controversies effect angiotensin‐converting enzyme inhibitors acei angiotensin ii receptor blockers arb covid‐<NUMBER> patients <NUMBER> authors expressed concern use renin‐angiotensin‐aldosterone system raas inhibitors variation ace<NUMBER> expression may partly responsible sars‐cov‐<NUMBER> virulence <NUMBER> <NUMBER> population‐based studies estimated small proportion hypertensive patients china <NUMBER> <NUMBER> treated antihypertensive therapy raas inhibitors used <NUMBER> <NUMBER> treated patients <NUMBER> <NUMBER> therefore anticipated small percentage covid‐<NUMBER> patients china actually treated acei arb hand prevalence cardiac damage covid‐<NUMBER> patients negligible associated adverse outcome subjects <NUMBER> <NUMBER> data regarding frequency heart failure covid‐<NUMBER> patients scarce valid chronic kidney disease therapeutic point view acei arb important roles treatment conditions—cardiac injury heart failure renal impairment particularly albuminuria therefore withdrawing raas inhibitors switching medications would uncertain benefits certain disadvantages would expected problem raas inhibitors would escalate western countries europe usa patients taking antihypertensive medications particularly raas inhibitors significantly higher percentage china however studies italy usa show association raas inhibitors susceptibility coronavirus complications mortality covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> even new investigation china confirmed findings <NUMBER> switching raas inhibitors another antihypertensive therapy would lead insufficient blood pressure control could induce complications covid‐<NUMBER> patients infection sars‐cov‐<NUMBER> novel data showed raas inhibitors could even improve outcome hypertensive patients covid‐<NUMBER> <NUMBER> authors hypothesized raas inhibitors indirect antiviral role regulating immune function inhibiting inflammatory responses <NUMBER> based available data despite theoretical possibilities multiple specialty societies recommended covid‐<NUMBER> patients continue therapy raas inhibitors <NUMBER> <NUMBER> <NUMBER> limited number studies provided outcome data short follow‐up therefore one careful interpretation findings guan et al demonstrated patients severe covid‐<NUMBER> primary end point admission intensive care unit use mechanical ventilation death significantly higher percentage hypertension diabetes coronary artery disease cerebrovascular disease copd chronic renal disease cancer <NUMBER> authors investigate relationship different demographic clinical parameters severity disease outcome shi et al reported hypertension diabetes coronary artery disease cerebrovascular disease copd cancer prevalent patients myocardial injury diagnosed elevation high‐sensitivity troponin creatinine kinase‐myocardial band ck‐mb <NUMBER> cardiac injury associated significantly higher mortality <NUMBER> vs <NUMBER> authors investigate comorbidities associated cardiac injury mortality must noted patients cardiac injury significantly older guo et al demonstrated similar results compared covid‐<NUMBER> patients without elevation troponin found <NUMBER> patients covid‐<NUMBER> cardiac injury <NUMBER> study chronic renal dysfunction usage raas also prevalent patients cardiac injury however patients cardiac injury almost <NUMBER> years older frequently men without injury also taken account also reported underlying cardiovascular disease worsening outcome patients myocardial injury <NUMBER> defining myocardial injury elevation troponin circumstances could questionable biomarker may increased many conditions inflammation andor sepsissystemic inflammatory response syndrome kidney injury authors clearly stated disorders included term “cardiovascular disease” clear whether hypertension included term furthermore difficult understand cardiomyopathies included whether patients heart failure included chen et al reported hypertension cardiovascular disease diabetes prevalent among covid‐<NUMBER> patients died comparison survivors <NUMBER> however large difference age sex distribution groups authors investigate effect comorbidities outcome population <NUMBER> table <NUMBER> zhou et al reported hypertension diabetes coronary heart disease chronic renal disease copd frequent among non‐survivors survivors <NUMBER> authors found hypertension diabetes coronary heart disease predictors mortality covid‐<NUMBER> patients nevertheless none comorbidities remained significant predictor mortality adjustment age sex smoking status findings confirmed importance comprehensive risk assessment including relevant risk factors comorbidities large original study included <NUMBER> patients guan et al showed adjusting age smoking status patients copd diabetes hypertension malignancy likely reach composite end points admission intensive care unit invasive ventilation death without <NUMBER> malignancy copd hypertension diabetes increased risk adverse outcome <NUMBER>‐ <NUMBER>‐ <NUMBER>‐ <NUMBER>‐fold respectively <NUMBER> patients two comorbidities significantly higher risk composite end point patients single comorbidity stratification patients according age <NUMBER> years vs ≥<NUMBER> years show significant difference strength associations number comorbidities mortality covid‐<NUMBER> <NUMBER> however cannot excluded confounding factors besides aging smoking might also responsible association comorbidities outcome would also helpful divide primary outcome two separate outcomes admission intensive care unit andor invasive ventilation b death would provide separated information independent predictors severity mortality covid‐<NUMBER> performed small study authors found hypertension diabetes predictors acute respiratory distress syndrome mortality covid‐<NUMBER> patients <NUMBER> unfortunately multivariable analysis adjustment relevant confounding factors performed investigation number limitations mentioned investigations self‐reporting comorbidities hospital admission represents one under‐reporting comorbidities due lack awareness andor lack diagnostic testing could interfere associations comorbidities clinical outcome importantly duration follow‐up short patients remained hospital time publishing studies means real outcome unknown obesity reported available studies influence could investigated furthermore one study reported basal values systolic diastolic blood pressure would help estimate percentage uncontrolled hypertension refers prevalence patients uncontrolled diabetes studies included small number patients additional obstacle one forget fact majority studies come china cautious extrapolating findings countries outbreak covid‐<NUMBER> studies consider potential sources bias confounding additional investigations improved design warranted recent findings reported arterial hypertension represented one common comorbidities patients covid‐<NUMBER> prevalence ranged <NUMBER> <NUMBER> impact hypertension outcome particularly mortality covid‐<NUMBER> patients clear due lack data studies provide evidence raas inhibitors avoided switched patients large studies consider potential sources bias confounding factors well longer follow‐up necessary public pressure find answers high physicians duty stay rational scientific approach available upcoming data ongoing outburst coronavirus disease <NUMBER> rattled entire human population potentiates lifethreatening acute medical complications death worldwide distinctive coronavirus designated severe acute respiratory syndrome sarscov<NUMBER> determined accountable ongoing covid<NUMBER> <NUMBER> sarscov<NUMBER> responsible covid<NUMBER> human proposed originated bats pangolins <NUMBER> first incidence transmission animal humans known occurred wuhan hubei province china late <NUMBER> <NUMBER> <NUMBER> <NUMBER> since covid<NUMBER> continues emerge world persontoperson transmission viral droplets victims encountered sarscov<NUMBER> reported develop wide range clinical symptoms include dry cough sore throat fever body pain headache abdominal pain diarrhoea fatigue <NUMBER> <NUMBER> severe stage sarscov<NUMBER> infection known cause pneumonia acute respiratory failure encephalopathy multiorgan dysfunctions thereby leading death <NUMBER> <NUMBER> <NUMBER> general coronaviruses known cross bloodbrain barrier bbb affect central nervous system cns <NUMBER> growing j u r n l p r e p r f <NUMBER> pathological impact covid<NUMBER> lungs heart brain sarscov<NUMBER> belongs family positivestrand rna viruses genus betacoronavirus shares genetic similarity two viral strains appear originated bats <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> recognized receptor sarscov<NUMBER> <NUMBER> thus cells express ace<NUMBER> vulnerable infection considered main target sarscov<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> gene highly expressed respiratory tract thus lungs major hotspot sarscov<NUMBER> infection pathogenic events <NUMBER> however sarscov<NUMBER> infection appears takes place also gastrointestinal tract cardiovascular system brain organs known express ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals diabetes obesity hypertension cardiovascular disorders recognised highly susceptible sarscov<NUMBER> infection leading development covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> abnormal expression functions ace<NUMBER> linked diabetes obesity hypertension cardiovascular disorders <NUMBER> <NUMBER> <NUMBER> moreover recent findings suggest density ace<NUMBER> cells increases upon ageing expression found higher men women since sarscov<NUMBER> appears affect men women many countries <NUMBER> sarscov<NUMBER> infection develops various symptoms host acute respiratory distress syndrome ards represents pathological hallmark covid <NUMBER> <NUMBER> many cases pneumonia appears major clinical consequence sarscov<NUMBER> infection due prominent proinflammatory process alveoli lungs <NUMBER> <NUMBER> <NUMBER> many reports vivo vitro studies histopathological findings postmortem human j u r n l p r e p r f lungs suggest sarscovs causes apoptosis alveolar cells degeneration small blood vessels lungs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> intensive conditions respiratory arrest major cause covid<NUMBER> associated death <NUMBER> <NUMBER> <NUMBER> addition available clinical data suggests significant portion covid<NUMBER> patients hypertension cardiovascular disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> medications used manage symptoms hypertension cardiovascular disorders association diabetes known induce expression ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> thus correlated individuals hypertension diabetes cardiovascular disorders high risk infected sarscov<NUMBER> developing covid<NUMBER> <NUMBER> <NUMBER> recent reports blood parameters indicated elevated levels creatine kinase lactate dehydrogenase significant proportion individuals covid<NUMBER> <NUMBER> <NUMBER> elevated levels creatine kinase lactate dehydrogenase circulation known biomarkers muscle degeneration tissue damage various organs including heart liver moreover cardiac arrest increasingly noticed one reasons mortality associated covidj u r n l p r e p r f sarscovs invade brain olfactory epithelium induce neuronal death transgenic mouse model expresses human ace<NUMBER> gene <NUMBER> though human subjects autoimmune disorders like multiple sclerosis reported highly susceptible get sarscov<NUMBER> infection neurological abnormalities increasingly expected critical stage individuals covid<NUMBER> <NUMBER> viral infections mediated neuropathogenicity brain regions regulate respiratory cardiac gustatory olfactory functions might highly relevant covid<NUMBER> cases addition covid<NUMBER> may exhibit abnormal regulations hpa association panic anxiety depressionlike disorders may need additional line scientific focus considering fact sarscov<NUMBER> infection might impair brain function level impaired synaptic plasticity neuroinflammation neurodegeneration abnormal neurogenesis gliosis leading cognitive impairment dementia similar neuroinvasive viruses including herpes simplex virus poliovirus hiv <NUMBER> moreover ace<NUMBER> gene expression functions linked cerebral blood flow cbf physiological state also expected sarscov<NUMBER> infection mediate abnormal regulation ace<NUMBER> gene <NUMBER> recent study revealed significant portion covd<NUMBER> victims overlapped signs cerebrovascular disease <NUMBER> <NUMBER> <NUMBER> taken bonts harmful biological substance currently known human <NUMBER> <NUMBER> bonts mainly produced strains anaerobic sporeforming bacterium clostridium botulinum <NUMBER> <NUMBER> seven major serotypes bonts characterized designated type g <NUMBER> among bonts types b e f directly liked induce lethal human diseases <NUMBER> <NUMBER> structurally bonts consist heavy light polypeptide chains <NUMBER> <NUMBER> kda size respectively coupled disulfide bridge <NUMBER> <NUMBER> heavy chain bonts binds receptors presynaptic terminals cholinergic neurons enters cytoplasm neurons receptormediated endocytosis disulphide bond two polypeptide chains bonts disassociates gains activated form <NUMBER> <NUMBER> light chain binds inactivate proteins like synaptosomalassociated protein snap <NUMBER> vesicleassociated membrane protein vamp syntaxin responsible fusion neurotransmitter containing vesicles lipid bilayer synaptic cleft thereby preventing release acetylcholine ach cholinergic parasympathetic postganglionic sympathetic nerve endings bontsmediated blockades ach release subsequent arrest cholinergic signalling synaptic junctions regarded induce dreadful muscle paralysis death <NUMBER> <NUMBER> bonts known induce symptoms like dryness mouth eyes urinary retention fluctuations blood pressure abnormal heart rate fatigue dyspnoea <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lungs primary target organ bonts inhaled induces acute pneumonitis paralysis breathing muscle leading respiratory arrest <NUMBER> <NUMBER> <NUMBER> <NUMBER> however mild dose purified forms bont extensively implemented treat wide range clinical symptoms <NUMBER> <NUMBER> <NUMBER> notably therapeutic bont implemented reduce severity disease j u r n l p r e p r f provide cure clinical conditions include hyperhidrosis chronic migraine strabismus hemifacial spasms blepharospasm abnormal heart rate dysphagia urinary bladder dysfunctions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover mild therapeutic dose bont clearly shown provide beneficial effect conditions obstruction lung functions like chronic cough bronchitis asthma dyspnoea <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> besides therapeutic bonts implemented attenuate number neurological disorders exhibit characteristics different forms movement disorders cerebral palsy <NUMBER> <NUMBER> <NUMBER> notably therapeutic bonts clinically practised control abnormal movement disorders noticed dystonia huntingtons disease hd spinocerebellar ataxia sca amyotrophic lateral sclerosis als parkinsons disease pd spasticity stroke different forms tic disorders <NUMBER> <NUMBER> <NUMBER> <NUMBER> though causative factors clinical symptoms aforementioned disorders highly dissimilar therapeutic bonts appear yield beneficial effect regardless aetiological differences taken together insight potential molecular targets therapeutic bonts would great help extend curative potential combat refractory ongoing diseases human thus far sarscov<NUMBER> induced acute ards responsible pneumonia respiratory arrest implicated key determining factor extending casualties covid<NUMBER> crisis worldwide <NUMBER> meanwhile cardiac arrest resulting sarscov<NUMBER> associated heart failure also linked mortality individuals j u r n l p r e p r f covid <NUMBER> <NUMBER> besides sarscov<NUMBER> appears enter brain elicit neuropathogenicity various brain regions controls body temperature reparation heart beat <NUMBER> studies neuropathological studies derived patients experimental animals strongly indicated sarscov<NUMBER> also induce neuropathological outcomes like neuroinvasive viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> owing aforementioned fact li yc coworkers recently reported patients covid<NUMBER> exhibit many neurologic signs indicated brainstem highly vulnerable subjects covid<NUMBER> <NUMBER> moreover ct mri based findings revealed thalamus medial temporal lobes subinsular region affected development encephalopathy apparently evident brain subject covid<NUMBER> <NUMBER> considering fact expected individuals recovered covid<NUMBER> high risk onset neurological motor cognitive deficits psychiatric symptoms therefore addition aiming druggable strategies peripheral systemic levels brain represents one major therapeutic targets manage symptoms evade covid<NUMBER> related mortalities though inhibition expression functions ace<NUMBER> gene using inhibitors may help prevention would yield ultimate cure positive cases covid<NUMBER> <NUMBER> apart vaccination based prevention covid<NUMBER> unaffected population number medical measures may considered order manage provide effectual defence covid<NUMBER> follows <NUMBER> reduction viral load pharmacological genetic interferencebased interventions therapies boost immunity sarscov<NUMBER> positive cases followed <NUMBER> assigning antiinflammatory regimes reduce sarscov<NUMBER> mediated chronic proinflammatory responses <NUMBER> supplementation cytoprotective agents <NUMBER> implementation neurotrophic support sustain neuroplasticity many drugs individually j u r n l p r e p r f meet one aforementioned strategies identification single drug establishment strategy multipurpose therapeutic potentials might highly appropriate moment therapeutic forms bont approved food drug administration fda treatment many clinical conditions including chronic headache dystonia <NUMBER> <NUMBER> <NUMBER> besides bonts licensed use antiageing cosmetics <NUMBER> <NUMBER> <NUMBER> particular mild therapeutic bont injection proven beneficial headache body pain persistent fever chronic cough pneumonia dyspnoea <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> considered general clinical symptoms covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> notably significant portion patients covid<NUMBER> reported exhibit lymphopenia condition low level lymphocytes blood <NUMBER> therapeutic bont injections appear elevate immune cell counts including platelets counts blood might help fight sarscov<NUMBER> enhance antigen presentation macrophagesmediated phagocytosis eliminate virulent factors <NUMBER> <NUMBER> moreover therapeutic bont known avert irregular heart rhythm even open heart surgery <NUMBER> therapeutic bont injection reported improve blood circulation oxygen supply thereby improving survival rate subjects ischemic conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER> besides implementation therapeutic bont eminent clinical practice manage movement disorders wide range neurological deficits <NUMBER> <NUMBER> <NUMBER> remarkably therapeutic bont appear provide neuroprotection cerebral ischaemic insults <NUMBER> eventually existing list diseases treated therapeutic bont associated increased levels ace<NUMBER> respective organs circulation example abnormal levels functions ace<NUMBER> recognized j u r n l p r e p r f biomarker therapeutic target chronic headache dyspnoea bronchitis cardiovascular disorders hypertension neuroinflammation neurological disorders <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> underlying mechanisms therapeutic bont recovery aforementioned clinical complications remains unclear therapeutic bont proposed suppress expression ace<NUMBER> <NUMBER> <NUMBER> taken together therapeutic bonts may also used preventive measure sarscov<NUMBER> infection population risk recently rigorous implementation many drugs therapeutic strategies envisaged covid<NUMBER> prediction clinical outcome proposed drugs therapies major focus underlying mode action possible adverse effects associated therapeutic approaches may excluded example hydroxychloroquine proposed treatment regime covid<NUMBER> along azithromycin <NUMBER> however exist considerable remarks antiviral mechanism action drugs sarscov<NUMBER> probable effects reduce pathological events covid<NUMBER> remains unknown besides use drugs reported associated fatal side effects <NUMBER> <NUMBER> transplantation different types stem cells proposed improve outcome covid<NUMBER> <NUMBER> use stem cells known associated risk developing tumor growth metastasis <NUMBER> however mounting optimism generated implementation aforementioned drugs cellbased therapeutics covid <NUMBER> fda indicated potential dangers bont therapeutic agent claimed bont could spread beyond injection site <NUMBER> <NUMBER> notably high doses bont known elicit adverse effects cns <NUMBER> toxic effect found due treatment using bont could neutralized using available antibodies bont <NUMBER> besides implementation antioxidants along bont treatment also reported minimize side effects <NUMBER> moreover clearly reported adverse effects therapeutic bont temporary reversible <NUMBER> use bont low dose reported comparatively safe <NUMBER> <NUMBER> <NUMBER> <NUMBER> repeatedly demonstrated mild doses bont attenuate many human diseases even <NUMBER> <NUMBER> units <NUMBER> <NUMBER> <NUMBER> <NUMBER> eventually mild dose bont injection accepted practice aesthetic procedure even healthy individuals despite rare reports adverse effects depending upon criteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent retrospective study chiu sy <NUMBER> indicates fda approved <NUMBER> units bont maximum dose per treatment session implemented patients neurological deficits <NUMBER>month interval <NUMBER> even highend dose bont reported improve functional outcome patients without obvious adverse effects <NUMBER> therefore mild dose bont translated benefit individuals covid<NUMBER> present exponential incessant covid<NUMBER> requires ultimate eradication therapy plans like nationwide lockdown social distancing selfquarantine imposed many countries avoid spread sarscov<NUMBER> establishment vaccination identifying pharmacological strategies disease modifying therapies j u r n l p r e p r f treatment like ivermectin <NUMBER> gained frontline attention therapeutic efficacy needs tested covid<NUMBER> adding therapeutic bont regarded magic bullet appears proven curative effect many explicated symptoms covid<NUMBER> including respiratory failure cardiac defects neurological deficits importantly therapeutic bont capacity migrate intramuscular injection site brain organs <NUMBER> therapeutic bont relatively safe beneficial effect single therapeutic dose bont appears long lasting <NUMBER> therapeutic forms bont available brand names like botox® onabotulinumtoxina dysport bocouture jeuveau countries thus article strongly proposes conception therapeutic forms bont also considered potent treatment covid<NUMBER> however high precaution measures author declares competing interest cov<NUMBER> receptor ace<NUMBER> different populations cell discov <NUMBER> <NUMBER> <NUMBER> httpsdoiorg<NUMBER>s<NUMBER> number coronavirus disease <NUMBER> covid<NUMBER> cases grows complications associated disease become apparent one concerning complications affects cardiovascular system thus far limited information available etiology clinical outcomes management options cardiovascular complications caused covid<NUMBER> common cardiovascular sequalae acute coronary syndrome cardiomyopathy arrythmia myocarditis cardiogenic shock cardiac arrest <NUMBER> interestingly observed cardiovascular injury similar caused middle east respiratory syndrome coronavirus merscov severe acute respiratory syndrome coronavirus <NUMBER> <NUMBER> sarscov<NUMBER> influenza <NUMBER> review focuses literature published year <NUMBER> covid<NUMBER> induced cardiovascular complications intention better understand pathophysiology process impact clinical outcomes available therapies order understand management options clinical outcomes mortality associated covid<NUMBER> induced cardiovascular injury important first better understand pathophysiology babapoorfarrokhran et al highlighted resemblance pathophysiology severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> sarscov<NUMBER> merscov <NUMBER> concluded three coronavirus outbreaks angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors played important role disruption receptors causes cardiomyopathy leads heart failure covid<NUMBER> linked development severe cardiovascular complications also found affinity patients underlying cardiovascular disease risk developing severe complications mechanism myocardial injury caused covid<NUMBER> fully understood proposed mechanism thought direct damage cardiomyocytes systemic inflammation fibrosis interferon cytokinemediated immune response coronary plaque destabilization hypoxia <NUMBER> rizzo et al also emphasized relationship covid<NUMBER> development cardiac disease work described pathophysiology cardiovascular injury covid<NUMBER> patients notch signaling implicated immune response viral infection regulation cardiovascular function important target therapies discussed later review etiology cardiovascular complications covid<NUMBER> patients suggested rizzo et al line babapoorfarrokhran et al proposed earlier also commented cardiac injury could due microvascular damage stressrelated cardiomyopathy rizzo et al explained sarscov<NUMBER> potential directly replicate within cardiomyocytes pericytes causing viral myocarditis <NUMBER> hendren et al proposed patients underlying coronary artery disease cardiomyopathy ventricular arrythmias hemodynamic instability common presentations cardiovascular complications <NUMBER> number case series case studies done help assess risk factors outcomes mortality related covid<NUMBER> induced cardiovascular complications case series <NUMBER> patients washington state mean age <NUMBER> years <NUMBER> male presented arentz et al concluded comorbidities identified <NUMBER> cases commonly chronic kidney disease congestive heart failure cardiomyopathy developing <NUMBER> cases <NUMBER> shi et al evaluated <NUMBER> patients covid<NUMBER> <NUMBER> evidence myocardial injury patients myocardial injury significantly higher mortality rate <NUMBER> compared patients without myocardial injury <NUMBER> patients myocardial damage greater degree elevation highsensitivity troponin levels associated higher mortality rates <NUMBER> guo et al researched impact preexisting cardiovascular disease cvd new myocardial injury fatal outcomes covid<NUMBER> patient population <NUMBER> patients retrospective singlecenter case series evaluated <NUMBER> developed new myocardial injury causing cardiac dysfunction arrhythmias concluded myocardial injury associated fatal outcomes covid<NUMBER> patients clinical prognosis patients preexisting cvd without superimposed myocardial injury favorable based results covid<NUMBER> patients known underlying cvd evidence myocardial injury require aggressive therapies <NUMBER> interestingly cases takotsubo cardiomyopathy also known broken heart syndrome covid<NUMBER> patients takotsubo cardiomyopathy oftentimes presents similar acute myocardial infarction marked elevation troponins motion wall abnormalities echocardiogram coronary artery disease catheterization chadha reported case takotsubo <NUMBER>yearold female underlying cardiac pulmonary disease reported case brought severe anxiety current covid<NUMBER> pandemic <NUMBER> dabbagh et al presented another case takotsubo cardiomyopathy covid<NUMBER> complicated large hemorrhagic pericardial effusion echocardiographic signs tamponade patient responded well treatment pericardiocentesis steroids hydroxychloroquine colchicine <NUMBER> minhas et al kir et al reported observed cases takotsubo covid<NUMBER> patients case presented kir et al also manifesting rarely seen highgrade atrioventricular block <NUMBER> <NUMBER> given high mortality poor outcomes associated cardiovascular complications covid<NUMBER> available treatment options need discussed important management plan st segment elevation myocardial infarction stemi nonst segment elevation myocardial infarction nstemi pandemic mahmud et al emphasized importance keeping covid<NUMBER> induced cardiac complications mind evaluating patients st elevations choosing reperfusion therapy pandemic percutaneous coronary intervention pci remain standard care patients stemi pci available fibrinolysis considered hand order limit healthcare worker exposure patients nstemi managed stabilization strategies hemodynamically stable given acuity interventions oftentimes lack known covid<NUMBER> status important healthcare professionals adequately attired personal protective equipment patient stemi pci necessary <NUMBER> hendren et al also recommended conservative approach extensive cardiac workup covid<NUMBER> patients elevated troponin otherwise medically stable hand summarized covid<NUMBER> patients ventricular arrythmias hemodynamic instability require full cardiological evaluation consideration experimental therapies clinical trials <NUMBER> cardiovascular sequelae bear poor outcomes high mortality covid<NUMBER> patients guidelines early screening prevention complications atallah et al recommended screening covid<NUMBER> patients using highsensitivity troponin better triage patients highor lowrisk groups symptomatic patients monitored troponin daily troponin normal levels monitored longitudinally predict potentially worsening disease surviving patients minimal elevation troponin levels using highsensitivity troponin screen possible severe complications poor prognosis early may beneficial <NUMBER> naksuk et al expressed concern addition virusinduced cardiovascular damage therapy currently used treatment covid<NUMBER> chloroquine hydroxychloroquine cause irreversible cardiomyopathy worsen underlying cardiac dysfunction chloroquine hydroxychloroquine along therapies used favipiravir lopinavirritonavir macrolide agents piperacillintazobactam cause atrioventricular block bundle branch block qtc prolongation due multiple investigational offlabel drug use uncertain cardiac safety profiles limited resources cardiac monitoring drugdrug interaction clear protocols therapies used cardiac monitoring provided patients multiple agents could affect heart function <NUMBER> important therapy target previously discussed rizzo et al notch signaling pathway implicated immune response virus infection regulation cardiovascular function sarscov<NUMBER> entry cell facilitated binding viral spike glycoprotein ace<NUMBER> receptor followed proteolytic cut glycoprotein host protease furin number ace<NUMBER> receptors cell membrane regulated adam<NUMBER> notch signaling positive regulator furin negative regulator adam<NUMBER> prevention notch signaling pathway activation interfere viral entry cells reducing furin increasing adam<NUMBER> notch signaling pathway used possible target therapy prevent sarscov<NUMBER> infection progressing cardiac disease <NUMBER> hendren et al proposed prior experience sarscov<NUMBER> may guide current management cardiovascular complications antiviral agents interleukin<NUMBER> inhibitors convalescent serum <NUMBER> cardiovascular complications covid<NUMBER> quickly becoming one concerning sequelae disease like previous outbreaks coronavirus sarscov<NUMBER> acts ace<NUMBER> receptors causes cardiac injury though direct damage cardiomyocytes systemic inflammation fibrosis interferon cytokinemediated immune response coronary plaque destabilization hypoxia comorbidities especially underling heart disease make patients predisposed severe cardiovascular complications covid<NUMBER> patients develop myocardial injury higher mortality rate compared interestingly number takotsubo cardiomyopathy cases related covid<NUMBER> reported research needs done assess association important consider covid<NUMBER> induced cardiac injury evaluating stemi nstemi stemi pci remain standard care nstemi given hemodynamic stability managed stabilization strategies order limit healthcare worker exposure monitoring hospitalized covid<NUMBER> patients high sensitivity troponin help screen possible severe complications early multiple investigational offlabel drugs uncertain cardiac safety profiles currently used treatment covid<NUMBER> therefore telemetry provided patients multiple agents notch signaling pathway important target therapy prevent cardiovascular complications therapies used control cardiovascular injury covid<NUMBER> antiviral agents interleukin<NUMBER> inhibitors convalescent serum research needs done assess effectiveness therapies pandemic novel coronavirus disease <NUMBER> covid<NUMBER> mediated severe acute respiratory syndrome coronavirus sarscov<NUMBER> viral infection serious geometrically expanding worldwide public health emergency newly recognized manifestations appreciated reported daily high contagiousness covid<NUMBER> largely attributed rapid community transmission high virulence sustained surface viability presentation covid<NUMBER> varies considerably rare asymptomatic cases mild flulike symptoms including high fever severe respiratory illness sarscov<NUMBER> pathogen singlestranded rna virus gravest clinical pathophysiology severe acute respiratory syndrome sars newly evolved virus estimated <NUMBER> <NUMBER>fold greater mortality rate usual seasonal haemophilus influenzaemediated respiratory illness <NUMBER>a critical cases characterized rapid respiratory deterioration septic shock andor multiple organ dysfunction failure <NUMBER> <NUMBER> contemporary infection rates rolling updates continuously displayed world health organization covid<NUMBER> website perspective report focus role angiotensinconverting enzyme <NUMBER> ace<NUMBER> key receptor sarscov<NUMBER> different organs body including lung heart kidney shall also discuss physiological role ace<NUMBER> testis theoretical adverse effects sarscov<NUMBER> male reproductive system virus may potential use ace<NUMBER> route infect part body since anecdotal evidence concern literature adverse effect coronavirus family specifically sarscov<NUMBER> male fertility call urgent targeted research topic clarify aspect current wave pandemic sarscov<NUMBER> belongs betacoronavirus genus recently sequenced <NUMBER> shown many similarities original sarscov first reported <NUMBER> spike proteins sarscov<NUMBER> sarscov almost identical threedimensional structures receptorbinding domain maintains van der waals forces shown share <NUMBER> identity amino acid sequences possess high rate homology <NUMBER> similar viruses sarscov sarscov<NUMBER> enter host cell type <NUMBER> alveolar epithelial cells receptor binding followed endocytosis genome replication exocytosis budding <NUMBER> viruses shown recognize human angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor host receptor sarscov<NUMBER> binds ace<NUMBER> receptor efficiently sarscov increasing damaging pathogenicity ability sarscov<NUMBER> transmit person person <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> receptor recognition first step viral infection key determinant host cell tissue tropism pathogenicity subsequent viral replication however ace<NUMBER> entry receptor virus also plays crucial role lung injury <NUMBER> ace<NUMBER> transmembranal zinc metallopeptidase high homology classic ace contains single catalytic domain ace isoforms part reninangiotensinaldosterone system raas cardinal endocrine system plays key role regulation blood pressure fluid balance whereas ace catalyzes conversion angiotensin ang angiotensin ii ang ii ace<NUMBER> responsible generation angiotensin <NUMBER>–<NUMBER> ang <NUMBER>–<NUMBER> ang ii ang ii exerts deleterious effects heart lungs kidneys brain via angiotensin ii type <NUMBER> at<NUMBER> receptors <NUMBER> ang <NUMBER>–<NUMBER>mas receptor axis provokes beneficial balancing salutary actions vital organs evident vasodilatory antiinflammatory antifibrotic diureticnatriuretic actions <NUMBER> <NUMBER> interestingly ace<NUMBER> widely expressed many organs including heart kidney lung intestine liver testis <NUMBER> <NUMBER> among several extrarespiratory organs ace<NUMBER> highly expressed human testis <NUMBER> <NUMBER> raises question whether covid<NUMBER> males via ace<NUMBER> may adverse reproductive implications especially young men planning children typical components raas found testis epididymis human mammalian animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance receptor mas identified rat testis <NUMBER>a mouse <NUMBER> testis starts increase around puberty reaches maximal expression reproductive life ace<NUMBER> expression testis restricted leydig sertoli cells humans <NUMBER> similarly mas mrna testis localized leydig sertoli cells much pronounced leydig cells <NUMBER> knockout mammalian models specifically various components raas masknockout mice showed aberrant expression genes involved mitochondrial function testicular steroidogenesis <NUMBER> <NUMBER> however unlike case alveolar cells yet known whether cells involved spermatogenesis depend intact ang <NUMBER>–<NUMBER> functional integrity studied basic question relevant model systems recently expression pattern ace<NUMBER> adult human testis level singlecell transcriptomes shown predominantly enriched spermatogonia leydig sertoli cells <NUMBER> clinical setting ang <NUMBER>–<NUMBER> mas detected seminiferous tubules well interstitial compartment mainly leydig cells men normal spermatogenesis however neither components raas found seminiferous tubules infertile men nonobstructive azoospermia <NUMBER> taken together raas specifically ace<NUMBER> seems play important role male reproduction accumulating evidence suggests raas components involved human male regulation steroidogenesis testosterone production spermatogenesis testis additional concern covid<NUMBER> pandemic might impact male fertility fever particularly high sustained elevation body temperature major manifestation covid<NUMBER> pandemic complicates <NUMBER> patients <NUMBER> concept fever elevation testicular temperature result impairment spermatogenesis widely accepted <NUMBER> importantly emerging evidence indicates subgroup patients severe covid<NUMBER> might secondary cytokine storm syndrome hemophagocytic lymphohistiocytosis <NUMBER> underrecognized hyperinflammatory syndrome characterized sustained fever fulminant fatal hypercytokinemia multiorgan failure patients particular serum blood cytokine profile cytopenia hyperferritinemia findings also suggest immunomodulatory therapy il<NUMBER> antagonist may improve mortality rate considerably patients <NUMBER> <NUMBER> cytokines contribute testicular function maintenance male reproductive health pathologies associated abnormal activity organ covid<NUMBER>induced changes cytokines profile may implications male fertility <NUMBER> addition immunomodulatory therapies may provoke potential longterm effects male fertility matter concern furthermore cytokine microenvironment deviations within testis may tumorigenic adverse effects cellular level leading eventually testicular cancer second longterm matter concern <NUMBER> best knowledge clinical studies male fertility investigated survivors previous coronavirus epidemics sarscov commenced <NUMBER> merscov commenced <NUMBER> may due fact viruses much less contagious comparison sarscov<NUMBER> epidemics shortlived limited scope date <NUMBER> <NUMBER> people infected worldwide sarscov merscov respectively website also possible effect previous epidemics male fertility explored targeted studies one study analyzed pathological changes testes six patients died sars suggesting sarscov orchitis <NUMBER> biopsies displayed widespread germ cell destruction spermatozoon seminiferous tubules sars viral genomic sequences situ hybridization detected specimens although immunohistochemistry demonstrated abundant igg precipitation indicating possible immune response cause damage contrast april <NUMBER> <NUMBER> number confirmed cases sarscov<NUMBER> <NUMBER> pandemic continues evolve highly contagious nature sarscov<NUMBER> virus using ace<NUMBER> receptor entry lungs testis imperative seize opportunity investigate impact covid<NUMBER> pandemic male fertility one nonpeerreviewed retrospective study examined impact sarscov<NUMBER> male sex hormones <NUMBER> hospitalized patients third sixth decade age <NUMBER> serum luteinizing hormone levels higher sarscov<NUMBER> group compared controls differences serum follicular stimulating hormone testosterone levels another recent nonpeerreviewed study examined <NUMBER> recovering adult chinese male patients <NUMBER>–<NUMBER> yr age following confirmed covid<NUMBER> diagnosis six men mild scrotal discomfort time disease suggesting viral orchitis none men sarscov<NUMBER> detected semen <NUMBER>–<NUMBER> days following recovery <NUMBER> one major limitation studies fact authors report sperm counts viability covid<NUMBER> patients ace<NUMBER> abundant adult human testis lungs kidney heart sarscov<NUMBER> virus uses ace<NUMBER> receptor entry clinical translational studies needed without delay determine effects sarscov<NUMBER> human spermatogenesis steroidogenesis testis inform medical consultation infected men especially reproductive years may greater importance men already known sperm production problem issue sperm banking following sarscov<NUMBER> infection safety also evaluated since infertility vitro fertilization embryo transfer treatments presently deferred may best time conduct targeted studies returning routine endeavors conflicts interest financial otherwise declared author jsy za ks created developed concept jsy drafted manuscript jsy za ks edited revised manuscript jsy za ks approved final version manuscript united states viral respiratory infections leading cause illness hospitalization infants <NUMBER> <NUMBER> infectious complications range upper respiratory tract diseases common cold croup otitis media lower respiratory tract infections bronchiolitis pneumonia children especially infants congenital heart disease increased risk morbidity <NUMBER> <NUMBER> respiratory illness following cardiac surgery compared matched controls <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite limited data cardiac surgeries infants often delayed <NUMBER> weeks suspected acute respiratory infection prior surgery due symptoms positive laboratory testing recommendation surgical delay based concerns prolonged hospital length stay los respiratory complications following surgery however standard clinical laboratory screening tests used preoperatively evaluate occult respiratory infections infants undergoing cardiac surgeries perioperative questioning families risk factors prior surgery used standardized introduction multiplex molecular tests using polymerase chain reaction pcr provides rapid screen respiratory viruses asymptomatic children results available within couple hours <NUMBER> <NUMBER> theoretically detection viruses preoperatively could used tool decrease incidence postoperative complications infants positive avoid unnecessary postponements surgery negative testing however data showing effectiveness either viral diagnostics perioperative questionnaires absence significant symptoms clinical impact viral respiratory pathogen detection positive screening risk factors postoperative outcomes following cardiac surgery infants unknown primary objective study prospectively estimate prevalence respiratory viruses using molecular testing asymptomatic infants presenting low complexity heart surgery winter season evaluate impact positive viral detection hospital length stay hlos cardiac intensive care unit length stay cicu los intubation time respiratory complications following cardiac surgery infants deemed suitable cardiac surgery clinical evaluation secondary objective study evaluate value screening questionnaire predictive tool presence viral pathogens well impact positive questionnaire outcomes listed hypothesized postoperative outcomes would worse infants testing positive respiratory pathogens molecular testing study questionnaire prospective observational study infants scheduled undergo cardiac surgery respiratory illness seasons november may years <NUMBER> <NUMBER> patients evaluated day surgery unit preoperatively deemed suitable candidates general anesthesia cardiac surgery infants admitted cicu postoperatively oversight study provided institutional review board university utah primary childrens hospital pch written informed consent research obtained parent caretaker enrolled subjects pch freestanding tertiary childrens hospital located <NUMBER> feet sea level <NUMBER>beds serves community hospital salt lake county utah tertiary referral center five states intermountain west utah idaho wyoming nevada montana pch houses <NUMBER>bed cicu admits approximately <NUMBER> openheart surgeries annually eligible cohort consisted infants <NUMBER> month <NUMBER> year undergoing cardiac surgery consecutively admitted tertiary cicu typical respiratory illness seasons <NUMBER> years infants included deemed free respiratory infection cleared undergo cardiac surgery following preoperative clinical evaluation existing standard practice infants never discharged hospital following birth known genetic syndromes excluding trisomy <NUMBER> symptomatic clinically diagnosed respiratory infections time surgery excluded trisomy <NUMBER> included encompasses frequent patient population requires surgery infancy majority cases requiring low complexity cardiac surgery tetralogy fallot tof atrioventricular canal avc ventricular septal defect vsd repairs cardiothoracic cardiology surgery lists used identify patients meeting inclusion criteria subjects meeting study criteria recruited preoperative visit day prior day surgery included subjects parents completed internally developed study questionnaire targeting signs symptoms respiratory infection well exposures ill see appendix nasopharyngeal oropharyngeal swabs obtained preoperatively infant day cardiac surgery results testing respiratory panel assay questionnaire shared infants cardiothoracic surgeon known care provider team clinical decisionmaking samples deidentified labeled infants study id samples transferred research laboratory testing see testing methods samples stored − <NUMBER>° centigrade prior testing filmarray respiratory panel fa rp bio fire diagnostics llc salt lake city ut rapid multiplex molecular diagnostic assay detection identification <NUMBER> respiratory pathogens upper respiratory specimens study questionnaire consisted questions specifically targeted identify infants risk acute respiratory infections may identified standard anesthesia preoperative screening see appendix study survey queries detailed information related signs symptoms respiratory illness within <NUMBER> weeks surgery presence sick contacts exposure second hand smoking immunization status palivizumab influenza vaccination status history prematurity asthma reactive airway disease preoperative use bronchodilators questionnaire distributed parents standard preprocedure history physical exam done patients felt suitable surgical candidates purposes study positive questionnaire defined presence one general respiratory symptoms within <NUMBER> weeks surgery history exposure sick contacts time period demographic clinical information obtained enrolled infant general demographics included gender age weight surgery history prematurity defined <NUMBER> weeks gestational age history trisomy <NUMBER> underlying conditions heterotaxy laryngomalacia pulmonary hypertension tracheoesophageal fistula diaphragmatic hernia gastroesophageal reflux disease data abstracted chart review surgical features recorded included main surgical procedure presence absence single ventricle physiology cross clamp cc cardiopulmonary bypass cpb times delayed sternal closure risk adjustment congenital heart surgery rachs<NUMBER> score merged <NUMBER> groups categories <NUMBER> <NUMBER> <NUMBER> postoperatively patients developed symptoms consistent respiratory tract infection clinical team would test respiratory viral infection rapid molecular diagnostic assay used preoperative phase study postoperative testing primarily guided cicu team based clinical suspicion infection established clinical criteria testing postoperative patients respiratory pathogens study outcomes included postoperative hlos cicu los intubation time presence respiratory complications use oxygen therapy home discharge definition respiratory complications composite outcome includes <NUMBER> use noninvasive ventilation continuous positive airway pressure cpap bilevel positive airway pressure bipap andor high flow nasal cannula hfnc <NUMBER> extubation failure need reintubation within <NUMBER> h planned extubation <NUMBER> need pulmonary pharmacology administration bronchodilators mucolytic agents steroids inhaled nitric oxide bronchoscopy continuous variables summarized using means standard deviations sds distributions approximately normal medians interquartile ranges iqrs otherwise categorical variables summarized counts percentages continuous data analyzed using twosample test exact wilcoxon rank sum test depending distribution skew categorical data evaluated chisquared fishers exact test used mcnemars chisquared test compare extent disagreement molecular diagnostic assay study questionnaire assessed accuracy study questionnaire screening patients viral detections reporting accuracy sensitivity specificity negative predictive values npv positive predictive values ppv associated <NUMBER> confidence intervals cis using exact clopperpearson method provided illustrate findings context sample size <NUMBER> statistical significance defined p <NUMBER> tests twotailed data analyzed using r v<NUMBER> <NUMBER> sixtynine infants enrolled demographic data collected study period eleven enrolled patients excluded either inadequate respiratory samples n <NUMBER> assay failure n <NUMBER> incomplete questionnaires n <NUMBER> thus fiftyeight <NUMBER> subjects complete data collection included analysis overall subject mean age <NUMBER> days thirtysix <NUMBER> <NUMBER> <NUMBER> months age twentythree <NUMBER> patients least one additional underlying condition including prematurity n <NUMBER> trisomy <NUMBER> n <NUMBER> heterotaxy n <NUMBER> laryngomalacia n <NUMBER> pulmonary hypertension n <NUMBER> tracheoesophageal fistula n <NUMBER> diaphragmatic hernia n <NUMBER> gastroesophageal reflux disease n <NUMBER> three patients pulmonary hypertension one trisomy <NUMBER> unbalanced avc palliated pulmonary artery band another vsd closed using amplatzer device final patient pulmonary hypertension nontrisomy <NUMBER> avc history congenital diaphragmatic hernia thirtynine <NUMBER> patients biventricular surgical repair via median sternotomy <NUMBER> <NUMBER> procedures falling within rachs categories <NUMBER> common defect vsd thus common surgical procedure closure vsd table <NUMBER> compares demographic clinical features subjects positive negative preoperative molecular testing significant differences baseline demographics infants positive vs negative preoperative viral respiratory testing exception greater proportion patients preoperative oxygen supplementation pcr group difference likely due higher percentage patients trisomy <NUMBER> single ventricle physiology underlying comorbid conditions pcr group seventeen <NUMBER> infants tested positive respiratory virus day surgery molecular methods viral detections shown table <NUMBER> <NUMBER> <NUMBER> positive table <NUMBER> outcomes infants tested positive respiratory virus day surgery similar compared negative preoperative testing furthermore statistical differences clinical outcomes comparing infants preoperatively tested positive hrv infants tested positive viruses additionally comparing patients single virus detection dual virus detection postoperative outcomes including postoperative cicu hlos similar however length postoperative intubation time longer incidence pulmonary complications higher use oxygen discharge frequent patients dual detection table <NUMBER> seven <NUMBER> infants developed respiratory symptoms average <NUMBER> days heart surgery clinically tested infection four seven patients positive assays three tested positive hrv <NUMBER> one tested positive rsv <NUMBER> two four viral pathogen detected preand postoperatively <NUMBER> rsv <NUMBER> hrv patients postoperative respiratory symptoms subsequently tested positive n <NUMBER> negative n <NUMBER> viral pathogen significantly longer hlos cicu los intubation time compared tested infection n <NUMBER> oxygen therapy home discharge common among patients pcr postoperatively <NUMBER> tested <NUMBER> however none three patients tested negative postoperatively required home oxygen discharge one patient died discharge two biventricular repairs prolonged length stay oxygen weaned prior discharge table <NUMBER> thirtyeight subjects <NUMBER> considered positive screen risk acute respiratory infection using study questionnaire <NUMBER> infants tested positive viruses time surgery <NUMBER> <NUMBER> positive questionnaire <NUMBER> <NUMBER> infants <NUMBER> tested negative positive questionnaire patients developed symptoms tested positive virus n <NUMBER> <NUMBER> positive screen tested negative n <NUMBER> <NUMBER> positive questionnaire postsurgical outcomes different infants positive questionnaire versus negative questionnaire table <NUMBER> study questionnaire low reliability identifying molecular testing positive subjects p <NUMBER> accuracy sensitivity specificity positive predictive value ppv negative predictive value npv <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> ppv <NUMBER> <NUMBER> ci <NUMBER> npv <NUMBER> <NUMBER> ci <NUMBER> respectively key finding study almost third otherwise healthy infants deemed fit undergo low complexity cardiac surgery standard preoperative history physical findings respiratory virus detected molecular testing additionally nearly twothirds study subjects positive screening study questionnaire risk respiratory infection however neither detection respiratory viruses molecular testing positive questionnaire identified asymptomatic infants risk poor postoperative outcomes introduction polymerase chain reaction pcr based diagnostic platforms detect multiple pathogens single sample increased positivity rate decreased turnaround time detection common respiratory pathogens contrast viral detection methods evaluate cellkilling viral antigen presentation molecular assays require live organisms detection therefore rates detection generally higher symptomatic individuals tests sometimes positive asymptomatic children <NUMBER> instance one study nuclear acid testing nat increased pathogen detection <NUMBER> <NUMBER> hospitalized children without symptomatic respiratory viral infection compared conventional testing enzyme immunoassay eia direct fluorescent antibody dfa <NUMBER> thus pcr testing sensitive test detection pathogens <NUMBER> positive testing may identify predict symptomatic illness present study unable demonstrate difference postsurgical outcomes infants positive preoperative pcr testing compared tested negative result likely due highly sensitive nature multiplex nucleic acid testing thus positive testing may indicative clinical infection contrast altman et al <NUMBER> examined utility preoperative testing utilizing nasopharyngeal eia respiratory viruses children <NUMBER> days <NUMBER> years age undergoing heart surgery twentytwo patients rsv positive surgery delayed approximately <NUMBER> weeks retesting prior delayed surgery reported <NUMBER> authors concluded perioperative screening rsv useful may prevent important postoperative morbidity mortality cost related hospitalization secondary community acquired rsv infection <NUMBER> important difference altmans study present study difference diagnostic testing eia assay detects antigens actively replicating viruses whereas pcr testing requires presence viral dna sample may explain difference outcomes altmans study preoperative testing also employed children hematopoietic stem cell transplantation practice advocated testing symptomatic patients order detect viral infection transplant positive testing resulted delay transplantation feasible however practice testing asymptomatic patients may necessary warrants study <NUMBER> <NUMBER> similarly study preoperative identification respiratory viruses rapid molecular testing absence clinical symptoms predict increased morbidity mortality correspondingly patients present study became symptomatic postoperatively whether tested positive negative significantly prolonged los intubation time freqeuent respiratory complications consistent previously published studies literature suggesting screening <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> similar previous studies hrv common virus detected study multiplex molecular testing utilized <NUMBER> self et al investigated prevalence respiratory viruses <NUMBER> children community acquired pneumonia used <NUMBER> asymptomatic children controls identified virus <NUMBER> children pneumonia <NUMBER> asymptomatic controls hrv common virus identified asymptomatic control group accounting <NUMBER> viral isolates <NUMBER> interestingly study also showed asymptomatic hrv detection declines increasing age hrv detected <NUMBER> asymptomatic children less <NUMBER> years age <NUMBER> adults older <NUMBER> years age <NUMBER> presence hrv pcr test result otherwise asymptomatic children necessarily represent risk group patients especially true light fact hrv shown persist <NUMBER> children <NUMBER> weeks beyond acute infection <NUMBER> however unlike hrv rsv hmpv piv viruses considerably shortlived rapidly cleared respiratory tract infection <NUMBER> <NUMBER> swedish study influenza rsv hmpv identified less <NUMBER> <NUMBER> asymptomatic controls <NUMBER> thus unlike hrv rarely detected asymptomatic children however identified almost always progress clinically evident respiratory disease <NUMBER> <NUMBER> advent molecular testing postponing surgery pcr hrv infants could result inappropriate delay timely cardiac surgery future studies need address age pcr testing hrv may fact predict adverse outcomes study show difference outcomes infants rsv hmpv piv identified preoperatively numbers quite small study needed determine detection viruses prior surgery considered decisionmaking proceed surgery theorized molecular testing may facilitate early detection respiratory viruses even prior onset symptoms virus loads low theory may benefit viral detection asymptomatic patients aid prevention transmission within hospital unfortunately studies address impact isolation asymptomatic patients thus clear appropriate use pcr testing <NUMBER> additionally isolation significant impact resource utilization limiting nursing ratios bed availability negatively affect patient care <NUMBER> study used questionnaire felt comprehensive uniform tool identifying infants risk respiratory infection standard preanesthetic screening used institution found twothirds patients <NUMBER> study positive questionnaire however positive questionnaire predict adverse hospital outcomes correlate presence virus pcr testing similar fashion study malviya et al used questionnaire identify children active uri symptoms presenting cardiac surgery surprisingly found children uris higher incidence respiratory complications longer duration mechanical ventilation icu length stay compared without symptoms <NUMBER> possible questionnaire broad targeted questionnaire would accurately predict postoperative risk may merit study addition study use supplemental oxygen frequent practice preand postoperatively due location hospital high altitude general many patients go home oxygen therapy regardless cardiac anatomy least first postoperative visit strengths study included prospective design enrollment several respiratory seasons study limited relatively small number patients tested single center addition infants tested otherwise healthy coming home undergoing low complexity cardiac surgery clearly creates selection bias questionnaire externally validated majority infants positive respiratory viruses hrv limiting ability evaluate effect preoperative detection viruses rsv parainfluenza hmpv postoperative outcomes despite positive molecular testing third infants cleared cardiac surgery respiratory season positive study questionnaire half postoperative outcomes cohort worse compared test negative subjects screening respiratory infection using molecular testing risk survey asymptomatic otherwise healthy infants undergoing lower complexity cardiac surgery appears effective strategy identify infants risk postoperative complications postponement cardiac surgery based detection pcr testing supported literature findings present study needs investigation funding biofire diagnostics llc provided film array respiratory pannel rp test kits study ajb collaborates bio fire diagnostics llc federally funded studies received research funding bio fire diagnostics investigatorinitiated research ajb intellectual property licensed bio fire diagnostics llc receives royalties university utah conflict interest authors claudia delgadocorcoran zhining ou angela p presson phillip burch charless g pribble shaji c menon declare conflict interest financial relationships relevant article disclose ethical approval procedures performed study accordance ethical standards instutition national research committee informed consent informed consent obtained individual participants included study disaster event occurs suddenly whose impact may increase intensity stops society normal functioning causes losses life economies environment kilci et al <NUMBER> kaur singh <NUMBER> disaster management involves fulfillment operations occurrence disaster order reduce detrimental effects galindo batta <NUMBER> oruc kara <NUMBER> sarma et al <NUMBER> covid<NUMBER> disaster hit globe late <NUMBER> involved <NUMBER> countries affected <NUMBER> people taken life <NUMBER> individuals end march <NUMBER> mentioned statistics pertain end march <NUMBER> significantly numbers infected people mortality rates change every day <NUMBER> fact covid<NUMBER> infectious disease resulting previous variant coronavirus ting et al <NUMBER> outbreak wuhan china december <NUMBER> unknown viral disease fever tiredness dry cough among common symptoms virus huang et al <NUMBER> rothan byrareddy <NUMBER> patients may also exhibit nasal congestion runny nose aches pains sore throat diarrhea symptoms generally begin severity may develop little little fact infected individuals may even feel unwell hence remain unaware contagious affected people recover disease without specific treatment hospitalization <NUMBER> covid<NUMBER> sufferers experience severe illness breathe difficulty people higher age underlying medical conditions including diabetes heart problems high blood pressure greater risk suffering seriously negative effects united nations <NUMBER> one problems confronting societies lack equipment successfully encounter virus virus propagates rapidly failure dealing prevalence dramatically increases number infected people communities faced shortage medicalhealthcare equipment increase number infected people initiate irreparable incredible catastrophe provision strategies solutions reduce outbreak rate disease coordinated management infected people lead breakdown deceleration virus chain since definitive cure identified disease point healthcare equipment services coronavirus testing kits masks gloves etc available people society therefore effective way make optimal use available healthcare equipment manage demands healthcare supply chain identify classify individuals without accordingly propose instructionsregulations class generally main purpose study respond following research questions possible develop decision support system order classify community members management demand healthcare supply chain disrupt virus chain control outbreak epidemic mitigate impact healthcare supply chain paper proposes decision support system based physicians knowledge fuzzy inference system fis order classify community members objective managing demand healthcare supply chain breaking decelerating virus chain highly practical tool fis proposed basis expert knowledge realm fuzzy set theory order deal nonlinear mapping input output variables since covid<NUMBER> new disease reliable datasets pertaining disease available desired use fis approach based expert knowledge addition input output variables approach follow linear function therefore fis makes possible define proper functions rules different conditions another rationale employment fis paper healthcare chain proposed paper twoechelon chain including community members service recipients healthcare system service providers supply chain healthcare equipment services provided healthcare system considered product structure study healthcare supply chain shown figure <NUMBER> proposed approach sudden increase demands healthcare supply chain first prevented based regulations notified class secondly disruptions must mitigated chain addition community members stress reduced reach covid<NUMBER> virus decreases increase accuracy proposed decision support system criteria including age preexisting diseases diabetes heart problems high blood pressure considered addition three main criteria fever tiredness dry cough generally contributions study summarized follows  developing decision support system based fis manage demand healthcare supply chain break decelerate virus chain control outbreak epidemic mitigate impact healthcare supply chain  grouping people service recipients based two criteria including age preexisting diseases diabetes heart problems high blood pressure providing independent classification method group  evaluating efficiency proposed approach using real world data validity sensitivity analysis procedure rest paper structured follows section <NUMBER> review literature disaster management epidemic outbreaks fis problem statement proposed approach presented section <NUMBER> apply case study evaluating efficiency proposed approach section <NUMBER> finally sensitivity analysis conclusion explained section <NUMBER> <NUMBER> respectively supply chains ivanov <NUMBER> choi <NUMBER> following section <NUMBER> examines concept disaster management section <NUMBER> discusses studies undertaken operations management related diseases epidemic outbreaks end section <NUMBER> dedicated introduction fis suggested carter <NUMBER> disaster management cycle attempt plan strategies measures play beginning end disasters lifespan framework repeatedly modified tomasini van wassenhove <NUMBER> way currently entails two phases relief development four activities preparedness rehabilitation response mitigation ahmadi et al <NUMBER> addition mentioned phases activities subcategories example response rehabilitation two activities included relief phase two activities preparedness mitigation placed development phase goldschmidt kumar <NUMBER> loree arosvera <NUMBER> activities measures preplanned guarantee effectiveness responses impact risks threats pertinent hazards warnings temporary evacuation occupants homes workplaces exposed disasters fall within category preparedness shahparvari et al <NUMBER> indeed activities seek minimize negative effects disasters devise relevant strategies within realm socioeconomic physical environmental domains wang wang <NUMBER> regard efforts provide effective responses encompass various factors resources urgent measures life saving environmental conservation socioeconomic political status affected society altay green <NUMBER> way activities grouped within rehabilitation domain seek rebuild damaged areas properties also establish new situation significantly better previous one rehabilitation actions designed avoid similar detrimental effects future disasters exercising resilience goldschmidt kumar <NUMBER> mitigation efforts seek either prevent initiation disaster decrease damages may come play sheu <NUMBER> hossain paul <NUMBER> epidemic outbreaks specifically considered among supply chain disruptions denote particular variety threat supply chain recognized three following components <NUMBER> presence longterm unexpected scaling disruption <NUMBER> disruption propagation supply chain epidemic outbreak propagation population <NUMBER> disruptions infrastructure logistics demand supply contrast disruption threats risks epidemic outbreaks minor outset develop spread various geographic areas quickly liu <NUMBER> latest pertinent examples include mers sars swine flu ebola newest one coronavirus covid<NUMBER> outbreak started wuhan china quickly affected chinese economy result supplies worldwide supply chains considerably diminished accordingly araz et al <NUMBER> asserted outbreak viral disease one critical disruptions occur recent decades thereby ravaging large portion supply chains across world investigate epidemic outbreaks struck covid<NUMBER> one find limited information connection supply chain measures example johanis <NUMBER> framework required measures logistic policies could adopted following disaster ivanov <NUMBER> studied impact epidemic outbreaks supply chain networks specifically considered propagation covid<NUMBER> virus global networks using characteristics uncertainty type methodology anylogic software used predict simulate shortand longterm impacts experiments show closing opening dates facilities impactful factors propagation results could help decision makers mitigate uncertainties curb decelerate propagation nonlinear system fis obtained integration expert system technology fuzzy logic lin et al <NUMBER> system includes set fuzzy ifthen rules arranged based experts decisionmakers knowledge rules used system simulating process human reasoning fis advantages benefiting human knowledge changeable rules indicate experts judgment asklany et al <NUMBER> tavana et al <NUMBER> vein fuzzy logic modeling techniques fall within two groups either mamdani mamdani assilian <NUMBER> takagisugenokang sugeno <NUMBER> fis applied tool various areas risk management ilbahar et al <NUMBER> supplier selection amindoust et al <NUMBER> manufacturing systems evaluation pourjavad mayorga <NUMBER> healthcare supply chain nazari et al <NUMBER> forth paper mamdani fis used classify community residents demand managed healthcare supply chain disaster arising covid<NUMBER> model strives control epidemic outbreaks disease mitigate supply chains disruptions pertain healthcare supply chains however use expertbased management tools control epidemic outbreaks mitigate supply chain disruptions received much attention accordingly decision support system based fis physicians knowledge developed purpose study many societies proposed solutions address disasters taken measures tailored preparedness response rehabilitation mitigation activities regarding disaster control example many countries minimize human economic environmental losses face disasters floods earthquakes storms etc means proper disaster management rezaeimalek et al <NUMBER> acar kaya <NUMBER> effective management kinds disasters benefits past similar experiences historical data yan et al <NUMBER> disasters epidemic scale affect parts country last short duration localized nature disasters presents possibility nonaffected countries help disasterstricken society however ability assist takes different shape novel longrunning rapidly growing disaster covid<NUMBER> emerges disastrous situation confuses decisionmakers governments disrupts almost community activities supply chains since covid<NUMBER> new unknown virus many unknown aspects thereby identification access aspects timeconsuming costly importantly endangers lives many humans many communities face shortage medical human resources treatment staff conditions due high rate disease outbreaks heightened demand services leads disruptions among many supply chains especially healthcare supply chain therefore prioritization community members provision better services solutions manage demand healthcare supply chain improve government performance reduce disruptions chain paper decision support system based fis physicians knowledge developed classify prioritize community members terms severity physical condition proposed decision support system aims using mitigation activities reduce effects covid<NUMBER> reduce disruptions healthcare supply chains provide better service disadvantaged communities ultimately manage increased demand healthcare supply chain however noted possible give people one community prescription words group society specific characteristics differentiate needs another group thus older residents preexisting diseases diabetes heart problems high blood pressure vulnerable according world health organization reports accordingly community members subdivided four groups based level vulnerability covid<NUMBER>  sensitive group people <NUMBER> years age suffers least one diseases diabetes heart problems high blood pressure  sensitive group people <NUMBER> years age least one diseases diabetes heart problems high blood pressure  slightly sensitive group people <NUMBER> years age diseases  normal group people <NUMBER> years age diseases comes classification members aforementioned groups various approaches based fis accomplish words fis used classify individuals society fuzzy inference rules different group people society figure <NUMBER> structure decision support system demand management healthcare supply chain depicted proposed decision support system indeed acts connecting bridge service recipients service providers healthcare supply chain service recipients classified inserting information responding questions presented system informed type services receive service providers way decision support system provides grounds demand management healthcare supply chain classifying service recipients proposed approach also described following steps model management step <NUMBER> step assessment criteria individuals physical condition community determined according reports three criteria namely fever tiredness dry cough early symptoms covid<NUMBER> considered input variables fis addition classification community members acts output variable system membership functions input output variables defined input variables consist three membership functions low mid high output variable composed five membership functions follows based proposed membership functions assessed individuals fall one five classes step <NUMBER> step fuzzy inference rules determined related experts physicians making link input output variables noteworthy different set fuzzy inference rules defined group people society step <NUMBER> step community members assessed purpose user enters system proposed fis activated groups determined group user belongs finally user evaluated classified responding three questions fever tiredness dry cough section performance proposed decision support system evaluated using latest information covid<NUMBER> physicians knowledge domain noted evaluated criteria community members selected based reports issued furthermore physicians knowledge contributed extract fuzzy inference rules determine membership functions following presents stepbystep implementation proposed approach step <NUMBER> step input output variables system first determined fever tiredness dry cough defined input variables classification community members defined output variable system input variables entail three membership functions low mid high output variables include five membership functions classes also noteworthy membership functions input variables vary different groups figure <NUMBER> membership functions input variables presented group membership functions output variable illustrated step <NUMBER> step fuzzy inference rules determined physicians knowledge four defined groups proposed fis contains three input variables three membership functions defined input variable therefore fuzzy <NUMBER> <NUMBER> <NUMBER>  inference rules group individuals extraction fuzzy inference rules implementation matlab r<NUMBER>b software using fis editor gui toolbox one observe relationship input output variables threedimensional space figures <NUMBER> <NUMBER> fuzzy inference rules shown threedimensional space normal slightly sensitive sensitive sensitive groups respectively step <NUMBER> step individuals society classified purpose following three questions asked users  many hours fever  many hours tiredness  many hours dry cough responses obtained questions considered inputs rule viewer box fis finally output computed system output always value within range zero one value obtained output lies exactly one membership function class user belong class however resulting number falls two membership functions membership degree considered selection index end membership degree output variable calculated classes membership degree classes matter class placed membership degree class greater class b placed class following example illustrating efficiency proposed approach assume four users follows  user <NUMBER> user belongs sensitive group  user <NUMBER> user belongs sensitive group  user <NUMBER> user belongs slightly sensitive group  user <NUMBER> user belongs normal group answers given questions users presented table <NUMBER> values presented table <NUMBER> considered inputs proposed fis output variable value calculated user reported table <NUMBER> classification users benefited results table <NUMBER> membership functions classes presented figure <NUMBER> observed output value user <NUMBER> equal <NUMBER> although value lies classes <NUMBER> <NUMBER> figure <NUMBER> placed right side intersection two classes words tendency class <NUMBER> thus user <NUMBER> placed class <NUMBER> output values users <NUMBER> <NUMBER> <NUMBER> equal <NUMBER> <NUMBER> <NUMBER> respectively according figure <NUMBER> values class <NUMBER> hence three users belong class <NUMBER> section four scenarios based changing user groups used assess performance proposed approach case study section assumed four users belonged one four defined groups current section sensitivity analysis proposed approach assumed desired user belongs three groups strive see class user placed whether change class makes sense purpose four scenarios defined follows  scenario <NUMBER> scenario assumed user <NUMBER> belong sensitive group belongs one three groups user <NUMBER> grouped sensitive group would belong class <NUMBER> user expected fall class <NUMBER> lower one placed groups membership functions input variables sensitive group denser higher slope groups hand fuzzy inference rules considered cautious sensitive group table <NUMBER> output value classification user shown seen table <NUMBER> obtained results consistent claim made therefore performance proposed model confirmed  scenario <NUMBER> scenario assumed user <NUMBER> belongs sensitive slightly sensitive normal groups classes user belongs differ output value classification scenario presented table <NUMBER> results scenario also line logical expectations reflect accuracy proposed approach performance  scenario <NUMBER> scenario performance proposed approach measured user <NUMBER> belongs one groups slightly sensitive group table <NUMBER> results scenario presented results obtained scenario also show model follows reasonable trend performance confirmed  scenario <NUMBER> scenario assumed user <NUMBER> belong normal group belongs one three groups user belonged normal group would placed class <NUMBER> user expected placed classes <NUMBER> <NUMBER> <NUMBER> belongs groups however different result obtained would indicate inaccurate performance proposed approach table <NUMBER> results scenario shown show proposed approach follows logical patterns performance confirmed paper practical decision support system proposed classify community members accordingly manage demand control epidemic outbreaks healthcare supply chain proposed approach users first grouped according two criteria age range preexisting diseases diabetes heart problems high blood pressure users classified using fis mentioned three criteria fever tiredness dry cough used classify users different membership functions variables considered various groups finally proposed approach validated using data pertaining four users results results sensitivity analysis process indicate proper effective performance proposed approach besides benefits research may suffer limitations paper exception one limitations current study three symptoms fever tiredness dry cough considered criteria assessment community residents three criteria figure among common symptoms covid<NUMBER> infection symptoms diarrhea vomiting like also observed patients huang et al <NUMBER> rothan byrareddy <NUMBER> paper three membership functions considered input variables possible promote accuracy decision support system increasing number membership functions thus future research recommended criteria diarrhea vomiting etc added input variables order design accurate decision support system increase number membership functions input output variables well paper expertbased approach employed control epidemic outbreaks recommended use integrated data science expert knowledge propose adaptive neurofuzzy inference system control epidemic outbreaks moreover decrease disruptions caused epidemic outbreaks supply chain network design using scenariobased stochastic programming model interesting practical topic explored future works epidemic disasters availability vast amounts data usually evident employment disruptive technologies useful tool area choi et al <NUMBER>a choi et al <NUMBER>b shen et al <NUMBER> ting et al <NUMBER> therefore use larger amounts data blockchain technologies choi <NUMBER> choi <NUMBER>a dolgui et al <NUMBER> koh et al <NUMBER> control disruptions another attractive new topic recommended considered future scope researchers avec la multiplication des cas de syndrome respiratoire aigu sévère covid<NUMBER> dus au sras cov<NUMBER> certaines préoccupations concernant les inhibiteurs de lenzyme de conversion de langiotensine <NUMBER> iec et les antagonistes des récepteurs de type <NUMBER> à langiotensine ii arb ont été soulevées lenzyme membranaire ace<NUMBER> enzyme de conversion de langiotensine <NUMBER> sert de récepteur au sras cov<NUMBER> permettant ainsi son entrée dans les cellules ainsi la crainte quun traitement préexistant par iec ou arb pourrait augmenter le risque de développer un syndrome respiratoire aigu sévère en cas dinfection au covid<NUMBER> émergé lace<NUMBER> est une enzyme carboxypeptidase qui contribue à linactivation de langiotensine ii et par conséquent soppose physiologiquement aux effets de langiotensine ii les iec ninhibent pas lace<NUMBER> bien quil ait été démontré vitro que les arb régulent positivement lexpression membranairelactivité tissulaire de lace<NUMBER> les études chez lhomme ne sont pas concordantes de plus à ce jour il ny pas de données pour soutenir lhypothèse quun traitement par iec ou arb pourrait faciliter lentrée cellulaire du sras cov<NUMBER> en augmentant lexpression membranaire et lactivité tissulaire dace<NUMBER> enfin certaines études soutiennent lhypothèse selon laquelle laugmentation de lexpression membranaire dace<NUMBER> ladministration darb ou ladministration dace <NUMBER> soluble circulante pourrait conférer des effets protecteurs potentiels sur la survenue de lésions tissulaires inflammatoires sévères en cas dinfection par le covid<NUMBER> des essais thérapeutiques sont en cours en résumé sur la base des preuves actuellement disponibles et comme le préconisent de nombreuses sociétés savantes les iec ou arb ne doivent pas être interrompus en raison dune infection par le covid<NUMBER> en dehors des situations où la situation hémodynamique est précaire avec alors un ajustement au cas par cas préconisé mots clefs covid<NUMBER> système rénineangiotensinealdostérone hypertension artérielle multiplication covid<NUMBER> severe acute respiratory syndrome cases due sars cov<NUMBER> concerns angiotensinconverting enzyme <NUMBER> ace<NUMBER> inhibitors acei angiotensin ii type <NUMBER> receptor blockers arb emerged ace<NUMBER> angiotensinconverting enzyme <NUMBER> enzyme receptor allows sars cov<NUMBER> entry cells fear preexisting treatment acei arb might increase risk developing severe fatal severe acute respiratory syndrome case covid<NUMBER> infection present article discusses concerns ace<NUMBER> membranebound enzyme carboxypeptidase contributes inactivation angiotensin ii therefore physiologically counters angiotensin ii effects aceis inhibit ace<NUMBER> although arbs shown upregulate ace<NUMBER> tissue expression experimental animals evidence always consistent human studies moreover date evidence acei arb administration facilitates sars cov<NUMBER> cell entry increasing ace<NUMBER> tissue expression either animal human studies finally studies support hypothesis elevated ace<NUMBER> membrane expression tissue activity administration arb andor infusion soluble ace<NUMBER> could confer protective properties inflammatory tissue damage covid<NUMBER> infection summary based currently available evidence advocated many medical societies acei arb discontinued concerns covid<NUMBER> infection except hemodynamic situation precarious casebycase adjustment required keywords covid<NUMBER> reninangiotensinaldosterone system arterial hypertension cardiovascular patients show increased risk severe forms coronavirus <NUMBER> covid <NUMBER> infection <NUMBER> <NUMBER> clinical manifestations principally respiratory patients may also show cardiovascular complications <NUMBER> present article reviews current state knowledge regarding relation reninangiotensinaldosterone system raas particularly ace<NUMBER> covid<NUMBER> raas blockers covid<NUMBER> human physiology peptides degraded limited number nonspecific extracellular enzymes known peptidases proteases membrane proteins active sites face extracellular space endopeptidases cut within peptide chain exopeptidases release cor nterminal amino acids angiotensinconverting enzymes exopeptidases carboxypeptidases relatively specific amino acids surrounding cut site although may common several peptides therefore important aware given peptidase specific given peptide angiotensinconverting enzyme <NUMBER> ace<NUMBER> enzyme carboxypeptidase mainly located membrane circulating forms created enzyme splicing membrane anchor homologous angiotensinconverting enzyme formerly simply known ace better denoted ace<NUMBER> first described <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> downregulates reninangiotensin system acts deactivator angiotensin ii also known angiotensin<NUMBER> active peptide causing vasoconstriction profibrosis proinflammation action stimulating aldosterone secretion binding at<NUMBER> receptor converting angiotensin<NUMBER> active peptide opposite properties angiotensin ii <NUMBER> several animal studies showed angiotensin<NUMBER> binding mas receptor induced vasodilatation showed antifibrosis antiinflammatory properties <NUMBER> figure <NUMBER> angiotensin ii also deactivated aminopeptidase converts angiotensin ii angiotensin iii induces vasodilatation increases natriuresis bradykinin preferential binding at<NUMBER> receptors <NUMBER>fold greater affinity at<NUMBER> receptors <NUMBER> <NUMBER> ace<NUMBER> also converts angiotensin <NUMBER> also known angiotensin<NUMBER> angiotensin<NUMBER> unknown action converted angiotensin<NUMBER> ace<NUMBER> raas thus divided activator system comprising classical historical angiotensin iiace<NUMBER>at<NUMBER>raldosterone pathway inhibitor system comprising angiotensin<NUMBER>ace<NUMBER>masr pathway latter able deactivate angiotensin ii counter effects pharmacology angiotensin<NUMBER>ace<NUMBER>masr pathway contrast angiotensin iiace<NUMBER>at<NUMBER>raldosterone pathway little explored invitro studies showed beneficial cardiovascular impact activated possibly involving gmpc <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> elevation ace<NUMBER> also reported interact angiotensin<NUMBER> receptor at<NUMBER>r targeted angiotensin ii receptor blockers arb arbs counter at<NUMBER>rmediated effects angiotensin ii thus stimulating angiotensin ii liberation response increase angiotensin ii thus increase ace<NUMBER> expression <NUMBER> ace<NUMBER> seems expressed cells various organs including heart kidney vessels digestive tract testicles ent region lung <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> enter infect cells coronavirus recognize via spike surface glycoprotein bind membrane receptor protein lipid carbohydrate <NUMBER> depends prior activation spike protein human proteases including tmprss<NUMBER> <NUMBER> membrane enzyme extracellular domain ace<NUMBER> seems provide entry human cells sars cov<NUMBER>covid<NUMBER> therefore acts receptor coronavirus <NUMBER> <NUMBER> figure <NUMBER> precise identification sars cov<NUMBER> spike glycoproteins ace<NUMBER> binding site shows latter identical sars cov <NUMBER> despite two viruses distinct showing <NUMBER> homology moreover affinity sars cov<NUMBER> ace<NUMBER> greater sars cov <NUMBER> <NUMBER> spike protein activation tmprss<NUMBER> proteases followed sars cov<NUMBER> binding extracellular domain membrane ace<NUMBER> explains virus binds penetrates cell see figure <NUMBER> reference <NUMBER> conversely circulating soluble ace<NUMBER> bind sars cov<NUMBER> unable induce cell infection experimentally antibodies targeting sars cov seem also block sars cov<NUMBER> binding ace<NUMBER> suggesting possible therapeutic strategies notably repositioning certain protease inhibitors <NUMBER> certain invitro studies reported positive correlation membrane expression andor tissue activity ace<NUMBER> risk covid<NUMBER> infection <NUMBER> moreover binding ace<NUMBER> virus induces decrease ace<NUMBER> tissue activity thus aggravating covid<NUMBER>induced inflammation organs notably lung <NUMBER> invitro study reported decreased membrane expression ace<NUMBER> mouse lung following sars cov administration concomitant respiratory impairment <NUMBER> administration arb losartan improved respiratory function perhaps restoring ace<NUMBER> membrane expression tissue activity thus level ace<NUMBER> membrane expression andor tissue activity may influence onset covid<NUMBER> infection thus risk developing severe inflammatory tissue injuries likewise recent retrospective study <NUMBER> chinese covd<NUMBER> patients requiring hospital admission <NUMBER> showed hypokalemia authors explained altered angiotensin ii deactivation shift ace<NUMBER>ace<NUMBER> balance reduced ace<NUMBER> tissue activity covid<NUMBER> favor ace<NUMBER> thus inducing aldosterone synthesis hypokalemia occurrence <NUMBER> figure <NUMBER> hypothesis confirmed mineralocorticoid receptor blockers may able contribute correcting hypokalemia therefore clear ace<NUMBER> particularly membrane expression tissue activity play key role covid<NUMBER> infection exact roles however complex may deleterious contamination phase ace<NUMBER> acts receptor covid<NUMBER> severity may correlate membrane expression tissue activity <NUMBER> <NUMBER> beneficial inflammatory lesion phase <NUMBER> <NUMBER> many questions thus remain present unanswered knowledge pharmacologic ace<NUMBER> activators inhibitors available date humans groups suggested using circulating soluble ace<NUMBER> capture many viruses possible plasma restricting fixation cellmembrane ace<NUMBER> thus limiting cell infection invitro studies showed genetically engineered recombinant soluble ace<NUMBER> could useful therapeutic option <NUMBER> <NUMBER> moreover soluble ace<NUMBER> might favor angiotensin<NUMBER>ace<NUMBER>masr pathway angiotensin iiaceat<NUMBER>raldosterone pathway preventing treating severe inflammatory tissue lesions <NUMBER> human recombinant soluble ace<NUMBER> fdaapproved treatment since <NUMBER> <NUMBER> phaseii trial acute respiratory distress syndrome <NUMBER> would allow rapid transfer covid<NUMBER> dedicated clinical trial launched soon nct<NUMBER> angiotensinconverting enzyme inhibitors acei principally inhibit ace<NUMBER> thus blocking angiotensin ii release figure <NUMBER> action ace<NUMBER> never reported thought effect <NUMBER> <NUMBER> acei like arb widely prescribed maintenance therapy several chronic cardiovascular diseases including arterial hypertension heart failure diabetic nephropathy invitro models free covid<NUMBER> reported acei arb treatment increased membrane expression ace<NUMBER> especially heart <NUMBER> <NUMBER> <NUMBER> invitro findings human studies healthy covid<NUMBER>free subjects discordant <NUMBER> <NUMBER> <NUMBER> <NUMBER> also borne mind circulating ace<NUMBER> levels may match membrane expression tissue activity latter possibly varying depending tissue certain invitro studies reported low levels circulating ace<NUMBER> despite high membrane thus tissue expression <NUMBER> also evidence impact aceiarb pulmonary expression ace<NUMBER> notably context covid<NUMBER> groups suggested increased angiotensin ii expression may underlie compensatory response increasing ace<NUMBER> expression humans arbs could thus induce ace<NUMBER> elevation aceis inhibit angiotensin ii release <NUMBER> likewise arbs blocking at<NUMBER> receptors may favor conversion angiotensin ii angiotensin iii enhancing benefit at<NUMBER> receptor activation figure <NUMBER> also keep mind cardiovascular diseases notably ischemic cardiopathy heart failure arterial hypertension diabetes associated increased ace<NUMBER> membrane expression tissue activity noncovid<NUMBER> animal models independently aceiarb administration <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical situation infection contracted yet contracted patient without cardiovascular history covid<NUMBER> infection probably plays major role studies reported high levels aceiarb covid<NUMBER> infection especially severe forms requiring hospital icu admission although noticed arterial hypertension common especially elderly aceiarb prescribed <NUMBER> cases <NUMBER> thus positive negative impact aceiarb covid<NUMBER> humans remains unknown complex <NUMBER> possibly even depending clinical stage negative contamination phase beneficial tissue inflammation phase <NUMBER> <NUMBER> studies question forthcoming nct<NUMBER> early data extracted retrospective study performed china potential confounders factors exhibited reassuring results possible beneficial effect mortality aceisarbs<NUMBER> authors suggest arbs aceis may provide benefit covid<NUMBER> infection preventing onset severe tissue lesions <NUMBER> <NUMBER> two clinical trials losartan arb covid<NUMBER> without hospital admission due launched nct<NUMBER> nct<NUMBER> thus many scientific societies including french society arterial hypertension sfhta european society cardiology see httpwwwsfhtaeup<NUMBER> many publications <NUMBER> <NUMBER> <NUMBER> advise stopping maintenance treatments attempt prevent covid<NUMBER> infection especially imbalance blood pressure heart failure may deleterious remains difficult unanswered question longcourse aceiarb therapy case covid<NUMBER> infection especially severe individual personalized attitude seems essential considering clinical presentation severity hemodynamic respiratory renal failure blood pressure etc indications acei arb noncomplicated hypertension heart failure impaired lvef etc also noticed effects acei arb covid<NUMBER> infection unknown two may guidelines may rapidly revised light incoming data ongoing clinical trials especially concerning arb antihypertensive cardiovascular drugs dihydropyridines <NUMBER> <NUMBER> <NUMBER> combination sacubitrilvalsartan <NUMBER> thiazide diuretics <NUMBER> mineralocorticoid receptor antagonists <NUMBER> <NUMBER> <NUMBER> affected invitro ace<NUMBER> tissue expression regarding betablockers retrieved single invitro study reporting impact atenolol aortic tissue expression ace<NUMBER> <NUMBER> found studies impact loop diuretics tissue expression ace<NUMBER> although impact physiologically conceivable present theoretical concerns around ace<NUMBER> aceiarb covid<NUMBER> require detailed dedicated human studies seems clear ace<NUMBER> key point sars cov<NUMBER> cellentry therefore represents reasonable pharmacological target reducing ace<NUMBER> membrane activity tissue expression especially lung prevent infection reduce severity patients yet experiencing inflammatory lesions may represent valuable option prevent onset severe inflammatory tissue lesions especially lung hand angiotensin<NUMBER>ace<NUMBER>masr pathway favored angiotensin iiaceat<NUMBER>raldosterone pathway order increase ace<NUMBER> membrane expression andor tissue activity pharmacological therapeutic target eg arbs circulating soluble ace<NUMBER> also therapeutic option actually evaluated questions currently unresolved scrupulously investigated ongoing trials ace<NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> arb angiotensin ii receptor blocker acei angiotensinconverting enzyme inhibitor clinical spectrum covid<NUMBER> appears wide encompassing asymptomatic infection mild upper respiratory tract illness severe viral pneumonia respiratory failure systemic inflammatory syndrome even death <NUMBER> respiratory tract primary target sarscov<NUMBER> virus however cardiovascular involvement documented different studies heart involved <NUMBER> patients dying covid<NUMBER> disease <NUMBER> cardiovascular complications influenza coronavirus infection including myocarditis acute myocardial infarction exacerbation heart failure documented previous epidemics significant impact morbidity mortality <NUMBER> underlying myocarditis described electrocardiographic changes troponin elevation echocardiographic evidence diastolic systolic dysfunction previous coronavirus epidemics adverse outcomes including hypotension arrhythmia sudden cardiac death reported patients preexisting cardiovascular disease <NUMBER> patients preexisting comorbidities thought increased risk infection sarscov<NUMBER> also tend worse clinical outcomes specifically patients cardiovascular disease diabetes hypertension thought high complication rate mortality rate <NUMBER> reported cardiac patients mortality rates <NUMBER> <NUMBER> diabetes hypertension patients respectively <NUMBER> <NUMBER> covid <NUMBER> heart epidemiology men higher risk covid<NUMBER> epidemic admitted hospital higher rates suffer higher degrees morbidity mortality united states data covid<NUMBER> net dataset may <NUMBER> <NUMBER> found men represented <NUMBER> hospitalized population compared <NUMBER> women report <NUMBER> patients new york hospital system found men represented <NUMBER> admitted patients covid<NUMBER> mortality study higher men women every age <NUMBER> pathophysiology significance male predominance covid<NUMBER> disease uncertain study ongoing area age increases risk developing severe covid<NUMBER> disease data cdc united states reveal patients covid<NUMBER> disease less <NUMBER> years age risk hospitalization <NUMBER> <NUMBER> compared risk hospitalization greater <NUMBER> patients age <NUMBER> <NUMBER> furthermore patients cohort less <NUMBER> years age required icu care age group <NUMBER> <NUMBER> years hospitalization rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> year cohort rate hospitalization increased <NUMBER> <NUMBER> <NUMBER> trend noted increasing mortality age united states case fatality rates <NUMBER> <NUMBER> patients less <NUMBER> years age <NUMBER> <NUMBER> patient <NUMBER> years older <NUMBER> recently reports rare multisystem inflammatory syndrome associated covid<NUMBER> disease resembling kawasaki disease children <NUMBER> much remains unclear commonly occurs risk factors may patients preexisting comorbidities thought increased risk infection sarscov<NUMBER> tend worse clinical outcomes specifically patients cardiovascular disease diabetes hypertension thought high complication rate mortality rate <NUMBER> reported cardiac patients mortality rates <NUMBER> <NUMBER> diabetes hypertension patients respectively <NUMBER> aside race ethnicity socioeconomic factors shown worsen outcome covid<NUMBER> disease nursing homes assisted living facilities proved areas easy spread high subsequent morbidity mortality inmates correctional staff us prisons documented risk homeless shelters also identified risk covid<NUMBER> disease <NUMBER> progression covid<NUMBER> disease divided three intermingling phases early infection phase pulmonary phase hyperinflammation phase <NUMBER> figure <NUMBER> first phase features virus spread proliferation lung tissues initial innate immunity including recruitment monocytes macrophages characterized mild constitutional symptoms early phase symptomatic patients suffer mild respiratory symptoms may require supportive care like supplemental oxygen followed adaptive immunity stage falling titers virus resolution symptoms second stage includes several mechanisms leading pulmonary tissue injury vasodilation endothelial permeability leukocyte recruitment cause pulmonary damage hypoxemia cardiovascular stress ten percent patients second stage may experience exacerbation immune response hyperinflammation stage become criticallyill may suffer acute respiratory distress syndrome ards acute cardiac injury multiorgan failure secondary bacterial infections sepsis require intensive care <NUMBER> mechanisms cardiac injury well established acute myocardial injury common cardiovascular complication covid<NUMBER> manifested elevation highsensitivity cardiac troponin incidence acute myocardial injury reported around <NUMBER> <NUMBER> <NUMBER> acute myocardial injury shown strong negative prognostic marker patients covid<NUMBER> <NUMBER> several mechanisms thought responsible direct myocardial injurysarscov<NUMBER> viral invasion cardiomyocytes thought occur binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> binding sarscov<NUMBER> ace<NUMBER> result alteration ace<NUMBER> signaling pathways leading acute myocardial lung injury however autopsy studies thus far failed confirm pathway <NUMBER> discussed detail later section article b indirect myocardial injurywhich expressed two ways <NUMBER> <NUMBER> severe hypoxia acute respiratory damage may result oxidative stress increased cardiometabolic demand leads acute myocardial injury <NUMBER> postmortem studies however histopathologic changes consistent diffuse alveolar damage reactive type ii pneumocyte hyperplasia hyaline membrane formation intraalveolar fibrin exudates epithelial damage along loose interstitial fibrosis chronic inflammatory infiltrates <NUMBER> intravascular coagulopathy noted autopsy study fibrin thrombosis small arterial vessels <NUMBER> specimens microvascular thrombosis hemorrhage linked extensive alveolar interstitial inflammation shares features macrophage activation syndrome may explain severe hypoxemia characterizes clinical feature ards covid<NUMBER> patients <NUMBER> limited cardiac autopsies shown interstitial mononuclear inflammatory infiltrates virus identified cardiac tissues <NUMBER> commonly reported arrhythmia covid<NUMBER> disease symptomaticasymptomatic tachycardia bradycardia also reported arrythmia may occur setting myocarditis myocardial ischemia critically ill patients hypoxia shock <NUMBER> forms arrythmias reported several mechanisms may trigger aggravate arrhythmias subjects covid <NUMBER> potential causes include electrolyte disturbance mainly hypokalemia adverse effects therapies eg chloroquinehydroxychloroquine azithromycin prolong qt interval potential development polymorphic ventricular tachycardia vt <NUMBER> fever may unmask cases cardiac channelopathies brugada syndrome long qt syndrome <NUMBER> clear statistics incidence st segment elevation myocardial infarction stemi intracoronary plaque rupture obstruction setting covid <NUMBER> disease likely low acute coronary events may triggered plaque rupture coronary thrombosis due inflammationincreased shear stress high risk patients tam et al reported significant decline number patients stemi seeking medical care institute <NUMBER> attributed reluctance patients go hospital covid<NUMBER> outbreak delays evaluating patients stemi hospital arrival due precautions detailed travel contact history symptomatology chest xray taken together may delay patient transfer catheterization laboratory additional precautions taken catheterization laboratory time needed wear protective gear may delay intervention <NUMBER> lack data incidence left ventricular systolic dysfunction acute left ventricular failure cardiogenic shock one study demonstrated heart failure <NUMBER> deceased patients <NUMBER> discharged patients <NUMBER> many critically ill patients may develop reversible sepsisrelated cardiomyopathy left ventricular dilatation impaired systolic function recovery within <NUMBER> <NUMBER> days <NUMBER> covid<NUMBER> infection cause decompensation underlying heart failure may lead mixed shock syndrome combination septic shock cardiogenic shock invasive hemodynamic monitoring feasible may helpful manage cardiac component shock cases <NUMBER> early predict long term cardiovascular outcome patients recovered covid <NUMBER> infection however potential outcome may similar seen severe acute respiratory syndrome sars caused sarscov virus outcome studies patients recovered sars followed <NUMBER> years showed <NUMBER> cardiovascular abnormalities <NUMBER> altered glucose metabolism <NUMBER> abnormal lipid metabolism <NUMBER> covid<NUMBER> infection associated prothrombotic state causing venous arterial thrombosis elevated ddimer reported incidence cerebrovascular disease among severe covid<NUMBER> f g u r e <NUMBER> pathophysiology covid<NUMBER> cardiac related complications patients varied <NUMBER> <NUMBER> <NUMBER> increased production antiphospholipid antibodies suggested possible cause ischemic stroke <NUMBER> stroke found associated <NUMBER>fold increased disease severity patients covid<NUMBER> <NUMBER> showed good invitro activity virus great excitement potential medications early stages pandemic <NUMBER> however rcts far shown benefit chloroquine hydroxychloroquine rather study stopped midtrial due side effects therapy <NUMBER> patients died group taking chloroquine analysis multinational registry <NUMBER> <NUMBER> patients <NUMBER> hospitals six continents mehra colleagues <NUMBER> found benefit hydroxychloroquine chloroquine used alone macrolide inhospital outcome covid<NUMBER> drug regimens associated decreased inhospital survival increased frequency ventricular arrhythmias used treatment covid<NUMBER> complications drug include severe cardiac electrical abnormalities electrical irregularities heart polymorphic vt torsade de pointes long qt syndrome increased risk sudden death <NUMBER> remdesivir nucleotide analogue prodrug inhibits viral rna polymerases initially developed treat ebola virus also shown good invitro activity sarscov<NUMBER> virus <NUMBER> clinical trials remdesivir currently ongoing two trials reported reduction time clinical improvement patients took drug compared placebo <NUMBER> convalescent plasma tocilizumab monoclonal antibody interleukin<NUMBER> therapies shown promise reducing severity illness case series results rcts still awaited <NUMBER> renin angiotensin aldosterone system raas complex hormonal system comprised interactions renin angiotensinogen angiotensin converting enzyme ace angiotensin converting enzyme <NUMBER> ace<NUMBER> angiotensin ii aldosterone summary raas system responds physiologic state hypovolemia hyponatremia adrenergic activation hypotension activates system increases vasoconstriction fluid retention <NUMBER> acei arb cause upregulation ace<NUMBER> thought increase viral entry <NUMBER> hand markedly elevated angiotensin ii levels noted plasma samples sarscov<NUMBER> infected patients linearly associated viral load lung injury indeed enhanced ace activity decreased ace<NUMBER> activity shown contribute lung injury mouse models <NUMBER> discontinue covid<NUMBER> disease <NUMBER> statins effective cholesterol lowering drugs act primarily blocking <NUMBER>hydroxy<NUMBER>methylglutarylcoa hmgcoa reductase enzyme found statins particularly pitavastatin bind strongly inhibit sarscov<NUMBER> main protease mpro key coronavirus enzyme potential drug target <NUMBER> need explored studies nonsteroidal antiinflammatory drugs nsaids medications work inhibiting cyclooxygenase enzyme produces prostaglandins commonly used relief pain fever initial public concern medications context covid<NUMBER> raised french minister health midmarch basis concern appeared anecdotal report four patients appeared worsen context nsaid use medications shown increase expression ace<NUMBER> cellular membranes could theoretically increase viral entry respiratory cells <NUMBER> however aside case reports evidence nsaids lead poor outcomes covid<NUMBER> patients contrast one nsaid indomethacin shown vitro evidence inhibition rna synthesis sarscov<NUMBER> virus independent cyclooxygenase activity <NUMBER> studies needed given concern many european countries suggested patients respiratory tract infections acetaminophen used preference nsaids control pain fever <NUMBER> review examined cardiac complications covid<NUMBER> also sheds light peculiar characteristics virus relationship cardiac therapies particularly acei arbs research ongoing various aspects novel coronavirus clinicians watching keenly learn much process wuhan union hospital large hospital system <NUMBER> <NUMBER> yearold male presented <NUMBER> days fever following hospital admission february <NUMBER> th <NUMBER> diagnosed novel coronavirus pneumonia rna nucleic acid testing nat patient records past medical history available however reported history heart failure history coronary artery disease diabetes hypertension cerebral infarction acute coronary syndrome tumour kidney liver disease history angiotensin converting enzyme inhibitor acei angiotensin receptor blocker arb therapy physical examination revealed blood pressure <NUMBER> mmhg heart rate <NUMBER> bpm temperature <NUMBER>°c normal oxygen saturation <NUMBER> upon lung auscultation decreased breath sounds crackles noted course hospital patient continued febrile experience dyspnea require ventilation given ct bnp symptoms cardiac ultrasound conducted february <NUMBER> th <NUMBER> rapidly assess left ventricular function bedside targeted assessment help guide management testing right ventricular size function normal aortic valve appeared structurally normal however significant aortic regurgitation noted color doppler aortic regurgitation thought severe visual assessment fully quantified given limits quicklook cardiac ultrasound scan management heart failure treatment initiated betablockers diuretics course next <NUMBER> days patients symptoms improved bnp levels decreased markedly cardiac ultrasound pointofcare demonstrated value rapid bedside binary assessment left ventricle especially setting cause dyspnea difficult discern underlying respiratory condition settings north america bedside quicklook scan would described cardiac pocus cardiac pocus provide binary information achieved limited training often conducted highly portable hand held mobile devices performed noncardiologists case full chamber valvular function quantified pocus required immediately thereby limiting operator andor sonographer exposure impacting management comprehensive tte evaluation degree aortic regurgitation clinically warranted could attained later date targeted manner clinical status changes teaching point <NUMBER>patient impact cardiac ultrasound played important role guiding heart failure management decision conduct cardiac ultrasound based upon finding symptoms elevated bnp value known generally associated unfavourable course heart failure pneumonia however patients elevation bnp may require evaluation treatment heart failure case patient continued symptomatic cardiac pocus affected management suggesting need heart failure therapies likely aortic regurgitation dilated cardiomyopathy underlying conditions however etiology could confirmed technique due severe shortage medical resources pandemic one cardiac ultrasound conducted hospital stay answer targeted clinical question thus aetiology aortic regurgitation fully determined deferred examination comprehensive tte later time following resolution pandemic covid<NUMBER> infection correlated dilated cardiomyopathy study required confirm association covid<NUMBER> infection like many acute illnesses may play role unmasking exacerbating underlying chronic cardiovascular conditions thus suggested excessive cytokine release syndromes might occurring infection syndrome contributing cardiac injury cardiovascular events <NUMBER> <NUMBER> <NUMBER> yearold man presented hospital following <NUMBER> days fever <NUMBER> days chest pain patient bedbound <NUMBER> days history hypertension coronary artery disease diabetes hypertension cerebral infarction acute coronary syndrome tumour kidney liver disease upon admission february <NUMBER> nd <NUMBER> patient found positive novel coronavirus nat diagnosed viral pneumonia physical examination revealed blood pressure <NUMBER> mmhg elevated heart rate <NUMBER> bpm temperature <NUMBER>°c decreased oxygen saturation <NUMBER> requiring invasive ventilation cardiac examination noncontributory however mild lower leg edema noted initial evaluation patients geneva score <NUMBER> wells score <NUMBER> suggesting high risk deep vein thrombosis pulmonary embolism laboratory tests revealed elevated white blood cell wbc count <NUMBER> x pgl patient required noninvasive ventilation given presence chest discomfort tachycardia ddimer elevation leg edema cardiac lower leg ultrasound recommended assess possible pulmonary embolism patient underwent bedside limited tte february <NUMBER> th <NUMBER> apical aneurysm mural thrombus lvef significantly reduced visually estimated <NUMBER> significant valvular abnormalities figure <NUMBER> supplemental videos <NUMBER>a <NUMBER>b <NUMBER>c <NUMBER>d management given diagnosis acute myocardial injury acute coronary syndrome protocol heparinization administered betablockade myocardial protection begun critical care echocardiogram repeated <NUMBER> days later segmental wall motion abnormality still present mural thrombus appeared larger anticoagulation therapy continued resolution pneumonia patient discharge stable condition mechanisms myocardial injury covid<NUMBER> infection well understood thought due direct myocardial tissue damage rather coronary obstruction similar acute viral respiratory illnesses case presented left ventricular dysfunction segmental thus addition fulminant myocarditis acute myocardial infarction triggered infection may possible underlying mechanism either due plaque rupture segmental injury supplydemand mismatch recently proposed stage iii extrapulmonary stage covid<NUMBER> infection represents host inflammatory response multiorgan dysfunction may ensue <NUMBER> typically stage may characterized ards shock cardiac failure stage associated elevation inflammatory markers troponin bnp investigation required delineate mechanisms disease stage personnel equipment scans conducted trained individuals either caring patient provided findings immediately treating physician directly covid<NUMBER> isolation unit simultaneously images stored ultrasound machine end day following inspection cleaning images copied hard disk saved dicom jpg later viewing variety handheld portable fullservice machines used devices dedicated covid<NUMBER> unit leave unit scan device probes cleaned hydrogen peroxide disposable wipes day scanning entire devicemachine stored dedicated room uv disinfection air disinfection machine entered covid<NUMBER> ward remained ward shared parts hospital goal case series illustrate variety applications focused cardiac ultrasound covid<NUMBER> pandemic  viral respiratory infections vri one leading causes hospitalization first year life <NUMBER> prevalent viruses respiratory syncytial virus rsv rhinovirus bocavirus others <NUMBER> <NUMBER> strategies used selected children including congenital heart disease chd prevent vrirelated hospitalizations like palivizumab <NUMBER> <NUMBER> children chd altered lung mechanics decreased lung compliance increased pulmonary vascular resistance therefore susceptible complications vri especially undergo openheart surgery <NUMBER> <NUMBER> clinical detection vri children openheart surgery challenging task potentially lead unnecessary use antibiotics depending magnitude problem aggressive intervention towards vri prevention may needed frequency vri prevalent agents children chd undergoing heart surgery hospital known hypothesis vri highly prevalent patients associated poorer outcomes aimed determine frequency vri children submitted heart surgery chd estimate impact major outcomes duration mechanical ventilation length hospital icu stay mortality longitudinal observational cohort study patients scheduled heart surgery chd institution tertiarycare university hospital may <NUMBER> may <NUMBER> eligible patients routinely assessed respiratory symptoms day surgery since patients without respiratory symptoms operated included study approved httpsdoiorg<NUMBER>jppedcard<NUMBER> received <NUMBER> july <NUMBER> received revised form <NUMBER> september <NUMBER> accepted <NUMBER> september <NUMBER> local institutional review board <NUMBER> signed informed consent required enrollment study consisted collection respiratory secretion samples extraction nucleic acids pcr amplification microarray detection reading collection respiratory secretion samples performed follows day surgery three days surgery seven days surgery patients tested three moments virus detection tests done study finished therefore results timely available affect medical decisions used automated method clart pneumovir® genomica madrid spain method qualitatively detect <NUMBER> different respiratory viruses rsv b parainfluenza <NUMBER> <NUMBER> <NUMBER> <NUMBER>a <NUMBER>b coronavirus <NUMBER>e metapneumovirus b adenovirus enterovirus b rhinovirus influenza including h<NUMBER>n<NUMBER> b c bocavirus specificity <NUMBER> viruses demographic surgical data outcomes collected medical charts surgical complexity categorized using stat stseacts congenital heart surgery mortality category <NUMBER> patients firstsample preoperative positive result considered homeinfected admitted <NUMBER> h hospitalinfected admitted <NUMBER> h prior sample collection hospitalacquired vri defined positive result time initial within <NUMBER> h admission negative result viruses pulmonary complications congestion atelectasis diagnosed agreement respiratory therapists least three medical staff looking chest radiographs light clinical data used ibm spss <NUMBER> chicago il results expressed mean standard deviation median range counts proportions according data type distribution frequency vri calculated dividing number cases vri number patients comparison groups without vri used fishers exact test students ttest mannwhitneys u test appropriate multivariate logistic linear regression models used binary continuous outcomes respectively identify influence vri major outcomes independent variables presence vri age stat category effect sizes estimated parameter estimates significance associations assessed <NUMBER> confidence intervals significance level <NUMBER> adopted sixtyone patients operated time frame <NUMBER> patients included study among nonincluded patients four underwent emergency surgery nine consent twentythree patients <NUMBER> male <NUMBER> <NUMBER> died tables <NUMBER> <NUMBER> <NUMBER> present demographic surgical data outcomes respectively according presence vri although patients vri likely lower stat categories neither stat age surgery significantly different patients without vri patients admitted pediatric intensive care unit picu surgery mechanically ventilated forty patients <NUMBER> extubated least <NUMBER> <NUMBER> least one extubation failure tracheostomy needed <NUMBER> patients regarding postoperative pulmonary complications found pulmonary congestion <NUMBER> patients <NUMBER> pleural effusions <NUMBER> patients <NUMBER> atelectasis <NUMBER> patients <NUMBER> twentyfour patients <NUMBER> two pulmonary complications vri present preoperatively <NUMBER> patients <NUMBER> total <NUMBER> patients acquired vri hospital stay <NUMBER> total cohort total frequency <NUMBER> number type viruses found shown fig <NUMBER> among children vri association two viruses found four patients two enterovirus b plus influenza h<NUMBER>n<NUMBER> one adenovirus plus rhinovirus one enterovirus b plus rhinovirus vri frequent winter <NUMBER> fall <NUMBER> spring summer <NUMBER> immunoprophylaxis rsv given seven patients surgery four vri caused rsv univariate analyses two groups differ studied outcomes duration mechanical ventilation p <NUMBER> arteriovenous oxygen difference p <NUMBER> vasoactiveinotropic score p <NUMBER> extubation failure p <NUMBER> picu hospital lengthofstay p <NUMBER> <NUMBER> respectively surprisingly mortality lower patients vri <NUMBER> vs <NUMBER> p <NUMBER> although statistically significant due small number patients better understand apparently similar outcomes patients without vri multivariate regression models used adjust age stat categories <NUMBER> versus <NUMBER> multivariate logistic regression models oddsratio death strongly influenced age surgery stat ≥<NUMBER> presence vri extubation failure influenced predictors multivariate general linear models arterialvenous oxygen difference av <NUMBER> vasoactiveinotropic score vis influenced predictors length mechanical ventilation influenced stat ≥<NUMBER> age surgery presence vri length ventilatory support invasive noninvasive hospital stay influenced age surgery stat ≥<NUMBER> presence vri finally picu lengthofstay influenced age surgery stat ≥<NUMBER> presence vri overall presence vri affect major outcomes results depicted tables <NUMBER> <NUMBER> cohort <NUMBER> patients <NUMBER> given antibiotics suspected postoperative bacterial infection five patients positive vri negative cultures bacteria found high frequency children vri undergoing openheart surgery hospital <NUMBER> frequency hospitalacquired vri <NUMBER> prevalent respiratory viruses found study rhinovirus bocavirus enterovirus b influenza h<NUMBER>n<NUMBER> influenza c adenovirus rsv coronavirus study since results available long surgery none cancelled postponed bicer et al studied incidence etiology viral infections among hospitalized children vri symptoms found prevalence <NUMBER> prevalent viruses rsv adenovirus parainfluenza rhinovirus <NUMBER> study frequency lower probably studied asymptomatic children types viruses also different study used polymerase chain reaction pcrbased commerciallyavailable automated method detect <NUMBER> different viruses kanashito et al compared three different methods detecting vri humans direct immunofluorescence single multiplexpcr <NUMBER> nasopharyngeal samples children congenital heart disease found vri prevalence <NUMBER> multiplex pcr performed better methods <NUMBER> krause et al highlighted usefulness multiplex pcr tests distinguish vri bacterial infections children <NUMBER> vri lead unnecessary use antibiotics study may occurred five patients study presence vri associated major outcomes openheart surgery children findings confirm reported investigators delgadocorcoran et al investigated prevalence rhinovirus children submitted heart surgery showed patients vri longer duration table <NUMBER> anatomic diagnosis patients pulmonary valve atresia stenosis <NUMBER> aortopulmonary shunt n <NUMBER> right ventricle pulmonary artery conduit placement n <NUMBER> atrioventricular canal total <NUMBER> atrioventricular canal repair n <NUMBER> asd vsd <NUMBER> asd primary closure n <NUMBER> vsd patch repair n <NUMBER> n <NUMBER> tetralogy fallot <NUMBER> aortopulmonary shunt n <NUMBER> vsd closure myomectomy transannular patch total repair n <NUMBER> hypoplastic left heart syndrome <NUMBER> norwood procedure n <NUMBER> pulmonary artery banding n <NUMBER> tricuspid atresia <NUMBER> aortopulmonary shunt n <NUMBER> total partial anomalous pulmonary vein connection <NUMBER> anastomosis anomalous veins left atrium total repair n <NUMBER> mitral stenosis <NUMBER> mitral valve plasty n <NUMBER> coarctation aorta <NUMBER> coarctation repair n <NUMBER> subaortic stenosis <NUMBER> aortic valve plasty n <NUMBER> anomalous origin left coronary artery <NUMBER> reimplantation anomalous artery n <NUMBER> patent ductus arteriosus <NUMBER> ligation n <NUMBER> transposition great arteries <NUMBER> arterial switch operation n <NUMBER> legend asd atrial septal defect vsd ventricular septal defect legend stat stseacts congenital heart surgery mortality category vri viral respiratory infection bold means significant effect p <NUMBER> mechanical ventilation extubation failures frequent use bronchodilators longer hospital stay <NUMBER> another study children submitted openheart surgery vri experienced longer hospital picu lengthofstay compared matched controls <NUMBER> altman et al studied impact rsv infection children chd found patients significant morbidity higher mortality higher healthcareassociated costs <NUMBER> speculate results negative limited power given small sample size b detection viruses asymptomatic children since ones symptoms vri rescheduled study delgadocorcoran et al <NUMBER> children considered infected symptoms vri study spaeder et al <NUMBER> infection defined presence viruses nasopharyngeal endotracheal specimens although evidence symptomatic vri negatively impact outcomes <NUMBER> clear whether asymptomatic presence virus respiratory system affect outcomes therefore usefulness costeffectiveness screening children scheduled congenital heart surgery regarding presence respiratory viruses need clarification brazil rsv common cause vri requiring hospitalization children <NUMBER> systematic review <NUMBER> published studies homaira et al showed patients benefit passive immunization rsv preterm infants <NUMBER> weeks children chronic lung disease children congenital heart disease <NUMBER> however frequent virus patients rhinovirus rsv detected single patient finding cannot attributed use passive immunization rsv since patients given authors recommend screening rhinovirus among patients scheduled congenital heart surgery especially infants toddlers respiratory symptoms surgery postponed positive however acknowledge costeffectiveness unknown <NUMBER> simsic et al adopted preoperative testing respiratory virus pcr cardiac surgery patients singleventricle test positive surgery rescheduled <NUMBER> weeks pending negative followup viral pcr <NUMBER> rapid tests vri market like abbott testpack rsv abbott diagnostics santa clara ca quickvue rsv test quidel corp san diego ca ramp® rsv test response biomedical corp vancouver canada rapid enzyme immunoassay direct detection rsv antigen nasopharyngeal swab specimens <NUMBER> clinical value rapid tests children chd unknown children admitted emergency department bedside testing rsv immediately available could changed medical management <NUMBER> cases reduced number tests ordered antibiotics prescribed saved average usd <NUMBER> per patient <NUMBER> another issue may considered lack preventive strategies viruses cause vri patients besides rsv new vaccines viruses could bring benefit many patients similar situations hospital screening vri routine patients scheduled congenital heart surgery undergo clinical evaluation surgery postponed weeks patient symptoms vri findings important bring awareness high frequency asymptomatic vri patients chd scheduled open heart surgery although associated poorer outcomes although screening test noninvasive technically simple hand expensive besides identification respiratory virus necessarily mean active infection since respiratory viruses detected weeks vri nevertheless despite limitations study results suggest screening asymptomatic children vri openheart surgery costeffective since difference outcomes limitations study include heterogeneity patients regarding anatomic diagnoses b wide range ages surgery c higher mortality centers developed countries therefore results may apply resourcerich centers developed countries least part limitedresource centers developing countries conclusion vri frequent children undergoing openheart surgery presence vri impact major outcomes cohort less <NUMBER> months <NUMBER> coronavirus disease covid<NUMBER> spread marketplace wuhan china <NUMBER> countries territories world virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infects lower respiratory tract causing fevers cough pneumonitis many <NUMBER> cases severe requiring hospitalization approximately <NUMBER> fatal <NUMBER> therapeutics desperately needed reduce morbidity mortality pandemic disease waiting unregistered products go testing process best opportunity identifying active therapeutics immediate use repurposing existing drugs several candidates proposed treatments much attention directed toward remdesivir however even remdesivir efficacy established randomized controlled trials limitations imposed intravenous iv administration may prevent widespread utility another candidate orally administered antimalarial drug chloroquine cq reported cq successfully used treatment sarscov<NUMBER> infection china <NUMBER> initial report cq efficacy clinic followed publication describing cq analog hydroxychloroquine hcq active sarscov<NUMBER> vitro well <NUMBER> finding quickly supported openlabel nonrandomized clinical trial limited size france provided first published clinical evidence hcq may viable treatment option covid<NUMBER> <NUMBER> based early hints efficacy us food drug administration issued emergency use authorization emergency use oral formulations hydroxychloroquine sulfate treatment covid<NUMBER> although cq hcq considered antimalarial agents alternative uses rheumatology treatment systemic lupus erythematosus rheumatoid arthritis <NUMBER> two hcq preferred treatment option due improved safety profile cq hcq weakly basic <NUMBER>aminoquinolines enter acidic compartments host cells concentration drugs accumulate cells process known lysosomal trapping <NUMBER> <NUMBER> treatment sarscov<NUMBER> infection reduction lysosomal ph believed adversely impact multiple stages viral replication eg membrane fusion spike protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor modifications <NUMBER> <NUMBER> pharmacokinetics pk standpoint lysosomal trapping result variable sequestration drug within tissues total drug concentration tissue may much higher plasma <NUMBER> drug levels reach steady state relationship tissue plasma drug concentrations represented partitioning coefficient k p treatment viral pneumonia specific interest drug levels vary lung unfortunately predicting impact lysosomal trapping drug levels individual tissues time difficult clear whether hcq maximum concentration c max andor area curve associated efficacy lack confidence tissue hcq concentrations impacts ability assess toxicity concerns well longterm hcq use associated qt prolongation <NUMBER> <NUMBER> efforts model hcq pk consider efficacy known toxicities associated treatment despite challenges recent publication described development simcyp physiologically based pharmacokinetic pbpk model support whether hcq lung levels sufficiently high enough treat sarscov<NUMBER> infection <NUMBER> authors briefly described development model model validated based previous studies characterized hcq plasma blood pk single hcq intravenous andor oral dose although provided information limited authors state final pbpk model used hcq lung k p value observed rats perfusionlimited lung model hcq lung simulations authors used final simcyp pbpk model simulate hcq lung concentrations multiple dosing regimens recommended dosing regimen believed provide sufficient hcq lung concentrations moving forward several concerns pk model used support recommended hcq dosing regimen treatment covid<NUMBER> course treatment average simulated plasma hcq plasma levels <NUMBER> ngml recommended dosing regimen well vitro hcq concentration required reach <NUMBER> maximum observed sarscov<NUMBER> elimination ec <NUMBER> verocell model viral infection <NUMBER> furthermore lowest concentration vitro cleared <NUMBER> sarscov<NUMBER> <NUMBER> ngml however relatively low blood levels necessarily problem previous studies dogs observed hcq blood exposure necessarily correlate tissue exposure pk outcomes <NUMBER> treatment viral pneumonia vivo efficacy predicted driven primarily high lung hcq concentrations however relatively high hcq lung k p pbpk model used simulate hcq human lung concentrations based hcq lung k p values observed rat pk studies accurate determination k p value requires drug reaching distribution equilibrium target tissue <NUMBER> months hcq rats large amount observed variability reported values <NUMBER> <NUMBER> furthermore relatively high hcq lung concentrations based perfusionlimited lung model although rat pk data suggest perfusionlimited lung model may suitable hcq clear data used inform perfusion limited lung model authors simcyp model additional concern initial study focused average unbound lung trough hcq levels compared vitro ec <NUMBER> hcq treatment covid<NUMBER> using conservative estimates hcq lung levels rely lower end predicted confidence intervals furthermore instead relating lung hcq levels current hcq ec <NUMBER> values believe hcq lung concentrations compared hcq concentration required clear <NUMBER> sarscov<NUMBER> vitro <NUMBER> ngml current hcq ec <NUMBER> values vary time timedependent kinetics hcq efficacy characterized detail <NUMBER> however hcq concentration required clear <NUMBER> sarscov<NUMBER> vitro <NUMBER> ngml timepoints <NUMBER> <NUMBER> hours study published hcq simcyp pbpk model used initially address concerns first used hcq pbpk model investigate differences hcq lung k p impact simulated hcq concentrations next simcyp population simulator used determine conservative estimates hcq lung concentrations <NUMBER>th percentile compare hcq vitro efficacy data finally due known qt prolongation issues hcq heart concentrations simulated understand unbound hcq heart c max values may vary different dosing regimens overall modeling approach designed illustrate current lack data support hcq pk modeling efforts predict hcq dosing treatment sarscov<NUMBER> infection pbpk modeling developed performed simcyp simulator see supplementary range hcq lung k p values investigated simcyp hcq model changes hcq lung k p impact simulated plasma blood hcq concentrations however panel k p values generated large differences simulated lung hcq levels relative hcq vitro efficacy hcq sulfate dosed <NUMBER> mg bid <NUMBER> day followed <NUMBER> mg bid <NUMBER> days unbound hcq lung troughs simulated lung k p <NUMBER> barely reach levels fivefold higher reported hcq ec <NUMBER> levels never reach value required clear sarscov<NUMBER> vitro table <NUMBER> assume hcq lung k p value rats humans k p <NUMBER> unbound hcq lung troughs predicted well vitro ec <NUMBER> hcq troughs reach minimum value required vitro virus elimination contrast hcq dosing regimen used clinical trial france <NUMBER> mg tid <NUMBER> days predicted generate unbound lung hcq troughs levels clear virus vitro hcq lung k p values ≥<NUMBER> table <NUMBER> however noted <NUMBER> days hcq dosing required reach sufficient hcq lung concentrations dosing regimens summary results illustrated figure <NUMBER> finally unbound hcq heart c max values predicted dosing regimen table <NUMBER> although hcq dosing <NUMBER> mg bid <NUMBER> day followed <NUMBER> mg bid <NUMBER> days predicted generate higher unbound hcq heart c max day <NUMBER> hcq dosing <NUMBER> mg tid <NUMBER> days higher hcq unbound c max values remainder study differences hcq heart c max values relatively small first <NUMBER> days unbound hcq heart c max day <NUMBER> predicted hcq <NUMBER> mg tid <NUMBER> days simulated tissue drug concentrations used support dosing recommendations quality data used inform timedependent drug distribution tissues carefully considered researchers hcq simcyp model described study changes lung k p values impact hcq blood plasma concentrations adjustments generated dramatic differences simulated hcq lung levels multiple preclinical vivo studies support relatively large hcq lung k p relying entirely rat pk study drastically limits ability current hcq pbpk models translate vitro efficacy data clinic given complex tissue distribution kinetics hcq attempts simulate human hcq lung levels basis hcq treatment covid<NUMBER> met caution time future additional robust mechanistic data acquired improve understanding hcq levels vary throughout body time previous study provided strong evidence lysosomal trapping responsible high hcq many tissues <NUMBER> authors used pbpk modeling approach supported mouse hcq tissue pk data illustrate hcq lysosome levels vary across multiple tissues furthermore model predicted human gut liver hcq lysosomal concentrations exceed <NUMBER> mmoll single oral <NUMBER>mg dose lysosomal trapping phenomenon occurs across many cell types including leukocytes leukocytes compared hcq uptake similar lymphocytes polymorphonuclear cells greatest purified monocytes <NUMBER> macrophages accurately accounted current simcyp model prediction accuracy may improved explicitly accounting phenomenon model furthermore sarscov<NUMBER> believed effect cellular entry via attachment virion spike protein ace<NUMBER> receptor receptor commonly found alveolar cells lung epithelium <NUMBER> future studies characterize hcq concentrations human epithelial lining fluid elf plasma alveolar macrophages andor bronchial tissue significantly improve confidence hcq pk modeling crucial development advanced hcq multicompartment lung models additional hcq pk concerns include known difference rand shcq enantiomer rat tissue distribution large amount variability observed human bp values incomplete understanding role hcq metabolites may play efficacy sarscov<NUMBER> <NUMBER> furthermore hcqsimulated pk data generated healthy populations necessarily reflect patient populations need treatment option covid<NUMBER> many patients urgent need treatment comorbidities liver andor kidney disease diseases likely impact hcq disposition finally concern hcq toxicity also drive dose selection although reports hcqassociated qt prolongation possible patients greatest need covid<NUMBER> treatment may susceptible hcq toxicity <NUMBER> <NUMBER> given concerns current protocol hcq treatment covid<NUMBER> university washington medical center includes monitoring heart issues placing patients telemetry track electrocardiographic data course treatment university washington medical center infectious disease physicians direct communication currently established hcq concentration plasma heart associated toxicity concerns simcyp hcq model account relative differences hcq levels without referring toxic threshold researchers acknowledge current lack hcq pk information also carefully consider vitro experiments designed characterize hcq efficacy sarscov<NUMBER> initial studies characterizing hcq efficacy sarscov<NUMBER> conducted vero cells kidney epithelial cells extracted african green monkey previous work middle east respiratory syndrome cov suggests phagocytes may serve viral reservoirs future work address use monocytederived macrophages host model characterize therapeutic efficacy sarscov<NUMBER> <NUMBER> addition researchers going relate hcq levels vitro efficacy data suggest using hcq concentrations required eliminate sarscov<NUMBER> vitro currently available ec <NUMBER> values vary time <NUMBER> hopeful hcq provide muchneeded treatment option covid<NUMBER> however believe current pk models used inform hcq dose selection high degree certainty based hcqs complex pk unclear mechanism action sarscov<NUMBER> improved hcq pk models needed increase confidence predicting hcq efficacy assessing potential drugdrug interactions identifying possible side effects qt prolongation supporting information supplementary information accompanies paper clinical translational science website www ctsjournalcom pulmonary hypertension chronic disease developing progressively high mortality pulmonary hypertension patients need persistent medical care however limited reports focused outbreak coronavirus disease <NUMBER> china national survey aimed evaluate overall condition pulmonary hypertension patients period questionnaire regarding living condition pulmonary hypertension patients coronavirus disease <NUMBER> designed pulmonary hypertension diagnostic experts wuhan asia heart hospital pulmonary hypertension patients family members invited participate survey online onehundred twenty pulmonary hypertension patients <NUMBER> family members participated survey <NUMBER> n <NUMBER> participants came hubei others <NUMBER> provinces <NUMBER> n <NUMBER> participants home quarantine <NUMBER> n <NUMBER> pulmonary arterial hypertension associated congenital heart disease <NUMBER> n <NUMBER> patients proclaimed heart function well maintained class ii one <NUMBER> patient confirmed severe acute respiratory syndrome coronavirus <NUMBER> infection two <NUMBER> patients hospitalized due heart function worsening nearly <NUMBER> n <NUMBER> participants implied shortage medications coronavirus disease <NUMBER> outbreak total <NUMBER> n <NUMBER> patients indicated medications discontinued due insufficient supply participants stayed optimistic either coronavirus disease <NUMBER> outbreak pulmonary hypertension disease <NUMBER> n <NUMBER> patients would go hospital followup immediately outbreak preliminary data show pulmonary hypertension patients able avoid severe disease home quarantine medication supplement important pulmonary hypertension patients heart function well maintained addition might increasing requirements medical care pulmonary hypertension patients outbreak understanding current status patients pulmonary hypertension covid<NUMBER> outbreak smallscale national survey china pulmonary hypertension ph chronic progressive lung disease caused multiple differing etiologies increasing pulmonary vascular resistance led overloading right ventricle eventually death <NUMBER> ph characterized mean pulmonary artery pressure mpap <NUMBER> mmhg rest addition treatment relieving symptoms targeted therapy aiming improve heart function extended threeyear survival pulmonary arterial hypertension pah <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported wuhan china last december <NUMBER> studies observed severe damage lung raised hypothesis ph patients might vulnerable others <NUMBER> subsequently whole country placed lockdown prevent spread disease potentially could compromise ph patient care factors made ph patients potentially vulnerable group hereby designed questionnaire ph patients understand disease condition mental condition medication supplement requirements medical care covid<NUMBER> outbreak survey would provide general information future medical care support ph patients conditions study conducted experts congenital heart disease center wuhan asia heart hospital wuhan collaboration ph centers unofficial patients groups patients diagnosed ph families considered survey ph defined mpap <NUMBER> mmhg rest diagnosis made according right heart catheter examination smallscale national online survey performed ph patients one family members invited participate survey via quick response qr code answers listed nonmedical descriptions reviewed unprofessional individuals better understanding personal information included study protocol questionnaire reviewed approved ethics committee wuhan asia heart hospital <NUMBER>s<NUMBER> participants given informed consent survey questionnaire designed experts ph wuhan asia heart hospital wuhan china understand status ph patients covid<NUMBER> outbreak china questions designed cover following issues <NUMBER> basic clinical information patients including age gender medical history ph current heart function <NUMBER> physical mental conditions associated covid<NUMBER> <NUMBER> details medications using requirements medical care questions designed single choice multiple choices yes offered questions answers choices required fill questionnaire still open recruitment questionnaire supplement present preliminary data first respondents baseline characteristics presented number categorical data mean ae standard deviation median interquartile range appropriate continuous data percentage applied illustrating constitution comparison made variables using students ttest wilcoxon signedrank test continuous variables regarding distributions v <NUMBER> test categorical variables pvalue <NUMBER> considered statistically significant statistical analyses performed spss <NUMBER> ibm corp armonk ny <NUMBER> individuals invited participate survey total <NUMBER> ph patients <NUMBER> family members <NUMBER> provinces responded <NUMBER> march <NUMBER> <NUMBER> march <NUMBER> questionnaires included final analysis total <NUMBER> n ¼ <NUMBER> participants hubei among <NUMBER> n ¼ <NUMBER> wuhan <NUMBER> n ¼ <NUMBER> henan <NUMBER> n ¼ <NUMBER> anhui <NUMBER> n ¼ <NUMBER> came <NUMBER> provinces shown fig <NUMBER> patients family members completed survey <NUMBER> families however failed identify due design table <NUMBER> shows general information participants overall participants aged <NUMBER> ae <NUMBER> years total <NUMBER> patients suffered ph seven years three family participants know ph history relatives possibly due different etiology <NUMBER> chdpah contributed ph groups <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> family participants p <NUMBER> total <NUMBER> n ¼ <NUMBER> participants home quarantine covid<NUMBER> outbreak table <NUMBER> shows majority participants <NUMBER> <NUMBER> felt much change disease progress surprisingly patients less severe symptoms <NUMBER> n ¼ <NUMBER> participants proclaimed new york heart association heart functional class <NUMBER> <NUMBER> class ii total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants reported disease progression fatigue less active reported patients <NUMBER> vs <NUMBER> p ¼ <NUMBER> however cough common patients family participants <NUMBER> vs <NUMBER> p ¼ <NUMBER> shown fig <NUMBER> symptoms others included sleeping well chest pain aching pain limbs catching cold recovered three <NUMBER> patients hospitalized covid<NUMBER> outbreak two heart failure one due pneumonia none family participants reported death patients actually three patients passed away <NUMBER> march <NUMBER> one patients died due unexpected fall unable go hospital outbreak two died worsening pah deaths reported family privately included survey fever important symptom indicating covid<NUMBER> survey <NUMBER> n ¼ <NUMBER> patients fever highest temperature <NUMBER> c one patient confirmed sarscov<NUMBER> infection two patients reported covid<NUMBER> related symptoms cough families family participants denied covid<NUMBER> related symptoms either patients bosentan ambrisentan tadalafil sildenafil commonly used medications target therapy shown fig <NUMBER> specifically ambrisentan preferred <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants chose chinese generic ambrisentan lower price chinese generic medication <NUMBER> patients enrolling clinical trial using macitentan free patients sensitive shortage medications family participants <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> p ¼ <NUMBER> <NUMBER> participants <NUMBER> patients <NUMBER> family participants thought enough medications time survey least <NUMBER> days national lockdown shown fig <NUMBER>a total <NUMBER> n ¼ <NUMBER> patients able buy medications great effort however <NUMBER> n ¼ <NUMBER> discontinued one medications <NUMBER> <NUMBER> patients changing medications without consulting doctors shown fig <NUMBER>a two previously took macitentan total <NUMBER> participants <NUMBER> thought medications shortage covid<NUMBER> outbreak shown fig <NUMBER>b psychological conditions <NUMBER> patients n ¼ <NUMBER> family participants n ¼ <NUMBER> panic <NUMBER> <NUMBER> thought protection important shown fig <NUMBER>a though <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants felt bad due disease <NUMBER> <NUMBER> patients <NUMBER> family participants participants still kept optimistic time shown fig <NUMBER>b ph patients families requested medical care despite lack clear clinical worsening according survey total <NUMBER> n ¼ <NUMBER> patients <NUMBER> n ¼ <NUMBER> family participants would like contact doctors covid<NUMBER> outbreak <NUMBER> n ¼ <NUMBER> patients would go hospital followup immediately public transportation available eight preferred hospitalization <NUMBER> n ¼ <NUMBER> family participants would ask relatives ph go hospital soon possible similar patients additionally <NUMBER> n ¼ <NUMBER> family participants would also encourage patients positive outbreak covid<NUMBER> changed peoples life last winter specifically patients chronic diseases might suffer high risk covid<NUMBER> uncontrolled existing diseases time ph patients require sustained medical care similar chronic diseases interruption medications may result clinical worsening death however living condition covid<NUMBER> unknown smallscale national survey brought insight group results questionnaire indicated incidence covid<NUMBER> higher ph patients according survey regardless incidental cough fever patients one patient confirmed sarscov<NUMBER> infection medication insufficiency common problem patients nearly <NUMBER> participants implied medications shortage covid<NUMBER> outbreak total <NUMBER> patients discontinued medications <NUMBER> patients changed medications without consulting doctor total <NUMBER> participants stayed home outbreak depressed either ph covid<NUMBER> according survey however requirements medical care might significantly increase due high desire followup even hospitalization patients families covid<NUMBER> outbreak early studies covid<NUMBER> patients often stayed wuhan history exposure confirmed cases family cluster also observed several cases <NUMBER> <NUMBER> n ¼ <NUMBER> participants wuhan study might result hospital location one patients groups hubei none reported covid<NUMBER> neither patients family participants persontoperson transmission confirmed covid<NUMBER> <NUMBER> lockdown wuhan began <NUMBER> january <NUMBER> prevent spread infectious disease total <NUMBER> patients families home quarantine covid<NUMBER> outbreak might key factor prevented patients infected previous studies showed <NUMBER> patients covid<NUMBER> existing diseases diabetes hypertension cardiovascular diseases males vulnerable mean age patients <NUMBER> years different study cohort <NUMBER> <NUMBER> <NUMBER> participants <NUMBER> years old mean age much younger previous covid<NUMBER> patients study cohort consisted <NUMBER> females quite different proportion covid<NUMBER> addition patients chdpah maintained fairly well heart function therefore younger age females different etiology better cardiac function ph patients might result lower incidence covid<NUMBER> similar chronic diseases ph patients take lifetime medications higher medication adherence <NUMBER> bosentan first used pah <NUMBER> <NUMBER> significantly improved sixminute walk distance heart function since targeted treatment extended half patients life three even five years <NUMBER> combination therapy recommended recent years reduced adverse events slowed ph progression <NUMBER> <NUMBER> <NUMBER> <NUMBER> study patients took ambrisentan bosentan partly due lower price chinese generic medication total <NUMBER> patients taking macitentan free treprostinil used patients high price inconvenience chdpah pulmonary arterial hypertension associated congenital heart disease cteph chronic thrombotic embolism pulmonary hypertension ctdpah pulmonary arterial hypertension associated connective tissue disease ipah idiopathic pulmonary arterial hypertension na applicable nyha new york heart association ph pulmonary hypertension intravenous application <NUMBER> luckily <NUMBER> patients able continue medications great effort national lockdown different cardiovascular diseases ph target medications expensive unavailable small cities might result shortage medications ph patients lockdown cities additionally prevented patients getting supplement nearly <NUMBER> patients either discontinued medications changed without consultation tried help patients buy medications however shutdown public transportations made process difficult could hardly predict prognosis changed treatment less <NUMBER> days interruption treatment around three days might tolerated <NUMBER> clinical worsening might happen due discontinuation medications <NUMBER> patients preferred clinic visiting consult doctors modification patients showed higher desire contact doctors even though provided online consultation survey mental condition ph patients aroused attentions recent years concerns invasive examination disease progression social interactions may directly impact tolerance treatment <NUMBER> outbreak covid<NUMBER> brought unexpected crisis first wuhan spread cities surprisingly ph patients families mostly panicking outbreak overall positive optimistic even though shortages medications reasons response might follows first ph patients stayed home familiar comfort second many clinical worsening patients disease condition mostly constant outbreak maintained optimism third doctors active patients groups including available consultation online offering assistance medication supplement might helpful reduce anxiety results provided preliminary view living condition ph patients covid<NUMBER> china however several limitations study need addressed first <NUMBER> ph patients participating survey smallscale survey might give us general information also might bring bias aspects results might highlight chdpah due chdpah contributed study population study try include patients get details questionnaire designed generate information patients family members however failed match patients family members beginning studies could avoid mistakes focus patients second survey started <NUMBER> days wuhan lockdown lasted <NUMBER> days ph patients might still stable short time studies conducted later longer might observe clinical worsening anxiety patients families although death reported survey three patients passed away based knowledge neither patients families would participate survey critical condition therefore results might optimistic real world followup real mortality initialed third many uncertainties online survey involved question estimate whether participants seriously taking survey result showed <NUMBER> patients <NUMBER> family participants went survey carefully indicated might misunderstanding incorrect answers smallscale national survey first investigated living condition ph patients covid<NUMBER> disease spreading world doctors aware ph patients could invulnerable covid<NUMBER> good protection sustaining medical care including medication supplement important ph patients time covid<NUMBER> might impact ph patients psychologically physically higher hospitalization even death might seen outbreak covid<NUMBER> pandemic caused sarscov<NUMBER> demonstrated broad spectrum presentations ranging asymptomatic disease severe respiratory failure myocardial injury death <NUMBER> patients hospitalized covid<NUMBER> evidence myocardial involvement manifested elevated troponin levels <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalent cardiac expression angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> target sarscov<NUMBER>s spike protein implicated pathophysiology associated myocardial injury multiple pathways myocardial injury fig <NUMBER> including type <NUMBER> <NUMBER> myocardial infarction myocarditis vasculitis mechanisms related inflammation thrombosis andor stress depending type myocardial injury may important sequelae residual inflammation fibrosis exists sarscov<NUMBER> new pathogen longterm data cardiovascular abnormalities dysrhythmias may occur convalescent phase patients covid<NUMBER> plausible myocardial involvement initiator pathway inflammation subsequent fibrosis <NUMBER> extent distribution fibrosis produces electrophysiologic abnormalities predispose atrial fibrillation ventricular arrhythmias early detection intervention could improve longterm outcomes patients asymptomatic overt clinical cardiac disease would benefit standard therapy patients subclinical disease may risk cardiac arrhythmias therefore identification survivors covid<NUMBER> infections subclinical myocardial disease andor arrhythmias creates rationale consider agents demonstrated cardioprotective properties mineralocorticoid antagonists betablockers statins <NUMBER> given large number covid<NUMBER> survivors enhanced surveillance treatment significant electrophysiologic abnormalities could substantially lower burden subsequent morbidity mortality treatment covid<NUMBER> infections included standard novel experimental therapies specific antiviral antiinflammatory immunosuppressive cellbased therapies continue evolve <NUMBER> <NUMBER> nevertheless hypothesize substantial number patients survive covid<NUMBER> evidence myocardial injury time initial presentation may longterm overt subclinical myocardial andor electrophysiologic abnormalities unknown whether severity cardiopulmonary injury type treatment host factors influences long term sequelae heightened surveillance therefore warranted patients consideration primary prevention approaches despite novelty covid<NUMBER> infections numerous case reports case series editorials review articles cardiovascular complications acute covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> review highlight potential cardiovascular arrhythmia complications may occur convalescent phase survivors covid<NUMBER> infection sarscov<NUMBER> caused global covid<NUMBER> pandemic serious infections major morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> virus attaches ace<NUMBER> found extensively alveolar tissue myocardial tissue <NUMBER> numerous studies shown ace<NUMBER> cardioprotective transmembrane protein whose expression downregulated sarscov<NUMBER> virus infection <NUMBER> including macrophage infiltration suggests direct causal effect viral infiltration associated inflammation also noted study patients sarscov infection heart suffered significantly aggressive illness succumbed earlier death compared sarscov without myocardial infiltration <NUMBER> cardiac involvement patients covid<NUMBER> table <NUMBER> attributed multiple mechanisms patterns injury fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> evidence myocardial involvement manifested elevated troponin levels associated worse shortterm outcomes table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> case series <NUMBER> patients covid<NUMBER> elevated troponins without history cardiovascular disease associated malignant arrhythmias acute respiratory failure higher mortality interestingly patients known cvd without elevated troponins favorable outcome <NUMBER> acute cardiac injury portends worse prognosis greater need mechanical ventilation higher mortality shi colleagues <NUMBER> reported cardiac injury associated acute respiratory distress syndrome ards acute kidney injury coagulation disorders coagulation disorders metabolic derangements acute kidney injury also contribute cardiac injury mechanisms cardiac injury fig <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> evidence myocardial involvement manifested elevated troponin levels associated worse shortterm outcome table <NUMBER> acute cardiac injury portends worse prognosis greater need mechanical ventilation higher mortality shi colleagues <NUMBER> reported cardiac injury associated acute respiratory distress syndrome acute kidney injury coagulation disorders coagulation disorders metabolic derangements acute kidney injury also contribute cardiac injury acute stsegment elevation myocardial infarction well recognized viral respiratory illnesses <NUMBER> study kwong et al showed incidence acute coronary syndrome <NUMBER> times high within first seven days influenza diagnosis <NUMBER> recommendations experts suggest patients preferentially treated fibrinolytic therapy <NUMBER> therefore patients acute stsegment myocardial infarction covid<NUMBER> may expected larger infarcts fibrinolytic therapy result timely complete reperfusion given high prevalence cardiac injury reasonable expect spectrum heart disease present residual postmyocarditis abnormalities fact media recent reports already suggested patients suffer new onset cardiomyopathy convalescent phase covid<NUMBER> infection httpswwwnbcnewyorkcomnewscoronaviruscoronavirusaftereffectsnydoctordevelopsheartdiseaseafterrecovery<NUMBER> current data longterm covid<NUMBER> cardiovascular complications would instructive review recovery types myocardial injury patients acute coronary syndrome type mi standard followup care warranted chapman colleagues studied consecutive hospital inpatients elevated troponins <NUMBER> patients type ii mi supplydemand mismatch evidence ischemia cardiac injury elevated troponin evidence ischemia compared patients type mi <NUMBER> years followup patients type ii mi andor cardiac injury significantly higher rates major cardiovascular events adjustment clinical covariates higher rates noncardiovascular death <NUMBER> data would relevant patients recovered covid<NUMBER> associated cardiac injury patients stress induced myocardial injury longterm followup patients takotsubo cardiomyopathy may relevant one recent small study patients recovered takotsubo cardiomyopathy demonstrated longterm symptomatic functional impairment despite normalized ejection fraction <NUMBER> however mri study reveal late gadolinium enhancement although atrial ventricular arrhythmias common acute phase appear significant risk ventricular arrhythmias convalescent phase recovery takotsubo cardiomyopathy <NUMBER> microemboli andor microvascular coronary dysfunction posited one mechanisms acute coronary injury covid<NUMBER> preclinical studies microemboli demonstrated vasoconstriction inflammation increase tumor necrosis factor α <NUMBER> microemboli described acute percuatenous coronary interventions may lead microvascular dysfunction heart failure <NUMBER> covid<NUMBER> myocarditis andor fibrosis due inflammation regional local associated acute illness one study <NUMBER> patients biopsy proven inflammatory carditis <NUMBER> patients developed aborted actual sudden cardiac death andor appropriate icd shocks <NUMBER> recent study inpatients symptomatic active prior myocarditis increased prevalence atrial ventricular arrhythmias <NUMBER> moreover arrhythmic burden different among patients active versus previous myocarditis although type arrhythmias differed <NUMBER> patients previous myocarditis mean ejection fraction <NUMBER> ± <NUMBER> atrial fibrillation present <NUMBER> ventricular tachycardia present <NUMBER> late gadolinium enhancement nonischemic pattern observed cardiac mri <NUMBER> patients prior myocarditis ventricular arrhythmias occurred even among patients left ventricular ejection fraction <NUMBER> <NUMBER> longterm followup study <NUMBER> patients recovered acute myocarditis mean age <NUMBER> years authors noted heart failure hospitalizations <NUMBER> <NUMBER> currently studies specifically evaluated burden arrhythmias postmyocarditis followup particularly patients whose ventricular function recovered one study longterm survival <NUMBER> patients biopsy proven myocarditis ejection fraction ≤<NUMBER> borderline predictor mortality p<NUMBER> suggesting substantial number patients preserved left ventricular function died followup <NUMBER> series patients myocarditis also show diminished survival sudden cardiac death <NUMBER> case report describes patient myocarditis monitored ventricular fibrillation event <NUMBER> months later left ventricular function normal <NUMBER> autopsy series <NUMBER> patients sudden cardiac death identified myocarditis potential explanation significant number cases even grossly normal appearing heart finding myocarditis significant cause sudden death young notable relevant survivors covid <NUMBER> <NUMBER> myocarditis typically considered manifestations ventricle atrium also involved <NUMBER> endomyocardial biopsies patients idiopathic atrial fibrillation shown high incidence myocarditis atrial septal right ventricular biopsy specimens <NUMBER> taiwanese study found adjusted odds ratio <NUMBER> p <NUMBER> developing atrial fibrillation individuals influenza versus <NUMBER> obesity observed risk factor worse outcomes covid<NUMBER> infections ace<NUMBER> also expressed adipose tissue recent publications point pathophysiologic link covid<NUMBER> obesity <NUMBER> obesity modulates inflammatory response secretion proand antiinflammatory adipokines modulation il<NUMBER> therefore covid<NUMBER> infection interaction adipocytes may contribute deleterious outcomes <NUMBER> inflammation involving epicardial adipose tissue eat may impacted myocarditis due contiguity myocardium eat epicardial fat linked atrial fibrillation coronary artery disease <NUMBER> <NUMBER> hence covid<NUMBER> interaction epicardial fat may provide plausible link acute longterm atrial fibrillation coronary artery disease much unknown covid<NUMBER> infection like entities acute cardiac injury likely diverse response depending mechanism myocardial injury severity acute illness therapy delivered hemodynamic response host factors immunemediated factors post recovery care followup based studies patients recovered myocarditis type ii mi cardiac injury expected patients subclinical possibly overt cardiovascular abnormalities patients ostensibly recovered cardiac function may still risk coronary artery disease atrial fibrillation ventricular arrhythmias current paradigms treatment appropriately focus acute recovery unknown whether treatment given acute illness may affect future cardiovascular pathology given size pandemic important determine whether acute delivery antifibrotic therapy antiinflammatory therapy cellbased therapy antiviral therapy impacts longterm well shortterm outcomes optimal screening patients following recovery covid<NUMBER> unknown one paradigm fig <NUMBER> would define population highest risk identifying patients covid<NUMBER> infection elevated highsensitivity troponin andor bnp already shown provide important shortterm prognostic information patients followed monitor assess longterm prognostic impact covid<NUMBER> myocardial involvement screening residual cardiac involvement convalescent phase needed establish population burden longterm cardiac disease contributed covid<NUMBER> significant burden disease identified trials prophylactic therapies prevent longterm complications may appropriate type testing costeffectiveness screening tests post covid<NUMBER> myocardial dysfunctionarrhythmias need determined recommend standard ecg echocardiogram possibly cardiac monitor <NUMBER> months post recovery recognition even tests may detect subtle clinical abnormalities consideration given advanced imaging ie mri gadolinium enhancement echocardiographic strain initial testing reveals abnormalities clinically indicated future studies clarify whether postcovid<NUMBER> cardiac syndrome best manage patients recovering covid<NUMBER> cardiac involvement currently facing pandemic unseen lifetime potential longterm cardiovascular complications time action plan appropriate registries american heart association covid<NUMBER> registry clinical studies assess incidence significance potential midand longterm cardiac abnormalities dysrhythmias hope promise mitigate longterm sequelae central illustration flow chart recommendations identify patients cardiac injury acute phaseobtain troponin tn brain natriuretic peptide bnp following identification patients potential cardiac injury recommendation screen patients electrocardiogram ecg echocardiogram echo depending symptoms cardiac monitor may considered testing treatment would guided patients symptoms cardiac risk factors findings initial testing novel coronavirus disease covid<NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> become pandemic since initial outbreak december <NUMBER> wuhan china <NUMBER> risk factors severe outcomes increasingly reported early reports china indicated patients underlying cardiovascular disease <NUMBER> mortality rate compared <NUMBER> case fatality rate general population <NUMBER> data european north american infection hotspots suggest older age hypertension diabetes coronary artery disease associated higher odds mortality <NUMBER> <NUMBER> therefore might postulated covid<NUMBER> may uniquely endangering patients heart failure common cause death disability united states however little known prevalence infection among heart failure patients covid<NUMBER> endemic regions risk factors associated clinical deterioration yale new health system one largest academic integrated health care systems us <NUMBER> hospitals <NUMBER> licensed beds care majority heart failure patients connecticut created curated realtime registry within systemthe yale heart failure registry nct<NUMBER>that currently includes <NUMBER> patients diagnosis hf contains detailed information demographics comorbidities laboratory imaging studies medications clinical outcomes including hospital readmissions aim report describe demographic characteristics coexisting conditions early outcomes among realworld registry heart failure patients tested covid<NUMBER> hotspot rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> queried yale heart failure registry nct<NUMBER> april <NUMBER> th <NUMBER> patients tested covid<NUMBER> briefly yale heart failure registry live registry patients seen within integrated yale new health system figure <NUMBER> meet following evaluation logic patient least one encounter within health system last <NUMBER> years meets one four criteria <NUMBER> problem list contains systematized nomenclature medicine clinical terms snomedct concept heart failure <NUMBER> encounter diagnosis contains snomedct concept heart failure two face face encounters within last <NUMBER> months <NUMBER> encounter diagnosis contains snomedct concept heart failure least <NUMBER> admission within last <NUMBER> months <NUMBER> coded diagnosis contained within one drgs <NUMBER> <NUMBER> <NUMBER> heart failure least <NUMBER> admission within last <NUMBER> months note conditions yale electronic health record ehr use snomedct standard vocabulary diagnosis codes registry exclusions age<NUMBER> cardiac failure obstetrical surgery procedure cardiac insufficiency resulting procedure registry detailed information demographics comorbidities laboratories left ventricular ejection fraction lvef medications geospatial mapping clinical outcomes including hospital readmissions registry data linked national death index centralized database death record information file state vital statistics offices registry updated daily queried clinically relevant questions aimed research quality improvement registry undergone extensive quality control independent cardiologists rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity pharmacists found near identical patient characteristics published registry data heart failure patients <NUMBER> institutional review board irb yale university school medicine approved study yale new health system one single integrated electronic health record system across <NUMBER> hospitals single instance epic epic corporation verona wi common drug formulary set decision support tools order sets standardized across system expert clinicians different hospitals participated create standardized covid<NUMBER> order sets documentation templates smart phrases use hospitals physicians providers however enter specific individual orders outside covid order sets appropriate individual patients system wide guidance standardize treatment supplementary data brief admitted patients confirmed sarscov<NUMBER> infection initiated treatment either hypoxic evidence lower respiratory tract involvement either symptoms andor chest radiography hydroxychloroquine utilized antiviral properties patients required mechanical ventilation ecmo combination hypoxia hyperinflammatory state tocilizumab used antiinflammatory properties via il<NUMBER> receptor inhibition rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity continuous variables presented median interquartile range iqr categorical variables expressed number patients percentage χ <NUMBER> mannwhitney rank sum tests used compare categorical variables predictors testing covid<NUMBER> done using stepwise logistic regression selection akaike information criterion aic evaluated cstatistic delongs test r version <NUMBER> mass proc package logistic regression used assess association demographic variables outcomes statistical tests <NUMBER>tailed statistical significance defined p<NUMBER> analyses performed using stata version <NUMBER> statacorp based data extracted yale heart failure registry april <NUMBER> th <NUMBER> found <NUMBER> patients <NUMBER> total registry patients n<NUMBER> tested table <NUMBER> hf registry patients tested covid<NUMBER> <NUMBER> positive tested positive significantly likely older black hypertensive coronary artery disease higher bun creatinine baseline rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint significantly less likely renin angiotensin system ras blockers time diagnosis note use sodiumglucose cotransporter<NUMBER> inhibitors sglt<NUMBER>i directacting oral anticoagulants doacs diuretics statins also lower patient cohort significantly higher percentage patients medicaid overall cohort multivariable modeling revealed black race hypertension lung disease less doac statin use number prior hospital admissions independent predictors testing positive covid<NUMBER> p<NUMBER> auc <NUMBER> shown patients tested negative tended diffusely spread across state tested positive largely clustered around cities bridgeport new connecticut testing associations baseline demographics age sex race bmi hfref key clinical outcomes intensive care unit icu admission intubation death revealed following bmi associated increased risk icu certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> significantly likely treated hydroxychloroquine azithromycin atazanavir likely reflecting advanced disease died also significantly likely admitted icu require intensive oxygen support intubation rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity realworld analysis live heart failure registry across large integrated health care system found <NUMBER> patients <NUMBER> symptoms met criteria able get covid<NUMBER> testing among patients tested <NUMBER> positive tended cluster around cities bridgeport new covid<NUMBER> patients likely black comorbid conditions less likely renin angiotensin blockade time testing covid<NUMBER> heart failure patients <NUMBER> died tended elderly mean age <NUMBER> white patients hfpef entirety data demonstrate need greater geographical based testing interventions particularly vulnerable communities greater focus goals care discussions among elderly heart failure patients test positive first report describing impact covid<NUMBER> infection geographically contained population heart failure patients purview integrated health care system found although testing scattered across state tested positive tended cluster around two citiesnew bridgeport two cities lowest median household income state <NUMBER> <NUMBER> versus <NUMBER> state highest percentage black inhabitants <NUMBER> <NUMBER> versus <NUMBER> state <NUMBER> disparity testing infection rates recently noted preliminary data showing underrepresented minorities developing covid<NUMBER> infection frequently <NUMBER> causes finding multifaceted hypothesized include disproportionate number minorities exposed covid<NUMBER> roles rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint essential workers spread disease residentially segregated communities taken together findings suggest urgent need nuanced strategy tackle disparate impact virus across vulnerable populations including heart failure particularly high risk interestingly noted significantly greater use renin angiotensin blockade untested negative patients registry compared patients registry aceiarb therapies <NUMBER> likely covid<NUMBER> furthermore rates also significantly lower patients tested negative whereas crosssectional observational data corroborate recent reports china demonstrating potential benefit therapies among covid<NUMBER> patients <NUMBER> least might suggest therapies increase risk patients heart failure supports ahaacchfsa statement supporting ongoing use renin angiotensin blockade heart failure patients pandemic <NUMBER> study shows large portion deaths occurred elderly patients high rates mortality morbidity described older patients italy however less <NUMBER> cohort <NUMBER> years <NUMBER> cohort noted <NUMBER> covid<NUMBER> positive patients ≥<NUMBER> years old patients hospitalization rates approximately <NUMBER> <NUMBER> died time analysis rest except one patient remained hospitalized suggests urgent need early goals care discussions elderly heart failure patients test positive covid<NUMBER> given long hospitalizations high mortality rates despite aggressive treatment <NUMBER> <NUMBER> limitations rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity study several notable limitations first included patients tested covid<NUMBER> patients registry infection might uncounted due either asymptomatic pursue testing symptoms may offered diagnostic testing currently practice medical centers across united states findings considered conservative estimate expanse covid<NUMBER> hf patients communities covered registry second despite laboratory testing interventions currently performed protocolized manner across yale new health care system patients might hospitalized prior widespread application care pathway third many patients described study remain hospitalized leading likely underreporting total deaths covid<NUMBER> cohort finally study limitations inherent registry high degree granularity heart failure missing testing solely performed clinicians discretion realworld snapshot covid<NUMBER> infection among large cohort heart failure patients purview integrated health care system peak infection time found small percentage underwent testing patients found covid<NUMBER> tended black multiple comorbidities clustered around lower socioeconomic status communities state elderly covid<NUMBER> patients likely admitted hospital experience high rates mortality rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint aknowledgements would like thank ynhhysm adhoc covid<NUMBER> treatment team allowing us share yale treatment protocol entire ynhhysm healthcare team efforts support patients pandemic rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity certified peer review authorfunder granted medrxiv license display preprint perpetuity data presented median iqr continuous measures n categorical measures rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint emerging reports suggest case fatality rate ranges <NUMBER> <NUMBER> according regions <NUMBER> <NUMBER> addition sarscov<NUMBER> infection higher incidence case fatality rate among elderly <NUMBER> chronic comorbidities <NUMBER> <NUMBER> immunosuppressed patients may different epidemiology fact questioned whether <NUMBER> immunosuppression may play role sarscov<NUMBER> infection <NUMBER> speculated <NUMBER> sarscov<NUMBER> damages host two overlapping mechanisms first direct damage <NUMBER> virus second abnormal host response may lead cytokine storm aim study report series heart transplanted patients sarscov<NUMBER> infection <NUMBER> two heart transplant centers north italy describing clinical characteristics <NUMBER> prognosis impact covid<NUMBER> heart transplant programs patients evaluated heart transplant specialist conjunction infectious disease <NUMBER> specialist data collection included anamnestic demographic data pharmacological treatment <NUMBER> immunosuppressive therapy physical evaluation clinical data first medical contact <NUMBER> laboratory radiological findings performed diagnosis treatment followup followup <NUMBER> performed direct phone clinical examination fever defined axillary temperature <NUMBER>°c higher leukopenia lymphocytopenia <NUMBER> defined count less <NUMBER> <NUMBER> cells per cubic millimetre respectively severe heart transplant programs covid era <NUMBER> since outbreak covid<NUMBER> italy specific protocols infection restraint applied <NUMBER> covid<NUMBER>free paths identified inside hospitals particular history contacts <NUMBER> confirmed suspected cases covid<NUMBER> carefully investigated donors <NUMBER> recipients rtpcr bronchoalveolar lavage performed donors negative <NUMBER> donors considered transplant recipients tested nasopharyngeal swab <NUMBER> negative patients accepted surgery surgery admission <NUMBER> dedicated covidfree intensive care unit second test bronchoalveolar lavage performed confirm absence virus induction maintenance immunosuppressive therapy <NUMBER> change icu discharge patients followed covid<NUMBER>free ward different <NUMBER> paths outpatients also identified outpatient followup regularly performed <NUMBER> without changes scheduled program recent transplanted patients followup <NUMBER> patients transplanted one year performed phone urgent visits <NUMBER> carried anyway entering transplant centre patients routinely tested <NUMBER> sarscov<NUMBER> positive followed dedicated rooms dedicated catheterization <NUMBER> echodoppler laboratories beginning february end march <NUMBER> twentysix heart transplanted recipients <NUMBER> microbiologically confirmed sarscov<NUMBER> infection among total seven hundred <NUMBER> forty patients followed two heart transplant centres incidence sarscov<NUMBER> infection <NUMBER> <NUMBER> least median followup <NUMBER> days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> followup <NUMBER> deaths <NUMBER> <NUMBER> occurred <NUMBER> patients hospitalized <NUMBER> fifteen patients hospitalization <NUMBER> scheduled inhospital visit <NUMBER> patients close contact confirmed case covid<NUMBER> <NUMBER> two weeks sarscov<NUMBER> testing testing performed symptomatic patients <NUMBER> patients regardless symptoms requiring outpatient clinic admission tested total <NUMBER> <NUMBER> patients positive patients older <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> years p <NUMBER> recently table <NUMBER> eighteen patients <NUMBER> least one comorbidity frequent ones <NUMBER> arterial hypertension chronic kidney disease seven patients <NUMBER> received heart <NUMBER> transplantation begin covid<NUMBER> outbreak china immunosuppressive treatment <NUMBER> shown table <NUMBER> cyclosporin frequent calcineurin inhibitor <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> received three immunosuppressive drugs including oral steroids patients died older survived <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> years respectively <NUMBER> p<NUMBER> higher incidence chronic kidney disease diabetes <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> respectively patients received heart transplantation begin <NUMBER> covid<NUMBER> outbreak survived <NUMBER> vs <NUMBER> patients p<NUMBER> patients receiving oral steroids <NUMBER> vs <NUMBER> patients steroids p<NUMBER> association calcineurin <NUMBER> inhibitors trough levels adverse events found clinical presentation described table <NUMBER> frequent symptom fever <NUMBER> <NUMBER> followed cough <NUMBER> dyspnea gastrointestinal symptoms less frequent <NUMBER> e <NUMBER> <NUMBER> respectively cough fever present two patients <NUMBER> presentation first <NUMBER> symptom fever <NUMBER> cough <NUMBER> gastrointestinal symptoms occurred patients <NUMBER> taking mycophenolate first clinical evaluation <NUMBER> patients <NUMBER> low oxygen saturation room air <NUMBER> <NUMBER> oxygen desaturation walk test respiratory rate higher <NUMBER> breaths per minute <NUMBER> recorded <NUMBER> patients <NUMBER> <NUMBER> patients <NUMBER> partial pressure oxygen lower <NUMBER> <NUMBER> mmhg patients died higher respiratory rate lower oxygen saturation first <NUMBER> clinical evaluation p<NUMBER> <NUMBER> <NUMBER> patients chest xray performed <NUMBER> patients <NUMBER> presented signs pneumonia ct <NUMBER> scan performed <NUMBER> patients showing interstitial involvement diffuse bilateral ground<NUMBER> glass opacities patients laboratory tests detailed table <NUMBER> leukopenia found <NUMBER> patients <NUMBER> <NUMBER> lymphopenia <NUMBER> <NUMBER> elevated creactive protein found <NUMBER> patients <NUMBER> among variables first clinical contact best predictors mortality age higher <NUMBER> <NUMBER> years procalcitonin higher <NUMBER> ngml oxygen saturation room air lower <NUMBER> <NUMBER> area curve <NUMBER> <NUMBER> <NUMBER> respectively table <NUMBER> cohort two centers north italy two centers located epicenter <NUMBER> italian epidemic testing performed patients symptoms requiring <NUMBER> outpatient clinic admission therefore real incidence cohort probably underestimated <NUMBER> however data show incidence sarscov<NUMBER> infection transplanted patients <NUMBER> higher overall italian population <NUMBER> higher incidence may related moreover mortality rate cohort higher expected fact italy general <NUMBER> population <NUMBER> years mortality rate covid<NUMBER> overall hospitalization rate <NUMBER> icu hospitalization rate <NUMBER> <NUMBER> <NUMBER> respectively cohort showed alarming <NUMBER> high rates mortality hospitalization icu admission <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> interestingly case fatality rate baseline characteristics similar recently <NUMBER> reported latif et al high case fatality rate observed heart transplanted patients may due <NUMBER> characteristics cohort evaluated analysis majority cohort <NUMBER> represented longterm heart transplanted survivors patients chronically exposed <NUMBER> long immunosuppressive therapy high risk develop sideeffects although show <NUMBER> good heart function population must considered fragile due presence different <NUMBER> comorbidities ie chronic kidney disease related long exposure immunosuppressive drugs <NUMBER> transplanted cohort association advanced age timedependent comorbidities <NUMBER> calcineurin inhibitor nephrotoxicity common complications immunosuppressive <NUMBER> therapy may detrimental also conditions often require frequent inhospital visits <NUMBER> increasing risk exposure sarscov<NUMBER> characteristics may therefore explain <NUMBER> higher incidence sarscov<NUMBER> infection severe clinical presentation higher <NUMBER> mortality rate transplanted patients incidence infection appeared unrelated time <NUMBER> transplant however recently transplanted patients survived seemed less prone <NUMBER> develop severe covid<NUMBER> transplanted longer period <NUMBER> clinical presentation similar nontransplanted patients incidence fever cough <NUMBER> line previous reports least one two present almost patients interestingly dyspnea onset less frequent associated adverse outcome gastrointestinal symptoms significantly frequent overall covid<NUMBER> <NUMBER> population <NUMBER> vs <NUMBER> difficult explain finding however patients <NUMBER> receiving mycophenolate may gastrointestinal sideeffects physical evaluation <NUMBER> radiological examination suggesting severe pneumonia onset accurate predictors <NUMBER> worse outcome diagnostic prognostic utility laboratory findings may challenged <NUMBER> since immunosuppressive drugs may reduce inflammatory response transplanted patients <NUMBER> however creactive protein procalcitonin higher patients died <NUMBER> leukopenia lymphopenia covid<NUMBER> outbreak management immunosuppression challenging <NUMBER> experience reduction immunosuppression could provide significant benefit <NUMBER> contrary strategy associated worse outcome must recognized <NUMBER> possible discriminate deterioration related strategy result <NUMBER> independent progression disease immunosuppression reduction marker <NUMBER> severely ill patients series patients oral steroids required age transplant ie <NUMBER> recent transplants recurrent acute rejection severe pneumonia died <NUMBER> moreover patients received heart transplantation within three months higher grade <NUMBER> immunosuppression ie three immunosuppressive drugs develop severe disease however must recognized results interpreted caution owing <NUMBER> potential bias residual confounders observational study small sample size <NUMBER> robust evidence required also considered patients received heart <NUMBER> transplantation last three months younger less comorbidities followed strict <NUMBER> protocol mitigation strategies quarantine social distancing characteristics may <NUMBER> adequately explain better observed outcome differences found incidence <NUMBER> covid<NUMBER> type immunosuppressive agent concentration associated <NUMBER> severity covid<NUMBER> evidence beneficial effect methylprednisolone emerged literature coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> declared international pandemic causing hospitalization deaths hundreds thousands people worldwide ramaiah arumugaswami <NUMBER> sarscov<NUMBER> singlestranded enveloped rna virus known use ace<NUMBER> receptor enter host lung tissue followed rapid viral replication hoffmann et al <NUMBER> clinical presentation demonstrates predominantly pulmonary symptoms including cough shortness breath pneumonia acute respiratory distress syndrome madjid et al <NUMBER> however mounting evidence sarscov<NUMBER> infection may cause cardiac complications including elevated cardiac stress biomarkers arrhythmias heart failure madjid et al <NUMBER> recent study demonstrated significantly elevated troponin levels among covid<NUMBER> patients indicating cardiac injury notably cardiac injury associated increased risk mortality shi et al <NUMBER>a etiology cardiac injury covid<NUMBER> however remains unclear cardiac injury may ischemiamediated profound inflammatory hemodynamic impacts seen covid<NUMBER> hypothesized cause atherosclerotic plaque rupture oxygen supplydemand mismatch resulting ischemia madjid et al <NUMBER> alternatively cardiac tissue expresses ace<NUMBER> receptor suggesting feasibility direct viral internalization cardiomyocytes chen et al <NUMBER> indeed case studies raised suspicion cardiac injury mediated direct myocardial viral infection resulting fulminant myocarditis hu et al <NUMBER> tavazzi et al <NUMBER> zeng et al <NUMBER> order gain insights cardiac pathophysiology covid<NUMBER> critical determine whether sarscov<NUMBER> directly infect isolated human cardiomyocytes vitro elucidating pathogenic mechanism cardiac injury covid<NUMBER> could ultimately guide therapeutic strategies antiviral agents could potentially mitigate cardiac complications underlying mechanism cardiac injury direct myocardial viral infection primary human cardiomyocytes difficult obtain maintain research use improved methods convert human induced pluripotent stem cells hipscs multiple somatic lineages enabled vitro mass production patientspecific cells including hipscderived cardiomyocytes hipsccms sharma et al <NUMBER> hipsccms express relevant proteins found adult human cms spontaneously contract made weeks using defined differentiation protocols genetically customized using genome editing sharma et al <NUMBER> hipsccms express ace<NUMBER> increases <NUMBER> days differentiation churko et al <NUMBER> hipsccms also responsive inotropic drugs norepinephrine beating rates controlled via electrical stimulation toepfer et al <NUMBER> hipsccms purified replated downstream applications research groups academia industry utilize cells cardiovascular disease modeling highthroughput drug screening assays hipsccms recapitulate cellular phenotypes cardiovascular diseases including various forms cardiomyopathy lan et al <NUMBER> sun et al <NUMBER> druginduced cardiotoxicity burridge et al <NUMBER> sharma et al <NUMBER> notably hipsccms also shown promise vitro model studying mechanisms direct cardiomyocyte viral infection context viral myocarditis previous study demonstrated coxsackievirus b<NUMBER> cvb<NUMBER> one major causative agents viral myocarditis rapidly infect proliferate within hipsccms sharma et al <NUMBER> cvb<NUMBER> like sarscov<NUMBER> positivesense singlestranded rna virus although unlike sarscov<NUMBER> viral envelope hipsccms produce coxsackie adenovirus receptor protein needed infection cvb<NUMBER> detrimental virusinduced cytopathic effect observed hipsccms within hours cvb<NUMBER> infection manifesting cell death contractility irregularities importantly study also established hipsccms cardiacspecific antiviral drug screening platform demonstrated drugs interferon beta ribavirin stymie cvb<NUMBER> proliferation vitro sharma et al <NUMBER> interferon beta able transcriptionally activate viral clearance gene networks cvb<NUMBER>infected hipsccms aforementioned foundational viral myocarditis study extended assess effect sarscov<NUMBER> hipsccms show hipsccms susceptible sarscov<NUMBER> infection resulting functional alterations cytopathic effects cellular phenotypes occurred absence inflammatory hemodynamic impacts results provide new mechanistic insights cardiac manifestations covid<NUMBER> suggest heart may susceptible direct infection sarscov<NUMBER> hipsc control line <NUMBER>ictr generated cedarssinai medical center ipsc core peripheral blood mononuclear cells shown fully pluripotent laperle et al <NUMBER> hipscs differentiated hipsccms using established monolayer differentiation protocol utilizing small molecule modulators wnt signaling sharma et al <NUMBER> differentiated hipsccms metabolically purified depriving cells glucose previously published sharma et al <NUMBER> purified hipsccms expressed standard cardiac sarcomeric markers cardiac troponin ctnt αactinin figure <NUMBER>a purified hipsccms replated <NUMBER>well plates <NUMBER> cells per well allowed regain contractility supplemental movie <NUMBER> subjected sarscov<NUMBER> infection sarscov<NUMBER> obtained biodefense emerging infections bei resources national institute allergy infectious diseases niaid titered veroe<NUMBER> cells see methods hipsccms infected sarscov<NUMBER> multiplicity infection moi <NUMBER> <NUMBER> hours mock treatment without virus serving control condition order determine virus could enter proliferate within hipsccms cells infected mock conditions stained cardiac marker cardiac troponin ctnt sarscov<NUMBER> viral capsid spike protein figure <NUMBER>b infected hipsccms stained positively spike protein suggesting sarscov<NUMBER> establish active infection hipsccms determine sarscov<NUMBER> induced cytopathic effect hipsccms mock infected hipsccms stained apoptosis marker cleaved caspase<NUMBER> well double stranded rna dsrna intermediate unique positive sense rna virus infection figure <NUMBER>c dsrna spike protein stains represent two independent assays visualizing sarscov<NUMBER> viral uptake genome replication hipsccms proportion infected cells positive dsrna also stained positive cleaved caspase<NUMBER> indicating hipsccms undergoing virusinduced apoptosis notably sarscov<NUMBER> spike protein dsrna intermediates localized perinuclear regions hipsccms figure <NUMBER>d <NUMBER>e consistent prior results coronavirus infection noncardiomyocytes hagemeijer et al <NUMBER> coxsackievirus infection hipsccms sharma et al <NUMBER> suggests presence viroplasm whereby hipsccm ribosomal machinery membranous components coopted viral replication protein translation quantification stained cells demonstrated percent total cells positive dsrna spike protein well cleaved caspase<NUMBER> figure <NUMBER>f simple beat rate contractility analysis also conducted whereby <NUMBER> second videos taken wells containing mock infected hipsccms supplemental movie <NUMBER> functionally infected hipsccms ceased beating <NUMBER> hours sarscov<NUMBER> infection whereas mock wells continued contract figure <NUMBER>g taken together results indicate hipsccms susceptible sarscov<NUMBER> infection downstream detrimental cytopathic effects sarscov<NUMBER> may able replicate distinct perinuclear locations within hipsccms coopting cellular organelles viral protein translation sarscov<NUMBER> infection significantly reduces functional contractility hipsccms results presented establish first time human ipscderived cardiomyocytes susceptible direct infection sarscov<NUMBER> virus may induce detrimental cytopathic effects cells moi <NUMBER> whereby approximately <NUMBER> viral particle introduced per <NUMBER> cells hipsccms experienced cytopathic effect <NUMBER> hours infection virus presumably enters cell ace<NUMBER> receptor previously shown produced hipsccms churko et al <NUMBER> immunostaining two sarscov<NUMBER> components unique dsrna intermediate spike capsid protein responsible viral entry virion particle assembly demonstrates novel coronavirus enter hipsccms unleash rna cargo hijack host hipsccm translational machinery produce new viral components notably dsrna spike stains localized perinuclear regions indicative formation hallmark viroplasm structures within hipsccms viroplasm inclusion body within cytoplasm recruits host cellular components ribosomes chaperones mitochondria establish de facto viral replication factory within cell netherton wileman <NUMBER> perinuclear viral component accumulation reported vitro coronavirus infection studies hagemeijer et al <NUMBER> parallels seen hipsccms infected coxsackievirus b<NUMBER> sharma et al <NUMBER> presumably increased viral load within hipsccms activated downstream apoptotic events indicated alterations cellular morphologies increased production cleaved caspase<NUMBER> parallel stains showing viral accumulation functional alteration hipsccm contractility cells ceased beating cause dramatic functional change hipsccm beating must investigated perhaps cytopathic effect associated hipsccm apoptosis significantly disrupted cellcell gap junctions therefore impaired proper excitationcontraction coupling within cardiomyocytes indeed significant alterations calcium handling contractility similarly observed cvb<NUMBER>infected hipsccms sharma et al <NUMBER> additional work remains done elucidate cardiomyocytespecific effects sarscov<NUMBER> particular impacts cell function gene expression cellular immaturity hipscderivative cell types must considered model known hipsccms electrophysiologically structurally genetically immature comparison adult counterparts bedada et al <NUMBER> although biomechanical efforts mature cells towards adult phenotype recently gained traction ronaldsonbouchard et al <NUMBER> however even immature cells current study showed overt virusinduced cardiotoxicity physiological effects low sarscov<NUMBER> moi since expression ace<NUMBER> increases hipsccms mature vitro culture churko et al <NUMBER> one could hypothesize maturation older cardiomyocytes would even susceptible sarscov<NUMBER> infection significant additional data needed test possibilities results presented isolated vitro system devoid immune system components thought critical many aspects covid<NUMBER> viral response vivo shi et al <NUMBER>b resulting myocarditis definition inflammation myocardium caused immune cell infiltration may may result direct cardiomyocyte viral infection however shown human ipscderived cardiomyocytes clearly susceptible sarscov<NUMBER> infection even absence immune response suggesting possibility direct infection heart playing role clinical syndrome indeed recent study using biopsied heart tissue shows sarscov<NUMBER> virus myocardium covid<NUMBER> patient tavazzi et al <NUMBER> needs replicated raises question whether sarscov<NUMBER> enters heart via viremic phase macrophages clearing virus lungs nevertheless studies suggest cardiomyocyte infection may contribute variety cardiac clinical sequelae presented patients covid<NUMBER> arrhythmias elevated cardiac troponin biomarkers heart failure predict future studies able use hipsccms cardiacspecific antiviral drug screening platform similar fashion previous studies coxsackievirus b<NUMBER> hipsccms sharma et al <NUMBER> variety antiviral approaches ranging repurposed small molecules nucleoside analogues viral polymerase inhibitors novel antibodies antisense oligonucleotides proposed covid<NUMBER> currently tested vitro clinical trials harrison <NUMBER> hipsccms could serve cardiacspecific auxiliary cell type vitro preclinical efficacy studies drug aiming stymie sarscov<NUMBER> proliferation parallel druginduced arrhythmias qtinterval prolongation also examined antiviral compounds preclinical development given existing covid<NUMBER> drug treatments exhibit offtarget cardiotoxicities roden et al <NUMBER> due enormity current covid<NUMBER> pandemic increasing evidence associated cardiac symptoms innovative approaches using technologies hipsccms presented critical understand counteract sarscov<NUMBER> infection appropriate institutional review board irb stem cell research oversight committee scro consulted ucla cedarssinai medical center <NUMBER>ictr hipsc line derived human peripheral blood mononuclear cells published previously laperle et al <NUMBER> cell line obtained cedarssinai medical center ipsc core facility derived irbscro protocol pro<NUMBER> ipsc core repository stem cell program ipsc differentiation work svendsen lab carried pro<NUMBER> svendsen stem cell program authorized cedarssinai medical center irb hipsccms generated hipscs using smallmolecule mediated differentiation approach modulates wnt signaling sharma et al <NUMBER> briefly approach uses chir<NUMBER> gsk<NUMBER>β inhibitor initiate mesoderm specification followed wntc<NUMBER> wnt inhibitor initiate cardiac specification cells began beating approximately day <NUMBER> postdifferentiation cardiomyocytes metabolically selected differentiated cells using glucose deprivation previously described sharma et al <NUMBER> selection hipsccms replated monolayer <NUMBER>well plate format <NUMBER> cells per well hipsccm culture medium rpmi <NUMBER> b<NUMBER> supplement insulin sarscov<NUMBER> isolate usawa<NUMBER> obtained biodefense emerging importantly studies involving sarscov<NUMBER> infection hipsccms conducted within biosafety level <NUMBER> facility ucla sarscov<NUMBER> passaged veroe<NUMBER> cells viral stocks aliquoted stored <NUMBER> c virus titer measured veroe<NUMBER> cells tcid<NUMBER> assay veroe<NUMBER> cells cultured dmem growth media containing <NUMBER> fetal bovine serum <NUMBER> mm lglutamine penicillin <NUMBER> unitsml streptomycin <NUMBER> unitsml <NUMBER> mm hepes cells incubated <NUMBER>°c <NUMBER> co<NUMBER> hipsccm infection viral inoculum moi <NUMBER> prepared using serumfree media culture media well containing hipsccms removed replaced <NUMBER> µl prepared inoculum mock infection serumfree media <NUMBER> µlwell alone added inoculated plates incubated <NUMBER> hour <NUMBER>°c <NUMBER> co<NUMBER> inoculum spread gently tilting plate sideways every <NUMBER> minutes end incubation inoculum replaced fresh hipsccm culture medium cells remained <NUMBER>°c <NUMBER> co<NUMBER> <NUMBER> hours analysis <NUMBER> hours sarscov<NUMBER> infection mock live cell images videos obtained bright field microscope leica dmil led immunofluorescence separate wells hipsccms fixed <NUMBER> paraformaldehyde phosphatebuffered saline pbs <NUMBER> minutes fixed samples permeabilized blocked <NUMBER> hour blocking solution containing pbs <NUMBER> bovine serum albumin <NUMBER> donkey serum <NUMBER> goat serum <NUMBER> triton x<NUMBER> primary antibodies diluted blocking solution added samples ab<NUMBER> samples rinsed <NUMBER> times <NUMBER> minutes pbs containing <NUMBER> triton x<NUMBER> followed dapi diluted pbs <NUMBER> <NUMBER> minutes immunofluorescence images quantified using imagej software dapi used count total cell numbers order obtain percentage cells positive dsrna spike protein cleaved caspase<NUMBER> thirtysecond video clips taken mock infected hipsccms <NUMBER> hours viral infection beatsperminute measurement obtained manually counting individual beats <NUMBER>second video multiplying <NUMBER> extrapolate <NUMBER> minute statistical analyses students test used comparison two datasets error bars refer standard deviation p value <NUMBER> considered statistically significant va cns designed analyses analyzed data drafted manuscript gg conducted experiments acquired data va cns analyzed data authors contributed final manuscript acknowledge review represents area study dramatically growing relevance thus apologize authors whose work able include authors declare competing interests human ipsccms exhibit standard sarcomeric markers including cardiac troponin ctnt αactinin dapi nuclear counterstain b immunofluorescence ctnt sarscov<NUMBER> spike protein demonstrates hipsccms infected sarscov<NUMBER> sarscov<NUMBER> spike protein present mock infected cultures c hipsccms sarscov<NUMBER> infection mock infection exhibit signs cellular apoptosis indicated morphological changes seen bright field bf cleaved caspase<NUMBER> production second sarscov<NUMBER> antibody marks viralspecific doublestranded intermediate rna dsrna magnified inset panel b shows merged immunofluorescence image sarscov<NUMBER> spike protein dapi arrows indicate perinuclear accumulation viral particles suggests active viral protein translation genome replication perinuclear ribosomes membranous compartments e magnified inset panel c shows merged immunofluorescence image sarscov<NUMBER> dsrna dapi arrows indicate perinuclear viral replication sites f quantification immunofluorescence indicates percentage total dapipositive cells positive spike protein viral dsrna cleaved caspase<NUMBER> cc<NUMBER> dsrnacc<NUMBER> hipsccms infected sarscov<NUMBER> compared mock infection n<NUMBER> images quantified stain mock infected conditions g quantification beats per minute wells containing hipsccms mock infection versus wells containing hipsccms infected sarscov<NUMBER> n<NUMBER> videos recorded condition see supplemental movie <NUMBER> representative video clips indicates p <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> pandemic caused severe acute <NUMBER> respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> infected <NUMBER> patients <NUMBER> linked <NUMBER> deaths worldwide may <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> infection <NUMBER> triggered binding angiotensinconverting enzyme<NUMBER> ace<NUMBER> highly expressed <NUMBER> nasopharynx lungs well cardiovascular system gastrointestinal <NUMBER> reviewed published literature including multiple search strategies <NUMBER> medline pubmed interface critically assessed early reports medrxiv <NUMBER> httpswwwmedrxivorg electronic search executed employing keywords <NUMBER> cardiovascular cardiac heart coronavirus <NUMBER> covid<NUMBER> <NUMBER> sarscov<NUMBER> <NUMBER> may <NUMBER> <NUMBER> language restrictions applied <NUMBER> title abstract full text articles captured search criteria assessed <NUMBER> social media twitter linkedin facebook also consulted <NUMBER> times methodologicallysound research covid<NUMBER> cardiovascular <NUMBER> manifestations hampered numerous challenges include sarscov<NUMBER> test <NUMBER> availability accuracy decision healthcare authorities screen infection <NUMBER> certain groups could lead underestimation pandemic burden heterogeneous <NUMBER> reporting across countries well fact estimates exact incidence specific <NUMBER> covid<NUMBER> complications prevalence baseline comorbidities often carried <NUMBER> suboptimal fashion eg small singlecenter cohorts isolated reports social media <NUMBER> etc limitations high degree caution criticism adopted <NUMBER> identify selective reporting biased data drawing conclusions based small <NUMBER> case series anecdotal case reports epidemiology <NUMBER> sarscov<NUMBER> transmitted people respiratory droplets fomites <NUMBER> basic reproduction number r <NUMBER> number cases one infected individual infect <NUMBER> average sarscov<NUMBER> ranges <NUMBER> <NUMBER> <NUMBER> however understand full epidemic <NUMBER> potential sarscov<NUMBER> necessary take consideration high fraction <NUMBER> <NUMBER> cases undocumented infections asymptomatic mild symptoms remains <NUMBER> unrecognized could expose far greater portion population virus <NUMBER> <NUMBER> case fatality rate covid<NUMBER> widely varies across countries ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speculated drugs could increase susceptibility developing <NUMBER> severe forms covid<NUMBER> patients preexisting cardiovascular disease receiving arb <NUMBER> acei upregulation ace<NUMBER> would therefore available great amounts <NUMBER> offer binding site sarscov<NUMBER> however concern derived invitro <NUMBER> animal studies found confirmation clinical practice <NUMBER> indeed large one possible mechanism acute myocardial injury caused sarscov<NUMBER> infection <NUMBER> could affinity ace<NUMBER> widely expressed heart cause direct <NUMBER> myocardial injury <NUMBER> <NUMBER> proposed pathways include cytokine storm triggered <NUMBER> imbalanced response type <NUMBER> type <NUMBER> thelper cells<NUMBER> sympathetic hyperactivity <NUMBER> anemia hypoxemic myocardial cells damage due respiratory dysfunction type <NUMBER> mi small metaanalysis <NUMBER> studies <NUMBER> patients standardized mean differences <NUMBER> cardiac troponin levels significantly higher severe covid<NUMBER>related <NUMBER> symptoms compared nonsevere presentation <NUMBER> myocardial injury present <NUMBER> <NUMBER> covid<NUMBER> patients associated higher levels inflammatory biomarkers <NUMBER> severe pulmonary involvement higher need noninvasive invasive ventilation series reporting <NUMBER> deaths cohort <NUMBER> covid<NUMBER> patients <NUMBER> <NUMBER> attributed myocarditis hemodynamic collapse <NUMBER> cases myocarditis <NUMBER> could played contributing role patient death <NUMBER> although clinical picture still <NUMBER> referred myocarditis many instances myocardial infection sarscov<NUMBER> <NUMBER> proven cases covid<NUMBER> myocardial involvement date isolated case <NUMBER> reports provided data pathology myocardial tissue covid<NUMBER> patients early mortality <NUMBER> interestingly angiography demonstrated absence <NUMBER> obstructive coronary artery disease <NUMBER> cases finding also reported us <NUMBER> bangalore et al <NUMBER> found nonobstructive disease onethird patients <NUMBER> underwent coronary angiography latter series prognosis stemi presentation <NUMBER> even worse previous report <NUMBER> inhospital mortality rate addition type <NUMBER> mi myocarditis stress cardiomyopathy microvascular <NUMBER> thrombosis also hypothesized mechanism underlying certain cases mimicking <NUMBER> stemi presentation without obstructive coronary artery disease given endothelial <NUMBER> dysfunction hypercoagulable state associated covid<NUMBER> table <NUMBER> potential artificial intelligence ai assist pandemic modeling <NUMBER> diagnosis covid<NUMBER> clinical manifestations immense epidemiologists public <NUMBER> health officials cannot replaced ai serve gather systematically organize rapidly <NUMBER> evolving information eg social media news media assist officials decision<NUMBER> making<NUMBER> moreover ai particularly suited massive analysis imaging data <NUMBER> moment taken advantage covid<NUMBER> pneumonitis diagnosis<NUMBER> <NUMBER> also potentially suitable cardiac applications automated interpretation <NUMBER> electrocardiograms imaging pathology specimens covid<NUMBER> pandemic represents important public health crisis <NUMBER> century health economic societal impacts felt many years come common symptoms fever dry cough dyspnea myalgias fatigue diarrhea anosmia dysgeusia uncommon symptoms sputum production headache hemoptysis rhinorrhea sore throat conjunctival injection lymphopenia prolonged prothrombin time elevated ddimer alanine aminotransferase total bilirubin lactate dehydrogenase pao<NUMBER>fio<NUMBER> <NUMBER> acute respiratory distress syndrome generally bilateral pneumonia multiple infiltrates groundgrass opacity realtime polymerasechain reaction rtpcr assay detect viral rna abbreviations fio<NUMBER> fraction inspired oxygen pao<NUMBER> partial pressure oxygen covid<NUMBER> testing telemedicine rationalization indications diagnostic therapeutic procedures conservative management firstline strategy whenever possible minimize number providers per procedure contact droplet precautions gown face mask eye protection gloves general care n<NUMBER> mask face shield papr waterproof gown gloves aerosolgenerating procedures surgical mask patients known suspected covid<NUMBER> education cardiopulmonary resuscitation use external mechanical compression devices minimize direct contact infected patients close coordination critical care anesthesia teams airway management catheterization laboratory environment switch negative pressure possible intubation prior transfer catheterization laboratory required specific consideration subspecialty care teams separation individuals overlapping skillsets guarantee continued availability care case covid<NUMBER> infection within team abbreviations papr powered airpurifying respirator recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> recent severe acute respiratory syndrome sars due coronavirus <NUMBER> cov<NUMBER> infection pandemic subsequent spread disease called covid<NUMBER> brought back discussion topic already highlighted sarscov<NUMBER> coronavirusrelated sars known middle east respiratory distress syndrome mers <NUMBER> <NUMBER> outbreaks observed particularly elevated incidence cardiovascular disease among patients also characterized elderly particular mers prevalently male <NUMBER> <NUMBER> another main topic discussion role angiotensinconverting enzyme ace <NUMBER> indeed carboxypeptidase identified functional receptor spike protein coronaviruses outer membrane including sarscov<NUMBER> <NUMBER> ace<NUMBER> strongly expressed epithelium different organs kidney heart lungs ace<NUMBER> shares large affinity amino peptidase ace target ace inhibitors class antihypertensive drugs ace inhibitors represent used class cardiovascular agents world treatment epidemic cardiovascular conditions hypertension heart failure although directly inhibited ace inhibitors ace<NUMBER> affected chronic treatment class drugs leads increase ace<NUMBER> expression several tissues <NUMBER> interestingly feature also shared another class drugs angiotensin receptor<NUMBER> blockers arbs whose chronic administration well able increase level expression ace<NUMBER> also activity assessed circulating levels ace<NUMBER> product angiotensin <NUMBER> <NUMBER> findings support concern treatment reninangiotensin system ras inhibitors could make covid<NUMBER> symptoms severe due increased expression ace<NUMBER> remarkably issues reproposed occurrence present epidemic covid<NUMBER> particular issue prevalence cardiovascular diseases among covid<NUMBER> patients proposed observational data obtained chinese <NUMBER> italian patients <NUMBER> context still lack analysis confounding effects age apparent association cardiovascular disease covid<NUMBER> infection clinical severity indeed observed prevalence male elderly patients observed especially italian covid<NUMBER> population confounding factor needs corrected conclusive association drawn concern expressed many <NUMBER> <NUMBER> <NUMBER> similarly ace<NUMBER> upregulation argument never demonstrated humans indeed conflicting evidence animal studies arbs probably ace inhibitors may upregulate membranebound ace<NUMBER> tissuespecific manners eg heart kidney data cannot extrapolated humans sufficient support facilitation sarscov<NUMBER> entry <NUMBER> particular never demonstrated ace<NUMBER> upregulation human lung occurs upon ras inhibition even less causes worsening covid<NUMBER> disease furthermore also speculated ace<NUMBER> upregulation protective indeed shown binding coronavirus ace<NUMBER> leads downregulation ace<NUMBER> <NUMBER> turn causes aceace<NUMBER> imbalance excessive production angiotensin ii related ace enzyme excess angiotensin ii stimulates angiotensin ii receptor type <NUMBER> at<NUMBER>r might cause increase pulmonary vascular permeability lung damage <NUMBER> therefore according hypothesis upregulation ace<NUMBER> caused chronic intake at<NUMBER>r ace inhibitors could protective two mechanisms first blocking increased production angiotensin <NUMBER> advocated possible mechanism protection lung second reducing production angiotensin ii removes cause lung damage <NUMBER> context uncertainty advocates within scientific community raising voices cessation ace inhibitors arbs among patients taking drugs claimed prevention infection attenuation symptoms case infection speculative claims taken laical press starting word mouth sustains panic behaviors among general population italian society hypertension siia therefore takes clear firm position line statements international societies see table <NUMBER> furthermore siia reiterates subsequent points acute suspension without medical control cardiovascular therapy specifically antihypertensive treatment increases occurrence acute events including hypertensive emergencies heart failure decompensation heart attacks stroke b favorable effects ace inhibitors arbs control progression cvds general particular hypertensive patients confirmed many years reason ras inhibitors represent central agents management cardiovascular conditions cannot easily substituted <NUMBER> c hypertensive patients covid<NUMBER> risk covid<NUMBER> infection ace inhibitors arbs treatment maintained according recommendations contained <NUMBER> escesh guidelines <NUMBER> similarly patients currently therapy ace inhibitors arbs case patients heart failure also arnis drugs must suspended e patients covid<NUMBER> severe symptoms sepsis ace inhibitors arbs like antihypertensive drugs used discontinued case case basis taking account current guidelines siia hopes promotes research analyzes constantly increasing data impact hypertension antihypertensive drugs particular ace inhibitors arbs clinical course covid<NUMBER> infections order update positions new evidence becomes available particular clarify mechanism prevalent role clinical manifestation covid<NUMBER> siia launched factfinding investigation verify impact therapy inhibitors reninangiotensin system onset clinical manifestation disease covid<NUMBER> observational research based online questionnaire made <NUMBER> questions collect information medical history evolution disease covid<NUMBER> patients id nct<NUMBER> clinicaltrialsgov conflict interest behalf authors corresponding author states conflict interest open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holderto view copy licence visit httpcreat iveco mmons orglicen sesbync<NUMBER> current outbreak novel coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> cause coronavirus disease <NUMBER> covid<NUMBER> quickly progressed global health emergency april <NUMBER> countries remain unfamiliar devastation virions consequences according johns hopkins covid<NUMBER> resource center <NUMBER> million people worldwide infected virus <NUMBER> april <NUMBER> since origin december <NUMBER> <NUMBER> <NUMBER> point organ involvement covid<NUMBER> appears primarily respiratory range disease severity range includes asymptomatic subclinical infection mild upper respiratory tract illness nonlifethreatening pneumonia severe pneumonia progressing acute respiratory distress syndrome ards requiring intensive care mechanical ventilation extracorporeal membrane oxygenation <NUMBER> however much unknown extrapulmonary manifestations disease currently evidence suggested gastrointestinal hepatic involvement well cardiac complications myocarditis sarscov<NUMBER> <NUMBER> j u r n l p r e p r f <NUMBER> known underlying cardiovascular disease cvd contributes severity covid<NUMBER> disease comorbid cvd increase likelihood developing severe disease andor increase risk myocardial injury lessons sars mers unclear regard impact cvd disease severity metaanalysis <NUMBER> cases mers identified prevalence cvd hypertension diabetes <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> authors suggest metabolic syndromerelated conditions cvd j u r n l p r e p r f <NUMBER> elevation <NUMBER> compared <NUMBER> individuals without cvd tnt elevations admission importantly individuals cvd significantly likely experience elevated tnt admission compared patients without underlying disease indicating increased susceptibility cardiac tissue insult due underlying chronic disease various mechanisms suggested explain increased vulnerability patients underlying cvd severe covid<NUMBER> disease one mechanism direct myocardial injury addressed subsequently review proposed mechanisms include <NUMBER> ineffective adaptation cardiovascular system increased demand severe viral illness coupled decreased systemic oxygenation pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> immune dysregulation including cell immune signaling dysfunction recognized important factor pathogenesis vascular disease may also adversely affect bodys response sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> electrolyte imbalances adverse medication effects may disproportionately challenge diseased heart special consideration regimen hydroxychloroquine azithromycin treatment due potential qtc prolongation <NUMBER> <NUMBER> future studies needed elucidate mechanisms continue identify targeted interventions patients underlying cvd cardiac dysfunction common sequela covid<NUMBER> disease however myocardial injury noted significant number infected patients would first time coronavirus associated cardiac complications previous sars infections patients developed systolic diastolic dysfunction subsequent heart failure arrhythmias sudden death due myocardial injury <NUMBER> <NUMBER> <NUMBER> study yu et al showed cohort <NUMBER> sars infected patients documented tachycardia despite afebrile disease resolution hypotension bradycardia cardiomegaly disease courses <NUMBER> many complications selflimiting demonstrates propensity sars coronavirus subfamily infect modulate cardiac tissue potentiating myocardial damage evidence implicating sarscov<NUMBER> cause myocardial damage appears concrete compared sars ancestors crosssectional study chen et al factors including elevated ntprobnp elevated ctni elevated hscrp markers myocardial injury inflammation respectively significantly correlated severe disease critical illness noted age male sex elevated serum creatinine hypertension coronary heart disease additional factors contributing severity disease <NUMBER> one initial studies wuhan huang et al reported increased high sensitive troponin hsctni levels <NUMBER> pgml <NUMBER> <NUMBER> covid<NUMBER> patients study <NUMBER> <NUMBER> patients elevated hsctni required icu admission <NUMBER> similar singlecenter case series <NUMBER> patients <NUMBER> patients required icu admission levels creatine kinase ckmb hsctni significantly higher <NUMBER> similarly retrospective chinese case series study <NUMBER> patients confirmed cases covid<NUMBER> nearly <NUMBER> demonstrated increased tnt levels consistent myocardial injury mentioned previously comorbid cardiovascular disease illness course study demonstrated patients underlying cvd increased tnt levels associated higher mortality compared cvd however even patients without underlying cvd elevated troponin associated higher mortality furthermore noted frequency arrhythmias higher patients j u r n l p r e p r f <NUMBER> elevated tnt finally reported patients died virus levels tnt ntprobnp increased course hospitalization <NUMBER> similar study wuhan total <NUMBER> <NUMBER> hospitalized patients showed myocardial injury via surrogate markers mortality rate higher group patients even adjustment age comorbidities <NUMBER> another caseseries <NUMBER> cases covid<NUMBER> shenzhen china patients divided <NUMBER> icu patients <NUMBER> nonicu patients reported hsctni level significantly higher icu group patients elevated enzymes cardiac symptoms underwent echocardiography demonstrating thickened interventricular septum <NUMBER> <NUMBER> patients associated enlarged left ventricular diastolic diameter decreased left ventricular ejection fraction increased pulmonary arterial pressure <NUMBER> <NUMBER> patients <NUMBER> additionally chinese case series ruan previously mentioned studies cardiac troponin myoglobin levels death group significantly higher discharge group <NUMBER> given clinical data group suspected course death patients due fulminant myocarditis formal studies incidence myocarditis since published well multicentered study <NUMBER> patients <NUMBER> <NUMBER> noted abnormal ecgs cardiac enzyme levels however <NUMBER> <NUMBER> clinically diagnosed myocarditis incidence myocarditis study lower reports likely due confirmation diagnosis based clinical criteria myocarditis mentioned previously <NUMBER> finally case series chen et al reported increased levels nterminal pro btype natriuretic peptide ctni <NUMBER> <NUMBER> patients respectively interestingly levels il<NUMBER> inflammatory cytokines noted elevated especially patients experienced severe disease course requiring icu admission group hypothesized elevated cytokines due cytokine storm attributed cause journal preproof j u r n l p r e p r f mechanisms may result myocardial injury secondary infection sarscov<NUMBER> pathophysiological mechanisms underlying myocardial injury caused covid<NUMBER> well known far studies need done delineate mechanisms discussed previously human sarscov infection myocardium known dependent ace<NUMBER> receptors disruption ace<NUMBER> leads agedependent cardiomyopathy cardiac dysfunction heart failure <NUMBER> <NUMBER> oudit et al hypothesized interaction sarscov ace<NUMBER> heart could contribute sarsmediated myocardial inflammation damage reported sarscov viral rna detected autopsied human heart samples suggesting direct myocyte invasion virus indicated marked regulation ace<NUMBER> reductions ace<NUMBER> protein heart samples moreover reported significant myocardial macrophage infiltration postmortem heart samples <NUMBER> detrimental effect ace<NUMBER> downregulation would impede cardioprotective effects angiotensin <NUMBER> leading increased tnfα production <NUMBER> <NUMBER> tnfα common inflammatory cytokine many researchers shown inflammatory response may least partially responsible myocardial damage example guo et al reported increased inflammatory marker creactive protein along elevated tnt levels patients underlying cvd poor outcomes supporting idea severe inflammatory response possible mediator cardiomyocyte damage <NUMBER> addition tnfα zhao et al discovered sars virus activates tgfβ signalling smad pathway induce lung fibrosis also common pathway interstitial fibrosis journal preproof j u r n l p r e p r f <NUMBER> development myocardium could potentially mode cardiac damage <NUMBER> also proposed patients sars strong interferonmediated responses could contribute myocardial dysfunction specifically regard interferons making switch hyperactive innate immunity protective adaptive immunity <NUMBER> <NUMBER> finally another proposed mechanism exaggerated cytokine response type <NUMBER> <NUMBER> helper cells <NUMBER> collectively due significant resemblance sarscov infection covid<NUMBER> possible mechanisms myocardial injury covid<NUMBER> could direct damage cardiomyocytes systemic inflammation myocardial interstitial fibrosis interferon mediated immune response exaggerated cytokine response type <NUMBER> <NUMBER> helper cells addition coronary plaque destabilization hypoxia sarscov<NUMBER> cause covid<NUMBER> disease emerged global health emergency affecting almost every country world given level global interconnectivity epidemiologists forecasted <NUMBER> worlds population infected covid<NUMBER> coming year <NUMBER> true means <NUMBER> population experience anything symptoms mild respiratory symptoms severe lifethreatening respiratory symptoms infected population appears underlying cardiovascular disease related worsening outcomes patients covid<NUMBER> one study case mortality rate tripled patients underlying cardiovascular disease <NUMBER> necessarily unique coronavirus many infections made worse underlying cardiac disease however also noted patients history cardiovascular disease likely elevated levels cardiac enzymes tnt j u r n l p r e p r f <NUMBER> suggests possibility patients susceptible cardiac injury via sars<NUMBER>cov <NUMBER> investigating also appears cohort experience extrapulmonary manifestations virus including cardiovascular complications coronavirus affecting organ systems new outbreak studied sarscov subfamily general well merscov past however reports myocardial involvement related covid<NUMBER> far seem increased compared previous sarscov outbreaks frequent manifestation cardiac involvement far appears myocarditis course since clinicians currently focusing common lethal manifestations sarscov<NUMBER> may see even reports cardiac complications pandemic progresses manifestations may become prevalent research regarding cardiac manifestations focused mostly myocardial damage including myocarditis cases fulminant myocarditis cardiogenic shock several reports already investigated incidence myocarditis covid<NUMBER> patients reported circulatory failure resulting myocardial damage secondary viral disease cause death <NUMBER> interestingly emerging case reports also showing patients presenting without respiratory symptoms instead chest pain pressure fatigue etc later found covid<NUMBER> positive myocarditis mechanisms leading cardiac damage numerous include direct insult myocytes virus cytokine interferon inflammatory responses myocardial interstitial fibrotic response t<NUMBER> t<NUMBER> helper cell response <NUMBER> <NUMBER> <NUMBER> <NUMBER> known sarscov subfamily general enter cells several key points gleaned review myocardial injury relates covid<NUMBER> first appears strain sarscov increased propensity developing extrapulmonary complications namely myocardial involvement reporting myocardial involvement likely still low given current focus common respiratory symptoms second shows cardiac involvement often selflimiting studies reported myocardial injury cause death thus important clinicians complication radar <NUMBER> third case reports accounts patients presented without respiratory symptoms later found covidpositive diagnosed myocarditis emphasis respiratory involvement covid<NUMBER> syndrome important keep high index suspicion disease patients presenting atypically ensure minimize community healthcare worker exposure finally review found many proposed mechanisms myocardial damage secondary covid<NUMBER> infection research required delineate whether virus causes direct myocardial injury inflammatory mediated injury injury another mechanism covid<NUMBER> infection associated myocardial injury implicated severe disease courses even death remarkable efforts done elaborate underlying mechanisms myocardial injury due acuteness pandemic scientific world currently lacks randomized controlled trials order fully elucidate pathophysiological mechanisms therapeutic measures however handful clinical trials way assess possible therapeutic targets treatment prevention j u r n l p r e p r f <NUMBER> disease even lacking substantial evidence certain conclusions drawn review namely appears extrapulmonary manifestations likely sars outbreak clinicians maintain high index suspicion covid<NUMBER> infection even patients without respiratory symptoms delayed testing result increased community healthcare worker spread multiple early reports novel coronavirus disease <NUMBER> covid<NUMBER> identified strong association cardiovascular disease cvd mortality infected patients analysis <NUMBER> confirmed cases china crude case fatality rate <NUMBER> patients without documented comorbidities whereas case fatality rate much higher patients cvd <NUMBER> diabetes <NUMBER> hypertension <NUMBER> <NUMBER> pattern threatens extensive mortality worldwide given high prevalence disorders may also clinically insightful conditions share pathophysiologic mechanisms could underly heterogeneity covid<NUMBER> outcomes possible comorbidity pattern simply artifact confounding age underlying pulmonary disease case fatality rates covid<NUMBER> may rise incidence increases countries older populations however covid<NUMBER> follow bimodal age distribution typically seen viral pneumonias due relative immunocompromise <NUMBER> unclear young children spared covid<NUMBER> symptoms due crossprotective immunity coronaviruses additional differences physiology related age conversely association cvd cvd risk factors mortality covid<NUMBER> may related differential expression function angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov<NUMBER> <NUMBER> latter mechanism warrants urgent attention international research community report highlight important known unknown features covid<NUMBER> related ace<NUMBER> ras activity suggest clinical research strategies clarify role ras blockade covid<NUMBER> virus responsible covid<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> positivesense singlestranded rna virus genus betacoronavirus <NUMBER> phylogenetic analysis sarscov<NUMBER> closely related several human coronaviruses cause range upper lower respiratory infections including sarscov <NUMBER> outbreak middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> viruses coronaviridae family characterized surface spike proteins associate cellular receptors mediate infection nature determines features related transmissibility pathogenesis <NUMBER> sarscov<NUMBER> infection triggered sprotein binds ace<NUMBER> <NUMBER> several clinical observations covid<NUMBER> likely relate <NUMBER> ace<NUMBER> membranebound peptidase highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways figure <NUMBER> <NUMBER> sarscov shown ace<NUMBER> overexpression facilitated viral entry replication cells otherwise resistant virus <NUMBER> similar pathogenesis identified sarscov<NUMBER> recently confirmed hostcell entry also depends ace<NUMBER> <NUMBER> suggests sarscov<NUMBER> could target spectrum cells targeted sarscov lungs primarily localized pneumocytes macrophages <NUMBER> <NUMBER> acute respiratory distress syndrome ards highly prevalent sars covid<NUMBER> likely explained lung tropism time extrapulmonary manifestations covid<NUMBER> may related systemic distribution ace<NUMBER> multiple organs ace<NUMBER> gastrointestinal tract may underly early gastrointestinal symptoms nausea vomiting diarrhea ace<NUMBER> heart may related cardiac damage fulminant myocarditis reported covid<NUMBER> <NUMBER> <NUMBER> ras cascade ace responsible conversion angiotensin ang ang ii ang ii vasoactive peptide principally responsible systemic vasoconstriction stimulation aldosterone release figure <NUMBER> <NUMBER> contrast ace<NUMBER> counteracts ras cascade providing inhibitory control ang ii via two primary mechanisms first ace<NUMBER> directly catalyzes ang ang ii depleting levels <NUMBER> second products ang ang ii degradation biologically active peptides promote vasodilation additional antifibrotic antiproliferative antiinflammatory effects <NUMBER> <NUMBER> <NUMBER> generation ang ii ace pharmacologically inhibited angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs function blocking downstream interaction ang ii at<NUMBER> receptor <NUMBER> conversely acei directly modulate ace<NUMBER> acei angiotensin receptor blockers arbs indirectly lead increased ace<NUMBER> expression <NUMBER> additional medications including thiazolidinediones ibuprofen may also increase ace<NUMBER> levels though data sparse <NUMBER> lastly aldosterone antagonists neprilysin inhibitors also intimately related ras activation unclear whether either drugs impact ace<NUMBER> three possibilities related ace<NUMBER> expression exist could explain association preexisting cvd covid<NUMBER> mortality three possibilities could synergistic even oppose although mutually exclusive time relative degree play covid<NUMBER> unknown first population differences ace<NUMBER> expression function may simultaneously predispose development cvd likelihood severity sarscov<NUMBER> infection humans ace<NUMBER> polymorphisms identified associated cvd <NUMBER> <NUMBER> <NUMBER> polymorphisms could impact affinity sprotein sarscov<NUMBER> making infection likely severe addition ace<NUMBER> gene xlinked <NUMBER> could underly protective effect female sex observed covid<NUMBER> second either cvd pharmacologic ras blockade used cvd may augment ace<NUMBER> levels increasing available substrate sarscov<NUMBER> infection within certain organs like lung heart indeed increased ace<NUMBER> levels seen multiple cardiovascular conditions related comorbidities diabetes hypertension <NUMBER> <NUMBER> <NUMBER> paradoxically pharmacologic ras blockade also associated increased ace<NUMBER> expression mouse models <NUMBER> however possible effect ras blockade covid<NUMBER> conditional whether patient preexisting ras dysregulation associated cvd effect ras blockade may differ acute vs chronic setting thus unclear whether ras blockade would ameliorate exacerbate severity covid<NUMBER> infection patients cvd lastly sarscov<NUMBER> infection may downregulate ace<NUMBER> function possibly greater extent patients preexisting cvd could lead toxic ang ii overaccumulation several pathologic sequelae ards fulminant myocarditis may follow based data <NUMBER> sarscov interaction novel coronaviruses ace<NUMBER> function may significant deleterious sarscov animal models showed infection virus downregulated ace<NUMBER> expression generating inflammatory response correlated acute lung injury impaired cardiac contractility <NUMBER> <NUMBER> <NUMBER> mechanism present sarscov<NUMBER> could underly development ards cardiac injury fulminant myocarditis ras activity patients cvd cardiovascular comorbidities could increase likelihood severity sarscov<NUMBER> infection lung heart may explain heterogeneity clinical course covid<NUMBER> direction furthermore extent association modified pharmacologic ras inhibition lack even basic epidemiologic descriptions medication use covid<NUMBER> begin making determination speculate reflecting disparate observations investigators recent weeks variably hypothesized use <NUMBER> avoidancewithdrawal <NUMBER> ras blockade could lead improved outcomes covid<NUMBER> clinicians worldwide need know either suggestions merit randomized controlled trial addressing mortality reduction covid<NUMBER> necessary clarify role ras blockade highest level certainty trials may soon underway yet highquality observational data still needed develop guide nuanced hypotheses table <NUMBER> importantly unclear whether trial initiation discontinuation ras blockade could rapidly informed observational data maximize probability successful therapy prospective identification communitybased cohort patients infected sarscov<NUMBER> would ideal practical electronic era mild asymptomatic cases represented equal proportion symptomatic cases still take time significant resources identify representative cohort answers questions urgently needed meantime data may already exist international cooperation could begin inform hypotheses guide trial development several biases confounders need considered observational studies order estimate direct effect ras blockade covid<NUMBER> outcomes particular hospitalbased cohorts exhibit selection bias sicker patients likely bias results towards null hypothesis ie effect ras blockade patients least prominent risk factors underrepresented significant confounding likely exists could also obscure direct effect ras blockade notably confounding disease indication addition minimum set confounders would purpose following must considered age measured continuously possible allowing nonlinear relationship tobacco exposure ideally quantified pack years distinguishing current former smokers preexisting pulmonary disease immunocompromise sex cvd diabetes hypertension strongly associated mortality covid<NUMBER> mechanisms underlying unknown dysregulation ras cascade present conditions could increase likelihood severity sarscov<NUMBER> infection suggests pharmacologic ras inhibition could impact covid<NUMBER> outcomes direction effect unclear mechanistic evidence suggests two competing hypotheses <NUMBER> ras blockade decreases proinflammatory activity ang ii decreasing risk ards myocarditis mortality covid<NUMBER> <NUMBER> ras blockade increases ace<NUMBER> expression promoting sarscov<NUMBER> virulence lungs heart leads ards myocarditis death basic pharmacoepidemiologic studies ras blockade covid<NUMBER> need rapidly performed could inform confirmatory randomized controlled trials analyses necessary first step clarify role pharmacologic ras blockade covid<NUMBER> role ras activation covid<NUMBER> even broadly patients require ras inhibitors including acei arbs change regimens without evidence even causal association ras blockade covid<NUMBER> outcomes immediately follow starting stopping medications benefit patients short term acute effects medications effect ace<NUMBER> inhibits angiotensin ang ii activity reninangiotensin system degradation ang ang ii ang <NUMBER> ang <NUMBER> ang ii at<NUMBER> receptor at<NUMBER>r proinflammatory effects may lead acute lung injury myocarditis whereas at<NUMBER> mas receptors antiinflammatory effects sarscov<NUMBER> uses ace<NUMBER> functional receptor induces acute lung injury myocarditis unknown mechanisms angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arb inhibit ang iiat<NUMBER>r axis may antiinflammatory also increase ace<NUMBER> expression may increase sarscov<NUMBER> virulence covid<NUMBER> pandemic strained health care resources around world causing many institutions curtail stop elective procedures resulted inability care patients valvular structural heart disease shd timely fashion potentially placing patients increased risk adverse cardiovascular complications including congestive heart failure death effective triage patients become challenging current environment clinicians weigh risk bringing susceptible patients hospital environment covid<NUMBER> pandemic versus risk delaying needed procedure document suggest guidelines triage patients need shd interventions provide framework decide may appropriate proceed intervention despite ongoing pandemic particular address triage patients need transcatheter aortic valve replacement percutaneous mitral valve repair also address procedural issues considerations function structural heart disease teams covid<NUMBER> pandemic coronavirus delayed therefore decisions regarding timing shd interventions must consider risk delaying procedure risk patient covid<NUMBER> exposure outside home shelter utilization limited hospital resources compounding challenge geographical variation peak pandemic within united states significant delay restoration normal health care operations immediate threat passed length delay unknown could many months subsequent peak poses distinct challenges rescheduling procedures purpose document provide framework shd teams triage patients need shd intervention covid<NUMBER> pandemic discuss evaluation procedural considerations patients general priorities minimize exposure coronavirus shd patients structural interventional team b maintain high quality durable structural interventional outcomes require procedure pandemic c reduce risk shd patients use resources might needed covid<NUMBER> patients prevent delay intervention patients particularly high risk clinical deterioration heart failure death understood individual patient local clinical judgment based impact covid<NUMBER> pandemic region institution ultimately guide evaluation treatment pathway given advanced age comorbidities many patients severe symptomatic aortic stenosis increased risk covid<NUMBER> complications death however multiple studies also shown higher mortality among patients severe symptomatic delay treatment <NUMBER> several months years rather weeks writing group proposes following timing tavr severe covid<NUMBER> pandemic inpatients severe symptomatic associated reduction ef thought secondary presence class iiiiv congestive heart failure chf syncope secondary tavr considered decrease risk clinical deterioration prolonged hospital stay repeat hospitalization would reasonable schedule tavr outpatients severe critical aortic stenosis class iiiiv chf symptoms patients class iii nyha chf symptoms quantitative measures valve severity indicate critically tight valve reasonable consider either urgent tavr close outpatient virtual monitoring valve coordinator data date robust enough give firm recommendations features warrant consideration tavr include particularly high peak mean gradient small calculated aortic valve area low dimensionless index truly asymptomatic patients reasonable postpone consideration tavr three months hospital operations resume elective procedures close outpatient monitoring possibly via telehealth continue patients severe tavr centers establish system provides weekly telephone followup patients whose procedures deferred expected patients develop worsening symptoms require procedure performed urgently pandemic recommend tavr team convene virtually least weekly basis review status patients waiting list single interventional cardiologist cardiac surgeon assume leadership position given authority arbitrate challenging cases triage system accurately identify patients may safely deferred triage system need individualized medical center institutional valve program patient population served pandemics local impact compromise quality interventional care provided tavr patients covid<NUMBER> pandemic majority tavr procedures performed using minimalist approach moderate conscious sedation recent data tvt registry shown steady increase utilization moderate sedation tavr improved safety recovery <NUMBER> <NUMBER> majority tavr procedures require intensive care unit recovery procedure important critical care beds limited covid<NUMBER> crisis parts country pci performed prior tavr coronary artery disease contributing patients clinical presentation would pose high risk tavr procedure otherwise pci may safely deferred majority percutaneous mitral valve repair edgetoedge repair safely deferred following groups patients considered treatment edgetoedge repair covid<NUMBER> pandemic responsibility procedural team keep contact patients deferred weekly basis ensure decompensation requiring earlier intervention viv tmvr transcatheter mitral valve intervention hat currently united states fda approved since procedures resource intensive deferred covid<NUMBER> pandemic adequately resolved providing mitral valve patients sufficiently managed medical therapy interim viv tmvr covid<NUMBER> pandemic considered patients severe bioprosthetic mitral stenosisregurgitation inpatients chf outpatients hospitalization chf within <NUMBER> days despite optimized gdmt transcatheter mitral valveinring vir tmvr valveinmitral annular calcification vimac tmvr offlabel procedures much higher risk complications may prolong hospitalization <NUMBER> <NUMBER> latter procedures generally avoided covid<NUMBER> pandemic pvl closure particularly mitral generally lengthy procedure requires general anesthesia transesophageal echocardiography tee patients significant pvl symptoms managed medically deferred moratorium nonessential procedures removed patients considered pvl closure covid<NUMBER> pandemic inpatients chf andor hemolysis commonly performed shd interventions include patent foramen ovale pfo closure atrial septal defect asd closure left atrial appendage laao occlusion alcohol septal ablation hypertrophic cardiomyopathy procedures treat conditions rarely result hospitalization death without procedure shortterm reasons procedures deferred deemed safe resume performing nonemergent procedures procedural suites offset risk particulate aerosolization preprocedural tee limited use patient planned emergent percutaneous mitral valve repair procedure shd clinics procedures sustained multidisciplinary heart team process team consists interventional cardiologists cardiac surgeons cardiac imaging specialists anesthesiologists nurse specialists depending workflows potential exposure within hospital rates exposurebased infections health care workers remain high pandemic workplace team members may need quarantined treated illness may lead interruptions scheduled cases depending length absence consideration clustered scheduling using designated teams may helpful addressing interruptions due temporary absence team personnel strong consideration given deferral clinical trial cases adequate resolution covid<NUMBER> pandemic recommendation also determined accordance institutional research policies several institutions limited enrollment clinical trials studies lifesaving therapies pandemic patients considered clinical investigation become clinically unstable smoking represents one leading causes preventable morbidity mortality worldwide causing plethora adverse medical conditions including coronary artery disease stroke chronic obstructive pulmonary disease cancer detrimental effects impact also passive smokers <NUMBER>• <NUMBER> even current coronavirusassociated disease <NUMBER> covid<NUMBER> pandemic smokers especially elderly appear increased risk getting infected progressing toward severely symptomatic disease dying due severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> abstinence easy preach harder achieve several strategies proposed ensure smokers discontinue abstain habit ranging telemedicine nicotine replacement therapy varenicline bupropion <NUMBER>•• recently novel forms smoking developed differ traditional combustion cigarettes tcc smoking due combustion vaporization nicotinecontaining liquids ie electronic vaping cigarettes evc heating tobacco products without combustion article part topical collection cardiovascular care ie heatnotburn cigarettes hnbc <NUMBER> <NUMBER> collectively alternative ways smoke called modified risk products mrp optimistically reduced risk products rrp <NUMBER> <NUMBER>•• <NUMBER> substantial evidence continues accrue mrp including results randomized controlled trials rct several systematic reviews already published topic <NUMBER>•• however interplay mrp cardiovascular physiology cardiovascular disease still uncertain conflicting results provided different scholarly sources <NUMBER> thus aimed conducting updated umbrella review systematic reviews cardiovascular effects terms pathophysiology symptomatic disease evc hnbc <NUMBER>• keeping prior similar projects led group work designed umbrella review ie overview systematic reviews following established recommendations evidence synthesis <NUMBER>•<NUMBER> specifically searched pubmed order find pertinent systematic reviews cardiovascular safety mpr using following string <NUMBER>• total <NUMBER> publications specific cardiac event reported chest pain relatively common compiled series cases <NUMBER> hua talbot screened several databases looking case reports adverse events associated evc use retrieving two cases case acute myocardial infarction young man case atrial fibrillation elderly woman <NUMBER> cases reported hypothesisgenerating systematic review nicotinecontaining evc used farsalinos polosa conducted systematic review several different generations evc focusing comparison versus tcc nicotine gums impact nicotine risk active well passive smoking <NUMBER>•• particular synthesized evidence <NUMBER> different reports including several chemical studies toxicological studies clinical trials concluded despite evident safety issues including presence many toxic agents established multidimensional risk eg acetaldehyde acrolein aluminum aminotandalafil copper diethylene glycol formaldehyde iron lead nickel particulate matter rimonambant silica evc represent appealing alternative tcc rrp strategy terms hazards highlighted risk tachycardia hypertension well impaired left anterior descending flow reserve even remained unclear whether effects depended mainly nicotine interestingly old review promising limited incomplete reporting lack quantitative synthesis garcia colleagues performed systematic review metaanalysis effects evc blood pressure bp heart rate hr heart rate variability hrv pooling data <NUMBER> studies using largely explicit valid methods <NUMBER> concluded evc associated acute increases systolic blood pressure sbp diastolic blood pressure dbp hr changes hrv typical sympathetic prevalence vagal activity even mostly explained nicotine exposure notably chronic use evc still adverse effects hrv effects bp hr much diluted potentially suggesting timedependent adaptation kennedy colleagues reviewed several experimental clinical studies cardiovascular safety evc highlighting may cause oxidative stress cardiomyocyte dysfunction mutagenesis vascular inflammation endothelial dysfunction vasospasm complement deposition platelet aggregation adhesion activation hypertension tachycardia arterial stiffening atherosclerosis thrombotic risk albeit less intensely tcc <NUMBER> importantly suggested studies conflicts interest less likely report adverse events skotsimara colleagues reviewed <NUMBER> studies ranging preclinical clinical ones performed formal metaanalysis <NUMBER> trials <NUMBER> overall identified following main signs detrimental effects evc cytotoxicity oxidative stress endothelial dysfunction bp hr arterial stiffness myocardial infarction notably effects heterogeneous quantitatively less intense associated tcc finally riley et al conducted systematic review originally focused interplay hormonal contraception evc cardiovascular risk <NUMBER> study explicitly focused hormonal contraception retrieved thus expanded analysis pathophysiologic link evc cardiovascular outcomes including total <NUMBER> studies concluded evc significantly impact bp hr may associated increased risk myocardial infarction umbrella review poignantly synthesizing evidence accrued far vitro animal human volunteers healthy subjects patients cardiovascular risk associated evc use either acute chronic shows data expanding progressively several conclusions already made <NUMBER> first acute evc use associated several toxic effects molecular eg dna cellular tissue organ system level <NUMBER> <NUMBER> instance oxidative stress cytotoxicity cardiomyocyte dysfunction established effects evc <NUMBER> second evc impact adversely bp management cause tachycardia worsen arterial stiffness <NUMBER> <NUMBER> third evc use associated increased risk adverse clinical events including atrial fibrillation myocardial infarction even causal link still debated <NUMBER> <NUMBER> yet reviews highlighted detrimental impact evc lesser magnitude tcc addition differential impact liquids nicotine clearly disentangled overall findings confirm prior reports support research topic cardiovascular safety evc several avenues research worth exploring instance translational studies precise cellular mechanisms involved evc toxicity needed exploring instance microrna inflammatory cascade autophagy apoptosis regeneration <NUMBER> <NUMBER> <NUMBER> observational studies large samples needed accurately gauge short longterm risks evc apparently healthy subjects patients cardiovascular disease <NUMBER> addition randomized trials smallsample speculative ones large pragmatic studies direly needed ensure place evc current clinical practice correctly defined <NUMBER> indeed premise evc considered overthecounter medical intervention suitable support chronic smokers journey eventual cessation accordingly comprehensive evidence platform hopefully summarized formal network metaanalysis able precisely define place role evc comprehensive approach aiming smoking cessation harm minimization <NUMBER> pragmatically based personal professional experience may suggest stepwise use evc hnbc eventual aim total continued abstinence fig <NUMBER> yet practitioners aware potential interactions mrp pharmacologic therapy patients risk cardiovascular disease ranging atherothrombosis heart failure valvular heart disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed plausible many adverse cardiovascular effects mrp depend nicotine thus raising evident risk cumulative toxicity nrt mrp inadvertently combined umbrella review several drawbacks top typical research design <NUMBER>• first studies reviews discussed hereby mostly small size limited followup often focus apparently healthy subjects second data longterm pulmonary cancer risk absent cannot considered proof absence oncologic risk longitudinal studies able inform safety dimension another elephant room lack comprehensive data hnbc mainstay mrp arena considered aspects safe safer evc others worse eg small measurable combustion <NUMBER>• accordingly expect additional research synthesis efforts needed future including updated umbrella reviews information accrued umbrella review coherently showing multidimensional adverse effects hnbc evc highlights evident risk adverse cardiovascular events associated mrp accordingly restrictions usage could considered including equating overthecounter even prescription drugs indeed best perspective considering hnbc evc another management strategy promote smoking cessation maintain abstinence fig <NUMBER> moreover usage monitored minimized intensity duration aiming clear timelines switch hnbc evc stop altogether hnbcfirst approach chosen instead goal evc usage followed cessation evcfirst approach adopted apparently banal potentially useful framework could indeed considering mrp novel palatable nrt maintaining many rituals tcc without abundance combustion byproducts nonetheless dedicated largescale pragmatic randomized trials needed test strategy recommending individuals patients large present umbrella review suggests evc despite clearly causing increase overall cardiovascular risk may represent temporary lesser evil tcc riskreduction riskmodification strategy aiming eventual abstinence tobacco nicotine products conflict interest authors declare conflict interest human animal rights informed consent article contain studies human animal subjects performed authors coronavirus disease pandemic rapidly produced substantial disruption worldwide addition health complications infection introduction raft public health measures including physical distancing legislation many countries broadened impact pandemic point touch members society health care professionals become increasingly cognisant direct cardiac complications covid<NUMBER> potential impact standard acute chronic management range cardiovascular disorders parallel pandemic physical isolation potential produce vast array mental health psychosocial challenges may impact patients families depression anxiety posttraumatic stress disorder related mental illnesses shown direct indirect effects acute chronic cardiovascular disease pathophysiological perturbations <NUMBER> <NUMBER> exposure extreme mental emotional stress natural disasters trauma war conflict well established risk factors incident atherosclerotic cardiovascular disease ascvd <NUMBER> early evidence direct indirect psychological consequences covid<NUMBER>both infectious disease associated public policy like quarantiningis emerging <NUMBER> data pandemics severe acute respiratory syndrome sars show infectious disease outbreaks associated considerable fear community largely due evolving nature uncertainties particularly risk illness death substantial <NUMBER> anxieties motivate behavioural changes shape population cardiovascular health ways may unintended consequences clear example global disengagement health care system treatment nonadherence since introduction public health containment strategies eg social distancing quarantine substantial decline accident emergency department visits observed much half england <NUMBER> well australia north america europe <NUMBER> spain significant decrease number cardiology procedures occurred postcovid outbreak contracted double risk serious disease <NUMBER> mortality high <NUMBER> <NUMBER> addition covid<NUMBER> aggravate damage heart patients develop evidence myocardial injury seem <NUMBER>times likely require admission intensive care units excess risk combined concerns relating physically attending hospitals may active covid<NUMBER> cases may exacerbate fear anxiety vulnerability helplessness hopeless trepidation thoughts mortality experienced many postacute coronary syndrome acs <NUMBER> anticipation loss ultimately result development andor progression anxiety perceived actual loss result depression patients experience cardiovascular disease cvd prevalence two three times matched controls general community <NUMBER> data australian new zealand patients stable coronary artery disease show compared patients distress patients even moderate levels distress higher risk cardiovascular cv death adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> allcause mortality adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> <NUMBER> american heart association recognises depression formal risk factor poor cv prognosis patients established disease australia simple tool depression screening patient health questionnaire<NUMBER> phq<NUMBER> shortform cardiac depression scale cds recommended use patients established cvd <NUMBER> physical social isolation unknown indefinite period time patients especially elderly induce rumination maladaptive thought processes contribute feelings loneliness china life satisfaction declined covid<NUMBER> outbreak period <NUMBER> pessimism loneliness established cardiovascular implications associated range mechanisms associated development progression atherosclerosis including increased peripheral vascular resistance elevated blood pressure <NUMBER> animal human studies social isolation demonstrated associate greater development progression atherosclerosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> fact magnitude influence cvd mental health outcomes including suicide equivalent smoking <NUMBER> influence may exert via various biobehavioural pathways including absence oxytocin serotonin mediated exposures companionship affection belongingness intimacy <NUMBER> similarly absence reduced assistance practical tasks associated disease selfmanagement eg filling scripts grocery shopping compromise make difficult cardioprotective medications health behaviour regimens conversely dense living environments proximity family members prolonged period may inhibit independence selfreliance cases incite conflict recent review concluded periods quarantine associated anger frustration posttraumatic stress symptoms confusion commonly owing longer periods quarantine infection fears boredom financial loss stigma <NUMBER> periods extreme stress including natural disasters economic hardship present vulnerabilities exacerbate family violence including alcohol drug taking financial stressors <NUMBER> family violence perpetration victimisation maladaptive dysfunctional relationships directly impact ones cv system likely elevate ones long term cvd risk <NUMBER> maladaptive behavioural responses neuroticism extreme hypervigilance infectious disease outbreaks may exaggerate induce compulsive behaviour <NUMBER> may include obsessive monitoring media social media hand washing compulsive behaviours case reports emerged documenting brief psychotic episodes covid<NUMBER> outbreak <NUMBER> individuals high external locus control externally driven thought processes eg things always happen little control future tend predict coping strategies historically poorer survival acs paradoxically however individuals may likely conform public health messaging <NUMBER> example immunisation programs <NUMBER> h<NUMBER>n<NUMBER> pandemic higher state anxiety greater trust authorities associated adherence recommended behaviours greater levels perceived susceptibility disease severity belief effectiveness recommended behaviours disease prevention <NUMBER> highlights complexity potential effects setting global pandemic understanding mental health implications pandemic moving postcovid era critical context ascvd management prevention australians also higher risk disengagement may require targeted strategies help seeking relation health care <NUMBER> issues may present compromise nonadherence selfmanagement regimens acvd including supply chain issues medications foods fears regarding hitherto unfounded safety claims eg angiotensin converting enzyme inhibitorsangiotensin receptor blockers acearbs difficulties maintaining secondary prevention behaviours may pronounced winter months time limited sunlight poor weather may increase risk depression seasonal affective disorders settings <NUMBER> increasing caregiver burden traditionally falls women may increase marital pressures separations divorces could plausibly spike risk factor cvd mortality men <NUMBER> life events characterised extreme distress grief including relationship breakdown increase risk takotsubo cardiomyopathy broken heart syndrome particularly women aged <NUMBER>years older <NUMBER> socioeconomic disparities present aftermath pandemics natural disasters appear enhance social gradient cvd given close correlation global domestic product life expectancy <NUMBER> threat global economic depression exerts influence population health deleterious impact high job insecurity health wellbeing comparable effects unemployment <NUMBER> financial economic hardship associated ascvd depression behaviours elevate ones risk like alcohol use smoking drug taking marital pressure suicide unemployment homelessness disengagement health care system transiency food insecurity digital divide may enhance disconnection loneliness data china show individuals serious psychiatric needs highly vulnerable contracting covid<NUMBER> <NUMBER> innovative approaches reengaging monitoring atrisk populations providing maintaining employment housing relationship social networks critical moving forward individuals recover covid<NUMBER> severe acute respiratory syndrome sarscov<NUMBER> recovery need occur parallel clinical cvd especially acute decompensated heart failure adhf enormous implications psychosocial sequelae rehabilitation patients comorbid prevalence covid cvd especially adhf patients need recover two entities parallel resulting complexity patients sociologically significant others health professionals known many years cardiac rehabilitation based exercise training group setting results improved psychosocial outcomes particularly less anxiety depression <NUMBER> unclear whether benefit primarily exercise accompanying group dynamics foster camaraderie source psychological support <NUMBER> inclusion psychosocial interventions part routine heart health checks cardiac rehabilitation promotion online telephone mental health support services settings warranted early evidence chinese experience covid<NUMBER> suggests establishment external emergency mental health expert teams provinces provision online public education psychological counselling hotline services may helped buffer negative mental health outcomes associated covid<NUMBER> <NUMBER> australia new zealand approach gaining traction governments announcing funding support expand mental health services including greater investment hotline services response <NUMBER> calls past fortnight covid<NUMBER> related well phone video support people serious mental illness smis extra youth adult acute mental health beds <NUMBER> <NUMBER> need expand upon support services postcovid era especially rural remote settings play critical part cvd related non communicable disease prevention management across australia new zealand effective introduction physical distancing protocols potential substantially limit spread covid<NUMBER> throughout community spare health care system overburdened beyond capacity care covid<NUMBER> associated complications however mental health psychosocial sequelae covid<NUMBER> pandemic likely considerable impact approach effective delivery cardiovascular health care many months come emergence novel coronavirus officially known severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> presented unprecedented challenge healthcare community across world high infectivity ability get transmitted even asymptomatic phase relatively low virulence resulted rapid transmission virus beyond geographic regions leading pandemic first case disease known coronavirus disease <NUMBER> covid<NUMBER> occurred december <NUMBER> <NUMBER> hubei province china <NUMBER> since within short span <NUMBER> months infection spread <NUMBER> countriesareaterritories across world <NUMBER> confirmed cases <NUMBER> deaths world health organization statistics march <NUMBER> <NUMBER> <NUMBER> respiratory involvement presenting mild flulike illness potentially lethal acute respiratory distress syndrome fulminant pneumonia dominant clinical manifestation covid<NUMBER> however much like respiratory tract infection preexisting cardiovascular disease cvd cv risk factors enhance vulnerability covid<NUMBER> covid<NUMBER> worsen underlying cvd even precipitate de novo cardiac complications review aimed providing overview various cv manifestations patients presenting covid<NUMBER> impact preexisting cvd new onset cardiac complications clinical outcomes patients also discussed since understanding subject evolving stage information contained subsequent text based mainly limited early experience covid<NUMBER> learnings previous coronavirus illnesses namely sars middleeast respiratory syndrome mers literature search done using pubmed google search engines original review articles advisories professional societies expert commentaries published since email address manishaiimshotmailcom onset current covid<NUMBER> epidemic search terms covid<NUMBER> coronavirus used combination cardiac cardiovascular arrhythmia myocardial infarction troponin heart failure relevant crossreferences previous studies sars mers also reviewed sarscov<NUMBER> caused novel enveloped rna betacoronavirus seven species betacoronaviruses known cause human infections four mainly causing mild flulike symptoms remaining three resulting potentially fatal illnesses sars mers ongoing covid<NUMBER> although respiratory tract primary target sarscov<NUMBER> cv system may get involved several different ways following common mechanisms responsible cv complications covid<NUMBER> <NUMBER> direct myocardial injurysarscov<NUMBER> enters human cells binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> membrane bound aminopeptidase highly expressed heart lungs ace<NUMBER> plays important role neurohumoral regulation cv system normal health well various disease conditions binding sarscov<NUMBER> ace<NUMBER> result alteration ace<NUMBER> signaling pathways leading acute myocardial lung injury <NUMBER> <NUMBER> particular concern hypokalemia covid<NUMBER> due interaction sarscov<NUMBER> reninangiotensinaldosterone system <NUMBER> hypokalemia increases vulnerability various tachyarrhythmias patients preexisting cvd appear heightened vulnerability develop covid<NUMBER> tend severe disease worse clinical outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> various cv risk factors also adversely affect porgnosis patients although seem increase likleihood developing infection metaanalysis six published studies china including <NUMBER> patients covid<NUMBER> reported <NUMBER> <NUMBER> <NUMBER> prevalence diabetes cardiocerebrovascular disease hypertension respectively <NUMBER> although prevalence diabetes hypertension cohort chinese general population prevalence cardiocerebrovascular disease considerably higher importantly presence diabetes cardiocerebrovascular disease hypertension associated <NUMBER>fold <NUMBER>fold <NUMBER>fold greater risk severe disease requiring intensive care unit icu admission suggesting prognostic impact comorbidities much larger report chinese center disease control prevention described clinical outcomes <NUMBER> confirmed cases covid<NUMBER> <NUMBER> overall case fatality rate cfr <NUMBER> entire cohort significantly higher <NUMBER> <NUMBER> <NUMBER> respectively patients hypertension diabetes cvd although data lacking prevalence various cv table <NUMBER> cardiovascular complications coronavirus disease <NUMBER> acute cardiac injury commonly defined elevation cardiac troponin <NUMBER>th percentile upper reference limit <NUMBER>e<NUMBER> average <NUMBER> commonly reported cardiovascular abnormality result following mechanismsdirect myocardial injury systemic inflammation myocardial oxygen demand supply mismatch acute coronary event iatrogenic strong adverse prognostic value acute coronary event reported appears low potential mechanismsplaque rupture due inflammationincreased shear stress aggravation preexisting coronary artery disease left ventricular systolic dysfunction reported causes myocardial dysfunction mentioned lead acute left ventricular systolic dysfunction heart failure reported one study<NUMBER> died <NUMBER> recovered discharged <NUMBER> causes myocardial dysfunction mentioned lead acute heart failure increased metabolic demand systemic disease cause acute decompensation preexisting stable heart failure arrhythmia <NUMBER> overall <NUMBER> severe illness <NUMBER> mild cases <NUMBER> tachyarrhythmia bradyarrhythmia occur exact nature described potential longterm consequences early assess early ascertain coronavirus disease <NUMBER> however patients recovering similar earlier illnesssevere acute respiratory syndromecontinued longterm abnormalities lipid glucose metabolism cardiovascular homeostasis <NUMBER> acute cardiac injury nonspecific term significant overlap cardiovascular manifestations however listed reporting done studies coronavirus disease <NUMBER> comorbidities impact clinical outcomes seem vary considerably across different geographic locations cfrs lower china outside hubei province many countries much higher european nations <NUMBER> small report including <NUMBER> patients washington united states america presented particularly grim scenario <NUMBER> comorbidities common cohort diabetes present <NUMBER> congestive heart failure <NUMBER> acute cardiac dysfunction occurred <NUMBER> patients <NUMBER> patients died however overall cfr united states seems much lower <NUMBER> deaths <NUMBER> confirmed cases <NUMBER> although likely rise many patients currently hospitalized yet definite outcome acute myocardial injury commonly described cv complication covid<NUMBER> table <NUMBER> different reports used different definitions acute myocardial injury including rise cardiac enzymes different biomarkers cutoffs andor electrocardiographic abnormalities however elevation highsensitivity cardiac troponin ctni <NUMBER>th percentile upper reference limit commonly used definition table <NUMBER> overall incidence acute cardiac injury variable roughly <NUMBER>e<NUMBER> positive cases known develop significant elevation ctni <NUMBER> aforementioned metaanalysis chinese studies <NUMBER> reported <NUMBER> incidence acute cardiac injury whereas another study including patients definite outcome death discharge hospital reported <NUMBER> incidence ctni elevation <NUMBER> regardless actual incidence acute cardiac injury consistently shown strong negative prognostic marker patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> patients admitted icu severefatal illness severalfold higher likelihood troponin elevation contrast incidence elevated troponin low <NUMBER>e<NUMBER> patients mild illness requiring icu admission mechanisms described lead acute cardiac injury rise cardiac troponins patients covid<NUMBER> relative role different mechanisms described direct ie noncoronary myocardial injury due viral myocarditis effect systemic inflammation appear common mechanisms observations supported previous autopsy study patients died due sars toronto sars outbreak <NUMBER> study viral ribonucleic acid detected <NUMBER> autopsied human heart samples providing evidence direct myocardial injury virus study described incidence stsegment elevation myocardial infarction covid<NUMBER> appears low similarly incidence left ventricular systolic dysfunction acute left ventricular failure cardiogenic shock also described one chinese study reported incidence heart failure covid<NUMBER> patients <NUMBER> heart failure occurred <NUMBER> patients subsequently died <NUMBER> patients discharged hospital tachyand bradyarrhythmias known occur covid<NUMBER> study describing clinical profile outcomes <NUMBER> chinese patients covid<NUMBER> reported <NUMBER> incidence arrhythmia <NUMBER> incidence much higher <NUMBER> requiring icu admission compared requiring icu admission <NUMBER> type arrhythmia described covid<NUMBER> emerged months ago early predict longterm outcome patients recover illness however important messages gleaned previous experiences sars caused sarscov shares considerable similarity sarscov<NUMBER> reported among patients recovered sars <NUMBER> continued abnormalities lipid metabolism <NUMBER>years followup cv abnormalities present <NUMBER> altered glucose metabolism <NUMBER> <NUMBER> similar findings also reported patients recovering respiratory tract infections <NUMBER> considering careful followup recovering current covid<NUMBER> would important understand longterm impact illness also protect patients future cvd overall management principles patients presenting covid<NUMBER> develop cv complications preexisting cvd patient without covid<NUMBER> however important points need consideration<NUMBER> caregivers utmost responsibility protect getting infected managing patients therefore heathcare personnel engaged care covid<NUMBER> patients must observe necessary precautions times trained donning usage doffing personal protective equipment accordance existing practice guidelines <NUMBER> hospital systems need ensure preparedness dealing large volume covid<NUMBER> patients many would need icu care andor acute cardiac care appropriate protocols rapid diagnosis triage isolation management covid<NUMBER> patients cv complications developed wellrehearsed rapid triaging management patients crucial allow efficient utilization healthcare resources also minimize exposure caregivers already reports highlighting delays delivering acute cardiac care due extra precautions need observed view covid<NUMBER> <NUMBER> efforts made minimize delays <NUMBER> strong emphasis placed avoiding unwarranted diagnostic tests eg cardiac troponin echocardiography etc patients required minimize unwarranted downstream diagnostictherapeutic procedures would strain already stretched healthcare resources would also subject caregivers added risk exposure infection american college cardiology released advisory discouraging random measurement cardiac biomarkers troponins natriuretic peptides <NUMBER> urges clinicians reserve assays circumstances would actually meaningfully add management patients covid<NUMBER> american society echocardiography also issued similar advisory regarding use echocardiography patients <NUMBER> <NUMBER> individual hospitals may also reconsider riskbenefit ratio primary percutaneous intervention vs fibrinolysis patients covid<NUMBER> present stsegment elevation myocardial infarction <NUMBER> concern regarding safety ace inhibitors acei angiotensin receptor blockers arb ongoing covid<NUMBER> pandemic agents upregulate expression ace<NUMBER> various tissues including cardiomyocytes <NUMBER> since sarscov<NUMBER> binds ace<NUMBER> gain entry human cells potentially increased risk developing covid<NUMBER> developing severe disease patients already background treatment aceiarb however date experimental clinical data emerged support concerns time risks discontinuing therapies well known therefore several leading professional societies strongly urged discontinue clinicallyindicated aceiarb therapy event patient develops covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> clinicians caring patients also need fully aware potential cv sideeffects various therapies used treating viral infection additionally various antiretroviral drugs significant interactions cardiac drugs need considered appropriate dose modification done recently chloroquinehydroxychloroquine azathioprine proposed potential therapeutic options based preliminary evidence <NUMBER> drugs known prolong qt interval due caution must exercised prescribing agents combination best avoided even using chloroquinehydroxychloroquine alone daily electrocardiogram monitoring qt interval warranted esp patients hepatic renal dysfunction receiving another drug potential prolong qt interval although respiratory illness dominant clinical manifestation covid<NUMBER> shear burden illness implies large number patients covid<NUMBER> would present preexisting cvd develop newonset cardiac dysfunction course illness considering current understanding interplay cvd covid<NUMBER> grossly inadequate therefore highly desirable future studies covid<NUMBER> specifically describe incidence mechanisms clinical presentation outcomes various cv manifestations patients diagnostic therapeutic challenges posed concurrence two illnesses also need adequately studied injuries cellular immune deficiency coagulation activation <NUMBER> <NUMBER> <NUMBER> reported <NUMBER> patients covid<NUMBER> suffered cardiac injury <NUMBER> however cardiovascular manifestations covid<NUMBER> infection reported systemically study aimed explore covid<NUMBER> affects cardiovascular system including myocardium conduction systems cardiac function blood pressure especially severe critical cases identify potential risk factors predicting severity covid<NUMBER> collected medical records <NUMBER> patients diagnosed severe critical cases admitted hospital january <NUMBER> february <NUMBER> <NUMBER> patients enrolled study diagnosed according sixth edition guideline issued chinas national health commission severe cases classified meeting one following <NUMBER> respiratory distress rr <NUMBER>times min <NUMBER> fingertip oxygen saturation <NUMBER> resting state <NUMBER> arterial partial pressure oxygen pao <NUMBER> fraction inspiration <NUMBER> fio <NUMBER> <NUMBER> mmhg <NUMBER> mmhg <NUMBER> kpa critical cases classified meeting one following <NUMBER> respiratory failure artificial airway required invasive mechanical ventilation <NUMBER> shock <NUMBER> combining failure organs requires icu monitoring treatment clinical laboratory electrocardiogram ecg echocardiographic data obtained electronic medical record system reviewed trained team cardiologists study approved institutional ethics blood pressure pulse rate measured least every <NUMBER> hours hospitalization using automatic blood pressure recording machines hypotension defined systolic blood pressure <NUMBER> mmhg andor diastolic blood pressure <NUMBER> mmhg tachycardia defined heart rate <NUMBER> beatsminute least two consecutive readings bradycardia defined daytime heart rate <NUMBER> beatsminutes awake least two consecutive readings temperature charted every <NUMBER> hours eardrum thermometers patients checked new onset change symptoms blood tests performed regularly cardiac injury defined serum level specific cardiac biomarkers eg troponin <NUMBER> upper reference limit serious cardiac injury defined serum level troponin tni <NUMBER> times upper reference limit <NUMBER> echocardiography performed deemed necessary physician charge significant hypotension necessitated inotropic support suspicious changes myocardial ischemia electrocardiogram ecg performed clinically indicated occurrence unexplained severe tachycardia bradycardia hypotension cardiac arrhythmia suspected continuous variables expressed means sds categorical variables summarized counts percentages category comparison nonparametric variables pearson χ <NUMBER> test used multifactor logistic regression model used analyze related factors covid<NUMBER> critical type p value <NUMBER> considered significant among <NUMBER> patients enrolled study <NUMBER> <NUMBER> diagnosed severe <NUMBER> <NUMBER> critical cases thirtysix <NUMBER> patients males gender differences similar severe critical groups median age <NUMBER> <NUMBER> <NUMBER> <NUMBER> years old patients <NUMBER> years old occupied almost one third average age similar severe critical groups nine patients history cardiocerebrovascular diseases including six patients coronary artery disease four severe two critical cases one patient aortic mitral valve replacement severe case one patient mild moderate mitral regurgitation critical case one patient persistent atrial fibrillation acute cerebral infarction critical case none cases studied previous history chronic heart failure chronic lung disease presenting symptoms fever occurred <NUMBER> <NUMBER> patients including <NUMBER> <NUMBER> lowgrade fever <NUMBER> <NUMBER> moderate fever <NUMBER> <NUMBER> high fever respectively difference fever type observed severe critical group occurrence diabetes level ddimer white blood cell wbc procalcitonin interleukin<NUMBER> il<NUMBER> erythrocyte sedimentation rate esr creactive protein crp critical cases significantly higher severe cases p <NUMBER> indicating patients diabetes higher level ddimer inflammation susceptible develop critical conditions cardiac biomarkers remarkedly higher critical group p <NUMBER> suggesting serious myocardial injury renal function biomarkers similar severe critical cases acute kidney injury occurred one third patients groups clinical features laboratory findings summarized table <NUMBER> four patients two severe two critical complained chest pain none found tni elevation ecg change presence chest pain may due pleuritis caused pneumonia elevation tni observed <NUMBER> <NUMBER> patients notably three patients highly elevated tni <NUMBER> times upper reference limit indicative severe myocardial injury critical cases serum levels tni ckmb myoglobin significantly higher demographic clinical characteristics severe critical patients critical group compared severe group p <NUMBER> addition elevation tni consistent elevation inflammatory markers especially procalcitonin il<NUMBER> supporting information figure s<NUMBER> indicating role inflammation cytokine storm cardiac injury stt changes ecg identified four patients one severe three critical three accompanied increase tni ntprobnp elevation occurred <NUMBER> <NUMBER> patients eight patients presented significantly elevated ntprobnp <NUMBER> times upper reference limit including five critical cases concentration ntprobnp remarkedly higher critical group compared severe group p <NUMBER> table <NUMBER> sixteen <NUMBER> patients history hypertension study table <NUMBER> sinus tachycardia common type arrythmia observed <NUMBER> <NUMBER> severe patients critical patients p <NUMBER> noteworthy rising heart rate consis performed echocardiography <NUMBER> patients including <NUMBER> severe <NUMBER> critical patients occurrence mild pericardial effusion observed one severe case five critical cases p <NUMBER> suggesting critical patients likely develop pericardial effusion three critical cases suffered new onset heart failure two cases presented right heart failure accompanied right heart enlargement pulmonary hypertension unfortunately ended death one case presented reversible left heart failure elevation tni indicative possibility myocarditis pity failed obtain histopathology hospitalization cardiomegaly found patient without heart failure table <NUMBER> study blood pressure <NUMBER> patients history hypertension control admission may attributed increased catecholamine related stress anxiety ace<NUMBER> pathway influenced sarscov<NUMBER> infection <NUMBER> noteworthy three patients suffered hypotension admission seven patients suffered persistent hypotension hospitalization developed critical status consequently presence hypotension echocardiographic data showed occurrence mild pericardial effusion onethird critical patients without manifestation heart failure might due inflammatory effusion three critical cases reported suffer new onset heart failure two cases developed right heart failure white lung end stage disease one case presented reversible left heart failure tni elevation indicative occurrence myocarditis regrettably lack pathological evidence patients without heart failure impaired diastolic function abnormal wall motion cardiomegaly found inconsistent previous publication <NUMBER> detailed studies needed get comprehensive understanding cardiovascular manifestations cardiac function change sarscov<NUMBER> infection first time systemically report cardiovascular manifestations covid<NUMBER> infection providing reference clinical practice results suggested attention paid old adult male patients diabetic patients susceptible develop critical conditions occurrence cardiac injury study significantly higher data previous studies probably due different severity enrolled patients urging us attach importance heart protection choosing optimal treatment strategies especially managing severe critical cases hypotension independent risk factor critical status poor prognosis therefore blood pressure closely monitored hospitalization period sinus tachycardia common type arrythmia patients covid<NUMBER> especially severe critical cases ventricular tachycardia atrioventricular block less common may act warning signs disease deterioration close observation vital signs advised mild pericardial effusion occurred onethird critical patients without manifestation heart failure another independent risk factor critical disease status detailed studies needed get deeper understanding cardiovascular manifestations sarscov<NUMBER> infection main limitation study small sample size <NUMBER> confirmed severe critical covid<NUMBER> patients single center enrolled making difficult get full understanding relation covid<NUMBER> cardiovascular system besides followup data collected get knowledge longterm impact covid<NUMBER> cardiovascular system study systemically reported impact covid<NUMBER> cardiovascular system including myocardial injury blood pressure arrythmia cardiac function severe critical cases hypotension treatment severe myocardial injury pericardial effusion independent risk factors critical disease status patients covid<NUMBER> monitoring vital signs cardiac function covid<NUMBER> patients applying potential interventions especially hypotension treatment severe myocardial injury pericardial effusion vital importance coronavirus disease <NUMBER> covid <NUMBER> emergency public health incident happening nearly <NUMBER> countries regions affecting <NUMBER> <NUMBER> <NUMBER> patients worldwide <NUMBER> <NUMBER> deaths <NUMBER> april <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes symptoms majority cases common fever cough shortness breath fatigue muscle pain <NUMBER> highresolution computed tomography ct allows accurate evaluation lung lesions thus enabling us better understand pathogenesis disease <NUMBER> acute respiratory distress syndrome ards respiratory failure sepsis acute cardiac injury heart failure common critical complications exacerbation covid<NUMBER> <NUMBER> growing body evidence suggests notable impact comorbidities chronic diseases clinical outcomes patients covid<NUMBER> infection according coronavirus reports centers disease control prevention us department health human services patients type <NUMBER> diabetes mellitus metabolic syndrome may <NUMBER> times greater risk death infected covid<NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed hospitalized patients <NUMBER> hospitals <NUMBER> <NUMBER> reported least one comorbidity <NUMBER> prevalent comorbidity covid<NUMBER> hypertension <NUMBER> followed diabetes <NUMBER> report drawn considerable attention covid<NUMBER> coexisting disorders patients presence coexisting illness found common among severe patients <NUMBER> covid<NUMBER> patients underlying risk factors associated mortality including male gender advanced age presence comorbidities including hypertension diabetes mellitus cardiovascular diseases cerebrovascular diseases <NUMBER> major comorbidities fatality cases include hypertension diabetes coronary heart disease cerebral infarction chronic bronchitis <NUMBER> notable diabetes demonstrated potential risk factor close association mortality <NUMBER> covid<NUMBER> places huge burden healthcare facilities especially regarding patients comorbidities intensive care required approximately <NUMBER> polymorbid covid<NUMBER>infected patients hospitalization associated case fatality rate cfr greater <NUMBER> <NUMBER> special attention efforts protect reduce transmission applied susceptible populations including children healthcare providers elderly people <NUMBER> given higher mortality higher proportion critically ill adult covid<NUMBER> patients diabetes good inpatient glycemic control particularly important comprehensive treatment covid<NUMBER> individualized blood glucose target goals treatment strategies made according specific circumstances covid<NUMBER> patients diabetes <NUMBER> <NUMBER> recent metaanalysis included <NUMBER> covid<NUMBER> patients nine studies covid<NUMBER> significantly correlated several metabolic diseases indicating hypertension diabetes coronary heart disease may exert profound effect progression covid<NUMBER> <NUMBER> adverse effects glucose lipid metabolism disorders immune system make patients vulnerable various infections however evidence worsening covid<NUMBER> patients diabetes compared nondiabetes required conclusions consolidated elucidate risk severity comorbidity diabetes patients infected covid<NUMBER> retrospective study carried investigate clinical features radiographic laboratory tests complications treatments clinical outcomes covid<NUMBER> patients without diabetes included <NUMBER> hospitalized patients ≥ <NUMBER> years old laboratoryconfirmed covid<NUMBER> hubei provincial hospital integrated traditional chinese western medicine <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> covid<NUMBER> diagnosed basis world health organization whos interim guidance confirmed case covid<NUMBER> defined positive result highthroughput sequencing realtime reversetranscriptase polymerase chain reaction rtpcr assay nasal pharyngeal swab specimens total <NUMBER> diabetic <NUMBER> nondiabetic patients randomly selected information recent exposure history clinical symptoms signs laboratory findings admission extracted electronic medical records determined presence radiologic abnormality basis documentation description medical charts major disagreement two reviewers resolved consultation third reviewer laboratory assessments consisted following complete blood count blood glucose lipids coagulation testing assessment liver renal function measures electrolytes creactive protein procalcitonin pct lactate dehydrogenase creatine kinase blood gas analysis detection inflammation markers divided cases two groups group patients covid<NUMBER> type <NUMBER> diabetes based guidelines prevention control type <NUMBER> diabetes china <NUMBER> edition <NUMBER> group covid<NUMBER> patients without diabetes medical data processed team experienced clinicians reviewed abstracted data data entered computerized database checked core data missing requests clarification sent coordinators subsequently contacted attending clinicians laboratory confirmation sarscov<NUMBER> performed hubei provincial hospital integrated chinese western medicine rtpcr assays performed accordance protocol established categorical variables described frequency rates percentages continuous variables described using mean median interquartile range iqr values means continuous variables compared using independent group ttests data normally distributed otherwise mannwhitney u test used proportions categorical variables compared using χ <NUMBER> test although fisher exact test used data limited statistical analyses performed using statistical package social sciences spss version <NUMBER> software spss inc unadjusted comparisons twosided p value less <NUMBER> considered statistically significant analyses adjusted multiple comparisons given potential type error findings interpreted exploratory descriptive shown table <NUMBER> <NUMBER> <NUMBER> patients type <NUMBER> diabetes <NUMBER> <NUMBER> patients without diabetes enrolled median age patients <NUMBER> years iqr <NUMBER> total <NUMBER> female fever body temperature ≥ <NUMBER> ºc present <NUMBER> patients admission developed <NUMBER> hospitalization common symptoms cough <NUMBER> fatigue <NUMBER> shortness breath <NUMBER> sputum <NUMBER> myalgia arthralgia <NUMBER> diarrhea <NUMBER> among overall population <NUMBER> least one coexisting glucoselipid metabolism disorder diabetes hypertension coronary heart disease cerebrovascular disease admission hospitalization body temperature diabetic patients lower nondiabetic patients <NUMBER> ºc iqr <NUMBER> vs <NUMBER> ºc iqr <NUMBER> p <NUMBER> <NUMBER> ºc iqr <NUMBER> vs <NUMBER> ºc iqr <NUMBER> p <NUMBER> <NUMBER> profile may attributed impaired immune response diabetic patients furthermore fatigue <NUMBER> vs <NUMBER> p <NUMBER> chills <NUMBER> vs <NUMBER> p <NUMBER> symptoms differed among diabetic nondiabetic patients since diabetic patients prone fatigue long time due energy metabolism disorders infection sarscov<NUMBER> may become less sensitive symptoms fatigue diabetes promotes detrimental proinflammatory state <NUMBER> may cause chill symptoms pronounced present study showed significant differences comorbidities diabetic covid<NUMBER> patients versus nondiabetic patients including hypertension <NUMBER> vs <NUMBER> p <NUMBER> coronary heart disease <NUMBER> vs <NUMBER> p <NUMBER> chronic renal disease <NUMBER> vs <NUMBER> p <NUMBER> well established hypertension coronary heart disease chronic renal disease coexist diabetes leading higher risk morbidity mortality covid<NUMBER> diabetic patients patients related glucose lipid dysfunctions angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor overexpresses multiple organs lung kidney liver facilitates receptorbinding domain spike protein sarscov<NUMBER> bound cell receptor ace<NUMBER> <NUMBER> several lines evidence suggest diabetes risk factor progression prognosis covid<NUMBER> <NUMBER> <NUMBER> study enhanced hypothesis nonetheless prevalence cerebrovascular disease hepatitis b infection cancer chronic obstructive pulmonary disease copd history comparable two groups radiologic data admission shown table <NUMBER> <NUMBER> ct scans performed time admission <NUMBER> showed abnormal results ct abnormality found seven <NUMBER> patients <NUMBER> without diabetes six <NUMBER> patients <NUMBER> diabetes common patterns chest cts groundglass opacity <NUMBER> vs <NUMBER> p <NUMBER> bilateral patchy shadowing <NUMBER> vs <NUMBER> p <NUMBER> among diabetic patients comparison nondiabetic patients consistent recent reports <NUMBER> suggest severe lung injury diabetic covid<NUMBER> patients table <NUMBER> shows laboratory findings admission blood glucose <NUMBER> mmol·l <NUMBER> iqr <NUMBER> vs <NUMBER> mmol·l <NUMBER> iqr <NUMBER> blood lowdensity lipoprotein cholesterol ldlc <NUMBER> regarding hematological parameters admission lymphocytopenia present <NUMBER> patients thrombocytopenia present <NUMBER> leukopenia present <NUMBER> presence lymphocytopenia suggested viral infection patients differences hematological parameters diabetic nondiabetic covid<NUMBER> groups levels inflammatory parameters erythrocyte sedimentation rate esr <NUMBER> creactive protein <NUMBER> elevated difference two covid<NUMBER> groups without diabetes difference proinflammatory cytokines procalcitonin pct tumor necrosis factor tnf interleukins ils forth two covid<NUMBER> groups blood biochemical parameters alanine aminotransferase alt aspartate aminotransferase ast blood urea nitrogen bun creatinine forth showed laboratory abnormalities suggesting less abnormal liver renal myocyte functions levels immunity parameters showed similar negative results although immunoglobulin iga positive change serum iga important role protection mucociliary areas acts barrier pathogenic organisms antigens even allergens <NUMBER> combination covid<NUMBER> diabetes different effect immune status covid<NUMBER> without diabetes glucose lipid metabolism disorders may increase immune response findings suggest diabetic patients covid<NUMBER> likely show abnormal blood coagulation function clinical practice inflammatory storm blood coagulation abnormal early stage result inflammationactivating plasmin subsequently hypoxiainduced molecules activate thrombin directly progressive inflammation activation monocytemacrophages also secretes number tissue factors activating exogenous coagulation pathway leads overall hypercoagulable state <NUMBER> compared nondiabetic cases diabetic cases much lower po <NUMBER> table <NUMBER> shows primary composite end point event occurred <NUMBER> <NUMBER> <NUMBER> patients including eight patients <NUMBER> admitted icu eight patients <NUMBER> underwent mechanical ventilation one patient experienced invasive noninvasive mechanical ventilation nine patients <NUMBER> died median duration hospitalization <NUMBER> iqr <NUMBER> among <NUMBER> patients diabetes tendency toward severe prognosis observed even though statistical significance clinical outcomes diabetic nondiabetic groups including primary composite end point event <NUMBER> vs <NUMBER> p <NUMBER> median duration hospitalization <NUMBER> vs <NUMBER> p <NUMBER> incidence admission icu <NUMBER> vs <NUMBER> p <NUMBER> discharge hospital <NUMBER> vs <NUMBER> p <NUMBER> death <NUMBER> vs <NUMBER> p <NUMBER> hospitalization <NUMBER> vs <NUMBER> p <NUMBER> majority patients <NUMBER> received intravenous antibiotic therapy <NUMBER> received antiviral therapy <NUMBER> received systemic glucocorticoids <NUMBER> received antifungal medication <NUMBER> received mechanical ventilation <NUMBER> treated traditional chinese medicine <NUMBER> treated acupuncture noninvasive mechanical ventilation initiated diabetic patients nondiabetic patients <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> hospital admission patients received diagnosis ards <NUMBER> acute kidney injury <NUMBER> septic shock <NUMBER> heart failure <NUMBER> physician patient entered disseminated intravascular coagulation dic stage clinical data <NUMBER> diabetic patients <NUMBER> given glucocorticoids accounting <NUMBER> diabetic patients <NUMBER> nondiabetic patients given glucocorticoids accounting <NUMBER> nondiabetic patients p <NUMBER> according retrospective study patients ards covid<NUMBER> showed lower mortality among receiving glucocorticoids <NUMBER> covid<NUMBER> patients benefit glucocorticoids treatment reduce autoimmunity cytokine toxicity <NUMBER> retrospective study blood glucose monitored every covid<NUMBER> patient treatment glucocorticoids due outbreak isolation management therefore could analyze impact glucocorticoids glucose level covid<NUMBER> patients without diabetes due insufficient clinical data limitation study although glucocorticoids unavoidably affect blood glucose level evidence administration glucocorticoids worsens covid<NUMBER> future influence glucocorticoids covid<NUMBER> patients diabetes investigated retrospective study provides first direct evidence supporting high frequency coexistence type <NUMBER> diabetes hypertension coronary heart disease chronic renal disease patients covid<NUMBER> new finding strongly supports proposed novel concept glucolipid metabolic disease glmd integrated strategy treatment whole spectrum metabolic diseases underlying sarscov<NUMBER> infection <NUMBER> recognized disorders metabolism glucose lipids act initial trigger potent driving force development progress various metabolic diseases including type <NUMBER> diabetes mellitus dyslipidemia nonalcoholic fatty liver disease hypertension atherosclerosis cardiovascular complications metabolism lipids glucose highly coordinated process physiological diseased conditions impairment signals corresponding metabolism either lipids glucose common mechanism also key mechanism underlying pathogenesis glmd <NUMBER> another novel finding present study potentiated severity covid<NUMBER> patients metabolic comorbidities although several previous studies reported diabetes one common comorbidities patients sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> pathophysiological consequence close association diabetes covid<NUMBER> progression still remains elusive analysis highlights markedly promoted morbidity diabetes patients covid<NUMBER> infection frequency degree abnormalities radiologic examinations diabetic covid<NUMBER> patients notably higher control group without diabetes addition disruption homeostatic control glucose metabolism blood pressure severe diabetic covid<NUMBER> patients diabetes related metabolic disorders consistently documented one key risk factors severe outcomes patients infected types coronavirus middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> sarsassociated coronavirus sarscov <NUMBER> thus data present study demonstrate diabetes associated metabolic complications crucial contributor enhanced morbidity mortality covid<NUMBER> patients conceptional construction glmd great relevance clinical management covid<NUMBER> one hand data suggest maintenance homeostasis glucose lipid metabolism via optimal clinical management covid<NUMBER> patients mandatory furthermore evidence infection another member coronavirus familynamely sarscovhas demonstrated binding sarscov receptor ace<NUMBER> pancreas results islet damage notable decrease release insulin thereby causing shortterm hyperglycemia even onset diabetes <NUMBER> furthermore sarscovevoked diabeteslike traits markedly potentiate progression multipleorgan failure via positive feedback loop therefore tight control parameter set glucose lipid metabolism may key optimal clinical outcomes covid<NUMBER> patients without history diabetes andor metabolic diseases hand diabetes attained epidemic proportions worldwide according estimated data international diabetes federation <NUMBER> million people diabetes mellitus <NUMBER> individuals type <NUMBER> diabetes mellitus <NUMBER> hence powerful integrated approaches launched comprehensive prevention glmd significant importance marked reduction morbidity mortality caused covid<NUMBER> emerging infectious diseases present study may possess limitations first retrospective study conducted historical cohorts recorded events already occurred thus information relevant risk factors potentially profound influence progression covid<NUMBER> may included database subsequent analysis therefore measurement impact diabetes complications clinical outcomes would accurate prospective study second sample size relatively small therefore findings observed present study warrant validation future study large sampling size conclusion diabetes coexisting metabolic disorders within spectrum glmd significantly boost morbidity covid<NUMBER> patients therefore findings deliver least two important messages clinical management covid<NUMBER> first optimal management metabolic hemostasis glucose lipids key ensuring better clinical outcomes second increased clinical vigilance warranted covid<NUMBER> patients glmd form fundamental chronic conditions first cases covid<NUMBER> reported december <NUMBER> originating wuhan china <NUMBER> rapid spread covid<NUMBER> become pandemic affecting <NUMBER> people across <NUMBER> countries around world <NUMBER> increasing number confirmed cases accumulating clinical data addition common clinical presentation respiratory failure caused covid<NUMBER> cardiovascular manifestations induced viral infection generated considerable concern huang et al reported <NUMBER> patients covid<NUMBER> diagnosed acute myocardial injury showed elevated levels highsensitive troponin <NUMBER> recent data among <NUMBER> hospitalized patients covid<NUMBER> <NUMBER> arrhythmias <NUMBER> acute myocardial injury <NUMBER> reports provides evidences cardiac involvement possible late phenomenon viral respiratory infection process subclinical interstitial inflammatory cells reported autopsy study <NUMBER> present overt manifestations even without respiratory symptoms <NUMBER> number increased cardiovascular manifestations also associated increased mortality among covid<NUMBER> patients tao guo et al conducted study <NUMBER> patients covid<NUMBER> total <NUMBER> <NUMBER> exhibited myocardial injury demonstrated elevation tnt levels mortality markedly higher patients elevated troponin tntlevels patients normal tnt levels <NUMBER> vs <NUMBER> patients underlying cardiovascular disease cvd escalation tnt levels highest mortality <NUMBER> shortest survival term <NUMBER> data suggest must also put concern cardiovascular manifestations patients covid<NUMBER> infections therefore review cardiovascular system involvement course covid<NUMBER> infection current data china italy well us show covid<NUMBER> present relatively mild symptoms affected individuals however patients suffer severe even deadly conditions require intensive care patients severe illness also greater risk mortality particularly older individuals underlying comorbidities including cardiovascular disease <NUMBER> <NUMBER> table <NUMBER> shows various risk factors several studies increases likelihood patients developing cardiovascular involvement covid<NUMBER> without prior cardiovascular disease history <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> risk factors author results hypertension diabetes shaw et al <NUMBER> kwong et common risk factors developing cardiovascular involvement covid failure cancer al <NUMBER> shi et al <NUMBER> oudit et al <NUMBER> troponin troponin factors increase risk developing acute coronary syndrome acute infections seen previous studies influenza acute inflammatory conditions although exact pathophysiological mechanism underlying myocardial injury caused covid<NUMBER> fully understood previous report showed <NUMBER> patients infected sarscov genome positively detected heart <NUMBER> shown figure <NUMBER> sarscov binds cells expressing appropriate viral receptors particularly ace<NUMBER> abundant heart <NUMBER> murine models human autopsy samples demonstrate sarscov downregulate myocardial pulmonary ace<NUMBER> pathways thereby mediating myocardial inflammation lung edema acute respiratory failure <NUMBER> raises possibility direct damage cardiomyocytes virus sarscov<NUMBER> may share mechanism sarscov <NUMBER> viruses highly homologous genome <NUMBER> <NUMBER> recent studies china address unique marked affinity sarscov<NUMBER> host angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor raising possibility direct viral infection vascular endothelium myocardium <NUMBER> <NUMBER> furthermore two experimental studies proved sarscov<NUMBER> uses ace<NUMBER> also expressed heart receptor entry cell <NUMBER> <NUMBER> data suggested sarscov<NUMBER> direct invasion mechanism heart oxygen supply destabilization coronary plaque micro thrombogenesis <NUMBER> chronic cardiovascular disease also may become unstable consequence imbalance infectioninduce increased metabolic demand reduced cardiac reserve acute coronary events patients covid<NUMBER> may result significant increase myocardial demand triggered infections precipitate myocardial injury infarct similar type <NUMBER> myocardial infarction <NUMBER> patients coronary artery disease heart failure may particular risk result coronary plaque rupture secondary virally induced systemic inflammation therefore rigorous use plaque stabilizing agents aspirin statins suggested possible therapeutic strategy <NUMBER> coagulation abnormalities arrhythmias also seen patients mechanism yet known table <NUMBER> shows potential mechanism cardiovascular manifestation covid<NUMBER> patients coronary heart disease <NUMBER> heart failure <NUMBER> coagulopathy <NUMBER> significantly higher mortality rate mainstay treatment covid<NUMBER> generally symptomatic supportive treatment intervention although currently specific guidelines regarding prevention treatment cardiovascular complications covid<NUMBER> yet established things taken consideration treating patients reasonable triage patients covid<NUMBER> according presence underlying cvd evidence myocardial injury measure provide prioritized treatment aggressive treatment strategies compared without conditions cardiac biomarkers ntprobnp electrocardiograms closely monitored early warning intervention many drugs used treat covid<NUMBER> patients may cause exacerbate cardiac insufficiency arrhythmia cardiovascular disorders antivirals possibility side effect must taken consideration close monitoring using ecg done patients treated drugs likelihood critically ill covid<NUMBER> patients develop thromboembolic disease thrombo phylactic utilization recommended still unknown drug optimal purpose drugdrug interaction antiviral therapy direct oral anticoagulant low molecular heparins unfractionated heparin without mechanical prophylaxis suggested preferred acutely ill patients <NUMBER> <NUMBER> reperfusion therapy pandemic settings trend reperfusion therapy intended stemi patients shifted fibrinolytic therapy preferred percutaneous coronary intervention pci whenever facilities infrastructure compatible deliver procedure institution also develop protocols appropriate triage isolation treatment covid<NUMBER> patients may need interventions <NUMBER> harm associated pursuing reperfusion therapy may exceed anticipated gain covid<NUMBER> patients particularly primary competing illness portends poor outcome underlying medical comorbidities appear significantly impact covid<NUMBER> severity mortality acknowledging lack data therefore highly desirable mechanisms clinical presentation outcomes various cv manifestations proper treatment patients studied finally concluded sarscov<NUMBER> devastating impact cardiovascular system thus patients require clinicians meticulous attention towards patient <NUMBER>monthold male baby time transplant born hypoplastic left heart syndrome underwent staged palliation norwood procedure sano modification followed bidirectional glenn procedure <NUMBER> months age norwood procedure complicated bilateral vocal cord paresis requiring tracheostomy remained hospitalized glenn procedure discharged home ventilator subsequently weaned developed clinical heart failure moderatetosevere tricuspid insufficiency associated ventricular dysfunction several months glenn procedure resulted initiation aggressive medical regimen including spironolactone furosemide enalapril carvedilol doses optimized weight gain following months required several hospitalizations viral infections leading worsening congestion never requiring inotropic support fully immunized including received <NUMBER> doses inactivated influenza vaccine <NUMBER> <NUMBER> months age accordance current national guidelines additionally received monthly injections palivizumab one month prior transplant developed severe congestion poor perfusion anuria reduced responsiveness resulted admission critical care unit milrinone infusion started along reinstitution positive pressure ventilation via tracheostomy due episode decompensation without obvious precipitating event evaluated transplant listed status <NUMBER>a blood type elevated antia antib isohemagglutinin titers listed abo compatible transplant remained hospitalized transplant resistant congestion despite milrinone infusion enteral heart failure regimen one month waitlist heart became available patient developed fever day organ offer additional symptom nasal congestion respiratory viral panel obtained fever reported next day positive coronavirus rhino enterovirus organ match run initially included patient sequence <NUMBER> four prior institutions declined organ organ quality using code <NUMBER> donor presented respiratory arrest following short illness cough part evaluation respiratory arrest donors nasopharyngeal secretions exhibited influenza positivity polymerase chain reaction testing chest shortage pediatric donor hearts waitlisted children yet nearly <NUMBER> organs offered transplanted donor quality often cited reason declining organs offered donors infected influenza presumably due concern disease transmission transplant leading severe disease previously described excellent outcome heart transplant donor infected influenza b treated complete course oseltamivir report describe similar outcome transplantation organ influenza apositive donor symptomatic disease incompletely treated oseltamivir due availability effective antiviral treatment suggest influenza also manageable donor infection need preclude heart placement radiograph demonstrated diffuse pulmonary interstitial markings consistent pneumonitis edema bronchoscopy demonstrated purulent secretions mixed gramnegative grampositive organisms pathologic organisms found cardiac structure function normal echo donor progressed brain death next <NUMBER> hours time <NUMBER> doses oseltamivir administered center accepted organ dose oseltamivir administered recipient twicedaily dosing continued <NUMBER> days posttransplant perception remains nearly <NUMBER> pediatric heart transplant waitlist mortality largely due donor organ shortage despite fact nearly <NUMBER> available organs declined placed <NUMBER> <NUMBER> expansion considered acceptable organ likely efficient way address problem <NUMBER> significant number donor hearts declined pediatric transplant centers due donor quality issues subsequently transplanted centers outcomes comparable organs previously declined donor quality suggesting ability identify quality donor organs refined <NUMBER> furthermore <NUMBER> waitlisted patients decline organ offer subsequently placed receive another organ offer expiring removed waitlist deterioration <NUMBER> led davies et al conclude pediatric heart transplant community may waiting perfect organ rather taking one good enough negatively impacts waitlist outcomes donor infectious disease impacts organ acceptance practices donation due concern transmission immunocompromised host time transplant reluctance extend either cytomegalovirus epsteinbarr virus status common least cytomegalovirus effective medical therapy organ donation hepatitis cpositive donors hepatitis cnegative recipients increasingly utilized adult transplantation due recent development highly effective antiviral agents used treat recipient <NUMBER> given expanded repertoire antiinfectious agents viruses microorganisms infections previously thought render donor heart unacceptable transplantation reconsidered influenza one disease influenza caused <NUMBER> childhood deaths united states yearly period <NUMBER> potential organ donors <NUMBER> although severe infection kidney recipient influenzapositive donor reported reports rare <NUMBER> recent survey american society transplantation infectious disease community practice demonstrated <NUMBER> practitioners would recommend accepting nonlung organs influenzapositive donors <NUMBER> multiple adult centers reported positive outcomes transplants influenzapositive donors uncertainty remains regarding duration donor recipient antiviral therapy necessary prevent disease transmission <NUMBER> recently published first case report pediatric patient receiving heart transplant donor symptomatic influenza b disease donor received full course oseltamivir documented tested negative influenza b organ harvest <NUMBER> recipient received <NUMBER>day course oseltamivir therapy disease transmission occur present case documents use oseltamivir donor recipient even without complete course donor may adequate mitigate risk influenza transmission uncertainty cases donors positive influenza need duration therapy donor recipient <NUMBER> <NUMBER> american society transplantation transplantation society canadian society transplantation endorsed recommendations influenzapositive donors considered nonlymphoid solid organ transplant acknowledging inadequate supporting data suggested full course antiviral therapy used prior organ procurement whenever possible <NUMBER> also note center disease control maintains updated information regard specific antiviral resistances reported may play role antiviral therapy choice <NUMBER> however <NUMBER> one united kingdom group reported success <NUMBER> solid organ transplants h<NUMBER>n<NUMBER>positive donors three completed therapy seven recipients received antiviral therapy reported cases influenza viral transmission experience also supports approach pediatric heart transplant <NUMBER> suggests inability completely treat donor full oseltamivir course may contraindication transplant using organs incompletely treated hosts may expand pool donor organs authors participated sufficiently work listed unlisted persons involved directly writing manuscript manuscript submitted published publication contrast spread using social distancing community containment <NUMBER> pharmacological treatment patients discerning mild severe infections waiting discover vaccine ever since pandemic started pulmonary impairment held account high morbidity mortality <NUMBER> <NUMBER> accordance coronavirus dissemination respiratory system including mouth nose mucosae <NUMBER> tissues rich angiotensin converting enzyme <NUMBER> ace<NUMBER> main binding site entry virus host cells <NUMBER> underlined ectoenzyme ace<NUMBER> expressed also several human organs small intestine jejunum kidneys cardiovascular central nervous systems <NUMBER> among tissues ace<NUMBER> highly expressed human vascular cardiac pericytes suggesting vulnerability cardiovascular system sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> observation may explain multiorgan damage arising covid<NUMBER> infections reported frontline doctors treatment disease <NUMBER> several cases cardiac complications reported patients <NUMBER> <NUMBER> <NUMBER> exemplificative case report concerns healthy <NUMBER>yearsold patient developed acute myopericarditis systolic dysfunction week onset fever dry cough due covid<NUMBER> infection <NUMBER> several risk factors associated worse outcome covid<NUMBER> patients recognized demographic characteristics older age male gender preexisting cardiovascular conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> latter hypertension coronary heart disease among common comorbidities recorded infected patients together type <NUMBER> diabetes mellitus t<NUMBER>dm <NUMBER> <NUMBER> <NUMBER> data istituto superiore di sanità iss italy show <NUMBER> patients hypertension <NUMBER> ischemic heart disease <NUMBER> atrial fibrillation <NUMBER> t<NUMBER>dm <NUMBER> furthermore authors demonstrated cardiac injury independently related increased mortality covid<NUMBER> patients <NUMBER> unfortunately cardiac injury mechanisms patients still well understood several authors suggested cardiovascular diseases diabetes mellitus linked endothelial dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> strictly related aging figure <NUMBER> general vasoconstriction induced vascular modulators increased elderly agonistmediated endothelial vasodilation attenuated <NUMBER> <NUMBER> <NUMBER> furthermore reduced chronic adaptive capacity older heart vessels reported animal models humans <NUMBER> speculated causeeffect relation covid<NUMBER> cardiovascular impairment bidirectional one hand patients cardiovascular diseases persistent endothelial dysfunction susceptible sarscov<NUMBER> infection higher ace<NUMBER> exposure vascular heart pericytes recently suggested <NUMBER> hand infection cause endothelial damage heavy inflammatory changes figure <NUMBER> besides authors showed patients pneumonia various alterations vascular responses endothelin <NUMBER> adrenomedullin nitric oxide etc <NUMBER> addition observed vascular changes agerelated evidencing decrease peripheral vascular resistance acute phase pneumonia younger patients increased resistance elderly patients <NUMBER> overall multiorgan damage arising covid<NUMBER> infections common basis could status endothelial dysfunction patient support idea several clinical evidences reported <NUMBER> endothelial dysfunction highlighted postmortem examinations also supported data reporting evident increase thromboembolic complications covid<NUMBER> patients suggesting treat lowmolecularweight heparin lwmh <NUMBER> <NUMBER> wellknown endothelial cell injury strongly activate coagulation system via exposure tissue factor pathways therefore covid<NUMBER> infection aggravating endothelial dysfunction patients generates detrimental hypercoagulable state <NUMBER> general main causes endothelial dysfunction <NUMBER> aging <NUMBER> sex hormones decline aging <NUMBER> ros <NUMBER> increased circulating endothelial microparticles progenitor cells empspcs ratio <NUMBER> proinflammatory status <NUMBER> <NUMBER> considering impact gender covid<NUMBER> epidemic even confirmed cases nation changing every day epidemiological data clearly evidence men infection causes worse outcomes compared women <NUMBER> <NUMBER> <NUMBER> <NUMBER> italy <NUMBER> may age range <NUMBER> years male deaths <NUMBER> total cases <NUMBER> reason behind difference genders appears clear however diversity sexhormones styles life believed play role patients susceptibility severe sarscov<NUMBER> outcomes known activation endothelial estrogen receptors increases decreases ros protecting vascular system angiotensin iimediated vasoconstriction inflammation ros production <NUMBER> <NUMBER> interestingly hudson coworkers suggested women congestive heart failure respond favourably angiotensin receptor blockers arbs men effective survival angiotensin converting enzyme inhibitors acei <NUMBER> china status ii study women showed greater antihypertensive response treatment arb valsartan combined amlodipine compared men treatment <NUMBER> recently suggested arbs could preferred ace inhibitors covid<NUMBER> patients since former preserve function ace<NUMBER> enzyme counterbalance renin angiotensin system activation <NUMBER> however topic still remains controversial <NUMBER> overall estrogens improve endothelial function several mechanisms <NUMBER> reduction oxidative stress <NUMBER> modulation reninangiotensin system <NUMBER> attenuation cellular endothelin<NUMBER> system <NUMBER> could use protective agents preserve cardiac vascular functions covid<NUMBER> treatments pandemic joining forces vital thus people help doctors limiting displacements houses avoiding hence spread infection doctors help patients overcome severe sarscov<NUMBER> infections using multiple pharmacological approaches context preservation endothelial function mitigation vascular inflammation prominent targets essential reduce severe outcomes also male older patients caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> primarily affects respiratory system although others organ systems also involved particular cardiovascular complications may occur among patients covid<NUMBER> high prevalence previous history cardiovascular diseases cvd andor cvd risk factors increased morbidity mortality patients recently reported several studies virus invades cardiomyocytes binding angiotensin converting enzyme <NUMBER> cell surface resulting myocardial injury elevates troponin levels particular covid<NUMBER> infection lead myocarditis vascular inflammation arrhythmias acute heart failure severe cases cardiogenic shock death studies patients covid<NUMBER> china indicated significantly higher inhospital mortality rate patients also myocardial injury acute infections increase risk acute coronary syndrome covid<NUMBER> may increase circulating cytokines potential cause instability rupture atherosclerotic plaques fever stress electrolyte disturbances use antiviral drugs patients covid<NUMBER> may proarrhythmic effects may issue patients inherited arrhythmia syndromes long qt syndrome brugada syndrome short qt syndrome catecholaminergic polymorphic ventricular tachycardia patients additional precautions specialised management advised moreover studies highlighted patients hospitalized covid<NUMBER> higher rate comorbidities including hypertension coronary artery disease characterized fatal events compared survivors zlancet<NUMBER> myocardial injury prevalent case interplay covid<NUMBER> cardiovascular complications healthy individuals patients preexisting cvd still far fully understood mechanisms cardiac injury patients covid<NUMBER> well established reasonable identify direct indirect mechanisms responsible cardiac failure possible causes effect covid<NUMBER> cardiac impairment due increased pulmonary vascular resistance consistent severe hyperinflammation microthrombosis side decreased blood saturation secondary respiratory failure may hamper cardiomyocytes contractility possibly leading decreased cardiac output compensatory mechanism reduced oxygen concentration blood consequence fever rise due covid<NUMBER> inflammation heart rate may significantly increase study provided examples possible scenarios investigate effect covid<NUMBER> cardiac features interest vital parameters aim exploited predictive nature computational methods based numerical solution ie aided computer mathematical equations underlying physical processes investigation context zerodimensional <NUMBER>d also known lumped parameters model simulates systemic pulmonary blood dynamics together cardiac function considered oabe<NUMBER> tool account broad range model parameters simulate variations pulmonary resistances heart rate cardiomyocyte contractility accordance covid<NUMBER> infection compute corresponding changes meaningful outputs stroke volume ejection fraction cardiac output arterial pulmonary pressures use <NUMBER>d mathematical model allowed us better understand strong interplay local changes reduced contractility global variables peripheral resistances heart rate cardiac function utmost importance view determining possible effects covid<NUMBER> infection patients affected cvd hand better evaluate impact cvd covid<NUMBER> possible scenario covid<NUMBER> infection individual exhibiting reduced ejection fraction cardiac output investigated sustain power computational study possible use patientspecific studies <NUMBER>d model provides mathematical description function several compartments cardiovascular system number locations depend complexity model hand level detail model consists system differential equations translate physical principles conservation mass momentum solution provides values flow rates pressures compartment rcvs<NUMBER> system obtained exploiting electric analogy current represents blood flow voltage pressure resistance represents blood resistance conductance vessel compliance inductance blood inertia referring figure <NUMBER> <NUMBER>d model composed four heart chambers whose mechanical behavior characterized suitable model parameters example left ventricle lv unloaded volumes ie volume zeropressure v<NUMBER>lv timevarying elastances elvteblv ealv flv considered eblv passive elastance ie inverse compliance ealv maximum active elastance flv function time ranging values <NUMBER> <NUMBER> accounts activation phases similar parameters definitions introduced right ventricle rv left atrium la right atrium ra four cardiac valves modeled diodes systemic circulation characterized arterial resistance compliance inductance rar sys car sys lar sys respectively quantities related venous system ie rven sys cven sys lven sys pulmonary circulation characterized systemic parameters rar pul car pul lar pul venous ones rven pul cven pul lven pul recent study <NUMBER>d model accounting pulmonary circulation see also quantities mentioned previous list parameters model together heart rate hr fully characterize individual patients condition healthy nonhealthy <NUMBER>d model thus provides tool able compute flow rate pressure compartment given chosen set parameters aim identified three sources changes abovementioned parameters corresponding reasonable value ranges hr clinical evidences showed tachycardia common covid<NUMBER> patients xehj<NUMBER> accordingly placed values hr range <NUMBER> bpm wood number w defined w rar pul rven pul <NUMBER> <NUMBER> represents information pulmonary resistances since according clinical evidences qcc<NUMBER> pulmonary resistances thus w increase presence covid<NUMBER> placed value w range <NUMBER> healthy <NUMBER> precisely multiplied baseline value rven pul base see table <NUMBER> factor kr range <NUMBER> rven pul kr rven pul base <NUMBER> also assumed rar pul rven pul <NUMBER> hijnmbe<NUMBER> analogous definitions hold true systemic resistances eaxx clinical evidences showed covid<NUMBER> may produce decreased blood saturation consequently also decreased cardiomyocyte contractility account decreased value four active elastance eaxx multiplying baseline values eaxxbase see table <NUMBER> first considered setting reported table <NUMBER> corresponding patient healthy conditions henceforth denoted baseline bsln figure <NUMBER> reported outcomes predicted <NUMBER>d model baseline setting computational model allowed reproduce ventricle pressurevolume pv loops well evolution time volumes pressures table <NUMBER> baseline setting starting point investigated effect variations mentioned methods section study possible impact covid<NUMBER> cardiac function particular considered two settings corresponding mild severe covid<NUMBER> infection denoted test <NUMBER>a test <NUMBER>b respectively test <NUMBER>a reflect effects reduced blood saturation due impaired pulmonary function decreased contractility whole heart muscle <NUMBER> baseline value moreover increased hr <NUMBER> bpm <NUMBER> bpm increased pulmonary resistance factor <NUMBER> corresponds wood number <NUMBER> test <NUMBER>b instead accentuated three abovementioned effects contractility <NUMBER> baseline hr <NUMBER> bpm increase pulmonary resistances factor <NUMBER> wood number <NUMBER> pv loops corresponding settings <NUMBER>a <NUMBER>b shown figure <NUMBER>a table <NUMBER> reports corresponding cardiac measurements tests showed lv pv loops impacted hypoxemia reduced contractility overall compared baseline values reduced cardiac contractility provides decrease sv <NUMBER> test <NUMBER>a <NUMBER> test <NUMBER>b together reduction lv ef <NUMBER> <NUMBER> test <NUMBER>a test <NUMBER>b respectively effect partially compensated increase hr considered hypoxic patientsas selfregulatory mechanism aimed preserve co bplos<NUMBER> matter fact co decreased <NUMBER> baseline test <NUMBER>a <NUMBER> test <NUMBER>b besides lv function also rv function significantly affected covid<NUMBER> related variations circulation model specifically rv ef decreased <NUMBER> test <NUMBER>a <NUMBER> test <NUMBER>b thus percentage lv moreover increased pulmonary resistance induced remarkable growth rv maximal pressure <NUMBER> <NUMBER> test <NUMBER>a <NUMBER>b respectively rv esv reports significant increase <NUMBER> <NUMBER> exploited predictive power computational model simulating effects covid<NUMBER> infection individual mildly impaired lv cardiac function particular assumed subject absence covid<NUMBER> contractility decreased <NUMBER> baseline hr equal <NUMBER> bpm pulmonary resistance equal <NUMBER> wood x<NUMBER> baseline systemic resistance equal <NUMBER> x<NUMBER> baseline test <NUMBER> see table <NUMBER> outputs computed <NUMBER>d model co <NUMBER> lmin lv sv <NUMBER> ml lv ef <NUMBER> rv ef <NUMBER> furtherly found lv edv <NUMBER> ml lv esv <NUMBER> ml rv edv <NUMBER> ml rv esv <NUMBER> ml however still normal ranges mehj<NUMBER> mjcmr<NUMBER> cbmc<NUMBER> test <NUMBER> considered two scenarios covid<NUMBER> infections furtherly decreasing heart contractility <NUMBER> <NUMBER> baseline increasing hr <NUMBER> <NUMBER> bpm increasing pulmonary resistance <NUMBER> <NUMBER> wood tests <NUMBER>a <NUMBER>b respectively data results reported figure <NUMBER>b table <NUMBER> outputs numerical simulations highlighted individual impaired lv cardiac function covid<NUMBER> infection furtherly worsen cardiac functional parameters chambers particular found reduction lv ef <NUMBER> <NUMBER> test <NUMBER>a test <NUMBER>b respectively lv ef <NUMBER> <NUMBER> rv ef <NUMBER> <NUMBER> co <NUMBER> <NUMBER> computational model able predict possible effects covid<NUMBER> infection cardiocirculatory system particularly cardiac function study confirmed infection able impact left right hearts decreasing ef co whose decrements partially compensated hr increase typically shown covid<NUMBER> patients maximum lv pressure reduced maximum rv pressure increased albeit latter remains within normal range values computational model predicted right heart strongly linked physiopathological standpoint pulmonary function indeed increased pulmonary resistance significantly affects rv pressure rv ef results seem well keeping recent data reporting lower rv systolic function echocardiographic parameters although still normal range frequent covid patients poor prognosis thus suggesting absence increase contractility response increase pulmonary resistancepressures could play role evolution illness ljacc<NUMBER> respiratory failure worsen rv function supposed susceptible impairment due increased rv afterload fact reported progressive decrease rv ef volume test <NUMBER>a test <NUMBER>b previously healthy subject since recent reports mjama<NUMBER> gjama<NUMBER> ricm<NUMBER> zlancet<NUMBER> ljacc<NUMBER> suggest cvd common finding patients covid<NUMBER> associated worse prognosis also simulated cardiac function response covid<NUMBER> patient history cardiac dysfunction although measured reduction lv ef simulate worse covid<NUMBER> infection measured severe reduction rv ef compared reduction lv ef finding could explain worse outcome case previous cvd fact rv dysfunction known important determinant symptoms powerful marker poor prognosis patients chronic heart failure gejhf<NUMBER> ccci<NUMBER> predict effect reduced contractility estimated end systolic pressure volume relationship espvr slope pv loop curve upper left corner matter fact highlighted figures <NUMBER>a <NUMBER>b left depressed inotropy reflected decreased espvr effect reported several experiments direct consequence reduced oxygen blood content wcr<NUMBER> bplos<NUMBER> moreover lv function experienced reduced systolic pressure reduced preload thus resulting significant decrease pva pressurevolume area biomarker known correlate hypoxia kajp<NUMBER> bplos<NUMBER> preliminary study highlighted covid<NUMBER> infection patient healthy cardiac function may able produce alterations maintain biomarkers within normal range values conversely starting scenario individual impaired cardiac function however values biomarkers within normal ranges mehj<NUMBER> mjcmr<NUMBER> cbmc<NUMBER> simulations revealed covid<NUMBER> infection could worsen cardiac biomarkers specifically reducing co sv normal values severely impacting lv rv efs computational model proposed carry sensitivity analyses rapid reliable reproducible way compares effect complex clinical situation patient employed medical practice outcome treatments several relevant cases study based <NUMBER>d computational model considers compartmental flow rates pressures detailed study predicting pointwise quantities interest heart could carried means <NUMBER>d<NUMBER>d model heart part simulated means <NUMBER>d electromechanical model whose geometry personalized starting clinical images ct mri acquired specific patient currently study regazzoni f salvador africa p fedele dede l quarteroni electromechanical modeling human heart coupled circulation model whole cardiovascular system preparation computational model neglected effect pressure variations due respiration rib cage hence cardiocirculatory system albeit deem assumption limited impact outcomes study plan improve <NUMBER>d model studies topic computational models could effective tool study effect covid<NUMBER> cardiac function preliminary <NUMBER>d model computations revealed possible worsening sv co lv ef rv ef biomarkers individuals otherwise normal cardiac function impaired cardiac function latter case values normal values even within normal ranges case without covid<NUMBER> effects provided quantitative although speculative confirmation covid<NUMBER> could important consequences cardiac function table <NUMBER> baseline values parameters used <NUMBER>d model table <NUMBER> model parameters simulating effects mild test <NUMBER>b severe test <NUMBER>c covid<NUMBER> infections individual impaired cardiac function test <NUMBER>a computed outputs pulmonary resistances maximum active elastances current values derived baseline ones owing equations <NUMBER> <NUMBER> baseline kr <NUMBER> kea <NUMBER> pictures computed output figure <NUMBER>b coronaviruses implicated cause respiratory gastrointestinal infections since isolation severe acute respiratory syndrome coronavirus sarscov<NUMBER> guangdong china <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov saudi arabia <NUMBER> <NUMBER> coronaviruses enveloped positive singlestranded rna viruses originated bats indeed sarscov<NUMBER> merscov transmitted initially humans market civets dromedary camels respectively <NUMBER> humans sarscov<NUMBER> infects ciliated bronchial epithelial cells type ii pneumocytes using angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor merscov utilises dipeptidyl peptidase<NUMBER> dpp<NUMBER> receptor infect unciliated bronchial epithelial cells type ii pneumocytes <NUMBER> recently novel coronavirus subsequently named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> isolated wuhan china december <NUMBER> causes disease termed coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> subsequently worldwide pandemic resulted <NUMBER> million people infected almost <NUMBER> deaths <NUMBER> countries time writing <NUMBER> notably sarscov<NUMBER> also appears infect ciliated bronchial epithelial cells type ii pneumocytes predominantly via ace<NUMBER> receptor structurally similar sarscov<NUMBER> <NUMBER> akin previous coronavirus outbreaks sarscov<NUMBER> likely originated bat outbreak initiated animaltohuman transmission markets wild animals sold <NUMBER> <NUMBER> whilst prevalence diabetes people infected sarscov<NUMBER> relatively low compared population prevalence diabetes chinese italian cohorts <NUMBER> <NUMBER> people diabetes appear develop severe forms disease data uk suggest diagnosis diabetes major risk factor hospital admission people covid<NUMBER> <NUMBER> <NUMBER> patients hospitalised covid<NUMBER> february april <NUMBER> underlying diabetes <NUMBER> see table <NUMBER> indeed onethird people dying covid<NUMBER> uk underlying diagnosis diabetes regrettably odds inhospital death people type <NUMBER> type <NUMBER> diabetes t<NUMBER>d <NUMBER> <NUMBER> compared people without diabetes adjusting confounding variables <NUMBER> moreover time writing underlying diagnosis diabetes commonest underlying health condition amongst died covid<NUMBER> uk <NUMBER> people diabetes infected sarscov<NUMBER> china italy also required greater use intensive care unit icu support andor mechanical ventilation higher mortality rate people without diabetes <NUMBER> indeed studies usa china report diabetes independent predictor death people covid<NUMBER> mortality <NUMBER> higher patient population people without diabetes <NUMBER> moreover recently published analysis people diabetes hospitalised covid<NUMBER> france found <NUMBER> people attained primary outcome measure mechanical ventilation andor death within <NUMBER> days hospitalisation covid<NUMBER> interestingly authors study reported high body mass index independently associated primary outcome <NUMBER> fact around <NUMBER> people hospitalised covid<NUMBER> usa underlying diabetes hyperglycaemia fourfold greater mortality <NUMBER> therefore would appear diabetes may act marker poor metabolic health turn increases risk severe disease infected sarscov<NUMBER> several highrisk medical conditions associated diabetes including hypertension obesity ischaemic heart disease chronic renal disease undoubtedly increased mortality people diabetes covid<NUMBER> possibly due association conditions poor outcomes covid<NUMBER> hypertension ischaemic heart disease obesity <NUMBER> commonly observed people diabetes see fig <NUMBER> therefore mortality association may confounded relationship however considerable biology links poor outcomes higher mortality people diabetes covid<NUMBER> review discuss likely biological interactions diabetes covid<NUMBER> potential impact diabetes medications covid<NUMBER> severity health outcomes article based previously conducted studies contain studies human participants animals performed authors diabetes associated poorer health outcomes result multisystem involvement association multiple cardiovascular renal comorbidities making leading cause death worldwide <NUMBER> diabetes results inflammatory condition hyperglycaemia triggers generation proinflammatory cytokines resulting oxidative stress thereby tissue inflammation moreover diabetes associated relative immunodeficiency result impaired macrophage neutrophil function reduced lymphocyte proliferation complement activation dysfunction <NUMBER> result fig <NUMBER> complex relationship diabetes coronavirus disease <NUMBER> covid<NUMBER> mortality may confounded association diabetes risk factors increased mortality persons covid<NUMBER> including obesity hypertension increasing age proinflammatory state chronic respiratory disease ethnicity vitamin deficiency copd chronic obstructive pulmonary disease proinflammatory immunodeficient state higher morbidity mortality previously associated several bacterial viral infections people diabetes <NUMBER> <NUMBER> predictably uncontrolled glycaemia previously associated worse outcomes people diabetes sarscov<NUMBER> <NUMBER> merscov <NUMBER> disease outbreaks however remains debate whether hyperglycaemia acts exacerbate infection simply consequence stress response results coronavirus infection owing high prevalence people diabetes covid<NUMBER> requiring hospitalisation andor icu support must specific mechanisms affect people diabetes infected sarscov<NUMBER> <NUMBER> given understanding mechanism sarscov<NUMBER> merscov review potential role ace<NUMBER> dpp<NUMBER> receptors pathogenesis sarscov<NUMBER> people diabetes ace<NUMBER> receptor widely expressed within epithelial cells respiratory tract tubular epithelial cells renal tract mucosal cells gastrointestinal tract arterial venous endothelial cells cardiac myocytes pancreatic bcells <NUMBER> <NUMBER> within respiratory system ace<NUMBER> converts angiotensin ii angiotensin therefore inhibition ace<NUMBER> leads elevated concentrations angiotensin ii thereby generating proinflammatory response stimulating aldosterone secretion collectively actions enhance local vascular permeability renal fluid retention thus engendering respiratory distress <NUMBER> sarscov<NUMBER> enters host cell utilising envelope spike glycoprotein surface bind ace<NUMBER> enzyme turn modulates enzymes activity potentiating cell damage respiratory failure <NUMBER> consequently hypokalaemia noted feature people critically ill covid<NUMBER> believed result renal potassium wasting excess aldosterone secretion moreover early normalisation serum potassium predictor improved prognosis people critically unwell covid<NUMBER> <NUMBER> interestingly one recent study concluded sarscov<NUMBER> may cause acute kidney injury via ace<NUMBER> receptor virus detected within human glomerular cells autopsy <NUMBER> people diabetes hyperglycaemia earlier stages covid<NUMBER> may worsen disease outcomes hyperglycaemia induces glycosylation ace<NUMBER> receptor promoting cellular linkage sarscov<NUMBER> virus therefore promoting infection host cell causing higher disease severity <NUMBER> moreover early correction hyperglycaemia reverse process may improve disease outcomes leading many authors argue case tight glycaemic control priority care people diabetes covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition enhanced ace<NUMBER> receptor glycosylation upregulation ace<NUMBER> receptor expression may enhance ability sarscov<NUMBER> enter infect host cell result safety concerns surrounding use many medications commonly used people diabetes including ace inhibitors angiotensinreceptor blockers ibuprofen thiazolidinediones appear increase expression ace<NUMBER> <NUMBER> nevertheless little evidence currently supports discontinuation routine practice current guidance supports continuation medications <NUMBER> <NUMBER> however study possibly harmful effect frequently utilised medications people diabetes cardiovascular disease warranted <NUMBER> genetic analyses ace<NUMBER> gene provide explanation poorer health outcomes seen people covid<NUMBER> diabetes ace<NUMBER> enzyme expressed ace<NUMBER> gene x chromosome <NUMBER> interestingly expression ace<NUMBER> linked development t<NUMBER>d expression single nucleotide polymorphism g<NUMBER>a ace<NUMBER> gene also increases risk developing t<NUMBER>d <NUMBER> <NUMBER> theoretically increased expression ace<NUMBER> specific ace<NUMBER> polymorphisms may result greater disease severity increased binding potential sarscov<NUMBER> virus one study observed asian men greater expression ace<NUMBER> white african american counterparts <NUMBER> implying may explain population differences observed covid<NUMBER> severity additionally cao colleagues observed east asian populations higher ace<NUMBER> receptor tissue expression may explain differences susceptibility response sarscov<NUMBER> <NUMBER> however investigation potential risk factor warranted <NUMBER> may lead therapeutic targets interest role ace<NUMBER> people diabetes comes studies identifying receptor pancreatic bcells <NUMBER> recent observations greater incidence rates diabetic ketoacidosis reported people without underlying diagnosis diabetes associated high mortality rate <NUMBER> diabetic ketoacidosis setting likely results destruction pancreatic bcells following sarscov<NUMBER> entry cell via ace<NUMBER> receptor indeed people insulintreated diabetes covid<NUMBER> appear greater insulin resistance require significantly higher insulin doses <NUMBER> may simply reflect severity infection inducing considerable catecholamine response generates greater insulin resistance direct mechanism sarscov<NUMBER> impairs bcell function latter argument supported previous study conducted sarscov<NUMBER> outbreak observed approximately <NUMBER> nondiabetic patients sarscov<NUMBER> infection developed diabetes inpatient although <NUMBER> participants diabetes followup <NUMBER> years later authors reason sarscov<NUMBER> binds ace<NUMBER> receptor pancreatic bcells resulting damage islet cells impairs insulin release <NUMBER> relative hypoinsulinaemia thought cause higher incidence hyperglycaemia diabetic ketoacidosis patients <NUMBER> result many argue tighter blood glucose control essential improve health outcomes people diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> interest dpp<NUMBER> receptors started finding merscov virus targeted receptor enter subsequently infect host cell <NUMBER> antibodies directed dpp<NUMBER> inhibit infection host cells merscov virus <NUMBER> course dpp<NUMBER> enzyme plays critical role glucose metabolism degrading incretin hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide resulting reduced insulin secretion <NUMBER> however dpp<NUMBER> also known cluster differentiation<NUMBER> cd<NUMBER> plays additional immunomodulatory role activating cells maintaining lymphocyte function <NUMBER> recent studies observed dpp<NUMBER>cd<NUMBER> molecule also interacts s<NUMBER> domain sarscov<NUMBER> viral spike glycoprotein <NUMBER> addition initially reported interaction ace<NUMBER> receptor <NUMBER> moreover structural similarities sarscov<NUMBER> merscov sarscov<NUMBER> viruses <NUMBER> <NUMBER> however results mixed studies support interaction sarscov<NUMBER> cells expressing dpp<NUMBER> cells expressing ace<NUMBER> <NUMBER> nevertheless remains potential role dpp<NUMBER> inhibitors treatment people covid<NUMBER> leading call studies explore potential therapeutic avenue <NUMBER> <NUMBER> drugs within class medication inhibit sodiumglucose cotransporter<NUMBER> sglt<NUMBER> protein proximal convoluted tubule thereby preventing reuptake sodium glucose promote urinary excretion <NUMBER> use medications associated significant improvements glycaemic control body weight reduced progression renal disease <NUMBER> <NUMBER> since introduction <NUMBER> prescribing usage increased dramatically amongst commonly used drugs treating t<NUMBER>d <NUMBER> strong rationale use sglt<NUMBER> inhibitors potential treatment people covid<NUMBER> firstly use medications promotes diuresis natriuresis improves heart failure outcomes <NUMBER> <NUMBER> additionally use appears selectively reduce interstitial fluid volume without significantly affecting intravascular fluid volume <NUMBER> collectively actions may improve covid<NUMBER> health outcomes discussed covid<NUMBER> locally increases vascular permeability within lung thereby increasing interstitial fluid volume consequently inducing respiratory distress <NUMBER> secondly use sglt<NUMBER> inhibitors associated shift myocardial renal metabolism carbohydrate andor lipids ketones energyefficient may improve myocardial renal function <NUMBER> thirdly sglt<NUMBER> inhibitors also believed exert antiinflammatory effect reducing serum leptin tumour necrosis factoralpha tnfa interleukin <NUMBER> il<NUMBER> levels increasing serum adiponectin level <NUMBER> given proinflammatory state associated diabetes <NUMBER> reducing inflammatory markers may result improved morbidity mortality associated covid<NUMBER> indeed use sglt<NUMBER> inhibitors appears associated favourable cardiovascular general health outcomes making attractive therapeutic option people diabetes covid<NUMBER> result studies establish whether drugs improve covid<NUMBER> outcomes people without diabetes would important dare<NUMBER> trial phase iii randomised doubleblind placebocontrolled trial aims establish whether dapagliflozin <NUMBER> mg reduces disease progression complications allcause mortality people covid<NUMBER> <NUMBER> interestingly study participants diagnosis diabetes requirement diagnosis either hypertension t<NUMBER>d atherosclerotic cardiovascular disease heart failure chronic renal disease participate <NUMBER> unaware clinical trials investigating use medications time writing however major concerns surrounding use sglt<NUMBER> inhibitors people diabetes covid<NUMBER> concerns due increased risk diabetic ketoacidosis associated use sglt<NUMBER> inhibitors result increased urinary glucose excretion reversal insulinglucagon ratio precipitates ketosis <NUMBER> given increased risk ketoacidosis people covid<NUMBER> discussed therefore potential harm associated use sglt<NUMBER> inhibitors current recommendation withhold drugs illness keeping sick day rules <NUMBER> <NUMBER> moreover sglt<NUMBER> inhibitors promote renal ace<NUMBER> activity thus potential use medications may promote sarscov<NUMBER> infectivity <NUMBER> however trials date demonstrate data required await outcome dare<NUMBER> trial anticipation investigate benefits potential risks associated use dapagliflozin discussed considerable interest dpp<NUMBER> receptor therapeutic target people covid<NUMBER> result potential interaction receptor infect host cell <NUMBER> whilst currently available clinical data support studies underway examine impact dpp<NUMBER> inhibition covid<NUMBER> outcomes people diabetes aim observational retrospective casecontrol study italy compare clinical biochemical outcomes people diabetes treated dpp<NUMBER> inhibitor sitagliptin people diabetes treated sitagliptin <NUMBER> objective randomised openlabel trial compare measures glycaemic control inflammation chest xray findings insulintreated patients t<NUMBER>d without dpp<NUMBER> inhibitor linagliptin <NUMBER> time writing clinical trials dpp<NUMBER> inhibitors found glucagonlike peptide<NUMBER> endogenous peptide secreted distal small bowel response glucose ingestion stimulate insulin release bcells pancreas subsequently degraded dpp<NUMBER> enzyme glp<NUMBER> analogues act directly stimulate pancreatic insulin secretion associated improved glycaemic control body weight reduced progression renal disease <NUMBER> <NUMBER> glp<NUMBER> analogues may interact covid<NUMBER> disease process two key processes upregulation ace<NUMBER> receptors antiinflammatory effects rats use glp<NUMBER> analogue liraglutide associated upregulation ace<NUMBER> receptors cardiopulmonary system <NUMBER> liver <NUMBER> secondly use glp<NUMBER> analogues known improve metabolic health generally least partly reducing endovascular inflammation <NUMBER> indeed one preclinical trial found use liraglutide rats associated reduced inflammatory measures including macrophage infiltration reduced tnfa il<NUMBER> levels <NUMBER> however paucity evidence human studies area <NUMBER> aware ongoing trials examining potential impact medications covid<NUMBER> outcomes time writing review covid<NUMBER> worldwide pandemic resulted extraordinary number infections deaths worldwide people diabetes particularly vulnerable develop severe forms disease possibly due clustering risk factors hypertension ischaemic heart disease chronic renal disease common pathways appear exist may explain susceptibility patient population covid<NUMBER> medications commonly used people diabetes may interact pathways however little known date whether interactions lead clinical harm benefit indeed whether impact although recent analysis people diabetes hospitalised france covid<NUMBER> demonstrated association need mechanical ventilation death within <NUMBER> days glucoselowering therapies metformin insulin <NUMBER> safe trials exploring medications welcomed hope shed light rapidly evolving area time great uncertainty whilst continue rapidly learn novel disease funding funding sponsorship received study publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work given approval version published nawaz nothing disclose marc evans received financial support consultancy novartis merck sharp dohme corp novo nordisk served speakers bureau novartis lilly boehringer lngelheim merck sharp dohme corp novo nordisk janssen takeda marc evans also editorinchief diabetes therapy compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors data availability data sharing applicable article datasets generated analyzed current study open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> emergence pneumonia cases wuhan hubei province china first reported world health organization december <NUMBER> <NUMBER> <NUMBER> novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> previously identified humans subsequently isolated patients identified source acute respiratory illnesses named coronavirus disease <NUMBER> march <NUMBER> <NUMBER> covid<NUMBER> subsequently declared global pandemic world health organization spread <NUMBER> countriesterritories worldwide far <NUMBER> <NUMBER> surpassed spread viral respiratory tract diseases severe acute respiratory syndrome sars <NUMBER> <NUMBER> specifically april <NUMBER>th <NUMBER> <NUMBER> reported laboratoryconfirmed cases worldwide <NUMBER> number expected continue increasing resulted unprecedented international public health crisis prompted numerous countries implement nationwide lockdowns mitigate spread virus reduce burden healthcare systems public health burden covid<NUMBER> reached beyond infectious respiratory illness may associations noncommunicable diseases ncds including cerebrovascular cardiovascular disorders cvds patients covid<NUMBER> often vascular risk factors comorbidities <NUMBER> <NUMBER> may increase need hospitalization need intensive care unit admissions andor intubation may also induce vascular injury would promote risk stroke <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevention management covid<NUMBER> top global health priority come cost compromising treatment management potentially lifethreatening diseases <NUMBER> present multicenter international study designed assess changes stroke rates severity subtypes ischemichemorrhagic outcomes covid<NUMBER> pandemic results initiative used monitoring model public health authorities policymakers regarding systems capacity global crisis magnitude ultimately enhanced simultaneous surveillance ncd covid<NUMBER> comorbidity populations would generate empirical data needed better understand dualdisease burden target coordinated care cascade study call action sarscov<NUMBER> cerebrovascular disorder retrospective prospective international multicenter cohort study comparing rate severity outcomes stroke following covid<NUMBER> outbreak study aims create multicenter stroke registry <NUMBER> describe changes stroke clinical care approach including imaging strokeunit care admission thrombolysis thrombectomy neurosurgery availability outpatient assistance different countries covid<NUMBER> outbreak <NUMBER> evaluate incidence cvd covid<NUMBER> positive cascade new initiative foresee continuous collaboration across multiple participating centers worldwide figure <NUMBER> neurological stroke centers evaluating cerebrovascular disease patients aged <NUMBER> covid<NUMBER> pandemic included project participating center overall types acute phase stroke therapy utilized crude agestandardized stroke rate vascular risk factors stroke severity stroke outcomes inhospital mortality tracked important data include date first report covid<NUMBER> date latest quarantine date end quarantine date nature phased social distancing lockdown restrictions date nature relaxation social distancing lockdown measure available corresponding countryregion according official local governmental reports also obtain data regarding covid<NUMBER> international databases eg european centre disease prevention control ecdc <NUMBER> united nations educational scientific cultural organization unescocovid<NUMBER> educational disruption response <NUMBER> environmental data specifically national air quality obtained nasas giovanni omi visualization tool <NUMBER> developed set common variables definitions facilitate standardization datacollection among participating centers supplement table <NUMBER> final database include data regarding important variables stroke incidence stroke severity vascular risk factors medications outcome eg inhospital mortality disability associationamerican stroke association census definition <NUMBER> severity stroke measured according national institutes health stroke scale nihss stroke disability assessed using modified rankin scale mrs admission discharge longitudinally <NUMBER> days <NUMBER> months followups available depending participating centers registry include stroke firsteverstroke recurrence cases stroke subtypes acute ischemic stroke ais intracerebral hemorrhage ich cerebral venous thrombosis subarachnoid hemorrhage sah addition available monitor prospectively cases admitted covid<NUMBER> develop strokes hospital within two weeks discharge also identify stroke patients laboratoryconfirmed covid<NUMBER> diagnosis <NUMBER> given limited availability covid<NUMBER> laboratory testing centers gather data regarding clinically suspected covid<NUMBER> following stroke approach provide broader understanding larger incidence communicable noncommunicable related disease local ethics committee approval obtained participating center data sharing according institutional ethics committees policies official agreements use anonymized data secured protected servers confidential data saved encrypted secured dataset eg redcap httpprojectredcaporg vanderbilt university anonymized data obtained center pooled together analyzed designated data processing center subject id coding designed specific designation code participating center shared data processing center corresponding site crude standardized hospitalization rates stroke per month calculated using direct method use poisson regression model log link compare number stroke hospitalizations covid<NUMBER> pandemic compared corresponding months previous possibly upcoming years calculate risk ratios <NUMBER> confidence intervals cis number stroke hospitalizations within pandemic period compared periods covid<NUMBER> use kaplanmeier survival method within study period coxregression model estimate hazard ratio hr <NUMBER> ci inhospital mortality interrupted time series analysis used assess change stroke hospitalization rates covid<NUMBER> center compare proportion different stroke care managements eg outpatient assistance craniectomy utilization discharge setting supported discharge covid<NUMBER> pandemic previous periods variables added timevarying confounder regression model prevalence stroke subtypes important neuroimaging features eg cortical vs subcortical anterior vs posterior circulation stroke size location etc estimated proportion total admitted strokes variables also analyzed model timevarying confounder using autoregressive integrated moving average arima model according boxjenkinstiao strategy serial autocorrelations hospitalization rates assessed qstatistic test analytically whether autocorrelation function different white noise process lag plot created using sample autocorrelation coefficients plotted corresponding lags calculate durbinwatson dw statistic test autocorrelation errors segmented regression models pandemic stroke occurrence severity care outcomes results initiative multiple clinical public health implications similar major global crises <NUMBER> similarly italy subset <NUMBER> patients died covid<NUMBER> <NUMBER> found comorbidities including diabetes <NUMBER> ischemic heart disease <NUMBER> atrial fibrillation <NUMBER> stroke <NUMBER> patients <NUMBER> systemic inflammatory response sarscov<NUMBER> may trigger rupture erosion atherosclerotic plaque <NUMBER> <NUMBER> destabilize previous stroke coronary artery disease <NUMBER> may associated acute cardiac injury myocarditis <NUMBER> <NUMBER> sarscov<NUMBER> may also peripheral vascular detrimental effect due ability act angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors play major role regulating cardiovascular function <NUMBER> <NUMBER> furthermore also potential negative neurotropic effect due expression ace<NUMBER> receptors neurons cerebral endothelial cells facilitates rupture bloodbrain barrier cerebral arteries <NUMBER> suggests development severe devastating strokes <NUMBER> presence covid<NUMBER> finally strokeinduced suppression innate adaptive immune system well described <NUMBER> may impact susceptibility severity sarscov<NUMBER> infection acute phase stroke ultimately impacting clinical outcomes given covid<NUMBER> closely related sars <NUMBER> anticipate similarities cardiovascular presentations arrhythmias specifically cohort study n<NUMBER> tachycardia <NUMBER> bradycardia <NUMBER> reported patients sars <NUMBER> addition hypoxemia resulting severe respiratory illness covid<NUMBER> particularly underlying cvds stroke heart failure may also lead atrial fibrillation <NUMBER> increased mortality rate <NUMBER> finally covid<NUMBER> associated abnormalities coagulation cascade <NUMBER> similar many global health crises covid<NUMBER> may also indirectly affect rate severity cvds prioritization medical resources towards covid<NUMBER> precautions assistance seen many countries may result reduction resources potentially fatal diseases <NUMBER> important healthcare system collapse significant burden covid<NUMBER> may directly indirectly affect major health conditions eg stroke resulting higher mortality morbidity among infected noninfected patients necessary note countries heavily impacted covid<NUMBER> typically impacted presence concurrent ncds rather communicable diseases general paper preparation possible lack prior exposure pandemic magnitude could resulted lack preparedness terms preventive emergency management plans covid<NUMBER> may also indirectly affect cvds heightened emotional responses stress <NUMBER> specifically within <NUMBER> weeks following <NUMBER> great east japan earthquake tsunami disaster significant increase number cardiovascular events including acute coronary syndrome congestive heart failure without change rate stroke <NUMBER> study observed french population <NUMBER> football world cup events time period considered stressful audience viewing matches <NUMBER> interestingly study found decrease rate stroke potentially due state euphoria associated viewing football game <NUMBER> similar study germany <NUMBER> world cup found incidence cardiac emergencies increased significantly days german team playing <NUMBER> difference incidence cvds national disasters events may explained heterogeneous nature cvd occurrences <NUMBER> due implementation mitigation strategies resulted physical isolation large subsets population covid<NUMBER> indirectly beneficially impacted air quality pollution recent observational satellite images obtained nasa depicted improvements air quality china periods quarantine february <NUMBER> time seen nationwide business closures prohibited vehicular transportation specifically <NUMBER> reductions <NUMBER> emissions <NUMBER> reductions co <NUMBER> emissions observed <NUMBER> <NUMBER> similar reductions normally seen chinese lunar new year due business closures emissions typically increase following weeks <NUMBER> however due quarantine number festivities outdoor events reduced similar trends observed states implemented shelterinplace orders within united states <NUMBER> march <NUMBER> <NUMBER> italy also implemented nationwide lockdown also seen improvements air quality specifically march <NUMBER> march <NUMBER> <NUMBER> rome seen <NUMBER> decrease <NUMBER> compared period <NUMBER> <NUMBER> particularly important air quality shown effects stroke ncds <NUMBER> conversely possible prolonged homestay due quarantine may lead increased sedentary behaviors physical inactivity unhealthy dietary intake habits leading increasing worsening chronic health conditions <NUMBER> cascade study feasible provide scientific answers many aforementioned hypotheses data gathered challenging resourcelimited situation covid<NUMBER> pandemic enormous impact healthcare economy many countries proposed initiative provide wide range information individualbased health related issues changes health policy high middle lowincome countries well cascade registry also combined international stroke registries expand knowledge field addition data reflect realworld systemic healthcare challenges currently facing many centers around world data gathered based available stroke information center possible transient ischemic attacks tias minor strokes may present emergency rooms due fear contracting covid<NUMBER> hospital andor social distancing measures however would ultimately expect see significant decrease rate severe fatal stroke presentations therefore changes rate severity outcome stroke within study period likely reflect direct indirect consequences covid<NUMBER> worldwide convergence ncd communicable infectious diseases potential overstretch global health systems cascade initiative potentially shed light challenges related stroke care major ncd within context identifying analyzing current healthrelated data covid<NUMBER> period help optimize resource allocation conduct proper assessments objectively identify nature problem implement strategies address issue effective efficient way better prepare future viral outbreaks authors investigators conflict interest converting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> hypertension preexisting cardiovascular disease risk factors morbidity covid<NUMBER> <NUMBER> remains uncertain whether use angiotensin converting enzyme inhibitors acei angiotensin receptor blockers arb impacts infection disease aim shed light question assessing ace<NUMBER> expression normal diseased human myocardial samples profiled bulk single nucleus rnaseq predominant portal entry sarscov<NUMBER> via ace<NUMBER> expression upper respiratory epithelium lungs <NUMBER> yet ace<NUMBER> also abundantly expressed intestine kidney heart testes observation twenty percent hospitalized patients covid<NUMBER> wuhan china evidence cardiac injury resuggest possible pathological role myocardial ace<NUMBER> expression <NUMBER> singlecenter report <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> evidence cardiac injury moreover presence cardiac injury associated <NUMBER>fold increase mechanical ventilation <NUMBER> mortality rate context potential primary viral myocarditis sarscov<NUMBER> gaining support prior findings viral rna sarscov<NUMBER> also infects cells via ace<NUMBER> <NUMBER> autopsied hearts earlier sarscov epidemic lends credence possibility <NUMBER> involvement ace<NUMBER> covid<NUMBER> pathogenesis led consideration whether inhibitors angiotensin converting enzyme acei angiotensin receptor blockers arb might modulate disease progression increased expression ace<NUMBER> <NUMBER> indeed trials proposing test impact initiation nct<NUMBER> withdrawal agents advanced current pandemic uncertainty provoked public statements three leading cardiovascular societies advising continuation agents absence compelling new data <NUMBER> address questions assessed ace<NUMBER> expression normal diseased human myocardial samples penn human heart tissue biobank bulk single nucleus rnaseq group previously utilized approach study transcriptional diversity cell subtypes associated gene programs normal human heart <NUMBER> ace<NUMBER> expression assessed left ventricles <NUMBER> individuals dilated cardiomyopathy dcm <NUMBER> individuals hypertrophic cardiomyopathy hcm <NUMBER> nonfailing controls defined individuals without overt indication cardiac dysfunction baseline characteristics study population provided supplementary table <NUMBER> exploratory analysis effects acei treatment ace<NUMBER> expression evaluated subset patients hcm six individuals receiving acei eight prescribed acei ace<NUMBER> expression heart strongest pericytes line microvasculature also appreciable vascular smooth muscle cells fibroblasts cardiomyocytes fig <NUMBER>a also evaluated expression proteases encoded tmprss<NUMBER> ctsl facilitate membrane fusion viral uptake sarscov<NUMBER> infection <NUMBER> <NUMBER> tmprss<NUMBER> minimally expressed across cell types ctsl displayed low levels expression cell types strongest expression fibroblasts <NUMBER> <NUMBER> cells two populations found nonfailing controls macrophages <NUMBER> adipocytes <NUMBER> cardiomyocytes <NUMBER> supplementary fig <NUMBER> results concordance recently released single nuclei data chen et al <NUMBER> analyses previously generated bulk rnaseq data individuals show significant alterations ace<NUMBER> expression context dilated hypertrophic cardiomyopathy compared nonfailing controls fig <NUMBER>b however single nucleus rnaseq highlighted stark downregulation ace<NUMBER> expression fibroblasts pericytes vascular smooth muscle concomitant upregulation ace<NUMBER> expression cardiomyocytes dcm hcm fig <NUMBER>c complete cell subtype differential expression analysis ace<NUMBER> dcm hcm compared nonfailing controls provided supplementary tables <NUMBER> <NUMBER> respectively sensitivity analysis comparing expression ace<NUMBER> left ventricles samples individuals hypertrophic cardiomyopathy compared nonfailing controls exclusion individuals ace inhibitors arbs provided supplementary table <NUMBER> since patients dcm acei nonfailing controls acei ability examine effects acei use ace<NUMBER> expression limited patients hcm among patients trend towards increased ace<NUMBER> expression acei treatment cell types fig <NUMBER>d supplementary table <NUMBER> results statistically significant future studies larger patient cohorts examine cell type specific ace<NUMBER> expression additional disease states nonfailing donors receiving acei arb urgently needed important note transcriptional assessments reflect effects rna halflife translation efficiency protein turnover important surface localized ace<NUMBER> protein also evaluated future studies conclusion data suggest prior cardiovascular disease predominant driver cardiomyocytespecific increased transcription ace<NUMBER> findings may provide pathological link sarscovassociated viral myocarditis rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint coronavirus disease originated wuhan province china late <NUMBER> serious illness caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> sarscov<NUMBER> genetically related coronavirus responsible sars outbreak <NUMBER> <NUMBER> infection spread globally declared pandemic world health organization march <NUMBER> <NUMBER> number confirmed cases deaths continue rise daily clinical manifestations covid<NUMBER> may range asymptomatic mild respiratory symptoms severe life threating respiratory cardiac failure tables <NUMBER> <NUMBER> figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among <NUMBER> patients covid<NUMBER> china clinical severity reported mild <NUMBER> severe <NUMBER> <NUMBER> critical <NUMBER> patients <NUMBER> recent study new york common presenting symptoms cough <NUMBER> fever <NUMBER> dyspnoea <NUMBER> myalgias <NUMBER> diarrhoea <NUMBER> nausea vomiting <NUMBER> <NUMBER> primary cause death covid<NUMBER> infection respiratory failure cardiac manifestations may contribute overall mortality even primary cause death patients table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> concomitant cardiovascular cv conditions present <NUMBER> overall covid<NUMBER> infected population higher proportion die <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> metaanalysis eight studies china <NUMBER> patients showed higher prevalence hypertension <NUMBER>±<NUMBER> diabetes mellitus <NUMBER>±<NUMBER> followed cardiovascular disease <NUMBER>±<NUMBER> covid<NUMBER> patients <NUMBER> another analysis <NUMBER> cases chinese center disease control prevention higher case fatality rate noted among patients preexisting comorbid conditions <NUMBER> cv disease <NUMBER> diabetes <NUMBER> chronic respiratory disease <NUMBER> hypertension <NUMBER> cancer compared overall casefatality rate <NUMBER> entire cohort <NUMBER> medications used treatment covid<NUMBER> infection also increase overall cardiovascular risk <NUMBER> sarscov<NUMBER> contains four structural proteins namely spike envelope e membrane nucleocapsid n proteins protein mediates viral entry host cells <NUMBER> <NUMBER> virus exhibits strong binding cellassociated soluble angiotensin converting enzyme ace <NUMBER> receptors expressed many organs heart kidneys intestine lung brain liver <NUMBER> <NUMBER> infected patients thus present spectrum atypical gastrointestinal manifestations cardiac renal injury neurological acute respiratory symptoms <NUMBER> <NUMBER> <NUMBER> lungs virus leads endothelial microvascular dysfunction alveolar exudative inflammation interstitial inflammation fibrosis focal bleeding causes severe respiratory manifestation disease <NUMBER> <NUMBER> <NUMBER> coronavirus particles observed ciliated columnar epithelial cells bronchiolar mucosa <NUMBER> gaining entry cells via ace<NUMBER> receptors sarscov<NUMBER> downregulates ace<NUMBER> expression enzyme unable exert organ protective effects <NUMBER> ace inhibitors acei angiotensin receptor blockers arb upregulate number ace<NUMBER> receptors surface myocardial alveolar gastrointestinal cells raised concern acei arb induced increase covid<NUMBER> acquisition myocardial alveolar cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> however renin angiotensin aldosterone system raas blockade shown reduce exposure sarscov<NUMBER> spike protein induced acute lung injury experimental mouse models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly recent study showed patients acei arb therapy lower rate severe covid<NUMBER> disease trend toward lower level interleukin<NUMBER> il<NUMBER> increased cd<NUMBER> cd<NUMBER> cell counts peripheral blood decreased peak viral load <NUMBER> acei arb therapy may therefore protective low level viraemia trials losartan covid<NUMBER> patients ongoing <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> related immune response may multiphasic illustrated siddiqi et al table <NUMBER> <NUMBER> similar influenza outbreak myocardial injury due covid<NUMBER> may related increased viscosity heightened coagulation cascade proinflammatory effects endothelial cell dysfunction caused sarscov<NUMBER> virus <NUMBER> <NUMBER> recent study covid<NUMBER> patients cardiomyocyte hypertrophy degeneration necrosis cardiomyocytes mild interstitial hyperaemia oedema along infiltration lymphocytes monocytes neutrophils virus component myocardial tissue <NUMBER> <NUMBER> another autopsy report scattered individual cell myocyte necrosis lymphocytes adjacent surrounding degenerating myocytes may represent early manifestation viral myocarditis <NUMBER> pericytes may infected sarscov<NUMBER> virus cause capillary endothelial cell microvascular dysfunction leading individual cell necrosis <NUMBER> <NUMBER> <NUMBER> myocardial injury covid<NUMBER> patients could due coronary spasm cholesterol plaque rupture hypoxic injury microthrombi direct endothelial vascular injury <NUMBER> myocardial injury fulminant myocarditis occur direct viraemic effect myocardial cells secondary effects bodys hyperimmune response virus overall systemic inflammatory response <NUMBER> increasing levels inflammatory markers creactive protein ddimer ferritin il<NUMBER> lactate dehydrogenase ldh associated higher mortality covid<NUMBER> patients possibly due cytokine storm secondary haemophagocytic lymphohistiocytosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> activate coagulation cascade leading thrombocytopaenia sometimes severe hypercoagulability sequelae ischaemia finger toes <NUMBER> <NUMBER> <NUMBER> higher incidence venous arterial thromboembolism despite prophylactic anticoagulation patients likely due excessive inflammation hypoxia immobilisation diffuse intravascular coagulation physicians even used tissue plasminogen activator tpa improvement ards <NUMBER> <NUMBER> myocardial injury defined elevation cardiac troponin concentration <NUMBER> th percentile upper reference limit observed <NUMBER> hospitalised covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore incidence myocardial injury reported china increases severity illness rising <NUMBER> patients needing icu care <NUMBER> patients died <NUMBER> <NUMBER> acute coronary syndrome acs one initial presentations covid<NUMBER> infection may range st elevation myocardial infarction stemi takotsubo cardiomyopathy <NUMBER> <NUMBER> <NUMBER> myocardial ischaemia infarction could secondary plaque rupture triggered virusinduced stress response thrombosis secondary hypercoagulability <NUMBER> <NUMBER> myocardial supplydemand mismatch cause type <NUMBER> mi <NUMBER> recent series <NUMBER> covid patients new york stemi initial presentation n<NUMBER> hospitalisation n<NUMBER> variability presentation high prevalence nonobstructive disease <NUMBER> underwent cardiac catheterisation poor prognosis <NUMBER> mortality <NUMBER> acute virusnegative lymphocytic myocarditis associated sarscov<NUMBER> respiratory infection reports showing improvement cardiac biomarkers treatment lopinavirritonavir hydroxycholoroquine <NUMBER> <NUMBER> rise serum troponin level interpreted context clinical scenario results evaluation invasive angiography coronary computed tomography ct angiogram <NUMBER> high risk patients may need admission hospital management per clinical practice guidelines low risk patients discharged emergency department discussing appropriate followup plan case recurrent symptoms <NUMBER> elevated cytokine levels lead systemic inflammatory response myocardial injury predispose atrial ventricular arrhythmias new onset malignant tachyarrhythmias sustained monomorphic ventricular tachycardia vt polymorphic vt setting elevated cardiac biomarkers raise suspicion myocarditis <NUMBER> patients admitted covid<NUMBER> disease hubei province heart palpitations noted one presenting symptoms <NUMBER> patients <NUMBER> <NUMBER> another study <NUMBER> hospitalised covid<NUMBER> patients arrhythmia noted <NUMBER> patients common patients admitted intensive care unit icu compared nonicu patients <NUMBER> vs <NUMBER> p <NUMBER> <NUMBER> reports complete heart block atrial fibrillation patients covid<NUMBER> infection <NUMBER> <NUMBER> increased inflammatory cytokines respiratory distress cause exacerbation preexisting left ventricular lv dysfunction lead new onset cardiomyopathy new onset lv dysfunction may represent myocarditis stress cardiomyopathy myocardial ischaemia increase risk death <NUMBER> study zhou et al incidence heart failure significantly higher non survivors infection compared survivors <NUMBER> vs <NUMBER> p≤<NUMBER>·<NUMBER> <NUMBER> right heart failure likely occur due elevated pulmonary artery pressure pulmonary complications <NUMBER> early stages exacerbation heart failure preserved ejection fraction occur due aggressive fluid resuscitation attempts later stages disease cytokine levels rise acute systolic heart failure leading cardiogenic shock reported <NUMBER> clinical manifestations covid<NUMBER> infection medication side effects pose challenges physicians taking care patients various antivirals antimalarial immunomodulating medications glucocorticoids convalescent plasma recovered patients used treatment covid<NUMBER> variable results table <NUMBER> table <NUMBER> <NUMBER> chloroquine hydroxychloroquine cause alkalinisation intracellular phagolysosome thus cause underglycosylation ace<NUMBER> receptors required cellular entry covid<NUMBER> prevents virion fusion uncoating <NUMBER> <NUMBER> hydroxychloroquine without azithromycin shown decrease viral carriage recent small studies <NUMBER> however evidence clinical efficacy hydroxychloroquine patients hospitalised covid<NUMBER> infection oxygen requirement recent french study <NUMBER> patients <NUMBER> chloroquine hydroxychloroquine used small studies covid<NUMBER> patients variable clinical outcomes carry risk prolonging qtc interval torsade de pointes due blockade kcnh<NUMBER>encoded hergkv<NUMBER> potassium channel <NUMBER> <NUMBER> <NUMBER> <NUMBER> electrolyte abnormalities concomitant use qt prolonging agents may increase risk fatal arrhythmias high risk patients <NUMBER> chloroquine also inhibit cyp<NUMBER>d<NUMBER> turn raise levels beta blockers metoprolol carvedilol thus necessitate close monitoring blood pressure heart rate <NUMBER> antiviral medications used treatment covid<NUMBER> also side effects lopinavirritonavir may cause bradycardia qt pr interval prolongation <NUMBER> <NUMBER> <NUMBER> <NUMBER> ribavirin affect warfarin dosing <NUMBER> similarly lopinavirritonavir increase levels rivaroxaban apixaban ticagrelor decrease levels clopidogrel prasugrel due interaction cytochrome p<NUMBER> enzymes <NUMBER> <NUMBER> <NUMBER> <NUMBER> tocilizumab sarilumab il<NUMBER> receptor blockers shown promising results treatment cytokine release syndrome secondary haemophagocytic lymphohistiocytosis <NUMBER> recent cohort patients hospitalised severe covid<NUMBER> treated compassionateuse remdesivir clinical improvement respiratory status observed <NUMBER> patients <NUMBER> national institutes health nih clinical trial also showed <NUMBER> faster recovery advanced covid<NUMBER> infection treated remdesivir <NUMBER> <NUMBER>day course remdesivir compared <NUMBER>day course phase <NUMBER> simple trial similar improvement clinical status side effects nausea elevated liver enzymes respiratory failure <NUMBER> however another study adult patients severe covid<NUMBER> infections admitted chinese hospitals remdesivir associated statistically significant difference time clinical improvement <NUMBER> based findings food drug administration fda issued emergency use authorization eua emergency use remdesivir treatment hospitalised covid<NUMBER> patients many side effects newer investigational medications still evaluated <NUMBER> <NUMBER> highly infectious nature covid<NUMBER> infection transmission risk health care workers makes challenging manage patients suspected confirmed infection tables <NUMBER> <NUMBER> figure <NUMBER> summarise proposed diagnostic approach patient suspected covid<NUMBER> infection management cardiovascular conditions sequential organ failure assessment sofa quick sofa score may helpful assess severity illness hospitals used initial triage tool <NUMBER> <NUMBER> <NUMBER> emphasis minimising exposure health care professionals viral infection performing limited bedside testing echocardiogram telemetry assess qt interval rather formal complete echocardiogram electrocardiograph ecg <NUMBER> supplemental oxygen maintain oxygen saturation <NUMBER> early intubation use low tidal volume high positive end expiratory pressure peep recommended management respiratory distress table <NUMBER> figure <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> infection require close monitoring respiratory status low threshold intubation minimise risk aerosolised respiratory secretions prevent highrisk emergency intubations <NUMBER> early stages respiratory infection challenging differentiate cardiogenic pulmonary oedema patients prior diagnosis heart failure serum brain natriuretic peptide bnp level myocardial imaging may helpful routine right heart catheterisation avoided due potential exposure risk health care workers table <NUMBER> patients covid<NUMBER> infection prone fluid overload aggressive resuscitation attempts acute kidney injury critically ill patients treatment steroids chronic lung disease therefore require close monitoring fluid balance electrolytes critical ill patients many may new onset worsening heart failure <NUMBER> <NUMBER> prone rapid fluctuations blood pressure heart rate norepinephrine recommended first line vasoactive drug shock vasopressin added hypotension persists although currently data use patients table <NUMBER> hydroxychloroquine azithromycin high risk qt prolongation drug interactions <NUMBER> <NUMBER> risk associated combination must reassessed avoiding unnecessary qt prolonging agents monitoring electrolytes use isoproterenol dopamine infusion increase heart rate patients bradycardia prevent arrhythmic complications table <NUMBER> figure <NUMBER> <NUMBER> <NUMBER> tisdale colleagues developed scoring system predicting qtc prolongation hospitalised patients may useful tool assess risk qtc prolongation <NUMBER> recent guidance mayo clinic authors qtc prolongation <NUMBER> msec increase qtc <NUMBER> msec initiation covid<NUMBER> treatment consideration given stop medications reverse qtc prolonging effect <NUMBER> <NUMBER> another recent case report late sodium channel blocking agents like lidocaine bolus infusion improved qtc interval patient covid<NUMBER> infection enable treatment hydroxychloroquine azithromycin <NUMBER> infection using caution drug interactions qtc prolongation <NUMBER> <NUMBER> <NUMBER> anecdotal reports sudden death sinus node dysfunction atrioventricular nodal disease covid<NUMBER> patients aetiology sudden death still unclear given possibility ventricular arrhythmias prolonged ambulatory monitoring may needed electrophysiology procedures ablation atrial ventricular arrhythmia postponed recovery acute illness prevent virus transmission unless procedure deemed lifesaving haemodynamic consequences recommended groups including csanz heart rhythm council covid<NUMBER> pandemic working group <NUMBER> <NUMBER> ischaemic heart disease primary percutaneous coronary intervention pci recommended treatment strategy stelevation myocardial infarction stemi table <NUMBER> figure <NUMBER> <NUMBER> <NUMBER> alternative therapeutic options systemic fibrinolytic therapy used china discussion among interventional cardiology community society cardiovascular angiography interventions emerging leader mentorship scai elm members graduates regarding consideration fibrinolytic therapy low risk stemi patients eg inferior stemi without right ventricular involvement lateral myocardial infarction without haemodynamic compromise <NUMBER> important regional centres equitable access thrombolytics stock rotation systems imperative ensure supply <NUMBER> patient transfer higher level care limited performed timely manner required <NUMBER> patients high risk non stelevation mi nstemi also need urgent invasive evaluation low risk nstemi patients serum troponin level elevation clearly suggestive type <NUMBER> mi obtaining coronary ct angiogram stratify extent coronary artery disease cad help decision regarding invasive coronary angiography <NUMBER> echocardiography advanced imaging eg magnetic resonance mri differentiate myocarditis diffuse myocardial dysfunction acute coronary syndromes focal wall motion abnormality distribution specific coronary artery observed table <NUMBER> stable patients symptoms suggestive covid<NUMBER> tested infection prior procedure due risk aerosol transmission procedural staff patients diagnosed covid<NUMBER> infection invasive procedures eg intraaortic balloon pump pericardiocentesis extracorporeal membrane oxygenation temporary transvenous pacemaker etc performed bedside rather cardiac catheterisation laboratory minimise infection risk health care workers <NUMBER> <NUMBER> elevation serum troponin bnp levels could nonspecific patients covid<NUMBER> infection clinicians use medical judgement suspected cases acute mi heart failure follow latest recommendations guiding societies <NUMBER> <NUMBER> also important mindful delayed presentations common cardiovascular pathology covid<NUMBER> pandemic significantly reduced number stemi cases hospital increase hospital cardiac arrest <NUMBER> <NUMBER> shock covid<NUMBER> infection could primarily cardiogenic acute heart failure myocarditis may multifactorial cardiac involvement often complicates respiratory failure sepsis <NUMBER> <NUMBER> serum bnp echocardiography troponin level help clarify degree cardiac involvement figure <NUMBER> <NUMBER> routine endomyocardial biopsy cardiac mri evaluate malignant arrhythmia myocarditis performed <NUMBER> utility extracorporeal membrane oxygenation ecmo management shock covid<NUMBER> patients unclear <NUMBER> patients cardiogenic shock complicating covid<NUMBER> illness die despite aggressive treatment one case series china reported <NUMBER> mortality despite ecmo use <NUMBER> therefore important identify contribution cardiac pulmonary systemic causes shock considering mechanical respiratory circulatory support ecmo <NUMBER> evaluation multidisciplinary shock team consisting interventional cardiologist heart failure specialist cardiac surgeon recommended evaluate risks benefits ecmo individual patient <NUMBER> lack sufficient health care resources pandemic raises ethical concerns around ecmo use calculations may change effective therapies emerge <NUMBER> covid<NUMBER> infection caused negative impact physical mental health health workers many health care workers frontline workers including firefighters infected virus <NUMBER> implementation stringent infection prevention protocols may caused delayed care many patients put health care workers difficult clinical decision making situations <NUMBER> however high level compliance <NUMBER> protocols may required effectively control spread covid<NUMBER> infection <NUMBER> recent editorial allahwalla colleagues elegantly pointed longterm consequences covid<NUMBER> related delay care chronic cardiovascular conditions possible second tsunami acute cardiac conditions <NUMBER> therefore need strategies minimise prepare impending second wave acute medical conditions may overwhelm health care system physicians <NUMBER> patients cardiovascular conditions continue receive health care services including preventive health services efforts made take advantage telehealth services <NUMBER> <NUMBER> psychological impact pandemic taken consideration evaluating patients <NUMBER> • avoid aerosolisation disconnect ventilator without following precautionary steps even code • avoid unnecessary transportation encourage bedside procedure feasible full ppe abbreviation cbc complete blood count cmp complete metabolic profile ntpbnp n terminal pro brain natriuretic peptide esr drythrocyte sedimentation rate icu intensive care unit sofa sequential organ failure assessment pe pulmonary embolism ppe personal protective equipment ldh lactate dehydrogenase ecg electrocardiograph ct computed tomography ino inhaled nitric oxide arrhythmia thromboembolism risk factor modification • echocardiogram assess lv function • troponin trend differentiate type mi assess prognosis along bnp • monitor arrhythmia consider ep consult malignant arrhythmia • inotropes vasopressor support haemodynamic instability lv dysfunction • discuss antiviral antiinflammatory therapies approved use • guideline directed medical therapy cardiomyopathy • exercise limitation <NUMBER> months prevent sudden cardiac death • address goals care early periodically patients • sbp<NUMBER> <NUMBER> mins impaired organ perfusion urine output <NUMBER> mhr • recognise delayed presentation mechanical complications myocardial infarction peritonitis bowel ischaemia related low perfusion state • check mixed venous saturation differentiate different types shock • conservative fluid resuscitation crystalloid preferred colloid • norepinephrine stabilise shock transition inotrope clinically indicated • inhaled pulmonary vasodilators ino preferred administered closed system prevent risk aerosolisation • evaluate alternate aetiologies shock haemodynamics improving • discuss interventional cardiology regarding activating shock team • ecmo mechanical circulatory support device highly selected cases • discuss heart transplant cardiology team regarding reducing immunosuppression especially anti metabolites due risk infections • discuss cardiology qtc<NUMBER> ms qt prolonging drug qtc<NUMBER> ms qtc increase started qt prolonging drug • assess interaction oral anticoagulant antivirals • follow standard bradycardia guidelines aha acls patient unstable • discontinue av nodal blocking agents • assess interaction antivirals table <NUMBER> abbreviations pc percutaneous coronary intervention lv left ventricle hf heart failure svt supraventricular tachycardia af atrial fibrillation afl atrial flutter ep electrophysiology acls advanced cardiac life support aki acute kidney injury sbp systolic blood pressure bbb bundle branch block ms milliseconds ecmo extracorporeal membrane oxygenation vt ventricular tachycardia aha american heart association av atrioventricular • unnecessary nonurgent procedures pose high risk healthcare providers • consider bedside procedures feasible minimize risk • coronary angiogram stemi highrisk nstemi • right heart catheterisation avoid unless necessary eg hf diagnosis uncertain clinical suspicion mixed refractory shock information change management • routine endomyocardial biopsy stable patients • urgent procedures eg pacemakers icd secondary prevention ablation haemodynamically significant arrhythmia controlled medications cardioversion cardioversion symptomatic arrhythmia lead revision pacemaker dependent patient generator change battery end life pacemaker dependent patient • defer nonurgent procedures svt vt ablation af ablation stable patient abbreviation mri magnetic resonance imaging icd implantable cardioverter defibrillator vt ventricular tachycardia svt supraventricular tachycardia icd implantable cardioverter defibrillator af atrial fibrillation hf heart failure stemi stelevation myocardial infarction nstemi non stelevation myocardial infarction ct computed tomography acs acute coronary syndrome tte transthoracic echocardiogram abbreviations bbb bundle branch block copd chronic obstructive pulmonary disease covid<NUMBER> pandemic included ireland march <NUMBER> <NUMBER> states health services retooled address dramatic changes resource allocation utilisation cardiac surgery heart lung transplant services particularly challenged three considerations intensive care availability patient covid<NUMBER> exposure impact risk concurrent major surgery patient willingness attend hospital surgery transplant domain also three challenges confirmation safe donor vulnerability immunocompromised recipient intensive care unit icu resource utilisation objective paper analyse activity patterns national centre cardiothoracic surgery transplantation discuss impact change provision cardiac transplant surgical care going forward data regarding cardiothoracic operative activity mater misericordiae university hospital collected prospectively standardised cardiothoracic digital database patient advocate tracking system pats retrospective review prospectively collected data performed first <NUMBER> months years <NUMBER> <NUMBER> number nature cases well patient demographic profile data reviewed cases referred public sector however surgery took place private institutions per agreement state private hospitals part pandemic emergency response relative reduction <NUMBER> expressed percentage caseload <NUMBER> study approved institutional review board ref code <NUMBER> tmr number major cardiac surgery procedures performed first <NUMBER> months <NUMBER> <NUMBER> cases time point achieved <NUMBER> <NUMBER> major cases <NUMBER> <NUMBER> expected case activity achieved first <NUMBER> months trend <NUMBER> change occurring march april fig <NUMBER> looking march april particular <NUMBER> <NUMBER> cases performed contrast <NUMBER> <NUMBER> overall trend continues instead performing expected <NUMBER> major cardiac cases <NUMBER> service deliver <NUMBER> major cardiac cases <NUMBER> expected total waiting list currently already <NUMBER> cases procedures classed urgent commonly performed priority class defined surgery performed admission acute event nonst elevation myocardial infarction <NUMBER> <NUMBER> cases classed urgent contrast <NUMBER> <NUMBER> looking closely march april <NUMBER> <NUMBER> cases urgent contrast <NUMBER> period <NUMBER> elective cases stop completely elective cardiac cases still time sensitive represented <NUMBER> activity <NUMBER> comparison <NUMBER> <NUMBER> although transplant activity reduced significantly relative proportion transplant activity remained <NUMBER> throughout study period <NUMBER> <NUMBER> including march april <NUMBER> <NUMBER> initial management stages suggested alternative options explored patients anticipated long icu postoperative stay particular basis assessed patient profile observed notable difference patient profile <NUMBER> <NUMBER> january april <NUMBER> median age <NUMBER> years <NUMBER> compared <NUMBER> <NUMBER> <NUMBER> focusing march april median age <NUMBER> <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> <NUMBER> wanted determine change pattern practise well volume analyse cases based type surgery leftsided valvular heart disease including aortic valve replacements mitral valve replacement repair without concomitant coronary artery bypass grafting cabg dramatically affected procedures <NUMBER> reduction <NUMBER> vs <NUMBER> cases seen <NUMBER>month period focusing march april <NUMBER> surgery continued <NUMBER> rate expected cases <NUMBER> vs <NUMBER> looking coronary artery bypass surgery alone noted <NUMBER> reduction number cabg cases performed <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> however dropoff focused <NUMBER> months march april time window <NUMBER> activity continued <NUMBER> expected activity <NUMBER> vs <NUMBER> fig <NUMBER>a <NUMBER>b major aortic surgery aortic root ascending aortic arch replacement seen overall decrease numbers <NUMBER> <NUMBER> vs <NUMBER> focusing period march april <NUMBER> activity continued <NUMBER> expected rate <NUMBER> vs <NUMBER> case numbers adult congenital operations initially increased january february <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> however three cases performed march april <NUMBER> whereas congenital procedures took place months <NUMBER> fig <NUMBER>a <NUMBER>b study included cases heart transplant lung transplant primary ventricular assist device vad observed <NUMBER> reduction overall <NUMBER> reduction since onset pandemic fig <NUMBER>b procedures included epicardial permanent pacemaker placement central cannulation extracorporeal membrane oxygenation ecmo myxoma excision emergency sternotomy cardiac trauma myomectomy incidence cases reduced <NUMBER> since pandemic restrictions put place <NUMBER> cases performed march april <NUMBER> one cases performed <NUMBER> <NUMBER> cases completed march april <NUMBER> period <NUMBER> cases performed onsite mater misericordiae university hospital <NUMBER> performed outsourced locations one cases would prove covid<NUMBER> swab positive associated prolonged icu stay care continues time writing covid<NUMBER> pandemic challenged nations health service proven adaptable flexible radically altered profile resource allocation context needs time major cardiac surgery dropped priority driven three factors need redistribute heath service resources emergency need balance risk delayed surgery perioperative covid<NUMBER> infection altered pattern emergency department presentation outpatient investigations findings review demonstrate significant drop major cardiac surgery procedures <NUMBER> reduction cardiac transplant surgery march april <NUMBER> occurred despite utilisation private capacity contracted state emergency findings consistent internationally observed salenger et al <NUMBER> saw <NUMBER> decrease cardiac surgical volumes restrictions implemented study used mathematical modelling estimate future delay <NUMBER> b fig <NUMBER> comparison breakdown cases january may <NUMBER> <NUMBER> b comparison breakdown cases march april <NUMBER> versus <NUMBER> months due backlog cases although study discusses different healthcare system inevitably backlog irish patients number patients elective waiting list surgery within speciality delay may critical know previously published data mortality irish heart transplant waiting list <NUMBER> every <NUMBER> months list <NUMBER> equally patients listed lung transplant often estimated survival <NUMBER> years without transplant <NUMBER> mortality risk general cases waiting list also real pattern profile delayed patients service able protect cabg surgery valve surgery extent significant reduction numbers major aortic cases performed mainly due dropoff elective aortic cases patients aortic aneurysms opposed emergency procedures dissection potential backlog cases current climate presents serious threat patients aortic diameters <NUMBER> cm estimated rate death risk rupture approximately <NUMBER> per year <NUMBER> however groups adult congenital cases transplant recipients would seem opportunity delayed one review netherlands <NUMBER> impact covid<NUMBER> transplant services considered reduction potential donation offers likely due reduction road traffic accidents people worked home time writing irish police force gardaí reported increase total collisions case fatalities <NUMBER> compared <NUMBER> including <NUMBER> fatalities march april <NUMBER> opposed <NUMBER> months <NUMBER> <NUMBER> however icu focusing addressing new pandemic may position focus donation process moratorium visitors may also compromise quality interaction family icu team strict criteria also developed protect recipient mandated tight secure clearance covid<NUMBER> possibilities regarding donor may excluded number potential donors although initial case report data suggested acceptable outcomes covid<NUMBER> solid organ transplant recipients <NUMBER> <NUMBER> larger scale observational data suggests seriously raised morbidity mortality patients heart transplants covid<NUMBER> <NUMBER> one consideration patients awaiting heart transplant may temporising ventricular assist device vad avoids immunosuppression taking account support care patients require community capacity provide amidst pandemic small numbers reported outcomes lung transplant recipients postcovid<NUMBER> infected mixed <NUMBER> <NUMBER> <NUMBER> adult congenital operations performed march april <NUMBER> patients may younger without chronic hypertension diabetes may among lowest risk cardiac surgery group currently available studies focus covid<NUMBER> outcomes <NUMBER> time writing review ireland thirteenth highest number cases european union eu despite ranking <NUMBER> eu terms population <NUMBER> despite number cases ireland surpassed available icu resources <NUMBER> consequently irish government proposed phased reopening country may <NUMBER> <NUMBER> <NUMBER> presents quandary cardiothoracic services provided mater hospital dedicated separate cardiac icu patients selected cardiac surgery icu continues care patients virus cardiac surgery patients particular relevance discussing covid<NUMBER> pandemic high rates hypertension diabetes two adverse risk factors mortality coronavirus infection <NUMBER> require mechanical ventilation hours days surgery necessitating icu level care means potentially covid<NUMBER> risk cocooning home risks therefore must balanced surgery delay covid<NUMBER> exposure time imperfect knowledge disease service reconstruction phase potential screen patients planned surgery needs optimised methods clinical history nasopharyngeal swab testing computed tomography thorax proposed ideally hospital would either covid<NUMBER>free hospital emergency department another model single campus two hospital divisions covid<NUMBER> noncovid<NUMBER> division minimal crossover two presents challenges icu organisation implies need two icus irish model previously one single unit patients become afraid also declined dates surgery offered early us definitive regarding patient confidence restored patients need demonstrable reassurance covid<NUMBER> exposure minimised results study highlight opportunity cost covid<NUMBER> pandemic response highlight future challenges lie ethical approval study conducted line principles declaration helsinki approved institutional review board mater hospital ref code <NUMBER> tmr coronavirus disease <NUMBER> caused novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> abruptly reached pandemic proportions sarscov<NUMBER> member betacoronavirus family well sarscov severe acute respiratory syndrome coronavirus merscov middle east respiratory syndromerelated coronavirus since beginning <NUMBER> number confirmed cases covid<NUMBER> dramatically increased worldwide leaping million march <NUMBER> <NUMBER> although majority covid<NUMBER> patients develop mild moderate clinical features <NUMBER> severe pneumonia acute respiratory distress syndrome ards multiorgan failure leading high death rate may develop notably marked sex differences emerged covid<NUMBER> prevalence prognosis particular agespecific risk disease reported significantly higher males females except age <NUMBER> years moreover agespecific risks death hospitalization least two fold higher males females among age ranges <NUMBER> furthermore patients advanced age underlying pathologies mainly hypertension diabetes cardiovascular disease cvd prone experience severe form disease <NUMBER> even though overall mortality considerably varies among countries fatalityrate age groups displays similar patterns rising consistently <NUMBER>year age group <NUMBER> importantly presence comorbidities increases mortality sample <NUMBER> patients died covid<NUMBER> italy prevalence diabetes <NUMBER> <NUMBER> differently covid<NUMBER> spread diabetes known boundaries number affected people reached nearly half billion worldwide <NUMBER> number deaths attributed diabetes complications around <NUMBER> million <NUMBER> <NUMBER> notably <NUMBER> diabetic patients <NUMBER> years old <NUMBER> thus although extremely different connotations covid<NUMBER> diabetes two pandemics share burden wide diffusion elderly population dramatic impact global mortality economic health resources short review focused open questions emerging effort fully understand link covid<NUMBER> diabetes mainly context possible harmful beneficial effects commonly used drugs patients diabetes course covid<NUMBER> infection diabetes reportedly major cause mortality morbidity worldwide conceivable link diabetes infectious diseases postulated particular lower respiratory tract infections known rather common severe elderly type <NUMBER> diabetes t<NUMBER>d <NUMBER> although evidence suggests diabetes unlikely significantly increase susceptibility sarscov<NUMBER> infection higher risk worse covid<NUMBER> progression outcomes observed <NUMBER> mechanisms underlying association completely clear yet exacerbated proinflammatory cascade impaired immune response diabetic patients covid<NUMBER> suspected crucially involved particular increased levels proinflammatory markers leukocyte neutrophil count procalcitonin creactive protein ferritin circulating cytokines trigger cytokine storm namely il<NUMBER> il<NUMBER> il<NUMBER> receptor tnfα detected diabetic patients severe covid<NUMBER> compared patients without diabetes <NUMBER> furthermore altered immune response diabetic patients possibly due impaired lymphocyte neutrophil monocytemacrophage function long hypothesised especially presence poorly controlled glycaemia <NUMBER> <NUMBER> higher concentrations ddimer fibrinogen hallmarks severe forms covid<NUMBER> also reported patients diabetes compared patients without diabetes suggesting patients might prone develop coagulation abnormalities course infection known significantly associated worse prognosis <NUMBER> <NUMBER> recent retrospective study involving chinese patients n <NUMBER> moderate severe critical disease major risk factors mortality poor outcomes evaluated among enrolled patients <NUMBER> n <NUMBER> diabetes including t<NUMBER>d type <NUMBER> diabetes gestational diabetes overall diabetes increased odds inhospital death poor prognosis diabetic patients older significant alterations several laboratory parameters associated poor prognosis compared patients without diabetes particular higher levels ddimer female diabetic patients increased ldh neutrophil count compared nondiabetic patients cvd common men diabetes nondiabetic men notably multivariable regression analysis insulin therapy independently associated poor prognosis creactive protein independent risk factor either mortality poor prognosis patients covid<NUMBER> diabetes <NUMBER> besides research also needed clarify whether hypoglycaemia might also contribute adverse outcomes increased mortality covid<NUMBER> patients diabetes <NUMBER> patients diabetes high prevalence high blood pressure increased risk cvd <NUMBER> hence treatment hypertension largely includes drug classes demonstrated reduce cardiovascular events angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs <NUMBER> since ace converts angiotensin angiotensin ii potent vasoconstrictor sodiumretentive agent blockage reninangiotensinaldosterone system raas leads effective reduction blood pressure ace shows homology angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor transmembrane spike glycoprotein surface sarscov sarscov<NUMBER> binds allowing internalization virus alveolar cells cell types <NUMBER> ace<NUMBER> clearly direct target ace inhibitors ubiquitous monocarboxypeptidase converts angiotensin ii antiinflammatory antifibrotic angiotensin<NUMBER> contrasting potent vasoconstrictor sodiumretentive proinflammatory profibrotic effects indeed angiotensin<NUMBER> binding mas receptor induces nitric oxide release protecting tissue injury <NUMBER> another known substrate ace<NUMBER> angiotensin converted angiotensin<NUMBER> <NUMBER> <NUMBER> latter turn converted angiotensin<NUMBER> ace therefore competing angiotensin ii binding <NUMBER> limited animal vitro studies reported upregulation ace<NUMBER> induced arbs far lesser extent ace inhibitors predominantly heart kidney effect partly explained increase local levels angiotensin ii induced arbs ace inhibitors <NUMBER> indeed arbs block angiotensin ii type <NUMBER> at<NUMBER> receptors consequently increase availability substrate angiotensin ii upregulates ace<NUMBER> <NUMBER> based assumption speculated treatment arbs ace inhibitors might favour entry sarscov<NUMBER> lung cells therefore increasing risk adverse outcomes severe forms covid<NUMBER> infection conversely beneficial effect background therapy arb course disease supposed two complex mechanisms might support hypothesis firstly angiotensin ii binding receptor at<NUMBER> might enhance shedding transmembrane ace<NUMBER> promoted adam<NUMBER> disintegrin metalloprotease therefore releasing soluble ace<NUMBER> locally soluble form ace<NUMBER> unable mediate sarscov<NUMBER> internalization longer annexed cell membrane <NUMBER> secondly upregulation ace<NUMBER> probably induced arbs might necessarily negative effects sarscov<NUMBER> internalization lung cells inevitably induces downregulation ace<NUMBER> increase substrate angiotensin ii potent vasoconstrictor proinflammatory agent might contribute exacerbation lung injury indeed animal models lung injury clear association activation angiotensin iiat<NUMBER> signalling severity lung damage observed detrimental effects cascade counterbalanced activation ace<NUMBER>angiotensin<NUMBER>mas receptor axis <NUMBER> specifically models sepsis acid aspiration frequently cause acute lung injury ards ace<NUMBER> knockout mice experienced severe tissue damage characterized marked inflammatory cell infiltration increased vascular permeability lung oedema bleeding compared wildtype mice similarly angiotensin ii type <NUMBER> at<NUMBER> receptors knockout mice marked lung damage models injection recombinant human ace<NUMBER> protein ace<NUMBER> knockout mice considerably decreased severity lung injury <NUMBER> line findings pretreatment recombinant human ace<NUMBER> able reduce inflammatory cell infiltration tissue injury mouse model respiratory syncytial virus infection <NUMBER> evidence clinical studies still rather limited patients ards recombinant human ace<NUMBER> increased angiotensin<NUMBER> decreased angiotensinii concentrations even though study prematurely discontinued lack clinical improvement <NUMBER> overall evidence animal models suggests conceivable pneumoprotective role ace<NUMBER> at<NUMBER> receptor context lung injury loss pulmonary ace<NUMBER> might therefore harmful effects exacerbating inflammation promoting respiratory distress fibrosis way activation ace angiotensin ii at<NUMBER> receptor axis might exert detrimental effects worsening lung damage rationale raas inhibition therefore counterbalancing effects reducing angiotensin ii increasing ace<NUMBER> notably arb ace inhibitors attenuated lpsinduced lung injury several preclinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently milne et al analysed gene expression ace<NUMBER> ace agtr<NUMBER> encoding at<NUMBER> tmprss<NUMBER> transmembrane protease serine <NUMBER> requested cofactor internalization sarscov<NUMBER> adam<NUMBER> large number healthy lung tissue samples collected patients undergoing lung resection cancer significant association use ace inhibitors reduced ace<NUMBER> gene expression observed differently use arbs linked relevant changes ace<NUMBER> expression significantly correlated increased ace decreased agtr<NUMBER> expression <NUMBER> although findings quite contrast data animal studies highlighted gene expression rather protein concentration analysed collected tissue samples exhibit lung injury ards covid<NUMBER> results severe lung damage imbalance raas system context cannot excluded recently pilot study covid<NUMBER> patients found higher levels circulating angiotensin ii compared healthy subjects correlation angiotensin ii concentration severity disease observed well <NUMBER> thus effects ace inhibitors arbs might different extremely damaged context therefore explored animal models covid<NUMBER> mounting evidence recent clinical studies suggests raas inhibitor use related increased risk covid<NUMBER> infection poor outcomes retrospective cohort study <NUMBER> patients screened covid<NUMBER> test positivity significantly associated ace inhibitor arb therapy <NUMBER> similarly us study relationship emerged prior ace inhibitor arb use increased likelihood positive sarscov<NUMBER> test result adjusting relevant confounding factors <NUMBER> italian communitybased casecontrol study association found ace inhibitor arb treatment covid<NUMBER> infection although use drugs rather frequent due high prevalence cvd <NUMBER> overall findings excluded increased risk covid<NUMBER> infection patients already treated raas inhibitors studies evaluated link covid<NUMBER> progression raas inhibitor therapy recent korean populationbased cohort study involving <NUMBER> covid<NUMBER> patients use ace inhibitors arbs associated higher mortality risk adjustment confounders <NUMBER> recent systematic review including total n <NUMBER> covid<NUMBER> patients different countries ace inhibitor arb use associated increased severity covid<NUMBER> illness <NUMBER> interestingly metaanalysis <NUMBER> covid<NUMBER> patients seven cohort studies five casecontrol studies use raas inhibitors linked higher risk covid<NUMBER> infection severity mortality whereas mortality risk significantly lower patients treated ace inhibitors arbs compared treated antihypertensive drugs <NUMBER> taking together data observational studies indicates raas inhibitor therapy unlikely negative impact course infection however whether patients covid<NUMBER> might take advantage initiating drugs terms disease progression outcomes explored clinical trials still ongoing cvd wellknown major complications diabetes risk developing cvd <NUMBER>to fivefold higher patients t<NUMBER>d nondiabetic patients mainly due diabetesrelated coronary atherosclerosis <NUMBER> addition diabetic cardiomyopathy may occur independently coronary artery disease likely developing helper <NUMBER> driven responses within cardiomyocyte <NUMBER> <NUMBER> besides common clinical features covid<NUMBER> cardiovascular damage may occur nearly <NUMBER> patients <NUMBER> cause major concern due high related mortality mechanisms underlying complication largely unknown direct viral damage destabilization coronary plaques reportedly suspected play consistent role notably sample <NUMBER> patients covid<NUMBER> guo et al observed presence background coronary heart disease cardiomyopathy associated frequent occurrence myocardial damage highlighted marked increase serum troponin course disease <NUMBER> accordingly mortality considerably higher among patients myocardial injury concomitant cvd <NUMBER> patients without cvd <NUMBER> remarkably considerable percentage patients displaying myocardial injury diabetes <NUMBER> compared patients without myocardial injury <NUMBER> myocardial injury may therefore contribute poorer outcomes observed diabetic patients covid<NUMBER> <NUMBER> note patients myocardial injury prone develop malignant arrhythmias ards coagulopathy acute kidney injury explained high mortality <NUMBER> importantly ace inhibitors arbs broadly used patients myocardial injury mortality significantly differ treated nontreated patients although consistent evidence excluding harms suggesting benefits raas inhibitors covid<NUMBER> patients hearth injury lacking arbs able increase ace<NUMBER> expression hearts animal models arterial hypertension <NUMBER> even pathological context possible effects drugs elucidated downregulation ace<NUMBER> cardiomyocytes blood vessels induced sarscov<NUMBER> internalization might exacerbate myocardial injury endothelial dysfunction compromising heart function patients diabetes underlying cvd <NUMBER> <NUMBER> addition patients t<NUMBER>d high rate lipid alterations statins first line therapy dyslipidaemia remarkably evidence preclinical studies suggests statins might modulate ace<NUMBER> expression several tissues including heart observed atorvastatin increased ace<NUMBER> protein expression heart kidney rabbits atherosclerosis <NUMBER> another study diabetic rats displayed significantly lower expression ace<NUMBER> impaired systolic diastolic function compared control rats combined treatment insulin fluvastatin associated higher levels ace<NUMBER> compared nontreated diabetic rats <NUMBER> ace<NUMBER> multisubstrate enzyme targeted several molecules although extremely limited evidence animal studies peroxisome proliferatoractivated receptor gamma pparγ agonists insulinsensitizer drugs treatment type <NUMBER> diabetes t<NUMBER>d might increase expression ace<NUMBER> different tissues animal model hypertension insulinsensitizer rosiglitazone modulated ace<NUMBER>angiotensin<NUMBER>angiotensin ii axis aortic tissue lowered blood pressure increasing expression ace<NUMBER> <NUMBER> similarly high fat diet fed rats animal model obesity pioglitazone increased expression ace<NUMBER> insulinsensitive tissues liver adipose tissue skeletal muscle likely modulation reninangiotensin system <NUMBER> ace<NUMBER> widely distributed human tissues remarkably expression found even lower lung sites <NUMBER> hence mediators thought play role facilitating sarscov<NUMBER> infection priming serine protease tmprss<NUMBER> requested binding ace<NUMBER> internalization sarscov<NUMBER> tmprss<NUMBER> cleaves protein s<NUMBER> s<NUMBER> subunits necessary step membrane fusion viral internalization contextually drags ace<NUMBER> alveolar cells <NUMBER> light antibodies targeting sprotein tmprss<NUMBER> inhibitors might prevent sarscov<NUMBER> entry lung cell <NUMBER> individuating possible candidate coreceptors therefore great importance development new therapeutic strategies contrast infection dpp<NUMBER> ubiquitously expressed cell surface exopeptidase important metabolic functions mainly regulates bioactivity gutderived hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide gip stimulate insulin secretion response oral glucose administration known incretin effect <NUMBER> dpp<NUMBER> inhibitors dpp<NUMBER>i commonly used drugs treatment t<NUMBER>d prevent degradation incretins inhibiting catalytic activity dpp<NUMBER> result ßcell insulin secretion potentiated glycaemia significantly reduced independently catalytic function dpp<NUMBER> displays inflammatory immune functions <NUMBER> indeed expressed mainly tlymphocytes involved activation proliferation <NUMBER> interestingly proinflammatory factors significantly increase dpp<NUMBER> expression circulating immune cells <NUMBER> unlike sarscov sarscov<NUMBER> binds ace<NUMBER> entry lung cells dpp<NUMBER> functional receptor merscov <NUMBER> hence several mouse human monoclonal antibodies preventing protein binding dpp<NUMBER> given promising results treatment mers <NUMBER> note recently reported dpp<NUMBER> shares patterns expression ace<NUMBER> lung precisely alveolar type <NUMBER> cells main target sarscov<NUMBER> <NUMBER> vankadari et al recently set docking model dpp<NUMBER> sarscov<NUMBER> spike glycoprotein <NUMBER> predicted several dpp<NUMBER> residues might involved interaction sarscov<NUMBER> s<NUMBER> domain spike protein also targeted coronaviruses enter host cells functional receptor dpp<NUMBER> however validation needed draw conclusions establish whether possible adhesion dpp<NUMBER> spike protein may play role sarscov<NUMBER> infection consequently important issues addressed claiming possible beneficial effects dpp<NUMBER> modulation covid <NUMBER> <NUMBER> according data chen et al patients diabetes moderatesevere covid<NUMBER> use dpp<NUMBER>i significantly impact mortality clinical outcomes <NUMBER> presence diabetes considerably influences course covid<NUMBER> infection risk factor poor outcomes limited preclinical studies ace<NUMBER> expression found modulated several players different tissues largely employed treatment diabetes antihypertensive considerably lesser extent insulinsensitizers statins light potential harmful protective effects treatments covid<NUMBER> infection might interesting soil research date data supporting drugs clearly interfere sarscov<NUMBER> access lung cells tissues completely lacking stressed absence evidence consistent clinical studies discontinuation adoption therapies attempt influence course infection strongly discouraged angiotensinconverting enzyme<NUMBER> ace<NUMBER> expression may increase due upregulation patients using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs reninangiotensin system blockers increase levels ace<NUMBER> protein facilitates coronavirus entry cells concern drugs could increase risk developing severe fatal form covid<NUMBER> impact discontinuing acei arbs patients covid<NUMBER> remains uncertain design brace corona pragmatic multicenter randomized phase iv clinical trial aims enroll around <NUMBER> participants <NUMBER> sites brazil participants identified ongoing national registry suspected confirmed cases covid<NUMBER> eligible patients using reninangiotensin system blockers aceiarbs confirmed diagnosis covid<NUMBER> randomized strategy continued aceiarb treatment versus temporary discontinuation <NUMBER> days primary outcome median days alive hospital <NUMBER> days secondary outcomes include progression covid<NUMBER> disease allcause mortality death cardiovascular causes myocardial infarction stroke transient ischemic attack new worsening heart failure myocarditis pericarditis arrhythmias thromboembolic events hypertensive crisis respiratory failure hemodynamic decompensation sepsis renal failure troponin btype natriuretic peptide bnp nterminalprobnp ddimer levels summary brace corona evaluate whether strategy continued aceiarb therapy compared temporary discontinuation drugs impacts clinical outcomes among patients covid<NUMBER> continuing versus suspending angiotensinconverting enzyme inhibitors angiotensin receptor blockers impact adverse outcomes hospitalized patients severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER>the brace corona trial j u r n l p r e p r f introduction december <NUMBER> first cases novel infectious viral respiratory illness severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> reported wuhan china highly contagious coronavirus disease caused sarscov<NUMBER> spread rapidly <NUMBER> countries declared global pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> new threatening situation led rapid response medical scientific community identify main characteristics disease interventions improve outcomes patients covid<NUMBER> infectious disease emergencies ongoing covid<NUMBER> pandemic trials interventions need implemented part efforts control spread disease improve patient outcomes <NUMBER> randomized clinical trials reliable approach evaluate effects interventions <NUMBER> context public health emergencies conducting randomized clinical trial even challenging <NUMBER> shortfalls contemporary clinical trial system include increasingly prohibitive costs local national regulatory requirements delays approval unnecessary trial processes <NUMBER> past decade innovations trial design deployed facilitate trial conduct attractive solution registrybased randomized clinical trials <NUMBER> including randomization clinical registry unselected consecutive enrolment advantages prospective randomized trial aligned strengths largescale allcomers clinical registry <NUMBER> prospective registrybased randomized trials may powerful tool conducting studies efficiently costeffectively particularly urgent situation like current covid<NUMBER> pandemic patients covid<NUMBER> comorbidities worse prognosis underlying medical issues however wellknown cardiovascular risk factors commonly identified patients could also explain higher risk population <NUMBER> <NUMBER> reninangiotensin system blockers commonly used patients cardiovascular comorbidities since group drugs routinely indicated patients heart failure hypertension coronary heart disease angiotensinconverting j u r n l p r e p r f enzyme<NUMBER> ace<NUMBER> may increase due upregulation patients using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockers arbs since sarscov<NUMBER> human pathogenic coronaviruses binds target cells ace<NUMBER> <NUMBER> worse prognosis patients cardiovascular disease could related interaction drugs commonly used patients may facilitate virus aggression <NUMBER> basis data indicating ace<NUMBER> effective receptor sarscov<NUMBER> healthcare professionals researchers assessing possible impact aceis arbs patients covid<NUMBER> <NUMBER> ace<NUMBER> receptor found surface type ii alveolar epithelial cells lungs well cells heart kidney liver gastrointestinal tract uncertainty surrounding reninangiotensin system inhibition patients covid<NUMBER> hypothesizing aceiarb use may increase propagation virus others hypothesizing may protective effect figure <NUMBER> <NUMBER> sarscov<NUMBER> gains entry cell binding ace<NUMBER> use acei arb could enhance ace<NUMBER> abundance consequently increase susceptibility viral entry theory effect could increase risk severity covid<NUMBER> hand increase expression angiotensin ii drives lung injury activating type <NUMBER> angiotensin receptor at<NUMBER>r producing inflammation fibrosis decreasing production angiotensin ii acei blocking angiotensin iiat<NUMBER>r activity arb enhances production angiotensin <NUMBER> angiotensin ii activates mas receptor attenuates inflammation fibrosis resulting decrease lung damage <NUMBER> indeed use recombinant human ace<NUMBER> tested promising therapy patients severe acute respiratory distress syndrome <NUMBER> finally reninangiotensin system inhibition protects cardiovascular system lowering blood pressure avoiding ventricular remodeling reducing plasminogen activator inhibitor<NUMBER> <NUMBER> thus withdrawal agents could harmful since potential risk disease complications related discontinuation established therapies already proven effective preventing cardiovascular events result j u r n l p r e p r f <NUMBER> data supporting potential benefit also data indicating potential risk maintaining agents covid<NUMBER> infection reinforces need prospective randomized study address clinical question several possible interactions medications commonly prescribed cardiovascular disease covid<NUMBER> might influence prognosis patients totality evidence taken account true equipoise maintenance suspension aceiarb therapy patients covid<NUMBER> date high quality clinical evidence confirm theories question clarified randomized clinical trial <NUMBER> initial hypothesis continuing aceiarbs beneficial overall course covid<NUMBER> infection compared withdrawing agents brace corona clinicaltrialsgov nct<NUMBER> academically led investigatorinitiated pragmatic phase iv multicenter registrybased randomized trial study openlabel blinded endpoint assessment probe include approximately <NUMBER> patients aceiarb therapy confirmed diagnosis covid<NUMBER> brace corona trial embedded registry patients covid<NUMBER> admitted <NUMBER> sites brazil patients first <NUMBER> eligible trial approached randomized maintenance discontinuation reninangiotensin system inhibition data necessary documenting baseline characteristics outcomes including acei arb doses collected already registry figure <NUMBER> study protocol approved national commission research ethics conep brazilian ministry health study conducted compliance protocol adheres fully ethical principles declaration helsinki specifications international j u r n l p r e p r f <NUMBER> council harmonisation good clinical practice protocol requires patient must provide informed consent study procedure initiated primary objective trial determine whether continued use versus discontinuation aceiarb therapy increases days alive hospital <NUMBER> days patients reninangiotensin system inhibition hospitalized covid<NUMBER> secondary objectives compare impact continued use versus discontinuation reninangiotensin system inhibition covid<NUMBER> disease severity allcause mortality cardiovascular death acute myocardial infarction new worsening heart failure hypertensive crisis transient ischemic attack stroke <NUMBER> days addition incidence myocarditis pericarditis arrhythmias requiring treatment thromboembolic phenomena respiratory failure hemodynamic decompensation sepsis renal failure compared groups <NUMBER> days cardiovascular biomarkers related covid<NUMBER> troponin btype natriuretic peptide bnp nterminalpro hormone bnp ddimer also assessed patients hospitalized suspected diagnosis covid<NUMBER> included registry followed diagnosis confirmed refuted patients ≥<NUMBER> years age confirmed diagnosis covid<NUMBER> chronic reninangiotensin system inhibitor aceiarb therapy assessed brace corona trial based international data around <NUMBER> <NUMBER> patients included brace corona diagnosis hypertension <NUMBER> <NUMBER> would diagnosis heart failure <NUMBER> <NUMBER> patients using sacubitrilvalsartan heart failure included trial patients using three antihypertensive agents hospitalized heart failure j u r n l p r e p r f <NUMBER> last <NUMBER> months eligible randomization patients clinical indication stop aceiarb therapy hypotension acute kidney injury andor shock excluded table <NUMBER> eligible patients randomized using <NUMBER> allocation ratio either continue aceiarb therapy group <NUMBER> discontinue aceiarb therapy <NUMBER> days group <NUMBER> patients randomized group <NUMBER> change reninangiotensin system blocker therapy result covid<NUMBER> dose adjustments concomitant therapies discretion treating physician patients randomized group <NUMBER> discontinue acei arb therapy <NUMBER> days agents replaced drugs needed discretion treating physician beta blockers maintained patients already using heart failure study protocol recommend treatment modification beyond reninangiotensin blockers use hydralazine nitrates preferred patients heart failure commonly used preferred treatment cannot tolerate acei arb therapy patients heart failure deteriorate medication withdrawal managed based hemodynamic profile use diuretics vasodilators type b profile among vasodilators preference acute phase short halflife medications possibility using parenteral agents nitrates associated hydralazine reintroduction acei done clinical compensation preferably <NUMBER> days randomization stable renal function patients hypertension study protocol recommends thiazide calcium channel antagonists hydralazine preferred options patients already using one classes antihypertensive agents may used based patient physician preferences eg betablockers commonly used patients ischemic heart disease heart j u r n l p r e p r f <NUMBER> failure thus beta blockers recommended firstline agents unless presence heart failure ischemic heart disease <NUMBER> cases used regardless blood pressure control study team assist treating physicians process drug replacement decisions based current guidelines since brace corona pragmatic study types acei arbs used defined according local practice following international guidelines <NUMBER> <NUMBER> <NUMBER> details around different types reninangiotensin system blockers reported publication results since currently specific intervention proven beneficial treatment covid<NUMBER> patients treated according current local standards supportive care without systematic use experimental therapies study treatment compliance assessed based medical prescription hospitalization discharge data collected systematically patients included covid<NUMBER> registry brace corona trial data collected include demographics cardiovascular risk factors relevant medical surgical histories clinical characteristics concomitant medications laboratory data data collection performed hospitalization discharge phone call <NUMBER> days capture clinical events discharge flowchart including registry clinical trial populations presented figure <NUMBER> detailed information collected study visit provided supplementary appendix j u r n l p r e p r f <NUMBER> primary outcome study days alive outside hospital daoh <NUMBER> days endpoint calculated patient calculation date randomization <NUMBER> days postrandomization daoh endpoint represents followup time <NUMBER> days subtracted hospitalization days andor days death end followup pragmatic endpoint encompasses time death also potential nonfatal complications could lead prolonged hospitalization sensitivity analysis using hierarchical approach death receiving zero daoh length hospitalization also performed main cardiovascular complications could prolong hospitalization lead death assessed individually secondary outcomes independent clinical events committee whose members unaware randomization assignment adjudicate following secondary clinical outcomes death vascular causes myocardial infarction new worsening heart failure stroke transient ischemic attack <NUMBER> days potential events detected electronic case report forms patients included trial generate alert upload source documents adjudication process detailed definitions secondary outcomes described supplementary appendix initial expected sample size brace corona around <NUMBER> patients however number may increase decrease according recruitment rate event rate data safety monitoring board dsmb assessments efficacy safety futility assuming standard deviation <NUMBER> days daoh <NUMBER> days based ongoing coalizao study brazil nct<NUMBER> <NUMBER> patients <NUMBER> power detect mean ration least <NUMBER> estimate full cohort patients enrolled <NUMBER> <NUMBER> months however may extended depending recruitment rate currently randomized studies field reported outcomes event rates inform calculations accurate sample size order maintain benefits randomization primary analysis follow intentiontotreat principle continuous variables described medians <NUMBER>th <NUMBER>th percentiles mean ± standard deviation according distribution medians compared using kruskalwallis test means compared using ttest categorical variables described absolute relative frequencies proportions compared using chisquare test pvalues <NUMBER> considered statistically significant primary outcome measured daoh <NUMBER> days analysis based median outcome analysis distribution daoh <NUMBER> days presented histograms two groups without discontinuation reninangiotensin system inhibitors median <NUMBER>th <NUMBER>th percentiles general population group calculated comparison groups made using quasipoisson model results presented mean ratios study groups respective <NUMBER> confidence intervals interaction tests performed specific subgroups including sex male vs female age <NUMBER> vs ≤<NUMBER> years days symptoms divided tertiles history myocardial infarction vs history stroke vs history heart failure vs history hypertension vs use acei vs use arb length acei arb use prior enrollment secondary endpoints mortality <NUMBER> days cardiovascular events <NUMBER> days compared log binomial models reporting relative risks respective <NUMBER> confidence intervals analyses performed using r software current version investigatorinitiated study financial support dor institute research education idor extramural funding used support work study coordinated idor brazilian clinical research institute bcri institutions coordinate data management idor manage electronic clinical report form database bcri manage clinical events adjudication database executive steering committees together operational teams idor bcri oversee medical scientific operational conduct study executive steering committee members responsible reporting results drafting editing forthcoming manuscripts authors solely responsible design conduct study study analyses drafting editing paper final contents independent dsmb monitor safety efficacy data ongoing basis access unblinded data dsmb review primary outcome study well secondary outcomes weekly evaluations also <NUMBER> formal interim analyses including hf group dsmb use pvalue <NUMBER> interim analyses declare statistically significant difference outcomes study groups guide recommendations <NUMBER> <NUMBER> overall pvalue <NUMBER> used declare statistical significance end study independent clinical events classification committee adjudicate causes death clinical outcomes described secondary outcomes death myocardial infarction stroke hypertensive crisis new worsening heart failure majority patients affected covid<NUMBER> favorable clinical outcomes acute phase infection <NUMBER> nevertheless risk severe forms infection increases significantly according age presence chronic comorbidities <NUMBER> <NUMBER> among comorbidities j u r n l p r e p r f cardiovascular diseases particularly important intrinsic risk adverse outcomes prevalence conditions global population <NUMBER> <NUMBER> hypertension diabetes heart failure coronary heart disease common comorbidities associated worse prognosis among patients covid<NUMBER> however higher risk detected group could also due related factors may facilitate infection increase propagation virus <NUMBER> reninangiotensin system inhibitors routinely used common cardiovascular conditions <NUMBER> <NUMBER> <NUMBER> benefits reducing cardiovascular events well established mainly longterm analyses patients chronic use therapies <NUMBER> <NUMBER> however acute clinical conditions drugs temporarily discontinued due imminent risk higher potential shortterm benefit therapies <NUMBER> currently intense debate suspension maintenance chronic aceiarb therapy patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> brace corona trial designed test impact discontinuation compared maintenance chronic aceiarb therapy patients covid<NUMBER> one several questions facing physicians setting covid<NUMBER> data needed randomized clinical trials like brace corona reninangiotensin system inhibitors increase levels ace<NUMBER> protein facilitates coronavirus entry cells concern drugs could increase risk developing severe fatal form covid<NUMBER> <NUMBER> presence ace<NUMBER> alveolar epithelial cells makes lungs preferred site entry virus explains respiratory manifestations patients covid<NUMBER> hypothesis worse outcomes associated use acei arb patients covid<NUMBER> recently shown observational studies <NUMBER> <NUMBER> however causeeffect relation use acei arb adverse events covid<NUMBER> cannot established since many confounding factors could explain worse better prognosis patients observational analyses recent retrospective study hospitalized covid<NUMBER> patients allcause mortality lower among patients aceiarb therapy compared using aceiarbs <NUMBER> observational analysis singlecenter study showed aceiarb use associated severity covid<NUMBER> infection worse outcomes hospitalized patients hypertension <NUMBER> j u r n l p r e p r f <NUMBER> nonetheless effect reninangiotensin system inhibition ace<NUMBER> uncertain potential harm related mechanism well defined <NUMBER> <NUMBER> addition use acei arbs could beneficial due wellknown cardiovascular protection <NUMBER> also potential respiratory system protection patients affected severe respiratory disease <NUMBER> <NUMBER> considering highrisk patients cardiovascular disease covid<NUMBER> commonly hospitalized decision regarding best approach management reninangiotensin system inhibitors critical scenario apparent equipoise without high quality scientific evidence medical decisions clinical practice heterogeneous thus randomized clinical trial necessary guide practice multicenter randomized clinical trial conducted pandemic follow steps commonly adopted pivotal phase iii trials however critical urgent nature pandemic encourages opportunities create efficient research processes adopted use clinical research conducted nonpandemic times new threatening situation like covid<NUMBER> pandemic specific evidence guide medical therapy yet urgent need quickly answer clinical questions arise order guide treatment hundreds thousands people infected potentially lethal disease collaborative pragmatic studies one best solutions scenario <NUMBER> brace corona took less <NUMBER> weeks protocol development first patient randomized including national ethics board review approval unprecedented brazil figure <NUMBER> covid<NUMBER> registry already collecting key clinical variables outcomes used randomized trial adding randomization structure allows efficient process provide scientific community streamlined approach answer relevant clinical question less bureaucracy lower cost addition clinicians frontline already interested answering medical question highly engaged trial source documents potential events adjudicated clinical events classification committee since many different complications could occur due interaction covid<NUMBER> baseline cardiovascular condition therapies used patients primary study outcome chosen brace corona daoh <NUMBER> days also pragmatic encompasses potential effect j u r n l p r e p r f <NUMBER> relevant medical complication therefore regardless type inhospital complication captured study daoh ultimately represent meaningful outcome net benefit patients perspective efficient model registrybased randomized trial first kind brazil already applied successfully countries <NUMBER> <NUMBER> represents unique opportunity global crisis covid<NUMBER> could serve important legacy medical community brace corona multicenter randomized trial patients hospitalized covid<NUMBER> reninangiotensin system blockers aims determine whether discontinuation compared maintenance drugs increases days alive hospital results study help guide may result alveolar collapse due loss surfactant type li cells acute lung injury reninangiotensinaldosterone system raas angiotensin ang converted angiotensin ii ang ii ace ang ii mediates vasoconstrictive proinflammatory prooxidative prothrombotic effects possibly increasing levels pai<NUMBER> agonism ang ii type <NUMBER> receptor at<NUMBER>r ace<NUMBER> converts ang ii angiotensin <NUMBER> finally binds mas receptor masr mediates many beneficial actions including vasodilation antiinflammatory antioxidant antiapoptotic effects thus ace<NUMBER>ang <NUMBER>masr axis opposite actions aceang iiat<NUMBER>r axis ace<NUMBER> limits adverse vasoconstrictor profibrotic effects ang ii degradation counteracting actions formation ang <NUMBER> sarscov<NUMBER> binding ace<NUMBER> may attenuate residual ace<NUMBER> activity consequence increased internalization shedding ace<NUMBER> cell surface tipping aceace<NUMBER> balance predominant aceang iiat<NUMBER> axis signaling ang ii may foster pulmonary vasoconstriction inflammatory oxidative organ damage ultimately progressing towards acute lung injury different postulated mechanisms inhibition raas acei arb might dangerous protective covid<NUMBER> acei arbs could theoretically increase risk sarscov<NUMBER> infection severe covid<NUMBER> owing role ace<NUMBER> viral binding site although aceis arbs directly affect ace<NUMBER> activity premise based part findings studies aceis arbs may increase ace<NUMBER> levels thus enhance viral entry aceis arbs may mitigate covid<NUMBER> attenuating ang iimediated acute lung impairment decreasing production ang ii acei blocking ang iiat<NUMBER>r actions arb may reduce levels prothrombotic substances pai<NUMBER> intensify formation ang <NUMBER> ace<NUMBER> activation masr attenuates inflammation fibrosis consequently may attenuate lung damage entry sarscov<NUMBER> cells mediated efficient binding spike viral protein <NUMBER> amino acid long protein belongs viral envelope protrudes outwards corona like appearance angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors <NUMBER> <NUMBER> ace<NUMBER> receptor discovered two independent groups year <NUMBER> <NUMBER> <NUMBER> transmembrane type glycoprotein monocarboxypeptidase composed <NUMBER> amino acids uses single extracellular catalytic domain remove one single amino acid octapeptide angiotensin ii generate angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> receptor also converts angiotensin angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> turn converted angiotensin <NUMBER> ace neprilisin figure <NUMBER> catalytic efficiency ace<NUMBER> <NUMBER> times higher angiotensin ii angiotensin <NUMBER> ace<NUMBER> shows <NUMBER> structural identity ace <NUMBER> although aceinhibitors block ace<NUMBER> different conformational structure catalytic site <NUMBER> ace<NUMBER> mediates cell entry three strains coronavirus sarscov nl<NUMBER> sarscov<NUMBER> <NUMBER> notably sarscov sarscov<NUMBER> share <NUMBER> identity amino acid sequence <NUMBER> thereby explaining propensity viruses binding ace<NUMBER> structural variations human ace<NUMBER> identified characterized lower binding affinity spike viral protein potential protective implications <NUMBER> first step viral entry process binding nterminal portion viral protein unit s<NUMBER> pocket ace<NUMBER> receptor second step believed utmost importance viral entry protein cleavage s<NUMBER> s<NUMBER> units operated receptor transmembrane protease serine <NUMBER> tmprss<NUMBER> member hepsintmprss subfamily <NUMBER> tmprss<NUMBER> stechiometrically contiguous ace<NUMBER> receptor <NUMBER> cleavage viral protein tmprss<NUMBER> crucial step s<NUMBER> detachment remaining viral s<NUMBER>unit undergoes conformational rearrangement drives completes fusion viral cellular membrane subsequent entry virus cell release content replication infection cells importance tmpsrr<NUMBER> supported evidence entry sarscov sarscov<NUMBER> cells partially blocked camostat mesylate inhibitor tmpsrr<NUMBER> <NUMBER> <NUMBER> site ace<NUMBER> receptors ace<NUMBER> genes map x chromosome <NUMBER> expression seems higher asian white africanamerican people <NUMBER> receptors ubiquitous particular ace<NUMBER> receptors expressed heart endothelium coronary arteries myocites fibroblasts epicardial adipocites vessels vascular endothelial smooth cells gut intestinal epithelial cells lung tracheal bronchial epithelial cells type <NUMBER> pneumocytes macrophages kidney luminal surface tubular epithelial cells testis brain <NUMBER> <NUMBER> <NUMBER> <NUMBER> lung wide surface alveolar epithelial cells might explain vulnerability organ consequences virus invasion ace<NUMBER> mostly bound cell membranes scarcely present circulation soluble form disintegrin metalloproteinase <NUMBER> adam<NUMBER> upregulated angiotensin ii type <NUMBER> receptors at<NUMBER> receptors cleaves membraneanchored ace<NUMBER> thereby releasing circulating active form ace<NUMBER> loss catalytically activity remaining part enzyme anchored membrane <NUMBER> elevated circulating levels soluble ace<NUMBER> markers different disease states characterized increased activity reninangiotensin system associated worse prognosis <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> angels devils current sarscov<NUMBER> pandemic ace<NUMBER> receptors considered devils entry door virus evidence phenomenon strong convincing hoffmann et al <NUMBER> walls et al <NUMBER> provided unequivocal evidence sarscov<NUMBER> gain access cells ace<NUMBER> receptors happened sarscov <NUMBER> evidences complete picture example mouse model sarscov infection virus entry enhanced overexpression ace<NUMBER> <NUMBER> antiace<NUMBER> antibodies antiace antibodies able block sarscov viral invasion <NUMBER> also blocked n<NUMBER>aminoethil<NUMBER> aziridineethamine specific ace<NUMBER> inhibitor <NUMBER> pulmonary lesions induced experimental sarscov infection less aggressive ace<NUMBER>knockout mice wildtype mice <NUMBER> time however ace<NUMBER> receptors exert salutary biological functions turn angels several aspects pivotal protective function ace<NUMBER> degradation angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although ace<NUMBER> able metabolize biological peptides including desarg<NUMBER>bradykinin <NUMBER> degradation angiotensin ii angiotensin <NUMBER> blocked selective ace<NUMBER> inhibitors like mln<NUMBER> <NUMBER> understand relevance angiotensin ii degradation ace<NUMBER> results important review biological effects angiotensin ii angiotensin ii serves potent vasoconstrictor stimulant aldosterone release different experimental clinical models angiotensin ii triggered variety important adverse reactions included myocardial hypertrophy dysfunction interstitial fibrosis endothelial dysfunction enhanced inflammation obesityassociated hypertension oxidative stress increased coagulation <NUMBER> <NUMBER> <NUMBER> <NUMBER> detailed discussion mechanisms angiotensin ii mediates reactions purposes review current pandemic sarscov<NUMBER> infection associated pulmonary inflammation acute respiratory distress syndrome ards interesting note angiotensin ii also interferes adaptive immunity activating machrophages <NUMBER> cells immune system consequent increased production il<NUMBER> <NUMBER> tnfα inflammatory citokynes <NUMBER> <NUMBER> important remark deleterious effects angiotensin ii summarized almost entirely result stimulation at<NUMBER> receptors chain events defined ace→angiotensin ii→at<NUMBER> receptor axis ace<NUMBER> receptors reduce adverse effects angiotensin ii degrading angiotensin ii thereby eliminating limiting deleterious potential also generating angiotensin <NUMBER> angiotensin <NUMBER> exerts numerous salutary opposite counterregulatory effects angiotensin ii efficient binding g proteincoupled receptor mas angiotensin ii type <NUMBER> receptors at<NUMBER> receptors therefore ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis counterregulatory ace→angiotensin ii→at<NUMBER> receptor axis santos et al provided excellent review multiple effects ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis lung studies addressing pulmonary effects angiotensin <NUMBER> appear particularly appealing mas receptors expressed surface bronchial smooth muscle cells alveolar epithelium <NUMBER> <NUMBER> experimental clinical models lung inflammation angiotensin <NUMBER> exerted antiinflammatory effects less infiltrates lymphocytes neutrophils reduced perivascular peribronchial inflammation prevention subsequent fibrosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> expressed luminal side bronchial ciliated epithelia removes single amino acid residue also polypeptide desarg <NUMBER> bradykinin dabk <NUMBER> thereby preventing binding dabk bradykinin receptor b<NUMBER> receptor <NUMBER> presence reduced ace<NUMBER> function lung induced endotoxins increase free dabk turn activates b<NUMBER> receptors release proinflammatory cytokines intense lung inflammatory injury <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis thrombosis ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis exerts antithrombotic effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> mas receptors expressed platelets <NUMBER> stimulation mas receptors angiotensin <NUMBER> increases prostacyclin release <NUMBER> <NUMBER> animals knockout mas receptors shorter bleeding time increased size thrombi <NUMBER> animals administration angiotensin <NUMBER> induces marked antithrombotic effect directly related plasma levels angiotensin <NUMBER> <NUMBER> inhibited a<NUMBER> antagonist mas receptors <NUMBER> thus angiotensin <NUMBER> plays important role opposing prothrombotic proinflammatory effects angiotensin ii <NUMBER> <NUMBER> <NUMBER> ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis endocrine system ace<NUMBER>→angiotensin <NUMBER> →mas receptor axis well expressed pancreas improves insulin secretion possibly improving periinsular blood flow inhibiting fibrosis result increased release <NUMBER> <NUMBER> ace<NUMBER> receptors also expressed adipose tissue <NUMBER> <NUMBER> reduction ace<NUMBER> noted adipose tissue obese animals <NUMBER> animal experiments diets rich fats decreased ace<NUMBER> activity angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> increased angiotensin ii blood pressure levels male female animals reactions inhibited at<NUMBER> blockade losartan <NUMBER> ovariectomy female animals showed similar reactions males <NUMBER> data suggest ace<NUMBER> deficiency may favor obesityinduced hypertension <NUMBER> ace<NUMBER> also expressed cardiac adipocytes <NUMBER> obese patients heart failure increased amount epicardial adipose tissue <NUMBER> suggested ace<NUMBER> deficiency induce heart failure preserved ejection fraction animals <NUMBER> phenomenon attributed adipose tissue inflammation local activation macrophages possess at<NUMBER> receptors cellular membrane <NUMBER> <NUMBER> happen ace<NUMBER> sarscov binding sarscov sarscov<NUMBER> bind ace<NUMBER> receptors subsequent membrane fusion virus entry cell leads downregulation receptors <NUMBER> <NUMBER> <NUMBER> terms virus appears entry cell along membrane receptor functionally removed external site membrane result ace→angiotensin ii→mas receptor axis markedly attenuated amplification ace→angiotensin ii→at<NUMBER> receptor axis since pulmonary inflammation resulting acute respiratory distress syndrome ards potentially deadly complications sarscov sarscov<NUMBER> studies addressing lung complications ace<NUMBER> downregulation outmost importance studies using different models lung injury showed downregulation ace<NUMBER> receptors triggers important inflammatory lesions respiratory tree alveolar wall thickening edema infiltrates inflammatory cells bleeding appear mediated angiotensin ii <NUMBER> <NUMBER> <NUMBER> <NUMBER> tracheal instillation cigarette smoke <NUMBER> particulate matter aerodynamic diameter less <NUMBER> ɥm <NUMBER> induces acute lung injury release inflammatory cytokines il<NUMBER> tnfα tgfβ<NUMBER> increased expression ace consistent ace→angiotensin ii→at<NUMBER> receptor axis overactivity <NUMBER> reactions increased ace<NUMBER> knockout mice <NUMBER> model acid aspiration induces acute lung injury lung inflammatory lesions severe lethal ace<NUMBER> knockout animals <NUMBER> animals injection recombinant ace<NUMBER> well at<NUMBER> receptor blockers attenuate degree lung injury <NUMBER> findings strongly suggest ace<NUMBER> protects lung injury induced acid aspiration <NUMBER> notably lung injury induced isolated spike viral protein sarscov ligand ace<NUMBER> binding absence viral components <NUMBER> model merit investigate impact ace<NUMBER> downregulation absence confounding effects viral invasion replication authors found even isolated spike viral protein induced downregulation ace<NUMBER> receptors concomitant increase angiotensin ii lung tissue precipitation severe pulmonary inflammatory lesions <NUMBER> also model at<NUMBER> receptor blockers attenuated pulmonary lesions induced spike viral protein <NUMBER> key point remark ace<NUMBER> mainly expressed pneumocytes type ii small cylindrical cells represent <NUMBER> pneumocytes <NUMBER> pneumocytes type <NUMBER> responsible production alveolar surfactant time function stem cells progenitors pneumocytes type <NUMBER> pneumocytes responsible gas exchanges <NUMBER> therefore damage pneumocytes type ii due binding coronavirus ace<NUMBER> receptors devastating least three reasons <NUMBER> local unopposed ace→angiotensin ii→at<NUMBER> receptor axis overactivity <NUMBER> reduced production alveolar surfactant injured pneumocytes type ii leading reduced lung elasticity <NUMBER> reduced repair pneumocytes type leading impaired gas exchanges fibrosis <NUMBER> <NUMBER> clinical characteristics patients infected sarscov sarscov<NUMBER> studies china italy shown hypertension diabetes history cardiovascular disease frequent comorbidities patients infected sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> older age male sex two additional factors associated sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> similar picture emerged years ago sarscov infection <NUMBER> <NUMBER> study conducted <NUMBER> patients infected sarscov<NUMBER> patients men <NUMBER> patients mean age <NUMBER> years frequent comorbidities hypertension <NUMBER> diabetes <NUMBER> history cardiovascular disease <NUMBER> <NUMBER> notably patients developed ards older higher prevalence hypertension <NUMBER> vs <NUMBER> diabetes <NUMBER> vs <NUMBER> compared develop ards <NUMBER> multivariate analysis factors associated progression ards syndrome death included older age neutrophilia hypercoagulation mainly reflected higher ddimer <NUMBER> abnormal coagulation parameters enhanced thrombosis predict poor prognosis patients sarscov<NUMBER> <NUMBER> metaanalysis <NUMBER> studies conducted china total <NUMBER> patients infected sarscov<NUMBER> confirmed hypertension diabetes history cardiovascular disease frequent comorbidities patients <NUMBER> hypertension history cardiovascular disease significantly prevalent among severe patients <NUMBER> recent analysis <NUMBER> infected patients italy mean age patients <NUMBER> years men <NUMBER> prevalence patients hypertension diabetes previous cardiovascular disease <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> patients hypertension older without hypertension <NUMBER> vs <NUMBER> years p<NUMBER> comparing patients died intensive care unit survived former older higher prevalence hypertension <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> <NUMBER> ace<NUMBER> deficiency central role sarscov<NUMBER> infection interesting note several conditions associated viral infection severity disease share variable degree ace<NUMBER> deficiency example ace<NUMBER> expression lungs markedly decreases ageing <NUMBER> greater extent men women <NUMBER> diabetes mellitus associated reduced ace<NUMBER> expression possibly effect glycosylation <NUMBER> <NUMBER> <NUMBER> several experimental clinical studies indicate ace<NUMBER> deficiency obtained deletion inhibition may causative factor hypertension <NUMBER> <NUMBER> treatment soluble recombinant ace<NUMBER> reduces blood pressure rise provoked angiotensin ii increases angiotensin <NUMBER> reduces angiotensin ii <NUMBER> ace<NUMBER> deficiency associated exacerbation hypertension cardiac hypertrophy induced angiotensin ii <NUMBER> maladaptive left ventricular remodeling myocardial infarction <NUMBER> furthermore deficiency ace<NUMBER> enhances susceptibility heart failure <NUMBER> heterozygote loss ace<NUMBER> believed sufficient increase susceptibility heart disease <NUMBER> given premises tempting speculate figure <NUMBER> ace<NUMBER> deficiency may play central role pathogenesis sarscov<NUMBER> infection downregulation ace<NUMBER> induced viral invasion could especially detrimental individuals baseline ace<NUMBER> deficiency due example older age diabetes hypertension prior heart diseases including heart failure possibility mild moderate ace<NUMBER> deficiency may protect viral invasion seems unlikely intrinsically high affinity sarscov<NUMBER> ace<NUMBER> receptors <NUMBER> <NUMBER> contrast setting ace<NUMBER> deficiency ace<NUMBER> downregulation induced virus could amplify imbalance ace→angiotensin ii→at<NUMBER> receptor axis adverse ace<NUMBER>→angiotensin <NUMBER> i→mas receptor axis protective lung level dysregulation would much facilitate progression inflammatory hypercoagulation processes share dependency upon local angiotensin ii hyperactivity insufficiently opposed angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chain events would deny concomitant role mechanisms including impaired immune response initial viral invasion genetic susceptibility hyperinflammation thrombosis <NUMBER> <NUMBER> context administration soluble recombinant ace<NUMBER> <NUMBER> angiotensin <NUMBER> <NUMBER> could promising therapeutic approaches requiring urgent evaluation clinical trials two trials losartan additional treatment sarscov<NUMBER> infection hospitalized nct<NUMBER> hospitalized nct<NUMBER> patients announced supported background huge adverse impact ace→angiotensin ii→at<NUMBER> receptor axis overactivity patients possibility ace inhibitors angiotensin ii receptor blockers arbs may discontinued even temporarily drugs appear increase expression ace<NUMBER> receptors site viral entry human organism <NUMBER> <NUMBER> <NUMBER> <NUMBER> actively debated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several scientific societies various experts area expressed position discontinuation drugs justified evidence could dangerous <NUMBER> <NUMBER> <NUMBER> <NUMBER> hand several experimental data discussed suggest potential utility arbs particularly limit lung inflammation viral invasion <NUMBER> <NUMBER> hoped results mentioned nct<NUMBER> nct<NUMBER> trials answer question suggest ace<NUMBER> downregulation induced cell entry sarscov nl<NUMBER> sarscov<NUMBER> may particularly detrimental subjects preexisting ace<NUMBER> deficiency degree ace<NUMBER> deficiency associated variety conditions including older age hypertension diabetes cardiovascular disease also characterize people likely infected present severe complications setting enhanced ace<NUMBER> deficiency produced viral invasion marked dysregulation adverse ace→angiotensin ii→at<NUMBER> axis protective ace<NUMBER>→angiotensin <NUMBER> →mas axis would contribute enhance progression inflammatory thrombotic processes considerations provide rationale investigating role therapeutic approaches conceptually linked ace<NUMBER> receptor activity include use soluble recombinant ace<NUMBER> angiotensin <NUMBER> angiotensin ii type <NUMBER> receptor blockers currently evaluated since earliest cases coronavirus disease <NUMBER> covid <NUMBER> reported <NUMBER> care delivery systems reorganized challenged unprecedented ways patients underlying cardiovascular conditions including heart failure hf risk severe infection complications <NUMBER> <NUMBER> special considerations needed patients advanced hf including supported durable left ventricular assist devices lvads heart transplant ht recipients review aims summarize emerging data regarding development hf secondary covid<NUMBER> covid<NUMBER> infection patients advanced hf implications pandemic care delivery noninfected patients hf covid<NUMBER> may cause worsen hf variety mechanisms including myocardial ischemia infarction increased oxygen demand elevations pulmonary pressures pulmonary embolism myocarditis stress cardiomyopathy diffuse cytokine release <NUMBER> figure <NUMBER> may concurrently lead arrhythmias cardiogenic shock sudden cardiac death <NUMBER> <NUMBER> patients covid<NUMBER> higher risk thrombosis arterial venous circulations due endothelial dysfunction inflammation oxidative stress platelet activation <NUMBER> acute coronary syndromes plaque rupture leading type myocardial infarction may occur setting <NUMBER> hypoxemic respiratory failure increased myocardial oxygen demand may lead oxygen supplydemand mismatch precipitate type <NUMBER> myocardial infarction <NUMBER> may trigger decompensation preexisting hf development de novo acute hf right ventricular failure also develop secondary elevated pulmonary pressures setting ards andor pulmonary embolism <NUMBER> covid<NUMBER>associated myocarditis demonstrated visualization covid<NUMBER> viral particles endomyocardial biopsy detection diffuse myocardial edema cardiac magnetic resonance imaging mri <NUMBER> <NUMBER> attempted myocarditis treatment strategies included lopinavirritonavir hydroxychloroquine systemic glucocorticoid therapy intravenous immunoglobulin <NUMBER> <NUMBER> data suggest cardiomyopathy may uncommon patients covid<NUMBER> us report <NUMBER> patients severe covid<NUMBER> disease <NUMBER> <NUMBER> developed cardiomyopathy defined newly decreased left ventricular systolic function one following <NUMBER> increased cardiac biomarkers <NUMBER> decreased central venous oxygen saturation <NUMBER> clinical signs shock <NUMBER> another cohort patients covid<NUMBER> china hf developed <NUMBER> <NUMBER> died compared <NUMBER> <NUMBER> recovered <NUMBER> among developed hf approximately <NUMBER> preexisting history hypertension cardiovascular disease underlying mechanisms cardiomyopathies difficult elucidate given inpatient diagnostic testing limitations example true prevalence myocarditis secondary covid<NUMBER> may hard determine without use definitive endomyocardial biopsies routine cardiac imaging wide cohort infected patients accordingly diagnosis myocarditis often made using elevations biomarkers echocardiography demonstrating reduction systolic function andor worsening hemodynamics arrhythmias large registries like american heart association aha covid<NUMBER> cvd registry <NUMBER> help capture prevalence systolic dysfunction incidence myocardial recovery ongoing studies also explore pathology myocarditis hf broadly sarscov<NUMBER> infection <NUMBER> patients covid<NUMBER> develop cytokine release syndrome hyperinflammation leading progressive shock multiorgan failure patients cardiac involvement important questions remain regarding use efficacy mechanical circulatory support device insertion maintenance require significant equipment blood products personnel health systems may limited resources deploy therapies particularly older patients comorbidities extracorporeal life support organization released guidance regarding use ecmo patients covid<NUMBER> develop severe cardiopulmonary failure <NUMBER> suggest resourcelimited settings younger patients without comorbidities andor health care workers highest priority support ecmo rarely used older patients significant comorbidities multiorgan failure <NUMBER> angiotensin converting enzyme inhibitors acei angiotensin ii receptor blockers arbs angiotensin receptor neprilysin inhibitors arni principal components guidelinedirected medial therapy patients chronic systolic hf sarscov<NUMBER> virus causative viral agent covid<NUMBER> uses ace<NUMBER> receptor cell entry figure <NUMBER> concerns raised regarding interaction respect disease virulence <NUMBER> large retrospective studies since suggested aceiarb use associated increased rates covid<NUMBER> infection risk severe disease <NUMBER> <NUMBER> joint statement heart failure society america hfsa american college cardiology acc aha recommends continuation raas antagonists patients prescribed medications hf cardiovascular indications <NUMBER> raas inhibition may potential therapeutic benefit data severe acute respiratory syndrome sars epidemic demonstrated injection sarscov<NUMBER> mice worsened acute lung failure attenuated reninangiotensinaldosteronesystem raas blockade <NUMBER> preclinical studies sacubitrilvalsartan shown reduce levels proinflammatory cytokines increase lymphocyte counts <NUMBER> inhibit expression proinflammatory genes including interleukin<NUMBER> potential therapeutic target covid<NUMBER> <NUMBER> patients hf preexisting risk factors venous thromboembolism including possible stasis blood legs heart endothelial injury <NUMBER> <NUMBER> similarly patients ischemic cardiomyopathy atrial fibrillation risk arterial thrombosis <NUMBER> women hf additional thrombotic risks include oral contraceptive use hormone replacement therapy breast cancer <NUMBER> patients durable lvad support already increased risk thrombosis effects covid<NUMBER> infection risk stroke pump thrombosis currently unknown patients hf anticoagulation require admission covid<NUMBER> continued agents unless strong contraindication exists hospitalized hf patients covid<NUMBER> without preexisting indication receive prophylactic doses anticoagulation <NUMBER> therapeutic considerations described central illustration underlying pulmonary disease common patients hf approximately <NUMBER> patients chronic obstructive lung disease independently increases risk hospitalization mortality <NUMBER> patients may pulmonary hypertension consequence parenchymal lung disease addition elevated left ventricular filling pressures <NUMBER> patients covid<NUMBER> hypoxemic respiratory failure ards exacerbate pulmonary vasoconstriction interstitial edema worsening pulmonary hypertension even patients without preexisting lung disease <NUMBER> patients preexisting biventricular failure elevation pulmonary pressures secondary ards worsen right ventricular function patients advanced hf including durable lvad support severely reduced functional capacity <NUMBER> <NUMBER> measured peak vo<NUMBER> impaired ability augment cardiac output response physiologic stressors factors collectively decrease cardiopulmonary reserve despite preliminary reports suggesting hydroxychloroquine azithromycin may improve agents associated qt interval prolongation increasing risk arrhythmias including torsades de pointes sudden cardiac death <NUMBER> <NUMBER> patients hf often structural electrical abnormalities leading delayed ventricular repolarization qt prolongation surface electrocardiogram ecg <NUMBER> prolonged qtc intervals independent predictors adverse outcomes patients hf <NUMBER> many patients hf may prescribed qtprolonging drugs well loop diuretics lead electrolyte abnormalities increase risk serious arrhythmias <NUMBER> additional risk factors qt interval prolongation hospitalized patients include female sex older age sepsis baseline qtc <NUMBER> milliseconds admission <NUMBER> systemic inflammation underlies acute chronic hf <NUMBER> hemodynamic stress hf stimulates release proinflammatory cytokines including tumor necrosis factor alpha interleukin<NUMBER> interleukin<NUMBER> beta <NUMBER> furthermore coexisting comorbidities obesity type <NUMBER> diabetes hypertension may perpetuate persistent inflammatory state leading multiorgan involvement endothelial dysfunction <NUMBER> inflammatory markers used determine covid<NUMBER> severity creactive protein lactate dehydrogenase ntprobnp interleukin<NUMBER> may already elevated hf including patients lvad support <NUMBER> <NUMBER> <NUMBER> therefore values obtained setting covid<NUMBER> compared prior values available despite efforts maintain social distancing community spread covid<NUMBER> increasing patients hf selfquarantine may still risk acquiring covid<NUMBER> commonly external nursing support advanced care planning critical hf patients including populations lvad support ht recipients particularly patients areas high covid<NUMBER> prevalence ideally clinicians initiate conversations patients caregivers onset hf diagnosis time emergent hospitalization patients hf develop covid<NUMBER> require hospital admission care teams involve hf specialists conversations regarding goals care including deactivation implantable cardioverterdefibrillators icds <NUMBER> patients encouraged discussions families even admission utilizing videoconferencing technology institutional visitor restrictions frequently limit bedside presence family members patients lvad support contract covid<NUMBER> risk severe viral infection due older age comorbidities immunosuppressed state suffer compromised cellular immunity evidenced aberrant tcell activation heightened susceptibility cd<NUMBER> cells spontaneous apoptosis cytokine imbalances <NUMBER> functionally immunosuppressed state increases susceptibility complications opportunistic infections <NUMBER> cases covid<NUMBER> reported patients destination therapy lvad support developed ards multiorgan failure evidence cytokine release syndrome <NUMBER> <NUMBER> cases highlighted challenges prone positioning lvad patients given concerns regarding increased right ventricular pressures right ventricular failure international society heart lung transplantation ishlt guidance suggests lvad patients proned management hypoxemic respiratory failure <NUMBER> data needed respiratory viruses shown cause rapid progression pneumonia greater disease severity prolonged viral shedding solid organ transplant recipients <NUMBER> posttransplant patients likely develop bacterial fungal superinfection due immunocompromised state <NUMBER> although antiinflammatory effects immunosuppressants may mitigate disease severity reduction cytokine production <NUMBER> <NUMBER> past experience sars mers showed clinical presentations transplant patients similar general population <NUMBER> notably mtor inhibitors associated increased susceptibility viral infections <NUMBER> <NUMBER> cases covid<NUMBER> reported ht recipients <NUMBER> table <NUMBER> given immunosuppressed states presentations may atypical high suspicion covid<NUMBER> illness maintained largest report <NUMBER> ht recipients covid<NUMBER> <NUMBER> hospitalized <NUMBER> required mechanical ventilation <NUMBER> mycophenolate mofetil discontinued <NUMBER> calcineurin inhibitors reduced <NUMBER> patients seven patients <NUMBER> died ht patients covid<NUMBER> illness transplant teams consider dose reducing calcineurin inhibitors reducing holding antimetabolites drug interactions immunosuppressants covid<NUMBER> therapeutics reviewed <NUMBER> leukopenia common patients covid<NUMBER> although typically manifest lymphopenia rather neutropenia <NUMBER> considered newly transplanted patients valganciclovir mycophenolate similar myelosuppressive effects patients develop allograft dysfunction distinguishing rejection viral myocardial involvement may difficult availability endomyocardial biopsies may restricted <NUMBER> reorganization healthcare structures spurred covid<NUMBER> pandemic significantly affected patients hf figure <NUMBER> reduce sarscov<NUMBER> transmission maintain healthy workforce health systems largely transitioned noncontact care delivery methods ambulatory care response challenges centers medicare medicaid response supplemental appropriations act early march <NUMBER> <NUMBER> waiver medicare pay telehealth services provided inpatient outpatient home settings range providers types covered services include telehealth visits audiovisual telecommunication system used virtual checkins brief checkins patient provider via telephone another device decide whether additional services needed evisits communications patients providers online portal <NUMBER> commercial payers also reimbursing telehealth however policies surrounding rates payments evolving penalties providers violations health insurance portability accountability act also waived allowing use commonly available telecommunications platforms feasibility safety telemedicine patients hf well established however use yet reliably associated reduction emergency department visits therapeutic inertia hf care ongoing risk period close monitoring electrolyte renal function critical safe dose adjustment guideline directed therapies hf reduced ejection fraction diuretics <NUMBER> however reduction available laboratory services pandemic patients hesitancy risk covid<NUMBER> exposure may limit uptitration raas antagonists addition providing standard hf care clinicians regularly inquire regarding dietary lifestyle habits related covid<NUMBER> due physical social isolation stresses changes nutritional status food availability alcohol intake physical activity social support may occur contribute worsening hf reliance remote care potential exacerbate preexisting health inequities <NUMBER> disadvantaged populations underrepresented racial ethnic groups limited access internet andor smart devices may derive benefit expansion innovations older adults comprise significant portion us population hf may educational visual auditory cognitive impairments hinder participation remote care programs incorporate social workers case managers maximize outreach atrisk populations option inperson clinic visits remain available patients without access telemedicine services highrisk patients eg patients continuous inotropes physical examination critical clinical decisionmaking aggressive risk reduction practices place visits programs may benefit establishing triage principles outpatient virtual versus inperson visits virtual visits may best utilized medication titration optimization stable patients accaha stage c hf ht recipients stable immunosuppression low risk allograft rejection hemodynamically optimized lvad patients may managed remotely inperson visits considered recently hospitalized patients patients approaching stage hf continuous inotropes undergoing evaluation advanced hf therapies newly postlvad implantationht newonset hf virtual inperson ambulatory schedules constructed accommodate routine urgent visits given uncertainty surrounding future course covid<NUMBER> telemedicine likely endure important component advanced hf disease management monitoring safety efficacy remote care hf establishing evidencebased best practices virtual visits become priority hf programs additional information regarding existing platforms workflows care models telemedicine hf provided recently published statement hfsa <NUMBER> cdc guidance risk mitigation strategies included postponement cancellation elective diagnostic therapeutic procedures <NUMBER> <NUMBER> stable patients advanced hf procedures include echocardiograms stress testing cardiopulmonary exercise testing right heart catheterizations coronary angiography implantation interrogation cardiac electronic devices among others individualized risk assessment needed classifying cases elective rationale delaying procedures reviewed patients documented medical record <NUMBER> although delay procedures may immediately affect clinical outcomes important longterm indirect implications patients hf <NUMBER> patients undergoing lvadht evaluation may experience delays listing andor surgery leading worsening nutritional functional hemodynamic status completion evaluation process highlight opportunities optimization pulmonary vascular resistance renal function weight adherence centers encouraged consider local covid<NUMBER> disease prevalence resource availability deliberating timing lvad implantation limiting implantation patients intermacs interagency registry mechanically assisted circulatory support profiles <NUMBER> reasonable approach time <NUMBER> ht patients <NUMBER> months posttransplant programs may defer routine surveillance endomyocardial biopsies stable allograft function low risk rejection immediate posttransplant period higher rejection risk decision perform surveillance biopsies weighed risk covid<NUMBER> exposure patient staff <NUMBER> covid<NUMBER> pandemic farreaching implications donor selection organ procurement organizations waitlist candidates transplant programs <NUMBER> given limitations current testing risks asymptomatic transmission infection ht community must careful select uninfected donors globally opos canada italy spain others performed universal screening deceased donors <NUMBER> recognizing false negative rates tests cases chest computed tomography may performed part donor assessment evaluate radiographic evidence covid<NUMBER> <NUMBER> negative covid<NUMBER> donors considered according ishlt guidance decisions regarding transplantation made transplanting center based covid<NUMBER> community prevalence potential risks benefits patient <NUMBER> institutions high burden covid<NUMBER> transplants reserved patients highest urgency statuses whose waitlist mortality risk supersedes risk nosocomial infection <NUMBER> beginning week march <NUMBER> transplant programs able inactivate waitlisted patients covid<NUMBER> precaution <NUMBER> weekly national regional data available united network organ sharing <NUMBER> evaluation changes transplant volumes outcomes time necessary understand implications covid<NUMBER> pandemic ht candidates recipients remains much learn pathophysiology covid<NUMBER> patients hf concurrently need robust health services research focused elucidating impacts telemedicine elective care deferral risk aversion behaviors practiced patients providers pandemic research questions others described table <NUMBER> economic upheaval caused covid<NUMBER> pandemic wideranging health consequences especially already suffer socioeconomic deprivation national burdens incident prevalent undertreated hf likely grow result new covid<NUMBER>related heart disease delays recognition treatment ischemic heart disease rising unemployment loss income health benefits large segments population <NUMBER> spite devastation covid<NUMBER> pandemic given hf community opportunities explore alternative care delivery models optimize ancillary support structures expand infrastructure home nursing palliative care hospice services covid<NUMBER> pandemic significantly impacted patients advanced hf including lvadht population care delivery systems coming months anticipated unforeseen challenges arise manage ramifications pandemic patients hf community potential contributing factors mechanisms worsening heart failure patients covid<NUMBER> include increased oxygen demand myocarditis stress cardiomyopathy ischemia infarction cytokine release syndrome elevated pulmonary pressures venous thromboembolism spike proteins sarscov<NUMBER> virus bind ace<NUMBER> receptor leading viral entry replication sarscov<NUMBER> infection adam<NUMBER> facilitates shedding ace<NUMBER> membrane leading release soluble form ace<NUMBER> soluble ace<NUMBER> may bind virus prevent binding membraneanchored ace<NUMBER> cells preventing cell entry reorganization care delivery resulted increased access telemedicine adaptations physical exam laboratory data changes procedural volume bp blood pressure crt cardiac resynchronization therapy gdmt guidelinedirected medical therapy hipaa health insurance portability accountability act jvd jugular venous distension considerations patients covid<NUMBER> develop acute heart failure well patients preexisting heart failure depicted presented typical symptoms require icu admission discharged hospital day <NUMBER> repeat pcr testing negative heartkidney recipient ards acute respiratory distress syndrome hcq hydroxychloroquine icu intensive care unit mmf mycophenolate mofetil pcr polymerase chain reaction coronavirus disease <NUMBER> presented substantial challenges patient care impacted health care delivery including cardiac electrophysiology practice throughout globe based upon undetermined course regional variability pandemic uncertainty resume deliver electrophysiology services arrhythmia patients joint document representatives heart rhythm society american heart association american college cardiology seeks provide guidance clinicians institutions reestablishing safe electrophysiological care achieve aim address regional local covid<NUMBER> disease status role viral screening serologic testing returntowork considerations exposed infected health care workers risk stratification management strategies based covid<NUMBER> disease burden institutional preparedness resumption elective procedures patient preparation communication prioritization procedures development outpatient periprocedural care pathways keywords covid<NUMBER> cardiac electrophysiology arrhythmia management abbreviations cied cardiac implantable electronic device ecg electrocardiography ep electrophysiology hcw health care workers icd implantable cardioverter defibrillator icu intensive care unit pcr polymerase chain reaction ppe personal protective equipment pui person investigation tee transesophageal echocardiography coronavirus disease <NUMBER> covid <NUMBER> presented unprecedented challenge world impacting everyday living resulting widespread international restrictions combat global pandemic restrictions travel schools businesses social gatherings including lockdowns imposed singular aim reducing spread dangerous viral illness health care services severely impacted posing challenges delivery care well preservation resources personal protective equipment ppe need limit exposure patients health care workers hcws led hospitals severely limit eliminate elective nonurgent services many hospitals meeting challenges covid<NUMBER> resulted reassignment hospital beds repurposing personnel reallocation financial resources toward care covid<NUMBER> patients order manage evolving challenges heart rhythm society american heart association american college cardiology issued guidance document aid electrophysiologists defining priorities electrophysiological procedures <NUMBER> collective efforts professional societies helped minimize patient health care professional exposure postponement elective cases careful management urgent otherwise timesensitive procedures even <NUMBER> months restrictive measures vigilant observation uncertainty remains forecasting course pandemic seen great regional variability surge volumes incidence curve flattening outcomes <NUMBER> stayathome orders lifted businesses reopen concerns remain regarding prospect secondary peaks disease incidence possibility continuation expansion existing restrictions clinical services likely global pandemic continue exert significant effects resistance pathogen developed vaccination herd immunity discovery definitive therapy degree patient outcomes adversely impacted delaying delivery usual cardiac care due resource limitations andor patient reluctance fully understood early data suggested cardiac patients presenting myocardial infarction experiencing heart failure may suffering worse outcomes due delayed presentations <NUMBER> <NUMBER> <NUMBER> many chronic diseases acute medical conditions often require nonurgent timesensitive intervention prevent becoming emergencies longterm sequelae questions remain long one delay nonurgent medical interventions prevent patients developing undesirable outcomes immediate critical needs pandemic response met least partially addressed ppe shortages improved many regions result efforts industry government even individuals manufacture masks develop methods process n<NUMBER> respirators reuse effective flattening curve sharing resources across hospital systems increased production eased concerns ventilator availability however pandemic far control access accurate testing serology remain limited <NUMBER> potentially effective antiviral drugs evaluated limited availability candidate vaccines still early stages development testing given remaining shortcomings still undetermined course pandemic uncertainty resume effectively deliver muchneeded electrophysiology ep services noncovid<NUMBER> arrhythmia patients covid<NUMBER> continue coexist present significant health care delivery challenges many patients remain fearful exposure health care settings <NUMBER> <NUMBER> creating relatively covid<NUMBER> safe clinical care continuum environment important strategy regain patient confidence enable health care institutions start providing elective cardiovascular <NUMBER> ep procedures rebooting ep many institutions may challenging shutting electrophysiologists may work services limited resources space may require hospital leadership understanding urgency ep care relates services accurate tracking modeling understanding covid<NUMBER> status well collaboration local regional state federal authorities critical health care organizations making informed decisions resumption ramping services considerations include hospital intensive care unit icu census ventilator ppe availability staffing capability areas severely affected entire hospitals converted covid<NUMBER> care units likely require longer time capacity provide care noncovid<NUMBER> nonurgent cases however may quite different regions less affected significantly lower prevalence incidence covid<NUMBER> cases general significant sustained drop local incidence observed health care organizations areas experiencing high case level increase elective medical interventions timing rollout process dictated governmental health system policies areas fortunate enough avoided high covid<NUMBER> burden assiduous attention ongoing local covid<NUMBER> incidence essential managing reboot process need respond rapidly second wave occurs accordingly resumption nonurgent ep services approached measured cautious manner contingency plans specific criteria limit stop elective cases event second wave predefined advance reopening compliance local regulations testing covid<NUMBER> infection critical tool embark safely restarting elective semielective procedures figure <NUMBER> illustrates model evolution detectable virus virusspecific immunoglobulin severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection current understanding regarding limitations tests timing results course exposure infection impacts interpretation test results shown figure <NUMBER> patient screening diagnostic testing important tools limit patient staff exposure however lack widespread access timely accurate viral testing major limitation onset pandemic <NUMBER> likely persistent variations regional availability testing greatly affecting ability identify infected individuals schedule cases prevent disease transmission clarify policies minimize risk restarting elective procedures test platforms available different advantages limitations including differences turnaround time throughput fortunately false positive rates low established viral polymerase chain reaction pcr tests <NUMBER> however sensitivity pcrbased viral testing varies among platforms significantly variable false negative rates available test kits reported may compounded sampling limitations variation presence virus different sites course disease <NUMBER> considerations may prompt repeat testing <NUMBER> evidence exposure typical symptoms clinical presentation although atypical symptom presentations well described <NUMBER> whether positive pcr test late course disease asymptomatic person represents detection noninfectious viral particles transmissible virus remains uncertain serologic antibody testing may supplement viral detection pcr available <NUMBER> remains controversial susceptible misinterpretation used make decisions related individual patient management pcr viral testing may accurate igm assessment early stages infection igg may helpful identification prior infection time figure <NUMBER> unfortunately limitations sensitivity specificity associated serologic testing compared covid<NUMBER> viral testing could result improper clinical decisions false positive serology tests uncertainties whether true seropositivity confers protection reinfection potential continued viral transmissibility could create false sense security ongoing research may clarify issues serologic testing likely continue improve time seropositivity used determine decreased standards ppe containment approaches given limitations viral antibody testing patients regardless test results treated universal precautions major concern inhibiting patients coming hospitals fear contracting covid<NUMBER> patients health care workers asymptomatic carriers potential infect patients health care staff <NUMBER> availability implementation universal testing policies patients prior procedures health care workers well universal masking sanitization hand hygiene favorably impact confidence institutions need define standardized comprehensive protocols testing including testing prior planned procedures electrophysiologists laboratory managers outpatient clinical team leaders define workflow processes preprocedure testing operational plans concordant hospital local policies many institutions testing policies extensive include multiple locations clinics procedural areas eg cardiac catheterization laboratory endoscopy suite interventional radiology suite etc offsite locations including drivethrough testing accommodations testing need based patients clinical condition geographic location inpatient versus outpatient status type urgency intervention test capability local conditions ideally viral pcr testing performed within <NUMBER> hours prior procedure whenever feasible allow sufficient time test results obtained reviewed event positive test results may change procedure planning mandatory preoperative isolation period testing procedure performance important mitigate possibility infection preoperative testing unavailable locally hospital health care system yet patients undergo nonurgent procedures alternative screening methods must established conjunction health care system local public health officials regardless availability testing organizations utilize mandatory symptom screening temperature analysis mandatory masking postoperative postprocedure covid<NUMBER> testing may need considered patients develop symptoms procedure performed atelectasis fever volume overload uncommon postoperative period establishing operational guidelines covid<NUMBER> testing patients management testing results determined transmission covid<NUMBER> exposed hcws documented since negative test preclude subsequent infection even soon testing periodic viral testing asymptomatic health care workers currently standard approach enhanced surveillance health care workers even mild symptoms fever history exposure universal masking generally adopted may reduce patient fear developing hospitalacquired covid<NUMBER> infection quarantine hcws confirmed suspected covid<NUMBER> returntowork criteria follow centers disease control prevention cdc guidelines local policy <NUMBER> active viral shedding remains possibility asymptomatic individuals positive igm andor igg serology <NUMBER> available viral testing performed help determine whether hcw true convalescence without active viral shedding institutions offer serology testing hcws may suggest exposure coronavirus whether antibodies confer immunity recurrent infection unproven ability perform elective semielective cases highly dependent covid<NUMBER> burden region regional risk categorized based severity disease burden state resource utilization projections figure <NUMBER> follows <NUMBER> high prevalence incidence <NUMBER> medium prevalence incidence <NUMBER> low prevalence incidence factors could impact whether health care systems region capacity start engaging elective procedural medical care availability ppe resources remains major consideration timing resumption semielective elective procedures adherence ppe policies according cdc local policies remains critical hcws hospital operatingprocedure rooms supply chains ppe needed aerosol airborne droplet contact precautions ideally project maintain adequate supplies covid<NUMBER>related care addition covering extra ppe needs elective procedures comprehensive hospitalwide multispecialty operational committees leadership oversee process valuable include supply chain data analytics strategic planning quality assessment infection prevention clinical expertise patients hcws need continue using ppe particularly masks community spread virus reduced threat level local federal regulations dictate important data needed inform health care system planning include following bed icu ventilator capacity procedural recovery room availability depth diagnostic laboratory services cleaning capacity housekeeping clinical areas along continuum care addressed eg clinic preoperative ep laboratories recovery areas icus ventilators transesophageal echocardiography probes cardiac implantable electronic device cied programmers etc operating room procedure schedules staffing need flexible accommodate influx cases modifications may include limiting block time assignments increase open scheduling time extending hours elective procedure scheduling repurposed rooms may need refitted appropriate equipment expand return prior capacity specific procedures need prioritize scheduling cases according urgency need hospitalization continue ideally preprocedure testing patients performed outside preoperative assessment areas facilitate appropriate preservation ppe preferably registration preand postprocedural areas ep laboratories ideally near proximity minimize exposure transport appropriate staffing reorientation redeployed staff new old processes important case scheduling escalation increasing caseload implemented gradually allow time assessment impact covid<NUMBER> positivity transmission note changes use ppe related precautions may increase procedure times adequate hcw staffing anticipated accommodate covid<NUMBER> surge second wave occur many physician practices shifted telehealth platforms communicate patients provide medical care informing patients organizational processes instituted minimizing exposure covid<NUMBER> facilitys preparedness restarting elective cases help allay patients fears coming hospital clinic facilities honest open communication infection mitigation strategies available testing options specific institutional plans help patient decide whether proceed elective procedure shared decisionmaking concerning risks benefits moving forward procedural options versus continuing noninvasive approaches critical shared decisionmaking ideally documented electronic medical records scheduling decisions complex involve provider patient also public health considerations procedure considered high medium prevalence region figure <NUMBER> elective procedure may delayed longer even patient provider usual shared decision participants would like proceed conversation completed patient agrees proceed written instruction preprocedural care notes location preanesthesiacovid<NUMBER> testing details periprocedural care helpful send patient policies may continue limit number family members accompany patient accordingly appropriate arrangements required drop pick patient avoiding areas known covid<NUMBER>positive patients timely updates patient condition procedural status facilitated dedicated patient navigator communicator readily accessible family members call written instructions routine procedural care covid<NUMBER> prevention strategies helpful suspension elective cases due covid<NUMBER> resulted accumulation deferred ep procedures ethical values used prioritize procedures need balance public health societal concerns commitment individual patient example risks postponing procedure individual fully weighed risk covid<NUMBER> spread transparency communication regarding scheduling decisions essential patient community trust covid<NUMBER>positive patients nonemergent cases delayed recovery change patients condition warrants reconsideration procedure prioritization essential contingent upon facility capacity nature deferred procedures well regional local policy restrictions emergent urgent procedures take precedence followed semiurgent timesensitive procedures followed elective procedures <NUMBER> triaging procedure categories vary geographic temporal variations covid<NUMBER> burden figure <NUMBER> ultimate decision regarding time sensitivity procedure based clinical judgment individual patient factors many tertiary referral institutions communication hospitals referring physicians availability vital ensure patients prioritized according medical need prioritizing inpatient procedures may minimize need reschedule later visits reducing exposure testing inpatient procedures require similar preprocedural covid<NUMBER> testing according local policies considerations include availability anesthesia team whose personnel may repurposed covering icus care sick covid<NUMBER> patients case type delay might impact patient outcomes long patients already waiting procedure risk given might impact bed resource needs complications result prolonged hospitalization icu stays one ensure appropriate followup assure deterioration clinical status attention local state federal orders also considered geographies may ongoing restrictions limiting scheduling elective procedures surgeries addition hospitals may require physician attestation medical necessity timesensitive procedure covid<NUMBER> successfully moved many clinical practices adopt digital telehealth platforms care pathways minimize patient exposure model though initially cumbersome proved useful means providing continued care patients similarly remote monitoring continued valuable resource patients cieds reestablishment inperson visits vary geographic temporal variation viral incidence use ppe patientfacing outpatient clinic visits continue per cdc local authority guidelines clinic areas configured comply regional social distancing directives regions high covid<NUMBER> burden inperson clinic visits may still need minimized using telehealth options majority incisionsite inspections following cied implantation catheter ablation managed via telehealth inspecting site utilizing video conference asking patient send picture via secure email often conjunction simple questions similarly many clinic followups new consults performed via telehealth leveraging electronic medical record data obtaining vital signs electrocardiography ecg tracings using digital wearables available number appbased technologies evolves continue integral part telehealth examples lowrisk patients inperson visits could deferred include asymptomatic patients satisfactory cied battery longevity primary prevention implantable cardioverter defibrillator icd patients without symptoms suggesting worsening heart failure arrhythmia burden patients antiarrhythmic drugs dofetilide require qtc laboratory monitoring may need defer testing prior values clinical condition remained stable new drugs may prolong qtc added addition remote monitoring may offer valuable supplement perhaps shortterm alternative ecg situations qtc clinical condition remained previously stable patients borderline values may need continued access ecg laboratory testing studies evaluated use mobile ecg devices qtc monitoring <NUMBER> <NUMBER> pandemic eases exceptions use less secure platforms may change practitioners advised remain date current reimbursement documentation requirements urgent semiurgent clinical indications evaluated person individualized basis might include patients worsening heart failure associated uncontrolled arrhythmia significant arrhythmia symptoms need device reprogramming icd patients recent shocks syncope cied patients recent symptoms suggesting possible device malfunction eg syncope heart failure exacerbation suspected device infection select patient populations vulnerable infants children arrhythmias may also warrant inperson evaluation possible inperson visits procedures coordinated day minimize multiple exposures patient patients presenting outpatient visits hcws masked measures taken screen concerning symptoms eg fever cough practitioners aware covid<NUMBER> may present atypical symptoms including diarrhea anorexia anosmia multisystem inflammatory disease consisting limited rash lymphadenopathy swelling hands feet mucus membrane changes seen children adolescents <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggestive symptoms fever present patients redirected appropriate screening clinic facility appropriate measures taken including testing covid<NUMBER> clinics follow local policies figure <NUMBER> depending regional stage pandemic local hospital departmental guidance may vary regions continuing concern pandemic spread order minimize exposure ep staff device manufacturer representatives patients suspected confirmed covid<NUMBER> infection prudent consider limiting inperson cied interrogations following indications • clinically actionable suspected cied abnormality • need reprogramming • evaluation potential arrhythmic symptoms alerts patients without access remote monitoring potential strategies maintain social distancing include reconfiguring waiting areas andor notifying patients time seen importantly device interrogation programmers cables wands disinfected patients plastic sleeves cover cable wand may also considered may helpful inform patients disinfecting procedures systematically performed visits current expert consensus statement gives remote monitoring class recommendation routine use patients cieds <NUMBER> based multiple studies demonstrating reduction unnecessary icd therapies mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite effectiveness prior pandemic remote monitoring significantly underutilized due variety patientand systembased issues <NUMBER> pandemic use remote monitoring even important used circumstances reduce need nonurgent clinic visits feasible remote monitoring reconsidered patients currently enrolled quality improvement programs care pathways help standardize support safe highquality highvalue patient care riskadjusted data used evaluate patient care outcomes based principles discussed example stepwise care pathway summarized follows figure <NUMBER> step <NUMBER> initial consultation intervention • appropriate covid<NUMBER> precautions followed • unnecessary exposure patient clinic hospital environment minimized carefully prioritizing problem utilizing telehealth platforms wherever necessary • patients comorbidity profile assessed event potential procedural complication remote possibility patient may acquire covid<NUMBER> infection periprocedural period • appropriate patient education provided potentially web resources thorough orientation health care environment review patients clinical situation greater transparency help patient understand risks benefits alternatives planned intervention • outpatient clinic visits universal masking social distancing may require blocking rearranging waiting exam room seating andor limiting number family members accompanying patient maximum one per local policy continue engaging family members via telehealth video options patient seeing clinician consultation way involve process step <NUMBER> preoperative period • decision intervene made prior authorization completed necessary hospitals states attestation necessity procedure covid<NUMBER> pandemic may necessary • formulation guidance previously obtained laboratory testing diagnostic imaging history physical consent utilized helpful determine whether need repeated rescheduled procedures previously deferred • avoidance elective interventions covid<NUMBER>positive patients persons investigation puis patients high comorbidity profile considered • use telehealth consolidation preoperative assessment day procedure preoperative area help minimize patient exposure significant change patients clinical status • preoperative covid<NUMBER> testing performed within <NUMBER> hours procedure feasible patients advised maintain isolation time testing planned procedure emergent procedures rapid testing feasible patients treated pui use appropriate ppe preoperative testing consolidated much feasible determining pathway followup reporting results patient procedure team important along standardized recommendations patients test positive covid<NUMBER> • limiting minimizing companions procedure facilities may still required initial limitations zero accompanying companions may able relaxed one minimal family members friends later evolution covid<NUMBER> pandemic telehealth digital platforms used communicate update patients family patient navigator excellent resource providing single point contact active discharge planning ahead time facilitate arrangements resources needed procedure step <NUMBER> intraoperative period • ppe use follow cdc hospital guidelines similar rules earlier covid<NUMBER> pandemic • procedure patient pui unless tested otherwise step <NUMBER> postoperative period • available recovery perioperative unit close ep laboratories minimize patient transport recovery within relatively covid<NUMBER> safe environment minimizing exposure patients hospital personnel involved care • possible sameday discharge considered patients need monitored overnight could potentially stay room discharged next day possible minimize contact • periodic viral pcr serologic testing may become routine health care workers periprocedure areas including housekeeping dietary staff • prohibiting minimizing family members accompanying persons recovery area reduce unnecessary exposure exceptions may considered minors adults special needs patients transported pickup area discharging staff member patient coordinator meet caretaker review discharge instructions • patient needs potential delayed complications anticipated appropriate standard care testing eg chest xrays device checks echocardiograms needed performed discharge especially sameday discharges • ppe use per guidelines step <NUMBER> postdischarge period • maintaining social distancing universal masking remain important patients • patients educated reminded importance avoiding covid<NUMBER> exposure infection recovery phase • single easy mechanism patients get touch ep care team address postprocedural concerns • incision checks device checks even postablation followup cases performed using telehealth platforms possible ep covid<NUMBER> working group representing stakeholders involved ep care continuum pathway coordinate institutional hospitallevel covid<NUMBER> leadership group may include electrophysiologist ep laboratory manager outpatient clinic manager ep nurse advanced practice providers device technician anesthesiologist imaging team provide insights various aspects workflow team clarify interpret iterate disseminate policies also provide necessary operational support plan successfully execute reboot process efforts contain covid<NUMBER> continue effective communication rest ep team extended cardiology team relevant clinical hospitalhealth care system teams essential logical methodical approach easing restrictions slowly revamping work without causing major disruptions work done care teams extremely important coordination hospital covid<NUMBER> teams developing similar pathways would synergistic regularly scheduled appraisals process adjustments made fit needs facility care teams decisions data driven transparency data sharing teams encouraged teams patients benefit collective experiences establishing institutional programs assess successes failures consistent progress occurs advantageous institutional teams take lead understanding implementing regulatory body policies new information testing changes ppe guidance patient waitlists insurance prior authorization issues implementation periodic timely communications patients keeping abreast ground situation covid<NUMBER> region pandemic far stayathome orders lifted people emerge social isolation fail practice masking social distancing humantohuman spread may surge could second even recurring waves covid<NUMBER> pandemic health care teams hospitals must continue prepared preserve adequate resources contingencies appropriate planning dealing second wave mandatory component elective reboot plan learn create relatively covid<NUMBER> safe zones within hospitals help isolate patients second waves yet able provide regular care noncovid<NUMBER> patients covid<NUMBER> presented health care systems across globe novel challenges ep professionals need determine minimize ravages living covid<NUMBER> ensuring provide exemplary care arrhythmia patients across agegroups document tried provide ep clinicians institutional administrators series guiding suggestions principles move forward start reboot provide necessary heart rhythm care patients understandably appropriately delayed main goal health care professionals whether serve clinical teaching research administrative role everything create safe environment patients receive excellent care deserve american college cardiology electrophysiology council contributed development endorses document figure <NUMBER> representative model illustrating presence viral rna igm igg human body time infection sarscov<NUMBER> understanding particularly important using polymerase chain reaction pcr serologic testing tools identify whether individual actively infected convalescence watershed time period test results interpreted care differences polymerase chain reaction pcr serologic testing well features limitations need understood prior using incorporating reboot testing workflow ppe personal protective equipment type procedures restarted see figure <NUMBER> figure <NUMBER> stepwise approach creating care continuum ep reboot ppe personal protective equipment • emphasize patient need maintain appropriate social distancing masking • maximize telehealth postdischarge care wound care device checks groin care monitor postop complications update workflow based testing availability national regional institutional guidelines coronavirus disease <NUMBER> pandemic profoundly affected health livelihood millions people worldwide unprecedented scale speed date definitive treatments specifically targeted sarscov<NUMBER> infection covid<NUMBER> therapy prevention moreover development effective vaccines new therapies curing timeconsuming likely well future thus repurposing existing approved drugs mitigate severity covid<NUMBER> viewed costeffective timesensitive strategy statins firstline lipidlowering therapies welltolerated side effects low cost broadly available worldwide including developing countries potent antiinflammatory immunomodulatory effects statins suggest could beneficial counter coronoviral infections including sars cov<NUMBER> castiglione et al <NUMBER> dashtikhavidaki khalili <NUMBER> fedson et al <NUMBER> indeed observational studies randomized controlled trials rcts demonstrated significant protective effect statins improving proinflammatory cytokine release immune cell functions among individuals viral bacterial pneumonia fedson <NUMBER> papazian et al <NUMBER> pertzov et al <NUMBER> sapey et al <NUMBER> recent report based molecular docking analysis showed statins might inhibit sarscov<NUMBER> entry host cells directly binding main protease coronavirus reiner et al <NUMBER> data led speculation regarding potential therapeutic benefits statins treatment covid<NUMBER> arabi et al <NUMBER> bifulco gazzerro <NUMBER> however concerns raised regarding whether individuals statins greater risk sarscov<NUMBER> infection covid<NUMBER> exacerbation class drugs shown increase expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor virus lab animals hoffmann et al <NUMBER> shin et al <NUMBER> tikoo et al <NUMBER> wang et al <NUMBER>b thus direct clinical evidence urgently needed answer question whether statin use detrimental beneficial hospitalized individuals covid<NUMBER> clinical setting statins often prescribed along reninangiotensinaldosterone system raas blockers particular angiotensinconverting enzyme ace inhibitors angiotensin ii receptor blockers arbs subjects hypertension cardiac pathologies ray et al <NUMBER> remarkably clinical applications ace inhibitors arbs covid<NUMBER> also share similar dilemma statins treatment regarding perceived contraindications increasing ace<NUMBER> expression versus antiinflammation cardioprotection south et al <NUMBER> recent <NUMBER> research shown individuals covid<NUMBER> ace inhibitors arbs lower risk <NUMBER>day allcause mortality treated ace inhibitors arbs aceiarb zhang et al <NUMBER>a moreover combination therapy statins arbs showed encouraging results improving survival ebolainfected individuals fedson et al <NUMBER> however effects combination treatment individuals covid<NUMBER> studied address important clinical questions conducted one largest retrospective cohort studies date one involving <NUMBER> clinically confirmed cases covid<NUMBER> determine association inhospital use statins clinical outcomes subgroup analysis investigated additional effects combining aceiarb statins clinical outcomes covid<NUMBER> timevarying cox model marginal structure model msm propensity scorematching analysis consistently showed lower risk allcause mortality covid<NUMBER> individuals statin use versus statin nonuse total <NUMBER> cases confirmed covid<NUMBER> admitted <NUMBER> hospitals hubei province china included analysis among <NUMBER> inhospital use statins statin group remaining <NUMBER> statin treatment nonstatin group figure <NUMBER> participants received statin treatment older <NUMBER> versus <NUMBER> years age p <NUMBER> higher prevalence chronic medical conditions including hypertension <NUMBER> versus <NUMBER> p <NUMBER> diabetes mellitus dm <NUMBER> versus <NUMBER> p <NUMBER> coronary heart disease <NUMBER> versus <NUMBER> p <NUMBER> cerebrovascular diseases <NUMBER> versus <NUMBER> p <NUMBER> chronic kidney diseases <NUMBER> versus <NUMBER> p <NUMBER> without statin treatment table <NUMBER> chest ct revealed bilateral pulmonary lesions common statin group compared nonstatin group <NUMBER> versus <NUMBER> p <NUMBER> table <NUMBER> larger proportions subjects statin group showed increased neutrophil counts procalcitonin levels ddimer compared nonstatin group table <NUMBER> addition inflammatory markers abnormal serum biochemistry including increased alt ast levels decreased estimated glomerular filtration rate egfr indicated prevalent organ impairments participants statin therapy compared nonstatin use table <NUMBER> frequencies individuals increased lowdensity lipoprotein cholesterol ldlc total cholesterol tc levels higher among statin group versus nonstatin group admission terms whole hospitalization period lipid profiles comparable two groups figure s<NUMBER> days onset symptom hospitalization median followup days longer individuals statin treatment compared nonstatin group table <NUMBER> absolute values median interquartile range iqr laboratory examination shown table s<NUMBER> laboratory values including creactive protein crp procalcitonin ddimer ldlc tc creatine kinase ck different reference ranges hospitals listed table s<NUMBER> subjects enrolled propensity score matching model psm conducted minimize differences baseline characteristics <NUMBER> participants statin group matched <NUMBER> ratio <NUMBER> participants nonstatin group baseline characteristics comparable two groups except proportion individuals spo<NUMBER> <NUMBER> lower statin group nonstatin group table s<NUMBER> lipid profiles also comparable hospitalization statin nonstatin groups psm figure s<NUMBER> among participants statin therapy <NUMBER> <NUMBER> hypertension participants hypertension <NUMBER> also treated ace inhibitors arbs regimen statinaceiarb group antihypertensive management <NUMBER> nonaceiarb antihypertensive drugs statinnonaceiarb group antihypertensive therapy figure <NUMBER> age gender distribution comparable two groups systolic blood pressure sbp levels prevalence dm higher prevalence copd lower individuals statinaceiarb compared combination statin types antihypertensive drugs table s<NUMBER> absolute values median iqr laboratory examination shown table s<NUMBER> psm <NUMBER> individuals statinaceiarb group matched <NUMBER> ratio <NUMBER> individuals statinnonaceiarb group baseline characteristics comparable two groups table s<NUMBER> s<NUMBER> among subjects received statin treatment atorvastatin frequently prescribed accounting <NUMBER> statins users followed rosuvastatin <NUMBER> statin users statin treatment started day hospital admission doses difference among statins converted equivalent dose atorvastatin table s<NUMBER> therapeutic duration individuals statin group <NUMBER> <NUMBER> days atorvastatin equivalent dose <NUMBER> <NUMBER> mg per day table <NUMBER> <NUMBER> individuals also treated aceiarb statin group compared <NUMBER> nonstatin group table <NUMBER> psm cohort percentage individuals aceiarb treatment comparable statin nonstatin groups table <NUMBER> distributions different brands statins therapeutic duration daily equivalent dose statin comparable individuals statinaceiarb group versus statinnonaceiarb group table s<NUMBER> median iqr day starting aceiarb treatment <NUMBER> <NUMBER> days admission median iqr therapeutic duration <NUMBER> <NUMBER> days table s<NUMBER> psm cohort median iqr aceiarb starting time <NUMBER> <NUMBER> days admission median iqr therapeutic duration <NUMBER> <NUMBER> days table s<NUMBER> incidence rate death <NUMBER>day followup <NUMBER> cases per <NUMBER> persondays statin group versus <NUMBER> per <NUMBER> persondays nonstatin group psm cohort crude incidence death statin group ir <NUMBER> cases per <NUMBER> persondays death rate <NUMBER> markedly lower nonstatin group ir <NUMBER> per <NUMBER> persondays death rate <NUMBER> due severe symptoms comorbidities subjects statin group matched nonstatin group severe baseline symptoms higher proportions cardiovascular metabolic comorbidities unmatched nonstatin group might account increased death rate statin nonusers propensity matching using mixedeffects cox model without accounting timevarying exposures psm cohorts statin treatment also associated decreased incidence death ahr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> table <NUMBER> figure <NUMBER> adjust potential bias competing medical issuescaused delayed start discontinued use statin therapy performed analysis using marginal structural model analysis individuals without statin treatment model use statins maintained associated lower <NUMBER>day mortality ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> individuals use statins table <NUMBER> sensitivity test excluded individuals admitted icu died within <NUMBER> hours admission performed analyses resting individuals similar results observed cox model timevarying exposure ahr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> msm analysis ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> mixedeffects cox model psm population ahr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> table s<NUMBER> also conducted evalue analysis found point estimate primary endpoint <NUMBER> mixed cox model since value larger strong confounders unlikely unmeasured confounders would overcome conclusion regarding statin use associated increased <NUMBER>day allcause mortality among individuals covid<NUMBER> recent retrospective report including <NUMBER> covid<NUMBER> cases indicated statin intake significantly associated asymptomatic status covid<NUMBER> unadjusted <NUMBER>anton de spiegeleer <NUMBER> previous observational studies metaanalyses shown statin treatment may associated reduced morbidity mortality individuals sepsisassociated ards mansur et al <NUMBER> however large rcts individuals ards shown neither atorvastatin simvastatin provided significant benefit overall mortality mcauley et al <NUMBER> national heart lung blood institute ards clinical trials network et al <NUMBER> papazian et al <NUMBER> discrepancy results observational rcts studies may due differences heterogeneity study populations plausible selection bias measuredunmeasured confounders observation studies analyses rcts data shown existence subphenotypes ards differential response statin treatment calfee et al <NUMBER> sinha et al <NUMBER> instance simvastatin associated improved survival hyperinflammatory rather hypoinflammatory subgroups atorvastatin therapy acute phase associated improved survival patients sepsis improved <NUMBER>day mortality pretreatment kruger et al <NUMBER> findings support efforts examine effect statins targeted subphenotypes individuals pursue approach stratify patients clinical trials minimize potential bias study conducted various models sensitivity tests evaluate reliability study results individual accessibility medical resources survivor treatment selection bias glesby hoover <NUMBER> competing medical issues redelmeier et al <NUMBER> three potential causes bias observational studies treatment efficacy study individuals received statins earlier initiation medical therapy hospital admission statin nonusers <NUMBER> days statin group versus <NUMBER> days nonstatin group implying unlikely imbalanced access health systemrelated lower risk covid<NUMBER> mortality statin group addition covid<NUMBER>associated medical expenses covered chinese government pandemic largely reduced impact socioeconomic level inhospital treatment regarding potential bias survivor treatment selection performed coxmodel timevarying exposure adjust potential bias caused differences initial time treatment meanwhile calculated average hospitalization period individuals discharged statin nonstatin groups similar <NUMBER> days versus <NUMBER> days indicating unlikely prolonged benefit hospital treatment statin group competing medical issues clinicians likely arrange urgent therapy critically ill patients versus less critically ill could lead bias resulting association using statins poor outcomes therefore conducted msm analysis adjusting timevarying confounders simultaneously influences time statin initiation risk mortality cox models without timevarying exposure msm analysis also performed patient populations excluding admitted icu died within <NUMBER> hours admission despite extensive efforts utilize multiple models rigorous controls still could possible biases impact magnitude statin useassociated benefits allcause mortality among individuals covid<NUMBER> thus calling need validations conclusions via rct studies encouragingly several rct studies started nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> looking forward release results among subjects hypertension incidence <NUMBER>day mortality <NUMBER> cases per <NUMBER> persondays versus <NUMBER> per <NUMBER> persondays statinaceiarb group statinnonaceiarb group respectively irr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> using cox model statin aceiarb timevarying exposures significant association aceiarb therapy <NUMBER>day mortality individuals hypertension statin treatment ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> although mixedeffect cox model psm cohorts showed aceiarb therapy treatment associated decreased incidence death ahr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> table <NUMBER> significant association appear marginal structure model ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> sensitivity test excluded participants admitted icu died within <NUMBER> hours admission performed analyses described resting subjects similar results found using cox model timevarying exposure msm analysis mixedeffects cox model psm population table s<NUMBER> results indicated using aceiarb conferred neither additive beneficial detrimental effects combination statin treatment <NUMBER>day mortality among subjects preexisting hypertension although use ace inhibitor arb speculated potentially harmful patients covid<NUMBER> fang et al <NUMBER> numerous observational studies shown either protective neutral effect mortality mancia et al <NUMBER> zhang et al <NUMBER>b definitive results rcts forthcoming several professional societies recommended continuation use ace inhibitors arbs patients covid<NUMBER> preexisting hypertension esc <NUMBER> ish <NUMBER> knowledge results study first clinical evidence supports notion risk covid<NUMBER> mortality increased using ace inhibitors arb combination statin treatment individuals covid<NUMBER> terms secondary endpoints covid<NUMBER> analyzed association statin use incidences invasive mechanical ventilation icu admission ards septic shock acute liver injury acute kidney injury acute cardiac injury adjusted baseline differences cox model analysis showed statin usage associated lower prevalence using mechanical ventilation ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> icu admission ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> ards ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> individuals covid<NUMBER> table s<NUMBER> matching baseline differences two groups psm statin group still showed lower incidence invasive mechanical ventilation compared nonstatin group ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> statin therapy significantly associated secondary outcomes eg acute kidney injury liver injury cardiac injury increased serum ck transaminase levels psm cohort table <NUMBER> among individuals covid<NUMBER> preexisting hypertension significant associations observed secondary outcomes statins without ace inhibitors arbs treatment unmatched subjects table s<NUMBER> matching baseline characteristics associations statinaceiarb treatment lower incidences ards ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> cardiac injury ahr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared statinnonaceiarb group shown mixedeffect cox model table <NUMBER> significant associations cotreatment statin aceiarb secondary outcomes raised serum ck transaminase levels table <NUMBER> given putative antiinflammatory immunomodulatory effects statins castiglione et al <NUMBER> dashtikhavidaki khalili <NUMBER> fedson et al <NUMBER> explored changes inflammatory markers statin users covid<NUMBER> dynamic changes inflammatory factors individuals covid<NUMBER> without statin treatment <NUMBER>day hospitalization fitted using locallyweighted regression smoothing scatterplots lowess model circulating crp interleukin <NUMBER> il<NUMBER> neutrophil counts three inflammation biomarkers selected represent overall status inflammation nathan <NUMBER> vasileva badawi <NUMBER> wang et al <NUMBER>a subjects matched baseline differences dynamic trajectories crp showed downward trend admission groups lower levels among statin users whole inhospital duration figure <NUMBER>a il<NUMBER> statin group showed lower level admission less increase nonstatin group entire duration followup figure <NUMBER>b meanwhile dynamic curve neutrophil counts level showed significant downward trend statin groups nonstatin group hospitalization figure <NUMBER>c furthermore eliminate artifacts due censoring death analysis also conducted participants alive tendencies similar individuals died <NUMBER>day followup excluded group figure <NUMBER>df dynamic trajectories circulating crp il<NUMBER> neutrophil counts also determined statin users statin nonusers psm found show similar patterns psm analysis figure s<NUMBER> individuals statins older greater incidence chronic diseases table <NUMBER> benefits statins suppressing circulating proinflammatory markers less remarkable matched cohort comparable baseline characteristics overwhelming inflammation response pathological hallmark covid<NUMBER>associated phenomena ards contributes extrapulmonary organ damage tay et al <NUMBER> statins reduce inflammation progression lung injury experimental models fan et al <NUMBER> mechanistic studies shown statins suppress tlr<NUMBER>myd<NUMBER>nfκb signaling cause immune response shift antiinflammatory status gallelli et al <NUMBER> yuan et al <NUMBER> recent evidence shown statins pleiotropic effects nlrp<NUMBER> inflammasome activation cytokine releases numerous disease conditions henriksbo et al <NUMBER> satoh et al <NUMBER> xu et al <NUMBER> metabolic dysfunction factors oxidized ldl advanced glycation endproduct promote nlrp<NUMBER> inflammasome activation magnify inflammatory responses pathogen infection duewell et al <NUMBER> sheedy et al <NUMBER> response may underlie patients metabolic disorder prone severe complications covid<NUMBER> potential benefit statin nlrp<NUMBER> inflammasome might also associated improved outcomes setting covid<NUMBER> clinical data date inconclusive impact statins inflammatory mediators mcauley et al <NUMBER> national heart lung blood institute ards clinical trials network et al <NUMBER> earlier studies reported bacterial infections acute lung injury inflammation mediators eg tnfα il<NUMBER> crp significantly lower either circulation bronchoalveolar lavage among subjects simvastatin however due selfcontrol comparison study design limited sample size results need interpreted caution craig et al <NUMBER> novack et al <NUMBER> rct conducted among patients icu treated atorvastatin found plasma level il<NUMBER> significantly affected atorvastatin therapy kruger et al <NUMBER> another study designed explore formation neutrophil extracellular traps nets representing responsiveness neutrophils bacterial infection showed simvastatin treatment patients pneumonia resulted altered formation study four days simvastatin adjuvant therapy associated improvements systemic neutrophil function ie netosis chemotaxis sapey et al <NUMBER> different results studies may result diverse disease conditions among different trials heterogeneity target populations thus address concerns regarding true effect statins inflammatory diseases rcts appropriate patient stratification required use statins hospitalized subjects covid<NUMBER> associated lower risk allcause mortality favorable recovery profile due nature retrospective studies results interpreted caution however data provide supportive evidence safety statin combination statin aceiarb treatment patients covid<NUMBER> rcts prospectively explore efficacy statins covid<NUMBER> outcomes urgently needed study several limitations firstly inherent limitation retrospective study makes impossible infer causality association use statins aceiarb ameliorated severity mortality covid<NUMBER> secondly even used multiple statistical models adjust potential bias performed sensitivity analysis show overall unmeasured confounders unlikely undermine main conclusion unforeseen confounders eg prehospital medication socioeconomic status may still potentially alter magnitude statin effects allcause mortality covid<NUMBER> thirdly marginal structural models require availability timevarying data day surrounding initiation statin exposure data timevarying confounders day fully available imputation days missing data would also lead uncertain bias conclusion however participants started statin treatment early phase admission thus would minimize impact imputation fourthly bmi statin nonstatin groups comparable thus adjusted following statistical analysis moreover due urgent status covid<NUMBER> pandemic bmi always measured relatively high missing proportion might lead uncertainty impact bmi associations statins use lower risk allcause mortality fifthly role different types statins covid<NUMBER> outcomes fully analyzed since majority cases taking atorvastatin rosuvastatin number individuals taking types statins relatively small sixthly study population included hospitalized subjects extrapolation conclusions general population covid<NUMBER>related complications nonhospital setting requires caution gs xm qx ppl lr edited manuscript provided valuable suggestions study design data analysis jx yw jc jg hli contributed equally designed project edited manuscript supervised study authors approved final version paper authors declare competing interests schematic overview illustrating participant enrollment exclusion inclusion criteria <NUMBER> participants without medical history hypertension hypertension taking antihypertensive medication excluded subgroup analyses adjusted hr calculated based mixedeffect cox model adjustment age gender spo<NUMBER> admission <NUMBER> confidence intervals represented shaded regions table graph indicated accumulated numbers risk death discharge loss followup indicated time point number atrisk defined total number individuals subtracting number death number loss followup participants loss followup group still hospital meet criteria <NUMBER>days followup end study followup day information requests resources reagents directed lead contact hongliang li lihlwhueducn study generate new reagents materials data codes related findings study available corresponding author publication upon reasonable request research team provide email address communication data approved shared others proposal detailed aims statistical plan informationmaterials may required guarantee rationality requirement security data patientlevel data without names identifiers shared review approval submitted proposal related requested materials retrospective multicentered study conducted <NUMBER> hospitals hubei province china total <NUMBER> participants diagnosed covid<NUMBER> following interim guidance new coronavirus pneumonia prevention control program <NUMBER>th edition published national health commission china included national health commission china <NUMBER> world health organization <NUMBER> participants admitted december <NUMBER> th <NUMBER> april <NUMBER> th <NUMBER> final date follow april <NUMBER> th <NUMBER> study protocols approved central ethics committee accepted approved collaborating hospital patient informed consent waived ethics committee among original participants covid<NUMBER> participants incomplete electronic medical records aged less <NUMBER> <NUMBER> years pregnancy severe medical conditions including acute lethal organ injury ie acute coronary syndrome acute stroke severe acute pancreatitis excluded individuals preexisting hypothyroidism fellstrom et al <NUMBER> national heart lung blood institute ards clinical trials network et al <NUMBER> contraindications statins use including presented serum levels ck aminotransferase five times upper limit normal uln admission also excluded fellstrom et al <NUMBER> national heart lung blood institute ards clinical trials network et al <NUMBER> avoid confounding effects nonstatin lipidlowering drugs participants taking statin combined lipidlowering drugs taking nonstatin lipidlowering agents excluded number participants enrolled study hospitals listed table s<NUMBER> explore whether using aceiarb brings additional benefit individuals hypertension taking statins subjects without hypertension taking antihypertensive medicine hospitalization excluded flowchart patient inclusion illustrated figure <NUMBER> demographic clinical characteristics vital sign laboratory tests radiological reports therapeutic interventions outcome data extracted electronic medical records using standardized data collection described previous reports lei et al <NUMBER> zhang et al <NUMBER>a zhu et al <NUMBER> laboratory data included routine blood test serum biochemical markers reflecting liver injury kidney injury cardiac injury lipid profile il<NUMBER> crp procalcitonin ddimer collected hospitalization inhospital medication life support intervention included classification drugs dosage course treatment using mechanical ventilation also extracted medical records data carefully reviewed confirmed experienced physician team doublechecked guarantee accuracy primary endpoint defined <NUMBER>day allcause death secondary endpoints occurrence ards septic shock acute liver injury acute kidney injury acute cardiac injury invasive mechanical ventilation intensive care unit admission ards septic shock defined according interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected acute kidney injury diagnosed elevation serum creatinine level ≥<NUMBER>ummoll within <NUMBER> hours khwaja <NUMBER> acute cardiac injury defined serum level cardiac troponin ctnit ulnhuang et al <NUMBER> yancy et al <NUMBER> acute liver injury defined using serum alt alkaline phosphatase <NUMBER> folds uln marrone et al <NUMBER> adverse effect statin determined ck increase uln alt increase <NUMBER>folds uln followup national heart lung blood institute ards clinical trials network et al <NUMBER> test association inhospital statin therapy mortality three statistical models applied one approach cox proportional hazards regression model propensity scorematching baseline characteristics without considering immortal time bias timevarying confounders second approach cox proportional hazards regression model accounting timevarying exposure adjusted baseline differences accounts immortal time bias statin statin aceiarb therapy timevarying exposure third approach marginal structural model adjusts baseline differences accounts indication bias examining impact timevarying confounders daily risk prescription statin aceiarb immortal time bias using statin statin aceiarb therapy timevarying exposure minimize baseline differences statin nonstatin groups performed propensity scorematched analysis psm baseline matching variables included age gender preexisting comorbidities copd dm hypertension coronary heart disease cerebrovascular disease chronic liver disease chronic kidney disease indicators disease severity organ injuries neutrophil counts increase lymphocyte counts decrease crp level increase alt increase creatine kinase ck increase egfr <NUMBER> mlmin<NUMBER>m <NUMBER> ldlc increase cholesterol increase use aceiarb residual imbalance spo<NUMBER> statin nonstatin group adjusted cox regression model match differences individuals statin combined aceiarb treatment statin combined types antihypertensive treatment matched variables including age gender blood pressure sbp dbp preexisting comorbidities copd dm coronary heart disease cerebrovascular disease chronic liver disease chronic kidney disease indicators disease severity organ injuries neutrophil counts increase lymphocyte counts decrease crp level increase alt increase creatine kinase ck increase egfr decrease ldlc increase cholesterol increase numbers antihypertensive drugs spo<NUMBER> preexisting coronary heart disease crp increase ldlc increase ddimer increase remaining imbalanced variables psm adjusted cox regression model used nonparametric missing value imputation based missforest procedure r account missing data laboratory variables increased crp ldlc egfr alt ck bun ddimer cholesterol well decreased lymphocyte counts waljee et al <NUMBER> random forest model using remaining variables data set performed predict missing values chest ct lesions decreased spo<NUMBER> internally crossvalidated errors also estimated statin users nonusers paired according propensity scores using exact matching caliper size <NUMBER> balance covariates evaluated estimating standardized differences matching small absolute value less <NUMBER> considered qualified balancing two groups mixed cox analysis statin versus nonstatin group ratio paired <NUMBER> subgroup analysis ratio paired <NUMBER> statinaceiarb versus statinnonaceiarb group caliper size subgroup cohort <NUMBER> according propensity scores risk primary secondary endpoints corresponding hazard ratio hr calculated using cox proportional hazard model comparing statin group versus nonstatin group statinnonaceiarb group versus statinnonaceiarb group cox analysis individuals discharged treated <NUMBER>at risk censored data two major reasons first individuals covid<NUMBER> would discharged symptoms significantly relieved continuous viral pcr negative two times second individuals discharged hospitals another <NUMBER>week quarantine death occurred would documented thus discharged individuals unlikely die due covid<NUMBER> survival information still available discharge regression adjustment applied remove postpsm residual confounding bias included covariates standardized difference greater <NUMBER> multivariable adjusted residual imbalances including age gender spo<NUMBER> performed analyzing association statin treatment clinical outcomes preexisting coronary heart disease crp ldlc ddimer adjusted analyzing association aceiarb treatment clinical outcomes subjects statin treatment modeled site random effect mixedeffect cox model proportional hazard assumptions verified using correlation testing based schoenfeld residuals examine endpoints time mortality statin nonstatin group performed cox proportional hazards model adjusting age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebral arterial disease chronic kidney disease indicators disease severity organ injuries lesions chest ct neutrophil counts increase procalcitonin increase ddimer increase alt increase ast increase creatinine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization covariates statin therapy timevarying exposure analyzing association statin combined without aceiarb mortality accounting timevarying exposure adjusted age gender preexisting comorbidities copd dm sbp medications admission using invasive mechanical ventilation support covariates statin aceiarb therapy timevarying exposures changes patient conditions influenced initiation termination statin therapy combined treatment statin aceiarb performed marginal structural model msm analysis inverse probability treatment weighting iptw account timevarying confounders analyzing association statin use mortality participants covid<NUMBER> timevarying confounders factors influence statin therapy initiation correlated risk mortality analysis curb<NUMBER> pneumonia severity score including confusion blood urea nitrogen respiratory rate sbp age table s<NUMBER> serum alt levels ck levels considered timevarying confounders reflected patient conditions might impact clinical decision initiating statin therapy baseline characteristic including age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebrovascular disease chronic kidney disease indicators disease severity organ injuries lesions lung ct neutrophil counts increase procalcitonin increase ddimer increase creatine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization adjusted model alt level ck level crub<NUMBER> score days missing values imputed lastobservationcarriedforward approach linear mixedeffects model imputation alt ck levels standardized dividing upper limit reference value corresponding institution analyzing association aceiarb use mortality statin treated patients timevarying confounders factors could influence aceiarb therapy initiation correlated risk mortality analysis curb<NUMBER> pneumonia severity score serum creatinine alt levels considered timevarying confounders reflected patient conditions could impact clinical decision initiating aceiiarb therapy imbalanced baseline characteristics including gender preexisting copd dm medication admission use mechanical ventilation number antihypertensive drugs adjusted model curb<NUMBER> score assessed every day hospitalization serum creatinine level alt level curb<NUMBER> score days imputed lastobservationcarriedforward approach treatment selection weights calculated evaluate probability patient receive statin therapy specific time k weights updated first day statin therapy kept constant afterward censoring weights calculated early patient dropout finally stabilized weights calculated multiplying treatment selection weights censoring weights timevarying intercept modeled smoothing function time using restricted cubic splines generalized additive model performed estimate effect statin use results age gender adjusted marginal structural cox proportional hazards model performed incorporating stabilized weights estimate effect statin therapy clinical outcomes side effects modeled probability receiving statin therapy assumption patient started statin therapy patient remain treatment evalue analysis conducted assess robustness association statin use allcause mortality cox models address potential unmeasured confounding effect using methodology vanderweele ding haneuse et al <NUMBER> mathur et al <NUMBER> vanderweele ding <NUMBER> evalue alternative approach sensitivity analyses unmeasured confounding studies avoids making assumptions turn require subjective assignment inputs formulas critically ill patients admission less likely receive statin treatment bias could lead association using statins poor outcomes performed sensitivity analysis using cox models without timevarying exposure marginal structural model patient population including admitted icu died within <NUMBER> hours admission longitudinal covariates baseline confounders also adjusted full cohort variables used matching propensityscore matched analysis adjusting cox analysis admission account missing data laboratory variables used nonparametric missing value imputation based missforest procedure r waljee et al <NUMBER> random forest model based rest variables data set constructed predict missing values estimation internally crossvalidated errors continuous variables nonnormal distributions expressed median iqr categorical variables expressed number percentage comparisons groups performed mannwhitney u test nonparametric variables fishers exact test χ<NUMBER> test categorical variables persontime data incidence two groups different exposures may expressed difference incidence rates ratio incidence rates irrs irrs endpoint outcomes calculated estimate incidence difference absolute change incidence two comparison groups cumulative rates death compared using kaplanmeier curves dynamic changes inflammatory factors tracking day <NUMBER> day <NUMBER> admission depicted using lowess model twoside α less <NUMBER> considered define statistical significance data analyzed r<NUMBER> r foundation statistical computing vienna austria spss statistics version <NUMBER> ibm armonk ny usa <NUMBER> sbp systolic blood pressure dbp diastolic blood pressure bmi body mass index copd chronic obstructive pulmonary disease alt alanine transaminase ast aspartate transaminase egfr estimated glomerular filtration rate ldlc low density lipoprotein cholesterol tc total cholesterol ck creatine kinase spo<NUMBER> oxygen saturation iqr interquartile range upper limit normal uln defined according criteria hospital b p values calculated mannwhitney u test nonnormally distributed continuous variables fishers exact test χ<NUMBER> test categorical variables <NUMBER> <NUMBER> <NUMBER> h <NUMBER> ir<NUMBER> personday incidence rate irr incidence rate ratio ahr adjusted hazard ratio ci confidence interval acei angiotensinconverting enzyme inhibitor arb angiotensin ii receptor blocker <NUMBER> <NUMBER> participants unmatched statin nonstatin groups respectively psm <NUMBER> ratio <NUMBER> <NUMBER> participants matched statin nonstatin groups respectively b <NUMBER> <NUMBER> participants unmatched statinaceiarb statinnonaceiarb groups respectively psm <NUMBER> ratio <NUMBER> <NUMBER> participants matched statin nonstatin groups respectively c adjusted age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebrovascular disease chronic kidney disease indicators disease severity organ injuries lesions chest ct neutrophil counts increase procalcitonin increase ddimer increase alt increase ast increase creatinine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization adjusted age gender blood pressure sbp preexisting comorbidities copd dm medications admission using invasive mechanical ventilation support covariates statin aceiarb therapy timevarying exposures e curb<NUMBER> pneumonia severity score serum alt levels ck levels considered timevarying confounders additionally adjustment factors included age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebrovascular disease chronic kidney disease indicators disease severity organ injuries lesions chest ct neutrophil counts increase procalcitonin increase ddimer increase ast increase creatinine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization f curb<NUMBER> pneumonia severity score serum alt levels creatinine levels considered timevarying confounders additionally adjustment factors included age gender preexisting copd medication admission use mechanical ventilation number antihypertensive drugs g ahr calculated based mixedeffect cox model adjustment age gender spo<NUMBER> admission h ahr calculated based mixedeffect cox model adjustment age gender coronary heart disease incidence increased crp ddimer ldlc admission p values calculated r package fmsb significant probability result nullhypothesis testing ir<NUMBER> persondays incidence rate irr incidence rate ratio ahr adjusted hazard ratio ci confidence interval icu intensive care unit ards acute respiratory distress syndrome ck creatine kinase alt alanine transaminase uln upper limit normal adjusted hr calculated based mixedeffect cox model adjustment age gender spo<NUMBER> admission b adjusted hr calculated based mixedeffect cox model adjustment age gender coronary heart disease incidence increased crp ddimer ldlc admission c p values calculated r package fmsb significant probability result nullhypothesis testing figure <NUMBER> timedays adjusted hr zhang et al retrospectively analyzed <NUMBER> covid<NUMBER> cases found inhospital statin use associated lower risk allcause mortality zhang et al table s<NUMBER> absolute values laboratory indicators admission statin nonstatin groups psm table s<NUMBER> reference range laboratory indicators study hospitals table s<NUMBER> characteristics patients statin nonstatin groups psm table s<NUMBER> characteristics patients statinaceiarb statinnonaceiarb groups table s<NUMBER> absolute values laboratory indicators admission statinaceiarb statinnonaceiarb groups psm leukocyte count medianiqr <NUMBER>l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> neutrophil count medianiqr <NUMBER>l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphocyte count medianiqr <NUMBER>l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> creactive protein medianiqr mgl <NUMBER> <NUMBER> <NUMBER> leukocyte count medianiqr <NUMBER>l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> neutrophil count medianiqr <NUMBER>l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphocyte count medianiqr <NUMBER>l <NUMBER> <NUMBER> ahr adjusted hazard ratio ci confidence interval acei angiotensinconverting enzyme inhibitor arb angiotensin ii receptor blocker adjusted age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebrovascular disease chronic renal disease indicators disease severity organ injuries lesions chest ct wbc increase neutrophil counts increase procalcitonin increase ddimer increase alt increase ast increase creatinine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization support covariates statin therapy timevarying exposures b adjusted age gender blood pressure sbp preexisting comorbidities copd dm medications admission using invasive mechanical ventilation numbers antihypertensive drugs support covariates statin aceiarb therapy timevarying exposures c curb<NUMBER> pneumonia severity score serum alt levels ck levels considered timevarying confounders additionally adjustment factors included gender blood pressure sbp dbp preexisting comorbidities dm coronary heart disease cerebrovascular disease chronic renal disease indicators disease severity organ injuries lesions chest ct wbc increase neutrophil counts increase procalcitonin increase ddimer increase ast increase creatinine increase spo<NUMBER> ldlc increase cholesterol increase medications admission using invasive mechanical ventilation support days symptom onset hospitalization curb<NUMBER> pneumonia severity score serum alt levels creatinine levels considered statin therapy timevarying confounders additionally adjustment factors included gender preexisting copd dm medication admission use mechanical ventilation number antihypertensive drugs e ahr calculated based mixedeffect cox model adjustment age gender blood pressure sbp dbp preexisting comorbidities dm hypertension coronary heart disease cerebrovascular disease chronic renal disease indicators disease severity organ injuries lesions chest ct incidence increased wbc neutrophil counts alt ast procalcitonin ddimer spo<NUMBER> decreased egfr ldlc increase cholesterol increase f ahr calculated based mixedeffect cox model adjustment age gender blood pressure sbp preexisting copd dm harris county medical society hcms houston academy medicine ham named dr richard allen williams winner john p mcgovern compleat physician award ceremony january <NUMBER> <NUMBER> dr williams first african american recipient award <NUMBER> john p mcgovern compleat physician award annual national award named first recipient john p mcgovern recognizes physician embodies ideals sir william oslermedical excellence humane ethical care commitment medical humanities writing research harmony academic medical practitioner dr williams commitment excellence demonstrated continued contributions field cardiology excelling clinician <NUMBER> years medical practice <NUMBER> lot discussion african americans acknowledged achievements true black community among foreigners international medical graduates women minority groups historically difference cardiovascular disease cvd burden among racialethnic groups usa one every four deaths usa caused cvd words one person dies every <NUMBER> <NUMBER> <NUMBER> <NUMBER> african americans died heart disease <NUMBER> male <NUMBER> female <NUMBER> heart disease <NUMBER> leading cause death men ages races origins <NUMBER> heart disease <NUMBER> also leading cause death women races origins <NUMBER> best predictors cvd age gender dyslipidemia hypertension diabetes risk factors strongly influenced lifestyle dietary behaviors physical inactivity smoking adiposity although genetic variation plays role susceptibility cannot account solely difference racial ethnic health disparities <NUMBER> laymans terms hypertension high blood pressure increases risk heart disease stroke causing permanent damage heart even without symptoms <NUMBER> unfortunately hypertension prevalent develops younger age african americans whites hispanics <NUMBER> furthermore african americans likely diabetes nonhispanic whites <NUMBER> <NUMBER> <NUMBER> american population covered medicaid <NUMBER> meanwhile <NUMBER> african americans supported medicaid compared <NUMBER> hispanics <NUMBER> whites <NUMBER> usa spent <NUMBER> billion <NUMBER> <NUMBER> heart disease alone includes cost healthcare services medicines lost productivity due death <NUMBER> dr williams founded association black cardiologists abc <NUMBER> address inequities cardiovascular care blacks whites served abc president <NUMBER> years <NUMBER> set form organization fact blacks misunderstood whites medicine dr williams said essay wrote <NUMBER>th reunion harvard class <NUMBER> essay revealed articles peerreviewed medical journals stating black patients experience chest pain whites blacks lack intellectual capacity perceive pain <NUMBER> dr williams started abc along <NUMBER> dedicated medical professionals since inception abcs membership grown <NUMBER> carrying forward abc <NUMBER> mission bring special attention adverse impact cardiovascular disease african americans close healthcare disparity gap years policy makers looked abc leading authority issues impact practice access cardiovascular care populations <NUMBER> abc members published <NUMBER> studies oped articlesbetween <NUMBER> presenton treatment black patients <NUMBER> one study achieving health equity normalizing cardiac care pegus et al compared rates percutaneous transluminal coronary angioplasty ptca acute myocardial infarction ami intermediate coronary syndrome ics rates transcatheter aortic valve replacement aortic stenosis white population versus black population covered equivalent insurance blacks similar prevalence rates ami ics experience lower rates ptca <NUMBER> compared whites study found black patients receive fewer evidencedbased cardiac procedural care white patients authors concluded normalizing procedure rates african american community match disease prevalence require education participation patients providers insurers advocacy organizations study stressed importance identifying factors contribute health disparities recommended application sciencebased care one solution help normalize procedure rates decrease disparities providing cardiovascular registries link health insurance claims electronic medical record emr data provide transparent information treatment cost various racial ethnic groups enhance treatment communication recommendation improve consistency appropriate cardiovascular procedures among patient groups <NUMBER> research suggests minority patients likely follow healthcare recommendations provided healthcare workers race mind abc aims improve diversity health workforce via support federal legislative efforts health equity accountability act <NUMBER> <NUMBER> dr williams believes importance diversity considerations healthcare nonbiased treatment people communities dissimilar status great deal poor underserved communities made african americans representing disenfranchised population receive good healthcare result poor quality care cardiology african americans worsened morbidity disease could face early mortality death <NUMBER> abcs mission eliminate cardiovascular disparities education research advocacy website httpwwwabcpatientcom offers free digital health guides <NUMBER> steps healthy heart acute coronary syndrome stroke heart attack prevention cooking heart soul featuring recipes good heart available purchase stock <NUMBER>min video eat church food watch video details unhealthy foods sedentary lifestyles contribute obesity diabetes fuel heart disease numbers <NUMBER> let us discuss racial disparities pain assessment treatment question black persons skin thicker white persons skin perfect world free bias would reply perception treatment pain blacks whites equal real world past present rarity <NUMBER> study conducted hoffman et al demonstrates beliefs held laymen exposure medical training medical students residents biological differences blacks whites contribute racial disparities pain assessment treatment false beliefs dating back time slavery idea blacks feel less pain whites continue held many folks today consequence inaccurate pain assessment inadequate pain treatment african americans study first provide evidence racial bias pain perception associated racial bias pain treatment recommendations <NUMBER> sadly racial disparities apparent midst covid<NUMBER> pandemic novel coronavirus infecting killing people world april <NUMBER> <NUMBER> total <NUMBER> deaths <NUMBER> cases covid<NUMBER> usa according centers disease control prevention cdc <NUMBER> coronavirus discriminate said physicians healthcare workers front lines article published april <NUMBER> <NUMBER> npr website reported african americans symptoms cough fever less likely tested coronavirus citing biotech data firm rubix life sciences reviews recent billing information several states especially detrimental african americans racial minority group higher rates certain diseases diabetes high blood pressure kidney disease delay possible diagnosis treatment covid<NUMBER> harmful puts greater risk death chronic illnesses lead severe cases covid<NUMBER> top hypertension coronary artery disease heart failure myocardial injury risk factors associated worse outcomes <NUMBER> dr james hildreth president meharry medical college infectious disease specialist shared observations npr said witnessed overt bias among healthcare workers distribution testing sites shows disparity access medical care long persisted <NUMBER> definition healthcare disparity simply defined difference health outcomes based race ethnicity rather circumferences attributable variables lead disproportionate access care social determinants health relevant current pandemic include limited job social mobility working frontline jobs lack adequate protective equipment living crowded housing eating food desserts without healthy foods uninsured relying public transportation <NUMBER> widening health status gap largely determined race clyde w yancy md article covid<NUMBER> african americans referenced johns hopkins university american community survey showed <NUMBER> predominant black counties usa infection rate <NUMBER> death rate <NUMBER> indicated infection rate threefold higher death rate sixfold higher predominantly white counties <NUMBER> example new york black people comprise <NUMBER> covid<NUMBER> deaths despite representing <NUMBER> population white people accounted <NUMBER> deaths although represent <NUMBER> population <NUMBER> know effective strategy reduce covid<NUMBER> infection social distancing selfquarantine able maintain socialphysical distancing become issue privilege much african american community resides poor areas simply inability practice social distancing <NUMBER> patient choice responsibility play essential role well patients minority communities present late selfreferral due distrust health beliefs disease fatalism <NUMBER> forms inequality injustice health care inhumane martin luther king jr important comprehensively researched book american health dilemma medical history african americans problem race beginnings <NUMBER> explores origin history medicine relation intellectual scientific racism suffered african americans starts time slave trade traces evolution racial attitudes healthcare practices civil war jim crow laws present day authors w michael byrd md linda clayton md physicians senior research scientists harvard school public health also present current statistics racial disparities american healthcare preface extensive documented history healthcare blacks historically african american physicians given recognition deserve quality work racial disparity theme dr williams acceptance speech john p mcgovern award ceremony understood significance first black physician receive award indicates progress areas diversity inclusion equity sign change better would made sir william osler father modern medicine proud dr williams one superstars medicine league two trailblazing cardiovascular surgeons dr michael debakey dr denton cooley <NUMBER> dr debakey pioneer coronary bypass operations <NUMBER> dr cooley performed first successful human heart transplant usa <NUMBER> give rewards honors people deserving based race gender culture age education john p mcgovern physician award loses value dr williams said speech award ceremony also knew value building strong effective relationships throughout healthcare community rahn dr bailey mentee dr williams decade think mentor mentee automatically think older wiser person helping younger person kickstart career dr williams valued concept mentorship tried help everyone matter age race gender focus always justice equity healthcare delivery <NUMBER> despite many accomplishments dr williams refuses rest laurels wants address cultural divide race ethnicity healthcare want something get rid focus calling names think get accomplished way solidarity unity working together long people aims stated august <NUMBER> <NUMBER> issue cardiology magazine <NUMBER> racism whether conscious unconscious pervasive society since days slavery feel responsible health care disparities suffer says extremely difficult erase disparities specific intent part government citizens case <NUMBER> data andor code availability applicable section conflict interest authors declare conflict interest ethics approval applicable section consent participate applicable section consent publish applicable section first covid<NUMBER> case greece recorded february <NUMBER> health system organized ready covid<NUMBER> fast possible greece italy neighboring countries lot information italy dont underestimate virus stay home learn us kept shouting <NUMBER> social distancing would countrys answer pandemic greece schools closed <NUMBER> th march <NUMBER> days first confirmed covid<NUMBER> case restaurants bars the<NUMBER> th march shops <NUMBER> th march general lockdown established <NUMBER> nd march less month first case recorded travel ban implemented inside greece exceptions dedicated covid<NUMBER> hospitals appointed around greece since early march since beginning outbreak greece suspicion covid<NUMBER> infection high every case considered possible covid<NUMBER> case march <NUMBER> private clinics nonurgent surgery cancelled days later regular clinics cancelled personnel emergency departments wards educated familiarized new status procedures needed infrastructure personnel also need personal protective equipment ppe healthcare workers cardiologists familiar type crisis still scared us families colleagues patients <NUMBER> enough ppe testing needed adequately trained cope new unknown situation impact coronavirus heart <NUMBER> biomarkers measure <NUMBER> supposed perform diagnostic therapeutic procedures <NUMBER> <NUMBER> heart failure medication changed <NUMBER> following heart failure patients situation prolonged calls take care echo covid<NUMBER> patients safe studied studied safety procedures proper management covid<NUMBER> patients learned bought time curve wasnt steep greece tired time take care establish communication via telemedicine regular patients course scared often presented acute conditions patients decompensated heart failure <NUMBER> arrhythmias clinics cancelled needed establish soon possible ways communication patients spontaneous wave compassion solidarity order keep patients safe away dangerous hospitals since march <NUMBER> possible prescribe remotely telemedicine safe solution heart failure patients patients coming hospitals blood tests absolutely necessary need hospitalization heart failure patients admissions reduced <NUMBER> greece fear facetoface medical care may result people urgent health problems remain home rather call help additionally enhanced communication cardiologists nurses could reason well intense adherence medical treatment healthier way accepted article living weapon covid<NUMBER> unknown enemy family support also robust crises major congresses cancelled travelling social media became way communication teleconferences substituted part major educational events scientific meetings april <NUMBER> <NUMBER> could say greeks flattened curve thanks timely government measures indicated experts infectious diseases strict timely social distancing course thanks healthcare workers completely strange situations managing heroism covid<NUMBER> non covid<NUMBER> patients end lockdown may <NUMBER> <NUMBER> greece one lowest rates morbidity mortality due covid<NUMBER> europe learnt lot important able communicate collaborate depth colleagues patients different forms communication may work scientific world never covid<NUMBER> pandemic solidarity healthcare professionals popped spontaneously importantly learned though social distancing imposes hardships save many millions lives date greece didnt ignore lessons italy proactive management covid<NUMBER> pandemic impressive result <NUMBER> th april <NUMBER> deaths per million people figure <NUMBER> around <NUMBER> confirmed covid<NUMBER> cases despite minimum morbidity mortality impact society economy healthcare services delivery immense look carefully towards future wayout social distancing total lockdown done gradually carefully socialeconomic crisis follow pandemic expected impact health services well community already psychologically affected concerning heart failure patients questions arising going see decompensated patients pandemic even later period telemedicine going broadly implemented post covid<NUMBER> era help digital health gadgets finally combination adequate communication followup new lifesaving medical treatments could reduce hospitalizations heart failure patients definitely need implementing new technologies ways communication <NUMBER> <NUMBER> became familiar well reestablishment face face patientdoctor relationship always going valuable article protected copyright rights reserved patients underlying cardiovascular disease cvd higher risk contracting coronavirus disease <NUMBER> covid <NUMBER> worse outcomes infection <NUMBER> <NUMBER> cardiac complications covid<NUMBER> include myopericarditis malignant arrhythmias biventricular heart failure <NUMBER> largest case series date <NUMBER> covid<NUMBER> patients china case fatality rate significantly higher preexisting cvd <NUMBER> vs <NUMBER> patients severe cases covid<NUMBER> frequently experience acute myocardial injury evidenced elevated troponin levels strongly associated clinical deterioration<NUMBER> increased mortality <NUMBER> patients myocardial injury prognosis particularly poor prior history cvd <NUMBER> across nations studies also consistently demonstrated significantly higher case fatality rates older persons <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> may reflect increased prevalence comorbid conditions well agerelated declines tcell bcell function <NUMBER> current literature yet include specific descriptions impact covid<NUMBER> patients structural heart disease shd reasonable extrapolate patients high risk adverse outcomes based advanced age numerous comorbidities absence analytic outcomes data guide evidencebased decisionmaking realitybased considerations necessary surrogates formulating clinical pathways context global pandemic focus crisisdriven recommendations <NUMBER> ensure appropriate sensitive timely treatment shd patients <NUMBER> minimize risk covid<NUMBER> exposure patients healthcare workers <NUMBER> limit resource utilization conditions constraint draw heavily early experiences highvolume heart team large academic medical center new york city currently global epicenter covid<NUMBER> degree disruption usual practice vary across regions united states elsewhere owing differences population density rates community spread time peak disease burden resource availability hope early experiences center may prove useful others adapting practice preparation local covid<NUMBER> surges widespread community transmission covid<NUMBER> throughout united states overarching goal minimize risk covid<NUMBER> exposure preserve limited resources anesthesia care ventilators intensive care unit icu beds personal protective equipment ppe early march <NUMBER> covid<NUMBER> infection rates rapidly increasing ny accordance guidelines issued hospital administration elective procedures surgeries cancelled nonurgent outpatient visits discouraged patients scheduled valve clinic visits next two months contacted offered two options either keeping original appointment converting telemedicine encounter postponing future date becomes safer inperson visit clearly selfselection bias patients greater symptoms generally agreed earlier telemedicine visit less symptomatic stable patients tended prefer delayed inperson visit conducting comprehensive new patient evaluation shd remotely laborintensive presents challenges elderly patients may lack sophisticated knowledge technology access device streaming video camera family members friends would otherwise assist setting devices navigating unfamiliar applications isolated elderly patients longer relied upon provide onsite technical support integrated team therefore necessary facilitate telemedicine multiple interactions patient needed prior scheduled visit physician streamline actual encounter office staff must obtain images recent prior echocardiogram guide patients process downloading registering telemedicine application preferred application institution mychart since provides secure hipaacompliant interface compatible epic electronic medical record platform physician assistant obtains detailed medical history reconciles medications sets expectations patients understand advance elective procedures currently postponed hour prior telemedicine visit medical assistant calls ensure patient logged application quiet appropriate space instances unstable internet connection technical limitations prevent patient successfully using mychart used facetime web conferencing applications zoom facilitate video encounter video encounter offers distinct advantages phone call alone enables subjective assessments frailty dyspnea limited evaluation volume status albeit imperfect web camera pointed patients legs convey severity peripheral edema else fails phone call substituted video visit still allow degree patient assessment acknowledged coverage medicare similarly coverage subsequent brief patientinitiated telephone online communications healthcare provider termed virtual checkins <NUMBER> ability deliver remote services facilitated decision centers medicare medicaid services cms effective march <NUMBER> <NUMBER> temporarily expand medicare coverage telemedicine using wider range communication tools including smartphones enabling beneficiaries receive many health services without incurring risks leaving homes ability convert nearly evaluation heart team telemedicine encounter enhanced temporary cms waiver statespecific licensing requirements allowing physicians see patients residing neighboring states <NUMBER> addition health human services office civil rights waived penalties providers acting good faith perform telemedicine visits using broadly available technologies like facetime hipaacompliant vast majority patientphysician interactions covid<NUMBER> pandemic transition remote interface clear communication critical ensure patients continue receive highquality cardiac care patients must given specific instructions selfmonitor symptoms home call clinic consider emergency department evaluation expectations conveyed regarding frequency followup medical team anticipated timeframe eventual structural intervention given fluidity changing dynamics current crisis cases may need postponed multiple times several months frequent transparent communication give patients confidence care neglected event heart team members reassigned new roles staffing covid<NUMBER> units become sick contingency plans coverage outpatient responsibilities assured intervention unlikely directly impact clinical care outcomes next two three months considered elective postponed includes procedures left atrial appendage occlusion closure atrial septal defects patent foramen ovales unlikely impact short term morbidity mortality similarly interventions tricuspid regurgitation currently possible part clinical trial investigations generally deferred unless local covid<NUMBER> burden low resources constrained rationale deferring elective procedures discussed patients documented medical record contrast patients imminent risk mortality threat irreversible clinical consequences eg permanent organ system dysfunction likelihood rapidly worsening symptoms could provoke hospitalization intervention deemed emergent urgent based acuity severity risk figure <NUMBER> emergent cases inpatients worsening hemodynamic compromise impending multiorgan failure require intervention within hours one two days examples would cases severe aortic stenosis cardiogenic shock requiring inotropes vasopressors severe mitral regurgitation mr refractory heart failure requiring intraaortic balloon pump examples urgent cases highest risk strata tier <NUMBER> would include inpatients cannot safely discharged without procedure patient admitted refractory heart failure outpatient high risk decompensation next two weeks patient recurrent syncope tier <NUMBER> patients treated hospitalization within one week whereas urgent patients lower risk tier <NUMBER> elective cases tier <NUMBER> triaged treatment subsequent months outlined outpatients triaged based previous heart valve clinic visit telemedicine center procedures originally scheduled next two months cancelled affected patients subsequently categorized reprioritized according criteria given limitations telemedicine every new outpatient currently receives followup call within one two weeks initial encounter ensure stable prior scheduling future checkins according tier risk tier <NUMBER> patients receive weekly biweekly checkin calls whereas tier <NUMBER> patients receive checkin calls every one two months tier <NUMBER> patients followed according existing guidelines possible priority still given minimizing risk exposure covid<NUMBER> resource consumption instance serial echocardiography patients asymptomatic severe performed less frequently every <NUMBER> months patient remains asymptomatic maintenance close communication patients critical ensure ongoing delivery optimal cardiac care report one hong kong hospital found significantly longer time symptom onset first medical contact patients presenting stsegment elevation myocardial infarction stemi late january midfebruary <NUMBER> possibly reflecting patients fear exposure covid<NUMBER> hospital <NUMBER> imperative heart teams educate patients referring physicians provide clear guidance request phone consultations urgent inperson evaluations minimize avoidable morbidity mortality due delayed care clearly dynamic situation patients clinical deterioration recategorized reprioritized appropriate covid<NUMBER> hospital admissions continue increase demand access medical treatment anticipated outstrip existing resources across united states context pandemic ethically permissible limit access procedures requiring disproportionate resource utilization hindering ability mount effective response pandemic <NUMBER> ensure fair consistent application limited access prospective guidelines fair allocation resources developed based upon maximizing number lives saved utilitarianism rewarding instrumental value social usefulness prioritizing worst <NUMBER> <NUMBER> context current covid<NUMBER> pandemic members heart team must determine patients unlikely derive sufficient benefit urgent procedure warrant diversion scarce resources including anesthesia services icu beds ventilators ppe propose patients less likely achieve meaningful improvement health status including advanced age especially associated frailty dementia deferred structural heart procedures additionally elderly patients severe hemodynamic compromise threatened multiorgan failure generally undergo salvage procedures making challenging decisions programs weigh patients severity presentation indicated tier expected benefit likelihood uncomplicated procedure degree resource limitation central illustration similarly surgical procedures including valve repair replacement avoided whenever possible general lowrisk patients severe would normally considered good candidates surgery instead considered tavr provided anatomy reasonable especially regions hospitals facing imminent surges icu occupancy weighing whether move forward even urgent structural heart intervention preference given patients straightforward anatomy whose procedures performed low reasonable risk complications minimal resource utilization example tavr candidates would include cases safely performed conscious sedation low risk vascular access complications need permanent pacemaker high probability sameday nextday hospital discharge home mitraclip cases generally avoided except emergent tier <NUMBER> cases due increased risks procedure team associated intubation transesophageal echocardiography balloon aortic valvuloplasty bav considered temporizing bridging procedure select patients severe particularly unfavorable iliofemoral arterial access suboptimal aortic valvular complex anatomy impaired renal function hindering ability obtain tavr cta however even careful planning cannot guarantee absence complications particularly elderly frail patients thus higherrisk comorbid patients considered bav good candidates tavr also considered palliative care decision made move forward structural procedure preprocedural testing streamlined minimize number interactions healthcare personnel echocardiograms performed within past six months generally sufficient coronary angiograms necessary performed time intervention preprocedural testing essential tavr computed tomographic angiography cta performed within past years enables assessment vascular access aortic valve anatomy overall procedural risk turn guides decision move forward procedure possible preprocedural testing performed outpatient settings lower risk patient exposure covid<NUMBER> guiding principles structural interventions similar recently proposed treatment patients acute coronary syndromes <NUMBER> patients undergo clinical screening expedited testing covid<NUMBER> minimize risk exposure covid<NUMBER> conserve ppe treatment team limited essential personnel include trainees agree recommendations acc interventional council scai scrub procedures ppe suitable airborne precautions including n<NUMBER> respirator face shield given risk emergent intubation need cardiopulmonary resuscitation <NUMBER> patients unstable deteriorating respiratory conditions intubated prior transfer minimize risk intubation ccl use highflow nasal cannula noninvasive positive pressure ventilation avoided associated increased generation infectious aerosols tavr performed modified minimalist approach including use conscious sedation avoidance transesophageal echocardiography specific plans minimize length stay hospital <NUMBER> <NUMBER> every effort undertaken ensure safe expedited recovery discharge home figure <NUMBER> <NUMBER>yearold woman multiple comorbidities recent hospitalization decompensated heart failure referred urgent evaluation symptomatic severe sievers type <NUMBER> bicuspid aortic valve preserved left ventricular function history type <NUMBER> diabetes mellitus coronary artery disease recently treated percutaneous coronary intervention chronic obstructive pulmonary disease presented local hospital acute pulmonary edema requiring emergent intubation aggressive diuresis discharged within <NUMBER> days soon afterward developed recurrent syncopal episodes importantly testing covid<NUMBER> negative given progressive symptoms failure medical management consensus qualified tier <NUMBER> candidate tavr consideration direct hospital transfer however due severe constraints icu availability risk exposure covid<NUMBER> expedited outpatient treatment preferred normal circumstances given young age bicuspid anatomy would considered surgical valve replacement however anatomy also reasonable tavr avoid increased risk covid<NUMBER> exposure inpatient admission well utilization icu bed heart valve team agreed proceed tavr preferred alternative plan sameday discharge patient underwent transfemoral tavr conscious sedation successful implantation <NUMBER> mm evolut pro plus valve developed printerval prolongation new left bundle branch block valve deployment current recommendations monitor patients <NUMBER> hours least overnight temporary transvenous pacemaker place <NUMBER> anticipation possible scenario however preemptive discussions electrophysiology colleagues ensure availability immediate implantation permanent pacemaker ccl avoid icu admission permanent dualchamber pacemaker implanted immediately plan reassess patient three months explant device found require significant pacing discharged home day procedure care family currently well without complications one week postprocedure though typical costeffective treatment strategy felt appropriate current pandemic environment balancing needs patient overall needs general population case illustrates several ways covid<NUMBER> pandemic necessitates deviation usual practice provision care patients shd first initial decision avoid inpatient transfer driven need thoughtful resource allocation time scarcity second decision offer tavr rather surgery heavily influenced need reserve icu capacity critically ill covid<NUMBER> patients minimize patients risk nosocomial infection third decision preemptively implant permanent pacemaker rather wait usual time monitoring arose aforementioned priorities decision reflected endeavor provide optimal cardiac care context global health crisis regional variations resource availability timing covid<NUMBER> surges determine extent programs need limit resource utilization care noncovid<NUMBER> patients shd severity covid<NUMBER> pandemic begins lessen gradual release strain healthcare system allowing staged return normalcy though flattening curve prevent hospitals overwhelmed pandemic likely long tail adjustments usual practice necessary well foreseeable future vaccine becomes widely available remain priority conduct outpatient services preprocedural testing structural heart procedures following general principles social distancing utilization adequate ppe minimize risk covid<NUMBER> transmission outpatients undergo evaluation categorized according framework delineated figure <NUMBER> maintained constantly evolving list reflecting order cases performed healthcare system recovers continual reassessment tier <NUMBER> cases ensure highrisk candidates intervention worsening point procedural risk becomes excessive opportunity derive meaningful benefit lost goal intervene tier <NUMBER> patients earliest reasonable time continuing minimize risk exposure covid<NUMBER> exercise responsible stewardship limited resources sameday nextday discharge without icu occupancy prioritized whenever possible possible patients admitted area lowest concentration covid<NUMBER> patients instances may necessitate moving patients hospital offsite facility dedicated noncovid<NUMBER> patients regions without heavy burden covid<NUMBER> present time reasonable continue performing tier <NUMBER> tier <NUMBER> cases long resulting prolonged hospital stays consuming disproportionate resources figure <NUMBER> figure <NUMBER> burden covid<NUMBER> healthcare system lightens increasing numbers postponed cases able performed programs need find creative ways alleviate backlog elective patients requiring procedures addition structural cases also backlog coronary endovascular cases compete limited time catheterization laboratory also also backlog elective surgical cases competing icu resources many programs expanded treatment hours including weekend schedules become necessary handle increased case numbers given significant geographical differences covid<NUMBER> burden subsequent resource restrictions patients means may advised travel programs less stressed healthcare environments important component maintaining strong relationships patients referring physicians period great uncertainty frequent transparent communication sensitivity patient needs preferences midst overwhelming crisis difficult chart path normalcy future though remains unclear current pandemic come end heart teams across country must prepared shift gears back best term comorbidity refers coexistence multiple diseases disorders relation primary disease disorder individual <NUMBER> comorbidity relationship two diseases exists whenever appear simultaneously patient chance alone <NUMBER> represents cooccurrence diseases presence httpwwwbiomedcentralcom<NUMBER> <NUMBER> chronic obstructive pulmonary disease copd <NUMBER> <NUMBER> obesity <NUMBER> mental disorders <NUMBER> immunerelated diseases <NUMBER> cancer <NUMBER> etc comorbidity attributed disease connections molecular level dysregulated genes ppis proteinprotein interactions metabolic pathways potential causes comorbidity <NUMBER> <NUMBER> <NUMBER> <NUMBER> genetic perspective pair diseases connected associated dysregulated genes <NUMBER> <NUMBER> whereas proteomics perspective phenotypically similar diseases related via biological modules ppis molecular pathways <NUMBER> <NUMBER> populationbased disease association important conjunction molecular genetic data uncover molecular origins diseases disease comorbidities patient medical records contain important clarification regarding cooccurrences diseases affecting patient <NUMBER> last years several researchers conducted disease comorbidity analysis understand origins many diseases <NUMBER> <NUMBER> <NUMBER> goh cusick valle childs vidal barabasi et al feldman rzhetsky vitkup et al built networks genedisease associations connecting diseases associated genes <NUMBER> <NUMBER> whereas lee park kay christakis oltvai barabási et al constructed network two diseases linked metabolic reactions associated <NUMBER> disease association studies proteomic point view studied rual venkatesan hao hirozanekishikawa dricot li berriz gibbons dreze ayiviguedehoussou et al stelzl worm lalowski haenig brembeck goehler stroedicke zenkner schoenherr koeppen et al <NUMBER> <NUMBER> rzhetsky wajngurt park zheng et al inferred comorbidity links <NUMBER> disorders disease history <NUMBER> million patients <NUMBER> however efforts focused role single molecular phenotypic measure capture diseasedisease relationships work used diseasegene associations ppis molecular pathways clinical information obtain statistically significant associations comorbidity risks among diseases inflammation hallmark many serious human infectious diseases associated wide variety infections hiv<NUMBER> <NUMBER> uk doctor max pemberton says id rather hiv diabetes life expectancy among diabetes patients lower hiv <NUMBER> however hiv comorbidity impact diabetes also flu cause complications including bacterial pneumonia worsening chronic health problems asthma common comorbidity patients hospitalized swine influenza h<NUMBER>n<NUMBER> infection <NUMBER> dengue cause myocardial impairment arrhythmias occasionally fulminant myocarditis <NUMBER> chronic medical conditions heart disease lung disease diabetes renal disease rheumatologic disease dementia stroke risk factors influenza complications <NUMBER> common chronic infections periodontitis infection helicobacter pylori may also increase stroke risk <NUMBER> moreover severity pneumonia patients coinfected influenza virus bacteria significantly higher infected bacteria alone incidence flu higher children younger adults older individuals influenzaassociated morbidity mortality increase age especially individuals underlying medical conditions chronic cardiovascular diseases <NUMBER> ageing process immune system becomes compromised causes increasing inflammation <NUMBER> particular chronic inflammation inflammageing metabolic function strongly affected ageing process <NUMBER> ageing populations leading unprecedented increase different diseases like cancer fatalities reported <NUMBER> elderly population three chronic conditions <NUMBER> hand respiratory viruses emerging threat global health security led worldwide epidemics substantial morbidity mortality <NUMBER> coronaviruses covs cause respiratory enteric diseases human animals induce fatal respiratory gastrointestinal neurological disease severe acute respiratory syndrome sars epidemic human disease caused coronavirus cov called sarsassociated coronavirus sarscov <NUMBER> sars patients may present spectrum disease severity ranging flulike symptoms viral pneumonia acute respiratory distress syndrome death <NUMBER> deaths attributed complications related sepsis ards multiorgan failure occurred commonly elderly comorbidities <NUMBER> age comorbidity eg diabetes mellitus heart disease consistently found significant independent predictors various adverse outcomes sars <NUMBER> children sars better prognosis adults <NUMBER> advanced age comorbidities significantly associated increased risk sarscov related death due acute respiratory distress syndrome <NUMBER> mild degree anaemia common sars infected patients patients recovered sars show symptoms psychological trauma <NUMBER> another novel coronavirus merscov new threat public health similar clinical characteristics sarscov comorbidity key aspect underline different impacts <NUMBER> <NUMBER> merscov causes respiratory infections varying severity sometimes fatal infections humans including kidney failure severe acute pneumonia <NUMBER> despite sharing clinical similarities sars eg fever httpwwwbiomedcentralcom<NUMBER> cough incubation period also important differences rapid progression respiratory failure studied comorbidities point view infection human immunodeficiency virus<NUMBER> hiv resulting acquired immune deficiency syndrome aids affects cellular immune regulation <NUMBER> hiv infection severely impacts immune system causing phenotypic changes peripheral cells dysregulates innate immune system <NUMBER> significant number hiv<NUMBER> infected patients exhibits osteopenia osteoporosis leading higher incidence develop weak fragile bones course disease <NUMBER> hiv also associated increased risk developing diabetes cardiovascular disease <NUMBER> infection hiv weakens immune system reduces bodys ability fight infections may lead cancer <NUMBER> <NUMBER> people infected human immunodeficiency virus hiv higher risk types cancer kaposi sarcoma nonhodgkin lymphoma cervical cancer anal liver lung cancer hodgkin lymphoma uninfected people <NUMBER> many people infected hiv also infected viruses cause certain cancers <NUMBER> <NUMBER> hiv infection even controlled highly active antiretroviral therapy haart linked chronic inflammation <NUMBER> people hiv<NUMBER> infection appear markedly higher rate chronic kidney disease general public <NUMBER> risk factors associated hiv<NUMBER> acquisition lead kidney disease virus therapies eg haart therapy antiretroviral therapy hiv may increase risk developing metabolic syndrome abdominal obesity hyperglycaemia dyslipidaemia hypertension thus predispose type <NUMBER> diabetes cardiovascular disease many biologic factors thought causally associated inflammation hiv disease also thought causally associated inflammation ageing <NUMBER> infections acute chronic conditions often associated comorbidity increases risk medical conditions lead morbidity mortality comorbidities related flu recently investigated <NUMBER> comorbidities tuberculosis also studied recently <NUMBER> <NUMBER> understand overall mechanism studied comorbidity associations sars hiv infections hiv sars emerging infectious diseases modern world diseases caused global societal economic impact related unexpected illnesses deaths <NUMBER> sras significant public health threat hiv long term chronic infection since two infections associated high mortality rates clinically approved antiviral treatments vaccines available either infections selected two infections study centred sars hiv<NUMBER> infections investigated highly heterogeneous disease comorbidity networks using diseasegene associations ppi subnetwork molecular pathways clinical information presented systematic quantitative approach discover human disease comorbidities using different sources available mrna expression proteinprotein interactions signalling pathways diseasegene associations diseasedisease associations diseasedrug associations data shown sars coronavirus infects replicates wide variety host cells susceptible animals human beings <NUMBER> <NUMBER> understand host response pathogen analysed gene expression patterns sars infected patients compared normal subjects using oligonucleotide microarrays ncbi geo httpwww ncbinlmnihgovgeoqueryacccgiaccgse<NUMBER> <NUMBER> analysed microarray gene expression data <NUMBER> genes pbmcs <NUMBER> sars patients compared healthy control samples found <NUMBER> genes p <NUMBER> <NUMBER> fold change differentially expressed compared healthy controls <NUMBER> genes significantly regulated <NUMBER> genes significantly regulated see additional file <NUMBER> table s<NUMBER> hand monocytes key immune responsive cells whose function adversely impacted hiv<NUMBER> hiv<NUMBER> infection radically alters monocyte phenotype reflected hiv<NUMBER> induced gene expression analysis monocyte gene expression microarray data collected control hiv patients ncbi geo httpwwwncbinlmnihgovgeoquery acccgiaccgse<NUMBER> <NUMBER> find significant dysregulated genes hiv<NUMBER> infection performed global gene expression analysis found <NUMBER> genes p <NUMBER> <NUMBER> fold change differentially expressed compared healthy controls <NUMBER> genes regulated <NUMBER> genes regulated see additional file <NUMBER> table s<NUMBER> considering significantly dysregulated genes sars <NUMBER> genes hiv<NUMBER> <NUMBER> genes infections genedisease associations information constructed two genedisease associations networks gdn used explore shared genetic associations disease comorbidity starting bipartite graph generated biologically relevant network projections constructed multirelational genedisease network nodes diseases genes edges indicate association gene disease bipartite httpwwwbiomedcentralcom<NUMBER> graph consists two disjoint sets nodes one set corresponds known genetic disorders set corresponds identified significant genes sars hiv<NUMBER> infections list disorders disease genes associations obtained online mendelian inheritance man omim <NUMBER> compendium human disease genes phenotypes see details methods section classified disorder one <NUMBER> disorder categories based physiological system affected introduced goh cusick valle childs vidal barabasi et al <NUMBER> gdn nodes represent diseases class genes two disorders connected share least one gene mutations associated diseases groups figures <NUMBER> <NUMBER> number interlinked genes sars infection diseases indicates immunological hematological neurological metabolic dermatological diseases categories strongly associated sars infection see figure <NUMBER> additional file <NUMBER> table s<NUMBER> genes also shared <NUMBER> categories diseases ie disease groups also associated least genes instance gene atm shared among sars infection cancer immunological diseases therefore cancer immunological diseases also interrelated gene atm among disease classes immunological diseases class tightly correlated sars infection due highest number genes <NUMBER> genes shared hand number associated genes hiv infection diseases indicates neurological metabolic cancer hematological diseases categories strongly correlated hiv infection see figure <NUMBER> additional file <NUMBER> figure <NUMBER> genedisease association network centred sars infection constructed based different categories diseases connected showed comorbidities sars infection different genes red colour represents different categories disorders green colour represents different genes common categories disorders size disease node proportional number dysregulated genes shared infectionsdisorder groups link placed disorder disease gene mutations gene lead specific disorder httpwwwbiomedcentralcom<NUMBER> figure <NUMBER> genedisease association network centred hiv infection constructed based different categories diseases connected showed comorbidities hiv<NUMBER> infection different genes red colour represents different categories disorders green colour represents different genes common categories disorders size disease node proportional number dysregulated genes shared infectionsdisorder groups link placed disorder disease gene mutations gene lead specific disorder table s<NUMBER> hiv dysregulated genes also shared <NUMBER> categories diseases gene tgfb<NUMBER> shared among hiv infection cancer skeletal diseases notable <NUMBER> significant genes <NUMBER> upregulated <NUMBER> downregulated similarly dysregulated sars hiv infections observe association sars hiv infections <NUMBER> important diseases chronic heart failure kidney disorders breast cancer parkinson osteoporosis type <NUMBER> type <NUMBER> diabetes collected mrna microarray raw data associated disease gene expression omnibus httpwwwncbinlmnihgovgeo accession numbers gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> <NUMBER> several steps statistical analysis selected significant expressed genes infection disease also performed cross compare analysis find common significant genes disease sars hiv<NUMBER> infection observed sars infection shares <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> genes corresponding chronic heart failure kidney disorders breast cancer parkinson osteoporosis hiv<NUMBER> infection type <NUMBER> type <NUMBER> diabetes hand hiv<NUMBER> infection shares <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> genes corresponding chronic heart failure kidney disorders breast cancer parkinson osteoporosis sars infection type <NUMBER> type <NUMBER> diabetes built diseasedisease relationships network sars hiv<NUMBER> infection diseases see figures <NUMBER> b additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> since genes function alone coordinate activities form complexes molecular pathways therefore two diseases potentially intercorrelated share least one commonly associated pathway httpwwwbiomedcentralcom<NUMBER> reason used reactome pathway database <NUMBER> selected pathways related <NUMBER> diseases well sars hiv<NUMBER> infections observed diseases infections shared pathways shown figures <NUMBER> b additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> dysregulation protein subnetwork may yield dysfunction multiple protein subnetworks therefore multiple diseases may caused malfunction protein complex two diseases potentially related share one commonly associated protein subnetwork identify association diseases based ppi subnetwork used significantly associated disease protein pairs data hprd data base <NUMBER> find statistically significant associations among diseases built disease networks centred sars hiv infections two diseases comorbid exists one protein subnetwork associated diseases disease similarity network proteinprotein interaction network integrated systematically comprehensively simple compact manner formulate disease comorbidity sars hiv<NUMBER> infections shown figures <NUMBER> <NUMBER> showed sars hiv infections shared ppi subnetworks <NUMBER> diseases infections similar genedisease pathwaydisease associations shown figures <NUMBER> <NUMBER> based gene expression proteinprotein interaction molecular pathways data found sars hiv<NUMBER> infections strong association <NUMBER> diseases infections chronic heart failure kidney disorders breast cancer parkinson osteoporosis hivsars infection type <NUMBER> type <NUMBER> diabetes diseases infections also strongly correlated among present correlation strength distance pair diseases infections figure <NUMBER> show diseases kidney disorders breast cancer osteoporosis heart failure associated sars infection see figure <NUMBER> kidney disorder also tightly connected hiv<NUMBER> infection probability occurring comorbidities tightly connected diseases others notable patient medical records contain important evidence regarding cooccurrences diseases affecting patient constructed phenotypic disease comorbidity network using <NUMBER> million medical records <NUMBER> patients data medpar analysed structural properties better understand connections among diseases infections nodes unique diseases edges indicate comorbidity diseases included edges disease pairs cooccurrence significantly greater random expectation based population prevalence diseases pointed <NUMBER> relative risk rr ij overestimates relations involving rare infections diseases underestimates relationships common disorders infections hand φcorrelation underestimates comorbidity rare frequent diseases discriminates associations disorders similar appearances thus built network selecting statistically significant network edges rr ij ≥ <NUMBER> φ ij ≥ <NUMBER> figure <NUMBER> summarises set comorbidity associations among diseases expressed study population constructing phenotypic disease network pdn pdn nodes disease phenotypes identified unique icd<NUMBER>cm international classification diseases disease codes links connect phenotypes show significant comorbidity according relative risk rr ij ≥ <NUMBER> correlation φ ij ≥ <NUMBER> phenotypic disease network consists <NUMBER> unique diseases nodes <NUMBER> comorbidity relationships sarsassociated coronavirus icd<NUMBER>cm diagnosis code <NUMBER> group viral chlamydial infection conditions classified elsewhere unspecified site icd<NUMBER>cm diagnosis code <NUMBER> moreover icd<NUMBER>cm code <NUMBER> pneumonia due sars associated coronavirus considered icd<NUMBER>cm codes <NUMBER> <NUMBER> phenotypic sars comorbidity study <NUMBER> digit code data considered <NUMBER> <NUMBER> digit code data considered <NUMBER> considering relative risk rr ij ≥ <NUMBER> disease group <NUMBER> disorder categories constructed pdn shown figure <NUMBER> considering relative risk rr ij ≥ <NUMBER> disease group <NUMBER> disorder categories constructed pdn shown figure <NUMBER> b presented significant relative risk associations see additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> icd<NUMBER>cm diagnosis code human immunodeficiency virus hiv infection <NUMBER> <NUMBER> group infectious parasitic diseases icd<NUMBER>cm code <NUMBER> considered <NUMBER> digit <NUMBER> digit icd<NUMBER>cm codes phenotypic comorbidity studies related hiv infection considering relative risk rr ij ≥ <NUMBER> disease group <NUMBER> disorder categories constructed pdn shown figure <NUMBER> considering relative risk rr ij ≥ <NUMBER> φcorrelation φ ij ≥ <NUMBER> disease groups sub categories <NUMBER> disorder categories constructed pdn shown figure <NUMBER> b significant relative risk association represented see additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> observe trend phenotypic relative risk corresponding number shared genes <NUMBER> httpwwwbiomedcentralcom<NUMBER> diseases computed number shared genes two diseases corresponding phenotypic relative risk occurrence comorbidities shown figure <NUMBER> observed increasing number shared biomarker genes <NUMBER> diseases phenotypic relative risk also increased may predict existing diseases patient prospective disease comorbidities identification highly dysregulated genes based available data could predict disease comorbidities level comorbidities using regression model figure <NUMBER> notable ageing also disease natural process agerelated diseases increase exponentially chronological time understand impact ageing disease comorbidities sars hiv infections considered ageing data genage database httpgenomicssenescence infogeneshumanhtml <NUMBER> <NUMBER> cross comparing httpwwwbiomedcentralcom<NUMBER> human lung epithelial cells likely among first targets encounter invading severe acute respiratory syndromeassociated coronavirus sarscov <NUMBER> thus comprehensive evaluation complex epithelial signalling sarscov crucial better understand sars pathogenesis since sarscov merscov infections cause severe lung pathology compare contrast genes expression level sarscov infection merscov infection compare sarscov merscov infections affect disease comorbidities performed time series microarray data analysis types infections lung compared controls considered gene expression microarray data ncbi geo httpwwwncbinlmnihgovgeoquery acccgiaccgse<NUMBER> <NUMBER> analysis sarscov vs mockinfected controls treated way except without virus found <NUMBER> genes highly significant analysis merscov vs mock found <NUMBER> gens highly significant see details additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> interestingly <NUMBER> genes nfkbia egr<NUMBER> ddit<NUMBER> ifit<NUMBER> common two infections see figure <NUMBER> however <NUMBER> genes nfkbia egr<NUMBER> play important role differentially expressed among infections lung also sars infected pbmcs hierarchical cluster analysis differentially expressed genes lung infection sarscov merscov observed distinct groups genes significantly changed time see additional file <NUMBER> figure s<NUMBER> additional file <NUMBER> figure s<NUMBER> additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> log fold changes common <NUMBER> genes nfkbia egr<NUMBER> ddit<NUMBER> ifit<NUMBER> expression level infection merscov sarscov presented figures <NUMBER> <NUMBER> observed log fold changes nfkbia genes expression level sharply upregulated types infections corresponding time point nfkbia important biomarker merscov sarscov infections also observed inflammatory genes nfkbia highly expressed pbmcs lung cells infection sars also infection mers lung cells see figure <NUMBER> indeed immune system plays pivotal role outbreak inflammatory state case sars infection nfkbia gene plays important role disease comorbidities hand similar diseases share common genes could treated drugs <NUMBER> may allow us make predictions new uses existing drugs instance antidiabetic drug metformin plays major protective effect cancer development increases significantly higher survival rate cancer patients <NUMBER> finding earlier metformin regimen initiated greater httpwwwbiomedcentralcom<NUMBER> preventive benefit cancer patient evidence antiviral medication ribavirin work case sars infection <NUMBER> end used connectivity map cmap database <NUMBER> drug transcriptional signatures several cell lines <NUMBER> database allows identify molecules induce similar opposite transcriptional changes relative query signature based connectivity enrichment scores query signature used <NUMBER> highly dysregulated genes sars infection generated connectivity score value ranges <NUMBER> <NUMBER> highly positive score indicates drug induces changes similar induced viral infection highly negative score indicates drug reverses expression sars signature based connectivity score selected potential positive negative regulators sars viral response see details additional file <NUMBER> table s<NUMBER> potential negative regulators indicate drugs reverse sars signature gene expression among negative potential regulator drug molecule tetracycline zalcitabine gibberellic acid prestwick<NUMBER> sulfaquinoxaline potential mcf<NUMBER> cell line vorinostat hl<NUMBER> cell line based data demonstrate efficacy different drug sars virus predicted effective drug treatment emergent viruses furthermore immunomodulatory drugs reduce excessive host inflammatory response respiratory viruses therapeutic benefit reduce sars infection well disease comorbidities presented analysed multirelational disease comorbidity relationships sars hiv<NUMBER> infections diseases infections based associations genetics proteomics molecular signalling pathways phenotypic disorders combination molecular biology genetics clinical medicine greatly facilitated understanding different diseases relate based combined genetics ppis pathways clinical data disease networks disclose potentially novel disease relationships captured previous individual studies underlying hypothesis behind line research catalogue diseaserelated genes ppi complex signalling pathways consider environmental changes able predict susceptibility individual future diseases using various molecular biomarkers help us enter era predictive medicine results indicate combination molecular populationlevel data could help build novel hypotheses disease mechanisms furthermore two diseases associated comorbidity occurrence one patient may increase likelihood developing diseases also studied differences merscov sarscov host response enables rapid assessment viral properties ability anticipate possible differences human clinical responses merscov sarscov impact comorbidities respect general comorbidities conditions used information predict potential effective drugs sarscov method could generally used identify candidate therapeutics future disease outbreaks investigation approach may also help generate hypotheses make rapid advancements characterising new viruses also found patients response sars appears mainly innate inflammatory response using nfkbia rather specific immune response viral infection hiv however hiv infection highly active antiretroviral therapy haart also increase immune reconstitution inflammatory syndrome iris inflammation nfκb pathways <NUMBER> moreover studied impact hiv infection bone diseases infection e g osteoporosis osteomyelitis observed genes eg rankl pathways eg nfκb dysregulated hiv infection also impact bone remodelling bone related diseases also recognised inflammation plays role cancer aetiology various studies found inflammation may causes iris obesity tumourpromoting effects <NUMBER> moreover inflammation important concomitant cause many major ageassociated pathologies cancer neurodegeneration diabetes <NUMBER> study provides important evidence associate diseases ageing process system level helps understand comorbidities complex diseases ageing process accompanied chronic lowgrade inflammation termed inflammageing combination metabolicdriven agedriven inflammatory pathways plays pivotal role disease progression observation suggests inflammageing metainflammation share stimuli pathogenic mechanisms comorbidities suppose happening comorbidities investigate similar found prions <NUMBER> <NUMBER> similar infectious agents prion causes inflammatory responses activating innate immunity glial cells brain complete transcriptome prion brain <NUMBER> different time points observed <NUMBER>week period <NUMBER> <NUMBER> beginning disease normal diseased mouse networks although disease started unique network prion accumulation replication progressed networks based approach may propose pathway model comorbidities hubs genes dysregulate several pathways influence comorbidities number dysregulated pathways could proportional amount dysregulation hub genes pathway model may states hubs turned may direct signal different pathways creating comorbidities shown figure <NUMBER> infection one pathways related inflammation starts dysregulation increasing time confidence level inflammation number dysregulated pathways increased moreover increasing inflammation number diseases comorbidities may increase initially infection dysregulates one signalling pathway cells causes pathways may dysrupted way disrupting pathways increase diseases patient make multimorbidity disease genes play central role human interactomes overlapping component genes serve bridges across relatively independent functional modules pathways perturbation one pathway nfκb signalling pathway could propagated throughout relevant pathways found sars hiv<NUMBER> infections share <NUMBER> significantly dysregulated genes well molecular pathways sars hiv<NUMBER> viruses may infect find already existing comorbidity generate new comorbidity perturbation infected pathways furthermore may provide us opportunity investigate role httpwwwbiomedcentralcom<NUMBER> genes pathway disease space therefore pathways could used represent underlying biology diseases make prediction disease comorbidities cases correlativeness among genes pathways diseases manytomany eg disease associated many different genes pathways pathway associated many different diseases study suggests single pathway involved many diseases whereas disease may dysregulation many biological processes hence drug already available treat disease modulating activity pathway could potentially used treat diseases strongly linked pathway hand disease shows dysregulation multiple pathways pathwayguided combined drug may employed treatment moreover protein subnetworkbased approach diseases may aid drug discovery fact potentially used treat diseases linked protein complex thus findings potentially help us understand different diseases related based underlying molecular mechanisms also provide insights design novel protein complexguided therapeutic interventions diseases extending concept subclassifying patient cohorts single patient level refers personalised medicine last years acceptance level personalised medicine sharply increased apparent standard treatment approaches rarely efficient across entire patient population advances highthroughput molecular assay technologies fields genomics proteomics omics increasing diagnostic therapeutic strategies personalised treatment result declining persample cost given rise numerous public repositories biomolecular data particular availability data sets many different diseases presents ripe opportunity use datadriven approaches advance current knowledge disease relationships systematic way identified disease patterns investigated regards diagnostic utility help predicting novel therapeutic targets medicine focus individual patient become intrinsically proactive increasingly focus wellness rather disease proactive personalised medicine bring fundamental changes healthcare taking carefully httpwwwbiomedcentralcom<NUMBER> targeted preventative therapeutic action earliest indications risk disease comorbidities entering genomic era medicine patients geneticgenomic data becoming important clinical decision making including disease risk assessment disease diagnosis subtyping drug therapy dose selection risk assessment adverse drug reaction family planning <NUMBER> today multiscale complex biomedical data gathered analysed uncover combinations predictive disease profiles genome well multiple proteomes multiple transcriptomes multiple metabolomes personalised data sets obtained different points lives readily available affordable prices individual near future clinicians consider geneticgenomic implications patient care throughout clinical workflow including electronic prescribing medications therefore implementation personalised medicine system model could developed take individual genetic data dysregulated biomarker genes identified genetic data disease identified genedisease association database based information existing disease model predict disease comorbidities using diseasedisease associations database provide us detect many diseases earliest detectable phase even weeks months maybe years symptoms appear afford crucial insights optimizing wellness thus personalised medicine give fundamental new insights disease mechanisms hence open new opportunities diagnosis therapy prevention disease comorbidities study considered available categories omics phenotypic data quantify sars hiv<NUMBER> infections centred comorbidity associations shown phenotype disease network pdn heterogeneous structure diseases highly connected others hardly connected findings showed disease progression represented studied using network methods offering potential enhance understanding origin evolution human diseases detecting comorbidity large population clinical interest due fact may reveal new information useful cause diseases well new treatment strategies study demonstrates value integrated approach revealing disease relationships new opportunities therapeutic applications say kind approach helpful making evidencebased recommendations disease comorbidities moreover considering environmental factors physiological stress diet ethnic group gender discriminations important factors comorbidity analysis network approach could extended comorbidity map integrating diet exercise factors <NUMBER> genedisease associations data used study collected online mendelian inheritance man omim database httpwwwncbinlmnihgov omim omim database bestcurated repository known disease genes associated httpwwwbiomedcentralcom<NUMBER> figure <NUMBER> progressive temporal activation pathways schematic view networks becoming disease comorbidities increased perturbation pathways dysregulation advances time red circles indicate increased levels dysregulated gene expression relative control red linked indicate dysregulated pathways increased infection compared normal control green indicated transcripts control infection condition four panels represent network time intervals infection progression time inflammation confidence level increased indicated confidence interval disorders <NUMBER> <NUMBER> genotypephenotype relationships summarised omim database contained <NUMBER> human diseasegenes associations involving <NUMBER> diseases <NUMBER> disease associated genes entry omim composed four fields name disorder associated gene symbols corresponding omim id chromosomal location selected entries <NUMBER> tag strong evidence least one mutation cause disorder omim initially focused monogenic disorders recent years expanded include complex traits associated genetic mutations confer susceptibility common disorders <NUMBER> subsequently classified disorder <NUMBER> primary disorder classes based physiological system affected introduced goh cusick valle childs vidal barabasi et al <NUMBER> disorders distinct multiple clinical features assigned multiple class classification scheme reflects phenotypic similarities among diseases class successfully used recent studies systematic disease analysis <NUMBER> gene expression data used study obtained ncbi gene expression omnibus geo httpwwwncbinlmnihgovgeo <NUMBER> considered <NUMBER> different data sets analysis accession numbers gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> gse<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data sets contain data patients different age sex several rounds filtering normalization statistical analysis microarrays representing sars mers hiv<NUMBER> infections <NUMBER> human diseases heart failure kidney disorders breast cancer parkinson osteoporosis type <NUMBER> type <NUMBER> diabetes httpwwwbiomedcentralcom<NUMBER> proteinprotein interaction ppi data human obtained human protein reference database hprd <NUMBER> hprd contains maximum number ppi data among publicly available literaturederived databases human ppi <NUMBER> used reactome knowledge base human biological pathways database pathways association analysis <NUMBER> cross compare analysis sars hiv infections ageing process download ageing data human ageing genomic resources httpgenomicssenescenceinfo downloadhtml <NUMBER> <NUMBER> collected human ageing genes extensive review literature genes commonly dysregulated ageing process test validity proposed disease associations examined disease cooccurrence information population level obtained statistically significant pairwise comorbidity associations reconstructed <NUMBER> million medical records us medicare claims database recorded icd<NUMBER>cm format httpwww icd<NUMBER>datacom frequently used epidemiological demographic studies collected <NUMBER> used medpar records <NUMBER> <NUMBER> dates reasons hospitalizations reported icd<NUMBER>cm format contains diagnoses <NUMBER> elderly patients record consists date visit primary diagnosis <NUMBER> secondary diagnosis diagnoses specified icd<NUMBER> codes <NUMBER> digits first three digits specify main disease category last two used give additional information disease total icd<NUMBER>cm classification consists <NUMBER> different categories <NUMBER> digit level <NUMBER> categories <NUMBER> digit level <NUMBER> determine whether existing drug compounds reverse sars infection signature used publicly available connectivity map cmap database <NUMBER> cmap provides associations among genes chemicals disease infection conditions collection genomewide transcriptional data cultured human cells treated <NUMBER> different compounds method global gene expression analysis using oligonucleotide microarrays proven sensitive method develop refine molecular determinants human disorders <NUMBER> using technology compared gene expression profiles sars hiv diseases avoid problems comparing microarray data different platforms experimental systems normalized gene expression data microarray sample disease state control using zscore transformation z ij disease gene expression matrix using z ij sd standard deviation g ij represents expression value gene sample j transformation allows direct comparison gene expression values across various microarray samples diseases combined one data series experiments given disease employed linear regression approach obtain combined ttest statistic two conditions data log <NUMBER> transformed calculated expression level gene using linear regression model gene expression value x disease state disease control coefficients β <NUMBER> β <NUMBER> parameters model estimated least squares ttest statistic estimating value β <NUMBER> standard ttest statistic disease control states time series microarray gene expression data analysis divide two steps preprocessing identification statistically significant points ttest anova regression analysis find differently expressed gene profiles different time points first step preprocessed experimental data using different statistical methods finally followed post less normalization recommended golden spike project <NUMBER> second step used suitable method masigpro microarray significant profiles identify differentially expressed genes timecourse microarray experiments two step regression method successfully applied one groups timeseries <NUMBER> <NUMBER> two steps regression strategy used find genes significant temporal expression changes significant differences experimental groups procedure first adjusts global model leastsquared technique identify differentially expressed genes selects significant genes applying false discovery rate control procedures stepwise regression applied variable selection strategy study differences experimental groups statistically significant profiles finding differentially gene expression profiles among group experiments next step cluster according profile similarities hierarchical clustering median gene expression profiles clusters performed according masigpro package r <NUMBER> students unpaired ttest performed identify genes differentially expressed patients normal samples significant genes selected threshold least <NUMBER> fold change p value ttests less <NUMBER> chosen addition twoway anova bonferronis posthoc test used establish statistical significance groups <NUMBER> pathways functional categories considered overrepresented fishers exact test p value <NUMBER> presenting signalling httpwwwbiomedcentralcom<NUMBER> interaction pathways different significant genes used cytoscape data integration network visualization <NUMBER> <NUMBER> reactome functional interaction fi cytoscape plugin knowledge base human biological pathways network processes <NUMBER> gene disease association considered neighbourhood based benchmark topological methods better suited networks <NUMBER> case topological refers methods rely structure network draw conclusions construct gdn genedisease associations node network either disease gene network also regarded bipartite graph diseases connected diseases share least one significant dysregulated genes let particular set human diseases set human genes g genedisease associations attempt find whether gene g ∈ g associated disease ∈ g g j sets significant dysregulated genes associated diseases j respectively number shared dysregulated genes n g ij associated diseases j follows cooccurrence refers number shared genes gdn common neighbours based jaccard coefficient method edge prediction score node pair e set edges number shared pathways protein subnetwork links diseases j calculated using equation <NUMBER> link prediction score measured using equation <NUMBER> estimate correlation starting disease cooccurrence need quantify strength disease association comorbidities dipicting distance two diseases analysis phenotypic data used relative risk rr ij quantified measures comorbidity tendency two disease pairs checked φcorrelation φ ij measure robustness comorbidity associations rr ij observing pair diseases j affecting patient two diseases cooccur frequently expected chance get rr ij <NUMBER> φ ij <NUMBER> however rr ij φ ij independent carries unique biases complementary <NUMBER> <NUMBER> used measures comorbidity ensure robustness investigations rr ij allows us quantify cooccurrence disease pairs compared random expectation calculated <NUMBER> n total number patients population p incidencesprevalences disease p j incidence disease j c ij number patients diagnosed diseases j rr ij <NUMBER> comorbidity larger expected chance rr ij <NUMBER> comorbidity smaller expected chance calculate significance relative risk rr ij used katz baptista azen pike et al method estimate confidence intervals <NUMBER> according estimation <NUMBER> confidence interval rr ij two diseases j calculated lower bounds confidence interval lb rr ij exp−<NUMBER> σ ij upper bounds confidence interval ub rr ij exp<NUMBER> σ ij σ ij given disease pairs within <NUMBER> confidence interval considered lb value larger <NUMBER> rr ij larger <NUMBER> ub value smaller <NUMBER> rr ij smaller <NUMBER> relative risk measure intrinsically biased towards overestimation relationships rare diseases underestimates comorbidity frequent diseases <NUMBER> bias reduced introduction φcorrelation measure quantify strength comorbidities calculating correlation coefficient associated pair diseases j c ij number patients affected diseases n total number patients studied population p p j morbidity incidence th j th diseases respectively φcorrelation pearsons correlation variables take <NUMBER> <NUMBER> values <NUMBER> φ ij <NUMBER> comorbidity larger expected chance φ ij <NUMBER> comorbidity smaller expected chance determine significance φ <NUMBER> performing ttest consists calculating according formula φ √ n−<NUMBER> √ <NUMBER>−φ <NUMBER> n number observations used calculate φ predict comorbidities considering primary index disease calculated conditional relative risk conditional rr ij follows possible disease pairs j cases one index disease present k true absent k false p <NUMBER> weighted edges using mutual information metric quantifies much greater edge relationship respect cooccurrence mutual information weight two diseases j defined w ij c ij p p j − c ij <NUMBER> c ij observed cooccurrence p p j morbidity prevalence th j th diseases respectively compare sarscov merscov gene set enrichment analysis undertaken using gsea <NUMBER> find correlation similarities distance dissimilarities among diseases integrated analysis multidimensional data gene expression protein protein interaction applied euclidian distance measurement metric multidimensional scaling mds using majorization <NUMBER> mds set methods discovering hidden structures multidimensional data based proximity matrix derived variables measured objects input entity distances mapped lower dimensional spatial representation optimization problem used find mapping target dimension data based given pairwise proximity information minimize objective function particular objective function loss function used work sum squares commonly called stress used majorization minimize stress mds solving strategy known smacof scaling majorizing complicated function stress majorization optimization strategy used multidimensional scaling mds set nmdimensional data items configuration x n points r mdimensional space sought minimizes stress function σ x r <NUMBER> means r × n matrix x lists points <NUMBER>dimensional euclidean space applied cost function σ measures squared differences ideal mdimensional distances actual distances rdimensional space follows x <NUMBER> dimension n <NUMBER> × p individuals judges configuration x <NUMBER> dimension n <NUMBER> × p objects configuration matrix least squares metric multidimensional scaling mds problem minimization σ × p configurations x w ij given nonnegative weights ij given nonnegative dissimilarities ij x euclidean distances rows j x thus ij x<NUMBER> x<NUMBER> p s<NUMBER> x <NUMBER>is − x <NUMBER>js <NUMBER> <NUMBER> w ij ≥ <NUMBER> weight measurement pair points j ij x euclidean distance j δ ij ideal distance points separation mdimensional data space note w ij used specify degree confidence similarity points eg <NUMBER> specified information particular pair configuration x minimizes σ x gives plot points close together correspond points also close together original mdimensional data space programming scripts freely available wwwclcam acukmam<NUMBER>comor httpwwwbiomedcentralcom<NUMBER> information regarding clusters genes described additional file <NUMBER> table s<NUMBER> additional file <NUMBER> table s<NUMBER> connectivity map results predicted drugs per instance drug cells line reverse sarscov early sustained signature drugs negative enrichment scores current ongoing pandemic covid<NUMBER> coronavirus disease outbreak end <NUMBER> based positivesense singlestranded rna virus associated nucleoprotein within capsid comprised matrix proteins together sarscov merscov sarscov<NUMBER> belongs human betacoronaviruses although viruses show many similarities differences genomic phenotypic structure resulting huge consequences pathogenesis whereas fatality rates previous sarscov merscov outbreaks much higher sarscov<NUMBER> shows several unique features much higher contagiosity high prevalence asymptomatic disease spreaders prolonged incubation period additionally helps virus spreading towards worldwide pandemic infected patients high rate asymptomatic mild courses reported leading symptoms fatigue coughing shortness breath fever <NUMBER> however quite number cases rapid spread virus various organs including lungs neurological system probably also heart <NUMBER> notion preexisting cardiovascular diseases cvds strongly increase covid<NUMBER> fatality rates important due least two causes general underlying diseases cvd cancer immunocompromising diseases probably increase fatality rates many infectious diseases including general flu sarscov<NUMBER> number preclinical studies shown various organ systems express primary sarscov<NUMBER> entry receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> importantly preclinical studies rats indicated increased expression ace<NUMBER> reninangiotensinaldosterone system raas inhibitor medication <NUMBER> ace inhibitor therapy increased cardiac ace<NUMBER> mrna cardiac ace<NUMBER> activity rats angiotensin ii type <NUMBER> receptor blocker arb increased cardiac ace<NUMBER> mrna activity <NUMBER> study published current issue european heart journal investigated expression ace<NUMBER> human hearts <NUMBER> nicin et al employed single nuclei rna sequencing analyse expression ace ace<NUMBER> different cell types human heart five patients aortic stenosis two patients heart failure reduced ejection fraction hfref two samples one healthy donor heart found ace<NUMBER> expressed cardiomyocytes pericytes lower level fibroblasts endothelial cells leucocytes ace<NUMBER> elevated cardiomyocytes patients heart disease compared healthy controls also slightly significantly increased endothelial cells lower extent fibroblasts immunostainings suggest increased expression ace<NUMBER> cardiomyocytes patients also protein level line previous preclinical data <NUMBER> cardiomyocytes patients treated ace inhibitors showed significantly higher ace<NUMBER> expression figure <NUMBER> contrast preclinical data found less ace<NUMBER> activation arbtreated patients although preliminary data provide novel insights cell typespecific expression regulation ace<NUMBER> human heart important hypothesisgenerating observation profound implications basic translational science well another piece puzzle ongoing discussion optimal pharmacotherapy sarscov<NUMBER>infected cardiovascular patients <NUMBER> several points wish discuss light findings general mentioned also authors study clearly underpowered conclusions drawn carefully especially includes observation less ace<NUMBER> activation cardiomyocytes patients treated arb previous preclinical studies rats shown partly different results <NUMBER> however might species differences well drug classspecific effects need investigated detail future studies eg opinions expressed article necessarily editors european heart journal european society cardiology † doi<NUMBER>eurheartjehaa<NUMBER> employing human induced pluripotent stem cell ipscderived cardiomyocytes clinical speculations optimal pharmacotherapy cardiovascular diseases especially heart failure patients least currently result change guidelinedirected therapies also includes antihypertensive treatments discontinued may greater risk factor severe complications future effects current future sarscov<NUMBER> antiviral medications comorbidities diabetes ace<NUMBER> expression also explored although several organ systems seem affected currently exactly know organspecific invasiveness sarscov<NUMBER> humans interestingly previous pathological study obtained autopsies fatal cases sarscov sarscov<NUMBER> found exception lungs gut viral detection heart liver spleen kidney lymph nodes bone marrow muscles observations elevated markers cardiac damage inflammatory reactions higher rate rhythmological problems however may also suggest direct cardiac infection sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> another important finding study nicin et al observation cell typespecific expression pattern ace<NUMBER> human heart also lead followup studies investigating cell typespecific role ace<NUMBER> potential functional implications importantly another recent study also used single cell nuclei rna sequencing <NUMBER> healthy donor hearts <NUMBER> failing explanted hearts obtained heart transplantation centre fuwai hospital <NUMBER> contrast observation nicin et al investigators found low ace<NUMBER> expression cardiomyocytes high expression pericytes conclude sarscov<NUMBER> infection human heart might attack primarily pericytes subsequently cause capillary endothelial cell dysfunction thus inducing microcirculation disorders explaining observed elevation markers cardiac damage mechanistic followup studies cardiomyocytes vascular cells including pericytes endothelial cells clearly warranted may also lead intriguing insights potential consequences patients heart failure ischaemic vascular origin well heart failure patients preserved ejection fraction impaired microvascular function finally become blinded covid<NUMBER> pandemic correct diagnosis therapy patients cvd covid<NUMBER> symptoms shortness breath coughing typical problems patients heart failure making fast correct diagnosis extremely important respect future treatment another impact covid<NUMBER> pandemic leading heavy overload hospitals several regions world potential increase eventtoballoon times patients acute myocardial infarction <NUMBER> whether initial findings extrapolated european us hospitals likely remains determined potentially covid<NUMBER> outbreak also lead increase longterm complications patients cvd heart failure patients infected sarscov<NUMBER> infected treated suboptimally ongoing pandemic figure <NUMBER> conclusion nicin coworkers report important observation future implications research potentially treatment sarscov<NUMBER>infected cardiovascular patients novel data least suggest important monitor sarscov<NUMBER>infected patients cardiovascular complications assess impact arbace inhibitor therapy detail objective evaluate incidence impact rhinovirus coronavirus infections older persons attending daycare design prospective descriptive study settlng three senior daycare centers rochester new york patients frail older persons staff members daycare centers developed signs symptoms acute respiratory illness measurements demographic medical physical findings recorded subjects baseline respiratory illness nasopharyngeal specimens viral culture well acute convalescent sera coronavirus <NUMBER>e enzyme immunoassay eia obtained illnesses results <NUMBER> months study <NUMBER> older persons experienced <NUMBER> illnesses thirtyfive <NUMBER> <NUMBER> cultures positive rhinovirus <NUMBER> <NUMBER> <NUMBER> serologies positive coronavirus <NUMBER>e infection clinical syndromes associated rhinovirus coronavirus infection similar characterized nasal congestion cough constitutional symptoms n patient died hospitalized approximately <NUMBER> evidence lower respiratory tract involvement average illness lasted <NUMBER> days period <NUMBER> staff developed <NUMBER> respiratory illnesses eight percent identified coronavirus <NUMBER> rhinovirus cough sputum production constitutional symptoms significantly common among older persons conclusions rhinovirus coronavirus <NUMBER>e common causes moderately debilitating acute respiratory illnesses among older persons attending daycare j geriatr soc <NUMBER> r morbidity mortality older persons viruses influenza respiratory syncytial virus rsv shown cause serious disease age group less known impact rhinoviruses coronaviruses causative agents majority common colds approximately <NUMBER> <NUMBER> upper respiratory tract infections uris adults caused rhinoviruses <NUMBER> <NUMBER> caused coronaviruses <NUMBER> serotypes rhinoviruses two major serotypes coronavirus <NUMBER>e oc<NUMBER> idertified reinfections viruses occur throughout life part multiple serotypes incomplete immunity infections lead significant time lost work school generally result serious disease children young adultsi<NUMBER> rates acute respiratory tract infections diminish advancing age likely result less frequent exposure however frail older persons attending adult daycare centers may represent special population increased risk infection risk complications common infection purpose study evaluate prospectively prevalence clinical features rhinovirus coronavirus <NUMBER>e infections frail older persons attending senior daycare volunteers recruited three sites senior daycare program rochester new york facilities allow frail older persons nursing homeeligible new york state medicaid standards maintained home providing comprehensive medical social services attendees daycare program recruited take part study daycare participants scheduled attend center average <NUMBER> days per week minimum week ill subjects encouraged attend program evaluation center physicians addition staff members direct contact older participants also recruited surveillance study informed consent obtained volunteers upon entrance daycare program volunteers unable provide informed consent consent obtained legal guardians baseline information including medical history demographics obtained daycare participants medical records subjects examined baseline arterial oxygenation saturation sao measured percutaneously pulse oximetry ohmedabiox ivboulder co baseline serum samples collected daycare participants staff members surveillance acute respiratory illnesses took place january <NUMBER> <NUMBER> october <NUMBER> <NUMBER> possible respiratory illnesses among daycare workers attendees reported daycare staff project nurse evaluation acute respiratory illness defined nasal congestion sore throat new increased cough wheezing sputum production respiratory difficulty without fever illness evaluations consisted directed history physical exam mcasurement sao nasopharyngeal swab viral culture subjects evaluated day attended center symptoms resolved end illness defined resolution symptoms physical findings participants well upon return center absence several days questioned symptoms resolved staff members became ill answered brief questionnaires nasopharyngeal cultures taken fourweek convalescent sera obtained many staff participants possible viral cultures sera collected asymptomatic individuals nasopharyngeal swabs performed gently rubbing posterior nasal turbinates posterior pharynx cotton tip swabs swabs placed veal infusion broth transported laboratory ice inoculated onto wi<NUMBER> cell cultures biowhittaker walkersville md within <NUMBER> hours collection tubes incubated <NUMBER>°c roller drums observed <NUMBER> days cytopathic effect cpe rhinovirus infection identified typical cpe confirmed acid lability testing serologic evidence coronavirus infection defined greater <NUMBER> rise coronavirusspecific igc measured enzyme immunoassay eia coronavirus antigens prepared expanding coronavirus <NUMBER>e virus wi<NUMBER> cells point visible cpe monolayers scraped cellular material pelleted sorvall <NUMBER> g <NUMBER> minutes pellets resuspended <NUMBER> np<NUMBER> suspensions sonicated every <NUMBER> minutes <NUMBER> hour eia plates prepared coating <NUMBER>e antigen immulon round bottom plates bicarbonate buffer stored <NUMBER>°c overnight control plates prepared using uninfected wi<NUMBER> cell lysates prepared procedure acute convalescent sera added serial <NUMBER>fold dilutions <NUMBER> <NUMBER> duplicate control antigen plates serum igc detected alkaline phosphatase conjugated goat human igg followed substrate coronavirus titer defined highest titer optical density od <NUMBER> <NUMBER> least twice od control plate part ongoing surveillance project respiratory infections daycare centers nasal specimens cultured viruses influenza rsv parainfluenza enteroviruses sera tested eia influenza b parainfluenza rsv infection details methodologies results project presented future publication <NUMBER> months study <NUMBER> older daycare attendees enrolled participated surveillance project mean <NUMBER> <NUMBER> <NUMBER> months illnesses evaluated viral cultures <NUMBER> <NUMBER> specimens <NUMBER> acute convalescent sera available coronavirus eia coronavirus <NUMBER>b rhinovirus infections identified approximately <NUMBER> illnesses viral cultures positive rhinovirus <NUMBER> <NUMBER> specimens coronavirus serology positive <NUMBER> <NUMBER> paired sera tested sixtyone subjects experienced <NUMBER> separate infections fifty persons single infection <NUMBER> subjects multiple infections three subjects two different rhinovirus infections two subjects two episodes coronavirus infection six people one rhinovirus one coronavirus infection study period six individuals evidence concurrent mixed viral infcctions four persons <NUMBER>fold rises rsv coronavirus titers two subjects one coronavirus infection one rhinovirus serologic evidence parainfluenza infection thus <NUMBER> illnesses coronavirus <NUMBER>e sole pathogen identified <NUMBER> illnesses rhinovirus organism found clinical features associated illnesses analyzed cases either coronavirus rhinovirus agent identified coronavirus <NUMBER>e infections identified commonly winter early spring whereas rhinovirus activity sporadic tended frequent summer fall figure <NUMBER> interestingly coronavirus circulating rhinovirus activity nearly ceased clear outbreaks infection occurred daycare center periods viral activity typically involved small clusters three six older persons several staff members clusters rhinovirus coronavirus infections infrequently preceded ill staff member spring <NUMBER> <NUMBER>week period increased coronavirus activity one center involving seven people preceded <NUMBER> days coronavirusinfected staff member mean age <NUMBER> subjects experienced illnesses <NUMBER> <NUMBER> years old demographics clinical characteristics group became infected reflective group whole except diabetes less common infected group <NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> approximately twothirds subjects underlying cardiac disease <NUMBER> yo chronic pulmonary disease addition significant differences group infected rhinovirus compared group infected coronavirus clinical syndromes produced coronavirus <NUMBER>b rhinovirus nearly identical table <NUMBER> illnesses characterized nasal congestion cough constitutional symptoms lowgrade fever uncommon temperature <NUMBER>°f greater occurred three subjects two coronavirus one rhinovirus although subjects generally recovered without significant sequelae illnesses lasted average <NUMBER> days approximately <NUMBER> illnesses associated evidence lower respiratory tract involvement defined presence sputum production shortness breath new wheezing andor new rales exam thirtysix percent complained feeling short breath twentytwo percent wheezing <NUMBER> rales found auscultation chest notably subjects wheezing <NUMBER> rales <NUMBER> baseline examinations although mean sao measurements group dropped modest amount <NUMBER> <NUMBER> baseline <NUMBER> <NUMBER> p <NUMBER> ill seven individuals greater <NUMBER>point drop sao illness one individual coronavirus fall sao baseline <NUMBER> <NUMBER> ill four illnesses evaluated chest roentgenograms three normal one showed congestive heart failure nine percent subjects rhinovirus <NUMBER> coronavirus received bronchodilators antibiotics frequently prescribed groups table <NUMBER> one individual rhinovirus infection hospitalized treated congestive heart failure complete recovery deaths occurred note six illnesses associated rsv parainfluenza significantly different rhinovirus coronavirus alone individuals underlying cardiac pulmonary disease compared without significant difference severity rhinovirus coronavirus infections noted wheezing found equally prevalent chronic lung disease without pulmonary problems <NUMBER> vs <NUMBER> subjects developed wheezing illnesses symptomatic slightly longer <NUMBER> <NUMBER> <NUMBER> days vs <NUMBER> <NUMBER> <NUMBER> p <NUMBER> received antibiotics much frequently <NUMBER> vs <NUMBER> p <NUMBER> evidence bronchospasm time period <NUMBER> staff members developed <NUMBER> respiratory illnesses figure <NUMBER>b cough sputum production constitutional symptoms significantly common among older persons twenty percent daycarc staff missed work secondary rhinovirus coronavirus illnesses study represents largest series date prospectively identified cases coronavirus <NUMBER>e rhinovirus infections older persons data show viruses common daycare setting although infections generally result serious complications many clinically significant prolonged symptoms evidence lower respiratory tract involvement relatively little information reported impact common viruses frail older populations study acute respiratory infections nursing home patients nicholson et al <NUMBER> persons identified coronavirus infection eia three evidence lower respiratory inolvement study <NUMBER> individuals found rhinovirus infection one lower respiratory tract disease previous study <NUMBER> nursing home residents rhinovirus infections illnesses mild <NUMBER> complaining sputum production <NUMBER> noting shortness breath patient hospitalized died<NUMBER> contrast recent report wald et al describing outbreak rhinovirus infection affected <NUMBER> institutionalized older persons high percentage <NUMBER> subjects lower respiratory tract symptoms <NUMBER> new abnormalities lung exami<NUMBER> persons underlying lung disease severe illnesses two individuals requiring hospitalization one radiographically documented pneumonia one death secondary respiratory failure although participants present study recovered without serious sequelae contrast previous study nursing home subjects seriously ill similar study wald colleagues current subjects frequently evidence lower respiratory tract involvement new auscultatory findings symptoms dyspnea drop arterial oxygen saturation additionally subjects ill approximately <NUMBER> wecks compared usual <NUMBER> <NUMBER> days illness young healthy adult also note worthy era increasing antimicrobial resistance antibiotics prescribed <NUMBER> illnesses caused rhinoviruses coronaviruses rhinovirus coronavirus infections rarely found cause pneumonia adults even severely immunocompromised patient however viruses implicated precipitating factor exacerbations asthma copd<NUMBER>z consistent published literature older subjects study evidence invasive disease pneumonia contrasts sharply infection influenza rsv parainfluenza older persons rates pneumonia high excess mortality rates nt e relatively milder illnesses associated rhinoviruses coronaviruses likely reflect biological characteristics viruses rhinovirus replicates poorly core body temperature <NUMBER>°c appears produce symptoms via chemical mediators rather direct viral invasion<NUMBER> although less well studied fastidious growth requirements coronaviruses also appear cause significant damage respiratory epithelium lower respiratory signs wheezing rales without evidence pneumonia patients suggest viruses cause disease older persons aggravating preexisting congestive heart failure inducing bronchospasm incidence rhinovirus coronavirus <NUMBER>e infections daycare centers found nearly identical since tested one two common serotypes coronavirus infection incidence <NUMBER>e oc<NUMBER> roughly equivalent possible number illnesses attributable coronavirus may actually double reported small intermittent clusters infections staff participants center suggest viruses introduced centers outside sources however introduced element nosocomial spread also likely close contact staff older persons daycare policy encourages participants attend daycare receive medical attention onsite physicians may influenced overall incidence infection daycare however concern must balanced need provide medical care debilitated group older persons daycare center requires employees febrile illnesses andor uncontrolled respiratory symptoms stay work symptoms resolve however many common respiratory viruses cause fever severe symptoms young healthy persons therefore healthcare workers suffering upper respiratory illnesses miss work many individuals staff participants experiencing colds close contact throughout winter months good infection control practices daycare centers critical respiratory viruses exception influenza viruses require relatively close contact transmission rhinoviruses transmitted either fomites autoinoculation aerosol p r e although less information available transmission coronavirus likely also spread fomites close contact many authorities field pediatrics feel control respiratory infections childrens daycare centers nearly impossible nature young childrens activities<NUMBER> however senior daycare centers outlook infection control may hopeful since transmission agents caused part fomites careful handwashing may interrupt pread addition architectural design centers attention square feet per resident adequate ventilation may important future control respiratory infection summary coronavirus <NUMBER> rhinoviruses found common causes acute respiratory illnesses among staff participants senior daycare program although illnesses severe associated viral pathogens influenza rsv older subjects moderately debilitated infections attention paid basic infection control principles limit spread common viruses novel coronavirus sarscov<NUMBER> coronavirus disease <NUMBER> covid <NUMBER> highly contagious devastating virus currently infected <NUMBER> million people worldwide resulted <NUMBER> <NUMBER> deaths april <NUMBER> <NUMBER> people diagnosed covid<NUMBER> exhibit mildtomoderate symptoms early reports china described vulnerable patient populations elderly chronic underlying medical conditions including immunosuppressed severe covid<NUMBER>related illness compared general original clinical sciencegeneral background novel coronavirus sarscov<NUMBER> coronavirus disease <NUMBER> covid <NUMBER> poses unique challenges immunosuppressed patients solid organ transplant sot recipients comprise large proportion group yet limited knowledge presentation clinical course immunosuppression management novel infection among heart lung liver pancreas kidney transplant recipients methods present <NUMBER> sot recipients diagnosed covid<NUMBER> january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> us highvolume transplant center diagnostic workup clinical course immunosuppressionantiviral management immediate outcomes described results twentyone <NUMBER> <NUMBER> symptomatic patients tested positive mean age diagnosis <NUMBER> ± <NUMBER> years median time transplant <NUMBER> years interquartile range <NUMBER> <NUMBER> median followup <NUMBER> days interquartile range <NUMBER> <NUMBER> fourteen patients required inpatient management <NUMBER> <NUMBER> placed intensive care unit icu transplant types represented nearly <NUMBER> exhibited gi symptoms half <NUMBER> presented elevated serum creatinine suggestive acute kidney injury majority patients <NUMBER> concomitant infections baseline required icu eighty percent received hydroxychloroquine ± azithromycin ten received toclizumab andor ribavirin <NUMBER> received remdesivir antimetabolites ± calcineurin inhibitors held reduced half hospitalized patients <NUMBER> discharged home <NUMBER> mortality <NUMBER> date critically ill heartkidney patient icu diagnosis conclusion covid<NUMBER> positive sot institution favorable shortterm outcomes concomitant infections severe illness data available evaluate longterm outcomes disease impact graft function transplantation <NUMBER>xxx <NUMBER> population <NUMBER> solid organ transplant sot recipients one largest cohorts immunosuppressed patients yet little known risk contracting virus postinfection outcomes effect immunosuppression clinical course disease unique challenges immunosuppression management interpretation laboratory data also exist current treatment strategies borrow upon prior experience pandemics severe acute respiratory syndrome sars influenza virus subtype <NUMBER> sarscov<NUMBER> primarily affects respiratory tract progressing pneumonia acute respiratory distress syndrome severe cases <NUMBER> cases recognized cytokine release syndrome crs occurs results multiorgan dysfunction failure <NUMBER> role immunosuppression mounting inflammatory response unclear inflammatory markers creactive protein crp lactate dehydrogenase ldh ddimer may reflect disease progression andor severity <NUMBER> lymphopenia reported common presentation among covid<NUMBER> positive patients <NUMBER> <NUMBER> treatment options limited antivirals hydroxychloroquine hcq without azithromycin widely used empiric options remdesivir rna polymerase inhibitor shown vitro activity sarscov<NUMBER> currently phase <NUMBER> trial <NUMBER> investigational agents combat cytokine response tocilizumab interleukin <NUMBER> il<NUMBER> receptor inhibitor studied although exact role immunosuppression progression covid<NUMBER> unknown early case reports kidney transplant recipients suggest minimizing immunosuppression continuing steroidal therapy <NUMBER> evaluation clinical symptoms utility biomarkers progression disease important understand optimizing management covid<NUMBER> positive sot recipients effect covid<NUMBER> heart lung liver pancreas kidney transplant organ systems well described herein present experience <NUMBER> consecutive sot recipients diagnosed covid<NUMBER> houston methodist jc walter transplant center followed april <NUMBER> <NUMBER> retrospective review covid<NUMBER> positive sot houston methodist jc walter jr transplant center houston tx january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> hospital active transplant program <NUMBER> sots completed <NUMBER> sot program started <NUMBER>s completed <NUMBER> transplants including heart lung liver kidney pancreas islet cell types multiorgan transplants data initially obtained prospectively reviewed purposes quality improvement within transplant center later analyzed retrospectively study personnel obtaining irb approval irb<NUMBER> covid<NUMBER> positive cases identified transplant center quality committee followed clinically respective transplant teams infectious disease specialists patient demographics age gender race body mass index bmi type organ transplant time transplant comorbidities angiotensinconverting enzyme inhibitor status aceiarb concomitant infections diagnostic modality clinical presentation immunosuppression regimen subsequent adjustment diagnostic findings cbc liver function tests lfts serum creatinine scr il<NUMBER> crp ddimer ldh lactate imaging results clinical course treatment modalities collected descriptive data reported median interquartile range iqr mean ± sd continuous variables frequency proportion categorical variables statistical analyses performed using stata mp v <NUMBER> <NUMBER> statacorp llc college station tx sot recipients tested covid<NUMBER> exhibited symptoms fever cough andor shortness breath sob diagnostic testing performed via reverse transcriptase polymerase chain reaction institutional laboratory patients concerning symptoms admitted monitored covid<NUMBER> unit icu test returned test positive admitted patients remained hospitalized resolution symptoms <NUMBER> negative covid<NUMBER> tests admission laboratories included cbc bmp lfts dic panel ddimer ldh crp il<NUMBER> fibrinogen serum triglycerides initial chest xray cxr andor computed tomography ct imaging evaluate pneumonia performed patients immunosuppression reduced holding antimetabolite mycophenolate mofetil mmf azathioprine without adjustment calcineurin inhibitors tacrolimus fk cyclosporine fk adjusted maintain trough <NUMBER> ngml per institutional protocol steroids either kept maintenance dose converted iv stress dosing administration hcq ± azithromycin ribavirin toclizumab remdesivir nebulized interferon α<NUMBER>b anakinra convalescent plasma based active institutional algorithm treatment nontransplant covid<NUMBER> positive patients various investigational study protocols figure <NUMBER> covid<NUMBER>specific treatment algorithms created hospitalbased multidisciplinary committee designed standardize treatment protocols prioritize potential research studies covid<NUMBER> positive patients institution group met twice weekly review hospital data covid<NUMBER>related patient outcomes evolving literature availability treatments adjust protocols necessary based committee review protocol changes implemented via hospital electronic medical records medical staff notified changes weekly hospitalwide updates algorithm divided patients based severity patient symptoms moderate symptoms defined presence fever coughsob <NUMBER> following age ≥ <NUMBER> years old presence diabetes mellitus dm coronary artery disease obesity bmi <NUMBER> ldh <NUMBER> times normal lactate ≥ <NUMBER> mmoll severe symptoms defined one following tachypnea respiratory rate <NUMBER> breathsmin hypoxia spo<NUMBER> <NUMBER> room air respiratory failure andor need icu admission due intubation status patients moderate symptoms received hcq <NUMBER> mg twice daily <NUMBER> doses followed daily <NUMBER> days patients severe symptoms received hcq dose ribavirin tapered <NUMBER> mg <NUMBER> times daily <NUMBER> mg daily <NUMBER> days azithromycin given depending qtc interval dosed <NUMBER> mg × <NUMBER> dose <NUMBER> mg <NUMBER> days crs grading system initially used institution monitoring chimeric antigen receptor tcell therapy adapted use covid<NUMBER> patients utilizing presence fever hypotension hypoxia guide initiating tocilizumab addition transplant patients immunosuppression medical management adjusted per daily inpatient multidisciplinary review specific organ type collaboration infectious disease consultants icu patients managed transplant teams infectious disease consultants intensivist transplant patients admitted managed transplant physicians infectious disease consultants instructed selfisolate monitor temperature daily scheduled weekly electronic followup outpatient medications adjusted reducing antimetabolite maintaining fk trough <NUMBER> ngml applicable <NUMBER> sots actively followed houston methodist jc walter jr transplant center <NUMBER> patients tested covid<NUMBER> april <NUMBER> <NUMBER> <NUMBER> <NUMBER> tests performed kidney transplant recipients fewer performed liver <NUMBER> <NUMBER> lung <NUMBER> <NUMBER> heart <NUMBER> <NUMBER> heart multiorgan <NUMBER> <NUMBER> kidneypancreas transplant <NUMBER> <NUMBER> liver multiorgan kidney <NUMBER> <NUMBER> ninetytwo percent <NUMBER> inpatient tests compared <NUMBER> <NUMBER> outpatient nearly <NUMBER> <NUMBER> transplant patients tested positive <NUMBER> <NUMBER> kidney transplant recipients covid<NUMBER> positive patients include liver <NUMBER> lung <NUMBER> heartlung <NUMBER> liver kidney <NUMBER> heartkidney <NUMBER> kidneypancreas <NUMBER> data summarized table <NUMBER> demographics covid<NUMBER> positive patients average age <NUMBER> ± <NUMBER> years old time diagnosis five patients age <NUMBER> oldest <NUMBER> years old <NUMBER> <NUMBER> covid<NUMBER> positive recipients male majority cases occurred caucasian patients <NUMBER> <NUMBER> average bmi <NUMBER> ± <NUMBER> kg <NUMBER> median time transplant <NUMBER> years iqr <NUMBER> <NUMBER> heartkidney patient recent transplant <NUMBER> years diagnosed index transplant hospitalization majority sarscov<NUMBER> patients <NUMBER> <NUMBER> least <NUMBER> comorbidity hypertension dm obesity chronic lung disease cardiovascular disease <NUMBER> patients <NUMBER> ace inhibitors eightyone percent <NUMBER> patients triple maintenance immunosuppression involving calcineurin inhibitor fk cyclosporine antimetabolite mmf azathioprine prednisone time diagnosis <NUMBER> patients <NUMBER> concomitant infections <NUMBER> patients tested positive <NUMBER> <NUMBER> presented fever cough andor sob group included <NUMBER> patients <NUMBER> also presented gi symptoms diarrhea vomiting abdominal pain secondary symptoms included encephalopathy <NUMBER> hallucinations <NUMBER> dysosmia dysgeusia <NUMBER> hypercoagulability ischemic limb <NUMBER> majority <NUMBER> patients tested positive first test remaining <NUMBER> <NUMBER> patient positive third attempt diagnostic imaging cxr andor ct scan obtained <NUMBER> patients one patient prior kidney transplant presented fever gi symptomatology tested covid<NUMBER> chest infiltrate suspicious covid<NUMBER> pneumonia identified cxr abdominal ct imaging results <NUMBER> patients <NUMBER> reveal acute findings suggestive covid<NUMBER> pneumonia remaining <NUMBER> patients imaging demonstrating groundglass opacities andor infiltrates multilobar involvement data summarized table <NUMBER> seven patients <NUMBER> lungheart liver kidney transplants mild disease treated outpatients <NUMBER> hospitalized patients included <NUMBER> kidney transplant recipients <NUMBER> <NUMBER> lung <NUMBER> <NUMBER> liver <NUMBER> <NUMBER> kidneypancreas <NUMBER> <NUMBER> liverkidney <NUMBER> <NUMBER> heartkidney <NUMBER> <NUMBER> inpatients <NUMBER> outpatients transplant protocol laboratory tests time covid<NUMBER> testing laboratory data summarized table <NUMBER> median wbc admission <NUMBER> kµl iqr <NUMBER> <NUMBER> range <NUMBER> median absolute lymphocyte count <NUMBER> cellsmm <NUMBER> iqr <NUMBER> <NUMBER> median crp <NUMBER> mgdl iqr <NUMBER> <NUMBER> <NUMBER> mgdl <NUMBER> <NUMBER> median ddimer <NUMBER> µg ml iqr <NUMBER> <NUMBER> il<NUMBER> ranged <NUMBER> <NUMBER> pg ml abnormal <NUMBER> <NUMBER> patients one liver kidney patient il<NUMBER> <NUMBER> pgml concomitant soft tissue infections mucormycosis pseudomonas extremities covid<NUMBER> diagnosis patients lfts normal except <NUMBER> kidney transplant recipient presented acute hepatitis lactate levels elevated <NUMBER> patients heartkidney liverkidney clinical evidence sepsis median ldh <NUMBER> iqr <NUMBER> <NUMBER> median scr presentation <NUMBER> mgdl iqr <NUMBER> <NUMBER> range <NUMBER> eleven patients <NUMBER> elevated scr suggestive acute kidney injury aki number include heartkidney patient diagnosed index transplant admission maintenance dialysis testing covid<NUMBER> <NUMBER> patients admitted <NUMBER> <NUMBER> admitted icu <NUMBER> icu patients <NUMBER> required ventilatory support table <NUMBER> one patients critically ill heartkidney recipient tracheostomy ventilator diagnosed covid<NUMBER> requiring icu monitoring consisted kidney <NUMBER> heartkidney <NUMBER> kidneypancreas <NUMBER> liverkidney <NUMBER> lung transplant <NUMBER> recipients immunosuppression adjusted reducing holding mmf azathioprine <NUMBER> maintaining baseline steroid dose inpatients fk kept trough level <NUMBER> <NUMBER> ngml <NUMBER> patients required dose reduction reach goal one patient liverkidney administered highdose steroids azithromycin ± hcq administered <NUMBER> <NUMBER> hospitalized patients <NUMBER> outpatient heartkidney patient deaths group tocilizumab given <NUMBER> patients <NUMBER> kidney <NUMBER> kidneypancreas <NUMBER> icu <NUMBER> inpatient floor deaths tocilizumab group <NUMBER> patients received tocilizumab <NUMBER> icu patient <NUMBER> inpatient require ventilatory support floor patient discharged home <NUMBER> days hospital remdesivir given liver transplant patient patient require icu admission discharged home <NUMBER> days six patients received ribavirin one patient prior kidney transplant received nebulized interferon α<NUMBER>b patient remains intubated icu another patient kidneypancreas transplant received anakinra patients condition worsened patient received convalescent plasma emergency use authorizationemergency investigational new drug patient currently extubated continues monitored icu date <NUMBER> patient expired patient heartkidney transplant recipient atypical prolonged postoperative transplant course covid<NUMBER> diagnosis four months hospitalization heart failure patient received combined heart kidney transplant required venoarterial extracorporeal membrane oxygenation followed intraaortic balloon pump support vasopressors dialysis delayed graft function required tracheostomy prolonged ventilatory support eventually developing e coli esbl pneumonia deconditioned due prolonged immobilization two months transplant patient developed fungal infiltration heart allograft continued require dialysis intermittent fevers suspicious sick contact patient tested covid<NUMBER> time diagnosis ddimer elevated <NUMBER> µgml lymphopenia absolute lymphocyte count <NUMBER> cellsmm <NUMBER> received hcq ribavirin patient expired <NUMBER> days diagnosis remaining <NUMBER> patients icu <NUMBER> discharged home <NUMBER> continue managed icu remaining <NUMBER> inpatients discharged home median length stay discharged <NUMBER> days iqr <NUMBER> <NUMBER> median icu days date <NUMBER> days iqr <NUMBER> <NUMBER> outpatients require hospitalization continued monitored outpatient median followup days date patients <NUMBER> days iqr <NUMBER> <NUMBER> case series describe <NUMBER> consecutive sot recipients diagnosed covid<NUMBER> majority patients relatively favorable shortterm outcomes mortality rate <NUMBER> nearly <NUMBER> inpatients discharged home nonhospitalized patients successfully managed outpatient setting mortality rate reflective us patients general population currently estimated around <NUMBER> <NUMBER> preliminary outcomes show lower mortality rate compared recently published series kidney transplant recipients alone sot uk new york montefiore columbia cornell madrid reported <NUMBER> <NUMBER> <NUMBER> rates respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> locations <NUMBER> centers significantly higher number covid<NUMBER> cases date general population compared houston approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively versus <NUMBER> <NUMBER> <NUMBER> new york epicenter covid<NUMBER> outbreak united states multicenter report sot columbia cornell observed worse outcomes transplant patients compared nontransplant patients higher rates severe disease mortality among hospitalized <NUMBER> several differences among cohort patients compared published reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> case series highest mortality rates madrid montefiore described patients higher median age <NUMBER> <NUMBER> years respectively compared <NUMBER> years center hospitalization rate somewhat lower seen montefiore <NUMBER> versus <NUMBER> <NUMBER> suggesting earlier presentation andor diagnosis patients respiratory insufficiency alone associated worse outcomes columbia cornell reports <NUMBER> patients concomitant infections highest need icu care worse outcomes similar published reports <NUMBER> measured inflammatory markers uniformly elevated presentation patients appear correlation inflammatory markers patient outcomes lymphopenia common finding nontransplant covid<NUMBER> patients <NUMBER> <NUMBER> also present cohort kidney transplant patients montefiore despite prevalence lymphopenia significance transplant patients outcome disease progression remains unknown unlike covid<NUMBER>related risk factors associated severe illness general population <NUMBER> observed columbia cornell experience <NUMBER> age ≥<NUMBER> years presence comorbidity appear play factor prognosis cohort <NUMBER> patients ≥<NUMBER> years old center <NUMBER> admitted <NUMBER> patient admitted icu without ventilatory support transfer outside hospital deaths older patients atrisk comorbidities hypertension dm obesity chronic lung disease cardiovascular disease <NUMBER> <NUMBER> <NUMBER> present <NUMBER> transplant patients suggesting comorbidities drive hospitalization severity illness additionally half <NUMBER> obese patients bmi ≥ <NUMBER> kgm <NUMBER> cohort treated outpatient setting also observed <NUMBER> patients presented elevated scr suggestive aki <NUMBER> although majority covid<NUMBER> positive patients kidney transplants <NUMBER> <NUMBER> <NUMBER> patients elevated scr kidney transplant recipients observed trend elevated scr higher <NUMBER> reported general population <NUMBER> <NUMBER> <NUMBER> observed case series kidney transplant recipients columbia <NUMBER> uk <NUMBER> observation may reflect potential association sarscov<NUMBER> uptake via ace<NUMBER> proximal tubular epithelium kidney thus increasing risk aki <NUMBER> despite uncertainty lack evidence regarding optimal management covid<NUMBER> transplant patients approach management focused primarily early diagnosis treatment reduction immunosuppression onset covid<NUMBER> positive cases region devised testing protocol sot would performed outpatient setting transplant center isolated area hospital hours patients instructed wear masks selfisolate similar columbia experience <NUMBER> utilized telemedicine aid triage symptomatic patients followup selfisolation patients exhibited symptoms suggestive covid<NUMBER> ie fever cough sob tested assigned designated transplant covid<NUMBER> isolation unit home depending severity symptoms antiviral therapy initiated early following positive test inpatients hospitalized patients early part experience received hcq ± azithromycin although use azithromycin since removed current protocol hcq restricted mostly clinical trials patients symptom progression immediately evaluated enrollment clinical studies applicable although early case series reported withholding fk across patients <NUMBER> critically ill <NUMBER> opted keep fk low levels experimental evidence calcineurin inhibitors may inhibit coronavirus replication <NUMBER> also continued maintenance steroid dosing reserving high dose steroids critically ill deteriorating patients several patients exhibited severe symptoms presentation received immunomodulatory therapy tocilizumab one patient received remdesivir shortterm outcomes agents positive adverse events infection deaths <NUMBER> patient group discharged home effect immunosuppression progression covid<NUMBER> unclear may dependent severity disease institutional algorithm borrows theoretical framework siddiqi et al <NUMBER> pathologic response covid<NUMBER> consists <NUMBER> phases viral phase host inflammatory phase early viral phase host autoimmunity important recovery viral infection similar management cytomegalovirus bk virus sot reduction immunosuppression necessary combat viral replication host response phase immunosuppression may beneficial reducing inflammatory sequalae cytokine response otherwise lead multiorgan dysfunction failure <NUMBER> use cytokine inhibitors may potentially beneficial later stage although may concern immunosuppression may increase risk secondary infection observe none inpatients developed subsequent infection intriguing speculate transplant patients may progress crs present immunosuppression immunomodulatory state related longterm immune suppression although hypothesis needs investigation substantiate paper retrospective review <NUMBER> covid<NUMBER> positive sots us highvolume transplant center although able describe patients provide shortterm outcomes unable make definitive conclusions regarding longterm outcomes treatment strategies patient population given limitations singlecenter observational study additionally standardized treatment protocol covid<NUMBER> positive patients center protocols constantly adjusted based new data growing number covid<NUMBER> published reports limitations improved upon future publications experience covid<NUMBER> continues grow future studies include evaluation graft function rejection risk via monitoring donorspecific antibodies longterm impact antivirals immunomodulatory therapy tocilizumab nebulized interferon alpha anakinra inflammatory markers disease progression comparison covid<NUMBER> outcomes transplant versus nontransplant patients according world health organization sarscov<NUMBER> infected close three million caused death <NUMBER> <NUMBER> individuals worldwide april <NUMBER>th <NUMBER> <NUMBER> prevalence covid<NUMBER> children remains low date <NUMBER> cases reported canada april <NUMBER>rd <NUMBER> <NUMBER> <NUMBER> patients aged <NUMBER> years old <NUMBER> <NUMBER> hospitalized two admitted intensive care unit deaths reported data gathered us february <NUMBER>th <NUMBER> april <NUMBER>nd <NUMBER> indicated <NUMBER> cases <NUMBER> <NUMBER> <NUMBER> children <NUMBER> underlying conditions <NUMBER> <NUMBER> hospitalized included three deaths <NUMBER> february <NUMBER>th <NUMBER> china reported <NUMBER> confirmed cases mainland china <NUMBER> <NUMBER> children one reported death <NUMBER> april <NUMBER>rd <NUMBER> total <NUMBER> cases reported germany <NUMBER> <NUMBER> <NUMBER> years old <NUMBER> <NUMBER> aged <NUMBER> <NUMBER> years old <NUMBER> numbers hospitalizations deaths available finally march <NUMBER>th <NUMBER> <NUMBER> cases reported republic korea <NUMBER> <NUMBER> pediatric deaths reported <NUMBER> based current available evidence children appear higher risk contracting covid<NUMBER> adults <NUMBER> however children comorbidities may vulnerable severe covid<NUMBER> disease <NUMBER> indeed children neurological neuromuscular conditions increased risk respiratory failure hospitalized influenza another viral infection <NUMBER> symptom manifestation children appears milder adults <NUMBER> <NUMBER> incidence individuals <NUMBER> years age quite low <NUMBER> <NUMBER> <NUMBER> children could even less susceptible covid<NUMBER> disease <NUMBER> best knowledge review searched impact covid<NUMBER> children brainbased disabilities affected covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> rapid review commissioned strategy patientoriented research spor funded childbright network innovative pancanadian network aims improve life outcomes children brainbased developmental disabilities families httpswwwchildbrightca concerned potential impact novel coronavirus children brainbased developmental disabilities requested support spor evidence alliance conduct rapid review within twoweek period topic thus review aimed answer following questions <NUMBER> children brainbased developmental disabilities likely develop covid <NUMBER> children brainbased developmental disabilities likely develop complications due covid<NUMBER> <NUMBER> children brainbased developmental disabilities likely poorer prognosis develop covid<NUMBER> engaged panel knowledge users patients caregivers clinicians decision makers researchers childbright network throughout review process question development literature search interpretation writing results dissemination findings ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint conducted rapid review based proposed methodology guide cochrane rapid reviews methods group <NUMBER> report results based preferred reporting items systematic reviews metaanalyses prisma statement <NUMBER> experienced medical information specialist developed search strategies iterative process consultation review team panel knowledge users used combination controlled vocabulary keywords eg coronavirus infections coronavirus child strategies adjusted vocabulary syntax across databases initially also included vocabulary keywords specific brainbased developmental disabilities removed piloting strategy yielded citations included review language restrictions searches possible animalonly records removed results limited results publication years <NUMBER> present specific details regarding strategies appear appendix <NUMBER> included studies reviews identified searches reviewed reference lists original studies crossreferenced list articles provided content experts knowledge users panel considering fast pace information becomes available context covid<NUMBER> developed grey literature search strategy consultation experienced medical information specialist consisted preprint articles ssrn medrxiv last consulted april <NUMBER> rd <NUMBER> ongoing trials international clinical trials registry platform last consulted april <NUMBER> rd <NUMBER> ongoing reviews ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint prospero last consulted april <NUMBER> rd <NUMBER> government health organizations websites reports consulted april <NUMBER> th april <NUMBER> th <NUMBER> appendix <NUMBER> followed peco framework establishing eligibility criteria <NUMBER> <NUMBER> table <NUMBER> considered study primary data included children aged zero <NUMBER> brainbased developmental disability risk developing disability confirmed suspected covid<NUMBER> see appendix <NUMBER> full list children <NUMBER> years brainbased developmental disabilities eg cerebral palsy autism developmental delay attention deficit hyperactivity disorder severe impairments risk developing brainbased disabilities eg premature congenital heart diseasedefect covid<NUMBER> outcome four reviewers individually performed screening titles abstracts full text using pilottested standardized forms <NUMBER> five citations respectively level screening developed standardized extraction form included study eg authors country study design case characteristics eg type disability age complications outcome reported single reviewers extracted data confirmed senior reviewer resolved discrepancies discussion risk bias performed due short turnaround timeline report data using narrative approach includes tables study characteristics detailed reporting case characteristics complications outcomes data synthesis focused providing descriptive summary inform knowledge users ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> search strategy identified <NUMBER> individual records following screening titles abstracts excluded <NUMBER> records fulltext screening <NUMBER> records excluded additional <NUMBER> records resulting total four records included review <NUMBER> figure <NUMBER> grey literature search identify ongoing trials preprint articles research regarding children brainbased developmental disabilities four included studies one case report <NUMBER> one cohort study <NUMBER> one retrospective crosssectional analysis <NUMBER> one retrospective study medical records <NUMBER> table <NUMBER> three studies took place wuhan hubei province china <NUMBER> <NUMBER> <NUMBER> one ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint us <NUMBER> four included studies reported total <NUMBER> pediatric patients <NUMBER> infected suspected infected identify study reporting children brainbased developmental disabilities included studies reported children risk developing brainbased developmental disability two studies included preterm infants <NUMBER> <NUMBER> others included children congenital heart disease epilepsy <NUMBER> <NUMBER> detailed information available three four studies <NUMBER> <NUMBER> <NUMBER> table <NUMBER> symptoms preterm infants ranged single fever overall mild symptoms <NUMBER> <NUMBER> one infant developing complications fetal distress neonatal respiratory distress syndrome pneumonia suspected sepsis requiring resuscitation birth <NUMBER> preterm infant ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint without complications discharged stable condition <NUMBER> whereas infant developing complications saw condition resolve day <NUMBER> life <NUMBER> children congenital heart disease expressed symptoms including cough dyspnea fever diarrhea required pediatric intensive care invasive mechanical ventilation <NUMBER> symptoms later partially significantly alleviated <NUMBER> fourth study identified one patient epilepsy resulting sequela previous encephalitis two history atrial septal defect surgery individual information available <NUMBER> overall symptoms mild eighteen <NUMBER> children cured discharged average stay <NUMBER> days <NUMBER> days ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint prevalence covid<NUMBER> children reported low however unable find information regarding prevalence coronavirus children brainbased developmental disabilities identify study investigating effects covid<NUMBER> children brainbased disabilities identify four studies discussing coronavirus disease children considered risk disability preterm infants children preexisting medical conditions although children included studies develop complications symptoms reported partially significantly alleviated resolved patients discharged hospital deaths reported results accordance studies covid<NUMBER> children reported symptoms pediatric population appeared milder adults occurrence death rare <NUMBER> <NUMBER> <NUMBER> review highlights lack evidence regarding effects covid<NUMBER> children brainbased disabilities atrisk conditions indeed appears though specific population overlooked lack data could due low occurrence rates well milder symptoms previously reported children <NUMBER> <NUMBER> <NUMBER> addition possible due milder absent symptoms cases simply get reported however clinical guidelines centers disease control prevention cdc clearly state individuals age underlying conditions including congenital heart disease may higher risk developing moderate severe symptoms covid<NUMBER> <NUMBER> moreover unicef warns children underlying disabilities may greater risk developing complications <NUMBER> data including presence brainbased disabilities atrisk conditions children required better understanding clinical impacts covid<NUMBER> potentially vulnerable populations goal mind one ongoing review currently examining comorbidities adult pediatric populations <NUMBER> rapid review limitations due study design screenings data extractions performed single reviewers however perform pilottesting review form optimize consistency reviewers despite best efforts identify relevant ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint studies relevant documentation possible missed due rapid flow new information becomes available rapid review identified knowledge gaps literature regarding effects covid<NUMBER> children developmental brainbased disabilities risk developing disabilities without data regarding children highrisk populations difficult decisionmakers determine best course action medical treatment also reintegration children disabilities school community regards eventually alleviated confinement measures severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spread worldwide respiratory complications pneumonia acute respiratory distress syndrome cardiac manifestations drawn attention due increased risk mortality morbidity related sarscov<NUMBER> infections mechanisms cardiac injury related sarscov<NUMBER> infections direct cardiac injury caused angiotensin converting enzyme <NUMBER> hypoxemia microvascular damage systemic inflammatory response stress induced cardiomyopathy critically ill condition acute coronary syndrome due vulnerable plaque rupture coagulopathy finally lead acute heart failure cardiac manifestations dealing highly contagious viral diseaserelated cardiac manifestations carefully apply diagnostic therapeutic methods achieve best therapeutic results without adding risk disease transmission updates cardiovascular manifestations covid<NUMBER> korean experience broaden worldwide perspectives coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spread worldwide <NUMBER> <NUMBER> <NUMBER> first case december <NUMBER> <NUMBER> wuhan outbreaks become pandemic within three months tremendous socioeconomic impact <NUMBER> south korea first sarscov<NUMBER> infection confirmed january <NUMBER> <NUMBER> <NUMBER> onemonth quiescent period outbreak started cult daegu february <NUMBER> <NUMBER> cases south korea occurred daegu north gyeongsang province together account <NUMBER> total korean population <NUMBER> million residents<NUMBER> million daegu <NUMBER> million north gyeongsang province figure <NUMBER> case fatality rate covid<NUMBER> worldwide exceeded <NUMBER> higher mortality found patients older age age <NUMBER> years history cardiovascular respiratory metabolic disorders <NUMBER> respiratory complications pneumonia acute respiratory distress syndrome ards cardiac manifestations drawn attention due increased risk mortality morbidity related underlying cardiovascular disease cvd common patients previous coronavirus infection severe acute respiratory syndrome sars middle east respiratory syndrome mers thought angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor coronavirus responsible increased incidence cardiac involvement <NUMBER> sars prevalence underlying cvd <NUMBER> twelvefold increased risk death <NUMBER> <NUMBER> mers cvd present approximately <NUMBER> patients also higher mortality reported patients <NUMBER> <NUMBER> increased presence cardiovascular comorbidities also noted covid<NUMBER> well notably among severe disease <NUMBER> <NUMBER> <NUMBER> prevalence cvd sarscov<NUMBER> infections reported previous reports ranges <NUMBER> depending patients characteristics disease severity <NUMBER> although mechanism association cvd sarscov<NUMBER> infection clearly identified explained fact cvd prevalent advancing age functionally impaired immune system elevated levels ace<NUMBER> predisposition covid<NUMBER> cvd <NUMBER> cardiac injury defined abnormality observed cardiac biomarkers electrocardiography echocardiography previous studies table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however definition study varies unified consensus definition covid<NUMBER> associated cardiac injury even though high incidence substantial impact cardiac injury always possible evaluate whole set cardiac injury general tests cardiac manifestation covid<NUMBER> performed patient cardiac symptoms chest pain dyspnea cardiomegaly observed chest xray chest computed tomography ct physician considered test necessary cases unstable vital sign cardiac injury associated covid<NUMBER> diagnosed one parameters positive cardiac enzyme elevation newonset first detected abnormality electrocardiography newonset first detected abnormality echocardiography diagnosis covid<NUMBER> associated cardiac injury investigation etiology decision future treatment strategy assessment prognosis need proceeded figure <NUMBER> incidence cardiac injury associated sarscov<NUMBER> infection reported <NUMBER> overall patients <NUMBER> nonicu patients <NUMBER> icu patients <NUMBER> reports incidence cardiac injury reach <NUMBER> accordance definitions patient characteristics <NUMBER> <NUMBER> incidence cardiomyopathy icu patients treated covid<NUMBER> <NUMBER> mortality study population <NUMBER> <NUMBER> mortality covid<NUMBER> caused mainly respiratory failure due severe acute pneumonia however systemic inflammatory response syndrome including cytokine storm myocardial damage acute fulminant myocarditis arrhythmic manifestations lead sudden cardiac death <NUMBER> <NUMBER> regard cardiac injury related sarscov<NUMBER> infection considered important issue patients previous history coronary vascular disease evidence cardiac injury elevated cardiac enzymes troponint levels higher incidence mortality <NUMBER> cardiac injury related sarscov<NUMBER> infection explained several mechanisms figure <NUMBER> first mechanism ace<NUMBER>mediated direct cardiac damage ace<NUMBER> identified functional receptor coronaviruses sarscov<NUMBER> infection triggered binding spike protein virus ace<NUMBER> highly expressed <NUMBER> httpsekcjorg httpsdoiorg<NUMBER>kcj<NUMBER> evaluation cardiac manifestation covid · cardiac symptoms chest pain dyspnea · cardiomegaly chest xray ct · unstable vital sign · physician discretion cardiac evaluation diagnosis covid associated cardiac injury one following positive · cardiac enzyme elevation th percentile url ckmb tni tnt · new onset first detected abnormality electrocardiography · new onset first detected abnormality echocardiography heart lungs second one hypoxiainduced myocardial injury oxidative stress intracellular acidosis mitochondrial damage followed hypoxia might result cardiac injury previously significantly lower oxygen saturation levels higher incidence dyspneic symptoms noted cardiac injury patients third cardiac microvascular damage caused vessel hyperpermeability angiospasms conditions inflammation fourth mechanism systemic inflammatory response syndrome cytokine storm caused inadequate responses type <NUMBER> type <NUMBER> helper cells may contribute myocardial injury <NUMBER> fulminant myocarditis related immunologic response viral infection <NUMBER> <NUMBER> <NUMBER> fifth explained epicardial coronary artery occlusions due acute plaque rupture owing coagulopathy plaque instability driven systemic inflammatory response last one stressinduced cardiomyopathy severe stress course sarscov<NUMBER> infection <NUMBER> cardiac injury related covid<NUMBER> cannot explained separately mechanism multiple factors affect cardiomyocytes epicardial coronary arteries coronary microvasculature various way timepoint disease trajectory <NUMBER> evaluation major mechanism cardiac injury covid<NUMBER> important set therapeutic strategies acute coronary syndrome although true incidence unclear acute coronary syndrome acs occur covid<NUMBER> patients risk acs sarscov<NUMBER> infected patients may increased due increased thrombotic tendency evidenced elevated ddimer levels previous studies <NUMBER> <NUMBER> inflammatory milieu endothelial smooth muscle cell activation macrophage activation tissue factor expression atheromatous plaque platelet activation elaboration inflammatory mediators precipitate plaque rupture resulting acs <NUMBER> typical type <NUMBER> myocardial infarction mi type <NUMBER> mi related increased demand virus infection develop especially patients underlying coronary artery disease <NUMBER> frequently symptoms infection signs nonischemic cardiac injury masquerade acs therefore high index suspicion alternative diagnosis mandatory utilizing noninvasive diagnostic methods cardiac biomarkers electrocardiography echocardiography cardiac ct <NUMBER> given risk infection spreading patients healthcare providers transportation procedure adjusting protocols acs treatment increasing consideration thrombolytics considered many centers virus pandemic <NUMBER> increased evidences shown covid<NUMBER> burdened higher risk arrhythmic events related risk mortality <NUMBER> palpitations reported one common initial symptoms disease <NUMBER> <NUMBER> <NUMBER> hospitalized covid<NUMBER> patients arrhythmias represented leading complication <NUMBER> acute respiratory distress syndrome increased risk <NUMBER> admitted intensive care units serious arrhythmic complications ventricular tachycardia ventricular fibrillation found <NUMBER> cases <NUMBER> risk arrhythmias associated cardiomyopathy caused cardiac injury possibly related usage antiviralantibacterial medications causing qtprolongation <NUMBER> physicians keep mind risk increased arrhythmic events covid<NUMBER> patients significantly affect overall mortality close monitoring arrhythmic events careful decision making antiviralantibacterial medications crucial especially serious disease status vulnerable status several reports sarscov<NUMBER> cardiac involvement presentation acute myocarditis <NUMBER> pathogenesis cardiac involvement associated sarscov<NUMBER> may reflect process replication dissemination virus blood lymphatic system respiratory tract tavazzi et al <NUMBER> reported myocardial localization sarscov<NUMBER> myofibrillar lysis inflammatory cell infiltration acute phase covid<NUMBER> general immunologic response viral myocarditis follows first viral entry activation innate immune response takes <NUMBER> days infection second activation acquired immune response natural killer cells macrophages tlymphocytes takes <NUMBER> weeks lastly either recovery clearance virus disease progression delayed ineffective viral clearance chronic inflammation takes months years <NUMBER> extent local tissue damage cytokine storm triggered host immune response contribute severity myocarditis exaggerated inflammatory response extremely fatal immunomodulators corticosteroids considered selected cases even though efficacy safety questionable <NUMBER> combined mechanisms related host immune response multiple factors responsible cardiac consequence covid<NUMBER> oxygen supply demand imbalance without coronary artery disease increased right ventricular afterload due respiratory acidosis hypoxemia positive pressure ventilation <NUMBER> even though difficult discriminate possible mechanisms related myocarditis accordingly effort identify dominant cause necessary selection proper target treatment patients sarscov<NUMBER> infection related cardiac injury including myocarditis could present acute decompensated heart failure hf figure <NUMBER> might hf reduced preserved ejection fraction <NUMBER> infection one major precipitating factors acute decompensation hf patients admitted acute hf precipitated infection high <NUMBER>day risk death <NUMBER> necessary exert every effort reduce risk sarscov<NUMBER> infections patients hfsocial distancing hand washing wearing personal protective equipment reducing unnecessary hospital visits <NUMBER> maintaining optimal guideline directed medical therapy including angiotensin converting enzyme inhibitors acei angiotensin receptor blockers arb also highly recommended since sufficient evidence discontinue critical medications concern increased viral invasion due increased expression ace<NUMBER> <NUMBER> issue discussed detail later separated part thrombosis common consequence infection associated poor patient outcome many viral infections affect pathways hemostasis coagulation inducing either thrombotic hemorrhagic complications <NUMBER> patients pneumonia caused influenza infection occurrence venous thromboembolisms shown increased <NUMBER> assessing risk venous thromboembolisms essential especially covid<NUMBER> patients critical condition early reports china showed higher prothrombin time ddimer level admission icu patients covid<NUMBER> compared nonicu patients <NUMBER> retrospective analysis <NUMBER> covid<NUMBER> patients also revealed higher ddimer fibrin degradation product nonsurvivals <NUMBER> patients covid<NUMBER> critical condition would complications renal failure respiratory failure liver dysfunction affect venous thromboembolisms bleeding status <NUMBER> among patients covid<NUMBER> high risk venous thromboembolism <NUMBER> <NUMBER> <NUMBER> also high risk bleeding <NUMBER> therefore anticoagulation considered balance thrombotic risk bleeding risk covid<NUMBER> patients indicated anticoagulation therapy dose duration drug adjusted individually nonmedical prophylactic measures need fully utilized mechanical compressions elastic compression stockings intermittent pneumatic compression although cardiac manifestation covid<NUMBER> important issue thorough examination cardiac injury using advanced diagnostic modalities often limited owing risk disease transmission diagnostic procedures shortage medical resources <NUMBER> <NUMBER> careful planning evaluation strategy cardiovascular manifestations mandatory covid<NUMBER> patients protect healthcare providers noninfected patients time save infected patients several instructions needed prevent infection spreading diagnostic procedures primary evaluation management procedures including laboratory tests electrocardiography echocardiography carried negative pressure isolation room patient needs evaluation different location hospital administration infection control departments need arrange patients transfer routes using portable isolation bed minimize exposure facilities cardiac ct magnetic resonance imaging rooms evacuated scan <NUMBER> hours sterilization according infection control strategy hospital <NUMBER> principle treatment cardiac manifestations covid<NUMBER> deliver timely therapeutic modalities reduced risk disease spread cardiac manifestations mostly urgent prudent approach crucial avoid infection transmission medical staff predicted outcomes different selecting less invasive therapeutic modality highly recommended <NUMBER> furthermore proper utilization telehealth including telephonic consultations proxy prescriptions may considered highly contagious virus outbreak <NUMBER> concern using acei arb covid<NUMBER> patients owing role altering ace<NUMBER> acts functional receptor sarscov<NUMBER> <NUMBER> high incidence sarscov<NUMBER> infections patients hypertension heart failure cardiovascular disease common reninangiotensinaldosterone system raas blocker users increased suspicion harmful effects <NUMBER> inconsistent results previous animal models respect effects raas inhibitors ace<NUMBER> also raised controversy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> beneficial effect acei arb suggested attenuating local raas activation unopposed angiotensin ii accumulation caused continued viral infection replication contribute reducing membrane ace<NUMBER> expression <NUMBER> concrete evidence proven benefit discontinue raas blockers well established medications improve outcomes various diseases hypertension myocardial infarction chronic kidney disease heart failure furthermore abrupt withdrawal highrisk patients may result clinical instability adverse outcomes therefore need maintain raas inhibitors covid<NUMBER> patients previous guidelines recommend heart transplant patients high risk infection challenges exist regarding maintenance immunosuppression therapy infection raise risk graft rejection case study two heart transplant patients hubei province china confirmed sarscov<NUMBER> infection revealed typical symptoms patients one milder presentation required hospitalization cessation immunosuppression along treatment methylprednisolone intravenous immunoglobulin <NUMBER> routine preventive measures well adopted incidence infection heart transplant patients minimized survey <NUMBER> heart transplant recipients wuhan china find higher risk infection sarscov<NUMBER> <NUMBER> may <NUMBER>st confirmed heart transplant patients reported south korea recommended continue heart transplantations unless risk infection spreading presents procedure surveillance donor recipient related healthcare providers needs performed per individual organizations protocol based date guideline recommendations <NUMBER> even though evidence lacking current consensus management heart transplant recipients developed covid<NUMBER> deliver best supportive treatment viral infection continuation immunosuppression mild disease serious disease reduction antimetabolites mycophenolate azathioprine treatment immunomodulators need considered <NUMBER> since proven therapy sarscov<NUMBER> mainstay treatment patients covid<NUMBER> remains supportive care including symptomatic treatment minor symptoms full intensive care support serious complications contemporary candidate drugs interleukin<NUMBER> inhibitors tocilizumab sarilumab type <NUMBER> transmembrane serine protease inhibitor camostat mesylate membrane fusion endocytosis inhibitors chloroquine hydroxychloroquine arbidol <NUMBER>chymotrypsinlike protease inhibitors lopinavir darunavir viral rnadependent rna polymerase inhibitors ribavirin remdesivir favipiravir <NUMBER> among chloroquine hydroxychloroquine lopinavir ritonavir ribavirin repurposed agents previously used treat sars mers <NUMBER> <NUMBER> recently remdesivir showed efficacy reducing hospitalization compared placebo <NUMBER> covid<NUMBER> patients randomized control trial <NUMBER> compassionate use remdesivir <NUMBER> patients severe covid<NUMBER> also revealed <NUMBER> clinical improvement <NUMBER> adjunctive therapies corticosteroids anticytokine immunomodulatory agents immunoglobulin therapy also considered selected cases applied caution owing serious complications cause <NUMBER> <NUMBER> clinical trials underway investigate effective medications vaccines overcome covid<NUMBER> important method point would keeping basic preventive measures wearing personal protective equipment hand sanitizing social distancing substantial evidence suggested nonnegligible incidence cardiac injury related covid<NUMBER> although clinical significance exact mechanisms investigation aware potentially fatal cardiac manifestations dealing patients covid<NUMBER> prudent selection diagnostic therapeutic methods outbreak crucial obtain best therapeutic results without adding risk disease transmission ventricular tachycardia vt important cause morbidity mortality patients structural heart disease implantable cardioverterdefibrillators icds enhance survival effectively terminating vts however icd shocks associated increase mortality reduction quality life <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one main approaches reduce risk shocks optimization icds programming highrate delayed therapy windows <NUMBER> <NUMBER> nevertheless shocks eliminated additional therapies often required prevent events main two options antiarrhythmic drug aad therapy catheter ablation ca different antiarrhythmic drugs associated increased mortality patients structural heart disease ineffective controlling ventricular arrhythmias poorly tolerated <NUMBER> <NUMBER> <NUMBER> drugs shown reduction vt episodes randomized clinical trials rcts amiodarone sotalol rcts demonstrated drugs reduce vt recurrences patients icd however efficacy moderate benefit overall mortality significant side effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonetheless based current expert consensus statement <NUMBER>•• referral catheter ablation usually prompted failure aads control vt episodes review focus status timing catheter ablation vt patients icd therapies latest expert consensus <NUMBER>•• class indications catheter ablation patients ischemic heart disease include <NUMBER> ablation vt storm refractory aad therapy different papers demonstrated benefit terms recurrences mortality group <NUMBER> <NUMBER> <NUMBER> metaanalysis <NUMBER> patients undergoing catheter ablation vt storm showed odds death four times higher failed procedure compared successful one article part topical collection invasive electrophysiology pacing failure acute procedure carried high mortality risk <NUMBER> patients recurrent vt despite chronic amiodarone therapy catheter ablation recommended preference escalating aad therapy vanish randomized clinical trial <NUMBER> significantly lower rate composite primary outcome death ventricular tachycardia storm appropriate icd shock observed among patients undergoing catheter ablation among receiving escalation antiarrhythmic drug therapy <NUMBER> patients ischemic heart disease recurrent vt despite aad therapy aad therapy contraindicated tolerated based prospective trials <NUMBER> <NUMBER> <NUMBER> showed vt recurrences associated increased mortality hospitalization worse quality life indications nonischemic cardiomyopathy nicm strengthened compared <NUMBER> guidelines <NUMBER> recommendations gained class indication based longterm data <NUMBER> <NUMBER> <NUMBER> electrical storm refractory aad therapy recurrent vt medications ineffective contraindicated tolerated order reduce vt recurrences icd shocks optimal timing catheter ablation important yet unresolved subject guidelines started raising issue <NUMBER> <NUMBER> searching density frequency vt warrants ablation whether patients receive prophylactic vt ablation icd implantation recurrence vt ablation could eliminate need icd prospective studies focused aspect prophylactic ablation comparison icd therapy currently published rcts addressing first question data available far come retrospective trials <NUMBER> <NUMBER> comparing early ablation versus late referral strategy patients structural heart disease evidence provided early strategy improved vtfree survival studies influence evolution guidelines leading new timing indication first <NUMBER> esc guidelines <NUMBER> recently expert consensus <NUMBER>•• recommended catheter ablation class iia class iib indication respectively first episode sustained vt ischemic patients icd regardless type icd therapy attitude toward timing ablation tends reflect locally available expertise logistics data <NUMBER> survey european heart rhythm society ehra report ablation treatment choice ischemic cardiomyopathy icm patients first icd shock due vt <NUMBER> centers <NUMBER> <NUMBER> new ehra survey conducted <NUMBER> showing patients ischemic cardiomyopathy impaired left ventricular ejection fraction lvef presenting first episode hemodynamically stable sustained monomorphic vt despite betablocker therapy treated vt ablation <NUMBER> responding centers amiodarone typically used firstline treatment <NUMBER> patients nonischemic etiology preferred initial strategy catheter ablation <NUMBER> centers amiodarone <NUMBER> centers <NUMBER> indicated appropriate treatment patient ischemic cardiomyopathy presenting multiple appropriate icd shocks despite long treatment amiodarone would vt ablation recommended <NUMBER> patients nonischemic cardiomyopathy reported data show increasing number centers across europe perform catheter ablation first icd shock following release <NUMBER> esc guidelines despite weaker strength recommendation unfortunately realworld data based large surveys american centers available three retrospective trials published timing vt ablation patients icd therapies frankel et al <NUMBER>• reported singlecenter experience <NUMBER> consecutive patients sustained vt structural heart disease icm nicm referred first catheter ablation procedure ninetysix percent patients icd implanted prior ablation divided two groups late referrals defined <NUMBER> episodes vt first recent episode separated least <NUMBER> month others considered early referrals patients referred late vt ablation likely high dose amiodarone longterm outcomes showed early referral group improved vtfree survival compared late group multivariate modeling early referral retained independent statistically significant association vtfree survival dinov et al <NUMBER> investigated similar population <NUMBER> patients timing ablation groups different early ablation strategy group <NUMBER> consisting patients ablated within <NUMBER> days first documented vt delayed ablation strategy group <NUMBER> patients ablated <NUMBER> month <NUMBER> year initial vt late ablation strategy group <NUMBER> ca performed <NUMBER> year first documented vt patients referred vt ablation within <NUMBER> days first documented vt group improved acute longterm success rates authors also analyzed impact timing cardiac mortality reporting early ablation strategy associated improved survival however vt recurrence associated cardiovascular mortality romero et al <NUMBER> included <NUMBER> consecutive patients presented first percutaneous catheter ablation sustained monomorphic vt addition icm nicm also included subjects without structural heart disease definition early vs late referral defined time number failed orally administered aads referral catheter ablation hence timing vt onset ca available patients divided <NUMBER> groups <NUMBER> failure aad single aad control vt singledrug failure <NUMBER> failure <NUMBER> aad control vt multidrug failure analyzed vtfree survival cardiac transplantation free survival overall survival authors report patients nicmrelated vt multidrug group substantially worse outcomes arrhythmia recurrence heart transplantation mortality compared patients referred ablation following drug failure singledrug failure whereas influence patients without structural heart disease icm group multidrug failure associated worse ventricular arrhythmia free survival overall survival however association weaker predominantly influenced worse outcomes patients failed amiodarone treatment consistent vanish study amiodarone failure associated worse outcomes icm systematic review metaanalysis clinical outcomes three studies <NUMBER>• confirmed early ablation associated improvement vtfree survival patients icm nicm well fewer complications however significant association lower mortality probably underpowered detect mortality benefit due limited followup limited sample size small number deaths one critical aspects underlined analysis standard definition early late referral factors like clustering frequency severity vt taken account making comparison less stringent however retrospective data provide solid background support need prospective randomized studies confirm benefits early referral catheter ablation ventricular tachycardia structural heart disease randomized controlled trials addressed issue prophylactic catheter ablation patients ischemic cardiomyopathy even though majority patients included icd implanted enrollment important data early referral catheter ablation vt episode impact subsequent icd therapy smashvt <NUMBER> study included <NUMBER> patients history myocardial infarction underwent icd implantation secondary prevention ventricular fibrillation hemodynamically unstable ventricular tachycardia syncope inducible ventricular tachycardia invasive electrophysiological testing received appropriate therapy primary prevention indications patients randomized icd implantation alone icd implantation plus catheter ablation followup patient received antiarrhythmic agent betablockers patients ablation group <NUMBER> reduction risk receiving subsequent icd shocks even trend toward decreased mortality ablation group although statistically significant vtach trial <NUMBER> enrolled <NUMBER> patients previous myocardial infarction indication icd secondary prevention documented stable clinical vt patients randomized either vt ablation followed icd implantation implantation alone drug management followup discretion investigator patients ablation group longer time free vt vf recurrence fewer appropriate icd shocks fewer hospital admissions cardiac reasons patients icd difference mortality groups sms study <NUMBER> published group complement vtach trial similar design enrolled <NUMBER> patients unstable ventricular arrhythmias contrast two previous studies prophylactic catheter ablation prolong time first ventricular arrhythmia recurrence reasons difference probably multiple including different icd programming mapping ablation strategy drug management fluctuations asymmetrical loss followup two arms however catheter ablation associated <NUMBER> reduction total number icd therapies throughout followup calypso pilot randomized study <NUMBER> aimed testing whether early use catheter ablation vt superior aad introduction reducing mortality twentyseven enrolled patients ihd icd randomized ca aad received icd intervention ≥ <NUMBER> icd shock ≥ <NUMBER> atps limited sample size followup period <NUMBER> months show significant difference two arms useful pilot study showed difficulty conduct trials early referrals substantial obstacles enrolling patients multicenter rcts comparing strategy early ca strategy aad due common clinical practice starting aad ablation resulting population referred ca progressed disease drugs already failed important alternative design vanish study <NUMBER> patients randomized ca escalated drug therapy failing aad showing significant benefit composite endpoint death vt storm icd shock ablation arm relatively advanced disease patients failing however show improvement respect mortality alone led ongoing vanish <NUMBER> trial clinicaltrials gov identifier nct<NUMBER> aims define best firstline therapy vt randomizing patients prior myocardial infarction catheter ablation aad introduction vt event objective evaluate reduction composite outcome death appropriate icd shocks vt storm treated sustained vt detection rate icd metaanalysis included five published rcts <NUMBER> showed patients ablation arm significantly less likely experience icd shocks vt storm cardiac hospitalization however benefit seen allcause mortality latest rct published topic berlin vt <NUMBER>• main difference previously randomized trials compares prophylactic catheter ablation deferred strategy instead nonablative treatments enrollment <NUMBER> patients randomly assigned receive catheter ablation vt either icd implantation third appropriate icd shock vt primary composite endpoint allcause death hospitalization heart failure arrhythmia secondary end points recurrent episodes vt change quality life <NUMBER> year study interrupted futility interim analysis primary endpoint increased sufficiently prophylactic treatment arm reaching futility stopping boundary authors concluded preventive vt ablation icd implantation reduce mortality hospitalization arrhythmia worsening heart failure <NUMBER>year followup compared deferred ablation strategy lack benefit prophylactic catheter ablation study surprising seems combination factors including study design population made trial underpowered examine hard endpoint like mortality population relatively high lvef ≥ <NUMBER> icds programmed reduce shocks use aads prespecified followup period short discern groups chance seemingly played role well allcause mortality reported <NUMBER> patients preventive ablation group including <NUMBER> case endocarditis post tavi procedure <NUMBER> noncardiac deaths one unknown cause whereas death cases reported due arrhythmias deferred ablation arm interesting aspect timing ablation comes observation deferred ablation group physicians patients adhere protocol catheter ablation performed <NUMBER> <NUMBER> icd shocks echoes shared opinion electrophysiologists community three shocks may long wait reflects realworld records available evidence recent rcts points lack net benefit prophylactic ablation vt time icd implantation even though reduction number recurrences advantage terms mortality eliminate need icd matter early performed view unfavorable costbenefit ratio unlikely prophylactic catheter ablation vt applied clinical practice hand learned deferring timing ablation undefined future definitely poses increased risk arrhythmia recurrence probable adverse effect subsequent clinical course hence future randomized clinical trials need address perform ablation two extreme timings even majority patients patient recruitment population rcts challenging first difficulty enroll subjects right time since referral large academic centers occurs aads failed disease advanced second limited duration available followup time comorbidities advanced age may concur overall noncardiac mortality thus increasing difficulty proving mortality benefit composite endpoints including mortality certainly increase number events shorten followup period need chosen carefully opinion right timing catheter ablation would icd implantation aad therapy icd shock could pivotal point natural history disease randomization risk stratification intervention prognostic value rcts published far comparison strategies however none true timing trials designed randomize patients icds two different moments natural history vt issue timing ablation patients vt recurrences leading icd shock investigated ongoing partita randomized clinical trial timing vt ablation affect prognosis patients implantable cardioverterdefibrillator clinicaltrialsgov identifier nct<NUMBER> study randomize patients first icd shock reflecting realworld practice patterns prospective randomized multicenter study patients followedup automatic daily remote monitoring patients icd ischemic nonischemic cardiomyopathy primary secondary prevention enrolled followedup first appropriate icd shock phase first appropriate shock delivered vt patients randomized phase b either control group ablation next electrical storm immediate vt ablation arm primary endpoint composite heart failure hospitalization death cause followup period <NUMBER> years icd shock secondary endpoints include correlation first appropriate icd shock burden previous vts phase cardiac death recurrent electrical storm recurrent vt phase b study began september <NUMBER> time writing <NUMBER> european sites actively enrolling nonablative policies protocol aim give insight natural history ventricular tachycardia icd implant abstention use aads help observe natural progression burden arrhythmia use remote monitoring standardized device programming reflecting current clinical practice long detection intervals favoring antitachycardia pacing atp help analyze predictive role atps icd shocks similarly trials primary mortality endpoint composite case includes heart failure hospitalization fact death cause used instead cardiac death could make challenging demonstrate net benefit secondary endpoints however target specific relationship timing catheter ablation cardiac death missing link needed current practice center shown fig <NUMBER> patients naïve vt fig <NUMBER>a tend use aads unless required arrhythmias uptitrate betablockers icd interventions occur recommend use home monitoring case shock reprogram device possible delay therapies perform catheter ablation <NUMBER> shocks occur <NUMBER> months therapeutic strategies failed vt ablation less standardized depend clinical characteristics patient ventricular tachycardia multicenter data shown repeated catheter ablation usually performed multiple electrical shocks electrical storm failed amiodarone multiple aads commonly nicm <NUMBER> center fig <NUMBER>b usually discharge patients ca home monitoring device optimized medical therapy without aads case atps betablockers uptitrated possible case icd shock tend perform ca earlier <NUMBER> shock patients ischemic substrate whereas prefer aad therapy nicm patients save catheter ablation recurrences case refractory vt storm abovementioned treatments surgical autonomic modulation reasonable option principle sympathetic modulation based fact autonomic nervous system plays important role triggering maintaining ventricular tachycardia indeed betaadrenergic receptor blockers standard therapy used neuromodulation aim block sympathetic transmission surgical interventions cardiac sympathetic denervation csd target stellate ganglia videoassisted thoracoscopy reduce burden sustained vt icd shocks <NUMBER> <NUMBER> guidelines <NUMBER> expert consensus <NUMBER>•• consider emerging therapeutic option reasonable patients vt storm betablockers aads vt ablation failed historic moment timely analyze management patients vt going change due coronavirus pandemic following outbreak common decisional pattern european centers adapt national health authorities request shut elective procedures thereby allowing shift personnel equipment resources favor intensive nonintensive covid care units result according recently published survey institution <NUMBER> number nonurgent procedures dropped almost zero number vt ablation procedures thereby performed emergency indication decreased roughly <NUMBER> respect preoutbreak metrics foreseeable future look like patient visits especially referrals become difficult also impact enrolment followup trials due important impact morbidity mortality ventricular tachycardia duty intensify activity remote monitoring ensure prompt recognition evolving arrhythmia patterns chasing warming patterns setting earlier indications vt ablation compared current behavior avoid progressive deterioration arrhythmia overall clinical course home monitoring become crucial evaluating disease progression adjusting therapy accordingly shortening referrals considering interactions class iii agents drugs used treatment viral infection use might reduced due impact qt prolongation resulting reduced shelter could lead increased susceptibility arrhythmias treated catheter ablation lastly increasing evidence elevated troponin levels covid<NUMBER> patients <NUMBER> <NUMBER> moment uncertain whether could lead significant cardiac damage substrate ventricular tachycardia prepared potential increase vulnerability ventricular arrhythmias risk stratification new scenario indication catheter ablation usually recommended aads failed control vt recurrences icd shocks patients advanced disease growing amount evidence early referral ablation reduces vt recurrences though benefit terms mortality demonstrated yet however led guideline indication consider icd patients ablation first vt episode realworld data suggest increasingly common clinical practice evaluate patients catheter ablation earlier natural history order avoid demonstrated negative impact patients quality life possible side effects drugs randomized clinical trials powered assess mortality essential order confirm beneficial effects early strategy conflict interest andrea radinovic francesca baratto declare conflict interest paolo della bella reports grants personal fees abbott biosense webster grants biotronik boston scientific human animal rights informed consent article contain studies human animal subjects performed authors coronavirus disease <NUMBER> covid <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> continues spread around world <NUMBER> world health organization recently declared public health emergency international concern <NUMBER> knowledge regarding epidemiologic features diagnostic tools covid<NUMBER> rapidly evolving health care systems challenged uncertainties surrounding various aspects optimal management strategies infection sarscov<NUMBER> characterized substantial variability clinical syndromes asymptomatic infected persons mild symptoms small proportion patients fatal outcome early stage infected patients generally present mild upper respiratory infection symptoms similar common cold reports china indicate patients covid<NUMBER> mild symptoms fever fatigue dry cough upper airway congestion shortness breath myalgiaarthralgia <NUMBER> subset patients presented gastrointestinal manifestations nausea vomiting diarrhea <NUMBER> among <NUMBER> severe disease additional manifestations eg respiratory rate <NUMBER>min blood oxygen saturation <NUMBER> present <NUMBER> critical respiratory failure septic shock andor multiorgan dysfunction failure <NUMBER> <NUMBER> significant subset patients develop acute respiratory distress syndrome ards hypoxemic respiratory failure common cause admission intensive care unit icu <NUMBER> <NUMBER> additionally becoming clear sequence distributive shock abrupt renal failure death occurs despite forms supportive care older age presence comorbidities cardiovascular pulmonary disease development complications early acute kidney injury aki among poor prognostic factors <NUMBER> <NUMBER> special note cause death <NUMBER> patients reported respiratory failure alone concomitant respiratory heart failure <NUMBER> due lack data treatment strategies specific severe cases covid<NUMBER> available evidence management critically ill needs extrapolated clinical features potentially fatal disease aberrancy immune response result failure clear virus viral sepsis proinflammatory cytokines interleukin<NUMBER> essential mediate innate immunity cause host damage part maladaptive process viral sepsis remains highly heterogeneous likely encompass complex yet fully understood pattern pathophysiologic pathways immune responses distinct bacterial infections <NUMBER> however current consensus guidelines primarily based studies bacterial sepsis pathogen specific <NUMBER> <NUMBER> patients covid<NUMBER> develop critical illness admitted icu <NUMBER> respiratory failure due expansion pulmonary infiltrates secondary bacterial infection septic shock multiorgan failure among reasons untoward clinical course setting <NUMBER> expression distribution angiotensin converting enzyme ii ace<NUMBER> primary host cell receptor sarscov<NUMBER> various systems make possible virus infect variety cells induce multiple organ failure figure <NUMBER> similar patients hemodynamic instability patients likely undergo aggressive fluid administration mainstay management fact fluid resuscitation remains enduring sepsis treatments predating even antibiotics although mounting evidence recently challenged central role setting <NUMBER> potentially simplistic possibly incorrect reasoning foundation conjecture presumed hypoperfusion resulting increase serum lactate levels accompanied low blood pressure oliguria hepatic dysfunction altered mental status patients sepsis <NUMBER> hypoperfusioncentric paradigm microcirculatory dysfunction key driver sequential pathophysiologic mechanisms ultimately leading multiorgan failure observations challenged validity hypothesis eg lack correlation oliguria renal blood flow sepsis <NUMBER> alternative plausible biological explanations eg bioenergetics failure also offered <NUMBER> moreover due known changes glycocalyx structure hyperpermeability vasculature sepsis administered fluid rapidly redistributed extravascular compartment <NUMBER> keeping concepts clinical evidence increase intravascular volume fluid bolus therapy might small short lived leading transient improvement hemodynamic parameters cardiac output <NUMBER> observations coupled strong evidence association adverse outcomes extravascular volume overload unintended consequence aggressive fluid therapy sepsissee make fluid stewardship serious consideration care patients concept even crucial critically ill patients covid<NUMBER> expanding lung infiltrates ards respiratory failure often coexist sepsis pragmatic endpoints fluid resuscitation difficult delineate general goal cardiac output become preload independent ie reaching plateau portion frankstarling curve difficult assess clinically <NUMBER> absence universally accepted objective measurement tools validated wide spectrum patients admitted sepsis syndromes acquired volume overload remains obvious risk aggressive fluid resuscitation <NUMBER> ample evidence detrimental impact interstitial edema congestion function multiple organ systems including kidney lungs <NUMBER> since ventricular pressurevolume relationship curvilinear atrial pressures increase rapidly patients reach plateau frankstarling curve increased atrial pressure associated increase pulmonary venous hydrostatic pressures leading shift fluid interstitial space disturbing capillary blood flow oxygen diffusion <NUMBER> effect pronounced clinical settings covid<NUMBER> lung tissue architecture already disturbed active rapidly expanding inflammatory process moreover significant subset patients covid<NUMBER> develops ards characterized pulmonary edema resulting increased capillary permeability making patients even vulnerable resuscitationinduced lung congestion incidence aki covid<NUMBER> varies widely estimates range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> noteworthy subset patients experiences fever malaise nausea vomiting possibly diarrhea several days seeking medical care prone intravascular volume depletion prerenal aki patients early aggressive volume resuscitation indicated avoid development extensive acute tubular injury due prolonged severe renal hypoperfusion suggested direct cellular injury via ace<NUMBER> expressed proximal renal tubules could contribute aki <NUMBER> remains likely shock cases cytokine storm primary causes acute tubular necrosis setting moreover similar rightsided heart failure following aggressive fluid administration increased right atrial pressure transmitted retrograde leading elevated venous pressure abdominal organs kidney liver guts kidneys particularly vulnerable rise interstitial pressure tubular compression due capsule surrounding ie renal intracapsular tamponade detrimental impact high backward venous pressure renal hemodynamics development congestive renal failure well studied heart failure <NUMBER> fluids catheters treatment trial facct incidence aki similar restrictive liberal fluid management groups <NUMBER> however liu et al showed correcting serum creatinine levels fluid balance incidence aki lower restrictive fluid strategy <NUMBER> besides venous wall stretch stimulus activation endothelium subsequent release inflammatory mediators turn may lead interstitial damage functional abnormalities diminished tubular reabsorption retention sodium water <NUMBER> increasing intraabdominal pressure due progressive volume overload also contribute impairment renal hemodynamics function keeping pathophysiologic mechanisms accumulating body evidence established positive fluid balance strong independent predictor poor outcomes critically ill <NUMBER> <NUMBER> <NUMBER> example large international study <NUMBER> patients sepsis found higher cumulative fluid balance <NUMBER> days icu admission proportionately associated increased risk death <NUMBER> similarly sepsis occurrence acutely ill patients soap study <NUMBER> patients sepsis <NUMBER> european icus reported positive fluid balance independent risk factor mortality <NUMBER> supporting notion observation achieving negative fluid balance volumeoverloaded patients sepsis associated improvement survival rates <NUMBER> increase understanding adverse consequences aggressive fluid administration volume overload several studies tried compare conservative fluid deresuscitation ie active removal fluid strategy standard care liberal fluid strategy critically ill patients <NUMBER> <NUMBER> <NUMBER> comprehensive review studies beyond scope article improved outcomes generally reported conservative deresuscitative fluid strategies patients sepsis ards <NUMBER> importantly also greater recognition phases shock importance dynamic approach takes consideration distinct clinical characteristics phase widely accepted international guidelines management severe sepsis septic shock ie surviving sepsis campaign gone much scrutiny updates emphasize early fluid resuscitation <NUMBER> mlkg within first <NUMBER> h <NUMBER> recently vincent et al proposed separating management shock four distinct phases rescue optimization stabilization deescalation <NUMBER> primary focus first phase reach minimum effective blood volume fluid administration main goal deescalation phase reach negative fluid balance interestingly early fluid resuscitation shown reduce mortality patients sepsis <NUMBER> earlier negative volume balance deescalation phase also associated improved survival rate <NUMBER> support notion murphy et al reported among patients acute lung injury secondary septic shock received adequate initial fluid resuscitation well conservative late fluid management ie negative even fluid balance <NUMBER> consecutive days first week sepsis best survival rates compared achieved one goals neither two <NUMBER> therefore dynamic approach optimal timing ie early administration followed early termination active removal appear key fluid resuscitation patients sepsis remains explored whether precise assessment volume status invasive methods eg central venous pressure measurement pulmonary arterial catheterization noninvasive techniques eg bioimpedance spectroscopy cardiac echography prove helpful certain subsets patients preexisting heart failure renal dysfunction fluid management goals beyond resuscitation salvage phase critical illness remain subject considerable uncertainty clear reaching even negative fluid balance deescalation phase would crucial order avoid complications associated lingering congestion loop diuretics often used counter positive fluid balance icu patients <NUMBER> studies evaluating impact loop diuretics icu yielded inconsistent results showing benefit <NUMBER> others reporting benefit <NUMBER> suggesting harm <NUMBER> interestingly recent study <NUMBER> patients lib orio et al found loop diuretic use critically ill patients positive fluid balance associated prolonged mechanical ventilation <NUMBER> since patients receiving diuretics serum bicarbonate level <NUMBER> meql others metabolic alkalosis reduce neural respiratory drive minute ventilation authors argued metabolic side effect diuretics could contribute observed mechanical ventilation weaning difficulties <NUMBER> <NUMBER> face positive fluid balance deescalation phase sepsis management one might consider earlier application renal replacement therapy rrt especially patients severe volume overload progressive metabolic alkalosis diuretic use suboptimal diuretic response diuretic refractoriness development oliguric aki light evidence detrimental impact rrt use treatment sepsis clearance inflammatory mediators cytokines <NUMBER> rrt considered indicated optimization volume status treatment azotemia modality provides clearance eg continuous venovenous hemofiltration needed cases progressive renal function impairment isolated ultrafiltration optimal strategy primarily focuses fluid extraction optimization volume status extraction sodiumrich fluid represents advantage diuretics use balanced unbalanced fluids salvage phase associated significant sodium loading urine generated use diuretics typically remains hypotonic portable ultrafiltration devices could prove particularly helpful extremely small extracorporeal volume ie <NUMBER> ml help avoid potential adverse hemodynamic impact critically ill moreover predictability fluid extraction make likely achieve precise goal deescalation process <NUMBER> applying aforementioned general concepts management specific features covid<NUMBER> key optimized therapy plans pulmonary involvement rapidly progress significant subset patients study <NUMBER> patients covid<NUMBER> shi et al reported incidence ards high <NUMBER> <NUMBER> addition respiratory failure shock course critically ill patients covid<NUMBER> characterized patients developing refractory heart failure features cardiogenic shock <NUMBER> remains unclear whether results direct myocardial damage infection stress cardiomyopathy similar forms shock right heart failure due prolonged ards myocardial injury identified elevated cardiac biomarkers reported among early cases china study <NUMBER> hospitalized patients covid<NUMBER> cardiac injury elevated highsensitivity troponin new electrocardiographic echocardiographic abnormalities present <NUMBER> patients required icu care <NUMBER> concomitant increase inflammatory biomarkers eg ddimer ferritin interleukin<NUMBER> implies rise highsensitivity troponin reflective cytokine storm secondary hemophagocytic lymphohistiocytosis isolated cardiac injury similar kidney yet wellstudied proposal direct viral injury ie myocarditis ace<NUMBER>dependent entry sarscov<NUMBER> cardiomyocytes cases covid<NUMBER> reported patients predominantly presented cardiac manifestations cardiogenic shock <NUMBER> <NUMBER> histological findings reported cases yet respiratory failure worsens need extracorporeal membrane oxygenation due hypoxemia distributive cardiogenic shock <NUMBER> large majority mortality patients attributed respiratory failure shock <NUMBER> observationsthe frequent development ards possibility cardiac dysfunction addition active expanding lung infiltratesmake crucial physicians vigilant fluid management strategies remain mindful fluid resuscitation exerts potentially therapeutic effect mainly increasing stressed volume circulation leading improved venous return cardiac output effects anticipated due concomitant pathophysiologic mechanisms eg onslaught cytokine storm declining cardiac function aggressive fluid administration likely result volume overload extensive adverse consequences patients already diminished respiratory reserve due pulmonary infiltrates reported restricted initial resuscitation strategy ie preventing overload might advantageous compared fluid removal liberal administration <NUMBER> proactive collaborative approach achieve negative fluid balance also warranted patients clinical status deemed stabilized addition aforementioned benefits rrt setting rapid device deployment capability ease use dedicated ultrafiltration machines eg possibility using peripheral venous access advantageous number infected patients rapidly escalating worldwide overutilization available resources outbreak covid<NUMBER> undoubtedly one challenging global health care problems recent years yet due explosive nature resource utilization potential help us refine skills reconsider approaches constantly reminding currently available evidence fluid resuscitation strategies judiciously applying principles specific features disease learn eg high percentage heart failure volume overload circulatory failure likely help optimize care patients specific financial support obtained preparation article ak following potential conflicts interest baxter inc cardiology advisory board consultancy fee chf solutions inc medical advisory board consultancy fee w l gore inc consultancy fee severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus composed single stranded positivesense rna specifics detailed pathobiology human cellular interactions described previously <NUMBER> <NUMBER> <NUMBER> <NUMBER> virus binds angiotensinconverting enzyme <NUMBER>ace<NUMBER> cellular transmembrane homologue angiotensinconverting enzyme ace order enter human cell lines including pneumocytes cardiovascular system <NUMBER> consequently addition eponymous respiratory complications covid<NUMBER> associated increased vascular thrombosis myocardial inflammation arrhythmia potentially increased risk adverse outcomes patients htn <NUMBER> recent metaanalysis <NUMBER> patients <NUMBER> studies htn associated increased composite poor outcome included mortality acute respiratory disease syndrome need intensive care disease progression patients covid<NUMBER> <NUMBER> studies shown similar findings deleterious effects covid<NUMBER> patients htn <NUMBER> <NUMBER> yet remains unclear contemporary guideline recommendations may impacted setting covid<NUMBER> pandemic moreover current public health crisis covid<NUMBER> already impacted patients htn multiple aspects approximately <NUMBER> million people us lost employmentbased health insurance coverage directly affecting patients htn chronic conditions <NUMBER> coverage losses likely steepest states without medicaid expansion patient protection affordable care act unfortunately access health coverage deficient states largest racialethnic disparities cardiovascular care potentially impacting adherence medication affordability <NUMBER> <NUMBER> specifically african americans may suffer worse outcomes related covid<NUMBER> exposure due variety reasons including socioeconomic factors limited health access <NUMBER> accordingly review summarize current best practices htn management taken account current covid<NUMBER> pandemic emerging data diagnosis bp monitoring evidencebased treatment certain special populations including related raceethnicity guidelinesdirected medical care provide best strategies battle acute longterm cardiac complications htn across diverse populations covid<NUMBER> era beyond htn widely prevalent potent risk factor atherosclerosis cardiovascular disease ascvd associated microvascular complications affects estimated <NUMBER> billion people worldwide disproportionately lowand middleincome countries globally upwards <NUMBER> <NUMBER> men <NUMBER> <NUMBER> women chronic htn <NUMBER> <NUMBER> consequently htn leading global cause mortality accounting <NUMBER> million deaths per year major cause premature death worldwide <NUMBER> regarding systolic blood pressures sbp <NUMBER> million deaths <NUMBER> million disease adjusted life years dalys attributed sbp <NUMBER>mmhg alone <NUMBER> <NUMBER> <NUMBER> well unique considerations persistent worldwide disparities htn death morbidity specific populations related racialethnicity female sex advanced age socioeconomic status recent data centers disease control prevention cdc noted significantly higher prevalence uncontrolled htn among us racialethnic minority groups compared nonhispanic whites <NUMBER> prevalence selfreported htn <NUMBER> ≥ <NUMBER> mmhg much higher nonhispanic blacks african americans american indians <NUMBER> vs <NUMBER> respectively selfreported prevalence htn hispanics whites <NUMBER> vs <NUMBER> respectively <NUMBER> introduction <NUMBER> accaha multisociety high blood pressure hbp guidelines prevalence htn increased <NUMBER> us <NUMBER> using bp threshold htn ≥ <NUMBER> mmhg disproportionately affecting blacks older individuals <NUMBER> due increasing prevalence htn younger patients us preventive task force recommendations support office bp screening patients <NUMBER> years age older <NUMBER> therefore may disparate prevalence among various groups htn time progresses review evaluates current recommended lifestyle interventions pharmacotherapy within major guidelines ongoing efforts combat challenges htn management setting covid<NUMBER> although recommended evidencebased guidelines covid<NUMBER> pandemic limited physical activity secondary social distancing home quarantining fitness center shutdowns <NUMBER> moreover covid<NUMBER> pandemic forced practice medicine new paradigm telehealth technologies selfmonitoring techniques developed prominent roles clinical management htn ascvd risk reduction current guidelines despite major minor differences serve tools advancement standard care recommendations clinical practice including specific populations usually regional emphasis <NUMBER> accaha recommendations tighter bp control supported several sources including several metaanalyses observational cohorts associated significantly higher range hazard ratios <NUMBER> cardiovascular disease cvd stroke sbpdbp ≥ <NUMBER>mmhg compared <NUMBER>mmhg <NUMBER> <NUMBER> furthermore data benefit tighter bp control also emerged systolic blood pressure intervention trial sprint national institute health landmark trial large randomized control study evaluated benefits intensive bp goals <NUMBER> mmhg compared standard treatment goals <NUMBER> mmhg <NUMBER> result overwhelming positive effect sprint stopped early demonstrating <NUMBER> <NUMBER> relative risk reduction rrr primary endpoint allcause mortality intensive bp lowering group compared standard treatment hr <NUMBER> <NUMBER> ci <NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> respectively thus prospect encouraging patients providers us manage htn intensively recommended decrease endorgan damage mortality fit low high resource settings advising essential optimal standards concise easy use format therefore overarching goal contemporary htn development reduce adverse outcomes populations interest regional differences often inhibit complete uniformity although cvd morbidity mortality increased bp linear direct continuous definition htn varies among guidelines table <NUMBER> current recommendations general provide bp thresholds based average measurements office setting rationale categorizations determined primarily inoffice observational data related association sbpdbp cvd risk randomizedcontrolled trials rcts lifestyle modifications lower bp rcts medication therapy reduce bp <NUMBER> <NUMBER> escesh htn definition characterizes optimal bp defined sbp <NUMBER> mmhg dbp <NUMBER>mmhg hand level blood pressure considered normal <NUMBER> accaha definitions <NUMBER> table <NUMBER> nice ish publications use similar thresholds definitions htn ≥<NUMBER> mmhg bp visit determined average least two measurements clinic setting least one minute apart final bp measurement <NUMBER> <NUMBER> mmhg nice ish guidelines recommend offering ambulatory blood pressure monitoring abpm confirm diagnosis <NUMBER> <NUMBER> additionally reviewed guidelines strongly recommend utilization outofoffice bp measurements monitoring andtitration antihypertensive therapies various reports reviewed herein support initial concomitant use nonpharmacological interventions patients include lifestyle modifications dietary activity levels prior medications individuals reduce bp values accurate measurement inoffice outofoffice bp crucial htn diagnosis management although traditional use devices calibrated column mercury still utilized regions guidelines report recommendations data using electronic devices bp monitoring guidelines recommend validated devices whether electronic manual <NUMBER> <NUMBER> us blood pressure validated device listing vdltm first us list blood pressure bp measurement devices developed assist physicians patients identifying bp devices validated clinical accuracy bp devices listed vdltm specific criteria detailed determined independent review visit validatebporg view current device listings information independent review process <NUMBER> escesh guidelines recommend validated devices association medical instrumentation <NUMBER> errors bp measurements common settings htn guidelines thoroughly describe protocols obtain accurate results <NUMBER> bp measured arms detect differences first office visit guidelines recommend using arm higher bp reading subsequent visit reviewed guidelines suggest taking bp <NUMBER> times separated least <NUMBER> minute apart averaging least two readings final result escesh nice guidelines also suggest measuring standing bp least standing <NUMBER> minute determine likelihood orthostatic bp changes <NUMBER> <NUMBER> guidelines also suggest measuring bp least two separate office visits diagnose htn interventions recommended expert panels aha acc published recent scientific statements evaluating accuracy bp measurements detail emphasizing need proper ongoing training technicians healthcare providers use validated devices <NUMBER> <NUMBER> reviewed htn guidelines acknowledge benefits abpm home blood pressure monitoring hbpm provide strong recommendations techniques confirm diagnosis htn monitor medication adjustments hbpm alternative confirm diagnosis htn abpm possible technology abpm available many years recommended accaha eshesc nice ish guidelines similar protocols suggested use abpm stronger association hypertensionrelated targetorgan damage adverse clinical outcomes <NUMBER> abpm devices usually measure bp every <NUMBER> minutes day every <NUMBER> minutes <NUMBER> hour night <NUMBER>hour period bp correlate values inoffice setting bp measurements within guidelines htn management assist htn management table ii abpm also useful detect certain bp phenotypes htn may confer increased cvd risk whitecoat htn occurs individuals demonstrate higher bp measurements office setting compared measurements outside office whitecoat effect term used describe phenomenon patients history htn receiving antihypertensive medications <NUMBER> although data limited may modest increase cvd risks patients experiencing conditions studies demonstrating increased cvd risk patients cvd risk factors could explain higher risk <NUMBER> <NUMBER> guidelines also reference terminology isolated office htn subclasses htn although conditions covered extensively within review <NUMBER> <NUMBER> <NUMBER> abpm also used detect masked htn refers individuals demonstrating mean outofoffice bp hypertensive range normal bp measurements office setting escesh guidelines suggest incorporation nighttime bp measurements daytime readings diagnosis although guidelines use daytime readings abpm <NUMBER> <NUMBER> incorporation nighttime readings also increases detection prevalence rates masked htn blacks associated higher rates declining renal function <NUMBER> <NUMBER> despite evidence supporting use abpm htn management several issues limit use availability patients monitoring requires proper training patients providers well compliance use provide accurate helpful information reimbursement rates utilization abpm historically low representing <NUMBER> medicare beneficiary claims studies <NUMBER> also modest data supporting better outcomes treatment whitecoat masked htn outside standard treatment existing cvd risk factors investigations whether abpm specify individuals requiring additional treatments reduce cvd risk may warranted recommended contemporary guidelines hbpm selfmonitored blood pressure smbp outside office considered practical alternative abpm agency healthcare research quality ahrq found strong evidence smbp plus additional support defined effective usual care lowering blood pressure among patients htn <NUMBER> <NUMBER> smbp protocols likely become much useful htn control covid<NUMBER> pandemic continues direct current day medical care public health organizations recognized devastating effects htn us population developed several initiatives utilize techniques smbp manage cvd outcomes htn million hearts <NUMBER> national initiative prevent <NUMBER> million heart attacks strokes within <NUMBER> years implementation evidencebased strategies improve cardiovascular health effort recognizes use outofoffice bp monitoring recommends use strategies according best evidence <NUMBER> targetbp national initiative formed aha american medical association also assists health care organizations care teams cost improving bp control rates quality improvement program <NUMBER> largescale efforts provide new insights challenges management adherence bp recommendations populations within us general use hbpmsmbp recommended several societies recently potential means manage htn covid<NUMBER> outbreak conjunction <NUMBER> surge telehealth <NUMBER> <NUMBER> <NUMBER> likely bp measuring methods become useful time readings outside office may decrease prevalence whitecoat hypertension inconsistent readings within office measurements measures conjunction advancing telehealth services potential provide responsibility patients htn management thus increasing steps use office bp monitoring telehealth services may indirectly increase patient engagement health literacy many health centers medical practices quickly introduced pronounced telehealth services current models care management ideal time several barriers overcome include payment regulatory structures state licensing credentialing across health centers <NUMBER> yet use remote patient monitoring patientinitiated messaging telephone visits video visits within reach telehealth medicine beneficial bp control large population effort wosik colleagues suggest covid<NUMBER> pandemic stimulate need telehealth services significant shifts phases care phase initial outpatient management conditions htn stay home order already begun health centers increased need telehealth services much <NUMBER> total outpatient visits phase ii described telehealth needs inpatient related surge use network care management econsultations phase iii considered postpandemic recovery period still unknown time authors appropriately discuss issues delayed care serious noncovid<NUMBER> related medical conditions acute coronary syndromes already occurred many communities care debt described well first two phases likely require intense sustained telehealth efforts <NUMBER> therapeutic lifestyle changes necessary prevent poor cvd outcomes htn major htn guidelines support interventions weightcontrol weight loss necessary sodium restriction smoking cessation regular physical activity healthy diet limiting alcohol consumption reduce blood pressure individuals table iii <NUMBER> <NUMBER> <NUMBER> however dietary approaches stop hypertension dash pattern appears effective yield significant reductions bp individuals blacks reductions sbp high <NUMBER>mmhg slowing decline renal dysfunction weight loss overweight status <NUMBER> <NUMBER> <NUMBER> increased potassium intake <NUMBER> mgday aside following dash diet nonadherence affecting much <NUMBER> patients htn increases associated risk cvd morbidity mortality approximately one every four patients filling initial prescription <NUMBER> <NUMBER> major htn guidelines equally recognize economic burden htn medications increasing nonadherence <NUMBER> recent study <NUMBER> patients experience financial barriers pharmacotherapy likely adherent normal bp within past <NUMBER> months <NUMBER> <NUMBER> <NUMBER> <NUMBER> promising data using highly sensitive highperformance liquid chromatographytandem mass spectrometry biochemical measurements drug levels serum urine surrogate compliance <NUMBER> <NUMBER> although measurements available clinical use covered insurance plans research warranted determining effect large populations mainstream use guidelinerecommended strategies include adherence feedback patient hbpmsbpm linkage behavior daily habits electronic aids mobile phones reduction polypharmacy utilizing single pill combination possible <NUMBER> <NUMBER> <NUMBER> table iv patients often require one antihypertensive agent control bp fixeddose combinations fdc pills htn supported major guidelines <NUMBER> <NUMBER> <NUMBER> recent metaanalysis <NUMBER> patients htn reported mean medication adherence difference <NUMBER> patients receiving fdc medications vs free separate equivalent dose pills <NUMBER> many common fdc htn therapies included formularies reduced copays may attenuate htn management costs covid<NUMBER> pandemic beyond polypill concept including htn lipid drugs may help reduce prescribing complexities cvd prevention <NUMBER> <NUMBER> <NUMBER> recent randomized controlled polypill atorvastatin <NUMBER>mg amlodipine <NUMBER> mg losartan <NUMBER> mg hydrochlorothiazide <NUMBER> mg trial involving adults cvd risk <NUMBER> demonstrated significant bp ldl reduction <NUMBER> months versus standard care participants federally qualified community health center alabama <NUMBER> mean estimated <NUMBER>year cardiovascular risk <NUMBER> participants mean baseline blood pressure ldl cholesterol <NUMBER> mmhg <NUMBER> mg per deciliter respectively monthly cost polypill <NUMBER> <NUMBER> months polypill adherence <NUMBER> mean systolic blood pressure decreased <NUMBER> mm hg polypill group compared <NUMBER> mmhg usualcare group difference <NUMBER> mm hg <NUMBER> confidence interval ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> previously noted telehealth prior covid<NUMBER> pandemic heralded potential advancement successful htn cvd risk management moreover due safety concerns covid<NUMBER> pandemic required telemedicine routine outpatient visits table v significant amount time detail must devoted modes communication assessment important providers receive adequate compensation therefore cms expanded telephone consultation payment temporary emergency basis <NUMBER> waiver authority coronavirus preparedness response supplemental appropriations act particularly highrisk covid<NUMBER> beneficiaries widespread availability smart phones telehealth may become future standard medical practice <NUMBER> <NUMBER> nevertheless use digital technology may increase disparities recent study evaluating telehealth cardiac clinics suggested disparate use video encounters low income black patients <NUMBER> <NUMBER> patients scheduled telehealth encounter study <NUMBER> <NUMBER> completed telehealth encounters <NUMBER> <NUMBER> patients cancelednoshow visit unadjusted analysis patients completed telehealth visit slightly older likely male speak english however low income black patients less likely video visits possibly related insurance coverage <NUMBER> investigation warranted future understand risks benefits video telehealth encounters enhance cardiac care although guideline provides specific comments management special populations including persons diabetes dm certain involving raceethnicity sex older age review detail various aspects care certain groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vast majority adults dm <NUMBER>years ascvd risk <NUMBER> placing highrisk category however recent ada recommendations patients dm <NUMBER>year ascvd risk <NUMBER> maintain target <NUMBER> mmhg <NUMBER> mmhg highest risk patients <NUMBER> accaha <NUMBER> major guidelines antihypertensive drug treatment diabetes initiated bp <NUMBER> mmhg higher treatment goal <NUMBER> mmhg <NUMBER> <NUMBER> moreover major guidelines recommend addition reninangiotensin modulators including angiotensin converting enzyme inhibitor acei angiotensin receptor blockers arb setting compelling comorbid issues diabetes albuminuria renal dysfunction hf <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> accaha escesh ish guidelines discuss significance raceethnicity htn management us well globally black ancestry may associated higher prevalence htn hispanic americans whites native americans groups <NUMBER> <NUMBER> <NUMBER> parts world htn prevalence greater <NUMBER> among blacks <NUMBER> <NUMBER> comparison us prevalence htn black population europe higher nonblack population escesh guidelines emphasize data scarce european black populations extrapolate much recommendations us studies <NUMBER> nonhispanic us white adults likely higher prevalence controlled htn compared groups lower rates control hispanic americans likely secondary decreased awareness however american blacks lower controlled rates due severe htn possibly less effective treatments <NUMBER> thiazidetype diuretics calcium channel blockers ccbs effective first step lowering bp stroke blacks although acei arb less effective blacks monotherapy compared whites combination therapy equally effective whites blacks <NUMBER> <NUMBER> <NUMBER> perhaps due suppression renin angiotensin aldosterone system acei arb may lower bp less effectively also prevention heart failure stroke <NUMBER> <NUMBER> <NUMBER> acei also associated higher incidence angioedema blacks arbs recommended acei escesh ish guidelines htn treatment combination diuretic ccbs accaha escesh ish guidelines recommend two antihypertensive medications achieve adequate bp control blacks diuretic ccbs used firstline agents patients bp <NUMBER> mmhg target may considered combination therapy treatment onset given resistant hypertension rhtn common african american patients multidrug pharmacological therapy may often indicated <NUMBER> <NUMBER> <NUMBER> ish guidelines acknowledge ethnicspecific characteristics east south asian populations greater likelihood saltsensitivity accompanied mild obesity <NUMBER> east asians also higher prevalence hemorrhagic stroke nonischemic heart failure compared western populations associated morning nighttime htn individuals indian subcontinent high risks cvd type <NUMBER>d although considerable interest special populations related sex older age detailed review although detailed accaha escesh guidelines <NUMBER> <NUMBER> furthermore ish guidelines also provide extensive recommendations treatment htn pregnancy whereas area covered supplementary documents others <NUMBER> recently aronow extensively reviewed management htn elderly <NUMBER> overall recognizing unique aspects treatment various populations including regional differences important component optimal care according recent data world health organization covid<NUMBER> infected <NUMBER> million people responsible <NUMBER> deaths worldwide <NUMBER> clinical observation may required determine longterm risk covid<NUMBER> htn devastating effects covid<NUMBER> also disproportionately affected several vulnerable populations including certain comorbid diseases advanced age lower socioeconomic status covid<NUMBER> also potential impact cvd outcomes via domino effect initiated social fears issues stemming social distancing due concerns visiting hospital facilities patients may present outpatient emergent care needed acute coronary syndromes furthermore physical inactivity unhealthy eating due home quarantine status along social stressors related increasing unemployment may increase rates htn obesity cvd events years come <NUMBER> despite early concern aceiarb therapy would worsen outcomes upregulating ace<NUMBER> ras inhibitors may actually improve clinical status covid<NUMBER> patients hypertension may even preferential antihypertensive treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent study <NUMBER> covid<NUMBER> patients htn china data suggest aceiarb therapy attenuated inflammatory response potentially inhibition il<NUMBER> levels consistent findings acei arb therapy alleviated pneumonic injury <NUMBER> perhaps aceiarb therapy beneficial effect immune system avoiding peripheral cell depletion thereby allowing better immune response virus patients standards practice heart failure society america acc aha american society preventive cardiology currently recommend continuation ras inhibitors compelling complications heart failure hypertension ischemic heart disease <NUMBER> <NUMBER> moreover abrupt withdrawal ras inhibitors highrisk patients including heart failure recent myocardial infarction may result clinical instability adverse health outcomes <NUMBER> hand dihydropyridines ccbs nifedipine amlodipine may benefit treatment hypertensive patients covid<NUMBER> retrospective analysis small cohort elderly hypertensive patients treated ccb covid<NUMBER> infection significantly higher survival rate much less likely require mechanical intubation <NUMBER> vs <NUMBER> respectively compare ccbs <NUMBER> although clinical studies warranted data promising treatment ccb hypertensive patients covid<NUMBER> may significantly improve outcomes current guideline recommendations emphasize importance evidencebased care curtail widespread mortality morbidity related htn associated ascvd additionally acute longterm effects covid<NUMBER> may influence treatment hypertensive population require investigation importance unifying recommendations help curve burden htn may become significant coming years learn new treatments longterm effects current covid<NUMBER> crisis covid<NUMBER> associated morbidity mortality including patients underlying htn cvd likely profound impact several decades due worldwide medical economic psychological effects however although contemporary guidelines suggest benefits use telehealth technologies outofoffice medical management recently required covid<NUMBER> pandemic evolving techniques increasingly used htn control cvd risk control ultimately future htn guidelines may increasingly reflect impact covid<NUMBER> pandemic utility measures smbphbmp time c oronavirus disease <NUMBER> covid<NUMBER> condition caused severe acute respiratory syndrome coronavirus <NUMBER> sars<NUMBER>cov<NUMBER> infections prevalent <NUMBER> states clustering cases major cities new york michigan california new jersey covid<NUMBER> initially thought great equalizerno discrimination become infectednow reveals patterns disparities lowincome persons racial ethnic minority populations novel coronavirus results increased rates respiratory failure death among infected individuals <NUMBER> <NUMBER> found disproportionally affect comorbidities diabetes heart disease asthma conditions known disproportionately affect minorities already impacted health disparities even covid<NUMBER> health disparities pervasive usa define disparities differences healthcare utilization health outcomes among distinct social groups <NUMBER> emerging data show racialethnic minorities working class worse health outcomes due covid<NUMBER> chicago blacks comprise <NUMBER> citys population <NUMBER> covid<NUMBER> deaths based personal experience data health system covid<NUMBER> uncovering disparities embedded within society paper identify areas covid<NUMBER> exacerbating existing disparities offer potential solutions address disparities structural barriers contributed disparities covid<NUMBER> testing diagnosis early weeks pandemic one major issues diagnosing covid<NUMBER> limited testing availability initially testing centralized testing sites control number patients presenting tests residents new york required obtain doctors prescription previous studies shown racialethnic minorities less likely access primary care provider <NUMBER> thus requirement may served structural barrier obtaining covid<NUMBER> testing state implemented drivethru testing increase number patients receiving tests required access vehicle though intention control number patients getting tested prescriptions drivethru testing patients without doctor without access vehicle less likely tested controlling access tests way likely disadvantaged racial ethnic minorities rely public transportation furthermore patient high clinical suspicion covid<NUMBER> infection lacks primary care provider vehicle recourse seek testing emergency room given cost emergency room copays patients decide whether pay get evaluated testing monitor symptoms home additionally covid<NUMBER> results available <NUMBER> <NUMBER> days time patients encounter dilemma whether quarantine home go work therefore established policy free easily accessible covid<NUMBER> testing would reduce impact structural barriers testing turn minimize disparities witnessing unintended consequences covid<NUMBER> outbreak patients noncovid<NUMBER> medical conditions avoid healthcare reduce risk covid<NUMBER> exposure hospitals filled patients test positive covid<NUMBER> covid<NUMBER>negative patients existing medical conditions susceptible complications conditions cardiologists noticing reduction number patients heart attacks presenting heart attacks worse outcomes surgeons also observe patients require surgical interventions presenting gangrene increased risk surgical complications patients racial ethnic minorities increased prevalence common medical conditions compared nonhispanic whites high percentage undiagnosed common medical conditions <NUMBER> reduce disparities arising management covid<NUMBER> noncovid disease outcomes critical develop testing rapidly assess covid<NUMBER> status isolate covid<NUMBER> patients noncovid patients efficiently manage noncovid<NUMBER> diseases public health recommendations contain covid<NUMBER> worsen disparities due lack resources underlying institutional racism reduce spread covid<NUMBER> states implemented various procedures including social distancing wearing masks public areas working home closing schools recommendations seem sensible containing disease may difficult implement depending ones social situation access masks difficult given nationwide shortage masks also wearing mask associated diseases instances society may perceive criminality none exists government communicates ambiguous messages wearing masks reduce covid<NUMBER> infection difficult public especially racial ethnic minorities working class interpret adopt recommendation therefore important clear recommendations ensure general public safety social distancing contributed decreased expected mortality positive outcome negative impacts hardest among working class new york bus drivers limit number passengers riding bus respect social distancing rules phone conversation patient stated practice would effectively double travel time clinic doctors visit usually rides two buses limits maximum number people allowed often needs wait next bus considering new york city public transportation running weekend schedule rely public transportation experience significantly longer travel times increased risk exposure pandemic becomes problematic someone asymptomatic carrier virus lastly anticipating significant disparities arising lack health insurance due one highest unemployment rates history coming months significant impact healthcare utilization health outcomes longer covid<NUMBER> outbreak persists employees risk becoming furloughed beginning outbreak television news anchor suggested people receive health checkups still health insurance majority people usa obtain health insurance employer given increase unemployment unclear happen situations uninsured patients need medical care also without health insurance longer receive routine checkups cancer screening disease management visits likely result widening disparity gap long term especially among vulnerable populations though present pandemic health disparities may increase society begins recover covid<NUMBER> covid<NUMBER> becomes eradicated vaccine developed society must combat disease one minimize mortality complications social consequences ie unemployment arising disease imperative rapid covid<NUMBER> screening freely available general public increased risk exposure elevate care medical conditions mitigate health disparities arising covid<NUMBER> though covid<NUMBER> great equalizer based disparities outcomes response result equitable access care segments population heart rate <NUMBER> saturating <NUMBER> respiratory rate <NUMBER> supplemental oxygen clinically stable respiratory point view physical examination unremarkable except ejection systolic murmur clinical evidence heart failure transferred institution surgical management week later past medical history significant tissue aortic novel coronavirus termed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused significant global impact economy politics health space <NUMBER> months covid<NUMBER> clinical syndrome virus declared pandemic world health organization cases fever common presenting symptom followed cough <NUMBER> natural disease process complicated acute respiratory distress syndrome multiorgan failure ultimately death prevalence covid<NUMBER> patients underlying cardiovascular disease underreported evidence preexisting cardiac disease render patients vulnerable disease process <NUMBER> report first case active prosthetic valve endocarditis complicated covid<NUMBER> establishing diagnosis covid<NUMBER> using rtpcr without limitations availability testing clinical suspicion complicated active endocarditis high falsenegative rate current test made difficult diagnose timely f g u r e <NUMBER> ct chest showing early signs supportive covid<NUMBER> pneumonia patient covid<NUMBER> swab negative clinically stable b transthoracic echocardiogram day <NUMBER> admission institution c cxr showing widespread infiltrative changes day <NUMBER> intubated ventilated ct head day <NUMBER> admission death covid<NUMBER> coronavirus disease <NUMBER> ct computed tomography cxr chest xray fashion <NUMBER> initial swab test negative referring institution raises concerns may false negative result however contact multiple health workers interhospital transfer may inadvertently exposed iatrogenic covid<NUMBER> contraction given patients clinical history presentation likely endocarditis almost certainly preceded covid<NUMBER> rather covid<NUMBER> complicated endocarditis ct thorax changes may even precede rtpcr findings clinical signs covid<NUMBER> alluded recent study inclusion ct thorax become part routine preoperative cardiac surgical workup institution pandemic <NUMBER> standard treatment active prosthetic valve endocarditis suspicion developing aortic root abscess almost always necessitates surgical replacement ct findings however played instrumental role heart teams decision continue medical therapy initially effects covid<NUMBER> pneumonia bypass followed mechanical ventilation recovery unknown hindsight likely correct decision given patient deteriorated ultimately respiratory covid<NUMBER> complications rather cardiac complication recent studies wuhan china suggested covid<NUMBER> could also manifest significant abnormal coagulation parameters particularly longer prothrombin pt activated partial thromboplastin aptt times <NUMBER> contrast sarscov<NUMBER> epidemic <NUMBER> higher risk vessel thrombosis predisposed worse prognosis patients routinely anticoagulated theme continuing current patients covid<NUMBER> patient mildly elevated aptt <NUMBER> seconds normal pt values throughout unlikely would caused sudden gi bleed likely stress injury precipitated acute rupture existing dieulafoys lesion welldocumented phenomenon patients acute hospitalization <NUMBER> started iv heparin post endoscopy atrial fibrillation subsequent requirement renal replacement therapy postulated acute intracerebral bleed likely secondary heparin therapy based ct report possibly yet unknown clinical disease manifestation covid<NUMBER> case highlights important facets managing complex cardiac surgical patients pandemic first patients fall highrisk surgical category discussed extended heart team meeting particularly crisis involved radiologists discussions due addition routine ct help clarify image interpretation done remotely via video conferencing specialists proved invaluable case patient initially tested negative covid<NUMBER> second important vigilant extracardiac clinical manifestations covid<NUMBER> whether specific nonspecific covid<NUMBER> disease process role cardiac surgery bypass active covid<NUMBER> infection still yet determined studies clearly needed determine right approach ortality related cardiovascular disease cvd single leading cause death united states us globally highincome countries accounting <NUMBER> american deaths <NUMBER> furthermore hypertension htn defined systolic blood pressure <NUMBER> mmhg andor diastolic blood pressure <NUMBER> mmhg prevalent potent cvd risk factor us affecting <NUMBER> adults aged <NUMBER> older <NUMBER>e<NUMBER> <NUMBER> <NUMBER>e<NUMBER> <NUMBER> recent epidemiologic data confirm diagnosed htn prevalent among nonhispanic blacks compared nonhispanic whites <NUMBER> adult males <NUMBER> adult females <NUMBER> established multiple decades htn disproportionately affects african americans compared whites increased cvd prevalence prematurity severity poorer htn control increased burden associated risk factors including diabetes chronic kidney disease ckd physical inactivity overweight status obesity <NUMBER> unfortunately despite advancements risk factor identification availability effective htn therapies cvd disparities including premature myocardial infarction stroke peripheral arterial disease ckd endstage renal disease ersd heart failure persist among african americans compared nonhispanic whites <NUMBER> review includes recent concepts htn african americans including perspectives casual factors effective approaches future considerations especially covid<NUMBER> pandemic era consideration poorly controlled htn markedly diminishes overall black life expectancy accordingly <NUMBER> primarily driven uncontrolled severe htn life expectancy white females <NUMBER> years compared <NUMBER> years black females <NUMBER> white males versus <NUMBER> years black males figure <NUMBER> <NUMBER> although control htn represents greatest opportunity cvd prevention african americans management uncontrolled blood pressure bp impeded multiple factors including delayed diagnosis less access insurance primary preventative care medication nonadherence <NUMBER> many individuals htn medication recommended untreated undiagnosed <NUMBER> tools american college cardiologyamerican heart association accaha atherosclerotic cardiovascular disease ascvd risk estimator used assess individuals <NUMBER>year risk developing cvd added risk calculated patients selfidentified black however despite similar even greater awareness treatment paradoxically blacks display lower htn control rates <NUMBER> blacks compared <NUMBER> whites <NUMBER> addition nonhispanic blacks likely uninsured compared nonhispanic whites <NUMBER> overall uninsured adults less likely aware treated htn less likely controlled treated compared insured adults <NUMBER> prevalence htn increases despite extensive available pharmacologic agents recent years us control htn plateaued showing improvement nonhispanic blacks individuals aged <NUMBER> greater individuals cvd risk factors <NUMBER> impact htn comorbid type <NUMBER> diabetes heart failure cardiovascular metabolic comorbidities shown increased association htn risk clustering increased prevalence blacks common risk factors type <NUMBER> diabetes t<NUMBER>d htn include overweightobesity status unhealthy diet physical inactivity <NUMBER> <NUMBER> recent data demonstrate approximately <NUMBER> adults diabetes comorbid hypertension <NUMBER> african americans greater cvd morbidity mortality compounded higher prevalence t<NUMBER>d increasing diseases including ckd esrd stroke heart failure <NUMBER> economic cost associated treatment management cvd us approximately <NUMBER> billion <NUMBER>e<NUMBER> accounting preventable costs healthcare loss productivity <NUMBER> heart failure predominantly due htn blacks opposed coronary artery disease whites leading cause hospitalization medicare population <NUMBER> hospital readmission costs associated medicare reimbursement penalties instances <NUMBER>day readmission particularly problematic burden heart failure provides additional burden already strained healthcare system emphasizing importance htn prevention early intervention control <NUMBER> mortality rates <NUMBER> <NUMBER> related heart failure studied glynn et al <NUMBER> comparison heartfailure related death rates adults aged <NUMBER>e<NUMBER> years black men black women showed <NUMBER>fold <NUMBER>fold increase respectively compared white men white women <NUMBER> notably prevalence heart failure markedly increased younger black male adults <NUMBER> younger adults aged <NUMBER>e<NUMBER> black men <NUMBER>fold greater increase death rate related heart failure consistent cvd complications occurring earlier age <NUMBER> therefore trends increasing htn t<NUMBER>d forms cvd particularly devastating blacks multiple causal factors increased prevalence difficult manage htn including unhealthy diet suboptimal lifestyle overall health inequity adverse social environment potentially harmful cultural beliefs <NUMBER> <NUMBER> unfortunately persistent unacceptable high prevalence htn htnrelated complications african americans heart failure projected increase future especially younger age groups <NUMBER> recent data jackson heart study reasons geographic racial differences stroke regard study analyzed including <NUMBER> black participants assess association htn cvd authors study calculated populationattributable risk found htn contributes <NUMBER> cvd black adults specifically noting increased coincidence coronary artery disease stroke heart failure <NUMBER> another recent study nambiar et al ageadjusted mortality data assessed observe correlation htn cvd death rates analysis demonstrated increased prevalence mortality attributed htn therefore underlying htn portends upward trend cvd associated htn major public health concern <NUMBER> moreover apparent current upward cvd mortality trend appears due cvd comorbidities especially diabetes obesity <NUMBER> several physiologic determinants implicated htn african americans including increased body mass index bmi overweightobesity status higher salt sensitivity low plasma renin levels abnormal vascular function due sympathetic overactivity attenuated nocturnal decrease bp greater prevalence comorbidities diabetes physical inactivity positive family history figure <NUMBER> <NUMBER> however overall increased prevalence risk htn mainly due environmental lifestyle factors versus definitive genetic underpinnings nevertheless genetic factors also theorized play role htnassociated risk ckd esrd metaanalysis conducted assess association htn traits apol<NUMBER> risk alleles polymorphisms acquired increased resistance trypanosoma brucei infections common subsaharan africa <NUMBER> elevated systolic bp preceded decline glomerular filtration rate earlier onset htn occurred individuals homozygous apol<NUMBER> variant alleles indicating predisposition htn ckd <NUMBER> also related emerging area study dungu et al described blacks increased incidence hereditary transthyretin amyloid cardiomyopathy genetic condition caused myocardial deposition amyloid misfolded liverproduced transthyretin due mutation ttr v<NUMBER>i <NUMBER> mutation due associated htn per se common across african diaspora including afrocaribbean populations uk variant alleles carried <NUMBER> african americans <NUMBER> possible finding increased heart failure incidence mortality blacks affected amyloid cardiomyopathy especially older black men unfortunately often misdiagnosed htnrelated cardiomyopathy delaying diagnosis application use newer potentially effective therapies <NUMBER> beyond genetic factors development htn cvd disparities exist among african americans influenced variety interconnected risk factors including poor diet adverse lifestyle deleterious environment social determinants according <NUMBER> acc aha multisociety guidelines prevention detection evaluation management high blood pressure diet lacking fruits vegetables whole grains higher sodium increases risk htn cvd <NUMBER> commonly due traditional cultural dietary preferences southern diet high sodium sugar fats african americans face unique challenges implementing adhering current dietary recommendations <NUMBER> regards study data demonstrated african americans likely consume typical southern diet regardless geographic location highest incidence stroke occurs among lowest adherence recommended diet <NUMBER> addition african americans demonstrated increased time spent engaged sedentary behavior compared whites <NUMBER> african americans general less likely fulfill acc aha primary prevention guideline recommended <NUMBER> minwk moderate intensity physical activity <NUMBER> minwk high intensity physical activity <NUMBER> overall socioeconomic environmental factors important influence cardiovascular health average african americans experience increased rate poverty <NUMBER> compared general population <NUMBER> leading decreased access preventative health resources availability healthy foods safe spaces exercise <NUMBER> additional psychological stressors income instability coping effects figure <NUMBER> life expectancy birth race sex united states <NUMBER>e<NUMBER> source cdcgov racial discrimination adversely affect contribute disparity cvd outcomes figure <NUMBER> <NUMBER> african americans less likely insured also greater risk uncontrolled undiagnosed hypertension due lack access preventative care screening tools longterm management <NUMBER> <NUMBER> additionally ahmad et al observed correlation poverty heart failure outcomes found individuals lower socioeconomic status experienced increased cvdrelated hospitalization mortality <NUMBER> according accaha multisociety <NUMBER> guidelines primary prevention cardiovascular disease hypertension htn recommendations concentrated lifestyle modifications recommendations prevent delay htn include weight loss adequate physical activity use dietary approaches stop hypertension dash diet reduced dietary sodium <NUMBER> release free fatty acids excess adipose tissue associated reduced arterial compliance secondary insulin resistance metabolic state also inhibitory effect nitric oxide production <NUMBER> systematic reviews randomized controlled trials shown weight reduction <NUMBER> kg correlates approximate <NUMBER> mmhg reduction systolic blood pressure sbp <NUMBER> improve htn prevention management promoting vasodilatory actions nitric oxide different types physical activity varying degrees impact blood pressure however aerobic exercise identified modality significant impact hypertension management <NUMBER> min exercise per week cause <NUMBER>e<NUMBER> mmhg decrease sbp aerobic exercise shown dampen excess autonomic nervous system activity postulated mechanism vascular dysfunction african american patients <NUMBER> dash diet widely evaluated dietary intervention primary htn across several patient populations especially african americans consisting lean protein sources low fat dairy foods fruits vegetables dash diet nonpharmacological intervention results comparable pharmacotherapy <NUMBER> <NUMBER> patients lifestyle modifications confer adequate blood pressure control pharmacotherapy indicated initial monotherapy race age primary clinical considerations choosing therapeutic agent african american patients consistently responded well dihydropyridine calcium channel blockers ccb andor thiazidelike diuretics initial therapy patients blood pressure <NUMBER> mmhg target may considered combination therapy treatment onset patients angiotensin ii receptor blocker arb angiotensin converting enzyme ace inhibitor prescribed conjunction ccb thiazidetype diuretic given resistant hypertension rhtn common african american patients multidrug pharmacological therapy may often indicated <NUMBER> <NUMBER> although review focuses htn african americans recent publication provided insights pharmacological approaches native africans comparison three combination therapies lowering blood pressure black africans creole study evaluated twodrug combinations subsaharan africans <NUMBER> randomized patients regimen amlodipine plus either hydrochlorothiazide perindopril effective reducing blood pressure six months compared perindopril plus hydrochlorothiazide <NUMBER> creole results indicate ccbbased regimens efficacious black african hypertensive patients communitybased interventions addition lifestyle modifications may improve control htn african american community success programs based identification mitigation barriers htn control african american patients increasing health knowledge impediments conventional medical hypertensive care includes historical distrust healthcare system lack access care inadequate communication patients providers goal community level intervention provide health information trusted source attendance certain national medical association association black cardiologists inc abc historically proposed various communitybased approaches continue advocate communitybased public health <NUMBER> pioneers community level interventions amongst african americans include late elijah saunders md b waine kong phd baltimore maryland <NUMBER> <NUMBER> team directed churchcommunity health awareness monitoring program champ concert abc program <NUMBER> parishioners representing <NUMBER> churches baltimore area trained monitor bp make adequate transfers care empowering community members bringing healthcare persistently underserved area drs saunders kong began initiative using barbershops bp control centers <NUMBER> <NUMBER> served model subsequent community level efforts especially difficult reach cohort african american men moreover <NUMBER>s daphne p ferdinand phd rn lead author established healthy heart community prevention project inc hhccp new orleans la original hhccp approach utilized threefold approach involving hair salons barbershops churches large group meetings healthcare professionals first initiative titled cut pressure trained barbers estheticians measure blood pressures counsel clients lifestyle modifications second titled give god hand involved working pastors develop teachings educated members improve cardiovascular risk profiles lastly hhccp hosted meetings educate health professionals best practices advances blood pressure management clinical standpoint <NUMBER> interestingly hhccp remains active today httpshealthyheartcpporg includes education outreach diabetes influenza immunization <NUMBER> federally sponsored randomized trial confirmed potent means controlling htn african american men study used interdisciplinary team bringing teambased care black barber shops west coast course six months <NUMBER> participants represented <NUMBER> barbershops los angeles ca underwent blood pressure screenings lifestyle modification training pharmacological intervention indicated evidencebased pharmacotherapeutic intervention led clinical advancetrained pharmacists conversation surrounding health interventions driven barbers end study <NUMBER> mmhg mean reduction systolic blood pressure baseline <NUMBER> mmhg <NUMBER> success study attributable three key components collaborative care delivery effective antihypertensive therapy trusted place intervention definition resistant hypertension rhtn inability meet blood pressure goals despite aggressive medical treatment three medications <NUMBER> <NUMBER> higher prevalence african americans fluid retention high dietary sodium intake excess aldosterone major mechanisms current evidencebased guidelines suggest threestep regimen first lifestyle modifications adequate three drug regimen including ccb thiazidetype diuretic ace inhibitor arb secondly replacing hydrochlorothiazide thiazidetype diuretic specifically indapamide chlorthalidone loop diuretics depending patients kidney function lastly adding mineralocorticoid receptor antagonist like spironolactone eplerenone often effective control difficult treat htn patients many clinicians opted clonidine setting rhtn due rapid onset action resistant hypertension optimal treatment rehot study randomized study performed brazil confirmed superior efficacy ease use spironolactone clonidine fourth line treatment aldosterone antagonists including spironolactone eplerenone effective better tolerated clonidine <NUMBER> present consensus clonidine antiquated therapy adverse side effects conducive long term use aldosterone antagonists depending adequate renal function ideal fourth line pharmacological therapy patients rhtn including african americans tragically covid<NUMBER> mortality disproportionately high african americans blacks representing <NUMBER> cases nationally despite comprising <NUMBER> population <NUMBER> <NUMBER> fact may <NUMBER> center disease control prevention cdc report surveyed raceethnicity among covid<NUMBER> cases demonstrated incidence increased among nonhispanic blacks represent <NUMBER> newly reported cases <NUMBER> louisiana may <NUMBER> blacks represent <NUMBER> population comprised <NUMBER> covid<NUMBER> related deaths throughout state <NUMBER> increased covid<NUMBER> mortality complications occur greater incidence individuals certain comorbidities preexistent among conditions htn <NUMBER> obesity <NUMBER> diabetesmetabolic disease <NUMBER> cvd <NUMBER> comorbidities prevalent african americans <NUMBER> special considerations regarding treatment approaches hypertensive covid<NUMBER> patients unproven presently review suggestion aceis arbs upregulate ace<NUMBER> receptors coronavirus enters tissue including pneumocytes <NUMBER> nevertheless recent clinical cohort data show ace inhibitors arbs deleterious effects covid<NUMBER> mortality importantly collaboration heart failure society american hfsa acc aha released statement march <NUMBER> recommending discontinuation acei arbs <NUMBER> however postulated issue use ccbs possible adverse effects covid<NUMBER> <NUMBER> therefore ccbs may alternative compelling indications heart failure postmyocardial infarction status ckd addition thiazidetype diuretics recent guidelines remain optimal firstline treatments african americans <NUMBER> however current evidencebased medical therapy confirms regardless race compelling indications acei arbs component cvd reduction htn regimen certainly social determinants profound impact risk mortality related covid<NUMBER> african americans likely reside densely populated areas thus encounter greater challenge adherence social distancing guidelines likely employment essential service jobs cannot performed remotely thus increasing risk exposure <NUMBER> additionally african americans less likely access financial resources event health emergency economic disruption notably blacks people color neither genetically biologically predisposed covid<NUMBER> social factors contribute increased risk coronavirus exposure <NUMBER> comorbid conditions htn t<NUMBER>d obesity contribute greater mortality risk covid<NUMBER> poorer prognosis upon development disease emergence covid<NUMBER> global health crisis opportunity address longstanding disparities underlying structural factors welldocumented contribute poorer overall health outcomes among african americans <NUMBER> furthermore regarding inequities specific approaches identify discrimination racialethnic variations testing treatment essential minimize covid<NUMBER> mortality among blacks <NUMBER> one unintended outcomes covid<NUMBER> pandemic increase virtual phone consultations providers although studied african american cohort recent european report suggested smart technology electronic home bp monitoring may yield similar percentages patients controlled htn compared standard care <NUMBER> especially conditions htn t<NUMBER>d require continued monitoring telemedicine may assist risk factor control provide access critical medication refills covid<NUMBER> new medicare provisions physicians providers receive greater reimbursement collaborating patients monitor bp home <NUMBER> us approach may necessary beneficial monitoring hypertension blacks minorities going forward although still investigational renal denervation growing area study treatment option htn recent study shown benefit method using spyral catheter participants randomly assigned one two groups renal denervation spyral catheter sham blacks comprised significant number groups ambulatory blood pressure changes modest significant improvement office blood pressure measurements specifically without medications denervation group <NUMBER> mmhg reduction sbp <NUMBER> mmhg diastolic blood pressure dbp <NUMBER> given significant representation african americans study future consideration may given renal denervation reasonable treatment strategy htn well controlled pharmacotherapy figure <NUMBER> previously noted one comorbidity commonly associated rhtn t<NUMBER>d <NUMBER> sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors hypoglycemic agents reduce blood glucose increasing excretion glucose urine beyond clinically approved use t<NUMBER>d treatment sglt<NUMBER> inhibitors shown cardioprotective although mechanisms still unclear suggested mechanisms include diuresis sympathetic nervous system attenuation increasing release nitric oxide <NUMBER> multiple cardiovascular renal outcome studies show clinical benefit use sglt<NUMBER> inhibitors improve multiple conditions unfortunately multiple major trials black patients underrepresented conventionally approximately <NUMBER> less blacks major studies composed treatment placebo groups respectively antihyperglycemic blood pressure effects empagliflozin african americans t<NUMBER>d htn recent study sought account disparity study <NUMBER> selfidentified blacks mean age <NUMBER> longstanding t<NUMBER>d htn notably treatment group showed stepwise reduction sbp <NUMBER>week à<NUMBER> mmhg <NUMBER>week à<NUMBER> mmhg points suggesting need extended use maximum therapeutic impact comparable results treatment single antihypertensive medication sglt<NUMBER> inhibitors studied consideration treatment rhtn <NUMBER> novel investigational approach htn management would firibrastat therapeutic agent acts renin angiotensin system ras brain system angiotensin iii activity at<NUMBER> receptor associated elevated bp due increased adh secretion <NUMBER> novel evaluation qgc<NUMBER> hypertensive overweight patients multiple ethnic origins newhope study investigated efficacy firibrastat aminopeptidase inhibitor group <NUMBER> minority participants end treatment period firibrastat caused mean reduction <NUMBER> mmhg sbp <NUMBER> mmhg dbp <NUMBER> firibrastat evaluation may future direction pharmacological therapy rhtn population fueled partly covid<NUMBER> crisis disruption inperson conventional outpatient care regardless emerging future developments htn treatment use inhome selfmonitoring bp measurements confirm hypertension diagnosis monitor htn control increase future clinicians staff continue reimbursed telemedicine including teaching patients take accurate bp measurements selfmeasured blood pressure smbp virtual visit evaluate smbp empower patients accurately measure bp home improve bp control figure <NUMBER> one recently launched website wwwvalidatebporg offers clinicians patients list home bp monitors certified appropriate validity accurate bp readings <NUMBER> smbp model embraced medicare services payment expected private health plans continue increase support approach african americans htn significant contributor increasing cvd burden mortality unfortunately number deaths htn factor steadily increased past decade <NUMBER> african americans highest prevalence htn us often poorly managed htn blacks burdened clinical inertia despite unacceptably high bp clinicians make changes intensification pharmacotherapy even patients access care providers often fail increase pharmacotherapy accordance treatment guidelines placing patients risk adverse cvd outcomes metaanalysis found combination regular blood pressure monitoring patient education provider training concerning implicit bias improved bp control <NUMBER> physicians providers seeking alleviate disparity must improve communication strengthen providerpatient relationship include culturallysensitive literacylevel appropriate communication using models webbased printed materials explain patients condition treatment plans unacceptable decades american healthcare system failed african americans minority communities primary secondary cvd prevention essential present pandemic future clinicians ensure continuation cvd medications including antihypertensives antiplatelets anticoagulation medications statins lipidmodifying agents possible prescribe <NUMBER>day supplies sufficient refills higher covid<NUMBER> african american mortality sentinel event similar hospital sentinel events harbingers poorquality inpatient care wrongsite surgeries falls higher black pandemic deaths place harsh spotlight longstanding higher mortality diminished longevity <NUMBER> beyond conventional clinical setting specific programs needed help patients overcome barriers care access appropriate lifestyle interventions utilize pharmacotherapy offer health education achieve health equity overcome structural bias unprecedented times coronavirus disease <NUMBER> covid<NUMBER> pandemic severe impact globally countries implemented strict lockdown social distancing isolation elderly vulnerable advised time writing review three million individuals affected globally <NUMBER> deaths <NUMBER> global infection curve flattened new infections continuing rise although pandemic originated china epicentre shifted europe presently affected country united states america usa timeline first cases atypical pneumonia linked huanan seafood wholesale market wuhan china described late december <NUMBER> china announced outbreak <NUMBER> december <NUMBER> closed market became apparent place origin early january <NUMBER> investigations chinese authorities continued contacts traced managed world health organization notified <NUMBER> january <NUMBER> novel coronavirus announced cause outbreak <NUMBER> <NUMBER> january <NUMBER> china shared viral gene sequence allow development reverse transcriptasepolymerase chain reaction rtpcr diagnostic kits <NUMBER> first case outside china confirmed thailand strict screening measures travel restrictions lockdown wuhan implemented <NUMBER> first case usa announced <NUMBER> january <NUMBER> <NUMBER> first cases europe reported france <NUMBER> january <NUMBER> individuals travel history hubei province china subsequent humantohuman transmission followed cases travel history reported <NUMBER> africa reported first case <NUMBER> february <NUMBER> egypt since number cases risen dramatically figure <NUMBER> third coronavirus outbreak many decades <NUMBER> previous two severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> mortality rates <NUMBER> <NUMBER> respectively <NUMBER> mortality rate sarscov<NUMBER> although lower compared sars mers seems devastating effect globally sarscov<NUMBER> singlestranded rna genome enveloped lipid membrane embedded glycoprotein spikes giving impression crown hence name coronavirus cov rna viruses use errorprone rna polymerase replication therefore high mutation rates easily mutate epidemics adapting local environment facilitate transmission <NUMBER> however mutations part virus life cycle impact outbreaks <NUMBER> zhu et al extracted viral rna respiratory samples three patients admitted wuhan <NUMBER> <NUMBER> january <NUMBER> chinese centre disease control prevention identified novel betacoronavirus one samples described <NUMBER> sequence homology bat sarslike cov caused sars outbreak <NUMBER> <NUMBER> <NUMBER> virus originally named <NUMBER> novel coronavirus <NUMBER>ncov later changed sarscov<NUMBER> seventh member coronavirus family six previously described covs four cause minimal common cold symptoms humans two members sarscov merscov covs zoonotic origins bats considered natural reservoir hosts <NUMBER> sarscov<NUMBER> sequence identity pangolin origin covs sarscov<NUMBER> <NUMBER> raised question whether virus pangolin origin <NUMBER> natural hosts namely bats limited inflammatory response seen lower interleukin il<NUMBER>b concentrations adequate type interferons giving rise generalized antiinflammatory milieu ability limit excessive inflammatory response <NUMBER> interestingly may also explain bats relatively long lifespan <NUMBER> years <NUMBER> type interferon known assist antiviral control cov cannot infect humans unless virus undergoes mutation recombination animal hosts sarscov<NUMBER> highly virulent virus original infection distribution mainland china found <NUMBER> patients <NUMBER> years age <NUMBER> patients less <NUMBER> years old <NUMBER> easily transmissible initial studies finding infected person capable infecting another <NUMBER> individuals <NUMBER> virus stable plastic stainlesssteel surfaces <NUMBER> h <NUMBER> enhancing ability spread relatively long incubation period worsens situation individuals may asymptomatic carriers two weeks thereby releasing virus surroundings process called viral shedding common symptoms covid<NUMBER> respiratory transmission via droplets directly surfaces direct contact sarscov<NUMBER> also detected stool may point possible faecooral route transmission <NUMBER> <NUMBER> risk comorbidity although covid<NUMBER> may present mildly flulike disease even asymptomatic patients develop significant cardiovascular adverse effects according present data <NUMBER> infected individuals mild flulike symptoms recover within two weeks <NUMBER> severe symptoms requiring hospitalization <NUMBER> become critically ill <NUMBER> differences presentation thought due viral load age presence comorbidities <NUMBER> many carriers may asymptomatic underestimated source transmission <NUMBER> effective screening contact tracing important identify highrisk individuals advise selfisolation transmission risk high trace possible cases limit community spread children may also possible carriers asymptomatic infection lu et al described children <NUMBER> years old may asymptomatic <NUMBER> cases <NUMBER> elderly considered high risk may due aging immune system concomitant lymphopaenia decreased cd<NUMBER>count tcell regulation <NUMBER> elderly people propensity excessive autoimmune inflammatory responses may exacerbated covid<NUMBER> infection <NUMBER> male patients associated comorbidities also increased risk risk factors complicated infection identified early studies corroborated increased risk associated age male sex certain comorbidities studies also described several laboratory clinical markers used determine prognosis first study reported <NUMBER> cases admitted early january <NUMBER> wuhan china median age <NUMBER> years adolescents children <NUMBER> male <NUMBER> exposure huanan seafood wholesale market cohort <NUMBER> <NUMBER> admitted intensive care unit icu lymphopaenia increased ddimer levels increased partial thromboplastin time ptt increased aspartate aminotransferase ast increased highsensitivity troponini hstni increased inflammatory cytokines indicated poor prognosis outcome <NUMBER> another early study described <NUMBER> hospitalized cases wuhan average age <NUMBER> years male <NUMBER> history exposure huanan seafood market age obesity comorbid illness associated increased mortality concern expressed individuals compromised immune function human immunodeficiency virus hiv increased age diabetics immunosuppressive therapy <NUMBER> subsequent study six family members shenzhen china returned visit wuhan described first persontoperson transmission virus <NUMBER> yang et al described clinical course outcomes <NUMBER> patients covid<NUMBER> pneumonia including <NUMBER> critically ill critically ill mean age <NUMBER> years <NUMBER> male <NUMBER> comorbidities <NUMBER> died <NUMBER> days median time seven days nonsurvival risk associated advance age comorbidities <NUMBER> li et al collected demographic information exposure history illness timelines <NUMBER> initial confirmed cases wuhan median age <NUMBER> years <NUMBER> male <NUMBER> cases linked original huanan seafood wholesale market evident humantohuman transmission described doubling cases every <NUMBER> days suggested <NUMBER>day observation quarantine period exposed persons described infected person spread virus average <NUMBER> people come contact none cases children postulated children may less likely infected milder symptoms <NUMBER> ruan et al examined factors associated increased mortality <NUMBER> patients wuhan collected demographic clinical laboratory data found age presence comorbidities secondary infections increased cardiac tn creactive protein crp il<NUMBER> concentrations predictors fatal outcome <NUMBER> cytokine storm occurs subgroup patients severe covid<NUMBER> defined hyperinflammatory state characterized fulminant fatal increase inflammatory cytokines subsequent multiorgan failure ferritin concentrations raised cytopaenia occurs approximately half patients develop significant pulmonary involvement acute respiratory distress syndrome ards <NUMBER> findings suggest study ruan et al mortality severely ill patients probably caused cytokine storm study <NUMBER> covid<NUMBER> patients two hospitals china one wuhan found <NUMBER> <NUMBER> died hospital increased risk inhospital death associated older age organ failure raised ddimer levels authors postulated could possibly used admission identify patients worse prognosis <NUMBER> wang et al examined epidemiological demographic clinical laboratory radiological treatment data <NUMBER> patients hospitalized covid<NUMBER> found <NUMBER> patients needed icu admission <NUMBER> died median patient age <NUMBER> years <NUMBER> male older age comorbidities abnormal laboratory tests including lymphopaenia increased ddimer increased lactate dehydrogenase ldh prolonged ptt associated worse prognosis <NUMBER> liu et al performed small study <NUMBER> patients shenzhen china eight males seven older <NUMBER> years found laboratory parameters associated worse prognosis decreased albumin concentrations lymphopaenia elevated crp ldh concentrations measured angiotensin ii concentrations enzymelinked immunosorbent assay elisa found increased increased angiotensin ii associated high viral load lung injury suggesting imbalanced renin angiotensin system ras authors therefore questioned possible utility angiotensin converting enzyme ace inhibitor angiotensin receptor blocker arb possible treatment modalities <NUMBER> first case diagnosed usa <NUMBER> january <NUMBER> young male patient travelled wuhan china never visited wuhan market healthcare facility also contact ill people city usas patient zero initially presented mild symptoms progressed pneumonia day nine laboratory results showed leucopaenia mild thrombocytopaenia elevated creatinine liver enzymes alkaline phosphatase alp alanine transferase alt aspartate transferase ast <NUMBER> arentz studied <NUMBER> critically ill covid<NUMBER>infected patients washington state mean age <NUMBER> years <NUMBER> male seventeen <NUMBER> admitted icu <NUMBER> developed cardiomyopathy mortality rate <NUMBER> elderly patients comorbidities <NUMBER> reninangiotensin system angiotensinconverting enzyme <NUMBER> ras normal physiology receptors ras important regulator blood pressure homeostasis renin protease secreted kidney cleaves angiotensinogen serpin family protein produced liver inactive angiotensin cleaved active angiotensin ii ace secreted kidneys lungs expressed ubiquitously vasculature angiotensin ii binds angiotensin type <NUMBER> at<NUMBER> receptors causes vasoconstriction secretion aldosterone antidiuretic hormone subsequent renal sodium water reabsorption raised blood pressure <NUMBER> angiotensin ii binds at<NUMBER> receptor leads increase blood pressure well inflammation fibrosis oxidative stress vasoconstriction <NUMBER> important regulation cardiovascular haemodynamic neurological endothelial functions <NUMBER> receptors ras <NUMBER> figure <NUMBER> angiotensin type <NUMBER> at<NUMBER> originally thought receptor angiotensin ii actions facilitated via receptor <NUMBER> genetic polymorphisms associated hypertension myocardial infarction abnormal activation at<NUMBER> associated cardiovascular disease inflammation atherosclerosis endothelial dysfunction oxidative stress insulin resistance cancer malignant hypertension at<NUMBER> receptor blockers arb selective antagonists used treat hypertension cardiovascular disorders b angiotensin type <NUMBER> at<NUMBER> <NUMBER> homology at<NUMBER> low expression adults concentrations decrease soon birth found low concentrations adult cardiovascular system adrenal glands kidney brain uterine myometrium skin upregulation may occur physiological stressful conditions vascular injury myocardial infarction cardiac failure <NUMBER> studies knockout mice demonstrated development hypertension mutation receptor also associated mental retardation plays role antidiuretic antinatriuretic functions also found brain tissue <NUMBER> investigated possible therapeutic target neuropathic pain however treatment poor efficacy many side effects c mas receptor angiotensin <NUMBER> produced ace<NUMBER> activation mas leads synthesis arachidonic acid activation nitric oxide synthase high expression mas found brain important cardiovascular regulation also found play important role testicular function immunolocalization angiotensin <NUMBER> mas receptors showed impaired spermatogenesis male infertility <NUMBER> knockout mice present altered heart rate decreased blood pressure possibly due imbalance formation reactive oxygen species protective role masangiotensin <NUMBER> made possible drug target angiotensin type <NUMBER> at<NUMBER> receptor beyond scope review homologue ace namely ace<NUMBER> identified <NUMBER> <NUMBER> ace<NUMBER> ace catalytic domains <NUMBER> identical alluding two genes common ancestor <NUMBER> ace<NUMBER> type transmembrane metallopeptidase enzymatic domain external surface cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> involved regulation cardiac function blood pressure control possibly counterpart ace <NUMBER> ace<NUMBER> regulates ras modulating endogenous concentrations angiotensin angiotensin ii <NUMBER> cleaves single residue angiotensin generate angiotensin <NUMBER> single residue angiotensin ii generate angiotensin <NUMBER> figure <NUMBER> possibly cleaves substrates apelin cardioprotective properties desarginine bradykinin promotes inflammation neurotensin involved regulation luteinizing hormone prolactin <NUMBER> <NUMBER> angiotensin <NUMBER> also converted angiotensin <NUMBER> ace binding mas receptor angiotensin <NUMBER> shifts balance vasoconstriction angiotensin ii vasodilation gives rise antiinflammatory antifibrotic effects increased synthesis vasodilation <NUMBER> inactivation ace<NUMBER> leads increased angiotensin ii concentrations impaired cardiac contractility <NUMBER> although ace<NUMBER> mrna found almost organs protein expression mainly lung airways type ii alveolar cells heart kidney intestine also found oral nasal mucosa skin lymph nodes thymus bone marrow spleen liver testis brain <NUMBER> ace<NUMBER> extracellular domain receptor site spike protein sarscov<NUMBER> gain entry cell specifically lung alveolar epithelial cells enterocytes plays important role entry covs <NUMBER> ace<NUMBER> enterocytes duodenum jejenum ileum may explain virus found stool samples support possible faecooral transmission route <NUMBER> <NUMBER> ace<NUMBER> receptor tongue oral mucosa may implicate possible route transmission dental practice <NUMBER> keeping observation male individuals higher risk sarscov<NUMBER> infection important note ace<NUMBER> gene mapped xchromosome <NUMBER> females two copies ace<NUMBER> gene males one copy possible theory males higher risk two forms ace<NUMBER> fulllength ace<NUMBER> found cell membranes consists transmembrane anchor extracellular domain receptor site spike protein sarscov<NUMBER> second form soluble form shed circulation form ace lacks membrane anchors circulates low concentrations <NUMBER> circulating levels reflect issue levels proposed soluble form ace<NUMBER> may inhibit binding sarscov<NUMBER> membranebound ace<NUMBER> therefore proposed soluble recombinant ace<NUMBER> potential treatment covid<NUMBER> <NUMBER> angiotensin ii binds at<NUMBER> receptor vasoconstriction inflammation fibrosis proliferation follow leading hypertension cardiac fibrosis thrombosis ards binding angiotensin <NUMBER> mas receptor leads vasodilatation antiapoptotic antifibrotic antiproliferation activity reduction blood pressure decreased cardiac fibrosis decreased thrombosis decreased ards <NUMBER> at<NUMBER> bound released antiinflammatory vasodilator reduces platelet aggregation may facilitate insulin action <NUMBER> therefore angiotensin ii binding at<NUMBER> inflammatory mediator via reactive oxygen species ros nuclear factor kappa b nfkb provides mitogenic stimulus smooth muscles leading oxidative stress common feature atherosclerosis diabetes mellitus hypertension hyperlipidaemia stimulation at<NUMBER> also leads upregulation adhesion molecules interferes insulin signalling leading insulin resistance ace inhibitors arb therapy found decrease circulating crp thought due decreased angiotensin ii stimulation at<NUMBER> disruption ace<NUMBER> mice leads severe cardiac contractility defects increased angiotensin ii concentrations expression hypoxiainduced cardiac genes ace also decreased cardiac phenotype rescued however loss ace<NUMBER> affect blood pressure kidney development mice postulated ace could potentially compensate loss ace<NUMBER> yet even mice treated ace inhibitor similar reduction blood pressure wild type therefore ace<NUMBER> apparent direct effect blood pressure <NUMBER> strong association ras cardiovascular disease neurodegenerative disorders acute lung injury demonstrated mice acid aspiration lung injury severe acute lung failure significant downregulation ace<NUMBER> noted expression ace unchanged leading marked increase angiotensin ii formation upregulated ace therefore ace promotes disease increased angiotensin ii acedeficient mice partly protected acidinduced lung injury recombinant ace<NUMBER> at<NUMBER> receptor expression protected mice severe lung disease scenario <NUMBER> inactivation ace ace<NUMBER> knockout background rescued mice severe lung failure therefore postulated ace promotes acute lung injury ace<NUMBER> alleviates <NUMBER> patel verma found high pulmonary ace<NUMBER> concentrations protect lung injury <NUMBER> loss ace<NUMBER> expression acute lung injury led leaky pulmonary blood vessels at<NUMBER> receptor stimulation however hydrostatic oedema could excluded causative factor emphasizing need studies local effects angiotensin ii lungs <NUMBER> pathology ras associated pulmonary hypertension pulmonary fibrosis <NUMBER> angiotensin ii upregulates expression profibrotic cytokines leading pulmonary fibrosis severe inflammation increased vascular permeability treatment ace inhibitors arb may attenuate <NUMBER> animal models ards found reduced ace<NUMBER> concentrations treatment exogenous ace<NUMBER> alleviated symptoms <NUMBER> studies found loss ace<NUMBER> rendered subjects susceptible heart failure postulated increasing ace<NUMBER> concentrations cardioprotective loss ace<NUMBER> also led agedependant cardiomyopathy pulmonary cardiac renal injuries <NUMBER> diabetes mellitus major comorbid risk factor covid<NUMBER> associated increased ace<NUMBER> expression may explain patients suffering diabetes greater susceptibility sars infection <NUMBER> ace<NUMBER> involved possible protective arm ras ace<NUMBER>angiotensin <NUMBER>mas axis counterbalances aceangiotensin iiat<NUMBER> axis associated vasoconstriction inflammation cell proliferation hypertrophy fibrosis tissue modelling therefore ace<NUMBER> protects rasinduced injuries decreasing angiotensin ii generating angiotensin <NUMBER> increases substrate availability protective axis <NUMBER> ace<NUMBER> knockout mice ace<NUMBER> inhibitors increased susceptibility myocardial infarction hypertension angiotensin iiinduced myocardial hypertrophy microvascular complication inflammation fibrosis diastolic systolic dysfunction oxidative stress ace inhibitors block ace arb block action angiotensin ii ati receptors lead increased ace<NUMBER> activity <NUMBER> drugs may alleviate inflammation decrease endothelial dysfunction increase insulin sensitivity <NUMBER> arbs potential block ras acei <NUMBER> angiotensin ii formed via nonace pathways humans <NUMBER> arbs known less sideeffects ace inhibitors another area interest peroxisome proliferatoractivated receptorgamma pparc insulin resistance strongly associated hypertension ace<NUMBER> expression increased use pparc agonists <NUMBER> pparc agonists thiazolidinediones attenuate development hypertension improve endothelial dysfunction angiotensin iiinfused rats <NUMBER> rats decreased at<NUMBER> expression therefore effects likely mediated at<NUMBER> receptor activation <NUMBER> however pparc agonists shown increase risk congestive heart failure possibly myocardial infarction medications effect ace<NUMBER> concentrations include mineralocorticoid antagonists aldosterone receptor antagonist spironolactone possibly increases ace<NUMBER> concentrations macrophages case heart tissue patients suffering chronic heart failure <NUMBER> statins possibly augment ace expression heart kidney tissue may also bring epigenetic changes ace<NUMBER> gene work needed determine exact mechanism findings <NUMBER> presently still paucity evidence ace inhibitors arb may impact ace<NUMBER>angiotensin <NUMBER> pathway lung heart brain ongoing research field needed human ace<NUMBER> functional receptor essential cellular entry covs receptor used sarscov gain access cells <NUMBER> kuba et al provided first genetic proof ace<NUMBER> crucial receptor sarscov vivo <NUMBER> ace<NUMBER> knockout wildtype mice infected sarscov knockout mice low levels viral replication lungs wildtype mice sarscov infection associated lung failure attenuated treatment blocking ras postulated sarscov infection downregulated ace<NUMBER> concentrations possibly explaining decline lung function observed viral infection <NUMBER> spike proteins covs facilitate viral entry target cells attaching ace<NUMBER> entry receptor <NUMBER> sarscov<NUMBER> like sarscov viral envelope studded spikes consisting glycoproteins made two subunits namely s<NUMBER> s<NUMBER> subunit s<NUMBER> binds cell surface bound ace<NUMBER> subunit s<NUMBER> fuses cell membrane <NUMBER> cellular serine protease tmprss<NUMBER> essential sprotein priming facilitates viral cell entry <NUMBER> tmprss expressed sarscov target cells <NUMBER> subunit s<NUMBER> spike binds membrane bound ace<NUMBER> tmprss<NUMBER> activates spike cleaves ace<NUMBER> receptor tmprss<NUMBER> also acts s<NUMBER> subunit causing irreversible conformational change facilitating fusion viral membrane host cell membrane endocytosis <NUMBER> <NUMBER> therefore ace<NUMBER> tmprss<NUMBER> essential cellular entry sarscov<NUMBER> binds human ace<NUMBER> <NUMBER>fold higher affinity sarscov <NUMBER> may due compact virus structure enabling better receptor affinity enhanced ability internalized figure <NUMBER> shows cellular entry sarscov<NUMBER> binding sarscov<NUMBER> may decrease ace<NUMBER> concentrations increase angiotensin ii angiotensin <NUMBER> ratio may exacerbate pulmonary injury tissue fibrosis <NUMBER> angiotensin <NUMBER> may provide resilience development pulmonary failure covid<NUMBER> supporting finding <NUMBER> oudit et al <NUMBER> determined sarscov infection detrimental effect cardiac function led cardiac dysfunction arrhythmias death measured ace<NUMBER> concentrations mice infected human strain sarscov hearts obtained autopsy patients died sars infection found sarscov infection led decrease ace<NUMBER> expression myocardium mice subsequent myocardial dysfunction sarscov mrna expression found <NUMBER> autopsy heart samples associated decreased ace<NUMBER> protein expression therefore postulated sarscov leads cardiac dysfunction downregulating myocardial ace<NUMBER> possibly due cytokinemediated downregulation ace<NUMBER> mrna <NUMBER> gastrointestinal system also spared effects sarscov<NUMBER> infection xiao et al found ace<NUMBER> abundant glandular cells gastric duodenal rectal epithelia <NUMBER> hamming et al described ace<NUMBER> small intestine underlining importance sarscov<NUMBER> involvement gastrointestinal system <NUMBER> interesting observation difference infection rate adverse outcomes adults children although reports less covid<NUMBER> infection children lack evidence ace<NUMBER> changes age <NUMBER> possible hypothesis children less susceptible covid<NUMBER> infection due crossprotective antibodies multiple upper respiratory tract infections lower respiratory tracts less ace<NUMBER> <NUMBER> limited studies data children available conclusive evidence support postulations children less likely adversely affected sarscov<NUMBER> infection lacking clear statistical data older people especially men affected covid<NUMBER> increased ace<NUMBER> described older individuals males <NUMBER> could possibly linked worse outcome population group yet evidence causal relationship ace<NUMBER> activity sarscov<NUMBER> mortality also ace<NUMBER> concentrations correlate degree disease severity <NUMBER> activation ras associated endothelial dysfunction multiple organ injuries therefore theoretically treatment focusing manipulation control system may beneficial <NUMBER> covid<NUMBER>infected patients worse prognosis suffer comorbidities especially cardiovascular ras inhibitors shown protective effect kidney myocardium may therefore dangerous withdraw treatment patients higher risk relapse patients cardiovascular renal disease also demonstrated <NUMBER> angiotensin ii concentrations found increased covid<NUMBER> infection positively correlated viral load lung injury <NUMBER> increased ace<NUMBER> concentrations may possibly lead greater susceptibility covid<NUMBER> infection may also cardioprotective led crossroad clinical decisionmaking ras blocking treatment may increase ace<NUMBER> facilitate virus entry beneficial effects patients suffering comorbid conditions cannot ignored lot learned studies involving respiratory viruses use ace<NUMBER>lowering treatment investigated study patients novel influenza h<NUMBER>n<NUMBER> virus avian origin eastern china <NUMBER> found <NUMBER> developed ards high mortality patients markedly elevated angiotensin ii concentrations poorer disease outcome predictive value higher crp authors speculated recombinant ace<NUMBER> angiotensin iilowering treatment ace inhibitors arb could beneficial <NUMBER> avian influenza h<NUMBER>n<NUMBER> primarily infects poultry birds since <NUMBER> also infecting humans increased angiotensin ii downregulation ace<NUMBER> linked infection severity mortality mice infected h<NUMBER>n<NUMBER> given recombinant ace<NUMBER> virusinduced lung injury ameliorated <NUMBER> use intravenous ace inhibitors arb experimental animals increases ace<NUMBER> expression cardiopulmonary circulation systems causing possible increased risk sarscov<NUMBER> infection <NUMBER> severe covid<NUMBER> outcomes described patients existing hypertension coronary artery disease diabetes chronic kidney disease <NUMBER> question asked whether current treatment regimens increasing risk infection theoretically ace<NUMBER> activity cell membranes decreased reduce ability sarscov<NUMBER> enter cells also decreases protective effects ace<NUMBER> various organ systems ace<NUMBER> expressed angiotensin ii may contribute organ damage covid<NUMBER> <NUMBER> concentrations found correlate viral load lung injury <NUMBER> downregulation ace<NUMBER> lung tissue may facilitate neutrophil infiltration leading angiotensin ii accumulation ras activation <NUMBER> covid<NUMBER> binds ace<NUMBER> enters cell expression ace<NUMBER> downregulated downregulation essentially removes brakes angiotensin ii possibly induces local activation immune cells lungs decreased ace<NUMBER> alveolar type ii cells leads surfactant deficit development lung injury <NUMBER> although increase ace<NUMBER> may lead higher cell infection rates proliferation virus may beneficial patients lung injury withdrawal may harmful especially highrisk patients <NUMBER> study acidinduced lung injury mice ace<NUMBER> downregulation sarscov worsened lung injury induced lung injury improved use arbs findings suggestive sarscov exacerbates lung injury decreasing ace<NUMBER> also reversible arbs <NUMBER> increase ace<NUMBER> heart tissue may cardioprotective therefore sarscov<NUMBER> could possibly influence fine balance angiotensin ii angiotensin <NUMBER> whereas treatment could block ras protect heart organs <NUMBER> cardiac tissue function may compromised increase angiotensin ii angiotensin <NUMBER> ratio loss ace<NUMBER> central nervous system specifically brain stem cardiovascular centre may cause increased sympathetic drive changes baroreflex worsening hypertension <NUMBER> loss ace<NUMBER> vasculature contribute endothelial dysfunction inflammation exacerbate existing atherosclerosis diabetes concerns increased ace<NUMBER> expression heart brain urine treatment arb may increase individuals risk infection little evidence available showing significant changes serum pulmonary ace<NUMBER> concentrations however significance ace<NUMBER> expression effect covid<NUMBER> pathogenesis mortality uncertain <NUMBER> therefore benefits outweigh risks joint statement issued <NUMBER> march <NUMBER> found experimental clinical evidence demonstrating beneficial adverse outcomes covid<NUMBER> patients using ace inhibitors arb available urgent additional research needed stated treatment discontinued patients become infected sarscov<NUMBER> <NUMBER> potential covid<NUMBER> treatment involving ace<NUMBER> system since early stages covid<NUMBER> pandemic emphasis finding possible treatment modalities number possible treatment targets identified based previous studies conducted sarscov specifically involving ace<NUMBER>angiotensin <NUMBER> pathway decreasing ace<NUMBER> downregulation ace<NUMBER> proposed possible treatment reduce susceptibility covid<NUMBER> infection however ensuing relatively unopposed action angiotensin ii could lead worsening hypertension inflammation thrombosis adverse lung cardiac outcome <NUMBER> study kuba et al determined infection sarscov downregulates expression ace<NUMBER> low ace<NUMBER> concentrations associated lung oedema acute lung injury contributed severe lung pathology patients already ace inhibitors time sarscov infection concluded modulating ras may therefore useful treating infection <NUMBER> studies also questioned use antiace<NUMBER> antibodies inhibit viral replication sarscov could possibly inhibit virusinduced cytopathicity dosedependent manner <NUMBER> increasing ace<NUMBER> trials underway evaluate safety efficacy recombinant human ace<NUMBER> arb losartan covid<NUMBER>infected patients infusion recombinant human ace<NUMBER> may act decoy interfere viral replication soluble ace<NUMBER> could potentially bind sarscov thereby prevent binding viral spike protein full length membranebound ace<NUMBER> <NUMBER> reducing viral infection cells <NUMBER> recombinant ace<NUMBER> shown reverse lung injury sarscovinfected patients <NUMBER> wang et al found ace inhibitors arb offer partial cardiovascular protection increasing ace<NUMBER> iv recombinant ace<NUMBER> may beneficial preventing pulmonary arterial hypertension acute lung injury <NUMBER> however circulating ace<NUMBER> concentrations usually low undetectable accurately represent amount membranebound ace<NUMBER> would sufficient sequester sarscov<NUMBER> circulation <NUMBER> proposed clinical trial recombinant ace<NUMBER> withdrawn due unknown effects possibility drug inducing significant hypotension <NUMBER> ace<NUMBER> interaction sarscov important development sarsassociated cardiomyopathy viral rna found myocardium postmortem examination associated cardiac injury due reduced expression ace<NUMBER> possibly played major role morbidity mortality patients infected sarscov recombinant ace<NUMBER> found normalize angiotensin ii concentrations suggesting may beneficial prevent organ damage caused sarscov question thus arose possible beneficial balance ras control reduce infection prevent organ damage covid<NUMBER>infected patients <NUMBER> targeting tmprss<NUMBER> protease inhibitors tmprss<NUMBER> block viral entry vitro inhibiting entry sarscov<NUMBER> cells <NUMBER> camostat mesylate serine protease inhibitor used japan treat chronic pancreatitis inhibits tmprss<NUMBER> block entry sarscov<NUMBER> bronchial epithelial cells vitro <NUMBER> <NUMBER> angiotensin ii many patients severe covid<NUMBER> infection admitted icu septic shock angiotensin angiotensin ii conversion ace occurs lungs significant lung injury may decrease decreased ace function found predictor mortality angiotensin ii novel vasopressor agent may beneficial patient population strategies decrease ace<NUMBER> may possibly attenuate sarscov<NUMBER> infectivity may happen number ways firstly endogenous angiotensin ii theoretically prevents infection binding ace<NUMBER> degradation therefore may compete sarscov<NUMBER> bind receptor secondly binding angiotensin ii at<NUMBER> causes internalization downregulation ace<NUMBER> lastly angiotensin ii causes at<NUMBER>dependent destruction ace<NUMBER> decreasing virus ability enter cells angiotensin ii yet available use commercially due number critically ill patients promising outcome drug made available compassionate use italy germany uk <NUMBER> angiotensin <NUMBER> another focus area use angiotensin <NUMBER> novel treatment covid<NUMBER> <NUMBER> experimental studies found angiotensin <NUMBER> reduced acute inflammatory response subsequent fibrosis acidinduced ards mice <NUMBER> angiotensin <NUMBER> protected lung inflammation fibrosis inhibited alveolar cell apoptosis attenuated endothelial cell activation loss barrier function oedema decreased synthesis proinflammatory profibrotic cytokines authors therefore recommended concentrations angiotensin <NUMBER> increased protect covid<NUMBER>infected patients <NUMBER> effects ace<NUMBER> covid<NUMBER> infections need evaluated randomized control trials necessary obtain highest level evidence although ace<NUMBER> beneficial effects regulating protective arm ras authors postulate high levels make patients susceptible covid<NUMBER> infection ras numerous attractive therapy targets covid<NUMBER> infection trials needed evaluate use ace inhibitors arbs covid<NUMBER> patients type <NUMBER> diabetes t<NUMBER>d correlates worse outcome covid<NUMBER> zhu et al show among <NUMBER> cases covid<NUMBER> t<NUMBER>d associated higher death rate diabetics better controlled blood glucose die lower rate diabetics poorly controlled blood glucose wellcontrolled blood glucose upper limit ≤ <NUMBER>mm poorlycontrolled blood glucose upper limit <NUMBER> mm death <NUMBER> diabetes c v <NUMBER> <NUMBER> novel coronavirus disease <NUMBER> caused infection newly emerged highly contagious coronavirus sarscov<NUMBER> wu mcgoogan <NUMBER> sarscov<NUMBER> mainly invades respiratory tract lungs leading new type coronavirus pneumonia severe cases covid<NUMBER> rapidly progress acute respiratory distress syndrome ards septic shock multiple organ dysfunction syndrome mods guan et al <NUMBER> elderly individuals along preexisting conditions hypertension cancer cardiovascular diseases diabetes mellitus acute kidney injury demonstrated higher risk developing severe cases covid<NUMBER> well suffering higher risk mortality zhang et al <NUMBER>b zhou et al <NUMBER> collision two global pandemics covid<NUMBER> type <NUMBER> diabetes t<NUMBER>d led grim reality t<NUMBER>d already second common comorbidity covid<NUMBER> however current evidence implicating t<NUMBER>d worse covid<NUMBER> prognosis mostly come relatively limitedsized cohorts deng peng <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> thus clinical features patients t<NUMBER>d infected sarscov<NUMBER> remain comprehensively clarified largescale analysis needed efficiently precisely manage treatment patients well established patients diabetes susceptible infections general exhibit worse prognosis infected compared nondiabetic population kumar nathella babu <NUMBER> xu et al <NUMBER> higher susceptibility also previously observed coronaviral epidemics example patients severe acute respiratory syndrome sars preexisting t<NUMBER>d independently associated poor outcomes percentage known t<NUMBER>d history significantly higher among patients succumbed sars survived booth et al <NUMBER> yang et al <NUMBER> epidemiological studies also indicate t<NUMBER>d primary comorbidity associated severe lethal merscov infections alqahtani et al <NUMBER> regard current covid<NUMBER> pandemic several recent studies though limited participants already suggested t<NUMBER>d common comorbidity constitutes higher proportion patients severe icuadmitted cases covid<NUMBER> patients mild symptoms deng peng <NUMBER> wang et al <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> associations diabetes worse outcome viral infections unexpected hyperglycemia detrimental control viremia inflammation aggravating morbidity mortality variety patients forbes et al <NUMBER> however overly rigid glucose control may increase risk severe hypoglycemia also lead increased mortality rodriguezgutierrez et al <NUMBER> consequently previous clinical trials examining effects glucose control mortality yielded conflicting results forbes et al <NUMBER> van den berghe et al <NUMBER> individuals covid<NUMBER> preexisting t<NUMBER>d key challenge clinicians improve outcomes face uncertainty regarding degree glycemic management maintained effects might benefits risks overall treatment thus detailed analyses data patients needed links plasma glucose levels clinic outcomes including mortality report performed retrospective longitudinal multicentered study cohort <NUMBER> confirmed covid<NUMBER> cases enrolled among <NUMBER> hospitals hubei province china focusing association plasma glucose levels clinic outcomes covid<NUMBER> patients t<NUMBER>d addition significant association diabetic status higher mortality rate patients covid<NUMBER> preexisting t<NUMBER>d versus nondiabetic subjects covid<NUMBER> study indicated wellcontrolled glycemia associated markedly improved outcome patients covid<NUMBER> preexisting t<NUMBER>d clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d upon admission clinic characteristics collected total <NUMBER> participants <NUMBER> confirmed cases covid<NUMBER> including <NUMBER> subjects preexisting t<NUMBER>d n <NUMBER> male <NUMBER> <NUMBER> nondiabetic cases n <NUMBER> male <NUMBER> figure <NUMBER> initial <NUMBER> cases enrolled <NUMBER> patients covid<NUMBER> excluded study including <NUMBER> clinical translational report patients younger <NUMBER> older <NUMBER> years old <NUMBER> patients without complete medical records <NUMBER> patients acute myocardial infarction <NUMBER> patients acute coronary syndrome <NUMBER> patients acute pulmonary embolism <NUMBER> patients acute stroke <NUMBER> patients acute severe pancreatitis <NUMBER> patients cirrhosis <NUMBER> patients stage <NUMBER> chronic renal insufficiency <NUMBER> patients severe congestive heart failure <NUMBER> patients pregnancy <NUMBER> patients malignancy <NUMBER> patients type <NUMBER> diabetes <NUMBER> patients history gestational diabetes <NUMBER> patient druginduced diabetes final cohort <NUMBER> covid<NUMBER> patients analyzed prevalence t<NUMBER>d <NUMBER> similar nationwide prevalence t<NUMBER>d china <NUMBER> wang et al <NUMBER> median ages <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetic nondiabetic groups respectively schematic overview illustrating participant enrollment cohort study various exclusion inclusion criteria among initial case group briefly total <NUMBER> patients covid<NUMBER> included various exclusion criteria <NUMBER> patients removed study remaining <NUMBER> patients data <NUMBER> patients without diabetes nont<NUMBER>d placed one group <NUMBER> individuals type <NUMBER> diabetes t<NUMBER>d placed second group <NUMBER> cases t<NUMBER>d <NUMBER> cases excluded due hypoglycemia lack bg readings remaining <NUMBER> cases t<NUMBER>d <NUMBER> considered wellcontrolled bg <NUMBER> poorly controlled bg two t<NUMBER>d groups <NUMBER> used propensity scorematched analysis bmi patients without t<NUMBER>d <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively median duration first symptom admission <NUMBER> days <NUMBER> groups major symptoms groups fever <NUMBER> cough <NUMBER> fatigue <NUMBER> dyspnea <NUMBER> similar general population patients chen et al <NUMBER> guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> patients t<NUMBER>d reported significantly higher incidences fatigue <NUMBER> versus <NUMBER> dyspnea <NUMBER> versus <NUMBER> compared nondiabetic group preexisting hypertension <NUMBER> versus <NUMBER> coronary heart disease chd <NUMBER> versus <NUMBER> cerebrovascular disease <NUMBER> versus <NUMBER> chronic kidney disease <NUMBER> versus <NUMBER> higher frequencies t<NUMBER>d group compared nondiabetic group chest ct scans indicated incidence bilateral lung lesion higher <NUMBER> versus <NUMBER> diabetic group compared nondiabetic patients heart rate respiratory rates show differences diabetic nondiabetic groups systolic blood pressure modestly higher diabetic group <NUMBER> mmhg versus <NUMBER> mmhg <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lab findings showed blood glucose bg level much higher diabetic group compared nondiabetic group expected <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> higher levels hba<NUMBER>c <NUMBER> <NUMBER> versus <NUMBER> <NUMBER> patients t<NUMBER>d significantly higher incidence lymphopenia <NUMBER> versus <NUMBER> higher ratio elevation leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> counts peripheral blood relative nondiabetic individuals time elevated serum markers indicating inflammation creactive protein crp <NUMBER> versus <NUMBER> procalcitonin <NUMBER> versus <NUMBER> decreased kidney function creatinine <NUMBER> versus <NUMBER> increased coagulation status ddimer <NUMBER> versus <NUMBER> found frequently t<NUMBER>d group nondiabetic group furthermore spo<NUMBER> lower <NUMBER> occurred frequently diabetic group versus nondiabetic group <NUMBER> versus <NUMBER> admission patients covid<NUMBER> preexisting t<NUMBER>d require intensive inhospital treatment patients preexisting t<NUMBER>d received significantly intensive integrated treatments manage symptoms covid<NUMBER> nondiabetic subjects former group registered higher need antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> antihypertensive drug <NUMBER> versus <NUMBER> even vasoactive drugs <NUMBER> versus <NUMBER> oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> also applied significantly frequently individuals t<NUMBER>d compared patients without t<NUMBER>d table s<NUMBER> <NUMBER>day followup period performed retrospective longitudinal analysis various parameters starting time admission hospital patient study noticed despite received aggressive treatment covid<NUMBER> comorbidities diabetic group greater incidences decreased lymphocyte counts increased neutrophil counts well higher levels serum interleukin<NUMBER> il<NUMBER> crp lactic dehydrogenase ldh accompanied higher bg levels compared nondiabetic group bg level also significantly associated comorbid hypertension chd incidences decreased lymphocyte count elevated neutrophil count levels serum crp creatinine entire cohort figure s<NUMBER> <NUMBER>day followup period starting admission inhospital death rate significantly higher patients preexisting t<NUMBER>d relative nondiabetic individuals <NUMBER> versus <NUMBER> p <NUMBER> table s<NUMBER> crude hr <NUMBER>day allcause mortality diabetic group versus nondiabetic individuals <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender hospital site admission hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusted severity covid<NUMBER> found hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure s<NUMBER> table s<NUMBER> adjust comorbidities closely related t<NUMBER>d including hypertension chd cerebrovascular disease chronic kidney disease diseases often coexist t<NUMBER>d furthermore individuals t<NUMBER>d greater occurrence ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> disseminated intravascular coagulation dic <NUMBER> versus <NUMBER> nondiabetic group table s<NUMBER> mixedeffect cox analysis indicated t<NUMBER>d significantly correlated occurrence ards acute kidney injury septic shock respective adjusted hrs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> adjusting age gender severity covid<NUMBER> among patients table s<NUMBER> current study based largest diabetic covid<NUMBER> cohort far analyzed results unequivocal implicate diabetes mellitus higher risk death detrimental outcomes covid<NUMBER> notably care must taken interpreting significant difference outcomes diabetic nondiabetic patients covid<NUMBER> since notable differences covariate distributions two groups pathophysiological mechanisms underlying impact t<NUMBER>d covid<NUMBER> progression remain fully investigated patients diabetes pulmonary dysfunction involving lung volume pulmonary diffusing capacity control ventilation bronchomotor tone neuroadrenergic bronchial innervation reported fuso et al <NUMBER> may account propensity poor outcomes patients covid<NUMBER> t<NUMBER>d time dysregulated immune response caused t<NUMBER>d likely also responsible increased disease severity covid<NUMBER> patients t<NUMBER>d higher ratio lymphopenia increased levels neutrophils serum crp il<NUMBER> observed patients covid<NUMBER> preexisting t<NUMBER>d study findings dovetail immune dysregulation observed coronavirus infectiontriggered pneumonia kulcsar et al <NUMBER> experimental model mers diabetic mice lower numbers inflammatory monocytes macrophages cd<NUMBER> cells accompanied lower levels ccl<NUMBER> cxcl<NUMBER> expression kulcsar et al <NUMBER> furthermore t<NUMBER>d associated activation reninangiotensin system different tissues candido et al <NUMBER> considering sarscov<NUMBER> utilizes angiotensinconverting enzyme <NUMBER> ace<NUMBER> bind gain entry infected cells hoffmann et al <NUMBER> lu et al <NUMBER> reduces expression ace<NUMBER> kuba et al <NUMBER> overactivation reninangiotensin system may also contribute increased adverse risk patients covid<NUMBER> diabetes respect application reninangiotensin system inhibitors may therapeutic effect patients covid<NUMBER> preexisting t<NUMBER>d among cohort covid<NUMBER> t<NUMBER>d <NUMBER> individuals wellcontrolled bg <NUMBER> males <NUMBER> <NUMBER> individuals poorly controlled bg <NUMBER> males <NUMBER> median bg level much lower wellcontrolled bg group poorly controlled bg group <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> figure s<NUMBER> levels hba<NUMBER>c two groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively patients wellcontrolled bg group also significantly lower incidences lymphopenia <NUMBER> versus <NUMBER> lower rates increased counts leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> elevated serum crp <NUMBER> versus <NUMBER> clinical translational report clinical manifestations including chest ct imaging incidences major comorbidities similar two groups admission even patients covid<NUMBER> t<NUMBER>d wellcontrolled bg acquired significantly less integrated treatments poorly controlled bg significantly lower frequency pharmacological therapy wellcontrolled bg group versus poorly controlled group including usage antivirals <NUMBER> versus <NUMBER> antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> vasoactive drugs <NUMBER> versus <NUMBER> incidences oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> extracorporeal membrane oxygenation <NUMBER> versus <NUMBER> lower wellcontrolled group poorly controlled group table <NUMBER> reduced risk allcause mortality detrimental complications patients covid<NUMBER> preexisting t<NUMBER>d correlated persistent lower bg levels wellcontrolled group higher lymphocyte counts lower neutrophil counts lower serum levels il<NUMBER> crp ldh throughout <NUMBER>day observation period starting time hospital admission figure <NUMBER> noticed inhospital death rate significantly lower <NUMBER> versus <NUMBER> wellcontrolled group relative poorly controlled group table s<NUMBER> crude hr <NUMBER>day allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> comorbidities site effect hr allcause mortality wellcontrolled bg group versus poorly controlled bg group <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> evalue point estimate <NUMBER> upper limit ci <NUMBER> relative poorly controlled bg control patients wellcontrolled bg group developed less frequent occurrences ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> dic <NUMBER> versus <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> site effect comorbidities respective hrs ards acute heart injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> table <NUMBER> table s<NUMBER> propensity scorematched psm analysis performed avoid confounding variables could interfered association bg levels allcause mortality due lack reliable indicators severity t<NUMBER>d specifically included t<NUMBER>drelated comorbidities matching since comorbidities closely related severity t<NUMBER>d dynamic trajectories blood glucose lymphocytes c neutrophils e relative levels il<NUMBER> b crp ldh f <NUMBER>day followup duration <NUMBER> confidence interval represented shaded regions patients poorly controlled bg orange patients wellcontrolled bg blue bg represents averaged median bg patients day tested comorbidities included hypertension cardiovascular disease cerebrovascular disease chronic liver disease chronic kidney injury able match <NUMBER> patients wellcontrolled bg group <NUMBER> patients poorly controlled bg group ratio <NUMBER> <NUMBER> individuals included psm analysis figure <NUMBER> applying mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission results consistently significantly demonstrated lower risk allcause mortality patients wellcontrolled bg group adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared poorly controlled bg group figure <NUMBER> tables <NUMBER> s<NUMBER> although stronger integrated treatment applied poorly controlled bg group table s<NUMBER> robustness association glycemic variability mortality assessed additional sensitivity analyses using different matching variables results sensitivity analyses similar analysis hrs <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> first sensitivity analysis <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> second analysis table s<NUMBER> psm analysis respective adjusted hrs ards acute heart injury acute kidney injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> wellcontrolled bg group poorly controlled bg group table <NUMBER> glycemic variability shown important indicator possible risk predictor death complications individuals t<NUMBER>d forbes et al <NUMBER> impact hyperglycemia pathogenesis viralinduced respiratory diseases remains unclear elevated bg level reported increase glucose concentration airway epithelial secretion philips et al <NUMBER> may disrupt defensive capacity airway epithelia hand rigid glucose control increases risk severe hypoglycemia also result increased mortality rodriguezgutierrez et al <NUMBER> study found compared individuals wellcontrolled bg poor glycemic control patients covid<NUMBER> preexisting t<NUMBER>d associated worse outcome involving increased need medical interventions multiorgan injuries higher mortalities contrast patients glycemic variability <NUMBER> <NUMBER> mmoll significant association reduced medical interventions major organ injuries allcause mortality findings provide direct evidence supporting recent suggestions clinical management t<NUMBER>d covid<NUMBER> bornstein et al <NUMBER> conclusion t<NUMBER>d important risk factor covid<NUMBER> progression adverse endpoints wellcontrolled bg maintaining glycemic variability within <NUMBER> <NUMBER> mmoll associated significant reduction composite adverse outcomes death findings provide critical insights clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d possible avenues improving disease outcomes due retrospective nature study unprecedented scale covid<NUMBER> pandemic study several limitations first data obtained patient cohorts admitted <NUMBER> hospitals hubei province china therefore effect bg control may different among patients covid<NUMBER> preexisting t<NUMBER>d outpatient setting ethnically geographically diverse populations second able retrieve prehospital status t<NUMBER>d current cohort due urgent circumstance covid<NUMBER> pandemic status prehospital t<NUMBER>d could significantly associated numerous clinical parameters known independent risk factors poor outcomes covid<NUMBER> including cardiovascular abnormalities immunological dysfunction performed psm analysis support independent association t<NUMBER>d covid<NUMBER> pathology influence cofounders cannot fully excluded also given lack prehospital data possible us access bg levels changed result covid<NUMBER> progression andor severity third number patients t<NUMBER>d wellcontrolled bg study modest might powered sufficiently reflect overall complexity general population therefore largescale prospective cohort studies required ethnically geographically diverse cohorts better understand association importance bg control disease progression covid<NUMBER> fourth given retrospective nature study possible us determine active management bg levels normal range could ameliorate covid<NUMBER> severity adverse outcomes finally individuals type <NUMBER> diabetes excluded analysis initial cohort possible blood glucose control may also affect outcomes covid<NUMBER> detailed methods provided online version paper include following propensity scorematched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebral vascular disease chronic liver disease chronic renal diseases incidence increased creatinine matched c mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission medical records patients analyzed integrated research team including physicians data scientists statisticians deidentification process removing personal information eg name id participants designating using coding system basic information epidemiological records clinical manifestations laboratory findings radiographic characteristics ct treatments outcomes hospitalization recorded major clinical symptoms ie fever cough fatigue dyspnea comorbidities collected laboratory findings included routine blood test fasting blood glucose bg <NUMBER> h postprandial bg <NUMBER> hpg creactive protein crp procalcitonin ddimer serum indicators liver injury kidney injury heart dysfunction experienced physician team reviewed interpreted doublechecked data guarantee accuracy date disease onset defined day first symptom covid<NUMBER> noticed severe cases defined according whether patients indication respiratory rate <NUMBER> breathsmin spo<NUMBER> <NUMBER> room air pao<NUMBER>fio<NUMBER> <NUMBER> mmhg t<NUMBER>d status designated based patients medical history guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> timing frequency obtaining fasting <NUMBER>h postprandial bg <NUMBER> hpg varied individuals depending necessity related severity comorbid t<NUMBER>d severe t<NUMBER>d status accordingly obtained frequent bg surveillances glycemic variability defined range lowest fasting bg fbg <NUMBER> hpg level observation period wellcontrolled bg defined glycemic variability ranged <NUMBER> <NUMBER> mmoll since normal range fasting bg <NUMBER> <NUMBER> mmoll lower <NUMBER> mmoll targeting level <NUMBER> hpg dm management according guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> poorlycontrolled bg defined lowest fasting bg equal <NUMBER> mmoll highest <NUMBER> hpg level exceeded <NUMBER> mmoll observation window hypertension diagnosed systolic blood pressure equal <NUMBER> mm hg andor diastolic blood pressure equal <NUMBER> mm hg ards septic shock defined following interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected cardiac injury defined serum level cardiac injury biomarkers cardiac troponin ctni cardiac troponin ctnt high sensitivity cardiac troponin hsctni higher upper limit normal uln acute liver injury defined acutely increased level serum alanine aminotransferase alt serum alkaline phosphatase alp upper limit normal uln observed marrone et al <NUMBER> acute kidney injury indicated value serum creatinine level reached exceeded <NUMBER> mmmoll within <NUMBER> h kellum et al <NUMBER> disseminated intravascular coagulation dic diagnosed according criteria published international society thrombosis hemostasis isth gando et al <NUMBER> primary endpoint study <NUMBER>day allcause death covid<NUMBER> patients secondary endpoints occurrence ards septic shock acute cardiac injury acute kidney injury dic variables potentially confounding association bg outcomes covid<NUMBER> addressed using propensity scorematching psm method waljee et al <NUMBER> psm requires complete set variables every patient randomly missing values <NUMBER> selected parameters noninvasive tests therefore imputed nonparameter imputation method missforest applied estimation imputation error <NUMBER> bootstrapped cross validation applied repeated <NUMBER> times evaluating imputation performance training data <NUMBER> parameters randomly introduced missforest method yielded <NUMBER> iqr <NUMBER> differences datasets parameters introduced algorithm psm follows logisticp lnp<NUMBER>p b<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk<NUMBER>eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p formula predicted probability glucose control procedure beta value variable regression coefficient variable variables potentially confounding association bg outcomes covid<NUMBER> addressed using psm method evaluating association glucose control level outcomes psm cohorts identified balancing age gender fever cough dyspnea ctdiagnosed lung lesions spo<NUMBER> breath frequency incidence increased leukocyte count alt ast ddimer creatinine crp procalcitonin decreased lymphocyte count well comorbidities hypertension coronary artery disease cerebrovascular disease chronic liver diseases chronic renal disease propensity score predicted probability glucose change contributed variables estimated based multivariable logistic regression model matching ratio <NUMBER> wellcontrolled bg versus poorlycontrolled bg entire hospitalization exact matching caliper size <NUMBER> applied matching pairs according propensity scores evaluation balance covariates conducted estimating standardized differences matching small absolute value less <NUMBER> considered qualified balancing robustness association bg level allcause mortality assessed analyzing evalue mixedeffect cox proportional hazards model address unmeasured confounders using methodology vanderweele ding haneuse et al <NUMBER> mathur et al <NUMBER> vanderweele ding <NUMBER> two sensitivity analyses performed evaluate robustness propensity scorematched cohort analyses among pairs statistical analysis performed using r<NUMBER> r foundation statistical computing vienna austria spss statistics version <NUMBER> ibm armonk ny usa data continuous variables presented median interquartile range iqr data categorical variables presented frequency rates percentage comparison <NUMBER> groups analyzed using students tests normally distributed mannwhitney u test nonnormally distributed continuous variables comparison categorical variables analyzed fishers exact test c<NUMBER> test generalized linear model glm performed evaluate correlation median blood glucose factors related viral infection glycemic control patients diabetes risk composite endpoints corresponding hazard ratio hr analyzed using cox proportional hazard model mixedeffect cox model cumulative rates death plotted applying kaplanmeier method difference twoside less <NUMBER> considered statistically significant cell metabolism <NUMBER> <NUMBER>e<NUMBER>e<NUMBER> june <NUMBER> <NUMBER> e<NUMBER> type <NUMBER> diabetes t<NUMBER>d correlates worse outcome covid<NUMBER> zhu et al show among <NUMBER> cases covid<NUMBER> t<NUMBER>d associated higher death rate diabetics better controlled blood glucose die lower rate diabetics poorly controlled blood glucose wellcontrolled blood glucose upper limit ≤ <NUMBER>mm poorlycontrolled blood glucose upper limit <NUMBER> mm death <NUMBER> diabetes c v <NUMBER> <NUMBER> novel coronavirus disease <NUMBER> caused infection newly emerged highly contagious coronavirus sarscov<NUMBER> wu mcgoogan <NUMBER> sarscov<NUMBER> mainly invades respiratory tract lungs leading new type coronavirus pneumonia severe cases covid<NUMBER> rapidly progress acute respiratory distress syndrome ards septic shock multiple organ dysfunction syndrome mods guan et al <NUMBER> elderly individuals along preexisting conditions hypertension cancer cardiovascular diseases diabetes mellitus acute kidney injury demonstrated higher risk developing severe cases covid<NUMBER> well suffering higher risk mortality zhang et al <NUMBER>b zhou et al <NUMBER> collision two global pandemics covid<NUMBER> type <NUMBER> diabetes t<NUMBER>d led grim reality t<NUMBER>d already second common comorbidity covid<NUMBER> however current evidence implicating t<NUMBER>d worse covid<NUMBER> prognosis mostly come relatively limitedsized cohorts deng peng <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> thus clinical features patients t<NUMBER>d infected sarscov<NUMBER> remain comprehensively clarified largescale analysis needed efficiently precisely manage treatment patients well established patients diabetes susceptible infections general exhibit worse prognosis infected compared nondiabetic population kumar nathella babu <NUMBER> xu et al <NUMBER> higher susceptibility also previously observed coronaviral epidemics example patients severe acute respiratory syndrome sars preexisting t<NUMBER>d independently associated poor outcomes percentage known t<NUMBER>d history significantly higher among patients succumbed sars survived booth et al <NUMBER> yang et al <NUMBER> epidemiological studies also indicate t<NUMBER>d primary comorbidity associated severe lethal merscov infections alqahtani et al <NUMBER> regard current covid<NUMBER> pandemic several recent studies though limited participants already suggested t<NUMBER>d common comorbidity constitutes higher proportion patients severe icuadmitted cases covid<NUMBER> patients mild symptoms deng peng <NUMBER> wang et al <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> associations diabetes worse outcome viral infections unexpected hyperglycemia detrimental control viremia inflammation aggravating morbidity mortality variety patients forbes et al <NUMBER> however overly rigid glucose control may increase risk severe hypoglycemia also lead increased mortality rodriguezgutierrez et al <NUMBER> consequently previous clinical trials examining effects glucose control mortality yielded conflicting results forbes et al <NUMBER> van den berghe et al <NUMBER> individuals covid<NUMBER> preexisting t<NUMBER>d key challenge clinicians improve outcomes face uncertainty regarding degree glycemic management maintained effects might benefits risks overall treatment thus detailed analyses data patients needed links plasma glucose levels clinic outcomes including mortality report performed retrospective longitudinal multicentered study cohort <NUMBER> confirmed covid<NUMBER> cases enrolled among <NUMBER> hospitals hubei province china focusing association plasma glucose levels clinic outcomes covid<NUMBER> patients t<NUMBER>d addition significant association diabetic status higher mortality rate patients covid<NUMBER> preexisting t<NUMBER>d versus nondiabetic subjects covid<NUMBER> study indicated wellcontrolled glycemia associated markedly improved outcome patients covid<NUMBER> preexisting t<NUMBER>d patients younger <NUMBER> older <NUMBER> years old <NUMBER> patients without complete medical records <NUMBER> patients acute myocardial infarction <NUMBER> patients acute coronary syndrome <NUMBER> patients acute pulmonary embolism <NUMBER> patients acute stroke <NUMBER> patients acute severe pancreatitis <NUMBER> patients cirrhosis <NUMBER> patients stage <NUMBER> chronic renal insufficiency <NUMBER> patients severe congestive heart failure <NUMBER> patients pregnancy <NUMBER> patients malignancy <NUMBER> patients type <NUMBER> diabetes <NUMBER> patients history gestational diabetes <NUMBER> patient druginduced diabetes final cohort <NUMBER> covid<NUMBER> patients analyzed prevalence t<NUMBER>d <NUMBER> similar nationwide prevalence t<NUMBER>d china <NUMBER> wang et al <NUMBER> median ages <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetic nondiabetic groups respectively chen et al <NUMBER> guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> patients t<NUMBER>d reported significantly higher incidences fatigue <NUMBER> versus <NUMBER> dyspnea <NUMBER> versus <NUMBER> compared nondiabetic group preexisting hypertension <NUMBER> versus <NUMBER> coronary heart disease chd <NUMBER> versus <NUMBER> cerebrovascular disease <NUMBER> versus <NUMBER> chronic kidney disease <NUMBER> versus <NUMBER> higher frequencies t<NUMBER>d group compared nondiabetic group chest ct scans indicated incidence bilateral lung lesion higher <NUMBER> versus <NUMBER> diabetic group compared nondiabetic patients heart rate respiratory rates show differences diabetic nondiabetic groups systolic blood pressure modestly higher diabetic group <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> versus <NUMBER> mmhg <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lab findings showed blood glucose bg level much higher diabetic group compared nondiabetic group expected <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> higher levels hba<NUMBER>c <NUMBER> <NUMBER> versus <NUMBER> <NUMBER> patients t<NUMBER>d significantly higher incidence lymphopenia <NUMBER> versus <NUMBER> higher ratio elevation leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> counts peripheral blood relative nondiabetic individuals time elevated serum markers indicating inflammation creactive protein crp <NUMBER> versus <NUMBER> procalcitonin <NUMBER> versus <NUMBER> decreased kidney function creatinine <NUMBER> versus <NUMBER> increased coagulation status ddimer <NUMBER> versus <NUMBER> found frequently t<NUMBER>d group nondiabetic group furthermore spo<NUMBER> lower <NUMBER> occurred frequently diabetic group versus nondiabetic group <NUMBER> versus <NUMBER> admission patients covid<NUMBER> preexisting t<NUMBER>d require intensive inhospital treatment patients preexisting t<NUMBER>d received significantly intensive integrated treatments manage symptoms covid<NUMBER> nondiabetic subjects former group registered higher need antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> antihypertensive drug <NUMBER> versus <NUMBER> even vasoactive drugs <NUMBER> versus <NUMBER> oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> also applied significantly frequently individuals t<NUMBER>d compared patients without t<NUMBER>d table s<NUMBER> <NUMBER>day followup period performed retrospective longitudinal analysis various parameters starting time admission hospital patient study noticed despite received aggressive treatment covid<NUMBER> comorbidities diabetic group greater incidences decreased lymphocyte counts increased neutrophil counts well higher levels serum interleukin<NUMBER> il<NUMBER> crp lactic dehydrogenase ldh accompanied higher bg levels compared nondiabetic group bg level also significantly associated comorbid hypertension chd incidences decreased lymphocyte count elevated neutrophil count levels serum crp creatinine entire cohort figure s<NUMBER> <NUMBER>day followup period starting admission inhospital death rate significantly higher patients preexisting t<NUMBER>d relative nondiabetic individuals <NUMBER> versus <NUMBER> p <NUMBER> table s<NUMBER> crude hr <NUMBER>day allcause mortality diabetic group versus nondiabetic individuals <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender hospital site admission hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusted severity covid<NUMBER> found hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure s<NUMBER> table s<NUMBER> adjust comorbidities closely related t<NUMBER>d including hypertension chd cerebrovascular disease chronic kidney disease diseases often coexist t<NUMBER>d furthermore individuals t<NUMBER>d greater occurrence ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> disseminated intravascular coagulation dic <NUMBER> versus <NUMBER> nondiabetic group table s<NUMBER> mixedeffect cox analysis indicated t<NUMBER>d significantly correlated occurrence ards acute kidney injury septic shock respective adjusted hrs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> adjusting age gender severity covid<NUMBER> among patients table s<NUMBER> current study based largest diabetic covid<NUMBER> cohort far analyzed results unequivocal implicate diabetes mellitus higher risk death detrimental outcomes covid<NUMBER> notably care must taken interpreting significant difference outcomes diabetic nondiabetic patients covid<NUMBER> since notable differences covariate distributions two groups pathophysiological mechanisms underlying impact t<NUMBER>d covid<NUMBER> progression remain fully investigated patients diabetes pulmonary dysfunction involving lung volume pulmonary diffusing capacity control ventilation bronchomotor tone neuroadrenergic bronchial innervation reported fuso et al <NUMBER> may account propensity poor outcomes patients covid<NUMBER> t<NUMBER>d time dysregulated immune response caused t<NUMBER>d likely also responsible increased disease severity covid<NUMBER> patients t<NUMBER>d higher ratio lymphopenia increased levels neutrophils serum crp il<NUMBER> observed patients covid<NUMBER> preexisting t<NUMBER>d study findings dovetail immune dysregulation observed coronavirus infectiontriggered pneumonia kulcsar et al <NUMBER> experimental model mers diabetic mice lower numbers inflammatory monocytes macrophages cd<NUMBER> cells accompanied lower levels ccl<NUMBER> cxcl<NUMBER> expression kulcsar et al <NUMBER> furthermore t<NUMBER>d associated activation reninangiotensin system different tissues candido et al <NUMBER> considering sarscov<NUMBER> utilizes angiotensinconverting enzyme <NUMBER> ace<NUMBER> bind gain entry infected cells hoffmann et al <NUMBER> lu et al <NUMBER> reduces expression ace<NUMBER> kuba et al <NUMBER> overactivation reninangiotensin system may also contribute increased adverse risk patients covid<NUMBER> diabetes respect application reninangiotensin system inhibitors may therapeutic effect patients covid<NUMBER> preexisting t<NUMBER>d among cohort covid<NUMBER> t<NUMBER>d <NUMBER> individuals wellcontrolled bg <NUMBER> males <NUMBER> <NUMBER> individuals poorly controlled bg <NUMBER> males <NUMBER> median bg level much lower wellcontrolled bg group poorly controlled bg group <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> figure s<NUMBER> levels hba<NUMBER>c two groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively patients wellcontrolled bg group also significantly lower incidences lymphopenia <NUMBER> versus <NUMBER> lower rates increased counts leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> elevated serum crp <NUMBER> versus <NUMBER> clinical translational report clinical manifestations including chest ct imaging incidences major comorbidities similar two groups admission even patients covid<NUMBER> t<NUMBER>d wellcontrolled bg acquired significantly less integrated treatments poorly controlled bg significantly lower frequency pharmacological therapy wellcontrolled bg group versus poorly controlled group including usage antivirals <NUMBER> versus <NUMBER> antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> vasoactive drugs <NUMBER> versus <NUMBER> incidences oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> extracorporeal membrane oxygenation <NUMBER> versus <NUMBER> lower wellcontrolled group poorly controlled group table <NUMBER> wellcontrolled blood glucose correlated reduced risk allcause mortality detrimental complications patients covid<NUMBER> preexisting t<NUMBER>d correlated persistent lower bg levels wellcontrolled group higher lymphocyte counts lower neutrophil counts lower serum levels il<NUMBER> crp ldh throughout <NUMBER>day observation period starting time hospital admission figure <NUMBER> noticed inhospital death rate significantly lower <NUMBER> versus <NUMBER> wellcontrolled group relative poorly controlled group table s<NUMBER> crude hr <NUMBER>day allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> comorbidities site effect hr allcause mortality wellcontrolled bg group versus poorly controlled bg group <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> evalue point estimate <NUMBER> upper limit ci <NUMBER> relative poorly controlled bg control patients wellcontrolled bg group developed less frequent occurrences ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> dic <NUMBER> versus <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> site effect comorbidities respective hrs ards acute heart injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> table <NUMBER> table s<NUMBER> propensity scorematched psm analysis performed avoid confounding variables could interfered association bg levels allcause mortality due lack reliable indicators severity t<NUMBER>d specifically included t<NUMBER>drelated comorbidities matching since comorbidities closely related severity t<NUMBER>d dynamic trajectories blood glucose lymphocytes c neutrophils e relative levels il<NUMBER> b crp ldh f <NUMBER>day followup duration <NUMBER> confidence interval represented shaded regions patients poorly controlled bg orange patients wellcontrolled bg blue bg represents averaged median bg patients day tested comorbidities included hypertension cardiovascular disease cerebrovascular disease chronic liver disease chronic kidney injury able match <NUMBER> patients wellcontrolled bg group <NUMBER> patients poorly controlled bg group ratio <NUMBER> <NUMBER> individuals included psm analysis figure <NUMBER> applying mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission results consistently significantly demonstrated lower risk allcause mortality patients wellcontrolled bg group adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared poorly controlled bg group figure <NUMBER> tables <NUMBER> s<NUMBER> although stronger integrated treatment applied poorly controlled bg group table s<NUMBER> robustness association glycemic variability mortality assessed additional sensitivity analyses using different matching variables results sensitivity analyses similar analysis hrs <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> first sensitivity analysis <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> second analysis table s<NUMBER> psm analysis respective adjusted hrs ards acute heart injury acute kidney injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> wellcontrolled bg group poorly controlled bg group table <NUMBER> glycemic variability shown important indicator possible risk predictor death complications individuals t<NUMBER>d forbes et al <NUMBER> impact hyperglycemia pathogenesis viralinduced respiratory diseases remains unclear elevated bg level reported increase glucose concentration airway epithelial secretion philips et al <NUMBER> may disrupt defensive capacity airway epithelia hand rigid glucose control increases risk severe hypoglycemia also result increased mortality rodriguezgutierrez et al <NUMBER> study found compared individuals wellcontrolled bg poor glycemic control patients covid<NUMBER> preexisting t<NUMBER>d associated worse outcome involving increased need medical interventions multiorgan injuries higher mortalities contrast patients glycemic variability <NUMBER> <NUMBER> mmoll significant association reduced medical interventions major organ injuries allcause mortality findings provide direct evidence supporting recent suggestions clinical management t<NUMBER>d covid<NUMBER> bornstein et al <NUMBER> conclusion t<NUMBER>d important risk factor covid<NUMBER> progression adverse endpoints wellcontrolled bg maintaining glycemic variability within <NUMBER> <NUMBER> mmoll associated significant reduction composite adverse outcomes death findings provide critical insights clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d possible avenues improving disease outcomes due retrospective nature study unprecedented scale covid<NUMBER> pandemic study several limitations first data obtained patient cohorts admitted <NUMBER> hospitals hubei province china therefore effect bg control may different among patients covid<NUMBER> preexisting t<NUMBER>d outpatient setting ethnically geographically diverse populations second able retrieve prehospital status t<NUMBER>d current cohort due urgent circumstance covid<NUMBER> pandemic status prehospital t<NUMBER>d could significantly associated numerous clinical parameters known independent risk factors poor outcomes covid<NUMBER> including cardiovascular abnormalities immunological dysfunction performed psm analysis support independent association t<NUMBER>d covid<NUMBER> pathology influence cofounders cannot fully excluded also given lack prehospital data possible us access bg levels changed result covid<NUMBER> progression andor severity third number patients t<NUMBER>d wellcontrolled bg study modest might powered sufficiently reflect overall complexity general population therefore largescale prospective cohort studies required ethnically geographically diverse cohorts better understand association importance bg control disease progression covid<NUMBER> fourth given retrospective nature study possible us determine active management bg levels normal range could ameliorate covid<NUMBER> severity adverse outcomes finally individuals type <NUMBER> diabetes excluded analysis initial cohort possible blood glucose control may also affect outcomes covid<NUMBER> detailed methods provided online version paper include following study generate new reagents materials data related findings study available corresponding author upon reasonable request research team provide email address communication data approved shared others proposal detailed aims statistical plan informationmaterials may required guarantee rationality requirement security data patientlevel data without names identifiers shared review approval submitted proposal related requested materials multicentered retrospective cohort study study protocol approved institution ethic committee renmin hospital wuhan university zhongnan hospital wuhan university study design also individually approved collaborating hospital institutional ethics boards given urgency covid<NUMBER> pandemic informed consent forms waived ethics boards hospitals study subjects included patients covid<NUMBER> diagnosed december <NUMBER> th <NUMBER> march <NUMBER> th <NUMBER> covid<NUMBER> diagnosed based chest computed tomography ct manifestations andor reverse transcriptionpolymerase chain reaction rtpcr following criteria new coronavirus pneumonia prevention control program <NUMBER>th edition published national health commission china interim guidance national health commission china <NUMBER> world health organization <NUMBER> zhang et al <NUMBER>b total <NUMBER> patients covid<NUMBER> initially screened study data individuals however excluded subjects younger <NUMBER> older <NUMBER> incomplete medical records eg transfer hospital acute lethal organ injury eg acute myocardial infarction acute coronary syndrome acute pulmonary embolism acute stroke decompensated end stage chronic organ dysfunction eg decompensated cirrhosis decompensated chronic renal insufficiency severe congestive heart failure pregnancy type <NUMBER> diabetes getational diabetes malignancy study remaining cohort n <NUMBER> categorized diabetic n <NUMBER> nondiabetic n <NUMBER> groups according clinical diagnosis andor medical history admission figure <NUMBER> medical records patients analyzed integrated research team including physicians data scientists statisticians deidentification process removing personal information eg name id participants designating using coding system basic information epidemiological records clinical manifestations laboratory findings radiographic characteristics ct treatments outcomes hospitalization recorded major clinical symptoms ie fever cough fatigue dyspnea comorbidities collected laboratory findings included routine blood test fasting blood glucose bg <NUMBER> h postprandial bg <NUMBER> hpg creactive protein crp procalcitonin ddimer serum indicators liver injury kidney injury heart dysfunction experienced physician team reviewed interpreted doublechecked data guarantee accuracy date disease onset defined day first symptom covid<NUMBER> noticed severe cases defined according whether patients indication respiratory rate <NUMBER> breathsmin spo<NUMBER> <NUMBER> room air pao<NUMBER>fio<NUMBER> <NUMBER> mmhg t<NUMBER>d status designated based patients medical history guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> timing frequency obtaining fasting <NUMBER>h postprandial bg <NUMBER> hpg varied individuals depending necessity related severity comorbid t<NUMBER>d severe t<NUMBER>d status accordingly obtained frequent bg surveillances glycemic variability defined range lowest fasting bg fbg <NUMBER> hpg level observation period wellcontrolled bg defined glycemic variability ranged <NUMBER> <NUMBER> mmoll since normal range fasting bg <NUMBER> <NUMBER> mmoll lower <NUMBER> mmoll targeting level <NUMBER> hpg dm management according guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> poorlycontrolled bg defined lowest fasting bg equal <NUMBER> mmoll highest <NUMBER> hpg level exceeded <NUMBER> mmoll observation window hypertension diagnosed systolic blood pressure equal <NUMBER> mm hg andor diastolic blood pressure equal <NUMBER> mm hg ards septic shock defined following interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected cardiac injury defined serum level cardiac injury biomarkers cardiac troponin ctni cardiac troponin ctnt high sensitivity cardiac troponin hsctni higher upper limit normal uln acute liver injury defined acutely increased level serum alanine aminotransferase alt serum alkaline phosphatase alp upper limit normal uln observed marrone et al <NUMBER> acute kidney injury indicated value serum creatinine level reached exceeded <NUMBER> mmmoll within <NUMBER> h kellum et al <NUMBER> disseminated intravascular coagulation dic diagnosed according criteria published international society thrombosis hemostasis isth gando et al <NUMBER> primary endpoint study <NUMBER>day allcause death covid<NUMBER> patients secondary endpoints occurrence ards septic shock acute cardiac injury acute kidney injury dic variables potentially confounding association bg outcomes covid<NUMBER> addressed using propensity scorematching psm method waljee et al <NUMBER> psm requires complete set variables every patient randomly missing values <NUMBER> selected parameters noninvasive tests therefore imputed nonparameter imputation method missforest applied estimation imputation error <NUMBER> bootstrapped cross validation applied repeated <NUMBER> times evaluating imputation performance training data <NUMBER> parameters randomly introduced missforest method yielded <NUMBER> iqr <NUMBER> differences datasets parameters introduced algorithm psm follows logisticp lnp<NUMBER>p b<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk<NUMBER>eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p formula predicted probability glucose control procedure beta value variable regression coefficient variable variables potentially confounding association bg outcomes covid<NUMBER> addressed using psm method evaluating association glucose control level outcomes psm cohorts identified balancing age gender fever cough dyspnea ctdiagnosed lung lesions spo<NUMBER> breath frequency incidence increased leukocyte count alt ast ddimer creatinine crp procalcitonin decreased lymphocyte count well comorbidities hypertension coronary artery disease cerebrovascular disease chronic liver diseases chronic renal disease propensity score predicted probability glucose change contributed variables estimated based multivariable logistic regression model matching ratio <NUMBER> wellcontrolled bg versus poorlycontrolled bg entire hospitalization exact matching caliper size <NUMBER> applied matching pairs according propensity scores evaluation balance covariates conducted estimating standardized differences matching small absolute value less <NUMBER> considered qualified balancing robustness association bg level allcause mortality assessed analyzing evalue mixedeffect cox proportional hazards model address unmeasured confounders using methodology vanderweele ding haneuse et al <NUMBER> mathur et al <NUMBER> vanderweele ding <NUMBER> two sensitivity analyses performed evaluate robustness propensity scorematched cohort analyses among pairs statistical analysis performed using r<NUMBER> r foundation statistical computing vienna austria spss statistics version <NUMBER> ibm armonk ny usa data continuous variables presented median interquartile range iqr data categorical variables presented frequency rates percentage comparison <NUMBER> groups analyzed using students tests normally distributed mannwhitney u test nonnormally distributed continuous variables comparison categorical variables analyzed fishers exact test c<NUMBER> test generalized linear model glm performed evaluate correlation median blood glucose factors related viral infection glycemic control patients diabetes risk composite endpoints corresponding hazard ratio hr analyzed using cox proportional hazard model mixedeffect cox model cumulative rates death plotted applying kaplanmeier method difference twoside less <NUMBER> considered statistically significant abbreviations ards acute respiratory distress syndrome dic disseminated intravascular coagulation hr hazard ratio ci confidence interval adjusted variables included age gender hospital sites random effect b adjusted variables included age gender indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular diseases chronic liver diseases chronic renal diseases hospital sites random effect c p values calculated based cox proportional hazard model <NUMBER> sensitivity analyses propensity score matched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular disease chronic renal diseases incidence increased creatinine matched b sensitivity analyses propensity score matched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular disease copd chronic liver diseases chronic renal diseases incidence increased creatinine matched c p values calculated based cox proportional hazard model ni el manuscrito ni parte de su contenido han sido publicados previamente por ninguno de los autores ni están en consideración para su publicación en ninguna otra revista al momento de su presentación hay conflicto financiero de interés relacionado con este trabajo todos los autores han participado en la concepción de este manuscrito world health organization declared sarscov<NUMBER> covid<NUMBER> pandemic although evidence date suggests cases manifest mildly <NUMBER> cases may require hospital admission <NUMBER> date relationship chronic obstructive pulmonary disease copd covid<NUMBER> clear although various studies show main comorbidities related development serious form disease high blood pressure diabetes mellitus cardiovascular disease <NUMBER> know copd associated increased risk admission intensive care unit well death <NUMBER> many common chronic diseases occur frequently patients copd compared general population <NUMBER> copd patients develop comorbidity aspect contribute severity symptoms jeopardize patient survival reported complications sarscov<NUMBER> infection extensive pneumoniaacute lung damage adult acute respiratory distress syndrome occurrence myocarditiscardiac arrhythmias development thromboembolic <NUMBER> episodes events may worsen baseline condition copd patient surviving process take account existence planning outpatient followup unfortunately information sarscov<NUMBER> infection impact patients mediumlong term time must make assumptions based knowledge gained coronaviruses sarscov<NUMBER> merscov viral infections cause intense systemic inflammatory response resulting imbalance homeostatic procoagulant anticoagulant mechanisms <NUMBER> therefore thromboembolic disease aspect analyse based limited evidence currently possibility sarscov<NUMBER> infection increases risk venous thromboembolic event <NUMBER> multiple pathogenic mechanisms appear involved including endothelial dysfunction elevation von willebrand factor tolllike receptor tissue factor pathway activation <NUMBER> however apart infection must aware factors strict prolonged quarantine subsequently immobilization could lead despite described lack evidence incidence pulmonary embolism patients sarscov<NUMBER> <NUMBER> <NUMBER> study published cui et al <NUMBER> determined incidence pulmonary thromboembolism <NUMBER> patients admitted intensive care unit severe sarscov<NUMBER> infection <NUMBER> case sarscov<NUMBER> postmortem studies infected patients detected thrombi pulmonary vascular bed <NUMBER> study carried singapore included autopsies <NUMBER> confirmed cases sarscov<NUMBER> described pulmonary thrombi <NUMBER> patients deep vein thrombosis <NUMBER> generalized multiorgan infarctions due thrombi two patients <NUMBER> although main scientific societies formulated positions consensus related diagnosis covid<NUMBER> role tests ct procedure specific proposals made indication ct angiography diagnose thromboembolic pulmonary event despite lack sufficient evidence moment results reported date pathogenic mechanisms plausibly involved make advisable consider aspect patients copd hospital discharge develop medium long term increase dyspnoea justified spirometric parameters hand consider risk cardiovascular disease development abnormal biomarkers consistent heart damage prominent feature sarscov<NUMBER> infection associated poorer prognosis <NUMBER> underlying mechanisms well established likely involves presence myocardial stress relation hypoxemia might related direct effect viral infection systemic inflammatory response combination <NUMBER> factors postmortem realtime pcr heart tissue sarscov<NUMBER> epidemic detected presence viral genome <NUMBER> deceased <NUMBER> noteworthy hearts decrease expression angiotensin <NUMBER> receptors aspect could highlight relationship receptor mediation infection greater hypertrophy <NUMBER> myocardial pericytes play important role maintaining endothelial function express angiotensin<NUMBER> receptors abundantly <NUMBER> pericyte endothelial cell dysfunction either due direct infection global inflammation lead coroj u r n l p r e p r f <NUMBER> nary microcirculation disruption subsequent ischemic consequences possible relationship sarscov<NUMBER> infection pure conjecture know patients suffering sarscov<NUMBER>related myocarditis develop type medium longterm heart failure aspects cardiac involvement consider sarscov<NUMBER> infection cardiac arrhythmias events may arise severe hypoxemia ion disorders systemic inflammation use drugs combat coronavirus direct damage myocardium caused sarscov<NUMBER> <NUMBER> furthermore patients sarscov<NUMBER> develop acute coronary syndromes acute myocardial infarction incidence events unclear priori risk coronary event patients may increase due increased thrombotic predisposition evidenced significantly high levels ddimer patients <NUMBER> underlying risk predisposing factors related inflammation relevant role process endothelial smooth muscle cell activation macrophage activation tissue factor expression addition platelet activation cardiovascular complications possible even recovery infection italy development fulminant myocarditis described convalescent patient one week respiratory symptoms resolved <NUMBER> suggests underlying inflammation may persist progress silently complications manifesting delayed manner sarscov<NUMBER> epidemic survivors developed avascular necrosis pulmonary fibrosis dyslipidaemia viral infection <NUMBER> <NUMBER> may relevant impact patients already underlying respiratory cardiovascular condition taking account aforementioned must carefully evaluate case case worsening de novo onset cardiovascular comorbidity planning outpatient followup patients copd suffered sarscov<NUMBER> infection since patients copd concomitant heart disease suffer greater degree dyspnoea exercise intolerance increased risk hospitalization finally must evaluate acute lung damage severe pneumoniaadult acute respiratory distress lung function deterioration similar described merscov sarscov<NUMBER> common radiological findings ground glass opacities without consolidation predominantly lung bases posterior peripheral location although considerable information available acute radiological manifestations disease yet information longterm progression possible impact lung function therefore moment one speculate whether future changes similar described viral infections chen et al <NUMBER> conducted followup <NUMBER> patients h<NUMBER>n<NUMBER> influenza intention assessing functional radiological progression ct <NUMBER> years infection despite persistence interstitial changes fibrosis imaging tests functional parameters ventilation diffusion showed tendency improve <NUMBER> months however <NUMBER> years mildmoderate impairment diffusing capacity lung co dlco persisted <NUMBER> cases ong et al <NUMBER> evaluated lung function <NUMBER> patients one year suffering sarscov<NUMBER> respiratory infection study demonstrated <NUMBER> cases slightmoderate <NUMBER> reduction dlco values <NUMBER> patients showed anomalies spirometric parameters zhang et al <NUMBER> monitored functional respiratory radiological progression sarscov<NUMBER> infection patients <NUMBER> years described first year followup radiological improvement stabilized subsequent years functional point view patients without interstitial changes ct showed significant improvement spirometric parameters compared interstitial involvement sarscov<NUMBER> infection behaves similarly described authors radiological functional improvement expected months following infection know whether certain degree irreversible deterioration persist especially patients copd changes functional decline know hypothetical functional impact depends prevalence phenotype airway lung parenchyma involvement emphysema finally evidence severe sarscov<NUMBER> infection cases may develop traction bronchiectasis <NUMBER> potential impact fact patient copd great since presence bronchiectasis subjects increases risk chronic bronchitis neutrophilic inflammation airway associated greater functional decline quality life deterioration increased risk exacerbation death conclusion sarscov<NUMBER> pandemic involve changes care copd patients suffering infection sufficient theoretical basis fear patients suffer new comorbidities worsening existing ones special impact cardiovascular health infection could impact lung function uncertain extent effect symptoms exacerbations vital prognosis patients still area uncertainty coming months incorporate information generated regarding foreseeable modifications made monitoring treatment schedules disease j u r n l p r e p r f outbreak coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus<NUMBER> rapidly progressed pandemic declared public health concern<NUMBER> genetic sequencing virus suggests sarscov<NUMBER> betacoronavirus closely linked sars virus people covid<NUMBER> would develop mild uncomplicated illness approximately <NUMBER> people develop severe disease finally require hospitalized receive oxygen support unfortunately <NUMBER> patients even need treated intensive care unit<NUMBER> <NUMBER> importantly large proportion affected patients reported underlying cardiovascular diseases cvd<NUMBER> <NUMBER> present additional challenge battle outbreaks novel virus infections however information factors affecting disease progression among patients mild covid<NUMBER> limited coronaviruses known affect cardiovascular system<NUMBER> prevalence underlying cvd common steadily increasing china recent decades may serve risk factor susceptibility severity infectious diseases<NUMBER> although mild patients covid<NUMBER> thought favorable prognosis chronic underlying conditions may suffer worse outcomes<NUMBER> nevertheless sparse data clinical presentation covid<NUMBER> specific populations mild illness coexisting cvd present study report clinical characteristics factors associated developing severe disease admission patients mild covid<NUMBER> consecutive patients admitted temporary hospital laboratoryconfirmed covid<NUMBER> february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> included retrospective cohort study criteria patient admission discharge referral established according world health organization interim guidance<NUMBER> guidance corona virus disease <NUMBER> prevention control diagnosis management tentative sixth edition<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients met following conditions discharged alive hospital <NUMBER> normal temperature <NUMBER> consecutive days <NUMBER> significantly improved respiratory symptoms <NUMBER> resting spo<NUMBER> <NUMBER> <NUMBER> radiology examination suggesting significantly reduced pulmonary inflammation <NUMBER> negative results two consecutive sarscov<NUMBER> testing realtime reverse transcriptionpolymerase chain rtpcr within <NUMBER>hour interval patients one following conditions referred designated hospital intensive care <NUMBER> respiratory rate ≥ <NUMBER> breaths per minute <NUMBER> resting spo<NUMBER> ≤ <NUMBER> <NUMBER> temperature ≥ <NUMBER>°c <NUMBER> consecutive days even proper treatment <NUMBER> severe dysfunction heart liver lung kidney brain <NUMBER> emergent conditions study approved national health commission china institutional review board renmin hospital wuhan university wuhan chinawritten informed consent waived ethics commission designated hospital patients emerging infectious diseases demographic characteristics age sex clinical data symptoms comorbidities laboratory findings outcomes participants hospitalization collected electronic medical records <NUMBER> investigators radiologic assessments included chest radiography computed tomography data independently reviewed entered computer database <NUMBER> analysts patients categorized according presence absence cvd cvd cardiovascular diseases include hypertension coronary artery disease cerebrovascular disease stroke peripheral vascular disease heart failure rheumatic heart disease congenital heart disease cardiomyopathies patients mild covid<NUMBER> treated according guidance corona virus disease <NUMBER> prevention control diagnosis management tentative sixth edition antiviral therapy umifenovir <NUMBER> g three times daily <NUMBER> days oseltamivir ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> mg twice daily <NUMBER> days administered traditional chinese medicine pneumonia number <NUMBER> decoction pneumonia number <NUMBER> decoction also used <NUMBER> days cycle symptoms relieved statins betablockers aspirin administered patients coronary heart disease nifedipine administered patients hypertension clinical outcomes ie discharges referral designated hospital intensive care length stay monitored march <NUMBER> <NUMBER> final date followup end point incidence covid<NUMBER> developing severe diseases status requirement intensive care successful treatment toward hospital discharge comprised relieved clinical symptoms normal body temperature significant resolution inflammation shown chest radiography least <NUMBER> consecutive negative results shown rtpcr chain reaction assay sarscov<NUMBER> descriptive statistics obtained study variables categorical variables compared study outcome using fishers exact test χ<NUMBER> test continuous variables compared using test mannwhitney u test appropriate continuous data expressed mean sd median interquartile range iqr values categorical data expressed proportions survival curves plotted using kaplanmeier method compared patients vs without cvd using logrank test multivariate logistic regression models used determine independent risk factors referral hospitalization data analyzed using stata<NUMBER> statistical charts generated using excel <NUMBER> microsoft stata<NUMBER> statistical analyses p <NUMBER> considered significant ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint table <NUMBER> presented clinical profile stable patients intensive care patients results showed prevalence chest tightness toothache cvd coronary heart disease hypertension twice positive sarscov<NUMBER> testing significantly higher positive radiology findings significantly lower intensive care group stable group patients also grouped noncvd cvd patients compared ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> table <NUMBER> terms laboratory findings significantly statistic differences patients without cvd including whitecell count neutrophil count neutrophil lymphocyte ratio nlr lymphocyte count platelet count creactive protein results sarscov<NUMBER> testing radiologic findings similar <NUMBER> groups subgroup analysis patients coronary heart disease vs without coronary heart disease better radiologic results admission table <NUMBER> kaplanmeier curves supplemental figure <NUMBER> <NUMBER> shown supplemental table <NUMBER> chest tightness cvd platelet count radiologic abnormality positive sarscov<NUMBER> testing rtpcr risk factors intensive care patient cohort evaluate whether cvd associated requirement intensive care patients mild covid<NUMBER> adjusted demographic characteristics comorbidities clinical profiles model <NUMBER> adjusted age sex model <NUMBER> adjusted age sex chest tightness diabetes mellitus lung diseases model <NUMBER> adjusted age sex chest tightness diabetes mellitus lung diseases platelet count radiologic abnormality positive sarscov<NUMBER> testing rtpcr shown table <NUMBER> cvd remains independent risk factor requirement intensive care patients mild covid<NUMBER> adjustment cofounders model <NUMBER> <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint since incidence cardiovascular disease steadily increasing china decades<NUMBER> <NUMBER> many hospitalized patients might naturally comorbid cvd recent observations patients preexisting cvd susceptible adverse complications among patients severe covid<NUMBER> diseases<NUMBER> <NUMBER> <NUMBER> <NUMBER> however impact cvd outcome mild covid<NUMBER> patients limited present study demonstrates comorbid cvd independent risk factor development severe covid<NUMBER> requirement intensive care among patients mild covid<NUMBER> present study among hospitalized patients mild covid<NUMBER> fever cough fatigue common symptoms consistent previous reports<NUMBER> <NUMBER> notably comparison patients without cvd patients cvd showed significantly higher rates chest tightness fatigue myalgia finding suggests patients comorbidities severe symptoms clearly overlapped clinical symptoms cardiovascular diseases process clinical practice cautious screening required determine whether symptoms caused covid<NUMBER> progression underlying diseases particularly chest tightness fatigue might associated cvd including heart failure therefore sarscov<NUMBER> may induce complicate typical symptoms manifestations acute myocardial infarction chronic heart failure nationwide retrospective study showed cvds common coexisting conditions patients hospitalized covid<NUMBER> metaanalysis six studies including <NUMBER> patients covid<NUMBER> examined prevalence cvd reported prevalence hypertension cardiac cerebrovascular disease diabetes <NUMBER> <NUMBER> <NUMBER> respectively<NUMBER> present study <NUMBER> patients mild cases cvd compared discharged patients patients progressive disease progression referred designated hospital intensive care likely coexisted cvd multivariate regression analysis suggested cvd independent risk factor patients developing severe disease adjustment various cofounders table <NUMBER> subgroup analysis although mild covid<NUMBER> patients cvd less positive radiologic findings patients without ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint cvd admission still faced higher risk unfavorable disease progression compared patients without cvd regarding possible mechanisms prevalent cvd inflammation disease may serve marker accelerated immunologic dysregulation thus aggravate immunological imbalance induced covid<NUMBER> hand covid<NUMBER> might aggravate myocardial injury recent studies wuhan demonstrated severe covid patients ominous outcome significantly higher tni tnt levels compared severe covid<NUMBER> patients undergoing recovery<NUMBER> known sarscov<NUMBER> elicit intense release multiple cytokines chemokines lead vascular inflammation plaque instability also myocardial inflammation<NUMBER> <NUMBER> might linked enhanced myocardial injury disease process interaction preexisted cvd harm sarscov<NUMBER> myocardial tissue might thus imply mechanisms responsible worse outcome among mild covid<NUMBER> patients hospitalized among patients mild cases hypertension common comorbidity followed coronary heart disease early analysis underlying clinical features <NUMBER> covid<NUMBER> fatal cases revealed highest prevalence hypertension <NUMBER> higher expression ace<NUMBER> patients hypertension postulated enhance susceptibility sarscov<NUMBER> although data conflicting without clear suggestion implication treatment<NUMBER> additional study needed understand potential mechanistic relationships hypertension covid<NUMBER> outcomes study several limitations first restricted limited medical resources laboratory biochemical testing insufficient second regarding time disease onset patients uncertainty exact dates recall bias might inevitably affected assessment lastly data earliest hospitalized patients could fully accessed ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mild covid patients coexisting cvd receive intensive monitoring prevent transition severe disease progression although mild covid<NUMBER> patients could discharged approximately half mild covid<NUMBER> patients comorbid cvd may progress severe disease status require intensive care special monitoring patient populations essential improve outcome patients funder role design conduct study collection management analysis interpretation data preparation review approval manuscript decision submit manuscript publication ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint data used support findings study included within supplementary information file ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> following recommendations achieve desired goals obstetrical population without adversely affecting maternal perinatal outcomes recommendations made vacuum reflect input experts across country review current literature coronaviruses singlestranded rna enveloped viruses <NUMBER> transmitted primarily respiratory droplets direct contact <NUMBER> <NUMBER> <NUMBER> diagnosis covid<NUMBER> primarily viral nucleic acid detection using realtime polymerase chain reaction rtpcr serology diagnostic procedure used rtpcr available <NUMBER> diagnostic signs include lymphopenia elevated creactive protein elevated liver transaminases radiographic findings consistent pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> variable clinical presentations <NUMBER> <NUMBER> symptoms typically mild may include fever fatigue anorexia malaise myalgias headache cough rhinorrhea nasal congestion sore throat shortness breath nausea emesis diarrhea <NUMBER> <NUMBER> approximately <NUMBER> affected individuals develop severe disease requiring hospitalization <NUMBER> theoretically pregnant women may susceptible general severe covid<NUMBER> morbidity due physiologic immunologic changes pregnancy evidenced experiences coronaviruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> case reports cohorts pregnant women covid<NUMBER> typically involve mild symptoms fever cough <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> association covid<NUMBER> pregnancy preterm rupture membranes preterm delivery intrapartum fetal heart rate abnormalities tachycardia cesarean delivery also suggested limited publications <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> zeng et al reported three neonates cohort <NUMBER> patients may infected severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> utero mothers covid<NUMBER> <NUMBER> evidence transmission based elevated immunoglobulin igm antibody values blood drawn neonates following birth infant specimen positive reverse transcriptasepolymerase chain reaction test result therefore virologic evidence congenital infection cases support serologic suggestion utero transmission <NUMBER> second study six known covid<NUMBER>positive mothers infants showed similar results <NUMBER> however several studies demonstrated evidence vertical transmission covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current coronavirusspecific vaccines therapeutics available <NUMBER> <NUMBER> absence vaccines targeted therapy management covid<NUMBER> pregnancy must focus prevention <NUMBER> current data suggest persontoperson transmission commonly occurs close contact infected individuals primarily respiratory droplets <NUMBER> individuals infected symptomatic therefore may identified screening upon entry hospital labor delivery unit therefore limited visitation labor delivery visitors allowed persons investigation pui covid<NUMBER>positive patients patients labor delivery current pandemic institutions could consider one visitor time delivery however areas country significant covid<NUMBER> burden universal visitation policy may advantageous women symptoms suggestive covid<NUMBER> immediately isolated confirmed testing patients placed negative pressure room negative pressure rooms available patients placed isolated rooms away occupied rooms isolation room filtration systems highefficiency particulate absorbing hepa units also utilized create portable negative pressure rooms options otherwise limited <NUMBER> <NUMBER> <NUMBER> movement puis confirmed positive patients limited throughout facility personnel involved patient care limited necessary standard respiratory precautions utilized areas labor delivery providers patients visitors health care professionals caring puis confirmed covid<NUMBER>positive patients use appropriate personal protective equipment ppe droplet contact precautions including face shield goggles surgical mask gown gloves used clinical interactions agreement centers disease control prevention cdc world health organization guidelines <NUMBER> <NUMBER> n<NUMBER> masks used whenever aerosolizing procedure performed likely performed patient suspected confirmed covid<NUMBER> cesarean delivery postpartum hemorrhage requiring transfer operating room intubation <NUMBER> <NUMBER> patients visitors encouraged wear surgical masks times particularly suspected confirmed infection designated room negative pressure capabilities reserved puis covid<NUMBER>positive patients negative pressure operating room pregnant women warrant cesarean delivery suspected confirmed infection also established advance need special consideration also made ensure designated isolation room newborns mothers suspected confirmed infection close proximity delivery operating room negative pressure rooms available patients placed isolated rooms away occupied rooms hepa units also considered prevention spread airborne viral organisms <NUMBER> <NUMBER> <NUMBER> mode delivery continue individualized based obstetric indications long appropriate indication performed appropriate gestational age scheduled cesarean deliveries delayed based covid<NUMBER> pandemic procedure efficiently moves patient delivery process allowing patient newborn discharged timely fashion consideration given day <NUMBER> postpartum discharge patient stable adequate home resources patient covid<NUMBER>positive scheduled cesarean delivery unrelated medical indications negative pressure operating room utilized described pui covid<NUMBER>positive patient requiring medical treatment due covid<NUMBER> complications cesarean delivery may need postponed optimize respiratory status prior procedure mother always stabilized prior delivery anesthesia maternalfetal medicine neonatology involved preoperative planning pui covid<NUMBER>positive patient ensure necessary resources available advance consideration delaying elective inductions poor bishops score cesarean section rate increased induction <NUMBER> weeks randomized trial induction versus expectant management arrive establish time delivery length stay increased <NUMBER> extended induction even successful vaginal delivery increases exposure time patients staff medically obstetrically indicated inductions however delayed decision delivery setting severe covid<NUMBER> infection challenging increased oxygen consumption reduced functional residual capacity pregnancy predisposes rapid deterioration maternal fetal status combined physiologic changes associated severe infection decision delivery take consideration gestational age maternal status fetal status importantly stabilizing mother prior emergent delivery fetal indications imperative stabilization mother fetus status likely improve <NUMBER> clinical scenarios delivery likely indicated maximize resuscitative efforts cases severe covid<NUMBER> complicated sepsis septic shock presented ►table <NUMBER> note uterine distention secondary multifetal gestations macrosomia polyhydramnios among processes result compromised cardiopulmonary function due diaphragm displacement patients compromised cardiopulmonary dysfunction requires intubation delivery <NUMBER> weeks considered decision balanced benefits pregnancy continuation following consultation neonatology potential benefits additional utero time preterm prelabor rupture membranes pprom must balanced light current covid<NUMBER> pandemic circumstances known adverse outcomes patients pprom chorioamnionitis placental abruption cord prolapse cord compression uteroplacental insufficiency <NUMBER> despite recent randomized control trial singletons <NUMBER> <NUMBER> <NUMBER> <NUMBER> weeks pprom morris et al demonstrating increased risk neonatal sepsis composite neonatal morbidity sepsis mechanical ventilation <NUMBER> hours stillbirth neonatal death current setting additional risks associated extended hospital stays considered patients <NUMBER> additionally trial also demonstrated increased maternal morbidity hemorrhage infection associated expectant management pprom <NUMBER> weeks would increase exposure different medical personnel movement different hospital settings ie labor operating room intensive care unit overall length stay <NUMBER> median latency following pprom <NUMBER> days particularly <NUMBER> <NUMBER> weeks potential benefits expectant management beyond <NUMBER> weeks may mitigated development associated adverse outcomes continued hospitalization covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> case could also made induction <NUMBER> weeks gestation based perinatal outcomes previous studies following consultation neonatology <NUMBER> <NUMBER> <NUMBER> pasquier et al conducted randomized control trial <NUMBER> women pprom <NUMBER> <NUMBER> <NUMBER> <NUMBER> weeks allocated either expectant management delivery <NUMBER> weeks delivery <NUMBER> hours completion steroid course <NUMBER> study found significant differences neonatal outcomes groups second randomized control trial conducted cox leveno <NUMBER> women pprom <NUMBER> <NUMBER> weeks similar results <NUMBER> primary risk factor infection covid<NUMBER> close contact infected individuals limiting frequency duration exposure key prevention medical professionals <NUMBER> <NUMBER> involves limiting unnecessary time rooms reducing number digital cervical exams nurses physicians possible uncomplicated labor patients exams spaced limit number providers direct contact patients ultrasound assessments limited utilized likely alter clinical management although recent trend allow longer second stage labor hope reducing cesarean delivery rate due failure progress second stage prolonged second stage may ill advised covid<NUMBER> pandemic due increased risk respiratory secretion exposures visitors medical personnel <NUMBER> may prudent resume previous recommendations <NUMBER>hour second stage multiparous patient without epidural <NUMBER> hours epidural <NUMBER>hour second stage nulliparous patient without epidural <NUMBER> hours epidural consideration also given shortening second stage operative vaginal delivery patients meet prerequisites including fully dilated cervix fetal head engagement low fetal station adequate clinical pelvimetry patient consent possible active pushing second stage labor minimized deep breathing maternal expulsive efforts may increase visitor personnel exposure patients respiratory secretions pushing process therefore potentiates risk transmission room particularly nurses physicians every effort made labor patients much feasibly possible however patient discouraged push strong urge push previously discussed two recent cohort studies suggest possibility covid<NUMBER> vertical transmission <NUMBER> <NUMBER> several studies shown results must remain cautious without definitive data <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recommend avoidance delayed cord clamping given potential increased risk viral transmission newborn individuals labor delivery particularly puis confirmed covid<NUMBER>positive cases cautiously treated intravenous iv fluids aggressive hydration worsen oxygenation status <NUMBER> although normal saline lactated ringers excellent choices iv fluid patient delivery anticipated additional sodium load predispose patients pulmonary congestion iv fluids required patient delivery anticipated iv fluids reduced sodium load <NUMBER>normal saline <NUMBER>normal saline considered several studies demonstrated use oxygen face nonrebreather masks cause aerosolization respiratory secretions thereby increasing viral transmission <NUMBER> <NUMBER> <NUMBER> labor delivery maternal oxygen supplementation historically used intrapartum resuscitation nonreassuring fetal heart rate tracings however available evidence suggested neonatal benefit intrapartum maternal oxygen supplementation <NUMBER> <NUMBER> rather trials suggested risks neonate including prolonged resuscitation acidemia <NUMBER> <NUMBER> <NUMBER> light increased risk viral transmission lack proven fetal benefit maternal oxygenation fetal resuscitation suggest use maternal oxygen therapy treatment maternal hypoxia limiting use fetal resuscitation recognize may difficult change therefore suggest physician review fetal heart rate tracing prior administration supplemental oxygen therapy patients maternal oxygen supplementation reserved patients fetal bradycardia prolonged recurrent persistent decelerations situations severely abnormal fetal heart rate tracing suspected hypoxia women <NUMBER> <NUMBER> weeks candidates initial course antenatal corticosteroids acs follow current practices administer acs indicated <NUMBER> however use acs <NUMBER> weeks rescue course reconsidered current covid<NUMBER> pandemic data regarding benefits late preterm steroids remain mixed studies support improved respiratory outcomes infants administered steroids late preterm period others show improved outcomes instead demonstrate increased risk adverse outcomes neonatal hypoglycemia sepsis <NUMBER> data regarding rescue course steroids similarly inconsistent <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> given inconsistencies regarding perinatal benefit late preterm rescue acs well suppression maternal immune response associated steroid administration recommend late preterm antenatal steroids rescue courses withheld pandemic <NUMBER> puis covid<NUMBER>positive women evaluate risk benefits steroid administration casebycase basis individuals riskbenefit ratio acs would suggest benefits seem outweigh risks facilitating worsening covid<NUMBER> infection patients unstable conditions including limited eclampsia pulmonary edema acute respiratory distress syndrome barotrauma disseminated intravascular coagulation suspected abruptio placentae nonreassuring fetal heart rate tracings delivered regardless benefit corticosteroids following maternal stabilization however decision deliver individualized involvement maternalfetal medicine intensivists neonatology magnesium sulfate widely used medication labor delivery usually recommended neuroprotection extremely premature fetuses <NUMBER> weeks seizure prophylaxis patients preeclampsia <NUMBER> however magnesium without risks one major albeit uncommon side effect respiratory depression serious implications maternal outcomes particularly puis known covid<NUMBER>positive patients already compromised respiratory status benefits magnesium sulfate neuroprotection seizure prophylaxis weighed risks maternal respiratory function light gestational age maternal respiratory status society maternal fetal medicine smfm suggested single <NUMBER>g bolus dose magnesium sulfate may serve alternative usual dosing setting mild respiratory distress caution use moderatetosevere respiratory distress <NUMBER> appropriate case impending delivery pregnancies <NUMBER> weeks patients preeclampsia without severe features gestational hypertension magnesium sulfate therapy administered severe features however magnesium sulfate prophylaxis indicated suggested results magpie trial iv loading dose <NUMBER>g magnesium sulfate <NUMBER> <NUMBER> minutes followed iv maintenance dose <NUMBER> gh could used rather traditional higher loading dose <NUMBER> g maintenance dose <NUMBER> gh <NUMBER> clinical trials covid<NUMBER> pandemic providing informed consent randomized trials requires extensive patient interactions research clinical staff studies directly related treatment management covid<NUMBER> delay studies resolution current pandemic may prudent limited data regarding use nonsteroidal antiinflammatory drugs nsaids covid<NUMBER> population <NUMBER> <NUMBER> reports suggested nsaids may exacerbate symptoms covid<NUMBER> largely based data regarding respiratory infections <NUMBER> <NUMBER> primary mechanism nsaids hypothesized impact covid<NUMBER>positive patients inhibition cyclooxygenases <NUMBER> however remains evidence nsaids worsen disease outcomes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies actually suggested benefit nsaid use <NUMBER> <NUMBER> <NUMBER> study demonstrated indomethacin may actually antiviral activity sarscov <NUMBER> given lack conclusive data regarding nsaid use covid<NUMBER> well limited analgesic options postpartum recommend continued use clinically indicated <NUMBER>methyl prostaglandin f <NUMBER>α commonly utilized uterotonic postpartum hemorrhage <NUMBER> used cautiously patients suspected confirmed covid<NUMBER> infection due ability increase pulmonary vascular resistance therefore contraindicated patients active respiratory disease severe covid<NUMBER> infection <NUMBER> covid<NUMBER>positive patients puis undergoing inpatient evaluation treatment venous thromboembolism vte prophylaxis considered patients risk factors vte including limited ambulation pregnant postpartum status infection among individualized risk factors clinical presentation pulmonary embolism mimic respiratory distress associated severe covid<NUMBER> infection considered differential puis particularly hypoxia unless otherwise medically indicated vte prophylaxis discontinued puis covid<NUMBER>positive patients upon discharge wake covid<NUMBER> pandemic health care professionals must seek ways adapt clinical practice protect patients health care resources health care system united states minimized elective encounters procedures large obstetricians unique position birthing process cannot considered elective labor delivery cannot scaled manner units within hospital however thoughtful deliberate planning feasible changes approach care make difference exposure potentially infected patients health care workers reducing length stay without impacting perinatal outcomes despite limited data regarding covid<NUMBER> pregnancy important make changes clinical practice consider current health care climate belief implementation recommendations protect patients health care workers also conserving health care resources following recommendations summarized • screen limit patients visitors labor delivery unit • health care workers use appropriate ppe labor delivery units comorbidities diabetes chronic lung disease cardiovascular disease highly prevalent patients covid<NUMBER> associated worse outcomes <NUMBER> <NUMBER> however whether conditions contribute directly sarscov<NUMBER> virulence simply worsen outcomes independent mechanisms reflect general disease burden population remain unclear <NUMBER> <NUMBER> furthermore clinical experimental evidence demonstrated addition lungs sarscov<NUMBER> infection target organ systems heart kidney blood may important deleterious consequences potentially compromise organ function compound disease burden covid<NUMBER> patients <NUMBER> <NUMBER> spike protein sarscov sarscov<NUMBER> key facilitator host cell entry binding host cell membranebound ace<NUMBER> <NUMBER> therefore impact modulation ace<NUMBER> related reninangiotensinaldosterone system genes covid<NUMBER> area interest <NUMBER> included current study additionally binding cleavage protein necessary proteinmediated membrane fusion drives viral entry host cells proteolytic activity may cathepsinl dependent occur upon ph change cellular endosomes may occur action membrane bound serine proteases host cell membrane surface within vesicles <NUMBER> additionally viral entry mechanisms proposed involve cleavage ace<NUMBER> membrane bound serine proteases leading increased viral entry <NUMBER> fact importance serine proteases viral entry mechanism may emphasized success serine protease inhibition vitro <NUMBER> however current mechanistic studies focused proteolytic activity tmprss<NUMBER> human airway trypsinlike protease hat also referred tmprss<NUMBER>d additional ttsps hypothesized similar extracellular cleavage activity <NUMBER> included current study furthermore influence comorbidities genes unknown thus current study examined influence comorbidities expression key reninangiotensinaldosterone system protease genes may prime cell entry mechanisms sarscov<NUMBER> across various organ systems recent thorough report ace<NUMBER> tmprss<NUMBER> expression mapped across various body sites normal healthy tissue single cell rna sequencing <NUMBER> however complete model viral entry sarscov sarscov<NUMBER> describe potential role tmprss<NUMBER> hat potentially ttsps <NUMBER> therefore confirm recent findings better understand expression patterns ttsps healthy setting expression data analyzed <NUMBER> different body sites <NUMBER> healthy individuals figure <NUMBER> healthy human tissues diverse transcription reninangiotensinaldosterone system related genes ace ace<NUMBER> agtr<NUMBER> well proteases adam<NUMBER> tmprss<NUMBER> tmprssd tmprsse tmprss<NUMBER> may prime cell entry mechanisms sarscov<NUMBER> across various organ systems results analysis agreement previously reported expression patterns <NUMBER> specifically surveys found high levels ace<NUMBER> andor tmprss<NUMBER> expression colon heart kidney lung prostate addition analysis suggests salivary gland small intestine testis thyroid trachea sites high expression additionally examined impact variety common comorbidities expression genes select organ systems pulmonary renal cardiac blood tissues based relevance infection expression levels baseline expression data displayed comorbidity heatmap displayed greatest left least right expression ace<NUMBER> pulmonary tissues figure <NUMBER>a found greatest increase ace<NUMBER> cancer substantial increases nearly ttsps consistent role tumor cell proliferation motility invasion <NUMBER> additionally samples patients history smoking showed increases ace<NUMBER> small large airways consistent recent findings <NUMBER> expression levels context preexisting asthma appeared largely unaffected pulmonary tissues average pronounced increases bronchial compared nasal epithelium renal tissues figure <NUMBER>b found greatest expression ace<NUMBER> obesity similar seen pulmonary tissues history smoking cancer associated increase ace<NUMBER> well slight increases ttsps renal biopsy hypertensives increases ace<NUMBER> tmprss<NUMBER> tmprss<NUMBER> renal cortical tubulointerstium glomerular medullar samples chronic kidney disease ckd resulted greatest diversity modulation genes however consistent increases tmrpss<NUMBER> <NUMBER> datasets tubular glomerular origin cardiac tissues figure <NUMBER>c found greatest increases ace<NUMBER> patients experienced heart failure preexisting diabetes patients aortic stenosis cardiomyopathies resulted variable expression levels increases ace<NUMBER> found left ventricle lv tissues decreases found right ventricle rv tissues average slight increases found many ttsps <NUMBER> datasets resulting increases tmprss<NUMBER> blood figure <NUMBER>d remarkable increases selected genes found patients coronary artery disease hypertension chronic lung pathologies resulted slight consistent increases selected genes including ace<NUMBER> many ttsps specifically hypertension increases found least <NUMBER> datasets ace<NUMBER> adam<NUMBER> agtr<NUMBER> tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER>a tmprss<NUMBER> contrast results seen renal tissues obesity appear modulate expression genes circulating immune cells notably increased expression levels found context type <NUMBER> diabetes decreases apparent type <NUMBER> diabetes whole blood peripheral blood mononuclear cells pbmcs lastly highly variable modulation found context ckd without hemodialysis increases ace ace<NUMBER> agtr<NUMBER> tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER> tmprss<NUMBER> least <NUMBER> datasets interest ttsps seems blossomed within last decade appearances micro array technologies therefore appearances data limited however understanding modulation expression genes across various organ systems context common comorbidities provide us complete understanding potential impact comorbidities viral proliferation increases expression genes suggested data common comorbidities across tissues hypertension cancer history smoking may help partially explain association higher morbidity mortality covid<NUMBER> comorbidities obesity diabetes tissue specificity cardiomyopathies chronic lung disease lack consistent alteration across tissues may suggest mechanism tropism virus sure sarscov sarscov<NUMBER> virulence driven factors outside viral entry may important understand influence varied expression genes among target organ systems across comorbidities demonstrated conclusion expression levels sarscov<NUMBER> viralentry related genes patients suffering common comorbidities hypertension cancer history smoking obesity diabetes cardiomyopathies chronic lung kidney disease may increased target organ systems capable directly contributing infection represents important step designing effective therapeutic preventative strategies improve outcomes vulnerable populations current study examined expression levels sarscov<NUMBER> entryrelated genes target organ systems including pulmonary renal cardiac pbmcs <NUMBER> patients across variety common comorbidities including hypertension n<NUMBER> hypertensives vs n<NUMBER> normotensives diabetes n<NUMBER> diabetic vs n<NUMBER> normoglycemic obesity n<NUMBER> obese vs n<NUMBER> healthy weight chronic lung disease n<NUMBER> asthmatic vs n<NUMBER> nonasthmatic chronic obstructive pulmonary disease copd n<NUMBER> vs healthy tissue n<NUMBER> cardiovascular disease ischemic n<NUMBER> dilated n<NUMBER> cardiomyopathy vs healthy tissue n<NUMBER> well common pathologies ckd cancer differential gene expression recently identified novel betacoronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> etiological agent coronavirus disease<NUMBER> covid <NUMBER> covid<NUMBER> emerged december <NUMBER> wuhan city china rapidly spread rest world <NUMBER> mortality rate covid<NUMBER> emerging threat global public health according world health organization china reported cluster pneumonia cases wuhan hubei province december <NUMBER> <NUMBER> international publisher reported deaths associated pneumonia outbreak involved <NUMBER> patients january <NUMBER> <NUMBER> january <NUMBER> <NUMBER> announced pneumonia outbreak due new virus originated huanan seafood market wuhan china january <NUMBER> <NUMBER> virus confirmed novel coronavirus ncov first case ncov outside china reported thailand january <NUMBER> <NUMBER> following day announced limited humantohuman transmission ncov mainly family members suggested possibility wider outbreak january <NUMBER> <NUMBER> declared <NUMBER>ncov public health emergency international concern pheic february <NUMBER> <NUMBER> <NUMBER>ncov named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus study group international committee taxonomy viruses officially named disease caused <NUMBER>ncov coronavirus disease month later march <NUMBER> <NUMBER> declared covid<NUMBER> pandemic sarscov<NUMBER> infection since reached pandemic status worldwide worldwide spread virus china associated international travel subsequent communal transmission currently virus aggressively rapidly spreading infecting millions people globally causing high mortality morbidity indeed compared sarscov merscov sarscov<NUMBER> virulent infecting greater number individuals worldwide earlier viruses available public health tools control transmission passive approaches isolation quarantine social distancing community containment measures moreover current crisis abates remains high probability reemergence srascov<NUMBER> covid<NUMBER> fall upcoming years currently vaccines specific treatment available covid <NUMBER> previous recognition sars pathogenesis greatly facilitates understanding pathogenesis covid<NUMBER> current understanding remains limited based largely clinical observations autopsy findings better understanding pathogenesis help us develop better specific treatment prevention strategies covid<NUMBER> one potential target therapeutic intervention angiotensin converting enzyme <NUMBER> ace<NUMBER> peptidase reninangiotensin system ras figure <NUMBER> ace<NUMBER> plays crucial role sars infection believed serve major entry receptor sarscov<NUMBER> humans figure <NUMBER> infected patients sarscov<NUMBER> mainly infects type ii pneumocytes lungs also infects proximal tubule epithelial cells kidney severe cases <NUMBER> cells express receptor ace<NUMBER> facilitates viral entry <NUMBER> <NUMBER> endothelial cells variety tissues may also infected virus although appear express little ace<NUMBER> infection leads downregulation ace<NUMBER> figure <NUMBER> impacts function ang ii ras variety tissues including lung heart vasculature kidney may facilitate progression covid<NUMBER> mild moderate severe disease figure <NUMBER> indeed direct infection endothelial cells may explain clinical features advanced disease including massive activation coagulation pathways platelets well immune cells monocytes neutrophils lung heart kidney observations suggest ace<NUMBER> may play critical pathogenic role covid<NUMBER> warrants extensive investigation review current view ace<NUMBER> pathogenesis sarscov<NUMBER> infection ace<NUMBER> serves entry receptor sarscov<NUMBER> sarscov humans binding viral envelope protein spike protein may contribute pathogenesis sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> prompt identification ace<NUMBER> receptor sarscov<NUMBER> largely due identification receptor sarscov emerged approximately <NUMBER> years ago time ace<NUMBER> identified functional receptor sarscov fusion protein gene sarscov characterized <NUMBER> vitro studies li et al <NUMBER> found <NUMBER> ace<NUMBER> efficiently binds s<NUMBER> domain sarscov protein <NUMBER> soluble form ace<NUMBER> ace<NUMBER> blocked association s<NUMBER> domain ace<NUMBER> <NUMBER> sarscov replicated efficiently ace<NUMBER>transfected mocktransfected <NUMBER>t cells <NUMBER> antiace<NUMBER> antiace<NUMBER> antibody blocked viral replication vero e<NUMBER> cells african green monkey kidney cell sensitive sarscov <NUMBER> middle east respiratory syndrome merscov <NUMBER> sarscov<NUMBER> infection <NUMBER> addition exogenous ace<NUMBER> expression allows refractory cell lines support sarscov replication <NUMBER> results convincingly demonstrate ace<NUMBER> functional receptor sarscov <NUMBER> angiotensinogen converted renin angiotensin ang ang subsequently converted angiotensin ii ang ii ace expressed surface endothelial cells lung kidney angiotensinconverting enzyme inhibitors aceis inhibit production ang ii angiotensin receptor blockers arbs inhibits binding ang ii angiotensin receptors ace<NUMBER> negatively regulates function ace converting ang ang <NUMBER> ang ii ang <NUMBER> sarscov<NUMBER> interacts ace<NUMBER> infects ace<NUMBER>expressing epithelial endothelial cells lung organs leading downregulation ace<NUMBER> endothelium lung presumably organs kidney downregulation ace<NUMBER> leads unopposed ang ii accumulation may accelerate progress covid<NUMBER> via increased activity ras vivo studies also consistently demonstrate ace<NUMBER> crucial sarscov receptor <NUMBER> deficiency ace<NUMBER> mice results dramatic decrease viral replication much less severe pathologic alterations lungs compared wildtype mice <NUMBER> <NUMBER> transgenic overexpression human ace<NUMBER> hace<NUMBER> mice renders likely develop severe sars phenotypes similar seen human patients <NUMBER> <NUMBER> <NUMBER> injection sarscov spike protein mice worsens acute lung failure vivo <NUMBER> recombinant ace<NUMBER> protect mice severe acute lung injury blocking sarscov binding membranebound form ace<NUMBER> pneumocytes suggests soluble ace<NUMBER> may therapeutic potential treatment sars <NUMBER> well covid<NUMBER> together extensive vitro vivo results demonstrate ace<NUMBER> serves major receptor sarscov infection sarscov<NUMBER> sarscov proteins share <NUMBER> identity amino acid sequences <NUMBER> protein sarscov<NUMBER> <NUMBER> amino acid aa protein consisting two important regions referred s<NUMBER> s<NUMBER> addition nterminal <NUMBER> aa signal peptide carboxy terminal short transmembrane domain short cytoplasmic domain s<NUMBER> region harbors nterminal domain ntd cterminal domain ctd function receptorbinding domain rbd figure <NUMBER>a ace<NUMBER> serves entry receptor sarscov<NUMBER> sarscov humans via binding proteins <NUMBER> <NUMBER> <NUMBER> almost identical <NUMBER>d structures recent studies three independent groups using biolayer interferometry binding analysis reported kd values ace<NUMBER> sarscov rbd <NUMBER> <NUMBER> <NUMBER> nm <NUMBER> <NUMBER> <NUMBER> nm ace<NUMBER> sarscov<NUMBER> rbd <NUMBER> <NUMBER> <NUMBER> <NUMBER>å crystal structure sarscov<NUMBER> ctd complexed hace<NUMBER> revealed sarscov<NUMBER> rbd similar sarscov rbd <NUMBER> separate study using surface plasmon resonance ace<NUMBER> reported bind sarscov<NUMBER> ectodomain <NUMBER> nm affinity <NUMBER>to <NUMBER>fold higher ace<NUMBER> binding sarscov <NUMBER> similar sarscov sarscov<NUMBER> utilizes cellular proteases transmembrane serine protease <NUMBER> tmprss<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> endosomal cysteine proteases cathepsin b l <NUMBER> protein priming enhance virus entry <NUMBER> <NUMBER> proteolysis protein s<NUMBER> s<NUMBER> essential proteinmediated cov infection <NUMBER> interestingly sequence analysis sarscov<NUMBER> demonstrates presence four novel amino acid prra insertions s<NUMBER> s<NUMBER> <NUMBER> comparison sarscov figure <NUMBER>b results introduction cleavage site furin member kexinlike subfamily proprotein convertases <NUMBER> sequence conserved among sarscov<NUMBER> isolates sequenced date found sequence protein closest relative ratg<NUMBER> <NUMBER> addition s<NUMBER>s<NUMBER> cleavage site sarscov<NUMBER> harbors several arginine residues present ratg<NUMBER> functional significance multibasic cleavage site remains ascertained hoffmann coworkers demonstrated endosomal ph modulator ammonium chloride blocks cathepsin b l activity strongly inhibited sarscov<NUMBER> entry tmprss<NUMBER> − <NUMBER>t cells <NUMBER> furthermore tmprss<NUMBER> inhibitor camostat mesylate partially blocked sarscov<NUMBER>s entry cells e<NUMBER>d inhibitor cathepsin b l combination camostat mesylate fully inhibited sarscov<NUMBER> smediated entry cells <NUMBER> tmprss<NUMBER> required activation viral fusion protein protein synthesized transported surface cells <NUMBER> tmprss<NUMBER> proteolytically cleaves activates protein subunit s<NUMBER> facilitates viral attachment surface target cells <NUMBER> <NUMBER> tmprss<NUMBER> expressed lung tissue subsegmental bronchial branches subsegmental bronchial branches ace<NUMBER> predominantly expressed transient secretory cell type <NUMBER> colocalization tmprss<NUMBER> ace<NUMBER> enhances cell entry correlates tmprss<NUMBER>mediated proteolysis adsorbed ace<NUMBER> complexes <NUMBER> significance tmprss<NUMBER> mediating efficient virus infection demonstrated mice deficient tmprss<NUMBER> reduced body weight loss virus lungs following challenge mouseadapted sarscov <NUMBER> adam<NUMBER> metalloprotease also cleave ace<NUMBER> <NUMBER> tmprss<NUMBER> found compete metalloprotease adam<NUMBER> ace<NUMBER> processing <NUMBER> suggesting adam<NUMBER>cleaved ace<NUMBER> may confer organ protection <NUMBER> conversely help tmprss<NUMBER> adam<NUMBER>regulated ectodomain shedding ace<NUMBER> may also support sarscov cell entry endocytosis thereby contributing infection <NUMBER> thus exact role adam<NUMBER>mediated ace<NUMBER> shedding sarscov<NUMBER> infection kidney lungs requires investigation findings suggest cell surface complex comprising primary receptor ace<NUMBER> tmprss<NUMBER> operates major portal activation sarscov <NUMBER> sarscov<NUMBER> cell entry <NUMBER> together observations demonstrate priming viral protein host cell proteases essential sarscov<NUMBER> entry cells involves cleavage s<NUMBER>s<NUMBER> s<NUMBER>′ sites cellular protease allowing fusion viral cellular membranes subsequent viral entry processes also contribute pathogenesis sars covid<NUMBER> <NUMBER> consistent widespread expression ace<NUMBER> several organ systems appear impacted infection indeed reports new disease symptoms disclosed almost daily however may also reflect existing comorbidities vulnerabilities infected individual typically patients initially present fever chills dry cough fatigue although less common gastrointestinal complications including abdominal pain nausea vomiting andor diarrhea also reported <NUMBER> <NUMBER> viral rna levels upper respiratory specimens appear higher soon symptom onset compared later times <NUMBER> <NUMBER> <NUMBER> thus sarscov<NUMBER> transmitted prior development symptoms throughout disease particularly early course <NUMBER> <NUMBER> <NUMBER> large number patients first show infection lower respiratory tract possibly requiring hospitalization mild symptoms <NUMBER> sarscov<NUMBER> mean incubation period <NUMBER> days median duration onset symptoms death <NUMBER> days patients ≥<NUMBER> years age shorter median duration onset initial symptoms death <NUMBER> days highlighting vulnerability particular patient cohort <NUMBER> among severe cases requiring hospitalization leukopenia reduced white blood cells lymphocytopenia reduced lymphocytes shortness breath may advance acute respiratory distress syndrome ards requiring mechanical ventilation frequently observed <NUMBER> <NUMBER> <NUMBER> bilateral lung groundglass opacity seen computed tomography ct imaging majority patients covid<NUMBER> consistent pulmonary involvement <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies focused clinical characteristics infection report patients underlying comorbidities likely progress severe respiratory disease even death <NUMBER> <NUMBER> <NUMBER> among aging hypertension diabetes obesity appear confer greatest risk development severe disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> majority individuals eventually recover infection even among requiring prolonged hospitalization concerns regarding whether patients attain full recovery prior discharge surfaced following anecdotal reports number cured patients testing positive virus later date although posited may reflect absence protective immunity among individuals recent report demonstrated sarscov<NUMBER> postmortem lung acquired patient slated discharge prior succumbing sudden cardiac arrest <NUMBER> interestingly individual three consecutive sarscov<NUMBER> pcr negative nasopharyngeal swabs improved significantly indicating recovered infection immunohistochemistry electron microscopy however revealed residual virus lung histopathological investigation showed diffuse alveolar damage consistent lung injury previously observed patients sars mers <NUMBER> findings postmortem investigation yield important insight sarscov<NUMBER>covid<NUMBER> pathogenesis argue idea previously infected individuals remain risk second sarscov<NUMBER> infection remains significant clinical public health concern requires investigation although lung appears primary site infection injury tissues also impacted covid<NUMBER> particularly vascular system comprehensive autopsy study <NUMBER> revealed deep vein thrombosis <NUMBER> <NUMBER> patients <NUMBER> studied venous thromboembolism suspected death investigation pulmonary embolism direct cause death <NUMBER> patients consistently postmortem examinations reveal diffuse alveolar damage severe capillary congestion variegated findings lung organs suggesting covid<NUMBER>related endothelial cell infection endotheliitis vascular dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> postmortem investigation tissues may harbor virus demonstrated high levels sarscov<NUMBER> rna lung <NUMBER> patients examined <NUMBER> <NUMBER> patients demonstrated high viral titers liver kidney heart <NUMBER> autopsy observations indicate pathogenesis severe covid<NUMBER> involves significant coagulation platelet activation endothelial cell severe ongoing lung damage organ failure although clinical observations autopsy studies greatly help us understand pathogenesis covid<NUMBER> mechanism underlying covid<NUMBER> pathogenesis still require experimental studies previous recognition role ace<NUMBER> sars pathogenesis greatly facilitates understanding pathogenesis covid<NUMBER> section review function ace<NUMBER> ras potential pathogenic role ace<NUMBER> sars ras consists renin angiotensin aldosterone ras plays important role regulating blood volume systemic vascular resistance together influence cardiac output arterial pressure <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> peptidase ras primary cardiovascular regulatory system <NUMBER> <NUMBER> <NUMBER> ace dipeptidyl carboxypeptidase ras converts inactive decapeptide ang active octapeptide potent vasoconstrictor ang ii figure <NUMBER> inactivates vasodilator bradykinin <NUMBER> ace<NUMBER> largely counteracts activity ace degrading ang nonapeptide ang <NUMBER> inactive form angiotensin also degrade hydrolyze vasoconstrictor ang ii heptapeptide ang <NUMBER> acts potent vasodilator <NUMBER> <NUMBER> <NUMBER> ang ii peptide multiple actions promotes cardiovascular diseases cvd antagonized effects ang <NUMBER> <NUMBER> <NUMBER> important note conversion ang ii ang <NUMBER> primary function ace<NUMBER> kinetic studies reveal ang ii much better substrate ace<NUMBER> ang <NUMBER> figure <NUMBER> effects ang ii largely mediated angiotensin ii receptor type at<NUMBER> opposed ang <NUMBER> <NUMBER> figure <NUMBER> ace breaks ang <NUMBER> ang <NUMBER> major degrading pathway ang <NUMBER> <NUMBER> ang ii responsible physiological pathophysiological effects ras figure <NUMBER> inhibitors ace reduce formation ang ii successfully applied effective hypertension treatment figure <NUMBER> ace inhibitors also standard therapy following myocardial infarction delay development heart failure reduce progression renal disease figure <NUMBER> ace<NUMBER> influences ace altering ratio ang ii ang <NUMBER> effectively modulating balance vasoconstrictors vasodilators within heart kidney <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> human ace<NUMBER> homology <NUMBER> identity <NUMBER> similarity amino acid level human ace <NUMBER> despite sharing significant homology many biochemical properties ace ace<NUMBER> activity cannot blocked classical ace inhibitors <NUMBER> ace<NUMBER> gene contains <NUMBER> exons map chromosome xp<NUMBER> thus gender differences ras cvd renal diseases may linked ace<NUMBER> gene <NUMBER> <NUMBER> human mouse ace<NUMBER> contain <NUMBER> amino acids include nterminal signal sequence single activesite catalytic region cterminal hydrophobic membraneanchor region <NUMBER> ace<NUMBER> expressed predominantly epithelial cells lungs kidneys cardio myocytes <NUMBER> primary targets sarscov sarscov<NUMBER> <NUMBER> scrnaseq data analyses recently revealed ace<NUMBER> highly expressed organs risk injury context covid<NUMBER> sars including lung heart esophagus kidney bladder ileum oral mucosa specific cell types eg type ii alveolar cells at<NUMBER> lung myocardial cells proximal tubule cells kidney ileum esophagus epithelial cells bladder urothelial cells <NUMBER> <NUMBER> ace<NUMBER> protein expression high renal cardiovascular tissues much gastrointestinal tract particularly ileum duodenum jejunum caecum colon <NUMBER> interestingly ace<NUMBER> expression regulated aging genetic alteration may explain varying susceptibility among different ages individuals one study showed genderrelated differences ace<NUMBER> expression young middleaged adults however greater ace<NUMBER> expression observed young adults advanced age may contribute predominance sarscov<NUMBER> infection development severe disease among older individuals <NUMBER> recent study however support finding <NUMBER> car et al analyzed four largescale datasets normal lung tissue found race age gender appear influence ace<NUMBER> gene expression <NUMBER> study reveal significantly higher ace<NUMBER> gene expression lung smokers compared nonsmokers suggesting smokers may susceptible covid<NUMBER> <NUMBER> genetic alterations expression ace<NUMBER> develop diverse pattern phenotypes ranging hypertension metabolic behavioral dysfunctions impairments serotonin synthesis neurogenesis <NUMBER> <NUMBER> level ace<NUMBER> also influenced cvd antihypertensive drugs targeted ras ang ii receptor blockers arbs ace inhibitors figure <NUMBER> <NUMBER> plasma ace<NUMBER> activity low healthy subjects elevated patients cvd <NUMBER> arbs olmesartan ace inhibitors increase urinary ace<NUMBER> <NUMBER> potentially offers additional renoprotective effects patients use olmesartan <NUMBER> ace inhibitors increase ang <NUMBER> ang conversion neprilysin altered ace<NUMBER> required <NUMBER> increased ang ii levels suggested upregulate ace<NUMBER> activity <NUMBER> ace<NUMBER>deficient mice ang ii levels approximately double wildtype mice ang <NUMBER> levels almost undetectable <NUMBER> loss ace<NUMBER> accelerates diabetic kidney injury mice contributes late development ang iidependent glomerulosclerosis <NUMBER> <NUMBER> using adenoassociated virus aav adenoviralmediated gene delivery ace<NUMBER> ang <NUMBER> protects diabetesinduced retinopathy glomerular injury rodent models <NUMBER> <NUMBER> <NUMBER> targeting degradation ang ii recombinant ace<NUMBER> prevents angiotensin iidependent hypertension <NUMBER> human recombinant ace<NUMBER> reduces progression diabetic nephropathy <NUMBER> together findings suggest ace<NUMBER> plays crucial role ras opposes actions ang ii <NUMBER> <NUMBER> figure <NUMBER> moreover ace<NUMBER> beneficial role therapeutic potential many diseases hypertension diabetes cardiovascular disease ace<NUMBER> performs vital functions well serving receptor sarscov<NUMBER> infection result downregulation conceivable ace<NUMBER> plays key role pathogenesis sars covid<NUMBER> sarscov protein downregulates ace<NUMBER> expression thereby promotes lung injury <NUMBER> downregulation effect may result enhanced sheddinginternalizing processes unknown mechanisms <NUMBER> <NUMBER> consistently sarscov replicated efficiently ace<NUMBER>positive vero cells also reduced ace<NUMBER> expression indicating robust receptor interference context sarscov <NUMBER> since virus must dock enter cells replicate surface localization ace<NUMBER> state cell differentiation may strong impact sarscov disease pathologies triggered acute lung injury <NUMBER> discussed maintenance normal ace<NUMBER> levels lung beneficial combatting inflammatory lung disease <NUMBER> <NUMBER> <NUMBER> ras acts systemically locally variety tissues including lung <NUMBER> results suggest molecular mechanism sarscovassociated severe often lethal lung failure support potential therapeutic strategy preventing attenuating sars covid<NUMBER> <NUMBER> <NUMBER> although ace<NUMBER> widely recognized primary receptor sarscov<NUMBER> role pathogenesis covid<NUMBER> remains elusive ace<NUMBER> plays essential role virus infection dissemination however whether ace<NUMBER> contributes progression severe covid<NUMBER> additional means remains unclear sarscov<NUMBER> infects ace<NUMBER>expressing cells lung leading shedding ace<NUMBER> tissue effectively reducing level ace<NUMBER> expression infected cells hand ace<NUMBER> shed bronchial space sarscov<NUMBER> peptidase still active cleave ang ii ang <NUMBER> within bronchial space ace<NUMBER> still bind sarscov<NUMBER> doesnt internalize since longer attached apical membrane epithelial cells figure <NUMBER> whether shedding prevents cells sarscov<NUMBER> infection remains elusive warrants investigation mouse model membranebound ace<NUMBER> demonstrated play critical role antiinflammation ras signaling conversion ang ii ang <NUMBER> protected animals acute lung injury <NUMBER> conceivable reduction ace<NUMBER> expression may promote inflammation lung subsequent cytokine storm presents many severe covid<NUMBER> patients figure <NUMBER> ace<NUMBER> maintains proper function heart kidney downregulation ace<NUMBER> sarscov<NUMBER> may compromise protective feature contribute damage caused infection organs figure <NUMBER> since ace<NUMBER> also serves binding site sarscov<NUMBER> enriched expression lung tissues may play dual role facilitating virus entry detrimental protection additional viral attack protective figure <NUMBER> depending stage infection <NUMBER> <NUMBER> note ace<NUMBER> collectrin domains facilitate amino acid transport <NUMBER> identity ace<NUMBER> collectrin domains tmem<NUMBER> collectrin <NUMBER> since tmem<NUMBER> expressed multiple tissues including guts lacks extracellular peptide domain ace<NUMBER> expected directly bind enable internalization sarscov<NUMBER> <NUMBER> <NUMBER> animal studies indicate angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs may increase ace<NUMBER> expression patients take aceis arbs assumed increased risk sarscov<NUMBER> infections due elevated ace<NUMBER> expression <NUMBER> <NUMBER> use aceis thought cause increased morbidity mortality covid<NUMBER> <NUMBER> however hypothesis supported clinical findings recent studies show aceisarbs unrelated severity mortality covid<NUMBER> patients <NUMBER> <NUMBER> may even improve outcome covid<NUMBER> discussed extensively <NUMBER> clinical studies suggest downregulation ace<NUMBER> caused sarscov<NUMBER> infections may accelerate progression covid<NUMBER> mild severe disease via increased activity ras figure <NUMBER> many patients covid<NUMBER> present dysfunction multiple organs including heart kidney intestine also rich ace<NUMBER> expression still unclear whether damage direct infection ace<NUMBER>expressed endothelial epithelial cells tissues indirect effect wholebody cytokine storm severe covid<NUMBER> patients enriched ace<NUMBER> expression endothelialepithelial cells might make tissues vulnerable virus entering circulation system lung sarscov<NUMBER> infection kidney tubules digestive system documented biopsy studies <NUMBER> <NUMBER> may result renal injuryfailure digestive disorders loss appetite diarrhea experienced infected individuals <NUMBER> <NUMBER> cardiovascular complications rapidly emerging key threat covid<NUMBER> addition respiratory renal digestive diseases <NUMBER> recent findings show presence viral elements within endothelial cells accumulation inflammatory cells addition endothelial inflammatory cell death <NUMBER> findings suggest sarscov<NUMBER> infection facilitates induction endotheliitis several organs direct consequence viral involvement noted presence viral bodies host inflammatory response <NUMBER> covid<NUMBER> patients also exhibit neurological manifestations including loss smell ataxia convulsions indicative potential direct indirect attack neurons andor glia <NUMBER> <NUMBER> likely disease exaggeration late stage may attributed direct viral damage also generalized hypoxia andor immunemediated injury induced sarscov<NUMBER> <NUMBER> two pathological features occur severe covid<NUMBER> patients progressive increase immune activation cytokine storm unusual trend hypercoagulation platelet activation <NUMBER> however whether ace<NUMBER> expression cells multiple organs contribute multiorgan damage patients unclear role ace<NUMBER> immune activation cytokine storm whether downregulation ace<NUMBER> infected organs facilitates multiple organ failure also remains unclear recent study using engineered human tissue system demonstrated soluble human ace<NUMBER> reduce viral growth vitro inhibit sarscov<NUMBER> infection blood vessels human kidney organoids early stages infection <NUMBER> suggesting exogenous ace<NUMBER> could block early entry sarscov<NUMBER> protective effects ace<NUMBER> chronic underlying diseases ards development therapeutic enhancers ace<NUMBER> activity diminazene aceturate dize <NUMBER> currently used antiparasitic drugs proposed treatment covid<NUMBER> patients late stages disease <NUMBER> however due lung gut liver kidney toxicity unlikely enter clinical trial <NUMBER> <NUMBER> whether administration soluble ace<NUMBER> ace<NUMBER> activator beneficial later stages disease requires study ace<NUMBER> gene polymorphisms affect outcome severe ards <NUMBER> results obtained human studies role ace<NUMBER> gene polymorphisms human hypertension inconclusive studies suggest gene polymorphism association human hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> supported studies <NUMBER> role ace<NUMBER> development covid<NUMBER> complex may serve binding target may also directly participate pathogenesis disease contribute immune activation dysfunction investigation animal models clinical trials much needed clarify mechanisms ideal animal model pathogenesis preclinical studies reflect clinical signs viral replication pathology seen humans <NUMBER> pathologically model show severe covid<NUMBER> symptoms severe pneumonia multiple organ failure even death essential pathogenesis studies animal models covid<NUMBER> also facilitate development vaccine therapeutics prevention treatment covid<NUMBER> although need replicate aspects disease provide useful information preclinical studies <NUMBER> reasons many labs rushing develop covid<NUMBER> models various species transgenic animals <NUMBER> considering sarscov sarscov<NUMBER> utilize hace<NUMBER> receptor entry host leading sars covid<NUMBER> humans review animal models sars covid<NUMBER> single model offers direct reproduction seen humans sars <NUMBER> <NUMBER> <NUMBER> spontaneous condition without molecular engineering monkeys cats ferrets mice swine chickens hamsters guinea pigs rats experimentally infected <NUMBER> <NUMBER> <NUMBER> <NUMBER> display mild signs severe acute pneumonialike symptoms infection show sarscov replication serum followed spontaneously clearing virus <NUMBER> <NUMBER> <NUMBER> studies show ferrets exhibit strongest clinical symptoms pathology <NUMBER> <NUMBER> <NUMBER> however findings reproduced later studies <NUMBER> <NUMBER> <NUMBER> studies conducted various species nhps rhesus macaques cynomolgus macaques african green monkeys support sarscov replication animals develop pneumonitis variable mild clinical symptoms depending upon species employed <NUMBER> <NUMBER> single nhp species highly preferred time <NUMBER> although mice best model pathogenesis studies sars inbred mouse strains b<NUMBER> balbc <NUMBER> mice infected sarscov show associated signs clinical illness overt pathology reproducible equivalent severity observed sars patients <NUMBER> addition sarscov infects old balbc wild type mice <NUMBER> months old shows severe phenotypes <NUMBER> sarscovinfected aged balbc mice demonstrate signs clinical illness characterized significant weight loss hunching ruffled fur slight dehydration measured skin turgor <NUMBER> although agerelated increase morbidity balbc mice represents clinical characteristics seen humans <NUMBER> sars outbreak well current sarscov<NUMBER> crisis age significant risk factor severe disease poor outcome old mice difficult procure experimental studies immune senescence also complicates pathogenesis studies <NUMBER> <NUMBER> compensate disadvantage using old mice mousesensitive sarscov derived urbani strain serial passage respiratory tract young balbc mice developed <NUMBER> fifteen passages resulted virus ma<NUMBER> lethal mice following intranasal inoculation <NUMBER> lethality preceded rapid high titer viral replication lungs viremia dissemination virus extrapulmonary sites accompanied lymphopenia neutrophilia pathological changes lungs <NUMBER> abundant viral antigen extensively distributed bronchial epithelial cells alveolar pneumocytes necrotic cellular debris present airways alveoli mild focal pneumonitis <NUMBER> observations suggest mice infected ma<NUMBER> die overwhelming viral infection extensive virally mediated destruction pneumocytes ciliated epithelial cells <NUMBER> ma<NUMBER> virus six coding mutations associated adaptation increased virulence introduced recombinant sarscov mutations result highly virulent lethal virus rma<NUMBER> duplicating phenotype biologically derived ma<NUMBER> virus <NUMBER> intranasal inoculation ma<NUMBER> reproduces many aspects disease seen severe human cases sars another new strain sarscov derived serially passaged <NUMBER> times balbc mice <NUMBER>day intervals resulted highly lethal strain designated v<NUMBER> <NUMBER> v<NUMBER> strain severe higher lethality even <NUMBER>to <NUMBER>weekold balbc mice ma<NUMBER> strains nine mutations affecting <NUMBER> amino acid residues strain v<NUMBER> increased interleukin il<NUMBER>α il<NUMBER> macrophage inflammatory protein mip<NUMBER>α monocyte chemoattractant protein mcp<NUMBER> regulated activation normal cell expressed secreted rantes mice high il<NUMBER> expression correlating increased mortality <NUMBER> infection largely mimicked human disease lung pathology lacked hyaline membrane formation <NUMBER> nonetheless strains may helpful pathogenesis studies <NUMBER> however since strains mutated sensitive mice humans concerns regarding clinical relevance obtained using strains preclinical studies mice compensate drawback transgenic overexpression hace<NUMBER> mice may serve viable alternative sars covid<NUMBER> models <NUMBER> <NUMBER> <NUMBER> introduction hace<NUMBER> mice renders highly sensitive development sars seen human subjects <NUMBER> <NUMBER> <NUMBER> yang coworkers developed mouse model human sarscov infection introducing hace<NUMBER> driven mouse ace<NUMBER> promoter mouse genome <NUMBER> mice infected human sars strain show pulmonary lesions including interstitial hyperemia hemorrhage monocytic lymphocytic infiltration protein exudation alveolar epithelial cell proliferation desquamation even death <NUMBER> additionally sarscov replicated efficiently lungs transgenic mice wildtype mice pathologic changes including vasculitis degeneration necrosis found extrapulmonary organs transgenic mice viral antigen found brain <NUMBER> two transgenic mouse models express hace<NUMBER> specifically airway epithelia systemically multiple tissues cells develop rapidly lethal infection intranasal inoculation sarscov <NUMBER> <NUMBER> infection begins airway epithelia subsequent alveolar involvement extrapulmonary virus spread brain <NUMBER> infection results macrophage lymphocyte infiltration lungs upregulation proinflammatory cytokines chemokines lung brain <NUMBER> another rapid model sars covid<NUMBER> achieved overexpressing hace<NUMBER> lungs wild type b<NUMBER> mice intranasally administering adenovirus <NUMBER>expressing hace<NUMBER> ad<NUMBER>hace<NUMBER> advantage model easily adapted performing pathogenesis studies given molecularengineered mouse lines without multiple mouse crosses approach successfully used generate rapid mouse model mers via instilling ad<NUMBER> vector encoding mers receptor hdpp<NUMBER> prior merscov infection <NUMBER> studies indicate mice cats hamsters ferrets nonhuman primates infected sarscov<NUMBER> <NUMBER> infection however mild phenotypes lung seen progress severe disease recent study demonstrates ferrets cats highly susceptible sarscov<NUMBER> dogs low susceptibility livestock including pigs chickens ducks susceptible virus <NUMBER> however sarscov<NUMBER> replicates nasal turbinate soft palate tonsils ferrets comparable sarscov replicates upper lower respiratory tract ferrets <NUMBER> another study reported syrian hamsters infected sarscov<NUMBER> developed mild moderate clinical syndrome mild lung pathology changes <NUMBER> maximal clinical signs included rapid breathing weight loss histopathological changes initial exudative phase diffuse alveolar damage extensive apoptosis later proliferative phase tissue repair airway intestinal involvement virus nucleocapsid protein expression high lung viral load spleen lymphoid atrophy associated marked cytokine activation observed within first week virus challenge <NUMBER> challenged index hamsters consistently infected naïve contact hamsters housed within cage resulting similar pathology weight loss <NUMBER> infected hamsters recovered developed mean serum neutralizing antibody titer ≥<NUMBER> fourteen days postchallenge immunoprophylaxis early convalescent serum achieved significant decrease lung viral load lung pathology <NUMBER> several laboratories across world shown high reproducibility rhesus macaques infectable sarscov<NUMBER> showing evidence virus replication shedding nasal swabs mild clinical signs <NUMBER> recent study sarscov<NUMBER>infected rhesus macaques show sarscov<NUMBER> infection protects rechallenge <NUMBER> indicating immunologic approaches prevention treatment sarscov<NUMBER> infection may possible <NUMBER> nonhuman primate models covid<NUMBER> currently developed several labs including tulane national primate research center using hace<NUMBER> transgenic mice bao et al documented mice overexpressing hace<NUMBER> infected sarscov<NUMBER> infected mice showed weight loss virus replication lung mild moderate changes lung pathology <NUMBER> typical histopathology interstitial pneumonia infiltration significant lymphocytes monocytes alveolar interstitium accumulation macrophages alveolar cavities viral antigens observed bronchial epithelial cells alveolar macrophages alveolar epithelia phenomenon found wild type mice sarscov<NUMBER> infection <NUMBER> pathogenicity sarscov<NUMBER> hace<NUMBER> mice clarified kochs postulates fulfilled <NUMBER> although develop severe clinical manifestations seen severe covid<NUMBER> mouse model facilitate understanding pathogenesis covid<NUMBER> together sarscov<NUMBER>infected nonhuman primate ferret cat hamster models mouse models useful development therapeutics vaccines sarscov<NUMBER> however require optimization including conducting experiments old mice mice induced preexisting conditions hypertension obesity diabetes respiratory deficits seen human patients immune compromised conditionally inducedimmune cell depleted conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> summary perfect animal models develop severe covid<NUMBER> phenotypes seen severe human covid<NUMBER> pressing need develop animal models show reproducible severe covid<NUMBER> symptoms pathogenesis studies role ace<NUMBER> covid<NUMBER> preclinical studies potential therapeutics vaccines currently effective antiviral therapy therefore prevention treatment covid<NUMBER> alternative approach mitigate rapid disease progression high mortality clinical trial studies targeting ace<NUMBER>ang <NUMBER> axis ace<NUMBER> interaction protein drawing great attention treating covid<NUMBER> patients lung cardiovascular damage preventing spreading disease <NUMBER> also clinical trial studies greatly facilitate pathogenesis covid<NUMBER> therefore review current therapeutic vaccine developments related blocking ace<NUMBER> protein interactions inhibiting ras antisarscov<NUMBER> drugs immunebased therapy spike protein mediates viral receptorbinding membrane fusion inhibitors prevent either receptor binding membrane fusion may serve viable strategies preventing virus dissemination infected patients specifically disruption interaction ace<NUMBER> critical motifs within s<NUMBER> subunit consisting fusion peptide fp region two heptad repeat regions hr<NUMBER> hr<NUMBER> figure <NUMBER> may particularly effective regard pancoronavirus fusion inhibitor peptide ek<NUMBER> targeting hr<NUMBER> domains hcov proteins proven effective sarscov<NUMBER> proteinmediated membrane fusion vitro <NUMBER> group also shown lipopeptide version ek<NUMBER> known ek<NUMBER>c<NUMBER> prevented sarscov<NUMBER> proteinmediated membrane fusion pseudovirus infection ic<NUMBER>s <NUMBER> <NUMBER> nm inhibitory effect <NUMBER>and <NUMBER>fold potent original ek<NUMBER> peptide respectively <NUMBER> regards spike protein ace<NUMBER> receptor interaction alternative approach mop virus using high concentrations apn<NUMBER> recombinant soluble form human ace<NUMBER> rhace<NUMBER> block viral entry also protect lungs injury reported protein sarscov influence hydrolysis ang ii ang<NUMBER> soluble ace<NUMBER> <NUMBER> therefore spike inhibitors may bind downregulate ace<NUMBER> ang ii peptide substrates would directly interfere sarcov<NUMBER> binding internalization clinical trial assessing effects rhace<NUMBER> covid<NUMBER> patients proposed china later withdrawn nct<NUMBER> <NUMBER> however apn<NUMBER> rhace<NUMBER> developed apeiron slated multicenter trial europe nct<NUMBER> important note giving ace<NUMBER> circulation would necessarily prevent sars<NUMBER> infection instead intranasal delivery rhace<NUMBER> would likely increase efficacy prevention treatment covid<NUMBER> warrants clinical trial studies potent recombinant ace<NUMBER> drugs ace<NUMBER>ig better pharmacological property potent neutralizing effect sarscov<NUMBER> pseudotyped virus development countermeasure covid<NUMBER> <NUMBER> contrast vaccines since antibody offers immediate protection development antibody binds conserved epitope spike protein sarscov<NUMBER> neutralize virus patients even produce antibodies following studies thus far successful generating neutralizing antibodies targeting protein effective vitro single domain antibodies vhhs llama immunized prefusionstabilized coronavirus protein neutralizes sarscov<NUMBER> pseudotyped viruses <NUMBER> human monoclonal antibody mab <NUMBER>d<NUMBER> likely targets conserved core structure s<NUMBER>b rbd neutralizes sarscov<NUMBER> cell culture <NUMBER> crossneutralization antibody s<NUMBER> potently neutralizes sarscov<NUMBER> sarscov pseudoviruses well authentic sarscov<NUMBER> engaging rbd <NUMBER> spikespecifc monoclonal antibodies derived single b cells sarscov<NUMBER> infected individuals isolated characterized <NUMBER> neutralizing antibodies tested preventing spread covid<NUMBER> treating covid<NUMBER> severe patients <NUMBER> convalescent plasma therapy covid<NUMBER> viable approach reduce covid<NUMBER> mortality since appears safe clinically effective regard several studies showed convalescent plasma obtained recently recovered covid<NUMBER> patients improved clinical outcomes neutralizing viremia severe covid<NUMBER> cases started early critically ill patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> amplified immune response cytokine release cytokine storm seen sarscov<NUMBER> infection could result multiorgan failure therefore monoclonal antibodies directed inflammatory cytokines receptors adjunctive therapies covid<NUMBER> regard clinical studies show increased il<NUMBER> key driver inflammation <NUMBER> several randomized clinical trials tocilizumab monoclonal antibody il<NUMBER> alone combination nct<NUMBER> chictr<NUMBER> sarilumab another il<NUMBER> receptor antagonist nct<NUMBER> underway patients covid<NUMBER> worldwide unprecedented need develop effective covid<NUMBER> vaccine meet challenge worldwide multipronged strategic approach vaccine development around globe effort released clinical data phase study mrna<NUMBER> vaccine candidate encoding perfusionstabilized form sarscov<NUMBER> spike protein report patients dosed <NUMBER> µg <NUMBER> µg seroconverted day <NUMBER> single dose mrna<NUMBER> vaccination resulted high neutralizing antibody titers eight patients exceeded levels seen convalescent sera national institute allergy infectious diseases niaid moderna recent study dna vaccine candidates expressing different forms sarscov<NUMBER> spike protein evaluated rhesus macaques vaccinated animals developed humoral cellular immune responses neutralizing antibody titers comparable found convalescent humans macaques infected sarscov<NUMBER> <NUMBER> strategy involves using ad<NUMBER>ncov recombinant vaccine incorporating adenovirus type <NUMBER> vector cansino received approval chinese authorities begin human trials inovio pharmaceuticals collaboration beijing advaccine biotechnology developing dna vaccine covid<NUMBER> called ino<NUMBER> development heterologous sarscov rbd recombinant protein proposed vaccine approach potential covid<NUMBER> <NUMBER> hypertension common risk factor mortality among individuals covid<NUMBER> postulated angiotensin system modulation acei enalapril lisinopril captopril ramipril arbs losartan candesartan valsartan could used prevention treatment sarscov<NUMBER> use two angiotensin system modulators clinical management covid<NUMBER> taken center stage due controversial findings animal studies show increase ace<NUMBER> expression use acei lisinopril arbs losartan doses much higher prescribed patients <NUMBER> inpatient use acei arbs associated lower risk allcause mortality improvement clinical outcomes compared aceiarbs nonusers <NUMBER> <NUMBER> treatment aceis arbs continues provide cardiovascular renal protection patients diagnosed covid<NUMBER> <NUMBER> <NUMBER> discontinuing medications may harmful patient population <NUMBER> therefore several scientific societies highly recommend patients continue current hypertensive medication regimen await results randomized controlled trials addressing impact reninangiotensin system inhibitors rasis covid<NUMBER> morbidity mortality <NUMBER> example current centers disease cdc control prevention guidance clinical care patients covid<NUMBER> april <NUMBER> <NUMBER> highlights …there data suggest link aceis arbs worse covid<NUMBER> outcomes american heart association aha heart failure society america hfsa american college cardiology acc recommends continuation drugs patients already receiving heart failure hypertension ischemic heart disease hfsaaccaha statement addresses concerns using raas antagonists covid <NUMBER> important note data human studies show increase ace<NUMBER> expression acei arbs <NUMBER> <NUMBER> <NUMBER> caveat arb acei effects ace<NUMBER> expression human shed form ace<NUMBER> studied plasma urine ace<NUMBER> content quite low local tissue concentration ace<NUMBER> unknown require investigation recent study shows acei offers greater protection arbs covid<NUMBER> patients <NUMBER> since hyperinflammation state seen covid<NUMBER> cases result angiotensin peptide <NUMBER> deficiency figure <NUMBER> nonrandomized interventional clinical trial evaluate possible effect plasma derived angiotensin peptide <NUMBER> supplementation treatment covid<NUMBER> cases nct<NUMBER> progress examine therapeutic values acei arbs covid<NUMBER> patients several clinical trial studies recently launched two randomized clinical trials examining role losartan covid<NUMBER> usa nct<NUMBER> nct<NUMBER> underway doubleblind placebocontrolled <NUMBER> randomized clinical trial assess arb valsartan may prevent development ards avert morbidity admission intensive care unit icu mechanical ventilation initiated netherland nct<NUMBER> existing antiviral drugs effective treating related lopinavirritonavir hydroxychloroquine chloroquine used patients sars mers outbreak assess effectiveness inhibiting sarscov<NUMBER> replication remdesivir inhibitor rnadependent rna polymerase date studies remdesivir show highly effective inhibiting <NUMBER>ncov infection vero e<NUMBER> cells <NUMBER> <NUMBER> recent study compassionateuse remdesivir patients hospitalized severe covid<NUMBER> showed clinical improvement <NUMBER> <NUMBER> patients <NUMBER> randomized doubleblind placebocontrolled multicenter trial severe covid<NUMBER> patient hubei china showed statistically significant clinical benefit <NUMBER> preliminary results randomized controlled clinical trial remdesivir indicate critically ill covid<NUMBER> patients given intravenous infusion remdesivir <NUMBER> faster time recovery received placebo median time recovery <NUMBER> days patients treated remdesivir compared <NUMBER> days placebo group nct<NUMBER> lopinavir shown antiviral effect sarscov<NUMBER> virus vero e<NUMBER> cells <NUMBER> study lopinavirritonavir showed shorten duration sars cov<NUMBER> shedding <NUMBER> however study hong kong compared ribavirin alone patients treated lopinavirritonavir plus ribavirin lower risk ards death caused sarscov onset symptoms <NUMBER> chloroquine cq hydroxychloroquine hcq aminoquinolines used treat malaria autoimmune diseases recent studies show cq hcq effective sarscov<NUMBER> infection vero e<NUMBER> cells <NUMBER> <NUMBER> however prospective randomized trial <NUMBER> adults covid<NUMBER> china revealed hcq conventional treatment compared <NUMBER> patients treated conventional treatment showed effectiveness hcq one patient hcq group progressed severe disease <NUMBER> openlabel nonrandomized clinical trial showed azithromycin added hcq significantly efficient virus elimination <NUMBER> outcome randomized doubleblind phase iib clinical trial clorocovid<NUMBER> study showed two different cq doses adjunctive therapy sarscov<NUMBER> patients patients high dose cq arm presented qtc <NUMBER> ms <NUMBER> higher fatality <NUMBER> lower dosage first recruited <NUMBER> patients <NUMBER> recent observational study assessing effects chloroquine hydroxychloroquine without macrolide <NUMBER> hospitalized covid<NUMBER> patients indicate benefit <NUMBER>aminoquinolinebased treatments population suggest could even increased risk denovo ventricular arrythmia <NUMBER> data prove hcq cq therapeutic role either treatment prophylaxis covid<NUMBER> sarscov<NUMBER> continues spread globally without approved therapies researchers urgently searching effective prophylactic therapeutic interventions therefore repurposing existing drugs approved uses could greatly benefit covid<NUMBER> patients around world despite benefits limitations example vitro studies using drugs lopinavirritonavir hcq cq remdesivir shown effectiveness sarscov<NUMBER> however small nonrandomized trials using drugs alone combination shown mixed results context convalescent plasma therapy vaccines earlier studies shown high concentrations antisera sarscov neutralized sarscov infection highly diluted antisera significantly increased sarscov infection wang et al <NUMBER> another study certain epitopes protein enhanced infection rhesus macaques attributed antibodydependent disease enhancement ade <NUMBER> <NUMBER> therefore even selection perfect adjuvant appropriate antigen antigens sarscov<NUMBER> vaccine development ade remains concern neutralizing antibodies elicited subneutralizing doses randomized placebocontrolled clinical trials existing drugs approved diseases attractive strategy since may reduce costs time furthermore existing pharmaceutical supply chain formulation distribution possibility rapid repositioning drugs covid<NUMBER> treatment summation covid<NUMBER> treatment guidelines panel recommends use following drugs treatment covid<NUMBER> combination hcq azithromycin potential toxicities use lopinavirritonavir hiv protease inhibitors unfavorable pharmacodynamics negative clinical trial data waiting results regarding therapeutic vaccine developments related blocking ace<NUMBER> protein interactions inhibiting ras sarscov<NUMBER> appears gained increased capacity transmission time infecting millions people globally causing significant morbidity mortality seen particularly among elderly comorbid conditions including advanced age hypertension diabetes obesity severity pandemic far beyond expectation much worse previous coronavirus epidemics including sars mers comparatively faster limited spread efforts minimize transmission including closure businesses limitation many activities significant lifechanging impacts including personal economic hardships damage global economies significant debate regarding best way restore economies bring people back work without enabling second wave infection critical identify means end current pandemic prevent emergence second wave infection clinical pathological features covid<NUMBER> similar sars several gaps current understanding covid<NUMBER> pathogenesis first although ace<NUMBER> serves receptor sarscov<NUMBER> pathogenic role ace<NUMBER> may complex remains unclear second sarscov<NUMBER> infection also downregulates ace<NUMBER> expression ace<NUMBER>expressing cells via shedding ace<NUMBER> tissue reducing level ace<NUMBER> infected cells whether changes tissue blood prognostic value predicting disease progress remains unclear <NUMBER> third although clinical trial studies ang ii inhibitors angiotensin receptor blockers indicates critical roles ace<NUMBER> covid<NUMBER> pathogenesis remains pressing need develop effective therapeutic strategies clinical trials studies animal models animal models dissecting pathogenic role ace<NUMBER> covid<NUMBER> evaluation therapeutic strategies targeting block ace<NUMBER> interaction protein inhibit immune activationcytokine storm modulating severe covid<NUMBER> also sorely needed finally current future preclinical clinical trials passive antibodies vaccine strategies focusing interaction ace<NUMBER> protein urgently needed inform development safe effective vaccines mitigate morbidity mortality covid<NUMBER> infection filling gaps multiple approaches effort add understanding covid<NUMBER> pathogenesis allow identification targets therapeutic intervention development safe effective neutralizing vaccine traditional calf feeding programs involved providing calves restricted levels milk milk replacer mr means encouraging starter intake thus facilitating earlier weaning rumen development <NUMBER> however restricted milk feeding programs also linked low live weight gains <NUMBER> increased abnormal nonnutritive feeding behaviours suggestive decrease calf welfare <NUMBER> recent years growing interest providing calves higher levels mr positively associated improved growth rates early life <NUMBER> reduced age first calving <NUMBER> increased first lactation milk yield <NUMBER> however providing greater volumes milk mr result reduced starter feed intake prior weaning <NUMBER> may impede rumen development <NUMBER> gradual weaning programs previously suggested means encouraging starter intake calves offered high levels milk <NUMBER> however reported de passille et al <NUMBER> calves fed higher milk levels may still display lower total dmi fed conventional levels milk following complete milk withdrawal despite adoption gradual weaning program could impact overall calf performance welfare postweaning period recently imani et al <NUMBER> reviewed varying effects forage provision calf intake performance transition liquid solid feed diet although results previous research inconclusive castells et al <NUMBER> khan et al <NUMBER> reported forage provision improved feed intake beneficial rumen development calves offered conventional increased levels milk respectively provision forage shown affect lying feeding behaviour calves offered high levels mr <NUMBER> however little known interactive effects milk replacer level forage inclusion calf activity could potential effect calf welfare insufficient nutrition prewean period impact negatively immune function increase potential susceptibility infectious disease <NUMBER> could expected providing increased levels mr would result fewer incidences illhealth however results previous research varied several authors reported either improvements differences health scores calves offered increased levels mr <NUMBER> <NUMBER> <NUMBER> whereas quigley et al <NUMBER> reported increased incidence diarrhoea number veterinary treatments calves fed greater volumes mr previous research suggested illhealth early calfhood impact negatively future performance <NUMBER> morbidity mortality disease increased presence physical psychological stressors <NUMBER> indicated khan et al <NUMBER> neonatal calf feeding regime extensive impact performance behaviour health welfare previous research also provided evidence longterm consistencies individual differences behavioural physiological response acute stressors <NUMBER> suggesting experiences early calfhood could impact development future coping strategies need examine nutritional regime impact behavioural physiological responses management strategies commonly encountered first months life recently peli et al <NUMBER> reported neurochemical effects stress related intake different diets veal calves study described increase oxytocin production veal calves offered either mr mr plus concentrate diet control diet compared calves offered diet mr concentrate hay results suggest stress related different diets impact measureable immunoreactive parameters highlights need examination nutritional regimes impact calf health welfare however traditional methods monitoring calf behaviour reaction stressors labour intensive eg visual observations invasive eg blood sampling immunohistochemical methods recently increasing interest employing use remotesensing technologies activity heart rate monitors could allow noninvasive measurement behavioural physiological responses stressors individual basis provide comprehensive indicator calf wellbeing <NUMBER> <NUMBER> within study primary objective examine behavioural physiological responses calves milk feeding level using remote monitoring technologies applicable onfarm use hypothesized reduction mr feeding frequency weaning would likely considered stressor particularly calves offered higher levels milk replacer would provoke measureable behavioural physiological response objective examine impact forage inclusion different ages calf activity interactive effect mr feeding level study conducted agrifood bioscience institute afbi research farm hillsborough <NUMBER> • <NUMBER> n <NUMBER> • <NUMBER> w study commenced <NUMBER>th february <NUMBER> ended <NUMBER>th july <NUMBER> study described manuscript approved agrifood biosciences institute animal welfare ethical review body procedures treatments conducted license department health social services public safety northern ireland accordance animals scientific procedures act <NUMBER> seventyfour holstein friesian calves <NUMBER> females <NUMBER> males born <NUMBER>th february <NUMBER>th april <NUMBER> allocated study following weighing ≤<NUMBER> h age used birth weight <NUMBER> ± <NUMBER> kg calves received <NUMBER> l colostrum via oesophageal feeding tube teated bottle transfer calfrearing unit single point blood samples taken via jugular venipuncture using <NUMBER> ml clot activated serum separation vacutainer tubes bd plymouth uk <NUMBER> h old allow determination calf immune status using zinc sulphate turbidity zst technique described mcewan et al <NUMBER> calves allocated study determined zst value <NUMBER> units indicative successful passive transfer immunity <NUMBER> calves individually penned order birth allocated treatment <NUMBER> milk replacer feeding level × <NUMBER> forage provision factorial design table <NUMBER> milk replacer levels provided either high hml conventional cml table <NUMBER> forage sources provided four different stages experimental period treatments designated chopped straw <NUMBER> cm length offered <NUMBER> <NUMBER> days age cs<NUMBER> ii chopped straw offered <NUMBER> <NUMBER> days age cs<NUMBER> iii grass silage offered <NUMBER> days age gs<NUMBER> iv forage provided prewean period nf forage source provided prior commencement treatments calves treatments provided grass silage sole forage source <NUMBER> days age end experiment day <NUMBER> individual pens <NUMBER>m × <NUMBER>m constructed using hurdles within two open ended concrete walled floored housing blocks base layer woodchip added floor pen sawdust bedding material added top replenished daily basis within pens calves visual contact calves within housing block nosetonose contact calves neighboring individual pens upon arrival calf rearing accommodation ≤<NUMBER> h age calves fitted jackets remained calves reached <NUMBER> days age calves remained individual pens end study day <NUMBER> liquid diets offered via teated bucket twice day days <NUMBER> <NUMBER> days <NUMBER> <NUMBER> feed consisted <NUMBER> l colostrumtransition milk day <NUMBER> <NUMBER>l feed consisted mixture half transition milkhalf wheybased milk replacer <NUMBER> <NUMBER> days age calves offered milk replacer rate <NUMBER>gl details milk replacer feeding regimes provided table <NUMBER> calves offered milk replacer <NUMBER> times daily feedings occurred <NUMBER> h <NUMBER> h pm <NUMBER> h pm offered milk replacer twice daily second second third feeds removed respectively concentrate solid feed fresh water provided ad libitum basis <NUMBER> days age details chemical composition feedstuffs offered throughout study reported table <NUMBER> calves vaccinated bovilis bovipast rsp msd animal health milton keynes uk <NUMBER> weeks age secondary dose given <NUMBER> weeks later point calves also vaccinated bovilis ibr marker live msd animal health milton keynes uk individual daily milk replacer concentrate intakes recorded daily basis <NUMBER> days age individual water intake recorded <NUMBER> daysweek <NUMBER> days age forage intake recorded daily basis applicable live weight recorded birth well weekly according individual calf age days <NUMBER> <NUMBER> trutest eziweigh <NUMBER> auckland new zealand results reported elsewhere faecal consistency qualitatively scored daily basis following morning feeding time using scale <NUMBER> normal consistency <NUMBER> slightly liquid consistency <NUMBER> moderately liquid <NUMBER> primarily liquid consistency <NUMBER> calf recorded scour score greater two respiratory disease scoring carried daily basis using university wisconsinmadison method <NUMBER> involved scoring calves three visual aspects including eyes ears nasal discharge presence absence cough rectal temperature core body temperature taken using digital rectal thermometer model ft<NUMBER> beurer uk ltd golborne uk daily basis <NUMBER> <NUMBER> days age aspect received score <NUMBER> <NUMBER> <NUMBER> representing normal <NUMBER> severely affected overall respiratory score derived cumulative score aspect cumulative respiratory score ≥<NUMBER> considered indicate bovine respiratory disease complex event faecal respiratory scoring carried trained technician individual basis cases calf ill health recorded treated according predefined protocols produced consultation veterinarian thermal images calf taken <NUMBER> h post feed <NUMBER> daysweek days <NUMBER> <NUMBER> images taken trained operator using calibrated flir e<NUMBER> camera flir systems uk kent uk right eye plus <NUMBER> cm area surrounding eye anus plus <NUMBER>cm area surrounding anus images taken consistent distance <NUMBER> angle <NUMBER> • whilst calf standing purposes standardisation images taken within individual pens prior introduction potential stressors weighing blood sampling calves quickly became habituated process limited handling camera operator required images processed using flir ® software flir systems uk kent uk maximum average minimum temperature images recorded ambient temperature relative humidity rh within rearing accommodation recorded using calibrated ebi <NUMBER>th data logger ebro electronic ingolstadt throughout experimental period average temperature rh values obtained time period images taken entered software program image processing allow atmospheric changes sampling period analysis eye images focused medial posterior palpebral border lower eyelid lacrimal caruncle found area consistent temperature <NUMBER> total <NUMBER> calves balanced across milk replacer forage treatments fitted icerobotics ® iceqube ® automatic activity sensors icerobotics ltd edinburgh scotland uk <NUMBER> days age remained calves throughout experimental period sensors affixed lateral side right rear leg accordance current best practice <NUMBER> <NUMBER> <NUMBER> sampling rate kept default <NUMBER> interval removed sensors downloaded optimal correction filter <NUMBER> removed sensor recordings lasting ≤ <NUMBER> applied data prior analysis total <NUMBER> calves balanced across milk replacer forage treatments fitted polar equine rs<NUMBER>cx science polar electro uk ltd heathcote way warwick uk heart monitor days −<NUMBER> −<NUMBER> <NUMBER> <NUMBER> <NUMBER> day <NUMBER> day <NUMBER>st vaccination day <NUMBER>nd vaccination days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> age ages represented calf jacket removal d<NUMBER> changes milk feeding frequency quantity d<NUMBER> <NUMBER> <NUMBER> weaning d<NUMBER> monitors fitted <NUMBER> h post feed remained calves <NUMBER> h allow data capture period calves undisturbed likely resting sampling conducted time day help decrease effects circadian rhythms electrode gel spectra <NUMBER> electrode gel parker laboratories inc new jersey usa applied ensure contact calf monitor <NUMBER> time period data analysis selected <NUMBER> min <NUMBER> following data selection recordings processed using artiifact polar software <NUMBER> preliminary error correction data set conducted using polar software settings described clapp et al <NUMBER> data set requiring <NUMBER> error correction rejected <NUMBER> following error correction data set processed using artiifact software resultant root mean squares successive differences rmssd inter heart beat intervals ibi heart rate hr used analysis <NUMBER> data analysed using genstat ® version <NUMBER> vsn international ltd statistical models included sex fixed effect birth weight covariate unless otherwise stated probability p <NUMBER> selected level significance data significant subjected fishers protected least significant difference plsd test variation daily faecal total respiratory scores low averaged weekly basis first four complete ten weeks experimental period respectively mean weekly scores fitted repeated measures residual maximum likelihood estimation reml mixed effects model fixed effects associated interactions milk replacer level forage treatment likelihood animal receiving treatment scour pneumonia high temperature signs respiratory illness analyzed modelling binomial proportions using logistic regression fixed effects sex milk level forage treatment interactions milk level forage treatment fitted individually model back transformed means reported thermal imaging rectal temperature data assigned four age bands d<NUMBER> represent period first vaccination occurred d<NUMBER> represent period following first vaccination prior first milk stepdown accelerated calves d<NUMBER> represent period following first milk stepdown time second vaccination occurred d<NUMBER> represent period milk step downs weaning occurred data fitted repeated measures reml model fixed effects associated interactions milk replacer level forage treatment time ambient temperature included covariate data also fitted repeated measures reml model fixed effects associated interactions milk replacer level forage treatment time method temperature assessment correlation coefficients three temperature methods determined linear regression using predicted means obtained repeated measures analysis daily hourly lying time along number duration lying bouts heart rate heart rate variability data fitted repeated measures reml model described results pertaining hourly lying behaviour presented supplementary data figure s<NUMBER> within lying behaviour heart rate analysis results refer period time following management event eg mr stepdown baseline covariate derived averaging data <NUMBER> activity sensors <NUMBER> heart rate monitors days prior event included within model calves offered high hml levels milk replacer increased average faecal score days <NUMBER> compared calves offered conventional cml levels milk replacer table <NUMBER> p <NUMBER> effect milk replacer level forage treatment average faecal score days <NUMBER> <NUMBER> <NUMBER> forage treatment d<NUMBER> table <NUMBER> p <NUMBER> faecal scores <NUMBER> recorded <NUMBER> days age cml calves increased average respiratory score days <NUMBER> compared hml calves table <NUMBER> p <NUMBER> however despite observed increase average respiratory scores across treatments remained threshold deemed indicative bovine respiratory disease effect forage treatment respiratory score table <NUMBER> p <NUMBER> effect milk level offered probability receiving treatment pneumonia p <NUMBER> pyrexia plus respiratory type symptoms p <NUMBER> calves offered chopped straw <NUMBER> days age cs<NUMBER> increased likelihood receiving treatment pneumonia p <NUMBER> however interactive effects mr level forage treatment observed p <NUMBER> increased likelihood receiving treatment scour observed hml calves p <NUMBER> values <NUMBER> <NUMBER> hml cml calves respectively significant effect forage treatment p <NUMBER> mr level × forage treatment p <NUMBER> likelihood receiving treatment scour effects mr feeding level forage treatment core body infrared ir eye ir rectal temperature days <NUMBER> <NUMBER> <NUMBER> table <NUMBER> p <NUMBER> average core body ir eye ir rectal temperatures recorded d<NUMBER> presented figure <NUMBER> core body temperature <NUMBER> <NUMBER> hml cml calves respectively days <NUMBER> table <NUMBER> p <NUMBER> however differences ir eye ir rectal temperature differences mr forage treatments core body ir eye ir rectal temperature data analysed <NUMBER> days prior following calf jacket removal step mr feeding frequency quantity weaning although unaffected mr feeding level effect day increase temperature parameters <NUMBER> days following <NUMBER>st <NUMBER>nd vaccination figure <NUMBER> p <NUMBER> calf temperature affected method temperature assessment across time periods positive correlations found core body ir eye temperature data analysed <NUMBER> <NUMBER> <NUMBER> <NUMBER> days age table <NUMBER> positive correlations also found core body ir rectal temperature days <NUMBER> <NUMBER> <NUMBER> ir eye ir rectal temperature days <NUMBER> <NUMBER> <NUMBER> table <NUMBER> correlations <NUMBER> <NUMBER> <NUMBER> found core body ir eye core body ir rectal ir eye ir rectal temperatures respectively analysed <NUMBER> days prior following removal calf jackets table <NUMBER> strong positive correlations also found methods temperature assessment <NUMBER> days prior following <NUMBER>nd vaccination table <NUMBER> table <NUMBER> pearson correlation coefficients methods temperature assessment specific age ranges <NUMBER> days preand postmanagement events daily lying time increased hml calves days <NUMBER> p <NUMBER> characterized increased number p <NUMBER> shorter p <NUMBER> lying bouts compared cml calves period calves offered chopped straw <NUMBER> days age cs<NUMBER> displayed increased number <NUMBER> vs <NUMBER> shorter <NUMBER> vs <NUMBER> min lying bouts offered chopped straw <NUMBER> days age cs<NUMBER> however despite variation significant impact forage treatment total daily lying time table <NUMBER> p <NUMBER> daily lying time <NUMBER> mind lower hml calves period following step three two mr feeds <NUMBER> days age compared cml calves table <NUMBER> p <NUMBER> significant effect mr feeding level daily lying behaviour d<NUMBER> table <NUMBER> p <NUMBER> however effect forage treatment whereby cs<NUMBER> calves fewer lying bouts table <NUMBER> p <NUMBER> cs<NUMBER> gs<NUMBER> calves <NUMBER> vs <NUMBER> vs <NUMBER> lying behaviour significantly impacted mr feeding level period following reduction mr <NUMBER>lday <NUMBER> days age table <NUMBER> p <NUMBER> however effect forage treatment whereby total daily lying time higher table <NUMBER> p <NUMBER> cs<NUMBER> calves compared gs<NUMBER> nf calves <NUMBER> vs <NUMBER> vs <NUMBER> mind daily lying time higher cml calves period following weaning <NUMBER> days age table <NUMBER> p <NUMBER> lying bouts also tended longer calves compared hml calves table <NUMBER> p <NUMBER> effect forage treatment lying behaviour post weaning period however effect mr level × forage treatment lying bout duration table <NUMBER> p <NUMBER> bouts approximately <NUMBER> min shorter hml calves receiving chopped straw <NUMBER> days age diurnal lying behaviour periods milk stepdown weaning presented supplementary data figure s<NUMBER> effect mr feeding level heart rate hr heart rate variability hrv measured root mean square successive differences rmssd period following calf jacket removal <NUMBER> days age also true periods following step hml calves three two two one mr mealsd <NUMBER> <NUMBER> days age respectively following reduction mr level <NUMBER>lday across treatments <NUMBER> days age heart rate rmssd values unaffected mr treatment period following weaning <NUMBER> days age however interactive effect mr treatment day hml calves displaying increased heart rate table <NUMBER> p <NUMBER> lower rmssd table <NUMBER> p <NUMBER> <NUMBER> days age significant effect forage treatment hr rmssd throughout experimental period table <NUMBER> table <NUMBER> heart rate bpm heart rate variability rmssd calves managed different nutritional regimes first ten weeks life responses common management practices restricted feeding weaning previously assessed using measures calf activity technological developments meaning standing lying behaviour recorded automatically <NUMBER> de paula vieira et al <NUMBER> reported decrease lying time observed limitfed calves suggested due hunger present study daily lying time reduced <NUMBER> mind cml calves characterized reduced number shorter lying bouts d<NUMBER> period prior reduction mr feeding frequency volume hml calves reported terré et al <NUMBER> calves offered lower levels mr consume concentrate present study reported elsewhere average daily concentrate consumption d<NUMBER> <NUMBER> g dm <NUMBER> g dm hml cml calves respectively p <NUMBER> likely cml calves present study spending time standing consume concentrate hml calves calves offered chopped straw <NUMBER> days age cs<NUMBER> also displayed increased number shorter lying bouts period castells et al <NUMBER> reported differences calf activity calves offered alfalfa hay provided forage could therefore changes behaviour observed present study due cs<NUMBER> calves consuming chopped straw <NUMBER> days age mr volume feeding frequency reduced hml calves period lying time reduced calves comparison prestep period recorded cml calves reduction lying time also observed hml calves period following complete milk withdrawal decrease lying time hml calves similar reported budzynska weary <NUMBER> likely sign increased hunger following reduction withdrawal mr indicated de passille et al <NUMBER> decrease overall dmi due reduced solid feed intake observed calves offered high levels mr prewean period even managed gradual weaning program decrease lying time hml calves period milk step complete weaning could therefore due hml calves spending longer standing consume solid feed means addressing reduction available feed energy d<NUMBER> cs<NUMBER> calves displayed increased lying time compared gs<NUMBER> nf calves calves spend time ruminating whilst lying <NUMBER> could considered rumen development potentially advanced calves offered forage earlier age increase lying time due increased rumination lack direct observations distinguish specific behaviours feeding rumination could considered limitation present study future research could implement use calf appropriate rumination halters allow feeding behaviours distinguished however results highlight activity monitors could used onfarm producers distinguish changes behaviour result changes nutritional regime application activity meters group housed situations could also provide information regarding impact feeding regime diurnal behaviour dairy calves heart rate monitors previously shown provide increased opportunities noninvasive monitoring physiological responses stress <NUMBER> increase heart rate hr decrease root mean square successive differences rmssd time domain measure heart rate variability hrv linked increased stress load <NUMBER> present study measures hr hrv comparable across prewean period however reduction rmssd hml calves following weaning hr hrv measurements collected calves rest <NUMBER> could indicate potential increase stress response corresponds changes lying behaviour observed hml period highlights calves high levels mr first weeks life could display increased stress response withdrawal mr compared calves previously fed conventional level mr adopting prolonged weaning approach whereby mr volume reduced daily basis described sweeney et al <NUMBER> may improve concentrate intake calves fed high levels mr thus reduce stress associated mr withdrawal illhealth early calfhood significant impact animal behaviour welfare productivity affect economic efficiency dairy operations <NUMBER> <NUMBER> enteric respiratory diseases common causes morbidity mortality first weeks life prevalence severity affected housing conditions colostrum intake feeding management <NUMBER> providing calves milk milk replacer level equivalent <NUMBER> calf birth weight per day two portions accepted industry standard designed encourage earlier intake solid feed <NUMBER> however suggested restricted feeding impact negatively growth rates immune function calves thus may potentially increase susceptibility disease <NUMBER> present study could considered calves offered high hml levels mr would less likely suffer illhealth compared offered conventional cml levels mr however comparable reported quigley et al <NUMBER> hml calves present study increased faecal scores d<NUMBER> likely receive treatment diarrhoea cml calves study quigley et al <NUMBER> calves fed either conventional increased levels mr subject transport stress housed hutches bedding material contaminated coronavirus increased incidence morbidity mortality observed calves provided increased levels mr study directly apportioned feeding level leading authors advise cautionary approach providing increased mr levels calves stress diaz et al <NUMBER> also reported increased faecal scores calves offered increased levels mr however considered result differences total volume feed water consumed opposed disease present study although faecal score elevated hml calves considered indicative neonatal calf diarrhoea ncd suggesting increased scores diaz et al <NUMBER> likely result fact hml calves receiving <NUMBER>lday mr cml calves additionally anecdotal evidence within present study indicated scour milky colour reinforcing consideration higher faecal scores hml calves due higher initial mr volume opposed infection research could aim examine scour scoring systems could modified improved take account presence milky scour average respiratory score observed cml calves days <NUMBER> although increased comparison hml calves threshold score considered indicative brd results indicate management conditions described calves fed either increased conventional levels milk replacer without severe impact health throughout prewean period may influenced fact calves individually housed shown reduce health problems <NUMBER> however increased faecal scores first <NUMBER> weeks life hml calves could suggest may advisable delay increasing mr levels period calves less susceptible enteric disease <NUMBER> one primary detectable physiological responses infection inflammation change core body temperature often used indicator illhealth <NUMBER> addition illness stress result common management practices early calfhood also result changes blood flow thus heat production result increased hypothalamic pituitary adrenal hpa axis activity <NUMBER> infrared thermography irt indicated noninvasive viable method detecting small changes radiated temperature <NUMBER> highlighted potential method early detection illhealth <NUMBER> present study difference radiated temperature eye rectal area suggesting calves able maintain thermoregulation throughout experimental period despite differences mr feeding levels particularly evident period following calf jacket removal could anticipated cml calves may struggled maintain thermoregulation faced combined factors reduced energy intake lower ambient temperatures however difference temperature measurements found could due fact calves <NUMBER> weeks age time calf jacket removal better able withstand lower ambient temperatures <NUMBER> age cml calves also likely consuming greater amounts solid feed <NUMBER> thus nutritional energy potentially sufficient cope increased heat production demands <NUMBER> result exposure lower ambient temperatures following calf jacket removal limited published research addressing correlation infrared ir temperature core body temperature young calves although variable present study correlation ir eye temperature core body temperature within range found jersey heifers salles et al <NUMBER> comparable correlation core body temperature indwelling rumen bolus temperature reported knauer et al <NUMBER> reason variability correlation unknown requires investigation however could ir temperature used standalone measure wherein individual calves used control particularly situations incidence illhealthpyrexia low results present study suggest ir temperatures affected mr feeding level however may also number calves used experimental design sufficient detect differences result feeding level additionally limited information regarding effects feeding level body temperature area requiring investigation comparable previous research <NUMBER> present study irt able detect febrile response linked vaccination response differ mr treatments however highlight potential irt used detection pyrexia associated symptoms disease automated per schaefer et al <NUMBER> could offer less invasive option continuous temperature assessment young calves management conditions described present study mr feeding level limited effects calf health physiological responses common management practices however changes activity could linked hunger result conventional feeding levels following reduction mr volume calves offered high levels mr early life detectable using automatic activity sensors additionally higher lying time observed cs<NUMBER> calves <NUMBER> days age could point increased rumination result earlier forage introduction suggests providing calves forage source addition concentrate feed could beneficial rumen development present study calves individually housed perhaps contributed low level illhealth amongst calves calves also monitored daily basis combination traditional novel indicators potentially resulting earlier detection treatment illhealth future research incorporate techniques described group housing systems results present study also provide evidence role remotesensing technologies within calf rearing systems using range traditional novel methods increases possibilities collection behavioural physiological data allow producers obtain overall indicator calf wellbeing responses common management practices encountered early life research aims compare correlate technologies hormonal biochemical immunological parameters could help development early warning systems calf health welfare issues supplementary materials following available online httpwwwmdpicom<NUMBER>s<NUMBER> figure s<NUMBER> diurnal lying behaviour calves offered increased hml conventional cml levels milk replacers periods milk step weaning pvalues represent effect milk replacer feeding level within framework campus project medical university graz joint laboratory working biological agents risk group <NUMBER> designated institutes pathology hygiene microbiology environmental medicine biobank context healthcare medical diagnostics mentioned unit enable safe immediate execution autopsies sample collection research pathogenhostinteractions able work pathogens causing diseases pandemic potential well therapy resistant pathogens whose risk group unknown laboratory additionally equipped mobile isolation unit glovebox furthermore include increased personal protection kind sample collection currently organised highly relevant determine whether mortality traced back agent comorbidities diseases caused pathogens occurring furthermore important information concerning organ specifity pathogens pathogenic mechanisms well bodys infection defense reactions gained establishment sample collection centre takes places within framework paneuropean infrastructure initiative european commission erinha european research infrastructure highly pathogenic agents one tasks linked project establishment master plan allpurpose sample collection autopsy concept set interface health system high security laboratory appropriate mockup solution europe reason mobile solution especially applicable countries warmer climate eg southeasteurope africa required planning takes place close collaboration high infectious disease transport team hitt red cross styria well provincial health directorate styria department civil protection styria beside safeguarding human beings environment unintentional disposal pathogenic agents important protect laboratory staff infections ensure sufficient protection following safety precautions intended <NUMBER> spatial infrastructure laboratory security level <NUMBER> <NUMBER> room setup gloveboxes negative pressure material lock manlocks opportunity decontamination <NUMBER> personal protective equipment virustightwholebody protective suits respiratory devices hepa filters virustight gloves boots study focuses predominantly barrier level <NUMBER> aim study identify wearing ppe longer period time different temperature conditions affects physical performance individual feeling power concentration error ratio elevated environmental temperature could pose limiting factor working increased personal protection furthermore raises question possible maximum working timeis feasible assume raising time limit implicates higher error ratio followed fact protective provisions cant met furthermore highly increases risk injury reason important identify indicators point loss concentration timely manner study planned monocentric randomised crossover study course study two protective suits compared two different temperature conditions study serves determine bodily performance concentration levels error rates subjective well laboratory work protective suits pilot phase planned order optimise simulated laboratory work glove boxes define meaningful simulated conditions eg many pipetting steps possible given time testing logistics procedure well determine relevance planned measurements pilot phase <NUMBER> voluntary test subjects included based evidence published studies regarding testing personal protective equipment participant number maximally <NUMBER> assumed although due relatively long time required study dropout rate <NUMBER> expected study split pilot execution phase <NUMBER> voluntary subjects included pilot phase maximum <NUMBER> voluntary subjects included execution phase recruiting trial exclusively carried voluntary registration base announcements kages medical university graz karlfranzens university university applied sciences joanneum mainly focused students employees mentioned institutions inclusion exclusion criteria taken consideration participant tested two ppe systems system fullbody suit including respirator eg tychem f protective suit including socks eg <NUMBER>m tm reusable light cap s<NUMBER> eg <NUMBER>m tm jupiter tm cooling unit eg sempermed surgical gloves optional eg boots b system b fullbody suit fully integrated ventilation system positive pressure eg <NUMBER>m tm jsseries typ <NUMBER> respiratory protective suit crps eg sempermed surgical gloves optional eg boots two different climate zones module <NUMBER>°c module ii <NUMBER>°c two different days testing day two four subjects perform series testings listed subject assigned system randomisation called httpwwwrandomizerat decided ppe system subject supposed start testing series test series described run succession test persons start timedelayed fashion <NUMBER> minutes change next test various tests fiveminute recreation break tests <NUMBER> repeated test person cannot tolerate conditions stops another reason test phases following parameters measured recorded regularly heart rate heart rate variability oxygen saturationand body temperature immediately separate modules urine saliva specimens taken order create metabolite profile weight body equipment measured order able calculate loss fluids addition measurements mentioned extensive instruction explanation anamnesis happen study starts test persons encouraged comment subjective feelings test series furthermore hourly survey way structured questionnaire including continuous record communications system type evaluation based subjective judgement c optimizing study protocol based results pilot phase issuing subjectid issuing randomly assigned ppe system short introduction first appointment getting dressed explaining testing series… anamnesis laboratory tutorial ii duration <NUMBER> minutes recovery period <NUMBER> minutes recording measured data hr oxygen saturation °c power concentration test duration <NUMBER> minutes recovery period <NUMBER> minutes measuring total weight subject including protective suit taking protective suit measuring body weight without ppe system measuring weight ppe system removing hrmonitorpulse oximetry removing thermometer collecting saliva samples refrigerated storage collecting urine samples refrigerated storage measuring hr recording database measuring oxygen saturation recording database measuring body temperature recording database measuring blood pressure recording database exporting coded subject data microsoft access microsoft excel forwarding coded data statistician interpreting generated data developing publication releasing publication scientific journal dissertation subject able quit study time reasons required mentioned module environmental temperature <NUMBER>°c automatically ends maximum <NUMBER> hours module ii environmental temperature <NUMBER>°c automatically ends maximum <NUMBER> hours neither benefit risk subjects included trial due water tightness protective suits used study strains like heat accumulation fluid loss heat generation inside suit could lead cardiovascular problems eg collapse certain circumstances scenario medical doctor callduty contacted immediately apart risk expected described trial data management subjects data exclusively made coded way help access database built following scheme body weight g body weight g body weight g weight suit system g weight suit system g weight suit system g weight suit system g total weight g total weight g total weight g total weight g dehydration g dehydration g dehydration g dehydration g guarantee regular contact study subjects different testing series contact details connection subjectid recorded separate password protected database contact data subjectid title surname family name email address phone number notes regarding benefit risk subjects see therapy safety clarification ethical aspects application ethical commission medical university graz made subjects instructed informal meeting repeated required informed consent paper provided individualrelated information connected data generated within study exclusively saved coded way database restricted access passwords contacting subjects separate contact data base restricted access password established generated data analysis publications exchange collaboration partner exclusively used coded way furthermore ensured results trial eg performance testing series appropriate influence current employment relationship studies number cases <NUMBER> subjects estimated basis findings previous trials regarding testing ppe due relatively high time requirement go trial drop rate <NUMBER> expected outcome intended published scientific journals dissertation well presented congresses im rahmen des campus projektes der medizinischen universität graz ist ein gemeinsames labor für biologische arbeiten im risikobereich <NUMBER> für die institute pathologie hygiene mikrobiologie umweltmedizin und die biobank vorgesehen im kontext von gesundheitsversorgung und medizinischer diagnose soll diese einheit für die sichere und rasche durchführung von autopsien und probensammlungen zur erforschung von pathogenhostinteraktionen zur verfügung stehen um auch erkrankungen durch erreger mit pandemischem potential bzw therapieresistente errerger deren risikogrupppe noch nicht bekannt ist bearbeiten zu können soll dieses labor zusätzlich mit mobilen isolationseinheiten gloveboxen sowie einem erhöhten personenschutz ausgestattet werden diese art der probensammlung ist derzeit nicht organisiert jedoch von großer bedeutung um bei neuauftretenden erkrankungen durch pathogenen festellen zu können ob die mortalität auf den erreger oder auf komorbiditäten zurückzuführen ist zusätzlich können dadurch wichtige informationen die sich auf die organspezifität von erregern pathogenitätsmechanismen sowie abwehrreaktionen des körpers beziehen gewonnen werden pandemics reemerging diseases put pressure health care system prepare patient care sample management diagnostics requiring personnel protective equipment ppe exposed health care workers hcws majority european hospitals equipped isolation units patients high security containments sample management event emerging reemerging infectious diseases high risk potential specific challenges hospital environment patient care handling infectious samples diagnostics work dead bodies various protective suit systems different applications commercially available selection appropriate ppe optimal protection best ergonomic features best tolerance wearers based evidence performing hazardous laboratory clinical work wearing ppe involves various constrictions compared work without ppe example multiple layers gloves limit dexterity longterm work ppe may cause heat stress viewing foils face shields dependent suit system reflect refract light making observation stressful leading eye fatigue therefore health care professionals wearing chemical biological radiation nuclear personal protective equipment cbrnppe performing intubation intravenous cannulation significantly slower even unsuccessful compared personnel skills performing work standard conditions shown uk study mimicking time critical emergency casualties caused cbrn incident <NUMBER> apart information provided suit manufacturers many systematic studies exist requirements cbrnppe particularly hcws consequently need test various types ppe material compatibility determination protection factors wearer comfort additional adaptations specific needs <NUMBER> <NUMBER> far tests mimicking event biological threat performed different contexts example assessment whole hospitals french biotoxpirotox network <NUMBER> performance resuscitation skills wearing ppe <NUMBER> <NUMBER> evaluation ppe protection factors <NUMBER> <NUMBER> furthermore valuable experience obtained performing autopsies bsl<NUMBER> facilities cases severe acute respiratory syndrome coronavirus sarscov china <NUMBER> increased awareness impact need measures protect hcws population biological threats triggered infections crimeancongo hemorrhagic fever virus cchfv <NUMBER> quick spread sarscov originating guangdong province china <NUMBER> countries worldwide within <NUMBER> months <NUMBER> ebola outbreak west africa demonstrated need quick response unusual emerging infections using rapidly deployable field laboratory equipment wearing ppe several limitations conditions <NUMBER> <NUMBER> <NUMBER> recent studies highlight additional research comparative studies various types ppe needed determine optimal ppe hcws <NUMBER> <NUMBER> furthermore testing current ppe configurations simulated environmental conditions determine length time could safely worn recommended <NUMBER> identify parameters affecting performance tolerability wearing ppe investigated pilot study format wearing ppe influences physical performance individual wellbeing concentration error rates wrongly processed items different tasks performing series different tasks simulating typical working steps handling infectious materials health care environment normal <NUMBER>˚c increased <NUMBER>˚c working temperatures particular evaluated advantages disadvantages two different ppe systems investigated mentioned parameters limiting working tested conditions study following good clinical practice guidelines nineteen study volunteers recruited wear one two different types randomly allocated ppe suits using webbased randomizer software wwwrandomizerat institute medical informatics statistics documentation medical university graz imi softwares gcpcompliance good clinical practice confirmed austrian agency health food safety subjects perform four different tasks six times <NUMBER>˚c one day four times <NUMBER>˚c another day local core facility clinical research center recruitment data collection done may july <NUMBER> study registered clinicaltrialsgov nct<NUMBER> testing personal protective equipment ppe completion since aim provide data certification approval process medical products devices recruiting healthy participants based voluntary registration response public announcement study approved ethical committee medical university graz austria <NUMBER> ex <NUMBER> persons gave written informed consent according helsinki declaration s<NUMBER>s<NUMBER> files key lifestyle medical parameters documented every subject exclusion criteria pregnancy latex polyvinyl chloride allergy claustrophobia hypotension history vein thrombosis chronic obstructive pulmonary disease epilepsy cardiovascular pulmonary diseases infectious diseases s<NUMBER> table ten male nine female volunteers recruited aged <NUMBER> <NUMBER> years bodymassindices <NUMBER> <NUMBER> table <NUMBER> enrollment allocation followup analysis performed according dedicated consort flow diagram fig <NUMBER> suit tychemr f overall wholebody dupont de nemours company <NUMBER>m austria suit including socks reusable light hood versaflo s<NUMBER> <NUMBER>m austria external <NUMBER>m jupiter powered air turbo unit <NUMBER>m austria providing headonly positive pressure ten participants randomly allocated wear suit fig <NUMBER>a suit b <NUMBER>m jsseries typ <NUMBER> chemical respiratory protective suit crps <NUMBER>m austria integrated respirator <NUMBER>m jupiter jper<NUMBER> powered air purifying turbo <NUMBER>m austria fixed rucksack generating wholesuit positive pressure nine participants randomly allocated wear suit b fig <NUMBER>b suits sempercare surgical gloves sempermed powderfree <NUMBER> semperit austria first layer ansell solvex gloves <NUMBER> ansell medical gbu vwr austria second layer white rubber boots worn gloves boots sealed suit using adhesive tape tasks ii table <NUMBER>a performed mockup glove box providing third layer latex gloves four tasks repeatedly performed well additional assessment comfort general condition tasks started every fourtask series table <NUMBER> task comprised correct assembly position coloured numbered <NUMBER> ml tubes screwcaps storage device test fine motor skills concentration error rate task ii checked skills different approach pipetting different volumes coloured water <NUMBER>well microliter plate according given pattern task iii d<NUMBER> test attention timed test selective attention standardized refinement visual cancellation <NUMBER> response discrimination similar visual stimuli test measures processing speed rule compliance quality performance allowing estimation individual attention concentration performance <NUMBER> task iv investigated reaction time mobility speed physical exercise tapping touch sensors directed signs screen tapping test talentsystems sportconsulting gmbh wwwwerthnerat table <NUMBER>a subjects performed tasks randomisation wwwrandomizerat starting exercise example subject one started test subject two started test ii time ten minutes working time five minute break subject one carried task ii subject two task five minute break subject one started task iii subject two performed task iv <NUMBER> minute period five minutes break subject one continued task iv subject two task iii table <NUMBER>b subjects documented individual comfort general condition structured assessment sheet tasks started every series tasks table <NUMBER>a four tasks repeated <NUMBER> times <NUMBER>˚c <NUMBER> hours total working time first study day four times <NUMBER>˚c <NUMBER> hours total working time second study day waiting times <NUMBER> <NUMBER> days mean waiting time <NUMBER> days limiting factors working conditions rated every series <NUMBER> <NUMBER> assessment sheet whereby ranking <NUMBER> reason terminating study heart rate hr measured wireless heart rate monitor placed sternum directly skin garmin forerunner <NUMBER> task series hr data task series used statistical analysis body temperature assessed tympanic infrared temperature measurement body weight measured without ppe undergarment beginning last test measurement accuracy <NUMBER>kg calculating dehydration subjects wearing randomly allocated suits participated task series <NUMBER>˚and <NUMBER>˚c physical measurements heart rate fluid loss body temperature measurement error rates task measurement concentration d<NUMBER> test task iii measurement reaction time task iv arranging closed tubes box following certain pattern comparison total amount handled tubes wrong combinations simulated glovebox sitting ii pipetting defined volume three coloured water reservoirs <NUMBER>well plate following certain amount pattern comparison total amount filled wells wrong omitted wells simulated glovebox sitting iii d<NUMBER> test attention ticking every ditem <NUMBER> bars pattern p different numbers adjustments bars <NUMBER> rows <NUMBER> items checked within <NUMBER> seconds per row <NUMBER> items total standardised matrix reveals correctly wrongly omitted ditems handwritten sitting digital readouts screen indicating beat four touch sensors hands located left right side front behind subject two additional touch sensors floor legs measurement individual perception wellbeing task series assessment sheet individualrelated information connected data generated exclusively stored coded way database restricted access password protection contacting subjects separate contact database restricted access password protection established data generated exclusively used coded way analysis publication descriptive statistics physical measurements task performance assessment data given mean standard deviation sd physical measurements heart rate body temperature measured tympanic infrared thermometer fluid loss determined basis body weight reduction documented task series heart rate additionally recorded whole study phase identify challenging task allow comparison different tasks error rates reaction times two working temperatures differences two suits regarding heart rate body temperature fluid loss assessed separately analysis covariance ancova prior analysis checked assumptions performing ancova fulfilled task performance data recorded <NUMBER> times <NUMBER>˚c <NUMBER> times <NUMBER>˚c assessment data recorded total <NUMBER> times <NUMBER>˚c <NUMBER> times <NUMBER>˚c including series started provide baseline result two working temperatures calculated repeated measurements analysis variances rmanova assess effects working time within subject factor suit b subject factor amount processed tubes amount wrongly screwed arranged tubes task exploratory purposes analysis performed assessment data task ii could evaluated due technical failure plate reading system therefore excluded statistical analyses data task iii calculated descriptive statistics task iv repeated measurements analysis variances rmanova assess effects series within subject factor suit b factor measured reaction time calculated well descriptive analysis graphic chart nineteen volunteers <NUMBER> male <NUMBER> female aged <NUMBER> <NUMBER> years participated study three subjects two suit b one suit terminated study end task series included analyses tasks participated two terminated due indication score <NUMBER> assessment sheet series <NUMBER> paranasal sinus obstruction series <NUMBER> hunger first study day <NUMBER>˚c subjects continued study study day two <NUMBER>˚c one subject assigned suit b resigned study task series <NUMBER>˚c physical stress without giving reason fluid loss fig <NUMBER>c statistically significant suit <NUMBER> kg sd <NUMBER> suit b <NUMBER> kg sd <NUMBER> <NUMBER>˚c ancova p <NUMBER> however higher statistically significant dehydration suit <NUMBER>˚c <NUMBER> kg sd <NUMBER> compared suit b <NUMBER> kg sd <NUMBER> ancova p <NUMBER> ancova showed significant effects suit b working temperature <NUMBER>˚c <NUMBER>˚c body temperature fig <NUMBER>d although slight significant decrease body temperature suit b working temperature <NUMBER>˚c <NUMBER>˚c sd <NUMBER> observed heart rate fig <NUMBER>e showed slight decrease suits <NUMBER>˚c whole duration task series <NUMBER>˚c average increase heart rate <NUMBER> sd <NUMBER> beats per minute wearing suit <NUMBER> sd <NUMBER> beats per minute wearing suit b ancova p <NUMBER> task working temperature amount processed tubes increased significantly series series suits rmanova p <NUMBER> <NUMBER>˚c p <NUMBER> <NUMBER>˚c fig <NUMBER> amount processed tubes significantly higher subjects wearing suit compared suit b <NUMBER>˚c rmanova p <NUMBER> similar tendency observed <NUMBER>˚c rmanova p <NUMBER> amount wrong tubes wrong position wrong cap constantly low suits temperatures heart rate stable whole performance suit b temperatures suit <NUMBER>˚c whereas increase measured suit individuals performing <NUMBER>˚c task iii working rate correctness accuracy discrimination measured evaluated d<NUMBER> test attention following characteristic numbers calculated <NUMBER> items per series maximum number tn total number items processed e error score sum mistakes including e<NUMBER> errors omission e<NUMBER> errors commission ie wrongly identified character wrong dashes wrong letters e calculated proportion errors made e within number items processed tne total number items processed minus error score e cp index concentration performance calculated difference correct items errors commission e<NUMBER> <NUMBER> <NUMBER> number least constant even increased duration working time fig <NUMBER> tne almost constant every participant series increase tne observed first second third series almost participants <NUMBER>˚c working temperature tendency observed <NUMBER>˚c e decreased first four series remained constant <NUMBER> th series <NUMBER> subjects <NUMBER>˚c four subjects showed increase e last two series <NUMBER>˚c trend decreasing e observed subjects wearing suit heart rates <NUMBER>˚c <NUMBER> beats per minute suits <NUMBER>˚c subjects suit showed average increase heart rate <NUMBER> <NUMBER> beats per minute increase obvious subjects wore suit b mean values heart rates calculated subject time point fig <NUMBER>c <NUMBER>d <NUMBER>g <NUMBER>h mean values tne e cp subjects time point calculated connected trend line fig <NUMBER>i <NUMBER>j <NUMBER>k <NUMBER>l trend line cp shows slight increase first last series e clear decrease task iv general reduction reaction time first following series observed suits <NUMBER>˚c rmanova p <NUMBER> fig <NUMBER>a indicating major training effect also improvement series <NUMBER>˚c significantly pronounced suit suit b rmanova interaction p <NUMBER> heart rate subjects wearing suit b <NUMBER>˚c significantly higher suit fig <NUMBER>b mean values showed shorter reaction time fig <NUMBER>c higher heart rate fig <NUMBER>d <NUMBER>˚c compared <NUMBER>˚c assessment individual perception comfort general condition assessment sheets comprised fifteen different statements individual perception comfort general condition documented range <NUMBER> low interference <NUMBER> high interference leading termination study assessment sheets completed task series <NUMBER>˚c <NUMBER>˚c respectively fig <NUMBER> <NUMBER>˚c found major effects parameters dizziness thirst concentration restricted respiration need toilet break urinary urgency impact wearing ppe health care fine motor skills mobility problems considerable significant differences seen temperature perception sweating headache hunger pronounced suit view considered restricted flexible face shield suit b fixed shield suit rmanova p <NUMBER> <NUMBER>˚c difference became pronounced proceeding working time rmanova interaction p <NUMBER> back pain noted pronounced suit b suit parameter show statistical significance p <NUMBER> <NUMBER>˚c working temperature view rated restricted suit b compared suit rmanova p <NUMBER> discomfort due sweat increased suits p <NUMBER> significantly suit suit b rmanova interaction p <NUMBER> still tolerable based facts wearing full body suits poweredairpurifyingrespirators papr protect exposure pathogens constrict mobility view cause heat stress tested whether restraints could impact example concentration increase error rates due fatigue combined evaluation biophysical conditions working performance test persons provide data usability ppe easily widely implemented health care biohazard protection <NUMBER> measurable physical parameters example fluid loss dependent working temperature <NUMBER>˚c average loss fluid higher although statistically significant fig <NUMBER>c unexpected observation slight statistically significant decrease body temperature subjects wearing total body ventilated suit b <NUMBER>˚c head ventilated suit although tympanic infrared body temperature measurement may show variability decrease might indicate cooling effect due continuous ventilation whole suit <NUMBER> hours <NUMBER>˚c difference observed <NUMBER>˚c mean body temperature suits fig <NUMBER>d increase body temperature <NUMBER>˚c sign dangerous heat stress <NUMBER> observed conditions tested decrease heart rates <NUMBER>˚c however show statistical significance expected physiological outcome could indicate impact wearing ppe health care certain stress level donning equipment first time leading increased heart rates beginning study decreased adaptation conditions increased heart rates <NUMBER>˚c suits indicate increased heat stress expected fig <NUMBER>e however increase body temperature well fluid loss perceived according individual perception moderate high stress limiting factor even <NUMBER> hours working high temperature <NUMBER>˚c analysis task suits working temperatures revealed increase correct tubes consequently better ratio total wrong tubes increasing numbers task series <NUMBER> <NUMBER> hours working respectively indicates effects fatigue less impact training effect experimental conditions since training effect also seen second series tasks performed another day higher temperature <NUMBER>˚c conclude training effects interfere general results tasks performed rather serve relative indicator stress fatigue intensity however tendency towards differences suit b respect total number correctly processed tubes higher suit difference likely explained improved dexterity due better fitting gloves suit b shown assessment fine motor skills fig <NUMBER> fine motor skills similar observations task made d<NUMBER> test task iii individual performances fig <NUMBER>a <NUMBER>b <NUMBER>e <NUMBER>f demonstrated subjects decreased errors red bars raised index concentration green bars increasing numbers task series fig <NUMBER>i <NUMBER>j <NUMBER>k <NUMBER>l significant differences performance d<NUMBER> test observed neither two suit types two working temperatures results reaction test task iv also demonstrated fatigue effects less pronounced training effects showing continuous decrease reaction times increasing number task series test required physical activity low reaction time indicated ambitious activity corresponded high heart rates parameters mirrored higher temperature perception heart rate subjects wearing suit b <NUMBER>˚c higher suit fig <NUMBER>b could attributed either increased physical activity indicated shorter reaction time increased work load exercising fully ventilated suit suit b surprisingly mean values reaction times fig <NUMBER>c suits showed lower reaction times <NUMBER>˚c <NUMBER>˚c assessment restrictions discomfort due different suit types revealed suit b restricted view caused flexible face shield relevant parameter furthermore respiration system worn rucksack led back pain contrast study participants reported suit increased temperature sweating pronounced factors expected suit head ventilation none parameters reduced performance result earlier termination study evaluate maximum possible working time since six hours <NUMBER>˚c four hours <NUMBER>˚c longer maximum allowed working periods typically maximal four hours <NUMBER>˚c positive pressure suited bsl<NUMBER> laboratories limitation must acknowledged <NUMBER> <NUMBER> subjects allocated suit <NUMBER> <NUMBER> subjects allocated suit b indicated previous experience ppe general precisely use kind protective suits without papr study use papr providing constant ventilation cooling head might increased tolerability heat stress probably would case face masks unpowered respirators <NUMBER> comparison papr devices focus study preferred use papr underlined increased safety due reduced risk unintentional contamination face papr also recommended us centers disease control prevention public health agency canada protect airborne infections eg tuberculosis ebola virus disease toxic aerosol generating procedures <NUMBER> however reports part contradictory conclusions concerning possible restrictions caused papr studies <NUMBER>s <NUMBER> <NUMBER> <NUMBER> stated change cognitive performance wearing respirators contradicting study <NUMBER> <NUMBER> ascertained significant effect errors made cognitive tasks wearing fullface respirator conclusion suit types well tolerated performing different tasks related sample processing analyses necessary protection hcws ppe required combined evaluation physical parameters subjective perception restrictions discomfort task series informative identifying limiting factors working different types ppe generate trust confidence personnel working ppe furthermore data generated impact wearing ppe prolonged stressful working conditions error rates considered defining working procedures safety measures study add data impact ppe health care worker performance comfort may value future pandemics table subject´s raw data table provides general information subjects measured performance data tasks iv data recorded assessment sheets first cases pneumonia due novel betacoronavirus first identified december <NUMBER> wuhan china <NUMBER> later named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus causes coronavirus disease <NUMBER> covid <NUMBER> infected hundreds thousands across <NUMBER> continents <NUMBER> overall casefatality rate covid<NUMBER> remains flux initially reported <NUMBER> mainland china italy reported casefatality rate <NUMBER> <NUMBER> <NUMBER> note casefatality rates reportedly higher patients preexisting cardiovascular disease <NUMBER> transmission sarscov<NUMBER> occurs persontoperson spread respiratory droplets selfinoculation contact virus contaminated surfaces disease incubation period approximately <NUMBER> days <NUMBER> common signs symptoms covid<NUMBER> include fever dry cough shortness breath myalgia however patients present gastrointestinal eg diarrhea nausea vomiting neurological eg headache hypogeusia hyposmia symptoms <NUMBER> <NUMBER> cardiovascular complications myocarditis acute myocardial infarction heart failure reported previously observed acute upper respiratory infections eg influenza <NUMBER> extensive discussion complications relationship covid<NUMBER> described elsewhere <NUMBER> currently established treatment vaccine sarscov<NUMBER> several antiviral immunomodulating therapies used clinical investigation sarscov<NUMBER> infection seems lead severe disease patients elderly comorbidities <NUMBER> review provide overview pharmacology cardiovascular considerations promising therapies investigated use patients covid<NUMBER> particular consideration treatment sarscov<NUMBER> infection may particularly challenging patients risk cardiovascular diseases fig <NUMBER> complete understanding covid<NUMBER> lacking reports china italy describe <NUMBER> phases disease <NUMBER> <NUMBER> initial phase primarily infection characterized predominantly lower respiratory symptoms patients recover however patients progress immunemediated respiratory failure leading acute respiratory distress syndrome ards multiple organ failure associated high mortality rate <NUMBER> early approaches treatment involved antiviral therapies aimed reducing viral replication representing main pathogenetic mechanism least early phase immunomodulatory therapies targeting inflammatory response leads ards also explored important recognize time lowquality data support use therapy covid<NUMBER> field evolving rapidly therefore review considered comprehensive summary current approaches prevention treatment described figure <NUMBER> important consider patients greatest risk covid<NUMBER>related mortality aggressive treatment considered also receiving concomitant cardiovascular therapies therefore drugdrug interactions must considered accounted managing cardiovascular patients covid<NUMBER> table <NUMBER> sarscov<NUMBER> rna betacoronavirus uses glycosylated spike protein gain host cell entry <NUMBER> single region spiked protein receptorbinding domain binds patients covid<NUMBER> increase metabolic demand occurs along progressive decrease cardiac contractility cardiac reserve responsible acute cardiovascular complications decompensation chronic cardiovascular disorders well covid<NUMBER> characterized severe systemic inflammation procoagulant effect may pave way thrombotic events impair immune response leading myocardial injury interestingly individuals history cardiovascular disease hypertension diabetes higher risk develop aggressive potentially lifethreatening disease currently available drugs evaluation may important implications cardiovascular health care providers many agents significant drugdrug interactions cardiovascularrelated side effects acute chronic figure partially created using servier medical art templates licensed creative commons attribution <NUMBER> unported license httpssmart serviercom cv cardiovascular doac direct oral anticoagulants investigational approach covid<NUMBER> management important recognize time approved therapies covid<NUMBER> preventative approaches critical prevent persontoperson spread include social physical distancing proper hygiene patients covid<NUMBER> positive either asymptomatic mild symptoms selfquarantine <NUMBER> weeks receive supportive care home overburden health care system patients severe illness eg worsening shortness breath may receive one several investigational therapies oxygen therapy minority patients require intensive care ventilation may appropriate candidates therapies aimed preventing cytokine storm blunt inflammatory response hostcell receptor host protease cleaves spike allows virus entry host cell humans sarscov<NUMBER> uses angiotensinconverting enzyme ii ace<NUMBER> entry receptor <NUMBER> thus antiviral therapies either interrupt replication sarscov<NUMBER> <NUMBER> eg remdesivir prevent viruscell fusion glycosylation cellular receptors sarscov<NUMBER> necessary binding ace<NUMBER> <NUMBER> eg chloroquine investigated potential treatments antimalarial agents hydroxychloroquine chloroquine commonly used treat autoimmune diseases systemic lupus erythematosus rheumatoid arthritis disrupt immune activation cellular level inhibiting innate adaptive immune responses addition impairing endosomal lysosomal acidification required viruscell binding therapies may exert antiviral activity <NUMBER> vitro studies suggest chloroquine may potent inhibiting sarscov<NUMBER> hydroxychloroquine hydroxychloroquine seems less toxic <NUMBER> hydroxychloroquine administered orally loading dose <NUMBER> mg twice daily followed maintenance dose <NUMBER> mg twice daily <NUMBER> days <NUMBER> electrocardiogram ecg monitoring recommended watch cardiac arrhythmias including qt prolongation torsade de pointe atrioventricular block <NUMBER> reduction dose discontinuation considered qtc <NUMBER> ms increase qtc <NUMBER> ms caution advised used together therapies prolong qtc especially antiarrhythmics antimalarialinduced hypertrophic restrictive cardiomyopathy also occur exceedingly rare occurs prolonged use concern given short duration <NUMBER> days treatment required covid<NUMBER> <NUMBER> chloroquine hydroxychloroquine also inhibit cyp<NUMBER>d<NUMBER> may increase betablocker exposure risk bradycardia pr interval prolongation atrioventricular block potential adverse effects include severe hypoglycemia erythroderma hematological psychiatric disturbances thus routine monitoring include complete blood count comprehensive metabolic panel small pilot study <NUMBER> randomized <NUMBER> patients either intervention hydroxychloroquine <NUMBER> mg daily <NUMBER> days conventional therapy day <NUMBER> patients tested respiratory pharyngeal swab evidence covid<NUMBER> nucleic acid difference number negative swabs hydroxychloroquine n <NUMBER> control n <NUMBER> groups p <NUMBER> favorable trends observed secondary measures including duration hospitalization body temperature regulation radiological progression another small singlearm study effects hydroxychloroquine <NUMBER> mg daily hospitalized patients presence absence virus day <NUMBER> studied <NUMBER> twentysix french subjects received protocol <NUMBER> served controls six stopped hydroxychloroquine therapy early due either transferred intensive care unit n <NUMBER> leaving hospital n <NUMBER> death n <NUMBER> nausea n <NUMBER> day <NUMBER> treatment <NUMBER> hydroxychloroquinetreated patients virologically cured compared <NUMBER> control group p <NUMBER> addition macrolide antibiotic azithromycin hydroxychloroquine significantly effective virus elimination <NUMBER> cure rate suggesting combination may superior hydroxychloroquine alone authors published preprint <NUMBER> larger sample n <NUMBER> patients received combination hydroxychloroquine azithromycin showing clinical improvement <NUMBER> patients authors report <NUMBER> subjects required oxygen therapy <NUMBER> negative nasopharyngeal viral load day <NUMBER> length stay limited average <NUMBER> days despite favorable outcomes reported observational studies proper randomized controlled trial warranted definitive decisions made regarding role therapies treating covid<NUMBER> although mechanism azithromycin would effective patients covid<NUMBER> azithromycin found antiviral antiinflammatory effects vivo vitro studies <NUMBER> <NUMBER> <NUMBER> azithromycin also activity proinflammatory cytokines interleukin il<NUMBER> il<NUMBER> may reduce development cytokine storm warrants study <NUMBER> one potential concern however concomitant antimalarial therapy azithromycin potential qtc prolongation warranting daily ecg monitoring <NUMBER> although macrolides demonstrated similar effects azithromycin minimally inhibits cyp<NUMBER>a<NUMBER> others eg erythromycin clarithromycin strong inhibitors cyp<NUMBER>a<NUMBER> well tolerated azithromycin time data supporting combination hydroxychloroquine azithromycin covid<NUMBER> limited given potential significant toxicity use regimen considered caution also suggested may role hydroxychloroquine chloroquine used prophylaxis highrisk individuals health care workers therefore chloroquine studied potential preventative measure covid<NUMBER> health care workers individuals highrisk environments nct<NUMBER> participants randomized placebo chloroquine loading dose <NUMBER> mgkg followed <NUMBER> mg daily <NUMBER> months primary outcome number covid<NUMBER> cases <NUMBER> days time however little evidence pharmacological measures reduce transmission sarscov<NUMBER> health care workers highrisk individuals remdesivir gilead sciences inc foster city ca nucleotide analog prodrug broad antiviral activity initially used ebola <NUMBER> vivo vitro testing shown inhibit human coronavirus replication including sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> <NUMBER> remdesivir initially available compassionate use received orphan drug status us food drug administration fda march <NUMBER> <NUMBER> recommended dosing initial single dose <NUMBER> mg intravenously followed <NUMBER> mg every <NUMBER> hours duration hospitalization <NUMBER> days <NUMBER> several phase <NUMBER> clinical trials underway united states south korea china europe nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> <NUMBER> two larger ongoing multicenter clinical trials nct<NUMBER> nct<NUMBER> evaluating remdesivir hospitalized patients moderate n <NUMBER> severe n <NUMBER> symptoms yet requiring mechanical ventilation patients studies randomized <NUMBER> <NUMBER> days remdesivir additional standard care arm moderate disease trial focus discharge fever oxygen saturation <NUMBER> days patients severe symptoms requiring mechanical ventilation must pursue individual compassionate use protocols receive access remdesivir importantly trials cardiovascularspecific reasons exclusion overall remdesivir generally well tolerated selflimiting hepatotoxicity observed nephrotoxicity also possible thus use recommended patients estimated glomerular filtration rate <NUMBER> mlmin<NUMBER> <NUMBER> dialysis monitoring recommendations include complete blood count differential comprehensive metabolic panel limited information available time regarding potential drugdrug interactions remdesivir information clinical trial protocol nct<NUMBER> suggests remdesivir prodrug metabolized active form substrate cyp<NUMBER>a<NUMBER> remdesivir substrate cyp<NUMBER>c<NUMBER> cyp<NUMBER>d<NUMBER> cyp<NUMBER>a<NUMBER> vitro yet also states coadministration drugs affect cyp isoforms unlikely significantly affect metabolism remdesivir lopinavir protease inhibitor primarily used treatment hiv combined ritonavir another protease inhibitor also inhibits cyp<NUMBER>a<NUMBER> combined lopinavir enhance potency <NUMBER> cardiovascular perspective lopinavirritonavir induce endothelial dysfunction insulin resistance however cause hypertriglyceridemia <NUMBER> <NUMBER> retrospective singlecenter study suggests ritonavirboosted regimens may worsen cardiovascular outcomes patients hiv heart failure <NUMBER> importantly data sufficient restrict use lopinavirritonavir patients cardiovascular disease heart failure given lifethreatening potential covid<NUMBER> shortterm <NUMBER> weeks duration treatment notable drugdrug interactions lopinavir ritonavir select cardiovascular therapies ritonavir potent inhibitor cyp<NUMBER>a<NUMBER> pglycoprotein mdr<NUMBER> <NUMBER> may result increased concentrations cardiovascular therapies metabolized cyp<NUMBER>a<NUMBER> rivaroxaban apixaban simvastatin lovastatin used combination ritonavir <NUMBER> <NUMBER> likewise ritonavir inhibits bioactivation clopidogrel prasugrel may decrease antiplatelet activity however may affect antiplatelet activity prasugrel making still reasonable option <NUMBER> <NUMBER> ticagrelor used strong inhibitors cyp<NUMBER>a<NUMBER> ritonavir due increased risk bleeding <NUMBER> <NUMBER> use p<NUMBER>y<NUMBER> platelet function assays may appropriate ensure adequate antiplatelet activity gastrointestinal symptoms eg nausea vomiting diarrhea elevations hepatic transaminases also occur routine monitoring includes complete blood count comprehensive metabolic panel baseline ecg recommended used concomitant agents eg antiarrhythmics prolong qt interval recently <NUMBER> hospitalized patients severe covid<NUMBER> disease randomized either fixed dose lopinavirritonavir <NUMBER> <NUMBER> mg respectively twice daily <NUMBER> days standard care <NUMBER> intervention improve time clinical improvement mortality although study underpowered detect mortality benefit gastrointestinal complaints nausea vomiting diarrhea also common <NUMBER> patients discontinued therapy due adverse events additional clinical trials ongoing including one clinical trial comparing lopinavir ritonavir hydroxychloroquine nct<NUMBER> another clinical trial comparing lopinavirritonavir remdesivir <NUMBER> patients covid<NUMBER> note interferonbeta may also used combination lopinavirritonavir shown improve pulmonary function reduce viral loads marmosets mice middle east respiratory syndrome coronavirus yet evaluated humans <NUMBER> <NUMBER> immune modulators patients severe infection may progress severe respiratory failure due ards mediated catastrophic inflammatory cascade <NUMBER> <NUMBER> early observations china italy led widespread use tocilizumab fully humanized monoclonal antibody interleukin<NUMBER> receptor il<NUMBER>r <NUMBER> <NUMBER> although originally fda approved use rheumatoid arthritis tocilizumab routinely used treatment cytokine release syndrome secondary chimeric antigen receptor tcell therapy hematologic malignancies <NUMBER> observational series patients severe respiratory symptoms china showed recovery <NUMBER> <NUMBER> treatment tocilizumab <NUMBER> mgkg iv maximum dose <NUMBER> mg <NUMBER> emerging treatment protocols recommend aggressive doses <NUMBER> mgkg <NUMBER> mg repeated doses <NUMBER> <NUMBER> hours patients showing inadequate responses primary risks tocilizumab relate immunosuppression neutropenia interruption tcellmediated immunity infusion reactions transient transaminase elevations may also occur frequently although tocilizumab significantly increases cholesterol levels blood pressure recent network metaanalysis found cardiovascular risk tocilizumab comparable diseasemodifying antirheumatic drugs <NUMBER> regardless given high mortality rate among patients covid<NUMBER>mediated ards <NUMBER> potential benefits shortterm tocilizumab use seem outweigh risks treatment patients parallels inflammatory pathophysiology chimeric antigen receptor tcell therapymediated cytokine release syndrome covid<NUMBER>mediated ards suggest il<NUMBER> suppression key advancement treatment severe covid<NUMBER> infection sarilumab regeneron pharmaceuticals inc tarrytown ny il<NUMBER> blocker currently market tocilizumab unavailable however limited evidence guide selection dosing agents time urgent public health priority combat covid<NUMBER> future develop safe effective vaccine widespread vaccination could also play role modulating cardiovascular risk similar observed influenza thus importance identifying safe effective vaccine <NUMBER> first phase <NUMBER> clinical trial nct<NUMBER> evaluating vaccine covid<NUMBER> mrna<NUMBER> began march <NUMBER> <NUMBER> sponsored national institutes health openlabel study enroll <NUMBER> healthy adults <NUMBER> <NUMBER> years <NUMBER> weeks although <NUMBER> vaccine candidates pipeline unlikely vaccine available least <NUMBER> increased concern regarding use ace inhibitors angiotensin receptor blockers arbs patients due potential ace inhibitors arbs upregulate ace<NUMBER> receptors found vascular endothelial cells heart kidneys lungs shown host cell entry point sarscov<NUMBER> <NUMBER> thus theoretical increased risk covid<NUMBER> patients taking medications also seems sarscov<NUMBER> consumes ace<NUMBER> increases angiotensin<NUMBER> at<NUMBER> activity activates inflammatory response resulting microvascular constriction ischemic injury <NUMBER> moreover sarscov led downregulation ace<NUMBER> severe lung injury mice could theoretically attenuated administration arb <NUMBER> mice lacking ace<NUMBER> also shown worse outcomes influenza h<NUMBER>n<NUMBER> infection <NUMBER> observational evidence suggests ace inhibitors arbs may reduce risk pneumonia <NUMBER> given limited data available supporting either harm benefit multiple professional organizations released statements provide guidance joint statement heart failure society america american heart association american college cardiology recommends add remove raasrelated treatments beyond actions based standard clinical practice calls research area <NUMBER> likewise council hypertension european society cardiology also released position statement recommending physicians patients continue treatment usual antihypertensive therapy clinical scientific evidence suggest treatment acei arbs discontinued covid<NUMBER> infection <NUMBER> help determine potential role harm ace inhibitors arbs <NUMBER> randomized multicenter clinical trials underway patients presumptive positive test covid<NUMBER> require hospitalization already taking ace inhibitor arb randomized either losartan <NUMBER> mg daily placebo nct<NUMBER> primary outcome study sequential organ failure assessment respiratory score used determine risk mortality respiratory failure similarly designed study nct<NUMBER> compare losartan <NUMBER> mg daily placebo patients test positive covid<NUMBER> require hospitalization primary outcome study hospitalization rates <NUMBER> days addition ace inhibitors arbs ibuprofen purported recent correspondence also increase ace<NUMBER> potentially risk worsening covid<NUMBER> <NUMBER> despite definitive evidence supporting claim promoted french health minister social media <NUMBER> although world health organization originally backed claim later retracted advice recommend nonsteroidal antiinflammatory drug nsaid use <NUMBER> european medicines agency <NUMBER> fda <NUMBER> also confirmed lack evidence support link nsaids worsening covid<NUMBER> regardless nsaids still avoided patients cardiovascular disease especially heart failure renal disease increase bp cause fluid retention well established statins vascular myocardial antiinflammatory effects may exert potential benefit patients acute viral respiratory infections <NUMBER> observational studies reported improvement cardiovascular outcomes even mortality statintreated patients influenza pneumonia however healthy user bias could contributing factor findings <NUMBER> <NUMBER> randomized controlled trial data limited found conflicted results <NUMBER> <NUMBER> importantly reported harm associated statin use patients supports continued use statins patients indication statin therapy established cardiovascular disease diabetes highrisk features particularly true given higher mortality rates observed covid<NUMBER> patients cardiovascular cardiometabolic comorbidities previously discussed however dose reductions therapy substitutions may warranted patients receive lopinavirritonavir treatment statin therapy table <NUMBER> rare instances patients covid<NUMBER> may develop rhabdomyolysis acute liver injury would require prompt statin discontinuation spectrum covid<NUMBER> disease ranges mild severe well described elsewhere <NUMBER> patients risk cardiovascular disease particular high risk severe illness mortality <NUMBER> myocardial injury witnessed elevation troponin levels common patients covid<NUMBER> <NUMBER> <NUMBER> likely reflect demand supply mismatch type ii myocardial infarction septic cardiomyopathy specific therapy recommended attempting optimize oxygen supply delivery demand much possible intervening pulmonary hematologic cardiac vascular systems increased troponin identifies patients severe covid<NUMBER> associated high mortality whether myocardial injury reflects specific pathologic mechanism disease subgroup patients severe disease unclear <NUMBER> anecdotal cases myocarditis reported <NUMBER> <NUMBER> seem rare elevation ddimer levels <NUMBER> suggests activation coagulation cascade patients covid<NUMBER> however increase thrombosis disseminated intravascular coagulation widely reported regardless anticoagulation unfractionated heparin enoxaparin patients markedly elevated ddimer levels considered although precise recommendations challenging given lack evidence recently international society thrombosis haemostasis released pragmatic statement recommending clinicians measure ddimers prothrombin time platelet count patients covid<NUMBER> <NUMBER> furthermore also recommend prophylactic dose low molecular weight heparin patients including critically ill barring contraindications additional study warranted understand anticoagulation needs patients covid<NUMBER> patients covid<NUMBER> experience acute coronary syndrome access emergency coronary angiography become restricted instances fibrinolysis become firstline therapy lower risk stsegment elevation patients preserve personal protective equipment prevent spread infection across different areas hospital hospitals also develop protocols stsegment elevation management patients covid<NUMBER> collaboration infection prevention departments optimize patient management reducing risk patient health care worker transmission patients heart failure reduced ejection fraction careful review medical treatments considered case initiation aforementioned investigational drugs treat covid<NUMBER> possible guidelinedirected medical therapy continued additional monitoring warranted lopinavirritonavir may modestly affect ace inhibitors arbs sacubitrilvalsartan levels increase warranting close monitoring bp lopinavirritonavir increase levels betablockers warranting ecg monitoring potentially dose downtitration hydroxychloroquine chloroquine may reduce levels betablocker require dose uptitration <NUMBER> among mineralocorticoid receptor antagonists spironolactone safely used lopinavirritonavir whereas eplerenone mainly metabolized cyp<NUMBER>a<NUMBER> coadministered reason coadministration ivabradine lopinavirritonavir avoided digoxin levels followed closely patients lopinavirritonavir hydroxychloroquine chloroquine limited contact others minimize spread sarscov<NUMBER> epidemic phase disease advised usually implies rescheduling routine followup visits options include use telehealth conduct brief focused remote visits postponement visits stable patients regardless additional considerations managing patients home blood pressure monitoring devices weight scales heart failure telemonitoring remote equipment offered possible augment telehealth visits equipment may require training patients health care providers also may reveal unequal access resources reinforcing heart healthy lifestyle stress management also important given inherent impact social distancing quarantine pandemic daily routines mental health additional medicationrelated considerations include ensuring patients sufficient refills prescribing longer supply maintenance medications represent potential challenges social isolation pandemic closing sarscov<NUMBER> novel virus spread rapidly throughout world causing potentially lifethreatening disease covid<NUMBER> causing disproportionally high mortality among elder patients concomitant pulmonary cardiovascular diseases although approved therapies currently exist multiple collaborative efforts underway identify effective therapies vaccine prevent future infection cardiovascular clinicians however may accustomed concomitant use antivirals immunomodulators patients thus need understand therapies might impact underlying cardiovascular conditions medications despite significant morbidity mortality associated covid<NUMBER> immense opportunity enhance understanding prevent treat emerging infections well improve understanding relationship infection immune response cardiovascular disease acute heart failure ahf lifethreatening condition typically mandates admission hospital urgent investigation treatment england wales ahf cited primary diagnosis <NUMBER> admissions <NUMBER> associated inhospital mortality <NUMBER> <NUMBER> furthermore among patients surviving discharge <NUMBER>year mortality <NUMBER> <NUMBER> several wellestablished factors associated <NUMBER>year postdischarge mortality broadly grouped three categories patient characteristics reflecting severity hf eg age nyha class left ventricular function hospitalization factors including specialist cardiology input initiation therapy heart failure reduced ejection fraction hfref length stay followup arrangements <NUMBER> shown repeatedly <NUMBER>year mortality lower patients admitted cardiology wards compared general medical wards well receiving specialist multidisciplinary heart failure hf management receiving optimal medical therapy hfref admission <NUMBER> <NUMBER> covid<NUMBER> pandemic global public health emergency high burden healthcare systems including nhs england wales mandated rapid redirection services manage influx patients covid<NUMBER> especially true london experienced highest burden covid<NUMBER> uk transformation included cessation routine treatment facetoface followup many conditions reduce risk infection atrisk groups create extra capacity personnel beds furthermore concurrent decline patients presenting many acute medical conditions including acute coronary syndromes acs <NUMBER> <NUMBER> date little known whether similar trends apparent ahf whether patient hospitalization followup factors predict outcomes changed current crisis also known article protected copyright rights reserved covid<NUMBER> contributed increase ahf admissions respiratory illness well known contribute hf decompensation <NUMBER> therefore present study compared patients presenting ahf tertiary heart failure unit london teaching hospital marchapril <NUMBER> period <NUMBER> aimed compare cohorts respect factors associated outcome described including absolute hospitalization rates patient characteristics management index admission hypothesized incidence hospitalization ahf would decline covid<NUMBER> pandemic inpatient management followup arrangements would worse pandemic compared corresponding period <NUMBER> numbers consecutive patients hospitalized ahf kings college hospital <NUMBER> nd march <NUMBER> date first coronavirus death england <NUMBER> th april compared hospitalization numbers number weeks study period corresponding time periods <NUMBER> next performed detailed comparison patients hospitalized covid<NUMBER> pandemic patients presenting period <NUMBER> finally examined hospital admissions diagnosis hf second position comparing study period period <NUMBER> ascertain whether patients admitted ahf secondary covid<NUMBER> heart failure unit hospital provides comprehensive multidisciplinary hf care inpatient outpatient settings including electronic referral service allow daily review admissions hospital hf consultant cardiologist irrespective place admission nurse education inpatients advice regarding optimal medical therapy facilitation followup post discharge service operated normally pandemic period patients admitted hospital via emergency department patients less <NUMBER> years age excluded analysis variables extracted local national heart failure audit nhfa data nhfa collects data relating ahf hospitalizations nhs trusts england health boards wales patients entered audit primary discharge diagnosis ahf based appropriate icd codes i<NUMBER> hypertensive heart disease congestive heart failure i<NUMBER> ischaemic cardiomyopathy i<NUMBER> dilated cardiomyopathy i<NUMBER> cardiomyopathy unspecified i<NUMBER> congestive heart failure i<NUMBER> left ventricular failure i<NUMBER> heart failure unspecified data interrogated study mandatory fields nhfa collected including demographics presenting symptoms signs comorbidities diagnostic tests place care specialist input length stay prescribing hfref inhospital mortality standard dataset used nhfa available nicor httpswwwnicororguknationalcardiacauditprogrammedatasets primary outcome rate hospitalization ahf secondary outcomes place care rates specialist input discharge medication hfref inhospital mortality demographic baseline characteristics study populations compared using pearson chi square test categorical variables student test parametric mann whitney u test nonparametric continuous variables oneway anova multiple comparisons normality distribution assessed shapirowilks test continuous variables reported means standard deviation median interquartile range appropriate categorical variables reported numbers percentage incidence rates primary article protected copyright rights reserved accepted article outcome heart failure hospitalizations per <NUMBER> people per week calculated dividing number cumulative events per week catchment population kings college hospital incidencerate ratios irr comparing exposed <NUMBER> unexposed <NUMBER> period calculated using poisson regression model number heart failure hospitalizations per week quadratic term used fit hospitalization trends exposed unexposed cohorts compared means extrasumofsquare f test gaussian fitting employed plot daily number covid<NUMBER> cases analyses conducted using spss statistics software version <NUMBER> ibm corp ny usa stata software version <NUMBER> statacorp tx usa r r project statistical computing study period identified <NUMBER> patients hospitalized kings college hospital ahf primary diagnosis significantly lower number admissions precovid period years <NUMBER> fig <NUMBER> furthermore relative risk hospitalization decreased time compared corresponding time period <NUMBER> fig <NUMBER> patients primary diagnosis ahf also diagnosis covid<NUMBER> patient baseline characteristics according exposure group shown table <NUMBER> patients similar mean age ahf admission <NUMBER>±<NUMBER> years <NUMBER> vs <NUMBER>±<NUMBER> years <NUMBER> similar proportions women <NUMBER> vs <NUMBER> respectively similar ethnicity <NUMBER> vs <NUMBER> respectively overall comorbidities cardiovascular risk factors similar patients presenting year table <NUMBER> although fewer patients <NUMBER> preexisting significant valve disease <NUMBER> vs <NUMBER> p<NUMBER> furthermore similar proportions presented decompensated hfref <NUMBER> vs <NUMBER> hfpef <NUMBER> vs <NUMBER> consistent overall nhfa data <NUMBER> article protected copyright rights reserved observed patients hospitalized <NUMBER> higher proportion nyha class iii iv symptoms <NUMBER> vs <NUMBER> p<NUMBER> severe peripheral oedema <NUMBER> vs <NUMBER> p<NUMBER> table <NUMBER> inhospital management patients similar centre <NUMBER> <NUMBER> fewer patients admitted cardiology wards <NUMBER> vs <NUMBER> reviewed heart failure hf specialists <NUMBER> vs <NUMBER> <NUMBER> compared <NUMBER> findings significant table <NUMBER> moreover length stay <NUMBER> <NUMBER> <NUMBER> <NUMBER> days <NUMBER> vs <NUMBER> iqr <NUMBER> days <NUMBER> multidisciplinary hf team followup <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> unchanged two cohorts observe differences discharge medication <NUMBER> <NUMBER> similar proportions discharged evidencebased therapy hfref table <NUMBER> furthermore observed difference discharge daily diuretic dose <NUMBER>±<NUMBER> mg <NUMBER> vs <NUMBER>±<NUMBER> mg <NUMBER> p<NUMBER> inhospital mortality low years precluded statistical comparison inpatient mortality rates significantly lower nhfa average last eight years finally one patient covid<NUMBER> primary diagnosis hf second diagnostic position identified seven patients hospitalized hf secondary diagnosis study period significantly lower <NUMBER> seen <NUMBER> p<NUMBER> <NUMBER> fig <NUMBER> impact covid<NUMBER> pandemic acs reported <NUMBER> <NUMBER> little known effects admission management patients ahf report significant decline hospitalization rates ahf covid<NUMBER> pandemic compared pandemic preceding three years compared period <NUMBER> relative risk hospitalization ahf progressively reduced covid<NUMBER> pandemic true hf diagnoses second position one patient coexisting diagnosis covid<NUMBER> despite known increase covid<NUMBER> among patients cardiovascular comorbidity <NUMBER> unknown incidence ahf declined findings reflect reluctance attend hospital although similar reports acs suggest latter <NUMBER> <NUMBER> observed higher proportion black patients reported ahf cohorts reflects local population example study using clinical practice research datalink cprd reported <NUMBER> incident hf cases among caucasians <NUMBER> compared <NUMBER> patients general unwell higher rates nyha class iii iv symptoms severe peripheral oedema known predictors poor outcomes ahf <NUMBER> <NUMBER> following admission inhospital management similar two cohorts observe difference discharge daily diuretic dose although may reflect inhospital treatment similarly observed significant difference rates specialty input main place care length stay pharmacological management hfref reflects fact continued provide comprehensive inpatient care model pandemic however despite early experience suggests trend towards patients managed general medical wards fewer receiving specialist hf input taken together data might suggest patients less severe ahf avoided presenting hospital although unable confirm study national lockdown social distancing restrictions may reduced respiratory tract infections common trigger hf decompensation however unlikely would account decline patients milder symptoms evidence outcome patients decompensated hf managed community expected translate subsequent increase hf hospitalization mortality likely exacerbated known decline acs presentations period doubt lead increase prevalence incidence hf months come based findings imperative carefully examine longitudinal primary care hospitalization mortality data heart failure ascertain reasons implications shift towards fewer sicker patients hospitalized ahf<NUMBER> likely analyses including comparison different models care covid<NUMBER> pandemic help inform response future public health emergencies nhfa well established registry sets performance standards hospitals constitutes optimal hf care well mechanism remuneration hospitals achieving key performance indicators best practice tariff submission least <NUMBER> primary admissions hf audit making sure <NUMBER> receive specialist care admission furthermore singlecentre study dataset accurate reliable low levels missing data however work usual limitations observational data including potential bias result unmeasured residual confounding fact observed differences may due unmeasured variables moreover results may generalizable heart failure units report associations year presentation rather causal relationships patients presenting different times may differ respect unrecorded variables report decline ahf hospitalization centre covid<NUMBER> pandemic hospitalized patients severe symptoms studies needed investigate whether incidence ahf truly declined patients present hospital importance heart injury easily induced viral infection adenovirus enterovirus however whether coronavirus disease <NUMBER> covid<NUMBER> causes heart injury hereby impacts mortality yet fully evaluated objective explore whether heart injury occurs covid<NUMBER> admission hereby aggravates mortality later design setting participants singlecenter retrospective cohort study including <NUMBER> covid<NUMBER> patients admitted december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> wuhan jinyintan hospital china follow completed february <NUMBER> <NUMBER> exposures high levels heart injury indicators admission hstni ck ckmb ldh αhbdh main outcomes measures mortality hospital days admission mortality survival days results <NUMBER> patients covid<NUMBER> mean age <NUMBER> years standard deviation <NUMBER> range <NUMBER> years <NUMBER> <NUMBER> male increased hstni levels admission tended occur older patients patients comorbidity especially hypertension high hstni admission ≥ <NUMBER> pgml even within clinical normal range <NUMBER> pgml already associated higher mortality high hstni associated increased inflammatory levels neutrophils il<NUMBER> crp pct decreased immune levels lymphocytes monocytes cd<NUMBER> cd<NUMBER> cells ck associated mortality increased ckmb levels tended occur male patients patients current smoking high ckmb admission associated higher mortality high ckmb associated increased inflammatory levels decreased lymphocytes increased ldh αhbdh levels tended occur older patients patients hypertension high ldh αhbdh admission associated higher mortality high ldh αhbdh associated increased inflammatory levels decreased immune levels hstni level admission negatively correlated survival days r <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> ldh level admission negatively correlated survival days r <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> conclusions relevance heart injury signs arise covid<NUMBER> especially older patients patients hypertension male patients current smoking covid<NUMBER> virus might attack heart via inducing inflammatory storm high levels heart injury indicators admission associated higher mortality shorter survival days covid<NUMBER> patients signs heart injury admission must early identified carefully managed cardiologists covid<NUMBER> never confined respiratory injury heart injury signs associated higher earlier mortality coronavirus disease <NUMBER> covid<NUMBER> invasion process requires protein priming facilitated host cell produced serine protease tmprss<NUMBER> <NUMBER> interaction viral spike protein ace<NUMBER> host cell surface significant interest since initiates infection process reported binding affinity sarscov<NUMBER> protein ace<NUMBER> <NUMBER>−<NUMBER> times higher sarscov protein <NUMBER> <NUMBER> hence speculated may contribute reported higher transmissibility contagiousness sarscov<NUMBER> compared sarscov <NUMBER> rapid increase confirmed cases makes prevention control covid<NUMBER> extremely serious <NUMBER> <NUMBER> sarscov<NUMBER> virus achieves cell entry spike highaffinity protein binding catalytic domain ace<NUMBER> receptor pneumocytes particularly vulnerable <NUMBER> sarscov influenza preferentially infect type ii cells compared type cells <NUMBER> <NUMBER> <NUMBER> moreover known pneumocytes equally threatened sarscov<NUMBER> infection type ii pneumocytes greater danger really matters short long term prognosis terms acute lung injury pulmonary fibrosis number promising treatments vaccines investigation none proven clinical efficacy time investigator reviewed summarized rapidly evolving data regarding evidence linking covid<NUMBER> increased morbidity mortality cardiovascular disease search methods strategies identification studies literature search performed reports pubmed scopus science direct also american heart association journals nature jama bmj lancet journals using following termsace<NUMBER> coronavirus covid<NUMBER> <NUMBER>ncov covid<NUMBER> cvd cardiovascular risk diseases find articles published january <NUMBER> may <NUMBER> <NUMBER> old data inappropriate topics pertinent focused purpose study excluded studies information pertaining india taken ministry health government india data infection mortality survival covid<NUMBER> rapidly changing sarscov<NUMBER> spread predominantly via respiratory droplets transmission may occur symptomatic asymptomatic patients secondary infection rates ranging <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> demonstrated remain stable <NUMBER> median incubation time <NUMBER> days <NUMBER> experience symptoms within <NUMBER> days exposure <NUMBER> <NUMBER> common symptoms fever dry cough shared many viral syndromes conspicuously rhinorrhea diarrhea also reported covid<NUMBER> cases <NUMBER> reports china <NUMBER> demonstrate significant majority patients <NUMBER> mild symptoms pneumonia mild pneumonia covid<NUMBER> among significant symptoms people experienced severe symptoms dyspnea respiratory rate ≥<NUMBER>min blood oxygen saturation ≤<NUMBER> partial pressure arterial oxygen fraction inspired oxygen ratio <NUMBER> andor lung infiltrates <NUMBER> within <NUMBER> <NUMBER> hours <NUMBER> critical respiratory failure septic shock andor multiple organ dysfunction failure pathogen covid<NUMBER> detected upper lower respiratory tracts initial assessments also detected fecal blood samples exposure ace<NUMBER> target sarscov<NUMBER> invasion blocking combination virus ace<NUMBER> become one therapeutic directions approved drug regimen reported treat infected cases far however recently another proposed treatment chloroquine old drug treatment malaria suggested apparent effectiveness acceptable safety covid<NUMBER> associated pneumonia <NUMBER> <NUMBER> several drug trials ongoing currently proof hydroxychloroquine drug cure prevent covid <NUMBER> misuse hydroxychloroquine cause serious side effects illness even lead death coordinating efforts develop evaluate medicines treat covid<NUMBER> using monoclonal antibodies proven viral respiratory diseases influenza yet <NUMBER> table<NUMBER> raas well characterized hypertension heart failure beyond ace<NUMBER> involved heart function development hypertension diabetes mellitus ace converts angiotensin ang ang ii predominantly lungs effects ang ii dependent receptor binding at<NUMBER> receptor binding stimulates classical effects ang ii ranging increased oxidative stress vasoconstriction ace<NUMBER> enzyme attached cell membranes lungs endothelium heart well kidneys main pharmacological effect lower blood pressure catalysing cleavage ang ang <NUMBER> ang ii ang <NUMBER> vasodilatory antiinflammatory activity ace<NUMBER> additional affinity vasoactive substrates including apelin<NUMBER> bradykinin ace<NUMBER> strong affinity type <NUMBER> type <NUMBER> receptors ang ii regulates blood pressure humoral balance inflammation cell proliferation hypertrophy fibrosis moreover tissue specific expression ace<NUMBER> suggests reports sex difference exists men higher ace<NUMBER> levels higher circulating levels reported heart failure atrial fibrillation renal disease <NUMBER> sarscov<NUMBER> shares high sequence similarity use cell entry receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> severe acute respiratory syndrome coronavirus sarscov covid<NUMBER> patients preexisting heart disease may suffer heart attack develop congestive heart failure due combination severe viral illness increased demands heart increased heart rate compounded low oxygen levels due respiratory symptoms myocarditis increased propensity blood clot formation addition increase heart problems unusual condition called myocarditis also observed covid understanding underlying mechanisms greatest importance treatment patients timely effective mortality reduced clinical controversy whether use angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs might detrimental beneficial covid <NUMBER> two classes drugs widely prescribed patients hypertension cardiovascular disorders reported <NUMBER> work ace gene expression patients essential hypertension normal healthy population another study <NUMBER> reported role angiotensin type receptor patients essential hypertension normal healthy controls pathological physiological differential expression mrna protein levels individuals proposed stopping drugs due concern upregulation ace<NUMBER> receptor acting sarscov<NUMBER> entry point others paradoxically suggest prescribing class drugs counteract dysregulated angiotensinaldosterone system symptoms severe patients cvd might associated increased levels ace<NUMBER> patients compared healthy individuals links reninangiotensinaldosterone system raas ace<NUMBER> receptor specifically expanding observation hypertension prevalent among diagnosed covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> whether patients covid<NUMBER> hypertension taking ace inhibitor angiotensinreceptor blocker switch alternative antihypertensive therapy remains controversial investigation required antiviral treatments used alleviate disease symptoms studies remedesevir antiviral agent revealed vitro activity covid<NUMBER> virus safety proven umifenovir oseltamivir covid<NUMBER> virus interesting lacks biological plausibility many antiviral drugs cause cardiac insufficiency arrhythmia cardiovascular disorders antiviral drug induced heart damage covid<NUMBER> treatment major concern monitoring risk cardiac toxicity use antiviral drugs important study <NUMBER> patients covid<NUMBER> <NUMBER> given antiviral drug <NUMBER> <NUMBER> report huang et al <NUMBER> myocardial injury associated sarscov<NUMBER> found <NUMBER> first <NUMBER> patients diagnosed covid<NUMBER> wuhan patients elevated cardiac troponin hsctni levels <NUMBER> pgml levels report four five patients myocardial injury admitted intensivecare unit icu systolic blood pressure levels chest tightness rather respiratory symptoms fever later diagnosed covid<NUMBER> therefore patients covid<NUMBER> incidence cardiovascular symptoms high owing systemic inflammatory response immune system disorders disease progression exact mechanism cardiac involvement covid<NUMBER> remains unclear one potential mechanism direct myocardial involvement mediated via ace<NUMBER> ace<NUMBER> widely expressed lungs also cardiovascular system therefore ace<NUMBER>related signalling pathways might role heart injury proposed mechanisms myocardial injury include cytokine involvement <NUMBER> respiratory dysfunction caused covid<NUMBER> detrimental myocardial cells covid<NUMBER> patients appear heart attack instead suffering marked inflammation heart muscle called myocarditis clear whether myocarditis due direct effect virus heart muscle whether due overactive immune response virus doctors yet know best treat patients coronavirus disease <NUMBER> associated high inflammatory burden induce vascular inflammation myocarditis cardiac arrhythmias wu et al <NUMBER> reported <NUMBER>year followup survey <NUMBER> patients recovered sarscov infection <NUMBER> hyperlipidaemia <NUMBER> cardiovascular system abnormalities <NUMBER> glucose metabolism disorders patients serum concentrations free fatty acids lysophosphatidylcholine lysophosphatidylethanolamine phosphatidylglycerol significantly increased compared individuals without history sarscov infection <NUMBER> cannot ignore role ethnicity could also peculiar genetic characteristics population may impact susceptibility viral infection disease severity march <NUMBER> world health organisation declared rapidly spreading sarscov<NUMBER> virus outbreak pandemic novel coronavirus cause contagious acute respiratory disease covid <NUMBER> first reported wuhan hubei province china <NUMBER> <NUMBER> <NUMBER> <NUMBER> april <NUMBER> infected two million people spread <NUMBER> countries territories around world precise statistics mortality determined covid<NUMBER> deadly estimated <NUMBER> case fatality rate rate increases dramatically elderly vulnerable underlying health problems <NUMBER> <NUMBER> outbreak covid<NUMBER> placed unprecedented burden healthcare systems mostaffected countries resulted considerable economic losses possible deep global recession <NUMBER> <NUMBER> date vaccine effective treatment widely adopted strategy use nonpharmaceutical interventions npis social distancing even full lockdown order control spread virus ease pressure health care systems <NUMBER> <NUMBER> npis implemented many countries including china italy spain united kingdom uk netherlands measures shown considerably reduce new confirmed cases china south korea among others <NUMBER> key success npis timing interventions response population might differ among countries could necessitate interventions case low compliance either nationally locally therefore urgently require objective quantitative way monitor population behaviour assess impact response interventions additionally need monitor potential effects rebound cases winter months social distancing measures relaxed order strategise understand course corrections required similarly understanding potential seasonal forcing covid<NUMBER> require good understanding effects different npis factored increasing availability widebandwidth mobile networks smartphones wearable sensors makes possible collect nearrealtime highresolution datasets large numbers participants greatly facilitates remote monitoring behaviour <NUMBER> <NUMBER> <NUMBER> leveraging sensor modalities smartphones includes global positioning system gps tracking fitbit devices includes step counts heart rate possible access mobility even wellness population manage data collected multiple sensor modalities mobile devices platforms opensource radarbase radarbaseorg mobile health platform developed <NUMBER> platform used enable remote monitoring range use cases including central nervous system diseases major depressive disorder mdd epilepsy multiple sclerosis ms part imi<NUMBER> radarcns major programme radarcnsorg <NUMBER> paper explore utility radarbase platform toolbox test effect impact npis aimed limiting spread infectious diseases covid<NUMBER> specifically investigate parameters derived smartphones including gps phone usage wearable fitbit devices including step counts heart rate sleep patterns may altered changes lifestyle due npis social isolation leveraged participant data already collected november <NUMBER> onwards part ongoing radarcns studies <NUMBER> <NUMBER> <NUMBER> radarcns studies approved local ethics committees participants signed informed consent <NUMBER> included <NUMBER> participants recruited five european countries italy spain denmark uk netherlands data collected purpose finding new ways monitoring mdd spain <NUMBER> netherlands <NUMBER> uk <NUMBER> ms milan italy <NUMBER> barcelona spain <NUMBER> copenhagen denmark <NUMBER> using wearable devices smartphone technology improve patients quality life qol potentially change treatment chronic disorders focused countrylevel behavioural changes response npis aggregated data collected spain focus analysing differences participants mdd ms except sensitivity analysis described discussion passive participant data collected smartphone fitbit device included location activity sleep heart rate phone usage data passive data required minimal conscious participant engagement collected continuously <NUMBER> basis addition passive data active data collected required clinicians participants fill forms questionnaires perform short clinical tests eg speech walking balance tests data managed radarbase platform study physicalbehavioural changes response covid<NUMBER> npis examined participants mobility analysing relative gps data smartphones step count data fitbit devices investigated phone unlock duration social app duration study socialbehavioural changes functional measures sleep heart rate fitbit devices also analysed identify possible changes result social distancing smartphonederived gps data sampled frequency five minutes default lower frequency dependent network connectivity spurious gps coordinates identified removed differed preceding following coordinates five degrees home location determined daily clustering gps data <NUMBER> pm <NUMBER> mean coordinate largest cluster used clustering implemented using densitybased spatial clustering applications noise <NUMBER> duration gated two adjacent coordinates regarded valid homestay duration condition coordinates <NUMBER> meters home location duration longer one hour excluded due large proportion missing data compared fiveminute sampling frequency valid home stay durations <NUMBER> <NUMBER> pm summed calculate daily homestay daily maximum distance home also computed based coordinates period addition mobility features extracted smartphones intraday time series step count taken fitbit device likewise daily sleep duration computed summation four fitbitoutput stages awake light deep rem sampled every <NUMBER> seconds finally daily mean heart rate calculated averaging fitbitoutput heart rate readings sampled every five seconds explore changes phone usage daily unlock duration calculated summing time intervals starting unlocked state ending standby state single intervals longer four hours excluded might result missing standby state unintentionally leaving phone unlocked app usage quantified classifying apps according categories listed google play particularly interested cyber social interactions time social distancing focused daily use time social apps facebook instagram whatsapp visualised data using time series plots participant daily average standard deviation feature calculated plotted minimum <NUMBER> participants data points prerequisite calculation given day order reduce variance noise calculation implemented excluding zeros excluding values <NUMBER> <NUMBER> day filtering step helped mitigate influence daily outliers caused example missing data facilitate interpretation also marked time points public announcements related lockdown policies <NUMBER> examine physicaland socialbehavioural changes induced lockdowns comparisons among baseline pre postlockdown carried using kruskalwallis tests filtered daily average features <NUMBER> consecutive days used three groups <NUMBER> baseline phase chose either <NUMBER>day period around one year lockdowns earliest stable <NUMBER>day period prelockdown phase chose period immediately first restrictive measure postlockdown phase chose period following recent lockdown significant difference among three groups found posthoc dunn test applied bonferroni corrections <NUMBER> boxplots used present results pvalue <NUMBER>·<NUMBER> correction deemed statistically significant noted applied corrections resulting multiple comparisons given feature given country time series plots <NUMBER> february <NUMBER> <NUMBER> april <NUMBER> boxplots features shown figure <NUMBER> figure <NUMBER> ag figure <NUMBER> shows zoomin time series plots figure <NUMBER> <NUMBER> features except total sleep duration baseline prelockdown phases significantly different postlockdown phases italy homestay duration started increase lombardy went lockdown remained high levels national lockdown ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> similarly maximum distance home reduced low levels end march ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> fitbit step count ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> heart rate ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> decreased saw increase phone usage measured unlock duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> social app duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> spain lockdown imposed sudden marked increase homestay duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> reduction maximum distance home ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> reduction fitbit step count ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> phone interaction unlock duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> social app duration ztest statistics <NUMBER>·<NUMBER> p<NUMBER>·<NUMBER> denmark changes homestay duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> fitbit step count ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> less evident restrictions applied maximum distance home dropped sharply ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> uk starting one week national recommendation saw dramatic increase homestay duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> sharp decrease maximum distance home ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> similar changes observed phone interaction unlock duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> social app duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> fitbit step count ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> well netherlands increase homestay duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> decrease distance home ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> observed changes fitbit step count ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> phone usage unlock duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> social app duration ztest statistics <NUMBER>·<NUMBER> pvalue <NUMBER>·<NUMBER> less obvious compared italy spain uk figure <NUMBER> observed marked changes following two announcements addition national npis time series plots observed behavioural changes induced countryspecific npis announcements study investigated covid<NUMBER> related changes features derived mobile devices smartphones wearable fitbit devices participants recruited five european countries radarcns programme studied lockdown response covid<NUMBER> pandemic affected participant behaviour terms mobility functional measures phone usage results demonstrate countries lockdown significantly altered lifestyles albeit different ways participants spent time home travelled much less active phone interacting others using social apps however response across nations differed may related countryspecific implementations npis perceived degree risk national level participants spain put hard stop daily outdoor activity day national quarantine contrast participants denmark maintained usual daily routine findings also line google mobility reports <NUMBER> according reports updated <NUMBER> april italy spain uk saw less <NUMBER> decrease mobility trends except residential stay witnessed <NUMBER> increase contrary denmark netherlands showed <NUMBER> increase mobility trends parks addition <NUMBER> increase residential stays furthermore mobility trends grocery pharmacy witnessed <NUMBER> decrease netherlands <NUMBER> increase denmark difference changes extracted features may reflect difference communication implementations npis population reactions different coping strategies cultural differences comparison google mobility reports provide valuable aggregated data short periods radarbase opensource highly configurable platform allows collecting analysing participantlevel data realtime potential targeted interventions addition radarbase also collects selfreported questionnaires related emotional wellbeing functional status disease symptom severity participants <NUMBER> april <NUMBER> new questionnaires distributed specifically assess covid<NUMBER> symptoms diagnosis status research participants future work use entirety data gain additional insights digital early warning signs covid<NUMBER> impact covid<NUMBER> qol clinical trajectory primary diagnosis mdd ms speculate decrease heart rate may attributed increase indoor stay greater sedentary behaviour slight increase total sleep duration decrease coupled increase social app duration could possibly serve indicators social distancing furthermore shown elevated resting heart rate may suggest acute infections <NUMBER> would interesting infer ones infection continuously monitoring heart rate especially population remains indoor vast majority time monitoring provides possibility generate early warning signals symptomatic presymptomatic respiratory infections thereby aiding timely selfisolation treatment covid<NUMBER> related questionnaires distributing allow us gain deeper understanding relationship mobile devices derived features including heart rateactivity covid<NUMBER> symptoms addition changes trends also identified interesting findings happened short periods see figure <NUMBER> dramatic change unlock duration observed denmark around <NUMBER> march <NUMBER> may related announcement pending lockdown day <NUMBER> increase confirmed cases denmark previous day another example seen mitigation phase announced uk <NUMBER> march social distancing strongly recommended participants seemed isolate voluntarily staying home much longer observation may also explain significant difference baseline prelockdown phases suggests people may acted ahead government restriction furthermore accompanied marked loss weekdayweekend periodic structure prepost lockdown period see figure <NUMBER> together observations highlight potential remote monitoring monitor population reactions interventions issues consider relation work firstly used limited duration periods <NUMBER> days compare behaviour across three phases limitation lockdowns recently imposed however even short periods still able detect significant differences among three phases highlighting potential advantages using mobile devices detecting behaviour changes future work focus collecting analysing data project data collection ongoing second participants included study different medical conditions depression multiple sclerosis led different baseline levels across countries nevertheless focus study changes pre postlockdown phases relative baseline still able identify compare changes induced lockdowns also analysed data collected spain split mdd ms separately trends statistical differences features remained except total sleep duration unsplit case showed statistical significance ztest statistics <NUMBER>·<NUMBER> p <NUMBER>·<NUMBER> split case probably due reduced sample size split mdd ms understanding artefacts effects introduced radarcns data npis crucial radarcns able deliver aim identifying signals predict prevent mdd ms third account requirements participants privacy radarcns studies location data purposely obfuscated participantspecific random value preventing precise localisation participants prevented us taking account geographic factors within country would interesting examine specific regions react lockdowns data available future work fourth limited sample sizes certain countries data loss impacted smoothness time series plots time series plots denmark netherlands showed relatively large variance particularly early phase sites recently begun recruiting several dips spikes step counts heart rate seen countries july august due fact data loss due connectivity issues fitbit server time fifth explored subset features derived smartphones fitbit wearable devices future work investigate whether features offer additional information complete description lifestyle changes finally national policy participant acceptability determine value placed privacy therefore level monitoring acceptable one end spectrum seen individuallevel contact tracing mobile apps privacypreserving approaches allow population intervention monitoring able demonstrate value data collected even strict privacypreserving conditions using individuallevel data smartphones wearable devices oneyear period covering outbreak subsequent spread covid<NUMBER> pandemic across five european countries able detect monitor physicalbehavioural socialbehavioural changes response npis found participants spent time home travelled much less active phone particular interacting others using social apps also showed different responses across countries denmark showing attenuated responses npis compared countries furthermore able identify features homestay duration maximum distance home step count varied significantly implementation npis features could used objective measures evaluating aspects npis performance introduction subsequent relaxation measures work demonstrates value generalised opensource platform radarbase leverage data wearables mobile technologies understanding behavioural impact public health interventions implemented response infectious outbreaks covid<NUMBER> ability monitor response interventions near real time particularly important understanding behaviour social distancing measures relaxed part covid<NUMBER> exit strategy future work include utilising participants responses covid<NUMBER> related questionnaires together expanded feature set gain specific understandings relationship mobile devices derived features covid<NUMBER> symptoms 